Name	Gene(s)	Protein change	Condition(s)	Clinical significance (Last reviewed)	Review status	Accession	GRCh37Chromosome	GRCh37Location	GRCh38Chromosome	GRCh38Location	VariationID	AlleleID(s)	dbSNP ID	Canonical SPDI	
NM_012179.3(FBXO7):c.[274G>C];[520T>A]			Parkinson disease 15	Uncertain significance(Last reviewed: Aug 7, 2017)	no assertion criteria provided	VCV000433544					433544			
NM_000157.3(GBA):c.[1448T>C];[167T>G]			Gaucher disease type I	Likely pathogenic(Last reviewed: Sep 25, 2015)	no assertion criteria provided	VCV000424819					424819			
NM_000157.3(GBA):c.[1448T>C];[407C>T]			Gaucher disease type I	Likely pathogenic(Last reviewed: Sep 25, 2015)	no assertion criteria provided	VCV000424818					424818			
NM_019112.4(ABCA7):c.161-2A>T	ABCA7		Alzheimer disease, type 9	Uncertain significance	criteria provided, single submitter	VCV001339045	19	1041828	19	1041829	1339045	1330088		NC_000019.10:1041828:A:T
NM_019112.4(ABCA7):c.3641G>A (p.Trp1214Ter)	ABCA7	W1214*	not specified|not provided|Alzheimer disease, type 9	Conflicting interpretations of pathogenicity(Last reviewed: Dec 31, 2019)	criteria provided, conflicting interpretations	VCV000225545	19	1054255	19	1054256	225545	227448	rs201060968	NC_000019.10:1054255:G:A
NM_019112.3(ABCA7):c.2126_2132del (p.Glu709fs)	ABCA7	E709fs	not provided|Primary degenerative dementia of the Alzheimer type, presenile onset|Alzheimer disease, type 9	Conflicting interpretations of pathogenicity; risk factor(Last reviewed: Dec 31, 2019)	criteria provided, conflicting interpretations	VCV000225544	19	1047508 - 1047514	19	1047509 - 1047515	225544	227447	rs547447016	NC_000019.10:1047508:GGAGCAGGG:GG
NM_020297.4(ABCC9):c.448A>G (p.Ile150Val)	ABCC9	I150V	Wolff-Parkinson-White pattern	Uncertain significance(Last reviewed: Jul 14, 2017)	no assertion criteria provided	VCV000487606	12	22069996	12	21917062	487606	480711	rs1555117063	NC_000012.12:21917061:T:C
NM_020297.4(ABCC9):c.2019+2T>C	ABCC9		Wolff-Parkinson-White pattern	Likely pathogenic(Last reviewed: Jul 14, 2017)	no assertion criteria provided	VCV000487597	12	22035698	12	21882764	487597	480710	rs1555100687	NC_000012.12:21882763:A:G
NM_005159.5(ACTC1):c.524_525insC (p.Ala176fs)	ACTC1|GJD2-DT	A176fs	Wolff-Parkinson-White pattern	Likely pathogenic(Last reviewed: Jul 14, 2017)	no assertion criteria provided	VCV000487625	15	35084700 - 35084701	15	34792499 - 34792500	487625	480715	rs1555418832	NC_000015.10:34792499::G
NM_005159.5(ACTC1):c.944T>A (p.Met315Lys)	ACTC1|GJD2-DT	M315K	Wolff-Parkinson-White pattern	Uncertain significance(Last reviewed: Jul 14, 2017)	no assertion criteria provided	VCV000487590	15	35083361	15	34791160	487590	480714	rs1555418685	NC_000015.10:34791159:A:T
NM_001103.4(ACTN2):c.2075T>A (p.Ile692Asn)	ACTN2	I692N, I484N	Wolff-Parkinson-White pattern	Uncertain significance(Last reviewed: Jul 14, 2017)	no assertion criteria provided	VCV000487588	1	236918419	1	236755119	487588	480672	rs1553304459	NC_000001.11:236755118:T:A
GRCh37/hg19 7q36.1-36.2(chr7:151550461-153195115)x4	ACTR3B|GALNT11|GALNTL5|KMT2C|PRKAG2|XRCC2		not provided	Uncertain significance(Last reviewed: Jun 29, 2021)	criteria provided, single submitter	VCV001328456	7	151550461 - 153195115			1328456	1319071		
NM_000669.5(ADH1C):c.232G>T (p.Gly78Ter)	ADH1C	G78*	Parkinson disease, mitochondrial	risk factor(Last reviewed: Jan 1, 2005)	no assertion criteria provided	VCV000018181	4	100268190	4	99347033	18181	33220	rs283413	NC_000004.12:99347032:C:A
NM_000674.3(ADORA1):c.835G>A (p.Gly279Ser)	ADORA1	G279S, G163S, G211S	not provided	Uncertain significance(Last reviewed: Feb 22, 2017)	no assertion criteria provided	VCV000375733	1	203134882	1	203165754	375733	362618	rs748346254	NC_000001.11:203165753:G:A
NM_005751.5(AKAP9):c.10591C>G (p.Gln3531Glu)	AKAP9	Q3523E, Q3531E, Q1746E	Long QT syndrome|Wolff-Parkinson-White pattern	Uncertain significance(Last reviewed: May 30, 2019)	criteria provided, single submitter	VCV000487601	7	91727092	7	92097778	487601	480699	rs767137372	NC_000007.14:92097777:C:G
NM_005751.5(AKAP9):c.11297G>A (p.Arg3766Gln)	AKAP9	R3758Q, R3766Q, R1981Q	Long QT syndrome|Wolff-Parkinson-White pattern	Uncertain significance(Last reviewed: Aug 5, 2020)	criteria provided, single submitter	VCV000487596	7	91732107	7	92102793	487596	480700	rs137892407	NC_000007.14:92102792:G:A
NM_001097577.3(ANG):c.110A>G (p.His37Arg)	ANG|EGILA|RNASE4	H37R	not provided	Uncertain significance(Last reviewed: Sep 26, 2021)	criteria provided, single submitter	VCV001381736	14	21161833	14	20693674	1381736	1341695		NC_000014.9:20693673:A:G
NM_001148.6(ANK2):c.1427A>G (p.Gln476Arg)	ANK2	Q455R, Q476R, Q462R, Q491R, Q381R, Q410R, Q406R, Q447R, Q464R, Q472R, Q485R, Q493R	Wolff-Parkinson-White pattern|Long QT syndrome	Uncertain significance(Last reviewed: Mar 9, 2018)	criteria provided, single submitter	VCV000487619	4	114186093	4	113264937	487619	480686	rs1203193073	NC_000004.12:113264936:A:G
NM_001148.6(ANK2):c.742G>A (p.Val248Met)	ANK2	V227M, V248M, V244M, V263M, V219M, V234M, V236M, V257M, V265M	Long QT syndrome|Wolff-Parkinson-White pattern	Uncertain significance(Last reviewed: Oct 14, 2021)	criteria provided, single submitter	VCV000487591	4	114161689	4	113240533	487591	480685	rs752395758	NC_000004.12:113240532:G:A
NM_001148.6(ANK2):c.11692A>G (p.Lys3898Glu)	ANK2	K1804E, K1813E, K3898E, K1742E, K1747E, K1758E, K1759E, K1792E, K1817E, K1822E, K1856E, K1001E, K1713E, K1726E, K1766E, K1780E, K1811E, K1812E, K1685E, K1718E, K1738E, K1751E, K1770E, K1779E, K1791E, K1803E, K1806E, K1823E, K1827E, K1834E, K1843E, K1858E, K989E, K996E, K1796E, K1828E, K1839E, K1652E, K1735E, K1740E, K1749E, K1755E, K1761E, K1768E, K1771E, K1808E, K1859E, K2698E, K3820E, K3968E, K3976E, K644E	Wolff-Parkinson-White pattern	Uncertain significance(Last reviewed: Jul 14, 2017)	no assertion criteria provided	VCV000487587	4	114294327	4	113373171	487587	480687	rs1554597130	NC_000004.12:113373170:A:G
NM_000543.5(SMPD1):c.1826GCC[1] (p.Arg610del)	APBB1|SMPD1	R610del, R303del, R609del, R566del	Niemann-Pick disease, type A|Niemann-Pick disease, type A|Niemann-Pick disease, type B|not specified|Niemann-Pick disease, type B|Sphingomyelin/cholesterol lipidosis|not provided	Pathogenic(Last reviewed: Oct 8, 2020)	criteria provided, multiple submitters, no conflicts	VCV000198093	11	6415767 - 6415769	11	6394537 - 6394539	198093	195254	rs120074118	NC_000011.10:6394536:GCCGCC:GCC
NC_000009.11:g.(?_34458994)_(35072710_?)dup	ARID3C|C9orf131|CCL19|CCL21|CCL27|CNTFR|DCTN3|DNAI1|DNAJB5|ENHO|FAM205A|GALT|IL11RA|PHF24|RPP25L|SIGMAR1|VCP		Distal spinal muscular atrophy, autosomal recessive 2|Amyotrophic lateral sclerosis 16, juvenile|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia	Uncertain significance(Last reviewed: Jul 29, 2020)	criteria provided, single submitter	VCV001042271	9	34458994 - 35072710			1042271	1022311		
NM_000487.6(ARSA):c.1325A>G (p.Asn442Ser)	ARSA	N356S, N442S	Metachromatic leukodystrophy|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Sep 27, 2021)	criteria provided, conflicting interpretations	VCV000726836	22	51063778	22	50625350	726836	743043	rs6151427	NC_000022.11:50625349:T:C
NM_177924.5(ASAH1):c.1004C>T (p.Thr335Met)	ASAH1	T270M, T329M, T351M, T335M	not provided|Farber lipogranulomatosis	Conflicting interpretations of pathogenicity(Last reviewed: Jan 27, 2022)	criteria provided, conflicting interpretations	VCV000691802	8	17916887	8	18059378	691802	679517	rs147233112	NC_000008.11:18059377:G:A
NM_022089.4(ATP13A2):c.1542+11A>G	ATP13A2		Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome	Likely benign(Last reviewed: Nov 8, 2021)	criteria provided, single submitter	VCV001667792	1	17322460	1	16995965	1667792	1657075		NC_000001.11:16995964:T:C
NM_022089.4(ATP13A2):c.2592C>T (p.Cys864=)	ATP13A2		Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome	Likely benign(Last reviewed: Nov 30, 2021)	criteria provided, single submitter	VCV001667404	1	17316203	1	16989708	1667404	1591342		NC_000001.11:16989707:G:A
NM_022089.4(ATP13A2):c.908-20C>T	ATP13A2		Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome	Likely benign(Last reviewed: Jun 2, 2021)	criteria provided, single submitter	VCV001663956	1	17326657	1	17000162	1663956	1588778		NC_000001.11:17000161:G:A
NM_022089.4(ATP13A2):c.3084-16A>T	ATP13A2		Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome	Likely benign(Last reviewed: Oct 24, 2021)	criteria provided, single submitter	VCV001663594	1	17313467	1	16986972	1663594	1588417		NC_000001.11:16986971:T:A
NM_022089.4(ATP13A2):c.144C>T (p.Ile48=)	ATP13A2		Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome	Likely benign(Last reviewed: Dec 26, 2020)	criteria provided, single submitter	VCV001660504	1	17332013	1	17005518	1660504	1575827		NC_000001.11:17005517:G:A
NM_022089.4(ATP13A2):c.3174C>T (p.Tyr1058=)	ATP13A2		Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome	Likely benign(Last reviewed: Aug 16, 2021)	criteria provided, single submitter	VCV001657355	1	17313361	1	16986866	1657355	1628519		NC_000001.11:16986865:G:A
NM_022089.4(ATP13A2):c.635+15G>A	ATP13A2		Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome	Benign(Last reviewed: Oct 23, 2021)	criteria provided, single submitter	VCV001657063	1	17328776	1	17002281	1657063	1562447		NC_000001.11:17002280:C:T
NM_022089.4(ATP13A2):c.1563C>T (p.Asp521=)	ATP13A2		Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome	Likely benign(Last reviewed: Oct 5, 2021)	criteria provided, single submitter	VCV001653694	1	17320310	1	16993815	1653694	1614044		NC_000001.11:16993814:G:A
NM_022089.4(ATP13A2):c.2340C>T (p.His780=)	ATP13A2		Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome	Likely benign(Last reviewed: Oct 14, 2021)	criteria provided, single submitter	VCV001652400	1	17316694	1	16990199	1652400	1664313		NC_000001.11:16990198:G:A
NM_022089.4(ATP13A2):c.1542+13G>A	ATP13A2		Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive	Likely benign(Last reviewed: Apr 2, 2021)	criteria provided, single submitter	VCV001651016	1	17322458	1	16995963	1651016	1578391		NC_000001.11:16995962:C:T
NM_022089.4(ATP13A2):c.288+12G>T	ATP13A2		Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome	Likely benign(Last reviewed: Jun 18, 2021)	criteria provided, single submitter	VCV001648317	1	17331857	1	17005362	1648317	1535013		NC_000001.11:17005361:C:A
NM_022089.4(ATP13A2):c.3144C>T (p.Thr1048=)	ATP13A2		Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive	Likely benign(Last reviewed: Jul 21, 2021)	criteria provided, single submitter	VCV001640924	1	17313391	1	16986896	1640924	1550595		NC_000001.11:16986895:G:A
NM_022089.4(ATP13A2):c.1104A>G (p.Thr368=)	ATP13A2		Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive	Likely benign(Last reviewed: May 4, 2021)	criteria provided, single submitter	VCV001640923	1	17323606	1	16997111	1640923	1550594		NC_000001.11:16997110:T:C
NM_022089.4(ATP13A2):c.1307-20G>T	ATP13A2		Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive	Likely benign(Last reviewed: Mar 16, 2021)	criteria provided, single submitter	VCV001639764	1	17322815	1	16996320	1639764	1571184		NC_000001.11:16996319:C:A
NM_022089.4(ATP13A2):c.1314C>T (p.Leu438=)	ATP13A2		Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive	Likely benign(Last reviewed: Dec 4, 2021)	criteria provided, single submitter	VCV001639563	1	17322788	1	16996293	1639563	1647151		NC_000001.11:16996292:G:A
NM_022089.4(ATP13A2):c.1845+15G>A	ATP13A2		Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome	Likely benign(Last reviewed: May 20, 2021)	criteria provided, single submitter	VCV001638665	1	17318966	1	16992471	1638665	1624351		NC_000001.11:16992470:C:T
NM_022089.4(ATP13A2):c.1195+18G>C	ATP13A2		Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome	Likely benign(Last reviewed: Oct 13, 2021)	criteria provided, single submitter	VCV001638650	1	17323497	1	16997002	1638650	1624336		NC_000001.11:16997001:C:G
NM_022089.4(ATP13A2):c.1857G>A (p.Pro619=)	ATP13A2		Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome	Likely benign(Last reviewed: Nov 4, 2021)	criteria provided, single submitter	VCV001637296	1	17318886	1	16992391	1637296	1525324		NC_000001.11:16992390:C:T
NM_022089.4(ATP13A2):c.288+16A>T	ATP13A2		Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive	Likely benign(Last reviewed: Oct 21, 2021)	criteria provided, single submitter	VCV001636931	1	17331853	1	17005358	1636931	1612220		NC_000001.11:17005357:T:A
NM_022089.4(ATP13A2):c.636-19G>A	ATP13A2		Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive	Likely benign(Last reviewed: Nov 27, 2021)	criteria provided, single submitter	VCV001636392	1	17328617	1	17002122	1636392	1558299		NC_000001.11:17002121:C:T
NM_022089.4(ATP13A2):c.1663C>T (p.Leu555=)	ATP13A2		Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive	Likely benign(Last reviewed: Jun 24, 2021)	criteria provided, single submitter	VCV001636171	1	17320210	1	16993715	1636171	1644196		NC_000001.11:16993714:G:A
NM_022089.4(ATP13A2):c.558-11C>T	ATP13A2		Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive	Likely benign(Last reviewed: Jul 13, 2021)	criteria provided, single submitter	VCV001634843	1	17328879	1	17002384	1634843	1546795		NC_000001.11:17002383:G:A
NM_022089.4(ATP13A2):c.3411G>C (p.Val1137=)	ATP13A2	A1037P	Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive	Likely benign(Last reviewed: Aug 6, 2021)	criteria provided, single submitter	VCV001634070	1	17312848	1	16986353	1634070	1632158		NC_000001.11:16986352:C:G
NM_022089.4(ATP13A2):c.2478C>T (p.Ser826=)	ATP13A2		Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome	Likely benign(Last reviewed: Aug 20, 2021)	criteria provided, single submitter	VCV001631445	1	17316433	1	16989938	1631445	1597249		NC_000001.11:16989937:G:A
NM_022089.4(ATP13A2):c.2481G>T (p.Gly827=)	ATP13A2		Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome	Likely benign(Last reviewed: Sep 29, 2021)	criteria provided, single submitter	VCV001631305	1	17316430	1	16989935	1631305	1543716		NC_000001.11:16989934:C:A
NM_022089.4(ATP13A2):c.1307-13G>A	ATP13A2		Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome	Likely benign(Last reviewed: Jan 14, 2021)	criteria provided, single submitter	VCV001628932	1	17322808	1	16996313	1628932	1617523		NC_000001.11:16996312:C:T
NM_022089.4(ATP13A2):c.635+19C>T	ATP13A2		Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome	Likely benign(Last reviewed: Nov 10, 2021)	criteria provided, single submitter	VCV001625381	1	17328772	1	17002277	1625381	1606942		NC_000001.11:17002276:G:A
NM_022089.4(ATP13A2):c.908-14C>T	ATP13A2		Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive	Likely benign(Last reviewed: Nov 19, 2021)	criteria provided, single submitter	VCV001624131	1	17326651	1	17000156	1624131	1562970		NC_000001.11:17000155:G:A
NM_022089.4(ATP13A2):c.558-20C>T	ATP13A2		Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive	Likely benign(Last reviewed: Oct 8, 2021)	criteria provided, single submitter	VCV001623781	1	17328888	1	17002393	1623781	1594548		NC_000001.11:17002392:G:A
NM_022089.4(ATP13A2):c.1543-15_1543-12del	ATP13A2		Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive	Likely benign(Last reviewed: May 26, 2021)	criteria provided, single submitter	VCV001618915	1	17320342 - 17320345	1	16993847 - 16993850	1618915	1548690		NC_000001.11:16993846:AGGT:
NM_022089.4(ATP13A2):c.2136G>A (p.Val712=)	ATP13A2		Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive	Likely benign(Last reviewed: Dec 2, 2021)	criteria provided, single submitter	VCV001617283	1	17318344	1	16991849	1617283	1548360		NC_000001.11:16991848:C:T
NM_022089.4(ATP13A2):c.153C>T (p.His51=)	ATP13A2		Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive	Likely benign(Last reviewed: Mar 25, 2021)	criteria provided, single submitter	VCV001616590	1	17332004	1	17005509	1616590	1526780		NC_000001.11:17005508:G:A
NM_022089.4(ATP13A2):c.3405+10G>A	ATP13A2		Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive	Likely benign(Last reviewed: Dec 2, 2021)	criteria provided, single submitter	VCV001616474	1	17312948	1	16986453	1616474	1526664		NC_000001.11:16986452:C:T
NM_022089.4(ATP13A2):c.2043A>G (p.Thr681=)	ATP13A2		Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive	Likely benign(Last reviewed: Oct 19, 2021)	criteria provided, single submitter	VCV001616154	1	17318587	1	16992092	1616154	1613874		NC_000001.11:16992091:T:C
NM_022089.4(ATP13A2):c.1095T>C (p.Cys365=)	ATP13A2		Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome	Likely benign(Last reviewed: Oct 21, 2021)	criteria provided, single submitter	VCV001612205	1	17323615	1	16997120	1612205	1535833		NC_000001.11:16997119:A:G
NM_022089.4(ATP13A2):c.1900C>G (p.Leu634Val)	ATP13A2	L629V, L634V	Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome	Likely benign(Last reviewed: Oct 14, 2021)	criteria provided, single submitter	VCV001611981	1	17318843	1	16992348	1611981	1535609		NC_000001.11:16992347:G:C
NM_022089.4(ATP13A2):c.1437G>A (p.Val479=)	ATP13A2		Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome	Likely benign(Last reviewed: Jan 13, 2021)	criteria provided, single submitter	VCV001609601	1	17322576	1	16996081	1609601	1639114		NC_000001.11:16996080:C:T
NM_022089.4(ATP13A2):c.3235+20C>T	ATP13A2		Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive	Likely benign(Last reviewed: Dec 2, 2021)	criteria provided, single submitter	VCV001608110	1	17313280	1	16986785	1608110	1539549		NC_000001.11:16986784:G:A
NM_022089.4(ATP13A2):c.3405+7C>T	ATP13A2		Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive	Likely benign(Last reviewed: Sep 17, 2021)	criteria provided, single submitter	VCV001605204	1	17312951	1	16986456	1605204	1537532		NC_000001.11:16986455:G:A
NM_022089.4(ATP13A2):c.429G>A (p.Lys143=)	ATP13A2		Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive	Likely benign(Last reviewed: Mar 1, 2021)	criteria provided, single submitter	VCV001598452	1	17331235	1	17004740	1598452	1630451		NC_000001.11:17004739:C:T
NM_022089.4(ATP13A2):c.706-4C>A	ATP13A2		Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive	Likely benign(Last reviewed: Aug 23, 2021)	criteria provided, single submitter	VCV001597538	1	17327033	1	17000538	1597538	1570677		NC_000001.11:17000537:G:T
NM_022089.4(ATP13A2):c.2083C>T (p.Leu695=)	ATP13A2		Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive	Likely benign(Last reviewed: Aug 31, 2021)	criteria provided, single submitter	VCV001595900	1	17318547	1	16992052	1595900	1569476		NC_000001.11:16992051:G:A
NM_022089.4(ATP13A2):c.3235+16C>T	ATP13A2		Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive	Likely benign(Last reviewed: Aug 17, 2021)	criteria provided, single submitter	VCV001595469	1	17313284	1	16986789	1595469	1656459		NC_000001.11:16986788:G:A
NM_022089.4(ATP13A2):c.642C>T (p.Ala214=)	ATP13A2		Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive	Likely benign(Last reviewed: Dec 26, 2020)	criteria provided, single submitter	VCV001595035	1	17328592	1	17002097	1595035	1590675		NC_000001.11:17002096:G:A
NM_022089.4(ATP13A2):c.3360G>C (p.Leu1120=)	ATP13A2		Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive	Likely benign(Last reviewed: Oct 28, 2021)	criteria provided, single submitter	VCV001594714	1	17313003	1	16986508	1594714	1621838		NC_000001.11:16986507:C:G
NM_022089.4(ATP13A2):c.2252-18T>C	ATP13A2		Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive	Likely benign(Last reviewed: Apr 2, 2021)	criteria provided, single submitter	VCV001591818	1	17316800	1	16990305	1591818	1577934		NC_000001.11:16990304:A:G
NM_022089.4(ATP13A2):c.1039+11A>G	ATP13A2		Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome	Likely benign(Last reviewed: Oct 25, 2021)	criteria provided, single submitter	VCV001588963	1	17326495	1	17000000	1588963	1553871		NC_000001.11:16999999:T:C
NM_022089.4(ATP13A2):c.3462C>T (p.Ala1154=)	ATP13A2	L1054F	Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive	Likely benign(Last reviewed: Oct 23, 2021)	criteria provided, single submitter	VCV001586487	1	17312797	1	16986302	1586487	1562645		NC_000001.11:16986301:G:A
NM_022089.4(ATP13A2):c.2529+7C>T	ATP13A2		Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive	Likely benign(Last reviewed: Feb 1, 2021)	criteria provided, single submitter	VCV001586079	1	17316375	1	16989880	1586079	1593724		NC_000001.11:16989879:G:A
NM_022089.4(ATP13A2):c.1196-14C>T	ATP13A2		Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive	Likely benign(Last reviewed: Dec 2, 2021)	criteria provided, single submitter	VCV001585449	1	17323005	1	16996510	1585449	1539965		NC_000001.11:16996509:G:A
NM_022089.4(ATP13A2):c.2119C>T (p.Leu707=)	ATP13A2		Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive	Likely benign(Last reviewed: Dec 3, 2020)	criteria provided, single submitter	VCV001584183	1	17318511	1	16992016	1584183	1581441		NC_000001.11:16992015:G:A
NM_022089.4(ATP13A2):c.1215G>T (p.Gly405=)	ATP13A2		Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive	Likely benign(Last reviewed: Apr 29, 2021)	criteria provided, single submitter	VCV001583884	1	17322972	1	16996477	1583884	1528330		NC_000001.11:16996476:C:A
NM_022089.4(ATP13A2):c.1750-20C>G	ATP13A2		Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome	Likely benign(Last reviewed: Jun 3, 2021)	criteria provided, single submitter	VCV001582453	1	17319096	1	16992601	1582453	1566723		NC_000001.11:16992600:G:C
NM_022089.4(ATP13A2):c.706-16C>T	ATP13A2		Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome	Likely benign(Last reviewed: Jul 3, 2021)	criteria provided, single submitter	VCV001578804	1	17327045	1	17000550	1578804	1652486		NC_000001.11:17000549:G:A
NM_022089.4(ATP13A2):c.2530-14C>A	ATP13A2		Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive	Likely benign(Last reviewed: Aug 23, 2021)	criteria provided, single submitter	VCV001577085	1	17316279	1	16989784	1577085	1639942		NC_000001.11:16989783:G:T
NM_022089.4(ATP13A2):c.2762+19G>C	ATP13A2		Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome	Likely benign(Last reviewed: Apr 25, 2021)	criteria provided, single submitter	VCV001574914	1	17314798	1	16988303	1574914	1585237		NC_000001.11:16988302:C:G
NM_022089.4(ATP13A2):c.1704C>T (p.Pro568=)	ATP13A2		Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome	Likely benign(Last reviewed: Mar 24, 2021)	criteria provided, single submitter	VCV001574855	1	17320169	1	16993674	1574855	1585179		NC_000001.11:16993673:G:A
NM_022089.4(ATP13A2):c.2538C>G (p.Val846=)	ATP13A2		Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome	Likely benign(Last reviewed: Jul 22, 2021)	criteria provided, single submitter	VCV001573370	1	17316257	1	16989762	1573370	1637085		NC_000001.11:16989761:G:C
NM_022089.4(ATP13A2):c.706-13G>A	ATP13A2		Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive	Likely benign(Last reviewed: Nov 23, 2021)	criteria provided, single submitter	VCV001572612	1	17327042	1	17000547	1572612	1658231		NC_000001.11:17000546:C:T
NM_022089.4(ATP13A2):c.3081A>G (p.Pro1027=)	ATP13A2		Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive	Likely benign(Last reviewed: Nov 3, 2021)	criteria provided, single submitter	VCV001569109	1	17313543	1	16987048	1569109	1603657		NC_000001.11:16987047:T:C
NM_022089.4(ATP13A2):c.1665G>A (p.Leu555=)	ATP13A2		Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive	Likely benign(Last reviewed: Aug 23, 2021)	criteria provided, single submitter	VCV001567755	1	17320208	1	16993713	1567755	1657263		NC_000001.11:16993712:C:T
NM_022089.4(ATP13A2):c.1182G>T (p.Val394=)	ATP13A2		Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive	Likely benign(Last reviewed: Nov 23, 2021)	criteria provided, single submitter	VCV001567631	1	17323528	1	16997033	1567631	1591791		NC_000001.11:16997032:C:A
NM_022089.4(ATP13A2):c.208C>T (p.Leu70=)	ATP13A2		Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive	Likely benign(Last reviewed: Dec 10, 2021)	criteria provided, single submitter	VCV001567403	1	17331949	1	17005454	1567403	1591563		NC_000001.11:17005453:G:A
NM_022089.4(ATP13A2):c.3236-13C>G	ATP13A2		Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome	Likely benign(Last reviewed: Sep 15, 2021)	criteria provided, single submitter	VCV001567047	1	17313140	1	16986645	1567047	1622689		NC_000001.11:16986644:G:C
NM_022089.4(ATP13A2):c.1975C>T (p.Leu659=)	ATP13A2		Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive	Likely benign(Last reviewed: Dec 13, 2021)	criteria provided, single submitter	VCV001564022	1	17318768	1	16992273	1564022	1589043		NC_000001.11:16992272:G:A
NM_022089.4(ATP13A2):c.24C>A (p.Leu8=)	ATP13A2		Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive	Likely benign(Last reviewed: Nov 14, 2021)	criteria provided, single submitter	VCV001556967	1	17332260	1	17005765	1556967	1561626		NC_000001.11:17005764:G:T
NM_022089.4(ATP13A2):c.1845+17C>T	ATP13A2		Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome	Likely benign(Last reviewed: Dec 2, 2021)	criteria provided, single submitter	VCV001553232	1	17318964	1	16992469	1553232	1553016		NC_000001.11:16992468:G:A
NM_022089.4(ATP13A2):c.585C>T (p.Asp195=)	ATP13A2		Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive	Likely benign(Last reviewed: May 30, 2021)	criteria provided, single submitter	VCV001550367	1	17328841	1	17002346	1550367	1659303		NC_000001.11:17002345:G:A
NM_022089.4(ATP13A2):c.2723C>T (p.Ser908Leu)	ATP13A2	S864L, S903L, S908L	Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive	Likely benign(Last reviewed: Nov 12, 2021)	criteria provided, single submitter	VCV001548582	1	17314856	1	16988361	1548582	1657949		NC_000001.11:16988360:G:A
NM_022089.4(ATP13A2):c.942C>T (p.Pro314=)	ATP13A2		Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive	Likely benign(Last reviewed: Oct 25, 2021)	criteria provided, single submitter	VCV001547876	1	17326603	1	17000108	1547876	1537694		NC_000001.11:17000107:G:A
NM_022089.4(ATP13A2):c.348-16T>C	ATP13A2		Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome	Likely benign(Last reviewed: Apr 13, 2021)	criteria provided, single submitter	VCV001546784	1	17331332	1	17004837	1546784	1645760		NC_000001.11:17004836:A:G
NM_022089.4(ATP13A2):c.106-4G>A	ATP13A2		Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive	Likely benign(Last reviewed: Jun 21, 2021)	criteria provided, single submitter	VCV001542197	1	17332055	1	17005560	1542197	1545951		NC_000001.11:17005559:C:T
NM_022089.4(ATP13A2):c.1233C>A (p.Ile411=)	ATP13A2		Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive	Likely benign(Last reviewed: Dec 26, 2020)	criteria provided, single submitter	VCV001540795	1	17322954	1	16996459	1540795	1609197		NC_000001.11:16996458:G:T
NM_022089.4(ATP13A2):c.2763-17C>T	ATP13A2		Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive	Likely benign(Last reviewed: Jul 30, 2021)	criteria provided, single submitter	VCV001539638	1	17314746	1	16988251	1539638	1660564		NC_000001.11:16988250:G:A
NM_022089.4(ATP13A2):c.192C>T (p.Leu64=)	ATP13A2		Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome	Likely benign(Last reviewed: May 20, 2021)	criteria provided, single submitter	VCV001537220	1	17331965	1	17005470	1537220	1596813		NC_000001.11:17005469:G:A
NM_022089.4(ATP13A2):c.219G>A (p.Val73=)	ATP13A2		Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome	Likely benign(Last reviewed: Oct 13, 2021)	criteria provided, single submitter	VCV001537192	1	17331938	1	17005443	1537192	1596785		NC_000001.11:17005442:C:T
NM_022089.4(ATP13A2):c.2673C>T (p.Val891=)	ATP13A2		Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome	Likely benign(Last reviewed: Dec 10, 2021)	criteria provided, single submitter	VCV001536998	1	17314906	1	16988411	1536998	1533282		NC_000001.11:16988410:G:A
NM_022089.4(ATP13A2):c.2556C>T (p.Ala852=)	ATP13A2		Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome	Likely benign(Last reviewed: Oct 19, 2021)	criteria provided, single submitter	VCV001534253	1	17316239	1	16989744	1534253	1647821		NC_000001.11:16989743:G:A
NM_022089.4(ATP13A2):c.975G>A (p.Gly325=)	ATP13A2		Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome	Likely benign(Last reviewed: Jan 1, 2021)	criteria provided, single submitter	VCV001530787	1	17326570	1	17000075	1530787	1635259		NC_000001.11:17000074:C:T
NM_022089.4(ATP13A2):c.2049T>C (p.Ala683=)	ATP13A2		Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome	Likely benign(Last reviewed: Nov 24, 2021)	criteria provided, single submitter	VCV001530071	1	17318581	1	16992086	1530071	1665427		NC_000001.11:16992085:A:G
NM_022089.4(ATP13A2):c.599C>G (p.Ser200Cys)	ATP13A2	S200C, S195C	Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome	Uncertain significance(Last reviewed: Aug 30, 2021)	criteria provided, single submitter	VCV001525431	1	17328827	1	17002332	1525431	1359889		NC_000001.11:17002331:G:C
NM_022089.4(ATP13A2):c.3083+2T>C	ATP13A2		Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome	Likely pathogenic(Last reviewed: Oct 26, 2021)	criteria provided, single submitter	VCV001523588	1	17313539	1	16987044	1523588	1346885		NC_000001.11:16987043:A:G
NM_022089.4(ATP13A2):c.3320C>T (p.Ala1107Val)	ATP13A2	A1102V, A1107V	Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive	Uncertain significance(Last reviewed: Oct 28, 2021)	criteria provided, single submitter	VCV001521402	1	17313043	1	16986548	1521402	1347297		NC_000001.11:16986547:G:A
NM_022089.4(ATP13A2):c.340G>A (p.Glu114Lys)	ATP13A2	E114K	Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive	Uncertain significance(Last reviewed: Aug 28, 2021)	criteria provided, single submitter	VCV001520997	1	17331516	1	17005021	1520997	1446650		NC_000001.11:17005020:C:T
NM_022089.4(ATP13A2):c.25G>A (p.Val9Met)	ATP13A2	V9M	Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive	Uncertain significance(Last reviewed: Aug 5, 2021)	criteria provided, single submitter	VCV001518330	1	17332259	1	17005764	1518330	1508723		NC_000001.11:17005763:C:T
NM_022089.4(ATP13A2):c.13A>G (p.Ser5Gly)	ATP13A2	S5G	Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive	Uncertain significance(Last reviewed: Sep 24, 2021)	criteria provided, single submitter	VCV001517525	1	17332271	1	17005776	1517525	1420428		NC_000001.11:17005775:T:C
NM_022089.4(ATP13A2):c.904G>A (p.Gly302Arg)	ATP13A2	G297R, G302R	Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive	Uncertain significance(Last reviewed: Aug 27, 2021)	criteria provided, single submitter	VCV001515925	1	17326744	1	17000249	1515925	1407203		NC_000001.11:17000248:C:T
NM_022089.4(ATP13A2):c.1795G>A (p.Val599Ile)	ATP13A2	V599I, V594I	Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome	Uncertain significance(Last reviewed: Nov 7, 2021)	criteria provided, single submitter	VCV001513126	1	17319031	1	16992536	1513126	1472181		NC_000001.11:16992535:C:T
NM_022089.4(ATP13A2):c.395C>T (p.Ala132Val)	ATP13A2	A132V	Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome	Uncertain significance(Last reviewed: Dec 15, 2021)	criteria provided, single submitter	VCV001511695	1	17331269	1	17004774	1511695	1459175		NC_000001.11:17004773:G:A
NM_022089.4(ATP13A2):c.1762G>A (p.Glu588Lys)	ATP13A2	E583K, E588K	Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome	Uncertain significance(Last reviewed: Aug 16, 2021)	criteria provided, single submitter	VCV001511423	1	17319064	1	16992569	1511423	1458904		NC_000001.11:16992568:C:T
NM_022089.4(ATP13A2):c.1846-2A>G	ATP13A2		Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome	Likely pathogenic(Last reviewed: Jul 13, 2021)	criteria provided, single submitter	VCV001510691	1	17318899	1	16992404	1510691	1465368		NC_000001.11:16992403:T:C
NM_022089.4(ATP13A2):c.3215G>A (p.Arg1072His)	ATP13A2	R1028H, R1067H, R1072H	Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome	Uncertain significance(Last reviewed: Aug 28, 2021)	criteria provided, single submitter	VCV001508485	1	17313320	1	16986825	1508485	1439696		NC_000001.11:16986824:C:T
NM_022089.4(ATP13A2):c.3001G>A (p.Val1001Met)	ATP13A2	V1001M, V996M, V957M	Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome	Uncertain significance(Last reviewed: Sep 24, 2021)	criteria provided, single submitter	VCV001508283	1	17313623	1	16987128	1508283	1442934		NC_000001.11:16987127:C:T
NM_022089.4(ATP13A2):c.1897G>T (p.Ala633Ser)	ATP13A2	A628S, A633S	Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome	Uncertain significance(Last reviewed: Oct 4, 2021)	criteria provided, single submitter	VCV001507857	1	17318846	1	16992351	1507857	1352316		NC_000001.11:16992350:C:A
NM_022089.4(ATP13A2):c.3408C>A (p.Ser1136Arg)	ATP13A2	R1036S, S1131R, S1136R	Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome	Uncertain significance(Last reviewed: Nov 19, 2021)	criteria provided, single submitter	VCV001492619	1	17312851	1	16986356	1492619	1516757		NC_000001.11:16986355:G:T
NM_022089.4(ATP13A2):c.3458G>C (p.Arg1153Pro)	ATP13A2	R1153P, R1148P	Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome	Uncertain significance(Last reviewed: Oct 30, 2021)	criteria provided, single submitter	VCV001490725	1	17312801	1	16986306	1490725	1511832		NC_000001.11:16986305:C:G
NM_022089.4(ATP13A2):c.3065T>C (p.Leu1022Pro)	ATP13A2	L978P, L1017P, L1022P	Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome	Uncertain significance(Last reviewed: Sep 1, 2021)	criteria provided, single submitter	VCV001490564	1	17313559	1	16987064	1490564	1433633		NC_000001.11:16987063:A:G
NM_022089.4(ATP13A2):c.2479G>A (p.Gly827Arg)	ATP13A2	G822R, G827R	Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome	Uncertain significance(Last reviewed: Sep 15, 2021)	criteria provided, single submitter	VCV001490249	1	17316432	1	16989937	1490249	1433318		NC_000001.11:16989936:C:T
NM_022089.4(ATP13A2):c.1856C>T (p.Pro619Leu)	ATP13A2	P614L, P619L	Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome	Uncertain significance(Last reviewed: Sep 17, 2021)	criteria provided, single submitter	VCV001490128	1	17318887	1	16992392	1490128	1515121		NC_000001.11:16992391:G:A
NM_022089.4(ATP13A2):c.148T>C (p.Tyr50His)	ATP13A2	Y50H	Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome	Uncertain significance(Last reviewed: Aug 31, 2021)	criteria provided, single submitter	VCV001490071	1	17332009	1	17005514	1490071	1515064		NC_000001.11:17005513:A:G
NM_022089.4(ATP13A2):c.401T>C (p.Val134Ala)	ATP13A2	V134A	Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive	Uncertain significance(Last reviewed: Oct 4, 2021)	criteria provided, single submitter	VCV001489238	1	17331263	1	17004768	1489238	1498730		NC_000001.11:17004767:A:G
NM_022089.4(ATP13A2):c.2905G>A (p.Val969Ile)	ATP13A2	V964I, V925I, V969I	Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive	Uncertain significance(Last reviewed: Sep 1, 2021)	criteria provided, single submitter	VCV001487275	1	17313719	1	16987224	1487275	1485169		NC_000001.11:16987223:C:T
NM_022089.4(ATP13A2):c.44G>C (p.Gly15Ala)	ATP13A2	G15A	Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive	Uncertain significance(Last reviewed: Oct 28, 2021)	criteria provided, single submitter	VCV001486724	1	17332240	1	17005745	1486724	1406581		NC_000001.11:17005744:C:G
NM_022089.4(ATP13A2):c.3503_3516dup (p.Pro1173fs)	ATP13A2	A1072fs, P1173fs, P1168fs	Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome	Uncertain significance(Last reviewed: Dec 17, 2021)	criteria provided, single submitter	VCV001481567	1	17312742 - 17312743	1	16986247 - 16986248	1481567	1367085		NC_000001.11:16986247:CGGCCAGGGCTGCTCGGCCAG:CGGCCAGGGCTGCTCGGCCAGGGCTGCTCGGCCAG
NM_022089.4(ATP13A2):c.1189C>T (p.Arg397Cys)	ATP13A2	R397C, R392C	Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive	Uncertain significance(Last reviewed: Aug 30, 2021)	criteria provided, single submitter	VCV001479114	1	17323521	1	16997026	1479114	1426485		NC_000001.11:16997025:G:A
NM_022089.4(ATP13A2):c.2859G>T (p.Thr953=)	ATP13A2		Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive	Uncertain significance(Last reviewed: Oct 27, 2021)	criteria provided, single submitter	VCV001478275	1	17314633	1	16988138	1478275	1351782		NC_000001.11:16988137:C:A
NM_022089.4(ATP13A2):c.1633C>T (p.Arg545Cys)	ATP13A2	R540C, R545C	Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive	Uncertain significance(Last reviewed: Sep 8, 2021)	criteria provided, single submitter	VCV001477626	1	17320240	1	16993745	1477626	1436505		NC_000001.11:16993744:G:A
NM_022089.4(ATP13A2):c.1360C>G (p.Leu454Val)	ATP13A2	L449V, L454V	Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive	Uncertain significance(Last reviewed: Aug 28, 2021)	criteria provided, single submitter	VCV001476951	1	17322653	1	16996158	1476951	1417016		NC_000001.11:16996157:G:C
NM_022089.4(ATP13A2):c.1542+13dup	ATP13A2		Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive	Uncertain significance(Last reviewed: Nov 8, 2021)	criteria provided, single submitter	VCV001476489	1	17322457 - 17322458	1	16995962 - 16995963	1476489	1339262		NC_000001.11:16995962:CC:CCC
NM_022089.4(ATP13A2):c.1750-3C>T	ATP13A2		Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive	Uncertain significance(Last reviewed: Oct 25, 2021)	criteria provided, single submitter	VCV001473177	1	17319079	1	16992584	1473177	1501422		NC_000001.11:16992583:G:A
NM_022089.4(ATP13A2):c.2456G>A (p.Arg819Gln)	ATP13A2	R814Q, R819Q	Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive	Uncertain significance(Last reviewed: Dec 6, 2021)	criteria provided, single submitter	VCV001472590	1	17316455	1	16989960	1472590	1397972		NC_000001.11:16989959:C:T
NM_022089.4(ATP13A2):c.1219C>A (p.Leu407Met)	ATP13A2	L407M, L402M	Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive	Uncertain significance(Last reviewed: Aug 24, 2021)	criteria provided, single submitter	VCV001464672	1	17322968	1	16996473	1464672	1514384		NC_000001.11:16996472:G:T
NM_022089.4(ATP13A2):c.1296C>T (p.Leu432=)	ATP13A2		Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive	Likely benign(Last reviewed: Mar 20, 2021)	criteria provided, single submitter	VCV001462311	1	17322891	1	16996396	1462311	1507638		NC_000001.11:16996395:G:A
NM_022089.4(ATP13A2):c.3041_3043dup (p.Gly1014dup)	ATP13A2		Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive	Uncertain significance(Last reviewed: Oct 12, 2021)	criteria provided, single submitter	VCV001460949	1	17313580 - 17313581	1	16987085 - 16987086	1460949	1419758		NC_000001.11:16987085:CGCCG:CGCCGCCG
NM_022089.4(ATP13A2):c.1859T>C (p.Val620Ala)	ATP13A2	V615A, V620A	Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive	Uncertain significance(Last reviewed: Sep 16, 2021)	criteria provided, single submitter	VCV001460808	1	17318884	1	16992389	1460808	1419617		NC_000001.11:16992388:A:G
NC_000001.10:g.(?_17330807)_(17332293_?)del	ATP13A2		Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome	Pathogenic(Last reviewed: Aug 4, 2021)	criteria provided, single submitter	VCV001458906	1	17330807 - 17332293			1458906	1491253		
NC_000001.10:g.(?_17316166)_(17332293_?)del	ATP13A2		Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome	Pathogenic(Last reviewed: Aug 6, 2021)	criteria provided, single submitter	VCV001456750	1	17316166 - 17332293			1456750	1454852		
NM_022089.4(ATP13A2):c.3084-20C>T	ATP13A2		Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive	Likely benign(Last reviewed: Dec 10, 2021)	criteria provided, single submitter	VCV001453138	1	17313471	1	16986976	1453138	1428424		NC_000001.11:16986975:G:A
NM_022089.4(ATP13A2):c.2126+20C>T	ATP13A2		Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive	Likely benign(Last reviewed: Sep 15, 2021)	criteria provided, single submitter	VCV001452853	1	17318484	1	16991989	1452853	1431996		NC_000001.11:16991988:G:A
NM_022089.4(ATP13A2):c.2745C>T (p.Cys915=)	ATP13A2		Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive	Likely benign(Last reviewed: May 31, 2021)	criteria provided, single submitter	VCV001451530	1	17314834	1	16988339	1451530	1425932		NC_000001.11:16988338:G:A
NM_022089.4(ATP13A2):c.1170C>A (p.His390Gln)	ATP13A2	H385Q, H390Q	Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive	Uncertain significance(Last reviewed: Aug 26, 2021)	criteria provided, single submitter	VCV001450740	1	17323540	1	16997045	1450740	1351261		NC_000001.11:16997044:G:T
NM_022089.4(ATP13A2):c.386G>A (p.Arg129Gln)	ATP13A2	R129Q	Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive	Uncertain significance(Last reviewed: Oct 28, 2021)	criteria provided, single submitter	VCV001448467	1	17331278	1	17004783	1448467	1423166		NC_000001.11:17004782:C:T
NM_022089.4(ATP13A2):c.864G>A (p.Met288Ile)	ATP13A2	M288I, M283I	Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome	Uncertain significance(Last reviewed: Aug 28, 2021)	criteria provided, single submitter	VCV001447568	1	17326784	1	17000289	1447568	1503622		NC_000001.11:17000288:C:T
NM_022089.4(ATP13A2):c.524G>T (p.Trp175Leu)	ATP13A2	W175L, W170L	Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome	Uncertain significance(Last reviewed: Aug 14, 2021)	criteria provided, single submitter	VCV001447161	1	17330860	1	17004365	1447161	1503216		NC_000001.11:17004364:C:A
NM_022089.4(ATP13A2):c.1787G>C (p.Gly596Ala)	ATP13A2	G596A, G591A	Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome	Uncertain significance(Last reviewed: Sep 15, 2021)	criteria provided, single submitter	VCV001445352	1	17319039	1	16992544	1445352	1397678		NC_000001.11:16992543:C:G
NM_022089.4(ATP13A2):c.529G>A (p.Glu177Lys)	ATP13A2	E172K, E177K	Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome	Uncertain significance(Last reviewed: Aug 26, 2021)	criteria provided, single submitter	VCV001444453	1	17330855	1	17004360	1444453	1388418		NC_000001.11:17004359:C:T
NM_022089.4(ATP13A2):c.619C>T (p.Gln207Ter)	ATP13A2	Q202*, Q207*	Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive	Pathogenic(Last reviewed: Dec 8, 2021)	criteria provided, single submitter	VCV001442231	1	17328807	1	17002312	1442231	1475096		NC_000001.11:17002311:G:A
NM_022089.4(ATP13A2):c.2464C>T (p.His822Tyr)	ATP13A2	H817Y, H822Y	Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive	Uncertain significance(Last reviewed: Sep 24, 2021)	criteria provided, single submitter	VCV001440780	1	17316447	1	16989952	1440780	1361927		NC_000001.11:16989951:G:A
NM_022089.4(ATP13A2):c.2483C>T (p.Pro828Leu)	ATP13A2	P823L, P828L	Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive	Uncertain significance(Last reviewed: Sep 17, 2021)	criteria provided, single submitter	VCV001440569	1	17316428	1	16989933	1440569	1461854		NC_000001.11:16989932:G:A
NM_022089.4(ATP13A2):c.3206C>A (p.Ala1069Glu)	ATP13A2	A1025E, A1069E, A1064E	Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive	Uncertain significance(Last reviewed: Dec 1, 2021)	criteria provided, single submitter	VCV001439777	1	17313329	1	16986834	1439777	1346304		NC_000001.11:16986833:G:T
NM_022089.4(ATP13A2):c.2339A>C (p.His780Pro)	ATP13A2	H775P, H780P	Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive	Uncertain significance(Last reviewed: Dec 13, 2021)	criteria provided, single submitter	VCV001438444	1	17316695	1	16990200	1438444	1355296		NC_000001.11:16990199:T:G
NM_022089.4(ATP13A2):c.484G>T (p.Val162Leu)	ATP13A2	V162L, V157L	Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive	Uncertain significance(Last reviewed: Aug 31, 2021)	criteria provided, single submitter	VCV001435938	1	17330900	1	17004405	1435938	1500934		NC_000001.11:17004404:C:A
NM_022089.4(ATP13A2):c.1157A>T (p.Tyr386Phe)	ATP13A2	Y381F, Y386F	Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive	Uncertain significance(Last reviewed: Dec 15, 2021)	criteria provided, single submitter	VCV001434845	1	17323553	1	16997058	1434845	1507049		NC_000001.11:16997057:T:A
NM_022089.4(ATP13A2):c.2867C>T (p.Thr956Ile)	ATP13A2	T912I, T951I, T956I	Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive	Uncertain significance(Last reviewed: Aug 28, 2021)	criteria provided, single submitter	VCV001434773	1	17313757	1	16987262	1434773	1506978		NC_000001.11:16987261:G:A
NM_022089.4(ATP13A2):c.2927T>C (p.Val976Ala)	ATP13A2	V971A, V976A, V932A	Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive	Uncertain significance(Last reviewed: Sep 21, 2021)	criteria provided, single submitter	VCV001434550	1	17313697	1	16987202	1434550	1494366		NC_000001.11:16987201:A:G
NM_022089.4(ATP13A2):c.3356T>G (p.Leu1119Arg)	ATP13A2	L1114R, L1119R	Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive	Uncertain significance(Last reviewed: Sep 8, 2021)	criteria provided, single submitter	VCV001434109	1	17313007	1	16986512	1434109	1497807		NC_000001.11:16986511:A:C
NM_022089.4(ATP13A2):c.2326G>A (p.Val776Ile)	ATP13A2	V771I, V776I	Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive	Uncertain significance(Last reviewed: Oct 23, 2021)	criteria provided, single submitter	VCV001433838	1	17316708	1	16990213	1433838	1497537		NC_000001.11:16990212:C:T
NM_022089.4(ATP13A2):c.374C>G (p.Ala125Gly)	ATP13A2	A125G	Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive	Uncertain significance(Last reviewed: Oct 8, 2021)	criteria provided, single submitter	VCV001431695	1	17331290	1	17004795	1431695	1405766		NC_000001.11:17004794:G:C
NM_022089.4(ATP13A2):c.20C>T (p.Pro7Leu)	ATP13A2	P7L	Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive	Uncertain significance(Last reviewed: Aug 2, 2021)	criteria provided, single submitter	VCV001429896	1	17332264	1	17005769	1429896	1477629		NC_000001.11:17005768:G:A
NM_022089.4(ATP13A2):c.2130C>A (p.Asp710Glu)	ATP13A2	D710E, D705E	Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive	Uncertain significance(Last reviewed: Sep 2, 2021)	criteria provided, single submitter	VCV001429475	1	17318350	1	16991855	1429475	1454590		NC_000001.11:16991854:G:T
NM_022089.4(ATP13A2):c.2888T>C (p.Phe963Ser)	ATP13A2	F958S, F963S, F919S	Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive	Uncertain significance(Last reviewed: Nov 30, 2021)	criteria provided, single submitter	VCV001428197	1	17313736	1	16987241	1428197	1379489		NC_000001.11:16987240:A:G
NM_022089.4(ATP13A2):c.1951G>A (p.Ala651Thr)	ATP13A2	A646T, A651T	Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive	Uncertain significance(Last reviewed: Aug 20, 2021)	criteria provided, single submitter	VCV001427100	1	17318792	1	16992297	1427100	1444502		NC_000001.11:16992296:C:T
NM_022089.4(ATP13A2):c.2905G>C (p.Val969Leu)	ATP13A2	V925L, V964L, V969L	Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive	Uncertain significance(Last reviewed: Sep 2, 2021)	criteria provided, single submitter	VCV001426447	1	17313719	1	16987224	1426447	1451054		NC_000001.11:16987223:C:G
NM_022089.4(ATP13A2):c.1710C>T (p.Gly570=)	ATP13A2		Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive	Uncertain significance(Last reviewed: Sep 4, 2021)	criteria provided, single submitter	VCV001424349	1	17320163	1	16993668	1424349	1438225		NC_000001.11:16993667:G:A
NM_022089.4(ATP13A2):c.3343G>A (p.Gly1115Ser)	ATP13A2	G1110S, G1115S	Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome	Uncertain significance(Last reviewed: Oct 28, 2021)	criteria provided, single submitter	VCV001422404	1	17313020	1	16986525	1422404	1416176		NC_000001.11:16986524:C:T
NM_022089.4(ATP13A2):c.3218G>A (p.Arg1073Gln)	ATP13A2	R1029Q, R1073Q, R1068Q	Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome	Uncertain significance(Last reviewed: Oct 11, 2021)	criteria provided, single submitter	VCV001420936	1	17313317	1	16986822	1420936	1399663		NC_000001.11:16986821:C:T
NM_022089.4(ATP13A2):c.3442C>T (p.Arg1148Cys)	ATP13A2	R1143C, P1047L, R1148C	Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome	Uncertain significance(Last reviewed: Aug 27, 2021)	criteria provided, single submitter	VCV001420889	1	17312817	1	16986322	1420889	1399617		NC_000001.11:16986321:G:A
NM_022089.4(ATP13A2):c.2681C>T (p.Ser894Leu)	ATP13A2	S850L, S889L, S894L	Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome	Uncertain significance(Last reviewed: Sep 15, 2021)	criteria provided, single submitter	VCV001420492	1	17314898	1	16988403	1420492	1403100		NC_000001.11:16988402:G:A
NM_022089.4(ATP13A2):c.2230A>G (p.Ile744Val)	ATP13A2	I744V, I739V	Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive	Uncertain significance(Last reviewed: Sep 15, 2021)	criteria provided, single submitter	VCV001416513	1	17318250	1	16991755	1416513	1383335		NC_000001.11:16991754:T:C
NM_022089.4(ATP13A2):c.2368G>A (p.Glu790Lys)	ATP13A2	E785K, E790K	Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive	Uncertain significance(Last reviewed: Dec 6, 2021)	criteria provided, single submitter	VCV001416504	1	17316666	1	16990171	1416504	1383326		NC_000001.11:16990170:C:T
NM_022089.4(ATP13A2):c.1405G>A (p.Val469Met)	ATP13A2	V464M, V469M	Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive	Uncertain significance(Last reviewed: Sep 1, 2021)	criteria provided, single submitter	VCV001415914	1	17322608	1	16996113	1415914	1371542		NC_000001.11:16996112:C:T
NM_022089.4(ATP13A2):c.2591G>T (p.Cys864Phe)	ATP13A2	C864F, C820F, C859F	Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive	Uncertain significance(Last reviewed: Nov 27, 2021)	criteria provided, single submitter	VCV001415595	1	17316204	1	16989709	1415595	1375102		NC_000001.11:16989708:C:A
NM_022089.4(ATP13A2):c.1099G>A (p.Glu367Lys)	ATP13A2	E362K, E367K	Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive	Uncertain significance(Last reviewed: Sep 17, 2021)	criteria provided, single submitter	VCV001414182	1	17323611	1	16997116	1414182	1358205		NC_000001.11:16997115:C:T
NM_022089.4(ATP13A2):c.2635G>A (p.Gly879Ser)	ATP13A2	G835S, G874S, G879S	Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive	Uncertain significance(Last reviewed: Aug 30, 2021)	criteria provided, single submitter	VCV001412798	1	17314944	1	16988449	1412798	1356396		NC_000001.11:16988448:C:T
NM_022089.4(ATP13A2):c.2858C>T (p.Thr953Met)	ATP13A2	T909M, T948M, T953M	Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive	Uncertain significance(Last reviewed: Nov 9, 2021)	criteria provided, single submitter	VCV001412411	1	17314634	1	16988139	1412411	1344392		NC_000001.11:16988138:G:A
NM_022089.4(ATP13A2):c.3443G>A (p.Arg1148His)	ATP13A2	R1148H, R1143H	Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive	Uncertain significance(Last reviewed: Aug 27, 2021)	criteria provided, single submitter	VCV001410594	1	17312816	1	16986321	1410594	1510032		NC_000001.11:16986320:C:T
NM_022089.4(ATP13A2):c.1685G>A (p.Ser562Asn)	ATP13A2	S557N, S562N	Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome	Uncertain significance(Last reviewed: Nov 29, 2021)	criteria provided, single submitter	VCV001409628	1	17320188	1	16993693	1409628	1340697		NC_000001.11:16993692:C:T
NM_022089.4(ATP13A2):c.1907G>A (p.Arg636His)	ATP13A2	R636H, R631H	Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome	Uncertain significance(Last reviewed: Oct 21, 2021)	criteria provided, single submitter	VCV001408461	1	17318836	1	16992341	1408461	1500127		NC_000001.11:16992340:C:T
NM_022089.4(ATP13A2):c.284A>G (p.Lys95Arg)	ATP13A2	K95R	Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive	Uncertain significance(Last reviewed: Nov 24, 2021)	criteria provided, single submitter	VCV001405469	1	17331873	1	17005378	1405469	1480410		NC_000001.11:17005377:T:C
NM_022089.4(ATP13A2):c.2970_2971delinsAT (p.Arg991Trp)	ATP13A2	R986W, R947W, R991W	Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive	Uncertain significance(Last reviewed: Nov 5, 2021)	criteria provided, single submitter	VCV001404164	1	17313653 - 17313654	1	16987158 - 16987159	1404164	1479863		NC_000001.11:16987157:GC:AT
NM_022089.4(ATP13A2):c.1631G>A (p.Arg544His)	ATP13A2	R544H, R539H	Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive	Uncertain significance(Last reviewed: Aug 30, 2021)	criteria provided, single submitter	VCV001403974	1	17320242	1	16993747	1403974	1467340		NC_000001.11:16993746:C:T
NM_022089.4(ATP13A2):c.226C>T (p.Arg76Trp)	ATP13A2	R76W	Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive	Uncertain significance(Last reviewed: Sep 6, 2021)	criteria provided, single submitter	VCV001403237	1	17331931	1	17005436	1403237	1470460		NC_000001.11:17005435:G:A
NM_022089.4(ATP13A2):c.821C>T (p.Ser274Leu)	ATP13A2	S269L, S274L	Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive	Uncertain significance(Last reviewed: Aug 9, 2021)	criteria provided, single submitter	VCV001398937	1	17326914	1	17000419	1398937	1450233		NC_000001.11:17000418:G:A
NM_022089.4(ATP13A2):c.3472C>A (p.Arg1158Ser)	ATP13A2	A1057E, R1153S, R1158S	Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive	Uncertain significance(Last reviewed: Aug 14, 2021)	criteria provided, single submitter	VCV001398352	1	17312787	1	16986292	1398352	1431281		NC_000001.11:16986291:G:T
NM_022089.4(ATP13A2):c.3164G>C (p.Ser1055Thr)	ATP13A2	S1050T, S1011T, S1055T	Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome	Uncertain significance(Last reviewed: Aug 27, 2021)	criteria provided, single submitter	VCV001397253	1	17313371	1	16986876	1397253	1437820		NC_000001.11:16986875:C:G
NM_022089.4(ATP13A2):c.334A>G (p.Ile112Val)	ATP13A2	I112V	Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome	Uncertain significance(Last reviewed: Sep 29, 2021)	criteria provided, single submitter	VCV001397162	1	17331522	1	17005027	1397162	1415035		NC_000001.11:17005026:T:C
NM_022089.4(ATP13A2):c.1592T>C (p.Leu531Pro)	ATP13A2	L526P, L531P	Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome	Uncertain significance(Last reviewed: Dec 13, 2021)	criteria provided, single submitter	VCV001396910	1	17320281	1	16993786	1396910	1414784		NC_000001.11:16993785:A:G
NM_022089.4(ATP13A2):c.4A>T (p.Ser2Cys)	ATP13A2	S2C	Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome	Uncertain significance(Last reviewed: Nov 23, 2021)	criteria provided, single submitter	VCV001393891	1	17338230	1	17011735	1393891	1422430		NC_000001.11:17011734:T:A
NM_022089.4(ATP13A2):c.464T>G (p.Val155Gly)	ATP13A2	V155G	Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome	Uncertain significance(Last reviewed: Sep 1, 2021)	criteria provided, single submitter	VCV001392106	1	17331200	1	17004705	1392106	1409447		NC_000001.11:17004704:A:C
NM_022089.4(ATP13A2):c.2478C>G (p.Ser826Arg)	ATP13A2	S826R, S821R	Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome	Uncertain significance(Last reviewed: Oct 20, 2021)	criteria provided, single submitter	VCV001388049	1	17316433	1	16989938	1388049	1374670		NC_000001.11:16989937:G:C
NM_022089.4(ATP13A2):c.3440G>A (p.Arg1147His)	ATP13A2	R1142H, R1147H	Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome	Uncertain significance(Last reviewed: Aug 26, 2021)	criteria provided, single submitter	VCV001387449	1	17312819	1	16986324	1387449	1474174		NC_000001.11:16986323:C:T
NM_022089.4(ATP13A2):c.1113del (p.His372fs)	ATP13A2	H372fs, H367fs	Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome	Pathogenic(Last reviewed: Apr 14, 2021)	criteria provided, single submitter	VCV001385899	1	17323597	1	16997102	1385899	1461046		NC_000001.11:16997101:CC:C
NM_022089.4(ATP13A2):c.3434G>A (p.Cys1145Tyr)	ATP13A2	C1140Y, C1145Y	Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive	Uncertain significance(Last reviewed: Nov 28, 2021)	criteria provided, single submitter	VCV001383259	1	17312825	1	16986330	1383259	1509855		NC_000001.11:16986329:C:T
NM_022089.4(ATP13A2):c.1594_1617dup (p.Lys532_Leu539dup)	ATP13A2		Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive	Uncertain significance(Last reviewed: Aug 20, 2021)	criteria provided, single submitter	VCV001383197	1	17320255 - 17320256	1	16993760 - 16993761	1383197	1509793		NC_000001.11:16993760:CAGGGGCAGGAATGCCTGCCCCTTCAGGGGCA:CAGGGGCAGGAATGCCTGCCCCTTCAGGGGCAGGAATGCCTGCCCCTTCAGGGGCA
NM_022089.4(ATP13A2):c.1477A>C (p.Ile493Leu)	ATP13A2	I488L, I493L	Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive	Uncertain significance(Last reviewed: Oct 18, 2021)	criteria provided, single submitter	VCV001383044	1	17322536	1	16996041	1383044	1509640		NC_000001.11:16996040:T:G
NM_022089.4(ATP13A2):c.1696G>A (p.Asp566Asn)	ATP13A2	D566N, D561N	Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive	Uncertain significance(Last reviewed: Oct 11, 2021)	criteria provided, single submitter	VCV001382478	1	17320177	1	16993682	1382478	1434907		NC_000001.11:16993681:C:T
NM_022089.4(ATP13A2):c.2417C>T (p.Pro806Leu)	ATP13A2	P801L, P806L	Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive	Uncertain significance(Last reviewed: Sep 15, 2021)	criteria provided, single submitter	VCV001381352	1	17316494	1	16989999	1381352	1496315		NC_000001.11:16989998:G:A
NM_022089.4(ATP13A2):c.3193G>T (p.Val1065Leu)	ATP13A2	V1021L, V1065L, V1060L	Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive	Uncertain significance(Last reviewed: Sep 15, 2021)	criteria provided, single submitter	VCV001380896	1	17313342	1	16986847	1380896	1499739		NC_000001.11:16986846:C:A
NM_022089.4(ATP13A2):c.889G>A (p.Val297Met)	ATP13A2	V292M, V297M	Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive	Uncertain significance(Last reviewed: Dec 19, 2021)	criteria provided, single submitter	VCV001380674	1	17326759	1	17000264	1380674	1421496		NC_000001.11:17000263:C:T
NM_022089.4(ATP13A2):c.2332G>A (p.Ala778Thr)	ATP13A2	A778T, A773T	Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive	Uncertain significance(Last reviewed: Sep 17, 2021)	criteria provided, single submitter	VCV001378228	1	17316702	1	16990207	1378228	1492658		NC_000001.11:16990206:C:T
NM_022089.4(ATP13A2):c.2208C>G (p.Ile736Met)	ATP13A2	I731M, I736M	Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive	Uncertain significance(Last reviewed: Aug 27, 2021)	criteria provided, single submitter	VCV001378111	1	17318272	1	16991777	1378111	1469915		NC_000001.11:16991776:G:C
NM_022089.4(ATP13A2):c.288+13C>G	ATP13A2		Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive	Uncertain significance(Last reviewed: Oct 21, 2021)	criteria provided, single submitter	VCV001376256	1	17331856	1	17005361	1376256	1466789		NC_000001.11:17005360:G:C
NM_022089.4(ATP13A2):c.361C>T (p.Pro121Ser)	ATP13A2	P121S	Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive	Uncertain significance(Last reviewed: Aug 14, 2021)	criteria provided, single submitter	VCV001375825	1	17331303	1	17004808	1375825	1470211		NC_000001.11:17004807:G:A
NM_022089.4(ATP13A2):c.3471G>T (p.Lys1157Asn)	ATP13A2	K1152N, K1157N, A1057S	Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive	Uncertain significance(Last reviewed: Nov 7, 2021)	criteria provided, single submitter	VCV001374900	1	17312788	1	16986293	1374900	1466187		NC_000001.11:16986292:C:A
NM_022089.4(ATP13A2):c.1196G>A (p.Gly399Glu)	ATP13A2	G394E, G399E	Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome	Uncertain significance(Last reviewed: Aug 3, 2021)	criteria provided, single submitter	VCV001372075	1	17322991	1	16996496	1372075	1365584		NC_000001.11:16996495:C:T
NM_022089.4(ATP13A2):c.2858C>G (p.Thr953Arg)	ATP13A2	T953R, T909R, T948R	Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome	Uncertain significance(Last reviewed: Jul 31, 2021)	criteria provided, single submitter	VCV001371264	1	17314634	1	16988139	1371264	1427470		NC_000001.11:16988138:G:C
NM_022089.4(ATP13A2):c.2860-7G>A	ATP13A2		Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive	Likely benign(Last reviewed: Jun 3, 2021)	criteria provided, single submitter	VCV001365508	1	17313771	1	16987276	1365508	1402378		NC_000001.11:16987275:C:T
NM_022089.4(ATP13A2):c.1589C>T (p.Pro530Leu)	ATP13A2	P525L, P530L	Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome	Uncertain significance(Last reviewed: Nov 27, 2021)	criteria provided, single submitter	VCV001363569	1	17320284	1	16993789	1363569	1489429		NC_000001.11:16993788:G:A
NM_022089.4(ATP13A2):c.1931C>G (p.Pro644Arg)	ATP13A2	P639R, P644R	Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome	Uncertain significance(Last reviewed: Sep 24, 2021)	criteria provided, single submitter	VCV001361282	1	17318812	1	16992317	1361282	1383654		NC_000001.11:16992316:G:C
NM_022089.4(ATP13A2):c.2015A>G (p.Asp672Gly)	ATP13A2	D672G, D667G	Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome	Uncertain significance(Last reviewed: Sep 24, 2021)	criteria provided, single submitter	VCV001358171	1	17318615	1	16992120	1358171	1460470		NC_000001.11:16992119:T:C
NM_022089.4(ATP13A2):c.1295T>C (p.Leu432Pro)	ATP13A2	L427P, L432P	Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome	Uncertain significance(Last reviewed: Sep 25, 2021)	criteria provided, single submitter	VCV001355002	1	17322892	1	16996397	1355002	1512630		NC_000001.11:16996396:A:G
NM_022089.4(ATP13A2):c.2527A>C (p.Lys843Gln)	ATP13A2	K838Q, K843Q	Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome	Uncertain significance(Last reviewed: Aug 14, 2021)	criteria provided, single submitter	VCV001354938	1	17316384	1	16989889	1354938	1434523		NC_000001.11:16989888:T:G
NM_022089.4(ATP13A2):c.1460G>A (p.Arg487Gln)	ATP13A2	R487Q, R482Q	Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome	Uncertain significance(Last reviewed: Aug 4, 2021)	criteria provided, single submitter	VCV001352645	1	17322553	1	16996058	1352645	1505854		NC_000001.11:16996057:C:T
NM_022089.4(ATP13A2):c.1772C>T (p.Ala591Val)	ATP13A2	A591V, A586V	Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive	Uncertain significance(Last reviewed: Nov 29, 2021)	criteria provided, single submitter	VCV001349838	1	17319054	1	16992559	1349838	1472661		NC_000001.11:16992558:G:A
NM_022089.4(ATP13A2):c.221G>A (p.Arg74Gln)	ATP13A2	R74Q	Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome	Uncertain significance(Last reviewed: Sep 24, 2021)	criteria provided, single submitter	VCV001348357	1	17331936	1	17005441	1348357	1459587		NC_000001.11:17005440:C:T
NM_022089.4(ATP13A2):c.880C>T (p.Arg294Trp)	ATP13A2	R289W, R294W	Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome|not provided	Uncertain significance(Last reviewed: Sep 17, 2021)	criteria provided, multiple submitters, no conflicts	VCV001312723	1	17326768	1	17000273	1312723	1302984		NC_000001.11:17000272:G:A
NM_022089.4(ATP13A2):c.2939G>A (p.Arg980His)	ATP13A2	R936H, R975H, R980H	not provided	Uncertain significance(Last reviewed: Dec 17, 2020)	criteria provided, single submitter	VCV001303171	1	17313685	1	16987190	1303171	1293449		NC_000001.11:16987189:C:T
NM_022089.4(ATP13A2):c.196C>T (p.Arg66Cys)	ATP13A2	R66C	Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome|not provided	Uncertain significance(Last reviewed: Oct 20, 2021)	criteria provided, multiple submitters, no conflicts	VCV001215759	1	17331961	1	17005466	1215759	1205740		NC_000001.11:17005465:G:A
NM_022089.4(ATP13A2):c.255C>T (p.Ala85=)	ATP13A2		not provided|Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome	Likely benign(Last reviewed: Oct 23, 2021)	criteria provided, multiple submitters, no conflicts	VCV001195382	1	17331902	1	17005407	1195382	1182808		NC_000001.11:17005406:G:A
NM_022089.4(ATP13A2):c.1195+66A>G	ATP13A2		not provided|Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive	Benign(Last reviewed: Jul 14, 2021)	criteria provided, multiple submitters, no conflicts	VCV001192485	1	17323449	1	16996954	1192485	1182343		NC_000001.11:16996953:T:C
NM_022089.4(ATP13A2):c.1766C>T (p.Pro589Leu)	ATP13A2	P584L, P589L	not provided|Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome	Uncertain significance(Last reviewed: Aug 14, 2021)	criteria provided, multiple submitters, no conflicts	VCV001187232	1	17319060	1	16992565	1187232	1175782		NC_000001.11:16992564:G:A
NM_022089.4(ATP13A2):c.1243C>T (p.Arg415Trp)	ATP13A2	R410W, R415W	not provided|not specified|Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive	Uncertain significance(Last reviewed: Oct 10, 2021)	criteria provided, multiple submitters, no conflicts	VCV001163729	1	17322944	1	16996449	1163729	1151861		NC_000001.11:16996448:G:A
NM_022089.4(ATP13A2):c.1234T>C (p.Leu412=)	ATP13A2		Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive	Likely benign(Last reviewed: Jul 23, 2020)	criteria provided, single submitter	VCV001159508	1	17322953	1	16996458	1159508	1130586		NC_000001.11:16996457:A:G
NM_022089.4(ATP13A2):c.1869C>T (p.Ser623=)	ATP13A2		Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome	Likely benign(Last reviewed: Jan 5, 2020)	criteria provided, single submitter	VCV001156514	1	17318874	1	16992379	1156514	1130583		NC_000001.11:16992378:G:A
NM_022089.4(ATP13A2):c.1398C>T (p.Thr466=)	ATP13A2		Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome	Likely benign(Last reviewed: Jun 23, 2020)	criteria provided, single submitter	VCV001153583	1	17322615	1	16996120	1153583	1130584		NC_000001.11:16996119:G:A
NM_022089.4(ATP13A2):c.1137C>G (p.Leu379=)	ATP13A2		Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome	Likely benign(Last reviewed: Feb 26, 2019)	criteria provided, single submitter	VCV001149175	1	17323573	1	16997078	1149175	1130588		NC_000001.11:16997077:G:C
NM_022089.4(ATP13A2):c.2796C>T (p.Ser932=)	ATP13A2		Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive	Likely benign(Last reviewed: May 31, 2019)	criteria provided, single submitter	VCV001148890	1	17314696	1	16988201	1148890	1130581		NC_000001.11:16988200:G:A
NM_022089.4(ATP13A2):c.2133T>C (p.Thr711=)	ATP13A2		Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive	Likely benign(Last reviewed: Apr 24, 2019)	criteria provided, single submitter	VCV001145104	1	17318347	1	16991852	1145104	1130582		NC_000001.11:16991851:A:G
NM_022089.4(ATP13A2):c.1353+8T>C	ATP13A2		Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive	Likely benign(Last reviewed: Jul 23, 2020)	criteria provided, single submitter	VCV001144737	1	17322741	1	16996246	1144737	1130585		NC_000001.11:16996245:A:G
NM_022089.4(ATP13A2):c.1167G>A (p.Pro389=)	ATP13A2		Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive	Likely benign(Last reviewed: May 11, 2020)	criteria provided, single submitter	VCV001142649	1	17323543	1	16997048	1142649	1130587		NC_000001.11:16997047:C:T
NM_022089.4(ATP13A2):c.270C>T (p.Ile90=)	ATP13A2		Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome	Likely benign(Last reviewed: Jun 12, 2020)	criteria provided, single submitter	VCV001133514	1	17331887	1	17005392	1133514	1109686		NC_000001.11:17005391:G:A
NM_022089.4(ATP13A2):c.1170C>T (p.His390=)	ATP13A2		Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive	Likely benign(Last reviewed: Sep 29, 2020)	criteria provided, single submitter	VCV001129464	1	17323540	1	16997045	1129464	1109684		NC_000001.11:16997044:G:A
NM_022089.4(ATP13A2):c.2454C>T (p.Pro818=)	ATP13A2		Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive	Likely benign(Last reviewed: Mar 2, 2020)	criteria provided, single submitter	VCV001129340	1	17316457	1	16989962	1129340	1109683		NC_000001.11:16989961:G:A
NM_022089.4(ATP13A2):c.3501C>T (p.Ala1167=)	ATP13A2	R1067*	Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive	Likely benign(Last reviewed: Oct 16, 2020)	criteria provided, single submitter	VCV001128805	1	17312758	1	16986263	1128805	1109680		NC_000001.11:16986262:G:A
NM_022089.4(ATP13A2):c.2742G>A (p.Glu914=)	ATP13A2		Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive	Likely benign(Last reviewed: Aug 8, 2020)	criteria provided, single submitter	VCV001126234	1	17314837	1	16988342	1126234	1109682		NC_000001.11:16988341:C:T
NM_022089.4(ATP13A2):c.2820C>T (p.Tyr940=)	ATP13A2		Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive	Likely benign(Last reviewed: Feb 27, 2020)	criteria provided, single submitter	VCV001124581	1	17314672	1	16988177	1124581	1109681		NC_000001.11:16988176:G:A
NM_022089.4(ATP13A2):c.471C>T (p.Val157=)	ATP13A2		Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive	Likely benign(Last reviewed: Jan 6, 2020)	criteria provided, single submitter	VCV001124202	1	17331193	1	17004698	1124202	1109685		NC_000001.11:17004697:G:A
NM_022089.4(ATP13A2):c.699G>T (p.Val233=)	ATP13A2		Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome	Likely benign(Last reviewed: Jul 8, 2020)	criteria provided, single submitter	VCV001115474	1	17328535	1	17002040	1115474	1088162		NC_000001.11:17002039:C:A
NM_022089.4(ATP13A2):c.2685G>A (p.Leu895=)	ATP13A2		Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome	Likely benign(Last reviewed: Sep 29, 2019)	criteria provided, single submitter	VCV001111167	1	17314894	1	16988399	1111167	1088158		NC_000001.11:16988398:C:T
NM_022089.4(ATP13A2):c.822G>A (p.Ser274=)	ATP13A2		Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome	Likely benign(Last reviewed: Aug 11, 2020)	criteria provided, single submitter	VCV001110896	1	17326913	1	17000418	1110896	1088161		NC_000001.11:17000417:C:T
NM_022089.4(ATP13A2):c.2397C>T (p.Ala799=)	ATP13A2		Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome	Likely benign(Last reviewed: Nov 27, 2019)	criteria provided, single submitter	VCV001109189	1	17316637	1	16990142	1109189	1088159		NC_000001.11:16990141:G:A
NM_022089.4(ATP13A2):c.1341C>T (p.Leu447=)	ATP13A2		Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome	Likely benign(Last reviewed: Aug 22, 2019)	criteria provided, single submitter	VCV001104646	1	17322761	1	16996266	1104646	1088160		NC_000001.11:16996265:G:A
NM_022089.4(ATP13A2):c.2943G>A (p.Thr981=)	ATP13A2		Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome	Likely benign(Last reviewed: Apr 26, 2019)	criteria provided, single submitter	VCV001103624	1	17313681	1	16987186	1103624	1088157		NC_000001.11:16987185:C:T
NM_022089.4(ATP13A2):c.3207G>A (p.Ala1069=)	ATP13A2		Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive	Likely benign(Last reviewed: Apr 8, 2020)	criteria provided, single submitter	VCV001102648	1	17313328	1	16986833	1102648	1088156		NC_000001.11:16986832:C:T
NM_022089.4(ATP13A2):c.723T>C (p.Tyr241=)	ATP13A2		Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome	Likely benign(Last reviewed: Aug 21, 2020)	criteria provided, single submitter	VCV001098141	1	17327012	1	17000517	1098141	1066436		NC_000001.11:17000516:A:G
NM_022089.4(ATP13A2):c.3321G>A (p.Ala1107=)	ATP13A2		Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome	Likely benign(Last reviewed: Jan 10, 2020)	criteria provided, single submitter	VCV001097983	1	17313042	1	16986547	1097983	1066430		NC_000001.11:16986546:C:T
NM_022089.4(ATP13A2):c.2994C>T (p.Ser998=)	ATP13A2		Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome	Likely benign(Last reviewed: Aug 14, 2020)	criteria provided, single submitter	VCV001090349	1	17313630	1	16987135	1090349	1066431		NC_000001.11:16987134:G:A
NM_022089.4(ATP13A2):c.1755G>A (p.Leu585=)	ATP13A2		Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome	Likely benign(Last reviewed: Aug 2, 2020)	criteria provided, single submitter	VCV001089057	1	17319071	1	16992576	1089057	1066434		NC_000001.11:16992575:C:T
NM_022089.4(ATP13A2):c.244C>T (p.Leu82=)	ATP13A2		Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome	Likely benign(Last reviewed: Jan 11, 2020)	criteria provided, single submitter	VCV001088122	1	17331913	1	17005418	1088122	1066437		NC_000001.11:17005417:G:A
NM_022089.4(ATP13A2):c.2082A>G (p.Pro694=)	ATP13A2		Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive	Likely benign(Last reviewed: Jun 22, 2020)	criteria provided, single submitter	VCV001080278	1	17318548	1	16992053	1080278	1066433		NC_000001.11:16992052:T:C
NM_022089.4(ATP13A2):c.1218C>T (p.Gly406=)	ATP13A2		Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive	Likely benign(Last reviewed: May 30, 2019)	criteria provided, single submitter	VCV001078242	1	17322969	1	16996474	1078242	1066435		NC_000001.11:16996473:G:A
NM_022089.4(ATP13A2):c.2580A>G (p.Thr860=)	ATP13A2		Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive	Likely benign(Last reviewed: Jul 9, 2019)	criteria provided, single submitter	VCV001077368	1	17316215	1	16989720	1077368	1066432		NC_000001.11:16989719:T:C
NM_022089.4(ATP13A2):c.2146del (p.Asp715_Leu716insTer)	ATP13A2		Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive	Pathogenic(Last reviewed: Feb 17, 2020)	criteria provided, single submitter	VCV001075284	1	17318334	1	16991839	1075284	1058472		NC_000001.11:16991838:GG:G
NM_022089.4(ATP13A2):c.3136G>T (p.Glu1046Ter)	ATP13A2	E1002*, E1041*, E1046*	Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive	Pathogenic(Last reviewed: Feb 17, 2020)	criteria provided, single submitter	VCV001075283	1	17313399	1	16986904	1075283	1058471		NC_000001.11:16986903:C:A
NM_022089.4(ATP13A2):c.1649C>A (p.Pro550His)	ATP13A2	P545H, P550H	Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive	Uncertain significance(Last reviewed: Dec 17, 2020)	criteria provided, multiple submitters, no conflicts	VCV001062357	1	17320224	1	16993729	1062357	1039599		NC_000001.11:16993728:G:T
NM_022089.4(ATP13A2):c.2270C>T (p.Ala757Val)	ATP13A2	A752V, A757V	Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive	Uncertain significance(Last reviewed: Jul 21, 2020)	criteria provided, single submitter	VCV001061042	1	17316764	1	16990269	1061042	1039597		NC_000001.11:16990268:G:A
NM_022089.4(ATP13A2):c.2771G>A (p.Arg924His)	ATP13A2	R880H, R919H, R924H	Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive	Uncertain significance(Last reviewed: Oct 26, 2020)	criteria provided, single submitter	VCV001056992	1	17314721	1	16988226	1056992	1039596		NC_000001.11:16988225:C:T
NM_022089.4(ATP13A2):c.778G>A (p.Ala260Thr)	ATP13A2	A255T, A260T	Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive	Uncertain significance(Last reviewed: Oct 11, 2020)	criteria provided, single submitter	VCV001056624	1	17326957	1	17000462	1056624	1039602		NC_000001.11:17000461:C:T
NM_022089.4(ATP13A2):c.1925C>T (p.Ala642Val)	ATP13A2	A637V, A642V	Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive	Uncertain significance(Last reviewed: Oct 21, 2020)	criteria provided, single submitter	VCV001056319	1	17318818	1	16992323	1056319	1039598		NC_000001.11:16992322:G:A
NM_022089.4(ATP13A2):c.1064C>T (p.Thr355Met)	ATP13A2	T350M, T355M	Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome	Uncertain significance(Last reviewed: Apr 20, 2020)	criteria provided, single submitter	VCV001052718	1	17323646	1	16997151	1052718	1039601		NC_000001.11:16997150:G:A
NM_022089.4(ATP13A2):c.1384C>G (p.Leu462Val)	ATP13A2	L457V, L462V	Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome	Uncertain significance(Last reviewed: Sep 24, 2020)	criteria provided, single submitter	VCV001051520	1	17322629	1	16996134	1051520	1039600		NC_000001.11:16996133:G:C
NM_022089.4(ATP13A2):c.2978C>G (p.Pro993Arg)	ATP13A2	P949R, P988R, P993R	Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome	Uncertain significance(Last reviewed: Jul 29, 2020)	criteria provided, single submitter	VCV001051144	1	17313646	1	16987151	1051144	1039595		NC_000001.11:16987150:G:C
NM_022089.4(ATP13A2):c.1957G>A (p.Val653Ile)	ATP13A2	V653I, V648I	Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive	Uncertain significance(Last reviewed: Jun 12, 2020)	criteria provided, single submitter	VCV001046235	1	17318786	1	16992291	1046235	1022752	rs761490954	NC_000001.11:16992290:C:T
NM_022089.4(ATP13A2):c.212G>C (p.Trp71Ser)	ATP13A2	W71S	Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive	Uncertain significance(Last reviewed: Jan 1, 2020)	criteria provided, single submitter	VCV001045786	1	17331945	1	17005450	1045786	1022754	rs373607247	NC_000001.11:17005449:C:G
NM_022089.4(ATP13A2):c.2309A>G (p.Gln770Arg)	ATP13A2	Q770R, Q765R	Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome	Uncertain significance(Last reviewed: Jan 31, 2020)	criteria provided, single submitter	VCV001042540	1	17316725	1	16990230	1042540	1022751	rs77630788	NC_000001.11:16990229:T:C
NM_022089.4(ATP13A2):c.1466G>T (p.Arg489Leu)	ATP13A2	R489L, R484L	Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome	Uncertain significance(Last reviewed: Sep 21, 2020)	criteria provided, single submitter	VCV001042103	1	17322547	1	16996052	1042103	1022753	rs760567858	NC_000001.11:16996051:C:A
NM_022089.4(ATP13A2):c.2859+5G>C	ATP13A2		Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome	Uncertain significance(Last reviewed: Jun 15, 2020)	criteria provided, single submitter	VCV001034961	1	17314628	1	16988133	1034961	1022750	rs1164759435	NC_000001.11:16988132:C:G
NM_022089.4(ATP13A2):c.2525C>G (p.Pro842Arg)	ATP13A2	P842R, P837R	Kufor-Rakeb syndrome	Uncertain significance(Last reviewed: Jan 29, 2018)	criteria provided, single submitter	VCV001031328	1	17316386	1	16989891	1031328	1019222	rs917176878	NC_000001.11:16989890:G:C
NM_022089.4(ATP13A2):c.265G>A (p.Val89Ile)	ATP13A2	V89I	Kufor-Rakeb syndrome|not provided	Uncertain significance(Last reviewed: Mar 1, 2021)	criteria provided, multiple submitters, no conflicts	VCV001029841	1	17331892	1	17005397	1029841	1015586	rs534590083	NC_000001.11:17005396:C:T
NM_022089.4(ATP13A2):c.2529+1G>A	ATP13A2		Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome	Likely pathogenic(Last reviewed: Sep 19, 2021)	criteria provided, multiple submitters, no conflicts	VCV001029840	1	17316381	1	16989886	1029840	1015584	rs776448394	NC_000001.11:16989885:C:T
NM_022089.4(ATP13A2):c.1843A>G (p.Met615Val)	ATP13A2	M610V, M615V	Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome	Uncertain significance(Last reviewed: Jul 2, 2020)	criteria provided, multiple submitters, no conflicts	VCV001028752	1	17318983	1	16992488	1028752	1015585	rs200529993	NC_000001.11:16992487:T:C
NM_022089.4(ATP13A2):c.2663C>T (p.Ala888Val)	ATP13A2	A844V, A883V, A888V	Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive	Uncertain significance(Last reviewed: Nov 2, 2020)	criteria provided, single submitter	VCV001025917	1	17314916	1	16988421	1025917	1002291	rs190323680	NC_000001.11:16988420:G:A
NM_022089.4(ATP13A2):c.1591C>G (p.Leu531Val)	ATP13A2	L526V, L531V	Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive	Uncertain significance(Last reviewed: Apr 11, 2017)	criteria provided, single submitter	VCV001019440	1	17320282	1	16993787	1019440	1002292	rs2077019135	NC_000001.11:16993786:G:C
NM_022089.4(ATP13A2):c.348C>G (p.Ser116Arg)	ATP13A2	S116R	Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome	Uncertain significance(Last reviewed: Jan 31, 2020)	criteria provided, single submitter	VCV001015771	1	17331316	1	17004821	1015771	1002294	rs2077491125	NC_000001.11:17004820:G:C
NM_022089.4(ATP13A2):c.841C>G (p.Gln281Glu)	ATP13A2	Q276E, Q281E	Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome	Uncertain significance(Last reviewed: Nov 2, 2020)	criteria provided, single submitter	VCV001015312	1	17326807	1	17000312	1015312	1002293	rs2077304764	NC_000001.11:17000311:G:C
NM_022089.4(ATP13A2):c.3040G>A (p.Gly1014Ser)	ATP13A2	G1009S, G1014S, G970S	Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome	Uncertain significance(Last reviewed: May 5, 2020)	criteria provided, multiple submitters, no conflicts	VCV001014208	1	17313584	1	16987089	1014208	1002290	rs202166353	NC_000001.11:16987088:C:T
NM_022089.4(ATP13A2):c.722A>G (p.Tyr241Cys)	ATP13A2	Y236C, Y241C	Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome	Uncertain significance(Last reviewed: Mar 29, 2020)	criteria provided, single submitter	VCV001008650	1	17327013	1	17000518	1008650	987035	rs1221004929	NC_000001.11:17000517:T:C
NM_022089.4(ATP13A2):c.2544C>T (p.Gly848=)	ATP13A2		Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome	Uncertain significance(Last reviewed: Aug 29, 2020)	criteria provided, single submitter	VCV001007416	1	17316251	1	16989756	1007416	987034	rs769033175	NC_000001.11:16989755:G:A
NM_022089.4(ATP13A2):c.1544C>T (p.Thr515Met)	ATP13A2	T510M, T515M	Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive|Spastic paraplegia 78, autosomal recessive|Inborn genetic diseases	Uncertain significance(Last reviewed: Oct 14, 2021)	criteria provided, multiple submitters, no conflicts	VCV000985083	1	17320329	1	16993834	985083	973151	rs984178348	NC_000001.11:16993833:G:A
NM_022089.4(ATP13A2):c.1749+442_2251+512del	ATP13A2		Kufor-Rakeb syndrome	Pathogenic(Last reviewed: Jan 7, 2020)	criteria provided, single submitter	VCV000978042	1	17317717 - 17319682	1	16991222 - 16993187	978042	966155		
NM_022089.4(ATP13A2):c.3458G>A (p.Arg1153Gln)	ATP13A2	R1148Q, R1153Q	ATP13A2-related disorders|Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome	Uncertain significance(Last reviewed: Feb 17, 2020)	criteria provided, multiple submitters, no conflicts	VCV000973287	1	17312801	1	16986306	973287	961498	rs772666861	NC_000001.11:16986305:C:T
NM_022089.4(ATP13A2):c.1321A>T (p.Ile441Phe)	ATP13A2	I441F, I436F	Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome	Uncertain significance(Last reviewed: Oct 4, 2019)	criteria provided, single submitter	VCV000971324	1	17322781	1	16996286	971324	952139	rs772446950	NC_000001.11:16996285:T:A
NM_022089.4(ATP13A2):c.3439C>T (p.Arg1147Cys)	ATP13A2	A1046V, R1147C, R1142C	Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome	Uncertain significance(Last reviewed: Nov 6, 2019)	criteria provided, single submitter	VCV000970791	1	17312820	1	16986325	970791	952138	rs370421723	NC_000001.11:16986324:G:A
NM_022089.4(ATP13A2):c.1465C>T (p.Arg489Trp)	ATP13A2	R484W, R489W	Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome	Uncertain significance(Last reviewed: Sep 15, 2019)	criteria provided, single submitter	VCV000962412	1	17322548	1	16996053	962412	941569	rs753825215	NC_000001.11:16996052:G:A
NM_022089.4(ATP13A2):c.994G>A (p.Ala332Thr)	ATP13A2	A332T, A327T	Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome	Uncertain significance(Last reviewed: Jul 30, 2019)	criteria provided, single submitter	VCV000958400	1	17326551	1	17000056	958400	941571	rs141816878	NC_000001.11:17000055:C:T
NM_022089.4(ATP13A2):c.2218C>G (p.Arg740Gly)	ATP13A2	R740G, R735G	Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome	Uncertain significance(Last reviewed: Sep 15, 2019)	criteria provided, single submitter	VCV000957849	1	17318262	1	16991767	957849	941568	rs973767624	NC_000001.11:16991766:G:C
NM_022089.4(ATP13A2):c.668T>C (p.Ile223Thr)	ATP13A2	I218T, I223T	Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome	Uncertain significance(Last reviewed: Jul 8, 2019)	criteria provided, single submitter	VCV000957471	1	17328566	1	17002071	957471	941572	rs771489150	NC_000001.11:17002070:A:G
NM_022089.4(ATP13A2):c.1306G>A (p.Ala436Thr)	ATP13A2	A431T, A436T	Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive	Uncertain significance(Last reviewed: Nov 12, 2019)	criteria provided, single submitter	VCV000954358	1	17322881	1	16996386	954358	941570	rs1439546959	NC_000001.11:16996385:C:T
NM_022089.4(ATP13A2):c.1864G>T (p.Val622Phe)	ATP13A2	V617F, V622F	Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive	Uncertain significance(Last reviewed: Apr 6, 2019)	criteria provided, single submitter	VCV000952741	1	17318879	1	16992384	952741	921740	rs779367060	NC_000001.11:16992383:C:A
NM_022089.4(ATP13A2):c.157G>A (p.Val53Met)	ATP13A2	V53M	Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive	Uncertain significance(Last reviewed: Jul 8, 2020)	criteria provided, single submitter	VCV000952316	1	17332000	1	17005505	952316	921741	rs142699829	NC_000001.11:17005504:C:T
NM_022089.4(ATP13A2):c.2422C>G (p.Gln808Glu)	ATP13A2	Q808E, Q803E	Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome	Uncertain significance(Last reviewed: Mar 7, 2020)	criteria provided, single submitter	VCV000949336	1	17316489	1	16989994	949336	921739	rs774997717	NC_000001.11:16989993:G:C
NM_022089.4(ATP13A2):c.3042C>T (p.Gly1014=)	ATP13A2		Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive	Uncertain significance(Last reviewed: Sep 3, 2019)	criteria provided, single submitter	VCV000940709	1	17313582	1	16987087	940709	930152	rs1415173041	NC_000001.11:16987086:G:A
NM_022089.4(ATP13A2):c.2326G>C (p.Val776Leu)	ATP13A2	V776L, V771L	Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive	Uncertain significance(Last reviewed: Jun 28, 2020)	criteria provided, single submitter	VCV000936424	1	17316708	1	16990213	936424	930153	rs56170027	NC_000001.11:16990212:C:G
NM_022089.4(ATP13A2):c.1880G>A (p.Arg627His)	ATP13A2	R627H, R622H	not provided|Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive	Uncertain significance(Last reviewed: May 5, 2020)	criteria provided, multiple submitters, no conflicts	VCV000935221	1	17318863	1	16992368	935221	930154	rs756516383	NC_000001.11:16992367:C:T
NM_022089.4(ATP13A2):c.1658G>A (p.Arg553Gln)	ATP13A2	R548Q, R553Q	Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive|not provided	Uncertain significance(Last reviewed: Aug 23, 2019)	criteria provided, multiple submitters, no conflicts	VCV000934675	1	17320215	1	16993720	934675	930155	rs376011760	NC_000001.11:16993719:C:T
NM_022089.4(ATP13A2):c.515G>A (p.Arg172His)	ATP13A2	R167H, R172H	Kufor-Rakeb syndrome	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000876420	1	17330869	1	17004374	876420	862773	rs776601823	NC_000001.11:17004373:C:T
NM_022089.4(ATP13A2):c.601C>T (p.Arg201Cys)	ATP13A2	R196C, R201C	Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome	Uncertain significance(Last reviewed: May 30, 2019)	criteria provided, multiple submitters, no conflicts	VCV000876419	1	17328825	1	17002330	876419	862772	rs760715676	NC_000001.11:17002329:G:A
NM_022089.4(ATP13A2):c.706-14C>T	ATP13A2		Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome	Benign/Likely benign(Last reviewed: Nov 27, 2021)	criteria provided, multiple submitters, no conflicts	VCV000876418	1	17327043	1	17000548	876418	865031	rs371532404	NC_000001.11:17000547:G:A
NM_022089.4(ATP13A2):c.840G>T (p.Lys280Asn)	ATP13A2	K275N, K280N	Kufor-Rakeb syndrome	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000876417	1	17326895	1	17000400	876417	862771	rs1326739914	NC_000001.11:17000399:C:A
NM_022089.4(ATP13A2):c.1774G>A (p.Asp592Asn)	ATP13A2	D587N, D592N	Kufor-Rakeb syndrome	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000876375	1	17319052	1	16992557	876375	862768	rs750921184	NC_000001.11:16992556:C:T
NM_022089.4(ATP13A2):c.1870G>A (p.Val624Ile)	ATP13A2	V619I, V624I	Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive|not provided|Kufor-Rakeb syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Dec 2, 2021)	criteria provided, conflicting interpretations	VCV000876374	1	17318873	1	16992378	876374	862767	rs368423685	NC_000001.11:16992377:C:T
NM_022089.4(ATP13A2):c.2927T>G (p.Val976Gly)	ATP13A2	V932G, V976G, V971G	Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome	Uncertain significance(Last reviewed: Sep 17, 2021)	criteria provided, multiple submitters, no conflicts	VCV000876341	1	17313697	1	16987202	876341	862760	rs776148733	NC_000001.11:16987201:A:C
NM_022089.4(ATP13A2):c.3112G>A (p.Ala1038Thr)	ATP13A2	A1038T, A994T, A1033T	Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome	Uncertain significance(Last reviewed: Sep 8, 2021)	criteria provided, multiple submitters, no conflicts	VCV000876340	1	17313423	1	16986928	876340	862759	rs757076945	NC_000001.11:16986927:C:T
NM_022089.4(ATP13A2):c.*182C>T	ATP13A2		Kufor-Rakeb syndrome	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000876292	1	17312534	1	16986039	876292	862755	rs970274162	NC_000001.11:16986038:G:A
NM_022089.4(ATP13A2):c.*231G>A	ATP13A2	V1158M	Kufor-Rakeb syndrome	Benign(Last reviewed: Jul 18, 2017)	criteria provided, single submitter	VCV000876291	1	17312485	1	16985990	876291	862754	rs76298930	NC_000001.11:16985989:C:T
NM_022089.4(ATP13A2):c.2190G>T (p.Pro730=)	ATP13A2		Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Oct 14, 2021)	criteria provided, conflicting interpretations	VCV000876256	1	17318290	1	16991795	876256	862766	rs148275181	NC_000001.11:16991794:C:A
NM_022089.4(ATP13A2):c.3235+15G>A	ATP13A2		Kufor-Rakeb syndrome	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000876202	1	17313285	1	16986790	876202	865029	rs761031832	NC_000001.11:16986789:C:T
NM_022089.4(ATP13A2):c.1112G>A (p.Arg371Gln)	ATP13A2	R366Q, R371Q	not provided|Kufor-Rakeb syndrome	Uncertain significance(Last reviewed: Aug 26, 2019)	criteria provided, multiple submitters, no conflicts	VCV000875386	1	17323598	1	16997103	875386	862770	rs779347442	NC_000001.11:16997102:C:T
NM_022089.4(ATP13A2):c.1307-14C>T	ATP13A2		Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Nov 25, 2021)	criteria provided, conflicting interpretations	VCV000875335	1	17322809	1	16996314	875335	865030	rs370771306	NC_000001.11:16996313:G:A
NM_022089.4(ATP13A2):c.2439C>T (p.Thr813=)	ATP13A2		Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Sep 17, 2021)	criteria provided, conflicting interpretations	VCV000875296	1	17316472	1	16989977	875296	862765	rs368244226	NC_000001.11:16989976:G:A
NM_022089.4(ATP13A2):c.2440G>A (p.Val814Met)	ATP13A2	V809M, V814M	Kufor-Rakeb syndrome	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000875295	1	17316471	1	16989976	875295	862764	rs748454159	NC_000001.11:16989975:C:T
NM_022089.4(ATP13A2):c.2517G>C (p.Lys839Asn)	ATP13A2	K839N, K834N	Kufor-Rakeb syndrome	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000875294	1	17316394	1	16989899	875294	862763	rs2076866081	NC_000001.11:16989898:C:G
NM_022089.4(ATP13A2):c.2558G>A (p.Arg853His)	ATP13A2	R848H, R809H, R853H	Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome	Uncertain significance(Last reviewed: Aug 31, 2021)	criteria provided, multiple submitters, no conflicts	VCV000875293	1	17316237	1	16989742	875293	862762	rs745954026	NC_000001.11:16989741:C:T
NM_022089.4(ATP13A2):c.-171G>C	ATP13A2		Kufor-Rakeb syndrome	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000874518	1	17338404	1	17011909	874518	862775	rs1350517492	NC_000001.11:17011908:C:G
NM_022089.4(ATP13A2):c.-99G>C	ATP13A2		Kufor-Rakeb syndrome	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000874468	1	17338332	1	17011837	874468	862774	rs569658051	NC_000001.11:17011836:C:G
NM_022089.4(ATP13A2):c.1387G>C (p.Asp463His)	ATP13A2	D458H, D463H	Kufor-Rakeb syndrome	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000874423	1	17322626	1	16996131	874423	862769	rs776550207	NC_000001.11:16996130:C:G
NM_022089.4(ATP13A2):c.2770C>T (p.Arg924Cys)	ATP13A2	R880C, R919C, R924C	Kufor-Rakeb syndrome	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000874374	1	17314722	1	16988227	874374	862761	rs567866687	NC_000001.11:16988226:G:A
NM_022089.4(ATP13A2):c.*9C>A	ATP13A2	H1084N	not provided|Kufor-Rakeb syndrome	Uncertain significance(Last reviewed: Feb 18, 2021)	criteria provided, multiple submitters, no conflicts	VCV000874315	1	17312707	1	16986212	874315	862758	rs773484997	NC_000001.11:16986211:G:T
NM_022089.4(ATP13A2):c.*58A>G	ATP13A2	D1100G	Kufor-Rakeb syndrome	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000874314	1	17312658	1	16986163	874314	862757	rs369126613	NC_000001.11:16986162:T:C
NM_022089.4(ATP13A2):c.*140C>G	ATP13A2		not provided|Kufor-Rakeb syndrome	Benign/Likely benign(Last reviewed: Sep 16, 2019)	criteria provided, multiple submitters, no conflicts	VCV000874313	1	17312576	1	16986081	874313	862756	rs557545457	NC_000001.11:16986080:G:C
NM_022089.4(ATP13A2):c.558-1G>T	ATP13A2		Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive	Likely pathogenic	criteria provided, single submitter	VCV000873473	1	17328869	1	17002374	873473	861603	rs2077392348	NC_000001.11:17002373:C:A
NM_022089.4(ATP13A2):c.2135_2136del (p.Val712fs)	ATP13A2	V712fs, V707fs	Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive	Likely pathogenic	criteria provided, single submitter	VCV000873463	1	17318344 - 17318345	1	16991849 - 16991850	873463	861588	rs2076942520	NC_000001.11:16991848:CACA:CA
NM_022089.4(ATP13A2):c.518A>G (p.Tyr173Cys)	ATP13A2	Y168C, Y173C	Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome|not provided	Uncertain significance(Last reviewed: Nov 28, 2021)	criteria provided, multiple submitters, no conflicts	VCV000872235	1	17330866	1	17004371	872235	858874	rs376963085	NC_000001.11:17004370:T:C
NM_022089.4(ATP13A2):c.1111C>T (p.Arg371Trp)	ATP13A2	R371W, R366W	Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome|not provided	Uncertain significance(Last reviewed: Sep 1, 2021)	criteria provided, multiple submitters, no conflicts	VCV000872234	1	17323599	1	16997104	872234	858873	rs746292302	NC_000001.11:16997103:G:A
NM_022089.4(ATP13A2):c.1847A>C (p.Glu616Ala)	ATP13A2	E616A, E611A	Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome|not provided	Uncertain significance(Last reviewed: May 30, 2020)	criteria provided, multiple submitters, no conflicts	VCV000872233	1	17318896	1	16992401	872233	858872	rs558165485	NC_000001.11:16992400:T:G
NM_022089.4(ATP13A2):c.3068C>T (p.Thr1023Ile)	ATP13A2	T1023I, T979I, T1018I	Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome|not provided	Uncertain significance(Last reviewed: Sep 17, 2021)	criteria provided, multiple submitters, no conflicts	VCV000872232	1	17313556	1	16987061	872232	858871	rs951420437	NC_000001.11:16987060:G:A
NM_022089.4(ATP13A2):c.955G>C (p.Val319Leu)	ATP13A2	V319L, V314L	Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive	Uncertain significance(Last reviewed: Feb 21, 2020)	criteria provided, single submitter	VCV000862331	1	17326590	1	17000095	862331	822984	rs1557702165	NC_000001.11:17000094:C:G
NM_022089.4(ATP13A2):c.409del (p.Val137fs)	ATP13A2	V137fs	Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive	Pathogenic(Last reviewed: Jun 26, 2019)	criteria provided, single submitter	VCV000859962	1	17331255	1	17004760	859962	822988	rs2077487643	NC_000001.11:17004759:CC:C
NM_022089.4(ATP13A2):c.407C>T (p.Ala136Val)	ATP13A2	A136V	Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome	Uncertain significance(Last reviewed: Feb 11, 2020)	criteria provided, single submitter	VCV000856542	1	17331257	1	17004762	856542	822989	rs562519835	NC_000001.11:17004761:G:A
NM_022089.4(ATP13A2):c.3518C>T (p.Pro1173Leu)	ATP13A2	P1173L, P1168L	Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome|not provided	Uncertain significance(Last reviewed: Dec 11, 2019)	criteria provided, multiple submitters, no conflicts	VCV000856355	1	17312741	1	16986246	856355	822981	rs372995036	NC_000001.11:16986245:G:A
NM_022089.4(ATP13A2):c.1102A>G (p.Thr368Ala)	ATP13A2	T363A, T368A	Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome	Uncertain significance(Last reviewed: Mar 7, 2020)	criteria provided, single submitter	VCV000856243	1	17323608	1	16997113	856243	822983	rs1236275703	NC_000001.11:16997112:T:C
NM_022089.4(ATP13A2):c.1845+1G>A	ATP13A2		Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome	Likely pathogenic(Last reviewed: Feb 21, 2019)	criteria provided, single submitter	VCV000854703	1	17318980	1	16992485	854703	851237	rs2076970587	NC_000001.11:16992484:C:T
NM_022089.4(ATP13A2):c.461C>T (p.Ala154Val)	ATP13A2	A154V	Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome	Uncertain significance(Last reviewed: Jan 8, 2019)	criteria provided, single submitter	VCV000854384	1	17331203	1	17004708	854384	822987	rs376169767	NC_000001.11:17004707:G:A
NM_022089.4(ATP13A2):c.595C>T (p.Arg199Cys)	ATP13A2	R194C, R199C	Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome	Uncertain significance(Last reviewed: May 11, 2019)	criteria provided, single submitter	VCV000845963	1	17328831	1	17002336	845963	822986	rs754074592	NC_000001.11:17002335:G:A
NM_022089.4(ATP13A2):c.146G>T (p.Gly49Val)	ATP13A2	G49V	Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome|not provided	Uncertain significance(Last reviewed: Jun 9, 2019)	criteria provided, multiple submitters, no conflicts	VCV000845664	1	17332011	1	17005516	845664	822992	rs372254666	NC_000001.11:17005515:C:A
NM_022089.4(ATP13A2):c.3538A>T (p.Arg1180Trp)	ATP13A2	E1079V, R1175W, R1180W	Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome	Uncertain significance(Last reviewed: Apr 5, 2019)	criteria provided, single submitter	VCV000845582	1	17312721	1	16986226	845582	822980	rs774920921	NC_000001.11:16986225:T:A
NM_022089.4(ATP13A2):c.1105C>G (p.His369Asp)	ATP13A2	H364D, H369D	Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome	Uncertain significance(Last reviewed: Dec 1, 2019)	criteria provided, single submitter	VCV000845242	1	17323605	1	16997110	845242	822982	rs2077158233	NC_000001.11:16997109:G:C
NM_022089.4(ATP13A2):c.394G>A (p.Ala132Thr)	ATP13A2	A132T	Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome	Uncertain significance(Last reviewed: Dec 27, 2019)	criteria provided, single submitter	VCV000843654	1	17331270	1	17004775	843654	822990	rs200934541	NC_000001.11:17004774:C:T
NM_022089.4(ATP13A2):c.816C>G (p.Cys272Trp)	ATP13A2	C267W, C272W	Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome	Uncertain significance(Last reviewed: Dec 13, 2019)	criteria provided, single submitter	VCV000843251	1	17326919	1	17000424	843251	822985	rs755969305	NC_000001.11:17000423:G:C
NM_022089.4(ATP13A2):c.356C>T (p.Pro119Leu)	ATP13A2	P119L	Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive	Uncertain significance(Last reviewed: Dec 13, 2019)	criteria provided, single submitter	VCV000835887	1	17331308	1	17004813	835887	822991	rs752619582	NC_000001.11:17004812:G:A
NM_022089.4(ATP13A2):c.839A>G (p.Lys280Arg)	ATP13A2	K275R, K280R	Kufor-Rakeb syndrome|not provided|Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome	Uncertain significance(Last reviewed: May 10, 2019)	criteria provided, multiple submitters, no conflicts	VCV000806074	1	17326896	1	17000401	806074	794490	rs148094721	NC_000001.11:17000400:T:C
NM_022089.4(ATP13A2):c.1205C>T (p.Thr402Met)	ATP13A2	T397M, T402M	not provided|Kufor-Rakeb syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Jul 12, 2021)	criteria provided, conflicting interpretations	VCV000806073	1	17322982	1	16996487	806073	794489	rs763632781	NC_000001.11:16996486:G:A
NM_022089.4(ATP13A2):c.7G>C (p.Ala3Pro)	ATP13A2	A3P	Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Oct 23, 2020)	criteria provided, conflicting interpretations	VCV000804554	1	17338227	1	17011732	804554	792838	rs549839037	NC_000001.11:17011731:C:G
NM_022089.4(ATP13A2):c.1749+2T>G	ATP13A2		Kufor-Rakeb syndrome	Uncertain significance(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000801452	1	17320122	1	16993627	801452	789877	rs74058364	NC_000001.11:16993626:A:C
NM_022089.4(ATP13A2):c.3490C>A (p.Arg1164=)	ATP13A2	T1063K	Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome|not provided	Likely benign(Last reviewed: Dec 26, 2020)	criteria provided, single submitter	VCV000788230	1	17312769	1	16986274	788230	706863	rs373003359	NC_000001.11:16986273:G:T
NM_022089.4(ATP13A2):c.3384C>T (p.Phe1128=)	ATP13A2		Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome|not provided	Likely benign(Last reviewed: Feb 24, 2018)	criteria provided, single submitter	VCV000784784	1	17312979	1	16986484	784784	706864	rs373514205	NC_000001.11:16986483:G:A
NM_022089.4(ATP13A2):c.2628C>T (p.Cys876=)	ATP13A2		Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome|not provided	Likely benign(Last reviewed: Dec 8, 2021)	criteria provided, single submitter	VCV000783201	1	17314951	1	16988456	783201	706865	rs561561604	NC_000001.11:16988455:G:A
NM_022089.4(ATP13A2):c.39C>T (p.Pro13=)	ATP13A2		Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome|not provided	Likely benign(Last reviewed: Jul 6, 2021)	criteria provided, single submitter	VCV000783174	1	17332245	1	17005750	783174	706866	rs752127537	NC_000001.11:17005749:G:A
NM_022089.4(ATP13A2):c.42C>T (p.Thr14=)	ATP13A2		Kufor-Rakeb syndrome|not provided|Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive	Conflicting interpretations of pathogenicity(Last reviewed: Dec 21, 2018)	criteria provided, conflicting interpretations	VCV000778704	1	17332242	1	17005747	778704	696261	rs371850140	NC_000001.11:17005746:G:A
NM_022089.4(ATP13A2):c.2709C>G (p.Val903=)	ATP13A2		not provided|Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome	Likely benign(Last reviewed: Feb 1, 2021)	criteria provided, multiple submitters, no conflicts	VCV000772797	1	17314870	1	16988375	772797	696255	rs145455452	NC_000001.11:16988374:G:C
NM_022089.4(ATP13A2):c.435G>A (p.Thr145=)	ATP13A2		not provided|Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome	Likely benign(Last reviewed: Aug 19, 2020)	criteria provided, single submitter	VCV000772607	1	17331229	1	17004734	772607	696260	rs201154350	NC_000001.11:17004733:C:T
NM_022089.4(ATP13A2):c.1688G>A (p.Arg563Gln)	ATP13A2	R558Q, R563Q	Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome|not provided	Likely benign(Last reviewed: Jun 21, 2021)	criteria provided, single submitter	VCV000772495	1	17320185	1	16993690	772495	696257	rs541385523	NC_000001.11:16993689:C:T
NM_022089.4(ATP13A2):c.2013C>T (p.Thr671=)	ATP13A2		Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome	Likely benign(Last reviewed: Dec 19, 2019)	criteria provided, single submitter	VCV000772292	1	17318617	1	16992122	772292	696256	rs1176219513	NC_000001.11:16992121:G:A
NM_022089.4(ATP13A2):c.3205G>A (p.Ala1069Thr)	ATP13A2	A1069T, A1064T, A1025T	Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome	Likely benign(Last reviewed: Nov 10, 2020)	criteria provided, single submitter	VCV000772041	1	17313330	1	16986835	772041	696253	rs774238872	NC_000001.11:16986834:C:T
NM_022089.4(ATP13A2):c.2919A>G (p.Thr973=)	ATP13A2		Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome	Likely benign(Last reviewed: Dec 31, 2019)	criteria provided, single submitter	VCV000767232	1	17313705	1	16987210	767232	696254	rs149403933	NC_000001.11:16987209:T:C
NM_022089.4(ATP13A2):c.528C>T (p.Ile176=)	ATP13A2		not provided|Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome	Likely benign(Last reviewed: Sep 14, 2018)	criteria provided, single submitter	VCV000767061	1	17330856	1	17004361	767061	696259	rs371992028	NC_000001.11:17004360:G:A
NM_022089.4(ATP13A2):c.1079G>A (p.Gly360Glu)	ATP13A2	G355E, G360E	Kufor-Rakeb syndrome|not provided|Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Nov 7, 2020)	criteria provided, conflicting interpretations	VCV000766995	1	17323631	1	16997136	766995	696258	rs566918264	NC_000001.11:16997135:C:T
NM_022089.4(ATP13A2):c.636-7C>T	ATP13A2		not provided|Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome	Likely benign(Last reviewed: Jun 29, 2018)	criteria provided, single submitter	VCV000761680	1	17328605	1	17002110	761680	774412	rs762753391	NC_000001.11:17002109:G:A
NM_022089.4(ATP13A2):c.2199G>A (p.Thr733=)	ATP13A2		not provided|Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome	Likely benign(Last reviewed: Jun 1, 2018)	criteria provided, single submitter	VCV000760005	1	17318281	1	16991786	760005	761324	rs1269645931	NC_000001.11:16991785:C:T
NM_022089.4(ATP13A2):c.2529+8C>T	ATP13A2		not provided|Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive	Likely benign(Last reviewed: Oct 28, 2020)	criteria provided, single submitter	VCV000750745	1	17316374	1	16989879	750745	758832	rs771708290	NC_000001.11:16989878:G:A
NM_022089.4(ATP13A2):c.1377C>T (p.Ile459=)	ATP13A2		not provided|Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive	Likely benign(Last reviewed: Mar 6, 2018)	criteria provided, single submitter	VCV000749465	1	17322636	1	16996141	749465	745837	rs1570823082	NC_000001.11:16996140:G:A
NM_022089.4(ATP13A2):c.2762+9G>A	ATP13A2		not provided|Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive	Likely benign(Last reviewed: Sep 4, 2018)	criteria provided, single submitter	VCV000749013	1	17314808	1	16988313	749013	758879	rs1570769698	NC_000001.11:16988312:C:T
NM_022089.4(ATP13A2):c.24C>T (p.Leu8=)	ATP13A2		Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome|not provided	Likely benign(Last reviewed: May 3, 2021)	criteria provided, single submitter	VCV000743198	1	17332260	1	17005765	743198	745839	rs1460426486	NC_000001.11:17005764:G:A
NM_022089.4(ATP13A2):c.2682G>A (p.Ser894=)	ATP13A2		Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome|not provided	Likely benign(Last reviewed: Jun 23, 2020)	criteria provided, single submitter	VCV000743172	1	17314897	1	16988402	743172	745835	rs767921922	NC_000001.11:16988401:C:T
NM_022089.4(ATP13A2):c.69A>G (p.Thr23=)	ATP13A2		not provided|Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome	Likely benign(Last reviewed: Nov 7, 2020)	criteria provided, single submitter	VCV000741503	1	17332215	1	17005720	741503	745838	rs1196381069	NC_000001.11:17005719:T:C
NM_022089.4(ATP13A2):c.823C>T (p.Leu275=)	ATP13A2		Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive	Likely benign(Last reviewed: Mar 28, 2019)	criteria provided, single submitter	VCV000727989	1	17326912	1	17000417	727989	731862	rs767056514	NC_000001.11:17000416:G:A
NM_022089.4(ATP13A2):c.2061C>T (p.Val687=)	ATP13A2		Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive	Likely benign(Last reviewed: Dec 31, 2019)	criteria provided, single submitter	VCV000714640	1	17318569	1	16992074	714640	718381	rs370622481	NC_000001.11:16992073:G:A
NM_022089.4(ATP13A2):c.1196-9C>T	ATP13A2		Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive	Likely benign(Last reviewed: Oct 6, 2019)	criteria provided, single submitter	VCV000712759	1	17323000	1	16996505	712759	729937	rs747077419	NC_000001.11:16996504:G:A
NM_022089.4(ATP13A2):c.111C>T (p.Leu37=)	ATP13A2		not provided|Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive	Likely benign(Last reviewed: Aug 9, 2018)	criteria provided, single submitter	VCV000711585	1	17332046	1	17005551	711585	718383	rs1331180219	NC_000001.11:17005550:G:A
NM_022089.4(ATP13A2):c.1767G>A (p.Pro589=)	ATP13A2		Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome|Kufor-Rakeb syndrome|not specified	Conflicting interpretations of pathogenicity(Last reviewed: Nov 16, 2020)	criteria provided, conflicting interpretations	VCV000707755	1	17319059	1	16992564	707755	690412	rs752208167	NC_000001.11:16992563:C:T
NM_022089.4(ATP13A2):c.423C>T (p.Ala141=)	ATP13A2		Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome	Likely benign(Last reviewed: Jun 22, 2019)	criteria provided, single submitter	VCV000707726	1	17331241	1	17004746	707726	690415	rs1258288001	NC_000001.11:17004745:G:A
NM_022089.4(ATP13A2):c.1629T>A (p.Pro543=)	ATP13A2		Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome|not provided	Likely benign(Last reviewed: Sep 1, 2021)	criteria provided, single submitter	VCV000706068	1	17320244	1	16993749	706068	690413	rs369352100	NC_000001.11:16993748:A:T
NM_022089.4(ATP13A2):c.106-5C>T	ATP13A2		Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome|Kufor-Rakeb syndrome	Benign/Likely benign(Last reviewed: Dec 4, 2020)	criteria provided, multiple submitters, no conflicts	VCV000705980	1	17332056	1	17005561	705980	695019	rs117838709	NC_000001.11:17005560:G:A
NM_022089.4(ATP13A2):c.2160G>T (p.Gly720=)	ATP13A2		Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome|not provided	Likely benign(Last reviewed: Dec 26, 2018)	criteria provided, single submitter	VCV000705946	1	17318320	1	16991825	705946	690410	rs61999317	NC_000001.11:16991824:C:A
NM_022089.4(ATP13A2):c.3327G>A (p.Arg1109=)	ATP13A2		Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome|not provided	Likely benign(Last reviewed: Dec 2, 2021)	criteria provided, single submitter	VCV000705760	1	17313036	1	16986541	705760	690408	rs112261486	NC_000001.11:16986540:C:T
NM_022089.4(ATP13A2):c.3087C>T (p.Phe1029=)	ATP13A2		Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome|Kufor-Rakeb syndrome|not provided	Benign/Likely benign(Last reviewed: Dec 30, 2020)	criteria provided, multiple submitters, no conflicts	VCV000705032	1	17313448	1	16986953	705032	690409	rs184878897	NC_000001.11:16986952:G:A
NM_022089.4(ATP13A2):c.36G>A (p.Thr12=)	ATP13A2		Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome|Kufor-Rakeb syndrome|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Dec 9, 2021)	criteria provided, conflicting interpretations	VCV000705000	1	17332248	1	17005753	705000	690416	rs61741838	NC_000001.11:17005752:C:T
NM_022089.4(ATP13A2):c.2252-8A>T	ATP13A2		Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Dec 31, 2019)	criteria provided, conflicting interpretations	VCV000704722	1	17316790	1	16990295	704722	695016	rs759020707	NC_000001.11:16990294:T:A
NM_022089.4(ATP13A2):c.1543-9C>T	ATP13A2		Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome	Likely benign(Last reviewed: Oct 12, 2020)	criteria provided, single submitter	VCV000704263	1	17320339	1	16993844	704263	695017	rs563459900	NC_000001.11:16993843:G:A
NM_022089.4(ATP13A2):c.588C>T (p.Asp196=)	ATP13A2		not provided|Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome	Likely benign(Last reviewed: Nov 6, 2020)	criteria provided, single submitter	VCV000703969	1	17328838	1	17002343	703969	690414	rs147384248	NC_000001.11:17002342:G:A
NM_022089.4(ATP13A2):c.705+228A>G	ATP13A2		not provided|Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome	Benign(Last reviewed: Dec 7, 2020)	criteria provided, multiple submitters, no conflicts	VCV000703790	1	17328301	1	17001806	703790	695018	rs2871776	NC_000001.11:17001805:T:C
NM_022089.4(ATP13A2):c.859G>A (p.Asp287Asn)	ATP13A2	D282N, D287N	Kufor-Rakeb syndrome	Uncertain significance(Last reviewed: Jul 2, 2019)	criteria provided, single submitter	VCV000689486	1	17326789	1	17000294	689486	677123	rs764560082	NC_000001.11:17000293:C:T
NM_022089.4(ATP13A2):c.431A>T (p.Asp144Val)	ATP13A2	D144V	Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive|not provided	Uncertain significance(Last reviewed: Apr 19, 2021)	criteria provided, multiple submitters, no conflicts	VCV000664804	1	17331233	1	17004738	664804	627073	rs145031260	NC_000001.11:17004737:T:A
NM_022089.4(ATP13A2):c.3157_3158del (p.Leu1053fs)	ATP13A2	L1009fs, L1053fs, L1048fs	Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome	Pathogenic(Last reviewed: Sep 19, 2018)	criteria provided, single submitter	VCV000660925	1	17313377 - 17313378	1	16986882 - 16986883	660925	627060	rs1570759415	NC_000001.11:16986881:AGAGAGA:AGAGA
NC_000001.11:g.(?_16991714)_(16992601_?)del	ATP13A2		Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome	Pathogenic(Last reviewed: Jul 13, 2018)	criteria provided, single submitter	VCV000660676	1	17318209 - 17319096	1	16991714 - 16992601	660676	650536		
NM_022089.4(ATP13A2):c.1017G>C (p.Met339Ile)	ATP13A2	M334I, M339I	Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome	Uncertain significance(Last reviewed: Sep 14, 2018)	criteria provided, single submitter	VCV000658891	1	17326528	1	17000033	658891	627070	rs1345269003	NC_000001.11:17000032:C:G
NM_022089.4(ATP13A2):c.658G>A (p.Val220Met)	ATP13A2	V220M, V215M	Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome	Uncertain significance(Last reviewed: Oct 19, 2019)	criteria provided, single submitter	VCV000657632	1	17328576	1	17002081	657632	627071	rs367693423	NC_000001.11:17002080:C:T
NM_022089.4(ATP13A2):c.706-3C>T	ATP13A2		Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome	Uncertain significance(Last reviewed: Sep 5, 2018)	criteria provided, single submitter	VCV000654444	1	17327032	1	17000537	654444	650592	rs753707797	NC_000001.11:17000536:G:A
NM_022089.4(ATP13A2):c.2951C>T (p.Ala984Val)	ATP13A2	A940V, A979V, A984V	Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome	Uncertain significance(Last reviewed: Dec 31, 2019)	criteria provided, single submitter	VCV000653589	1	17313673	1	16987178	653589	627063	rs375552345	NC_000001.11:16987177:G:A
NM_022089.4(ATP13A2):c.1896G>A (p.Ser632=)	ATP13A2		Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome	Uncertain significance(Last reviewed: Nov 14, 2018)	criteria provided, single submitter	VCV000652812	1	17318847	1	16992352	652812	627065	rs575694238	NC_000001.11:16992351:C:T
NM_022089.4(ATP13A2):c.233G>A (p.Arg78Gln)	ATP13A2	R78Q	Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive	Uncertain significance(Last reviewed: Nov 21, 2018)	criteria provided, single submitter	VCV000651864	1	17331924	1	17005429	651864	627074	rs773087322	NC_000001.11:17005428:C:T
NM_022089.4(ATP13A2):c.509G>T (p.Gly170Val)	ATP13A2	G170V, G165V	Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive	Uncertain significance(Last reviewed: Dec 17, 2018)	criteria provided, single submitter	VCV000651385	1	17330875	1	17004380	651385	627072	rs1369312171	NC_000001.11:17004379:C:A
NM_022089.4(ATP13A2):c.212G>T (p.Trp71Leu)	ATP13A2	W71L	Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive	Uncertain significance(Last reviewed: Dec 23, 2018)	criteria provided, single submitter	VCV000649178	1	17331945	1	17005450	649178	627075	rs373607247	NC_000001.11:17005449:C:A
NM_022089.4(ATP13A2):c.1876C>T (p.His626Tyr)	ATP13A2	H626Y, H621Y	Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive|not provided	Uncertain significance(Last reviewed: Nov 7, 2019)	criteria provided, multiple submitters, no conflicts	VCV000647413	1	17318867	1	16992372	647413	627066	rs778267471	NC_000001.11:16992371:G:A
NM_022089.4(ATP13A2):c.35C>T (p.Thr12Met)	ATP13A2	T12M	Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome	Uncertain significance(Last reviewed: Sep 19, 2018)	criteria provided, multiple submitters, no conflicts	VCV000646881	1	17332249	1	17005754	646881	627076	rs151117874	NC_000001.11:17005753:G:A
NM_022089.4(ATP13A2):c.1634G>A (p.Arg545His)	ATP13A2	R540H, R545H	Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive	Uncertain significance(Last reviewed: Nov 1, 2018)	criteria provided, single submitter	VCV000646609	1	17320239	1	16993744	646609	627067	rs200337290	NC_000001.11:16993743:C:T
NM_022089.4(ATP13A2):c.2828C>T (p.Thr943Ile)	ATP13A2	T938I, T899I, T943I	Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive	Uncertain significance(Last reviewed: Dec 3, 2018)	criteria provided, single submitter	VCV000645131	1	17314664	1	16988169	645131	627064	rs1401431520	NC_000001.11:16988168:G:A
NM_022089.4(ATP13A2):c.2978C>T (p.Pro993Leu)	ATP13A2	P993L, P988L, P949L	Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome	Uncertain significance(Last reviewed: Sep 10, 2018)	criteria provided, single submitter	VCV000644097	1	17313646	1	16987151	644097	627062	rs146559160	NC_000001.11:16987150:G:A
NM_022089.4(ATP13A2):c.2995G>A (p.Val999Met)	ATP13A2	V999M, V955M, V994M	Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome	Uncertain significance(Last reviewed: Jan 27, 2020)	criteria provided, single submitter	VCV000643225	1	17313629	1	16987134	643225	627061	rs764162255	NC_000001.11:16987133:C:T
NM_022089.4(ATP13A2):c.3535del (p.Pro1178_Leu1179insTer)	ATP13A2	P1078fs	Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome	Uncertain significance(Last reviewed: Nov 21, 2018)	criteria provided, single submitter	VCV000642673	1	17312724	1	16986229	642673	627059	rs1570752813	NC_000001.11:16986228:GGGGG:GGGG
NM_022089.4(ATP13A2):c.1126T>C (p.Cys376Arg)	ATP13A2	C376R, C371R	Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome	Uncertain significance(Last reviewed: Dec 13, 2018)	criteria provided, single submitter	VCV000642320	1	17323584	1	16997089	642320	627068	rs1570833382	NC_000001.11:16997088:A:G
NM_022089.4(ATP13A2):c.1103C>T (p.Thr368Ile)	ATP13A2	T363I, T368I	Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome	Uncertain significance(Last reviewed: Oct 19, 2018)	criteria provided, single submitter	VCV000641968	1	17323607	1	16997112	641968	627069	rs1033088325	NC_000001.11:16997111:G:A
NM_022089.4(ATP13A2):c.1777_1778del (p.Ala594fs)	ATP13A2	A589fs, A594fs	Kufor-Rakeb syndrome	Uncertain significance(Last reviewed: Jan 31, 2018)	criteria provided, single submitter	VCV000632090	1	17319048 - 17319049	1	16992553 - 16992554	632090	619966	rs1557683241	NC_000001.11:16992552:GAG:G
NM_022089.4(ATP13A2):c.2983del (p.Ala995fs)	ATP13A2	A951fs, A995fs, A990fs	Kufor-Rakeb syndrome	Uncertain significance(Last reviewed: Jul 12, 2017)	criteria provided, single submitter	VCV000632089	1	17313641	1	16987146	632089	619965	rs1414662479	NC_000001.11:16987145:CCCCC:CCCC
NM_022089.4(ATP13A2):c.2640C>T (p.Ala880=)	ATP13A2		Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Apr 29, 2021)	criteria provided, conflicting interpretations	VCV000626064	1	17314939	1	16988444	626064	614198	rs567287489	NC_000001.11:16988443:G:A
NM_022089.4(ATP13A2):c.2746G>A (p.Val916Met)	ATP13A2	V916M, V872M, V911M	Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome	Uncertain significance(Last reviewed: Aug 28, 2021)	criteria provided, multiple submitters, no conflicts	VCV000626063	1	17314833	1	16988338	626063	614197	rs768674400	NC_000001.11:16988337:C:T
NM_022089.4(ATP13A2):c.3405+9C>T	ATP13A2		Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome|not provided|Kufor-Rakeb syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Nov 16, 2020)	criteria provided, conflicting interpretations	VCV000626062	1	17312949	1	16986454	626062	614196	rs374766933	NC_000001.11:16986453:G:A
NM_022089.4(ATP13A2):c.1039+6C>T	ATP13A2		Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome|not provided	Uncertain significance(Last reviewed: Feb 1, 2022)	criteria provided, multiple submitters, no conflicts	VCV000625890	1	17326500	1	17000005	625890	614200	rs565724504	NC_000001.11:17000004:G:A
NM_022089.4(ATP13A2):c.1542+3G>A	ATP13A2		Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome	Uncertain significance(Last reviewed: Mar 22, 2021)	criteria provided, multiple submitters, no conflicts	VCV000625889	1	17322468	1	16995973	625889	614199	rs747456787	NC_000001.11:16995972:C:T
NM_022089.4(ATP13A2):c.1080G>C (p.Gly360=)	ATP13A2		Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Mar 29, 2020)	criteria provided, conflicting interpretations	VCV000596731	1	17323630	1	16997135	596731	587792	rs55943100	NC_000001.11:16997134:C:G
NM_022089.4(ATP13A2):c.3258G>A (p.Ala1086=)	ATP13A2		Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive|not provided|Kufor-Rakeb syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Nov 1, 2021)	criteria provided, conflicting interpretations	VCV000593131	1	17313105	1	16986610	593131	584195	rs377253172	NC_000001.11:16986609:C:T
NM_022089.4(ATP13A2):c.3084-10G>A	ATP13A2		Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Dec 16, 2020)	criteria provided, conflicting interpretations	VCV000592992	1	17313461	1	16986966	592992	584056	rs368908107	NC_000001.11:16986965:C:T
NM_022089.4(ATP13A2):c.2020G>A (p.Ala674Thr)	ATP13A2	A674T, A669T	Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive|not provided|History of neurodevelopmental disorder	Uncertain significance(Last reviewed: May 3, 2019)	criteria provided, multiple submitters, no conflicts	VCV000590155	1	17318610	1	16992115	590155	578784	rs143834546	NC_000001.11:16992114:C:T
NM_022089.4(ATP13A2):c.2151C>T (p.Ser717=)	ATP13A2		Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive|History of neurodevelopmental disorder	Benign/Likely benign(Last reviewed: Jun 12, 2020)	criteria provided, multiple submitters, no conflicts	VCV000590119	1	17318329	1	16991834	590119	578779	rs544545629	NC_000001.11:16991833:G:A
NM_022089.4(ATP13A2):c.1662A>T (p.Ala554=)	ATP13A2		Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive|History of neurodevelopmental disorder|not provided	Likely benign(Last reviewed: Apr 17, 2021)	criteria provided, multiple submitters, no conflicts	VCV000590107	1	17320211	1	16993716	590107	578787	rs1269279941	NC_000001.11:16993715:T:A
NM_022089.4(ATP13A2):c.114C>T (p.Ser38=)	ATP13A2		Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive|History of neurodevelopmental disorder|Kufor-Rakeb syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Mar 13, 2019)	criteria provided, conflicting interpretations	VCV000590096	1	17332043	1	17005548	590096	578804	rs368279466	NC_000001.11:17005547:G:A
NM_022089.4(ATP13A2):c.1536C>T (p.Phe512=)	ATP13A2		Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive|History of neurodevelopmental disorder|Kufor-Rakeb syndrome	Benign/Likely benign(Last reviewed: Oct 27, 2020)	criteria provided, multiple submitters, no conflicts	VCV000590058	1	17322477	1	16995982	590058	578811	rs536306337	NC_000001.11:16995981:G:A
NM_022089.4(ATP13A2):c.3257C>T (p.Ala1086Val)	ATP13A2	A1086V, A1081V	Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive|History of neurodevelopmental disorder|Kufor-Rakeb syndrome	Uncertain significance(Last reviewed: Sep 9, 2019)	criteria provided, multiple submitters, no conflicts	VCV000589979	1	17313106	1	16986611	589979	578794	rs370677966	NC_000001.11:16986610:G:A
NM_022089.4(ATP13A2):c.2655C>T (p.Ala885=)	ATP13A2		Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive|History of neurodevelopmental disorder|not provided	Likely benign(Last reviewed: Oct 10, 2021)	criteria provided, multiple submitters, no conflicts	VCV000589957	1	17314924	1	16988429	589957	578782	rs371975975	NC_000001.11:16988428:G:A
NM_022089.4(ATP13A2):c.2221A>C (p.Arg741=)	ATP13A2		Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome|History of neurodevelopmental disorder	Likely benign(Last reviewed: Jun 6, 2019)	criteria provided, multiple submitters, no conflicts	VCV000589241	1	17318259	1	16991764	589241	578776	rs754926284	NC_000001.11:16991763:T:G
NM_022089.4(ATP13A2):c.1399G>A (p.Val467Met)	ATP13A2	V467M, V462M	Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome|History of neurodevelopmental disorder	Uncertain significance(Last reviewed: Aug 6, 2018)	criteria provided, multiple submitters, no conflicts	VCV000588886	1	17322614	1	16996119	588886	578793	rs760443267	NC_000001.11:16996118:C:T
NM_022089.4(ATP13A2):c.648C>T (p.Tyr216=)	ATP13A2		History of neurodevelopmental disorder|Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome	Likely benign(Last reviewed: Nov 6, 2021)	criteria provided, multiple submitters, no conflicts	VCV000588786	1	17328586	1	17002091	588786	578837	rs769405638	NC_000001.11:17002090:G:A
NM_022089.4(ATP13A2):c.1667C>T (p.Ala556Val)	ATP13A2	A556V, A551V	History of neurodevelopmental disorder|Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome	Uncertain significance(Last reviewed: Sep 17, 2021)	criteria provided, multiple submitters, no conflicts	VCV000588607	1	17320206	1	16993711	588607	578786	rs760021599	NC_000001.11:16993710:G:A
NM_022089.4(ATP13A2):c.3342C>T (p.Thr1114=)	ATP13A2		History of neurodevelopmental disorder|Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome|not provided|Kufor-Rakeb syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Apr 1, 2021)	criteria provided, conflicting interpretations	VCV000588527	1	17313021	1	16986526	588527	578790	rs115985012	NC_000001.11:16986525:G:A
NM_022089.4(ATP13A2):c.145G>A (p.Gly49Ser)	ATP13A2	G49S	Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome|History of neurodevelopmental disorder|not provided|Kufor-Rakeb syndrome	Benign/Likely benign(Last reviewed: Dec 10, 2020)	criteria provided, multiple submitters, no conflicts	VCV000588136	1	17332012	1	17005517	588136	578803	rs56379718	NC_000001.11:17005516:C:T
NM_022089.4(ATP13A2):c.3529G>A (p.Gly1177Ser)	ATP13A2	G1177S, G1172S, R1076Q	Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome|History of neurodevelopmental disorder	Conflicting interpretations of pathogenicity(Last reviewed: Oct 29, 2020)	criteria provided, conflicting interpretations	VCV000587913	1	17312730	1	16986235	587913	578778	rs547860186	NC_000001.11:16986234:C:T
NM_022089.4(ATP13A2):c.3222G>A (p.Pro1074=)	ATP13A2		Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome|not provided	Conflicting interpretations of pathogenicity(Last reviewed: May 12, 2020)	criteria provided, conflicting interpretations	VCV000585471	1	17313313	1	16986818	585471	576436	rs372993383	NC_000001.11:16986817:C:T
NM_022089.4(ATP13A2):c.3059A>G (p.Tyr1020Cys)	ATP13A2	Y1020C, Y1015C, Y976C	Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome|not provided	Uncertain significance(Last reviewed: Dec 15, 2021)	criteria provided, multiple submitters, no conflicts	VCV000585470	1	17313565	1	16987070	585470	576437	rs372182128	NC_000001.11:16987069:T:C
NM_022089.4(ATP13A2):c.252C>T (p.His84=)	ATP13A2		Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome|not provided	Likely benign(Last reviewed: Dec 31, 2019)	criteria provided, multiple submitters, no conflicts	VCV000585469	1	17331905	1	17005410	585469	576441	rs554944790	NC_000001.11:17005409:G:A
NM_022089.4(ATP13A2):c.220C>T (p.Arg74Trp)	ATP13A2	R74W	Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome|not provided	Uncertain significance(Last reviewed: Oct 12, 2021)	criteria provided, multiple submitters, no conflicts	VCV000585468	1	17331937	1	17005442	585468	576442	rs753087058	NC_000001.11:17005441:G:A
NM_022089.4(ATP13A2):c.2198C>T (p.Thr733Met)	ATP13A2	T733M, T728M	History of neurodevelopmental disorder|Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Oct 1, 2020)	criteria provided, conflicting interpretations	VCV000585467	1	17318282	1	16991787	585467	576438	rs201883464	NC_000001.11:16991786:G:A
NM_022089.4(ATP13A2):c.746C>T (p.Ala249Val)	ATP13A2	A249V, A244V	Kufor-Rakeb syndrome|Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Nov 6, 2020)	criteria provided, conflicting interpretations	VCV000585085	1	17326989	1	17000494	585085	576078	rs145515028	NC_000001.11:17000493:G:A
NM_022089.4(ATP13A2):c.3329A>G (p.Asn1110Ser)	ATP13A2	N1110S, N1105S	Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive	Uncertain significance(Last reviewed: Aug 2, 2019)	criteria provided, single submitter	VCV000583336	1	17313034	1	16986539	583336	558224	rs758675397	NC_000001.11:16986538:T:C
NM_022089.4(ATP13A2):c.2T>G (p.Met1Arg)	ATP13A2	M1R	Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive	Uncertain significance(Last reviewed: Mar 30, 2018)	criteria provided, single submitter	VCV000583076	1	17338232	1	17011737	583076	558234	rs1557729552	NC_000001.11:17011736:A:C
NM_022089.4(ATP13A2):c.656A>G (p.Asn219Ser)	ATP13A2	N219S, N214S	Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive	Uncertain significance(Last reviewed: Apr 3, 2018)	criteria provided, single submitter	VCV000582385	1	17328578	1	17002083	582385	557038	rs776406555	NC_000001.11:17002082:T:C
NM_022089.4(ATP13A2):c.649G>A (p.Gly217Ser)	ATP13A2	G217S, G212S	Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive|Spastic paraplegia 78, autosomal recessive	Uncertain significance(Last reviewed: Jul 23, 2019)	criteria provided, multiple submitters, no conflicts	VCV000582023	1	17328585	1	17002090	582023	556688	rs199961048	NC_000001.11:17002089:C:T
NM_022089.4(ATP13A2):c.574C>T (p.Arg192Cys)	ATP13A2	R192C, R187C	Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome	Uncertain significance(Last reviewed: May 3, 2018)	criteria provided, single submitter	VCV000579676	1	17328852	1	17002357	579676	558230	rs372857244	NC_000001.11:17002356:G:A
NM_022089.4(ATP13A2):c.385C>T (p.Arg129Trp)	ATP13A2	R129W	Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome	Uncertain significance(Last reviewed: Jan 19, 2018)	criteria provided, single submitter	VCV000579095	1	17331279	1	17004784	579095	558232	rs1318096890	NC_000001.11:17004783:G:A
NM_022089.4(ATP13A2):c.1630C>T (p.Arg544Cys)	ATP13A2	R544C, R539C	Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome	Uncertain significance(Last reviewed: Oct 18, 2019)	criteria provided, single submitter	VCV000578934	1	17320243	1	16993748	578934	556739	rs893985839	NC_000001.11:16993747:G:A
NM_022089.4(ATP13A2):c.811A>G (p.Ile271Val)	ATP13A2	I271V, I266V	Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome	Uncertain significance(Last reviewed: May 2, 2018)	criteria provided, single submitter	VCV000577023	1	17326924	1	17000429	577023	557034	rs561097876	NC_000001.11:17000428:T:C
NM_022089.4(ATP13A2):c.2557C>G (p.Arg853Gly)	ATP13A2	R853G, R848G, R809G	Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive	Uncertain significance(Last reviewed: Jun 19, 2018)	criteria provided, single submitter	VCV000576357	1	17316238	1	16989743	576357	558226	rs772243999	NC_000001.11:16989742:G:C
NM_022089.4(ATP13A2):c.769T>C (p.Tyr257His)	ATP13A2	Y257H, Y252H	Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive	Uncertain significance(Last reviewed: May 22, 2018)	criteria provided, single submitter	VCV000572420	1	17326966	1	17000471	572420	557036	rs370403918	NC_000001.11:17000470:A:G
NM_022089.4(ATP13A2):c.813C>G (p.Ile271Met)	ATP13A2	I271M, I266M	Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive	Uncertain significance(Last reviewed: Mar 8, 2019)	criteria provided, single submitter	VCV000570178	1	17326922	1	17000427	570178	556686	rs1557703924	NC_000001.11:17000426:G:C
NM_022089.4(ATP13A2):c.472G>A (p.Gly158Arg)	ATP13A2	G158R	Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive|not provided	Uncertain significance(Last reviewed: Nov 8, 2019)	criteria provided, multiple submitters, no conflicts	VCV000569020	1	17331192	1	17004697	569020	556741	rs113643181	NC_000001.11:17004696:C:T
NM_022089.4(ATP13A2):c.3314C>T (p.Pro1105Leu)	ATP13A2	P1105L, P1100L	Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Dec 24, 2020)	criteria provided, conflicting interpretations	VCV000568939	1	17313049	1	16986554	568939	556737	rs201756175	NC_000001.11:16986553:G:A
NM_022089.4(ATP13A2):c.3409G>A (p.Val1137Met)	ATP13A2	V1137M, V1132M, R1036H	Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome	Uncertain significance(Last reviewed: Feb 17, 2018)	criteria provided, single submitter	VCV000567500	1	17312850	1	16986355	567500	558222	rs528943677	NC_000001.11:16986354:C:T
NM_022089.4(ATP13A2):c.878T>C (p.Met293Thr)	ATP13A2	M293T, M288T	Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome	Uncertain significance(Last reviewed: Feb 9, 2018)	criteria provided, single submitter	VCV000567424	1	17326770	1	17000275	567424	558228	rs772414750	NC_000001.11:17000274:A:G
NM_022089.4(ATP13A2):c.2972G>A (p.Arg991Gln)	ATP13A2	R991Q, R947Q, R986Q	not provided|Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome	Uncertain significance(Last reviewed: Dec 13, 2019)	criteria provided, multiple submitters, no conflicts	VCV000566669	1	17313652	1	16987157	566669	556682	rs145548316	NC_000001.11:16987156:C:T
NM_022089.4(ATP13A2):c.2260C>G (p.Leu754Val)	ATP13A2	L754V, L749V	Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome	Uncertain significance(Last reviewed: Apr 5, 2018)	criteria provided, single submitter	VCV000566479	1	17316774	1	16990279	566479	556684	rs139909551	NC_000001.11:16990278:G:C
NM_022089.4(ATP13A2):c.706-13G>T	ATP13A2		Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome|not provided	Likely benign(Last reviewed: Apr 16, 2021)	criteria provided, single submitter	VCV000559006	1	17327042	1	17000547	559006	549509	rs374468183	NC_000001.11:17000546:C:A
NM_022089.4(ATP13A2):c.2763-16G>A	ATP13A2		not provided|Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome	Benign/Likely benign(Last reviewed: Nov 30, 2020)	criteria provided, multiple submitters, no conflicts	VCV000559003	1	17314745	1	16988250	559003	549506	rs114407349	NC_000001.11:16988249:C:T
NM_022089.4(ATP13A2):c.3235+13G>A	ATP13A2		Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome|not provided	Likely benign(Last reviewed: Oct 18, 2021)	criteria provided, single submitter	VCV000559001	1	17313287	1	16986792	559001	549504	rs369278996	NC_000001.11:16986791:C:T
NM_022089.4(ATP13A2):c.3236-30C>T	ATP13A2		Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome|not provided	Benign(Last reviewed: Jul 14, 2021)	criteria provided, multiple submitters, no conflicts	VCV000559000	1	17313157	1	16986662	559000	549503	rs2076605	NC_000001.11:16986661:G:A
NM_022089.4(ATP13A2):c.3473G>A (p.Arg1158His)	ATP13A2	R1158H, R1153H	Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome|not provided	Uncertain significance(Last reviewed: Oct 24, 2019)	criteria provided, single submitter	VCV000558999	1	17312786	1	16986291	558999	549502	rs544885605	NC_000001.11:16986290:C:T
NM_022089.4(ATP13A2):c.477+2T>G	ATP13A2		History of neurodevelopmental disorder|Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive|Neurodegeneration with brain iron accumulation|not provided	Likely pathogenic(Last reviewed: Dec 28, 2020)	criteria provided, multiple submitters, no conflicts	VCV000546591	1	17331185	1	17004690	546591	537080	rs758014228	NC_000001.11:17004689:A:C
NM_022089.4(ATP13A2):c.2251+6A>C	ATP13A2		Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive|not provided	Uncertain significance(Last reviewed: Nov 27, 2021)	criteria provided, multiple submitters, no conflicts	VCV000546590	1	17318223	1	16991728	546590	537079	rs773458244	NC_000001.11:16991727:T:G
NM_022089.4(ATP13A2):c.1711G>A (p.Asp571Asn)	ATP13A2	D571N, D566N	not provided|Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome|Kufor-Rakeb syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Nov 16, 2020)	criteria provided, conflicting interpretations	VCV000546326	1	17320162	1	16993667	546326	536569	rs369863178	NC_000001.11:16993666:C:T
NM_022089.4(ATP13A2):c.844A>T (p.Ser282Cys)	ATP13A2	S282C, S277C	Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome|not provided	Likely benign(Last reviewed: Mar 6, 2020)	criteria provided, single submitter	VCV000533811	1	17326804	1	17000309	533811	515306	rs538497077	NC_000001.11:17000308:T:A
NM_022089.4(ATP13A2):c.2093T>C (p.Val698Ala)	ATP13A2	V698A, V693A	Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome|not provided|History of neurodevelopmental disorder|Kufor-Rakeb syndrome	Benign/Likely benign(Last reviewed: Dec 4, 2020)	criteria provided, multiple submitters, no conflicts	VCV000533810	1	17318537	1	16992042	533810	515265	rs61734958	NC_000001.11:16992041:A:G
NM_022089.4(ATP13A2):c.2610-9T>C	ATP13A2		Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome	Likely benign(Last reviewed: Oct 21, 2020)	criteria provided, single submitter	VCV000533809	1	17314978	1	16988483	533809	515351	rs376189607	NC_000001.11:16988482:A:G
NM_022089.4(ATP13A2):c.745G>A (p.Ala249Thr)	ATP13A2	A249T, A244T	Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome|not provided	Uncertain significance(Last reviewed: Mar 7, 2019)	criteria provided, multiple submitters, no conflicts	VCV000533808	1	17326990	1	17000495	533808	515315	rs199661793	NC_000001.11:17000494:C:T
NM_022089.4(ATP13A2):c.2899G>C (p.Asp967His)	ATP13A2	D967H, D923H, D962H	Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome	Uncertain significance(Last reviewed: Oct 10, 2018)	criteria provided, single submitter	VCV000533807	1	17313725	1	16987230	533807	515264	rs772870846	NC_000001.11:16987229:C:G
NM_022089.4(ATP13A2):c.2158G>T (p.Gly720Trp)	ATP13A2	G720W, G715W	Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome	Uncertain significance(Last reviewed: Mar 29, 2019)	criteria provided, single submitter	VCV000533806	1	17318322	1	16991827	533806	515354	rs865939676	NC_000001.11:16991826:C:A
NM_022089.4(ATP13A2):c.3476T>C (p.Phe1159Ser)	ATP13A2	F1159S, F1154S	Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome	Uncertain significance(Last reviewed: Nov 27, 2017)	criteria provided, single submitter	VCV000533805	1	17312783	1	16986288	533805	515274	rs1553164387	NC_000001.11:16986287:A:G
NM_022089.4(ATP13A2):c.1895C>T (p.Ser632Leu)	ATP13A2	S632L, S627L	Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome	Uncertain significance(Last reviewed: Aug 17, 2017)	criteria provided, single submitter	VCV000533804	1	17318848	1	16992353	533804	515276	rs376070950	NC_000001.11:16992352:G:A
NM_022089.4(ATP13A2):c.2942C>T (p.Thr981Met)	ATP13A2	T981M, T937M, T976M	Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome|History of neurodevelopmental disorder	Conflicting interpretations of pathogenicity(Last reviewed: Aug 21, 2019)	criteria provided, conflicting interpretations	VCV000533803	1	17313682	1	16987187	533803	515262	rs148201608	NC_000001.11:16987186:G:A
NM_022089.4(ATP13A2):c.2404G>A (p.Gly802Ser)	ATP13A2	G802S, G797S	Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome|not provided	Uncertain significance(Last reviewed: Dec 19, 2019)	criteria provided, multiple submitters, no conflicts	VCV000533802	1	17316630	1	16990135	533802	515352	rs752487771	NC_000001.11:16990134:C:T
NM_022089.4(ATP13A2):c.1171G>A (p.Val391Ile)	ATP13A2	V391I, V386I	Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome|History of neurodevelopmental disorder|not provided	Uncertain significance(Last reviewed: Feb 27, 2020)	criteria provided, multiple submitters, no conflicts	VCV000500604	1	17323539	1	16997044	500604	492028	rs113105667	NC_000001.11:16997043:C:T
NM_022089.4(ATP13A2):c.*120A>T	ATP13A2	T1121S	Kufor-Rakeb syndrome|not provided	Benign/Likely benign(Last reviewed: Nov 1, 2021)	criteria provided, multiple submitters, no conflicts	VCV000493023	1	17312596	1	16986101	493023	485986	rs41273151	NC_000001.11:16986100:T:A
NM_022089.4(ATP13A2):c.777C>T (p.Tyr259=)	ATP13A2		History of neurodevelopmental disorder|Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome	Likely benign(Last reviewed: May 31, 2019)	criteria provided, multiple submitters, no conflicts	VCV000465265	1	17326958	1	17000463	465265	447421	rs780133367	NC_000001.11:17000462:G:A
NM_022089.4(ATP13A2):c.508G>A (p.Gly170Ser)	ATP13A2	G170S, G165S	Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome	Uncertain significance(Last reviewed: Aug 8, 2017)	criteria provided, single submitter	VCV000465264	1	17330876	1	17004381	465264	447430	rs762075619	NC_000001.11:17004380:C:T
NM_022089.4(ATP13A2):c.453C>T (p.Ser151=)	ATP13A2		Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome|not provided|History of neurodevelopmental disorder|not specified	Benign/Likely benign(Last reviewed: Mar 19, 2021)	criteria provided, multiple submitters, no conflicts	VCV000465263	1	17331211	1	17004716	465263	447484	rs55979991	NC_000001.11:17004715:G:A
NM_022089.4(ATP13A2):c.3175C>T (p.Leu1059Phe)	ATP13A2	L1059F, L1015F, L1054F	Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome	Uncertain significance(Last reviewed: Oct 6, 2017)	criteria provided, single submitter	VCV000465262	1	17313360	1	16986865	465262	447270	rs764410859	NC_000001.11:16986864:G:A
NM_022089.4(ATP13A2):c.3084-10G>T	ATP13A2		Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome	Uncertain significance(Last reviewed: Jul 12, 2017)	criteria provided, single submitter	VCV000465261	1	17313461	1	16986966	465261	447277	rs368908107	NC_000001.11:16986965:C:A
NM_022089.4(ATP13A2):c.2412G>A (p.Lys804=)	ATP13A2		Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome	Uncertain significance(Last reviewed: Dec 27, 2018)	criteria provided, single submitter	VCV000465260	1	17316622	1	16990127	465260	447410	rs978493820	NC_000001.11:16990126:C:T
NM_022089.4(ATP13A2):c.2367C>T (p.Leu789=)	ATP13A2		Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome|History of neurodevelopmental disorder|not provided	Benign/Likely benign(Last reviewed: Oct 27, 2020)	criteria provided, multiple submitters, no conflicts	VCV000465259	1	17316667	1	16990172	465259	447369	rs140048110	NC_000001.11:16990171:G:A
NM_022089.4(ATP13A2):c.2348G>A (p.Arg783Gln)	ATP13A2	R783Q, R778Q	Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome|History of neurodevelopmental disorder|not provided	Benign/Likely benign(Last reviewed: May 11, 2021)	criteria provided, multiple submitters, no conflicts	VCV000465258	1	17316686	1	16990191	465258	447469	rs137955309	NC_000001.11:16990190:C:T
NM_022089.4(ATP13A2):c.2236G>A (p.Ala746Thr)	ATP13A2	A746T, A741T	Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome	Uncertain significance(Last reviewed: May 22, 2017)	criteria provided, single submitter	VCV000465257	1	17318244	1	16991749	465257	447278	rs147277743	NC_000001.11:16991748:C:T
NM_022089.4(ATP13A2):c.1831C>A (p.Gln611Lys)	ATP13A2	Q611K, Q606K	Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome	Uncertain significance(Last reviewed: Aug 2, 2017)	criteria provided, single submitter	VCV000465256	1	17318995	1	16992500	465256	447418	rs770682887	NC_000001.11:16992499:G:T
NM_022089.4(ATP13A2):c.1545G>A (p.Thr515=)	ATP13A2		Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome	Uncertain significance(Last reviewed: Jun 14, 2019)	criteria provided, single submitter	VCV000465255	1	17320328	1	16993833	465255	447279	rs373005131	NC_000001.11:16993832:C:T
NM_022089.4(ATP13A2):c.1195+7G>A	ATP13A2		Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome	Likely benign(Last reviewed: Apr 11, 2017)	criteria provided, single submitter	VCV000465254	1	17323508	1	16997013	465254	447476	rs1407939803	NC_000001.11:16997012:C:T
NM_022089.4(ATP13A2):c.3057del (p.Tyr1020fs)	ATP13A2	Y1020fs, Y976fs, Y1015fs	Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome|Neurodegeneration with brain iron accumulation|not provided|Kufor-Rakeb syndrome	Pathogenic/Likely pathogenic(Last reviewed: Feb 21, 2022)	criteria provided, multiple submitters, no conflicts	VCV000465253	1	17313567	1	16987072	465253	447466	rs765632065	NC_000001.11:16987071:G:
NM_022089.4(ATP13A2):c.1903C>T (p.Gln635Ter)	ATP13A2	Q635*, Q630*	Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive	Pathogenic(Last reviewed: Aug 13, 2019)	criteria provided, multiple submitters, no conflicts	VCV000465252	1	17318840	1	16992345	465252	447471	rs773246271	NC_000001.11:16992344:G:A
NM_022089.4(ATP13A2):c.3472C>T (p.Arg1158Cys)	ATP13A2	R1158C, R1153C, A1057V	not provided|Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome	Uncertain significance(Last reviewed: Aug 14, 2020)	criteria provided, multiple submitters, no conflicts	VCV000444159	1	17312787	1	16986292	444159	437799	rs201610681	NC_000001.11:16986291:G:A
NM_022089.4(ATP13A2):c.*24C>T	ATP13A2	H1089Y	Kufor-Rakeb syndrome|not provided	Uncertain significance(Last reviewed: Apr 1, 2017)	criteria provided, single submitter	VCV000441003	1	17312692	1	16986197	441003	434562	rs375521810	NC_000001.11:16986196:G:A
NM_022089.4(ATP13A2):c.229C>T (p.Leu77Phe)	ATP13A2	L77F	Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive|not provided	Uncertain significance(Last reviewed: Aug 27, 2021)	criteria provided, multiple submitters, no conflicts	VCV000388538	1	17331928	1	17005433	388538	364535	rs763004392	NC_000001.11:17005432:G:A
NM_022089.4(ATP13A2):c.3277G>C (p.Val1093Leu)	ATP13A2	V1093L, V1088L	Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive|not provided	Uncertain significance(Last reviewed: Aug 22, 2018)	criteria provided, multiple submitters, no conflicts	VCV000387937	1	17313086	1	16986591	387937	364534	rs1057522952	NC_000001.11:16986590:C:G
NM_022089.4(ATP13A2):c.197G>A (p.Arg66His)	ATP13A2	R66H	Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Dec 15, 2021)	criteria provided, conflicting interpretations	VCV000387935	1	17331960	1	17005465	387935	364614	rs367745335	NC_000001.11:17005464:C:T
NM_022089.4(ATP13A2):c.-170C>T	ATP13A2		Kufor-Rakeb syndrome	Likely benign(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000293806	1	17338403	1	17011908	293806	278400	rs150122517	NC_000001.11:17011907:G:A
NM_022089.4(ATP13A2):c.-151C>T	ATP13A2		Kufor-Rakeb syndrome	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000293805	1	17338384	1	17011889	293805	278429	rs886045583	NC_000001.11:17011888:G:A
NM_022089.4(ATP13A2):c.106-14C>T	ATP13A2		Kufor-Rakeb syndrome|Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive	Benign(Last reviewed: Nov 30, 2020)	criteria provided, multiple submitters, no conflicts	VCV000293804	1	17332065	1	17005570	293804	278416	rs199706883	NC_000001.11:17005569:G:A
NM_022089.4(ATP13A2):c.396G>A (p.Ala132=)	ATP13A2		Kufor-Rakeb syndrome|Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive	Conflicting interpretations of pathogenicity(Last reviewed: Apr 26, 2019)	criteria provided, conflicting interpretations	VCV000293803	1	17331268	1	17004773	293803	278414	rs140631323	NC_000001.11:17004772:C:T
NM_022089.4(ATP13A2):c.951C>T (p.Cys317=)	ATP13A2		Kufor-Rakeb syndrome|not provided|Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive	Conflicting interpretations of pathogenicity(Last reviewed: Aug 30, 2021)	criteria provided, conflicting interpretations	VCV000293802	1	17326594	1	17000099	293802	277554	rs148391179	NC_000001.11:17000098:G:A
NM_022089.4(ATP13A2):c.1040-6C>T	ATP13A2		Kufor-Rakeb syndrome	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000293801	1	17323676	1	16997181	293801	277347	rs886045582	NC_000001.11:16997180:G:A
NM_022089.4(ATP13A2):c.1065G>A (p.Thr355=)	ATP13A2		Kufor-Rakeb syndrome	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000293800	1	17323645	1	16997150	293800	278396	rs750819290	NC_000001.11:16997149:C:T
NM_022089.4(ATP13A2):c.1128C>T (p.Cys376=)	ATP13A2		History of neurodevelopmental disorder|Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive|not provided|Kufor-Rakeb syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Feb 9, 2021)	criteria provided, conflicting interpretations	VCV000293799	1	17323582	1	16997087	293799	278393	rs148970081	NC_000001.11:16997086:G:A
NM_022089.4(ATP13A2):c.1163G>A (p.Gly388Glu)	ATP13A2	G388E, G383E	Kufor-Rakeb syndrome	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000293798	1	17323547	1	16997052	293798	277552	rs769588580	NC_000001.11:16997051:C:T
NM_022089.4(ATP13A2):c.1195+9C>T	ATP13A2		Kufor-Rakeb syndrome|not provided|Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive	Benign/Likely benign(Last reviewed: Nov 14, 2020)	criteria provided, multiple submitters, no conflicts	VCV000293797	1	17323506	1	16997011	293797	278392	rs117758987	NC_000001.11:16997010:G:A
NM_022089.4(ATP13A2):c.1203C>T (p.Cys401=)	ATP13A2		Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome|not provided|History of neurodevelopmental disorder	Conflicting interpretations of pathogenicity(Last reviewed: Nov 17, 2020)	criteria provided, conflicting interpretations	VCV000293796	1	17322984	1	16996489	293796	277550	rs148026506	NC_000001.11:16996488:G:A
NM_022089.4(ATP13A2):c.1208C>A (p.Ala403Glu)	ATP13A2	A403E, A398E	Kufor-Rakeb syndrome	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000293795	1	17322979	1	16996484	293795	277332	rs373349384	NC_000001.11:16996483:G:T
NM_022089.4(ATP13A2):c.1244G>A (p.Arg415Gln)	ATP13A2	R415Q, R410Q	Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome	Uncertain significance(Last reviewed: Nov 2, 2020)	criteria provided, multiple submitters, no conflicts	VCV000293794	1	17322943	1	16996448	293794	278390	rs190746040	NC_000001.11:16996447:C:T
NM_022089.4(ATP13A2):c.1309C>G (p.Leu437Val)	ATP13A2	L437V, L432V	Kufor-Rakeb syndrome|History of neurodevelopmental disorder|not provided|Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive	Conflicting interpretations of pathogenicity(Last reviewed: May 4, 2021)	criteria provided, conflicting interpretations	VCV000293793	1	17322793	1	16996298	293793	277331	rs149372969	NC_000001.11:16996297:G:C
NM_022089.4(ATP13A2):c.1314C>A (p.Leu438=)	ATP13A2		Kufor-Rakeb syndrome|Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive	Uncertain significance(Last reviewed: Sep 20, 2018)	criteria provided, multiple submitters, no conflicts	VCV000293792	1	17322788	1	16996293	293792	277547	rs764435162	NC_000001.11:16996292:G:T
NM_022089.4(ATP13A2):c.1420C>G (p.Pro474Ala)	ATP13A2	P474A, P469A	Kufor-Rakeb syndrome|not provided	Uncertain significance(Last reviewed: Jan 19, 2021)	criteria provided, multiple submitters, no conflicts	VCV000293791	1	17322593	1	16996098	293791	278389	rs530658980	NC_000001.11:16996097:G:C
NM_022089.4(ATP13A2):c.1442C>T (p.Thr481Met)	ATP13A2	T481M, T476M	Kufor-Rakeb syndrome|Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive	Uncertain significance(Last reviewed: Aug 3, 2020)	criteria provided, multiple submitters, no conflicts	VCV000293790	1	17322571	1	16996076	293790	277328	rs752000462	NC_000001.11:16996075:G:A
NM_022089.4(ATP13A2):c.1449C>T (p.Tyr483=)	ATP13A2		Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Nov 14, 2020)	criteria provided, conflicting interpretations	VCV000293789	1	17322564	1	16996069	293789	277326	rs750600448	NC_000001.11:16996068:G:A
NM_022089.4(ATP13A2):c.1744G>A (p.Gly582Ser)	ATP13A2	G582S, G577S	Kufor-Rakeb syndrome|Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive	Uncertain significance(Last reviewed: Jul 24, 2020)	criteria provided, multiple submitters, no conflicts	VCV000293788	1	17320129	1	16993634	293788	278388	rs886045581	NC_000001.11:16993633:C:T
NM_022089.4(ATP13A2):c.1926G>A (p.Ala642=)	ATP13A2		History of neurodevelopmental disorder|Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive|not provided|Kufor-Rakeb syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Oct 15, 2020)	criteria provided, conflicting interpretations	VCV000293787	1	17318817	1	16992322	293787	278413	rs200916673	NC_000001.11:16992321:C:T
NM_022089.4(ATP13A2):c.1947C>G (p.Pro649=)	ATP13A2		Kufor-Rakeb syndrome|Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive	Conflicting interpretations of pathogenicity(Last reviewed: Dec 31, 2019)	criteria provided, conflicting interpretations	VCV000293786	1	17318796	1	16992301	293786	277544	rs369722835	NC_000001.11:16992300:G:C
NM_022089.4(ATP13A2):c.2252-11A>G	ATP13A2		Kufor-Rakeb syndrome	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000293785	1	17316793	1	16990298	293785	277539	rs775547036	NC_000001.11:16990297:T:C
NM_022089.4(ATP13A2):c.2263C>G (p.Gln755Glu)	ATP13A2	Q755E, Q750E	History of neurodevelopmental disorder|not provided|Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive|Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome	Uncertain significance(Last reviewed: Aug 6, 2021)	criteria provided, multiple submitters, no conflicts	VCV000293784	1	17316771	1	16990276	293784	278382	rs200924194	NC_000001.11:16990275:G:C
NM_022089.4(ATP13A2):c.2285G>A (p.Arg762Gln)	ATP13A2	R762Q, R757Q	Kufor-Rakeb syndrome|Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive	Conflicting interpretations of pathogenicity(Last reviewed: Nov 20, 2021)	criteria provided, conflicting interpretations	VCV000293783	1	17316749	1	16990254	293783	277323	rs766899425	NC_000001.11:16990253:C:T
NM_022089.4(ATP13A2):c.2331C>T (p.His777=)	ATP13A2		not provided|Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Dec 24, 2020)	criteria provided, conflicting interpretations	VCV000293782	1	17316703	1	16990208	293782	278410	rs144708504	NC_000001.11:16990207:G:A
NM_022089.4(ATP13A2):c.2381T>C (p.Met794Thr)	ATP13A2	M794T, M789T	Kufor-Rakeb syndrome	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000293781	1	17316653	1	16990158	293781	277313	rs151222153	NC_000001.11:16990157:A:G
NM_022089.4(ATP13A2):c.2406C>T (p.Gly802=)	ATP13A2		Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Oct 21, 2021)	criteria provided, conflicting interpretations	VCV000293780	1	17316628	1	16990133	293780	277312	rs886045580	NC_000001.11:16990132:G:A
NM_022089.4(ATP13A2):c.2407G>A (p.Val803Ile)	ATP13A2	V803I, V798I	Kufor-Rakeb syndrome|not provided|Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive	Uncertain significance(Last reviewed: Sep 25, 2021)	criteria provided, multiple submitters, no conflicts	VCV000293779	1	17316627	1	16990132	293779	277311	rs747785443	NC_000001.11:16990131:C:T
NM_022089.4(ATP13A2):c.2529+9G>A	ATP13A2		Kufor-Rakeb syndrome|Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive	Benign/Likely benign(Last reviewed: Dec 4, 2020)	criteria provided, multiple submitters, no conflicts	VCV000293778	1	17316373	1	16989878	293778	277309	rs200809857	NC_000001.11:16989877:C:T
NM_022089.4(ATP13A2):c.2563G>A (p.Ala855Thr)	ATP13A2	A855T, A811T, A850T	Kufor-Rakeb syndrome	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000293777	1	17316232	1	16989737	293777	277305	rs886045579	NC_000001.11:16989736:C:T
NM_022089.4(ATP13A2):c.2609+10C>T	ATP13A2		Kufor-Rakeb syndrome|Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive	Conflicting interpretations of pathogenicity(Last reviewed: Nov 6, 2021)	criteria provided, conflicting interpretations	VCV000293776	1	17316176	1	16989681	293776	277532	rs759204814	NC_000001.11:16989680:G:A
NM_022089.4(ATP13A2):c.2619G>C (p.Val873=)	ATP13A2		not provided|Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Dec 24, 2020)	criteria provided, conflicting interpretations	VCV000293775	1	17314960	1	16988465	293775	278381	rs199994961	NC_000001.11:16988464:C:G
NM_022089.4(ATP13A2):c.2808C>T (p.Tyr936=)	ATP13A2		Kufor-Rakeb syndrome	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000293774	1	17314684	1	16988189	293774	277299	rs886045578	NC_000001.11:16988188:G:A
NM_022089.4(ATP13A2):c.2952G>A (p.Ala984=)	ATP13A2		Kufor-Rakeb syndrome	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000293773	1	17313672	1	16987177	293773	278380	rs138212767	NC_000001.11:16987176:C:T
NM_022089.4(ATP13A2):c.3111C>T (p.Ala1037=)	ATP13A2		Kufor-Rakeb syndrome	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000293772	1	17313424	1	16986929	293772	278402	rs538236343	NC_000001.11:16986928:G:A
NM_022089.4(ATP13A2):c.3193G>A (p.Val1065Met)	ATP13A2	V1065M, V1021M, V1060M	Kufor-Rakeb syndrome|Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive	Uncertain significance(Last reviewed: Dec 27, 2018)	criteria provided, multiple submitters, no conflicts	VCV000293771	1	17313342	1	16986847	293771	277530	rs377431904	NC_000001.11:16986846:C:T
NM_022089.4(ATP13A2):c.3258G>C (p.Ala1086=)	ATP13A2		Kufor-Rakeb syndrome	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000293770	1	17313105	1	16986610	293770	278375	rs377253172	NC_000001.11:16986609:C:G
NM_022089.4(ATP13A2):c.3297C>T (p.Pro1099=)	ATP13A2		Kufor-Rakeb syndrome|History of neurodevelopmental disorder|Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive	Conflicting interpretations of pathogenicity(Last reviewed: Jan 13, 2018)	criteria provided, conflicting interpretations	VCV000293769	1	17313066	1	16986571	293769	277520	rs756650754	NC_000001.11:16986570:G:A
NM_022089.4(ATP13A2):c.3301C>T (p.Leu1101Phe)	ATP13A2	L1101F, L1096F	Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome	Uncertain significance(Last reviewed: Sep 18, 2020)	criteria provided, multiple submitters, no conflicts	VCV000293768	1	17313062	1	16986567	293768	278394	rs886045577	NC_000001.11:16986566:G:A
NM_022089.4(ATP13A2):c.3378C>T (p.Leu1126=)	ATP13A2		Kufor-Rakeb syndrome|Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive	Conflicting interpretations of pathogenicity(Last reviewed: Sep 24, 2021)	criteria provided, conflicting interpretations	VCV000293767	1	17312985	1	16986490	293767	278370	rs773914880	NC_000001.11:16986489:G:A
NM_022089.4(ATP13A2):c.3406-14C>T	ATP13A2		Kufor-Rakeb syndrome|Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive	Benign/Likely benign(Last reviewed: Dec 2, 2021)	criteria provided, multiple submitters, no conflicts	VCV000293766	1	17312867	1	16986372	293766	277296	rs139088170	NC_000001.11:16986371:G:A
NM_022089.4(ATP13A2):c.3429C>T (p.Pro1143=)	ATP13A2	R1043C	not provided|Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Feb 18, 2021)	criteria provided, conflicting interpretations	VCV000293765	1	17312830	1	16986335	293765	277512	rs377703085	NC_000001.11:16986334:G:A
NM_022089.4(ATP13A2):c.3539G>A (p.Arg1180Lys)	ATP13A2	R1180K, R1175K	Kufor-Rakeb syndrome	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000293764	1	17312720	1	16986225	293764	278367	rs771312962	NC_000001.11:16986224:C:T
NM_022089.4(ATP13A2):c.*124C>T	ATP13A2	P1122L	not provided|Kufor-Rakeb syndrome	Benign(Last reviewed: Jul 17, 2018)	criteria provided, multiple submitters, no conflicts	VCV000293763	1	17312592	1	16986097	293763	277295	rs15786	NC_000001.11:16986096:G:A
NM_022089.4(ATP13A2):c.*130C>T	ATP13A2	P1124L	Kufor-Rakeb syndrome|not provided|Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive	Conflicting interpretations of pathogenicity(Last reviewed: Nov 1, 2020)	criteria provided, conflicting interpretations	VCV000293762	1	17312586	1	16986091	293762	277511	rs189334432	NC_000001.11:16986090:G:A
NM_022089.4(ATP13A2):c.*155C>T	ATP13A2		Kufor-Rakeb syndrome	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000293761	1	17312561	1	16986066	293761	277510	rs762111359	NC_000001.11:16986065:G:A
NM_022089.4(ATP13A2):c.*158T>C	ATP13A2		Kufor-Rakeb syndrome|not provided	Likely benign(Last reviewed: Apr 1, 2021)	criteria provided, multiple submitters, no conflicts	VCV000293760	1	17312558	1	16986063	293760	278387	rs185521359	NC_000001.11:16986062:A:G
NM_022089.4(ATP13A2):c.*243A>C	ATP13A2		Kufor-Rakeb syndrome	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000293759	1	17312473	1	16985978	293759	278366	rs777596557	NC_000001.11:16985977:T:G
NM_022089.4(ATP13A2):c.*251A>G	ATP13A2		Kufor-Rakeb syndrome	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000293758	1	17312465	1	16985970	293758	278365	rs535432261	NC_000001.11:16985969:T:C
NM_022089.4(ATP13A2):c.846C>T (p.Ser282=)	ATP13A2		not provided|Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Nov 25, 2021)	criteria provided, conflicting interpretations	VCV000288964	1	17326802	1	17000307	288964	273201	rs762440899	NC_000001.11:17000306:G:A
NM_022089.4(ATP13A2):c.841-4A>G	ATP13A2		not provided|Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Nov 10, 2020)	criteria provided, conflicting interpretations	VCV000287582	1	17326811	1	17000316	287582	271819	rs112549590	NC_000001.11:17000315:T:C
NM_022089.4(ATP13A2):c.3235+17G>A	ATP13A2		not provided|not specified|Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome	Benign(Last reviewed: Dec 5, 2020)	criteria provided, multiple submitters, no conflicts	VCV000261542	1	17313283	1	16986788	261542	249527	rs56146840	NC_000001.11:16986787:C:T
NM_022089.4(ATP13A2):c.1614C>T (p.Pro538=)	ATP13A2		not specified|not provided|History of neurodevelopmental disorder|Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome	Benign/Likely benign(Last reviewed: Jul 1, 2020)	criteria provided, multiple submitters, no conflicts	VCV000261541	1	17320259	1	16993764	261541	249528	rs56351817	NC_000001.11:16993763:G:A
NM_022089.4(ATP13A2):c.132A>G (p.Pro44=)	ATP13A2		not provided|History of neurodevelopmental disorder|Kufor-Rakeb syndrome|not specified|Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome	Benign/Likely benign(Last reviewed: Mar 1, 2022)	criteria provided, multiple submitters, no conflicts	VCV000261540	1	17332025	1	17005530	261540	249529	rs200816691	NC_000001.11:17005529:T:C
NM_022089.4(ATP13A2):c.2859G>A (p.Thr953=)	ATP13A2		Kufor-Rakeb syndrome|Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive|History of neurodevelopmental disorder|not provided|not specified	Conflicting interpretations of pathogenicity(Last reviewed: Nov 27, 2020)	criteria provided, conflicting interpretations	VCV000210381	1	17314633	1	16988138	210381	206728	rs144557304	NC_000001.11:16988137:C:T
NM_022089.4(ATP13A2):c.1352G>A (p.Arg451Gln)	ATP13A2	R451Q, R446Q	not specified|Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive	Conflicting interpretations of pathogenicity(Last reviewed: Oct 5, 2020)	criteria provided, conflicting interpretations	VCV000210380	1	17322750	1	16996255	210380	206729	rs138546275	NC_000001.11:16996254:C:T
NM_022089.4(ATP13A2):c.106-8G>A	ATP13A2		Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive|not provided|Kufor-Rakeb syndrome|not specified	Conflicting interpretations of pathogenicity(Last reviewed: Nov 12, 2020)	criteria provided, conflicting interpretations	VCV000210379	1	17332059	1	17005564	210379	206730	rs200587951	NC_000001.11:17005563:C:T
NM_022089.4(ATP13A2):c.943G>A (p.Gly315Arg)	ATP13A2	G315R, G310R	Kufor-Rakeb syndrome	Likely pathogenic(Last reviewed: Jan 29, 2013)	criteria provided, single submitter	VCV000209136	1	17326602	1	17000107	209136	205722	rs150519745	NC_000001.11:17000106:C:T
NM_022089.4(ATP13A2):c.348-9_351del	ATP13A2		Kufor-Rakeb syndrome|Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Jun 20, 2018)	criteria provided, conflicting interpretations	VCV000209135	1	17331313 - 17331325	1	17004818 - 17004830	209135	205723	rs749798211	NC_000001.11:17004817:CAGGCTGGGGAAGCAGG:CAGG
NM_022089.4(ATP13A2):c.1195+10G>A	ATP13A2		not specified|Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome|Kufor-Rakeb syndrome|not provided	Benign/Likely benign(Last reviewed: Nov 28, 2020)	criteria provided, multiple submitters, no conflicts	VCV000194113	1	17323505	1	16997010	194113	191276	rs55689004	NC_000001.11:16997009:C:T
NM_022089.4(ATP13A2):c.993C>T (p.Ala331=)	ATP13A2		Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Jul 30, 2019)	criteria provided, conflicting interpretations	VCV000193926	1	17326552	1	17000057	193926	191089	rs568367953	NC_000001.11:17000056:G:A
NM_022089.4(ATP13A2):c.490C>T (p.Arg164Trp)	ATP13A2	R164W, R159W	Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome	Uncertain significance(Last reviewed: Oct 30, 2021)	criteria provided, single submitter	VCV000143196	1	17330894	1	17004399	143196	152914	rs199624796	NC_000001.11:17004398:G:A
NM_022089.4(ATP13A2):c.881G>A (p.Arg294Gln)	ATP13A2	R294Q, R289Q	History of neurodevelopmental disorder|Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome|not specified|not provided	Benign/Likely benign(Last reviewed: Mar 1, 2022)	criteria provided, multiple submitters, no conflicts	VCV000128476	1	17326767	1	17000272	128476	133925	rs56367069	NC_000001.11:17000271:C:T
NM_022089.4(ATP13A2):c.3516G>A (p.Pro1172=)	ATP13A2	A1072T	Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive|not provided|not specified|History of neurodevelopmental disorder|Kufor-Rakeb syndrome	Benign(Last reviewed: Jul 14, 2021)	criteria provided, multiple submitters, no conflicts	VCV000128475	1	17312743	1	16986248	128475	133924	rs3170740	NC_000001.11:16986247:C:T
NM_022089.4(ATP13A2):c.3430G>A (p.Ala1144Thr)	ATP13A2	A1144T, A1139T, R1043H	Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive|not specified|not provided|History of neurodevelopmental disorder	Benign/Likely benign(Last reviewed: Jan 5, 2022)	criteria provided, multiple submitters, no conflicts	VCV000128474	1	17312829	1	16986334	128474	133923	rs151181674	NC_000001.11:16986333:C:T
NM_022089.4(ATP13A2):c.3192C>T (p.Ala1064=)	ATP13A2		Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome|not provided|Spastic paraplegia 78, autosomal recessive|not specified|History of neurodevelopmental disorder	Benign(Last reviewed: Jul 14, 2021)	criteria provided, multiple submitters, no conflicts	VCV000128473	1	17313343	1	16986848	128473	133922	rs9435659	NC_000001.11:16986847:G:A
NM_022089.4(ATP13A2):c.3144C>G (p.Thr1048=)	ATP13A2		Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive|not specified|not provided|History of neurodevelopmental disorder|Kufor-Rakeb syndrome	Benign/Likely benign(Last reviewed: Nov 18, 2020)	criteria provided, multiple submitters, no conflicts	VCV000128472	1	17313391	1	16986896	128472	133921	rs56126202	NC_000001.11:16986895:G:C
NM_022089.4(ATP13A2):c.3084-3C>T	ATP13A2		History of neurodevelopmental disorder|Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome|not specified|Spastic paraplegia 78, autosomal recessive|not provided	Benign(Last reviewed: Jul 14, 2021)	criteria provided, multiple submitters, no conflicts	VCV000128471	1	17313454	1	16986959	128471	133920	rs7531163	NC_000001.11:16986958:G:A
NM_022089.4(ATP13A2):c.2970G>A (p.Val990=)	ATP13A2		Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive|not provided|not specified|Spastic paraplegia 78, autosomal recessive|History of neurodevelopmental disorder|Kufor-Rakeb syndrome	Benign(Last reviewed: Jul 14, 2021)	criteria provided, multiple submitters, no conflicts	VCV000128470	1	17313654	1	16987159	128470	133919	rs761421	NC_000001.11:16987158:C:T
NM_022089.4(ATP13A2):c.2836A>T (p.Ile946Phe)	ATP13A2	I946F, I941F, I902F	Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive|History of neurodevelopmental disorder|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Jan 8, 2021)	criteria provided, conflicting interpretations	VCV000128469	1	17314656	1	16988161	128469	133918	rs55708915	NC_000001.11:16988160:T:A
NM_022089.4(ATP13A2):c.2790G>A (p.Ser930=)	ATP13A2		Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome|not provided|not specified|History of neurodevelopmental disorder	Benign(Last reviewed: Dec 8, 2020)	criteria provided, multiple submitters, no conflicts	VCV000128468	1	17314702	1	16988207	128468	133917	rs3738815	NC_000001.11:16988206:C:T
NM_022089.4(ATP13A2):c.2724G>A (p.Ser908=)	ATP13A2		Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive|not specified|not provided|History of neurodevelopmental disorder|Kufor-Rakeb syndrome	Benign/Likely benign(Last reviewed: Nov 2, 2020)	criteria provided, multiple submitters, no conflicts	VCV000128467	1	17314855	1	16988360	128467	133916	rs79724242	NC_000001.11:16988359:C:T
NM_022089.4(ATP13A2):c.2637C>T (p.Gly879=)	ATP13A2		not provided|Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive|not specified|History of neurodevelopmental disorder	Benign(Last reviewed: Jul 14, 2021)	criteria provided, multiple submitters, no conflicts	VCV000128466	1	17314942	1	16988447	128466	133915	rs9435662	NC_000001.11:16988446:G:A
NM_022089.4(ATP13A2):c.1815C>T (p.Pro605=)	ATP13A2		Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive|not provided|not specified|History of neurodevelopmental disorder	Benign(Last reviewed: Jul 14, 2021)	criteria provided, multiple submitters, no conflicts	VCV000128465	1	17319011	1	16992516	128465	133914	rs2076603	NC_000001.11:16992515:G:A
NM_022089.4(ATP13A2):c.1617G>T (p.Leu539=)	ATP13A2		History of neurodevelopmental disorder|Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome|not specified|not provided	Benign(Last reviewed: Nov 28, 2020)	criteria provided, multiple submitters, no conflicts	VCV000128464	1	17320256	1	16993761	128464	133913	rs61739752	NC_000001.11:16993760:C:A
NM_022089.4(ATP13A2):c.1005C>T (p.Ala335=)	ATP13A2		Kufor-Rakeb syndrome|Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive|not specified|not provided|History of neurodevelopmental disorder	Benign(Last reviewed: Nov 30, 2020)	criteria provided, multiple submitters, no conflicts	VCV000128463	1	17326540	1	17000045	128463	133912	rs56290406	NC_000001.11:17000044:G:A
NM_022089.4(ATP13A2):c.1108C>T (p.Arg370Trp)	ATP13A2	R370W, R365W	Kufor-Rakeb syndrome	Uncertain significance(Last reviewed: Apr 27, 2017)	criteria provided, single submitter	VCV000069026	1	17323602	1	16997107	69026	79917	rs142616130	NC_000001.11:16997106:G:A
NM_022089.4(ATP13A2):c.2629G>A (p.Gly877Arg)	ATP13A2	G877R, G833R, G872R	Kufor-Rakeb syndrome	Pathogenic(Last reviewed: Feb 1, 2011)	no assertion criteria provided	VCV000066099	1	17314950	1	16988455	66099	77001	rs144701072	NC_000001.11:16988454:C:T
NM_022089.4(ATP13A2):c.2561T>G (p.Met854Arg)	ATP13A2	M810R, M854R, M849R	Kufor-Rakeb syndrome	Pathogenic(Last reviewed: Jun 15, 2012)	no assertion criteria provided	VCV000066098	1	17316234	1	16989739	66098	77000	rs587777053	NC_000001.11:16989738:A:C
NM_022089.4(ATP13A2):c.2552_2553del (p.Phe851fs)	ATP13A2	F807fs, F846fs, F851fs	Kufor-Rakeb syndrome	Pathogenic(Last reviewed: Feb 1, 2011)	no assertion criteria provided	VCV000030834	1	17316242 - 17316243	1	16989747 - 16989748	30834	39791	rs587776890	NC_000001.11:16989746:AAA:A
NM_022089.4(ATP13A2):c.1101_1102dup (p.Thr368fs)	ATP13A2	T363fs, T368fs	Kufor-Rakeb syndrome	Pathogenic(Last reviewed: Jun 15, 2010)	no assertion criteria provided	VCV000030833	1	17323607 - 17323608	1	16997112 - 16997113	30833	39790	rs762033589	NC_000001.11:16997112:TCTCT:TCTCTCT
NM_022089.4(ATP13A2):c.1510G>C (p.Gly504Arg)	ATP13A2	G504R, G499R	Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome|Kufor-Rakeb syndrome	Likely pathogenic(Last reviewed: Sep 14, 2021)	criteria provided, single submitter	VCV000001221	1	17322503	1	16996008	1221	16260	rs121918227	NC_000001.11:16996007:C:G
ATP13A2, 22-BP DUP	ATP13A2		Kufor-Rakeb syndrome	Pathogenic(Last reviewed: Aug 26, 2011)	no assertion criteria provided	VCV000001220					1220	16259		
NM_022089.4(ATP13A2):c.1306+5G>A	ATP13A2		Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome|Kufor-Rakeb syndrome	Pathogenic(Last reviewed: Sep 19, 2021)	criteria provided, single submitter	VCV000001219	1	17322876	1	16996381	1219	16258	rs786205056	NC_000001.11:16996380:C:T
ATP13A2, 1-BP DEL, 3057C	ATP13A2		Kufor-Rakeb syndrome	Pathogenic(Last reviewed: Aug 26, 2011)	no assertion criteria provided	VCV000001218					1218	16257		
NC_000021.8:g.(?_32439271)_(37133458_?)dup	ATP5PO|C21orf62|CFAP298|CLIC6|CRYZL1|DNAJC28|DONSON|EVA1C|GART|HUNK|IFNAR1|IFNAR2|IFNGR2|IL10RB|ITSN1|KCNE1|KCNE2|MIS18A|MRAP|MRPS6|OLIG1|OLIG2|PAXBP1|RCAN1|RUNX1|SCAF4|SLC5A3|SMIM11|SOD1|SON|SYNJ1|TCP10L|TIAM1|TMEM50B|URB1		Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Oct 29, 2020)	criteria provided, single submitter	VCV001035906	21	32439271 - 37133458			1035906	1022419		
NP_002964.3:p.Gln166(>=33)	ATXN2		Parkinson disease, late-onset|Spinocerebellar ataxia type 2	Pathogenic; risk factor(Last reviewed: Nov 20, 2007)	no assertion criteria provided	VCV000065668					65668	76576		
ATXN2, (CAG)n REPEAT EXPANSION, INTERMEDIATE	ATXN2		Amyotrophic lateral sclerosis 13	risk factor(Last reviewed: Oct 1, 2011)	no assertion criteria provided	VCV000008114					8114	23153		
NM_004993.5(ATXN3):c.892CAG[(8_36)]	ATXN3|LOC108663987		Parkinson disease, late-onset|Azorean disease	Pathogenic; risk factor(Last reviewed: Nov 1, 1994)	no assertion criteria provided	VCV000003551	14	92537355 - 92537357	14	92071011 - 92071013	3551	18590		
NR_002717.2(ATXN8OS):n.1103CTG[(107_127)]	ATXN8|ATXN8OS		Parkinson disease, late-onset|Spinocerebellar ataxia type 8	Pathogenic; risk factor(Last reviewed: Aug 1, 2009)	no assertion criteria provided	VCV000562101					562101	553277		
NR_002717.2(ATXN8OS):n.1103CTG[(15_40)]	ATXN8|LOC109461478|ATXN8OS		Spinocerebellar ataxia type 8	Benign(Last reviewed: Aug 1, 2009)	no assertion criteria provided	VCV000000192	13	70713516 - 70713518	13	70139384 - 70139386	192	15231		
NM_181575.5(AUP1):c.-54C>T	AUP1|HTRA2		Parkinson disease 13	Likely benign(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000897609	2	74756810	2	74529683	897609	885477	rs374306906	NC_000002.12:74529682:G:A
NM_181575.5(AUP1):c.-17C>T	AUP1|HTRA2		Parkinson disease 13	Uncertain significance(Last reviewed: Apr 27, 2017)	criteria provided, single submitter	VCV000896015	2	74756773	2	74529646	896015	885476	rs757541077	NC_000002.12:74529645:G:A
NM_181575.5(AUP1):c.51-4C>T	AUP1|HTRA2		Parkinson disease 13	Likely benign(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000896014	2	74756630	2	74529503	896014	885475	rs769713877	NC_000002.12:74529502:G:A
NM_181575.5(AUP1):c.141C>T (p.Ile47=)	AUP1|HTRA2		Parkinson disease 13	Uncertain significance(Last reviewed: Apr 28, 2017)	criteria provided, single submitter	VCV000896013	2	74756536	2	74529409	896013	885474	rs71640291	NC_000002.12:74529408:G:A
NM_181575.5(AUP1):c.-64C>T	AUP1|HTRA2		Parkinson disease 13	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000337121	2	74756820	2	74529693	337121	288015	rs377647662	NC_000002.12:74529692:G:A
NM_181575.5(AUP1):c.25C>T (p.Pro9Ser)	AUP1|HTRA2	P9S	Parkinson disease 13	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000337118	2	74756732	2	74529605	337118	290944	rs777371915	NC_000002.12:74529604:G:A
NM_181575.5(AUP1):c.90C>G (p.Leu30=)	AUP1|HTRA2		Parkinson disease 13|not provided	Likely benign(Last reviewed: Dec 12, 2020)	criteria provided, multiple submitters, no conflicts	VCV000337117	2	74756587	2	74529460	337117	290941	rs376231592	NC_000002.12:74529459:G:C
NM_181575.5(AUP1):c.129C>G (p.Leu43=)	AUP1|HTRA2		not provided|Parkinson disease 13	Benign(Last reviewed: Jun 26, 2018)	criteria provided, multiple submitters, no conflicts	VCV000337116	2	74756548	2	74529421	337116	290936	rs1183739	NC_000002.12:74529420:G:C
GRCh38/hg38 9q21.11-21.12(chr9:68802194-69342807)x3	BANCR|FAM189A2|FXN|LOC101927069|LOC108510657|LOC116186937|LOC121331328|LOC124292586|LOC124292587|LOC124292588|LOC124292589|PIP5K1B|PRKACG|TJP2		See cases	Uncertain significance(Last reviewed: Jan 25, 2013)	no assertion criteria provided	VCV000155100	9	71417110 - 71957723	9	68802194 - 69342807	155100	164854		
NM_001709.5(BDNF):c.196G>A (p.Val66Met)	BDNF|BDNF-AS	V66M, V74M, V81M, V148M, V95M	Memory impairment, susceptibility to|not specified|not provided	Benign(Last reviewed: Dec 17, 2021)	criteria provided, multiple submitters, no conflicts	VCV000017697	11	27679916	11	27658369	17697	32736	rs6265	NC_000011.10:27658368:C:T
NM_001200.4(BMP2):c.987C>A (p.Cys329Ter)	BMP2	C329*	Short stature, facial dysmorphism, and skeletal anomalies with or without cardiac anomalies 1|Short stature, facial dysmorphism, and skeletal anomalies with or without cardiac anomalies	Likely pathogenic(Last reviewed: Oct 15, 2018)	criteria provided, single submitter	VCV000492937	20	6759532	20	6778885	492937	485876	rs1555786156	NC_000020.11:6778884:C:A
NM_031448.6(C19orf12):c.391A>G (p.Lys131Glu)	C19orf12	K142E, K131E, K67E	Hereditary spastic paraplegia|Neurodegeneration with brain iron accumulation 4|Spastic paraplegia 43, autosomal recessive|Neurodegeneration with brain iron accumulation 4|Spastic paraplegia 43, autosomal recessive|Hereditary spastic paraplegia 5A|not specified|not provided|Dystonia|Peripheral visual field loss|Tremor|Mental deterioration|Adult-onset night blindness	Conflicting interpretations of pathogenicity(Last reviewed: Feb 18, 2022)	criteria provided, conflicting interpretations	VCV000031158	19	30193654	19	29702747	31158	40115	rs146170087	NC_000019.10:29702746:T:C
GRCh38/hg38 13q12.12(chr13:22943845-24355293)x3	C1QTNF9|C1QTNF9B|LINC00327|LINC00362|LINC00566|LOC106783494|LOC112163649|LOC121466729|MIPEP|MIR2276|PCOTH|SACS|SACS-AS1|SGCG|SPATA13|SPATA13-AS1|TNFRSF19		See cases	conflicting data from submitters(Last reviewed: Jan 25, 2013)	no assertion criteria provided	VCV000149939	13	23517984 - 24929431	13	22943845 - 24355293	149939	159690		
NM_000719.7(CACNA1C):c.2579G>A (p.Arg860Gln)	CACNA1C	R860Q, R857Q	Wolff-Parkinson-White pattern|not provided|Timothy syndrome|Long QT syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Mar 23, 2021)	criteria provided, conflicting interpretations	VCV000190654	12	2702427	12	2593261	190654	188574	rs730880056	NC_000012.12:2593260:G:A
NM_000719.7(CACNA1C):c.1485C>A (p.His495Gln)	CACNA1C	H495Q, H492Q	Wolff-Parkinson-White pattern|not provided|Long QT syndrome	Uncertain significance(Last reviewed: Oct 15, 2020)	criteria provided, multiple submitters, no conflicts	VCV000190639	12	2666120	12	2556954	190639	188550	rs373335068	NC_000012.12:2556953:C:A
NM_001205293.3(CACNA1E):c.6649C>T (p.Gln2217Ter)	CACNA1E	Q2174*, Q2217*, Q2155*	Wolff-Parkinson-White pattern	Uncertain significance(Last reviewed: Jul 14, 2017)	no assertion criteria provided	VCV000487600	1	181767677	1	181798541	487600	480669	rs766235230	NC_000001.11:181798540:C:T
NM_001232.4(CASQ2):c.2T>C (p.Met1Thr)	CASQ2	M1T	Wolff-Parkinson-White pattern|not provided	Likely pathogenic(Last reviewed: Sep 25, 2017)	criteria provided, single submitter	VCV000452250	1	116311161	1	115768540	452250	442590	rs1553197939	NC_000001.11:115768539:A:G
GRCh38/hg38 4q22.1(chr4:88504598-90127832)x3	CCSER1|HERC5|HERC6|NAP1L5|PIGY|SNCA|FAM13A|FAM13A-AS1|GPRIN3|HERC3|LOC110121083|LOC111365205|LOC123477786|MMRN1|PIGY-DT|PYURF|PPM1K|PPM1K-DT|SNCA-AS1|TIGD2		Parkinson disease 4	Pathogenic(Last reviewed: Feb 1, 2004)	no assertion criteria provided	VCV000014009			4	88268907 - 90128499	14009	29048		
NM_000077.5(CDKN2A):c.339_340delinsCT (p.Pro114Ser)	CDKN2A	P114S, A128L, P63S	Hereditary cancer-predisposing syndrome|Hereditary melanoma|Cutaneous malignant melanoma 2	Conflicting interpretations of pathogenicity(Last reviewed: Sep 14, 2021)	criteria provided, conflicting interpretations	VCV000009424	9	21971018 - 21971019	9	21971019 - 21971020	9424	24463	rs387906410	NC_000009.12:21971018:GC:AG
NM_001408.3(CELSR2):c.2858A>G (p.Asn953Ser)	CELSR2	N953S	Tracheoesophageal fistula	Likely pathogenic(Last reviewed: Jul 1, 2019)	no assertion criteria provided	VCV000916557	1	109795559	1	109252937	916557	904886	rs1223692503	NC_000001.11:109252936:A:G
NC_000021.9:g.(?_32601843)_(32634904_?)dup	CFAP298|SYNJ1		Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Oct 23, 2019)	criteria provided, single submitter	VCV000833199	21	33974153 - 34007214			833199	821361		
NC_000021.8:g.(?_33974153)_(34074377_?)dup	CFAP298-TCP10L|SYNJ1|CFAP298		Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Oct 14, 2018)	criteria provided, single submitter	VCV000584218	21	33974153 - 34074377	21	32601843 - 32702067	584218	573717		
NM_016139.4(CHCHD2):c.238A>G (p.Ile80Val)	CHCHD2	I80V	not provided	Uncertain significance(Last reviewed: Jan 22, 2020)	criteria provided, single submitter	VCV001303535	7	56171981	7	56104288	1303535	1293812		NC_000007.14:56104287:T:C
NM_016139.4(CHCHD2):c.300+5G>A	CHCHD2		Parkinson disease 22, autosomal dominant	Pathogenic(Last reviewed: Jul 1, 2015)	no assertion criteria provided	VCV000218884	7	56171914	7	56104221	218884	215641	rs750014782	NC_000007.14:56104220:C:T
NM_016139.4(CHCHD2):c.434G>A (p.Arg145Gln)	CHCHD2	R145Q	Parkinson disease 22, autosomal dominant	Pathogenic(Last reviewed: Jul 1, 2015)	no assertion criteria provided	VCV000218883	7	56170571	7	56102878	218883	215640	rs752169833	NC_000007.14:56102877:C:T
NM_016139.4(CHCHD2):c.182C>T (p.Thr61Ile)	CHCHD2	T61I	Parkinson disease 22, autosomal dominant	Pathogenic(Last reviewed: Jul 1, 2015)	no assertion criteria provided	VCV000218882	7	56172037	7	56104344	218882	215639	rs864309650	NC_000007.14:56104343:G:A
NM_014043.4(CHMP2B):c.85A>G (p.Ile29Val)	CHMP2B	I29V	not provided|Frontotemporal dementia and/or amyotrophic lateral sclerosis 7	Uncertain significance(Last reviewed: Apr 15, 2020)	criteria provided, multiple submitters, no conflicts	VCV000021507	3	87289899	3	87240749	21507	34359	rs63750818	NC_000003.12:87240748:A:G
NM_014043.4(CHMP2B):c.618A>C (p.Gln206His)	CHMP2B	Q206H, Q165H	Frontotemporal dementia and/or amyotrophic lateral sclerosis 7|not provided	Pathogenic(Last reviewed: Oct 4, 2012)	no assertion criteria provided	VCV000001654	3	87302948	3	87253798	1654	16693	rs63751126	NC_000003.12:87253797:A:C
NM_000093.5(COL5A1):c.1389G>A (p.Pro463=)	COL5A1		See cases|not provided|Arthralgia|Hyperextensible hand joints|Joint dislocation|Joint laxity|Wolff-Parkinson-White pattern|Cardiac arrhythmia	Uncertain significance(Last reviewed: Feb 28, 2017)	criteria provided, multiple submitters, no conflicts	VCV000373924	9	137623973	9	134732127	373924	360909	rs1057518771	NC_000009.12:134732126:G:A
NM_004369.4(COL6A3):c.5528T>C (p.Phe1843Ser)	COL6A3	F1637S, F1236S, F1843S	Bethlem myopathy 1|Collagen VI-related myopathy	Conflicting interpretations of pathogenicity(Last reviewed: Sep 25, 2021)	criteria provided, conflicting interpretations	VCV000899020	2	238274651	2	237366008	899020	884232	rs770876436	NC_000002.12:237366007:A:G
NM_004369.4(COL6A3):c.2195C>T (p.Thr732Met)	COL6A3	T732M, T325M, T526M	Bethlem myopathy 1|not provided|Collagen VI-related myopathy	Conflicting interpretations of pathogenicity(Last reviewed: Feb 10, 2021)	criteria provided, conflicting interpretations	VCV000573112	2	238287581	2	237378938	573112	561176	rs370719148	NC_000002.12:237378937:G:A
NM_000754.4(COMT):c.472G>A (p.Val158Met)	COMT	V158M, V108M	CATECHOL-O-METHYLTRANSFERASE POLYMORPHISM|not specified|Tramadol response	Benign	criteria provided, single submitter	VCV000017591	22	19951271	22	19963748	17591	32630	rs4680	NC_000022.11:19963747:G:A
NM_000096.4(CP):c.1430C>T (p.Pro477Leu)	CP	P477L	not specified|not provided|Deficiency of ferroxidase	Conflicting interpretations of pathogenicity(Last reviewed: Sep 1, 2021)	criteria provided, conflicting interpretations	VCV000210755	3	148917570	3	149199783	210755	207061	rs35331711	NC_000003.12:149199782:G:A
NM_000787.3(DBH):c.-979T=	DBH		Dopamine beta-hydroxylase activity	association(Last reviewed: Nov 1, 2011)	no assertion criteria provided	VCV000001749	9	136500515	9	133635393	1749	16788	rs1611115	NC_000009.12:133635392:T:T
NM_004082.5(DCTN1):c.3746C>T (p.Thr1249Ile)	DCTN1	T1249I, T1207I, T1115I, T1224I, T1242I, T1110I, T1226I, T1232I	not provided|Distal hereditary motor neuronopathy type 7B|Perry syndrome|Amyotrophic lateral sclerosis type 1|Amyotrophic lateral sclerosis type 1|Distal hereditary motor neuronopathy type 7B|Amyotrophic lateral sclerosis, susceptibility to|Perry syndrome	Benign/Likely benign(Last reviewed: Mar 1, 2022)	criteria provided, multiple submitters, no conflicts	VCV000008402	2	74588717	2	74361590	8402	23441	rs72466496	NC_000002.12:74361589:G:A
NM_005216.5(DDOST):c.315C>T (p.Gly105=)	DDOST|PINK1		Congenital disorder of glycosylation type Ir|Parkinson Disease, Recessive|Congenital disorder of glycosylation|not specified	Benign(Last reviewed: Jul 30, 2021)	criteria provided, multiple submitters, no conflicts	VCV000295156	1	20982631	1	20656138	295156	278588	rs4704	NC_000001.11:20656137:G:A
NM_005216.5(DDOST):c.831C>T (p.Ala277=)	DDOST|PINK1		Congenital disorder of glycosylation type Ir|not specified|Parkinson Disease, Recessive|Congenital disorder of glycosylation	Benign/Likely benign(Last reviewed: Dec 4, 2020)	criteria provided, multiple submitters, no conflicts	VCV000295114	1	20980231	1	20653738	295114	279913	rs6692016	NC_000001.11:20653737:G:A
NM_005216.5(DDOST):c.*40A>G	DDOST|PINK1		Congenital disorder of glycosylation type Ir|not provided|Parkinson Disease, Recessive|Congenital disorder of glycosylation	Benign(Last reviewed: Jul 30, 2021)	criteria provided, multiple submitters, no conflicts	VCV000295057	1	20978832	1	20652339	295057	279865	rs6893	NC_000001.11:20652338:T:C
NM_005216.5(DDOST):c.*375_*376dup	DDOST|PINK1|PINK1-AS		Parkinson Disease, Recessive|Congenital disorder of glycosylation	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000295050	1	20978495 - 20978496	1	20652002 - 20652003	295050	279979	rs200971370	NC_000001.11:20652002:TTTT:TTTTTT
NM_005216.5(DDOST):c.*457A>C	DDOST|PINK1|PINK1-AS		Parkinson Disease, Recessive	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000295048	1	20978415	1	20651922	295048	279978	rs150466875	NC_000001.11:20651921:T:G
NM_005216.5(DDOST):c.*462A>G	DDOST|PINK1|PINK1-AS		Parkinson Disease, Recessive	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000295047	1	20978410	1	20651917	295047	278569	rs559542	NC_000001.11:20651916:T:C
NM_005216.5(DDOST):c.*542TAAA[6]	DDOST|PINK1|PINK1-AS		Parkinson Disease, Recessive|Congenital disorder of glycosylation	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000295043	1	20978295 - 20978306	1	20651802 - 20651813	295043	279973	rs78039244	NC_000001.11:20651801:TTTATTTATTTATTTATTTATTTATTTATTTATTTAT:TTTATTTATTTATTTATTTATTTAT
NM_032409.3(PINK1):c.*672T>C	DDOST|PINK1|PINK1-AS		Parkinson Disease, Recessive|Congenital disorder of glycosylation|Parkinson disease 6, autosomal recessive early-onset|not provided	Benign/Likely benign(Last reviewed: May 14, 2021)	criteria provided, multiple submitters, no conflicts	VCV000295030	1	20977856	1	20651363	295030	279967	rs2078073	NC_000001.11:20651362:T:C
NM_032409.3(PINK1):c.*673_*675dup	DDOST|PINK1|PINK1-AS		Parkinson Disease, Recessive|Congenital disorder of glycosylation	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000295029	1	20977854 - 20977855	1	20651361 - 20651362	295029	278557	rs3077908	NC_000001.11:20651361:TTCTT:TTCTTCTT
NM_032409.3(PINK1):c.*573_*576dup	DDOST|PINK1|PINK1-AS		Parkinson Disease, Recessive|Congenital disorder of glycosylation	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000295026	1	20977754 - 20977755	1	20651261 - 20651262	295026	279815	rs143763511	NC_000001.11:20651261:CTGACT:CTGACTGACT
NM_032409.3(PINK1):c.*564T>G	DDOST|PINK1|PINK1-AS		Parkinson Disease, Recessive|not provided|Parkinson disease 6, autosomal recessive early-onset|Congenital disorder of glycosylation	Benign/Likely benign(Last reviewed: May 14, 2021)	criteria provided, multiple submitters, no conflicts	VCV000295024	1	20977748	1	20651255	295024	279966	rs1043502	NC_000001.11:20651254:T:G
NM_032409.3(PINK1):c.*490A>C	DDOST|PINK1|PINK1-AS		not provided|Parkinson Disease, Recessive|Parkinson disease 6, autosomal recessive early-onset|Congenital disorder of glycosylation	Benign/Likely benign(Last reviewed: May 25, 2021)	criteria provided, multiple submitters, no conflicts	VCV000295019	1	20977674	1	20651181	295019	278672	rs16824318	NC_000001.11:20651180:A:C
NM_032409.3(PINK1):c.*415C>G	DDOST|PINK1|PINK1-AS		Parkinson Disease, Recessive|Congenital disorder of glycosylation|Parkinson disease 6, autosomal recessive early-onset|not provided	Benign/Likely benign(Last reviewed: May 15, 2021)	criteria provided, multiple submitters, no conflicts	VCV000295018	1	20977599	1	20651106	295018	278658	rs8064	NC_000001.11:20651105:C:G
NM_032409.3(PINK1):c.*265G>T	DDOST|PINK1|PINK1-AS		Parkinson Disease, Recessive|Parkinson disease 6, autosomal recessive early-onset|Congenital disorder of glycosylation|not provided	Benign/Likely benign(Last reviewed: Jul 9, 2018)	criteria provided, multiple submitters, no conflicts	VCV000295015	1	20977449	1	20650956	295015	279965	rs512550	NC_000001.11:20650955:G:T
NM_032409.3(PINK1):c.*196T>C	DDOST|PINK1|PINK1-AS		not provided|Parkinson Disease, Recessive|Parkinson disease 6, autosomal recessive early-onset|Congenital disorder of glycosylation	Benign/Likely benign(Last reviewed: Jul 9, 2018)	criteria provided, multiple submitters, no conflicts	VCV000295014	1	20977380	1	20650887	295014	278656	rs1043443	NC_000001.11:20650886:T:C
NM_032409.3(PINK1):c.*181C>G	DDOST|PINK1|PINK1-AS		Parkinson Disease, Recessive|Congenital disorder of glycosylation|Parkinson disease 6, autosomal recessive early-onset|not provided	Benign(Last reviewed: Jul 9, 2018)	criteria provided, multiple submitters, no conflicts	VCV000295013	1	20977365	1	20650872	295013	278645	rs513414	NC_000001.11:20650871:C:G
NM_001256715.2(DNAAF3):c.484C>A (p.Arg162Ser)	DNAAF3|TNNI3	R108S, R162S, R209S, R230S	Dilated cardiomyopathy 2A|Familial hypertrophic cardiomyopathy 7|Familial restrictive cardiomyopathy 1|Familial Hypertrophic Cardiomyopathy with Wolff-Parkinson-White Syndrome	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000894094	19	55673190	19	55161822	894094	882938	rs760391305	NC_000019.10:55161821:G:T
NM_001256715.2(DNAAF3):c.990C>T (p.Thr330=)	DNAAF3|TNNI3		Familial hypertrophic cardiomyopathy 7|Familial restrictive cardiomyopathy 1|Dilated cardiomyopathy 2A|Familial Hypertrophic Cardiomyopathy with Wolff-Parkinson-White Syndrome	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000894093	19	55672066	19	55160698	894093	882937	rs371092262	NC_000019.10:55160697:G:A
NM_001256715.2(DNAAF3):c.1093= (p.Asn365=)	DNAAF3|TNNI3		Familial Hypertrophic Cardiomyopathy with Wolff-Parkinson-White Syndrome|Dilated Cardiomyopathy, Recessive|Ciliary dyskinesia, primary, 2|Hypertrophic cardiomyopathy|Primary ciliary dyskinesia|Familial restrictive cardiomyopathy|not specified	Benign/Likely benign(Last reviewed: Jul 30, 2021)	criteria provided, multiple submitters, no conflicts	VCV000369296	19	55671337	19	55159969	369296	353525	rs890872	NC_000019.10:55159968:T:T
NM_001256715.2(DNAAF3):c.1405G>A (p.Val469Met)	DNAAF3|TNNI3	V516M, V536M, V415M, V469M	Hypertrophic cardiomyopathy|Primary ciliary dyskinesia|Familial restrictive cardiomyopathy|Familial Hypertrophic Cardiomyopathy with Wolff-Parkinson-White Syndrome|Dilated Cardiomyopathy, Recessive	Benign/Likely benign(Last reviewed: Dec 6, 2020)	criteria provided, multiple submitters, no conflicts	VCV000369295	19	55670651	19	55159283	369295	353524	rs114601492	NC_000019.10:55159282:C:T
NM_001256715.2(DNAAF3):c.531C>T (p.Gly177=)	DNAAF3|TNNI3		Dilated Cardiomyopathy, Recessive|Familial Hypertrophic Cardiomyopathy with Wolff-Parkinson-White Syndrome|Familial restrictive cardiomyopathy|Primary ciliary dyskinesia|Hypertrophic cardiomyopathy	Conflicting interpretations of pathogenicity(Last reviewed: Jun 26, 2020)	criteria provided, conflicting interpretations	VCV000330217	19	55673143	19	55161775	330217	334413	rs559008223	NC_000019.10:55161774:G:A
NM_001256715.2(DNAAF3):c.790-14C>T	DNAAF3|TNNI3		not specified|Dilated Cardiomyopathy, Recessive|Familial Hypertrophic Cardiomyopathy with Wolff-Parkinson-White Syndrome|Primary ciliary dyskinesia|Familial restrictive cardiomyopathy|Hypertrophic cardiomyopathy|Ciliary dyskinesia, primary, 2|not provided	Benign/Likely benign(Last reviewed: Dec 18, 2021)	criteria provided, multiple submitters, no conflicts	VCV000257695	19	55672569	19	55161201	257695	257247	rs7260371	NC_000019.10:55161200:G:A
NM_001256715.2(DNAAF3):c.666T>C (p.Ala222=)	DNAAF3|TNNI3		Familial restrictive cardiomyopathy|not specified|not provided|Dilated Cardiomyopathy, Recessive|Familial Hypertrophic Cardiomyopathy with Wolff-Parkinson-White Syndrome|Primary ciliary dyskinesia|Hypertrophic cardiomyopathy|Ciliary dyskinesia, primary, 2	Benign/Likely benign(Last reviewed: Nov 27, 2020)	criteria provided, multiple submitters, no conflicts	VCV000257694	19	55672784	19	55161416	257694	257248	rs7260320	NC_000019.10:55161415:A:G
NM_001256715.2(DNAAF3):c.529G>A (p.Gly177Ser)	DNAAF3|TNNI3	G224S, G245S, G177S, G123S	Dilated Cardiomyopathy, Recessive|Familial Hypertrophic Cardiomyopathy with Wolff-Parkinson-White Syndrome|Primary ciliary dyskinesia|Familial restrictive cardiomyopathy|Hypertrophic cardiomyopathy|not specified|not provided	Benign/Likely benign(Last reviewed: Nov 27, 2020)	criteria provided, multiple submitters, no conflicts	VCV000257691	19	55673145	19	55161777	257691	257251	rs58824375	NC_000019.10:55161776:C:T
NM_001256715.2(DNAAF3):c.510A>G (p.Val170=)	DNAAF3|TNNI3		not specified|Dilated Cardiomyopathy, Recessive|Familial Hypertrophic Cardiomyopathy with Wolff-Parkinson-White Syndrome|Primary ciliary dyskinesia|Familial restrictive cardiomyopathy|Hypertrophic cardiomyopathy|not provided	Benign/Likely benign(Last reviewed: Nov 27, 2020)	criteria provided, multiple submitters, no conflicts	VCV000257689	19	55673164	19	55161796	257689	257252	rs56726774	NC_000019.10:55161795:T:C
NM_001256715.2(DNAAF3):c.327A>G (p.Arg109=)	DNAAF3|TNNI3		not specified|Dilated Cardiomyopathy, Recessive|Familial Hypertrophic Cardiomyopathy with Wolff-Parkinson-White Syndrome|Familial restrictive cardiomyopathy|Primary ciliary dyskinesia|Hypertrophic cardiomyopathy|not provided	Benign/Likely benign(Last reviewed: Nov 27, 2020)	criteria provided, multiple submitters, no conflicts	VCV000257688	19	55673654	19	55162286	257688	257253	rs3848618	NC_000019.10:55162285:T:C
NM_001256715.2(DNAAF3):c.1248G>A (p.Val416=)	DNAAF3|TNNI3		not specified|not provided|Familial Hypertrophic Cardiomyopathy with Wolff-Parkinson-White Syndrome|Primary ciliary dyskinesia|Familial hypertrophic cardiomyopathy 7|Familial restrictive cardiomyopathy 1|Dilated cardiomyopathy 2A	Conflicting interpretations of pathogenicity(Last reviewed: Mar 1, 2021)	criteria provided, conflicting interpretations	VCV000257685	19	55670808	19	55159440	257685	257237	rs111250144	NC_000019.10:55159439:C:T
NM_001256715.2(DNAAF3):c.1239-8A>G	DNAAF3|TNNI3		not specified|not provided|Dilated Cardiomyopathy, Recessive|Familial Hypertrophic Cardiomyopathy with Wolff-Parkinson-White Syndrome|Primary ciliary dyskinesia|Familial restrictive cardiomyopathy|Hypertrophic cardiomyopathy|Ciliary dyskinesia, primary, 2	Benign/Likely benign(Last reviewed: Jul 30, 2021)	criteria provided, multiple submitters, no conflicts	VCV000257684	19	55670825	19	55159457	257684	257238	rs28377509	NC_000019.10:55159456:T:C
NM_001256715.2(DNAAF3):c.1164-14C>T	DNAAF3|TNNI3		Familial restrictive cardiomyopathy|not provided|not specified|Dilated Cardiomyopathy, Recessive|Familial Hypertrophic Cardiomyopathy with Wolff-Parkinson-White Syndrome|Primary ciliary dyskinesia|Hypertrophic cardiomyopathy	Benign/Likely benign(Last reviewed: Dec 10, 2021)	criteria provided, multiple submitters, no conflicts	VCV000257682	19	55670989	19	55159621	257682	257239	rs60176657	NC_000019.10:55159620:G:A
NM_001256715.2(DNAAF3):c.1056G>A (p.Pro352=)	DNAAF3|TNNI3		not provided|not specified|Dilated Cardiomyopathy, Recessive|Familial Hypertrophic Cardiomyopathy with Wolff-Parkinson-White Syndrome|Primary ciliary dyskinesia|Familial restrictive cardiomyopathy|Hypertrophic cardiomyopathy|Ciliary dyskinesia, primary, 2	Benign/Likely benign(Last reviewed: Nov 27, 2020)	criteria provided, multiple submitters, no conflicts	VCV000257680	19	55671374	19	55160006	257680	257242	rs891187	NC_000019.10:55160005:C:T
NM_001256715.2(DNAAF3):c.1001T>C (p.Leu334Pro)	DNAAF3|TNNI3	L381P, L402P, L280P, L334P	not specified|Dilated Cardiomyopathy, Recessive|Familial Hypertrophic Cardiomyopathy with Wolff-Parkinson-White Syndrome|Familial restrictive cardiomyopathy|Primary ciliary dyskinesia|Hypertrophic cardiomyopathy|not provided	Benign/Likely benign(Last reviewed: Nov 27, 2020)	criteria provided, multiple submitters, no conflicts	VCV000257679	19	55672055	19	55160687	257679	257243	rs890871	NC_000019.10:55160686:A:G
NM_001256715.2(DNAAF3):c.875A>G (p.Glu292Gly)	DNAAF3|TNNI3	E339G, E360G, E238G, E292G	not provided|not specified|Dilated Cardiomyopathy, Recessive|Familial Hypertrophic Cardiomyopathy with Wolff-Parkinson-White Syndrome|Primary ciliary dyskinesia|Familial restrictive cardiomyopathy|Hypertrophic cardiomyopathy|Ciliary dyskinesia, primary, 2	Benign/Likely benign(Last reviewed: Nov 27, 2020)	criteria provided, multiple submitters, no conflicts	VCV000257676	19	55672470	19	55161102	257676	257246	rs2365725	NC_000019.10:55161101:T:C
NM_000363.5(TNNI3):c.-35C>A	DNAAF3|TNNI3		Primary ciliary dyskinesia|Familial Hypertrophic Cardiomyopathy with Wolff-Parkinson-White Syndrome|Dilated Cardiomyopathy, Recessive|Familial restrictive cardiomyopathy 1|Dilated cardiomyopathy 2A|Familial hypertrophic cardiomyopathy 7|not specified|Hypertrophic cardiomyopathy|Familial restrictive cardiomyopathy	Benign/Likely benign(Last reviewed: Jan 13, 2018)	criteria provided, multiple submitters, no conflicts	VCV000137687	19	55668992	19	55157624	137687	141390	rs3729707	NC_000019.10:55157623:G:T
NM_000363.5(TNNI3):c.537G>A (p.Glu179=)	DNAAF3|TNNI3		Cardiomyopathy|Familial restrictive cardiomyopathy 1|Dilated cardiomyopathy 2A|Primary ciliary dyskinesia|Familial hypertrophic cardiomyopathy 7|Cardiovascular phenotype|not specified|Hypertrophic cardiomyopathy|Familial Hypertrophic Cardiomyopathy with Wolff-Parkinson-White Syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Dec 4, 2020)	criteria provided, conflicting interpretations	VCV000043391	19	55665410	19	55154042	43391	52561	rs3729841	NC_000019.10:55154041:C:T
NM_000363.5(TNNI3):c.25-8T>A	DNAAF3|TNNI3		Dilated cardiomyopathy 2A|Primary ciliary dyskinesia|Familial restrictive cardiomyopathy 1|Familial hypertrophic cardiomyopathy 7|not specified|Hypertrophic cardiomyopathy|Cardiomyopathy|Dilated Cardiomyopathy, Recessive|Familial Hypertrophic Cardiomyopathy with Wolff-Parkinson-White Syndrome|Familial restrictive cardiomyopathy	Benign/Likely benign(Last reviewed: Sep 10, 2021)	criteria provided, multiple submitters, no conflicts	VCV000043371	19	55668509	19	55157141	43371	52541	rs3729836	NC_000019.10:55157140:A:T
NM_000363.5(TNNI3):c.204G>T (p.Arg68=)	DNAAF3|TNNI3		Dilated cardiomyopathy 2A|Cardiovascular phenotype|not provided|Primary ciliary dyskinesia|Familial restrictive cardiomyopathy 1|Familial hypertrophic cardiomyopathy 7|Cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Familial Hypertrophic Cardiomyopathy with Wolff-Parkinson-White Syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Dec 2, 2020)	criteria provided, conflicting interpretations	VCV000043366	19	55667647	19	55156279	43366	52536	rs3729711	NC_000019.10:55156278:C:A
NM_000363.5(TNNI3):c.150+13G>A	DNAAF3|TNNI3		Dilated cardiomyopathy 2A|not provided|Primary ciliary dyskinesia|Familial hypertrophic cardiomyopathy 7|Familial restrictive cardiomyopathy 1|Hypertrophic cardiomyopathy|Dilated Cardiomyopathy, Recessive|Familial Hypertrophic Cardiomyopathy with Wolff-Parkinson-White Syndrome|Familial restrictive cardiomyopathy|Cardiomyopathy|not specified	Benign/Likely benign(Last reviewed: Dec 18, 2021)	criteria provided, multiple submitters, no conflicts	VCV000043362	19	55667958	19	55156590	43362	52532	rs73617692	NC_000019.10:55156589:C:T
NM_000363.5(TNNI3):c.373-10=	DNAAF3|TNNI3|TNNT1		Familial hypertrophic cardiomyopathy 7|Familial restrictive cardiomyopathy 1|Dilated cardiomyopathy 2A|Primary familial hypertrophic cardiomyopathy|Hypertrophic cardiomyopathy|Cardiomyopathy|not provided|Familial Hypertrophic Cardiomyopathy with Wolff-Parkinson-White Syndrome|Nemaline Myopathy, Recessive|not specified|Primary ciliary dyskinesia	Conflicting interpretations of pathogenicity(Last reviewed: Dec 8, 2020)	criteria provided, conflicting interpretations	VCV000036881	19	55665584	19	55154216	36881	45542	rs7252610	NC_000019.10:55154215:C:C
NM_058246.4(DNAJB6):c.577A>G (p.Thr193Ala)	DNAJB6	T193A	Parkinson disease, late-onset|Autosomal dominant limb-girdle muscular dystrophy type 1D	Uncertain significance(Last reviewed: Aug 27, 2021)	criteria provided, single submitter	VCV000870632	7	157177659	7	157384965	870632	858794	rs770053224	NC_000007.14:157384964:A:G
NM_015268.4(DNAJC13):c.3872A>G (p.Glu1291Gly)	DNAJC13	E1291G, E1296G	Parkinson disease 21|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Dec 31, 2019)	criteria provided, conflicting interpretations	VCV000715477	3	132213034	3	132494190	715477	720180	rs61748101	NC_000003.12:132494189:A:G
NM_015268.4(DNAJC13):c.2564A>G (p.Asn855Ser)	DNAJC13	N855S, N860S	Parkinson disease, late-onset|Essential tremor|Parkinson disease 21	Conflicting interpretations of pathogenicity(Last reviewed: Apr 1, 2014)	no assertion criteria provided	VCV000056171	3	132196839	3	132477995	56171	70810	rs387907571	NC_000003.12:132477994:A:G
NM_001256864.2(DNAJC6):c.49G>T (p.Glu17Ter)	DNAJC6	E17*	Parkinson disease 19a, juvenile-onset	Likely pathogenic(Last reviewed: Jan 20, 2022)	criteria provided, single submitter	VCV001676536					1676536	1668024		
NM_001256864.2(DNAJC6):c.144G>T (p.Arg48=)	DNAJC6		Parkinson disease 19a, juvenile-onset	Likely benign(Last reviewed: Nov 2, 2021)	criteria provided, single submitter	VCV001669121	1	65775572	1	65309889	1669121	1603007		NC_000001.11:65309888:G:T
NM_001256864.2(DNAJC6):c.1533G>A (p.Glu511=)	DNAJC6		Parkinson disease 19a, juvenile-onset	Likely benign(Last reviewed: Nov 14, 2021)	criteria provided, single submitter	VCV001668669	1	65858178	1	65392495	1668669	1634043		NC_000001.11:65392494:G:A
NM_001256864.2(DNAJC6):c.751T>C (p.Leu251=)	DNAJC6		Parkinson disease 19a, juvenile-onset	Likely benign(Last reviewed: Mar 7, 2021)	criteria provided, single submitter	VCV001664053	1	65849960	1	65384277	1664053	1654222		NC_000001.11:65384276:T:C
NM_001256864.2(DNAJC6):c.2697C>T (p.Thr899=)	DNAJC6		Parkinson disease 19a, juvenile-onset	Likely benign(Last reviewed: Sep 9, 2021)	criteria provided, single submitter	VCV001657427	1	65876995	1	65411312	1657427	1628591		NC_000001.11:65411311:C:T
NM_001256864.2(DNAJC6):c.216G>A (p.Glu72=)	DNAJC6		Parkinson disease 19a, juvenile-onset	Likely benign(Last reviewed: Nov 10, 2021)	criteria provided, single submitter	VCV001653067	1	65830340	1	65364657	1653067	1579566		NC_000001.11:65364656:G:A
NM_001256864.2(DNAJC6):c.1755T>C (p.Phe585=)	DNAJC6		Parkinson disease 19a, juvenile-onset	Likely benign(Last reviewed: Nov 1, 2021)	criteria provided, single submitter	VCV001651122	1	65858400	1	65392717	1651122	1578497		NC_000001.11:65392716:T:C
NM_001256864.2(DNAJC6):c.1845A>G (p.Ser615=)	DNAJC6		Parkinson disease 19a, juvenile-onset	Likely benign(Last reviewed: Dec 10, 2020)	criteria provided, single submitter	VCV001644557	1	65858490	1	65392807	1644557	1522604		NC_000001.11:65392806:A:G
NM_001256864.2(DNAJC6):c.1269G>A (p.Gln423=)	DNAJC6		Parkinson disease 19a, juvenile-onset	Likely benign(Last reviewed: Apr 17, 2021)	criteria provided, single submitter	VCV001625972	1	65855014	1	65389331	1625972	1575187		NC_000001.11:65389330:G:A
NM_001256864.2(DNAJC6):c.1904-12A>G	DNAJC6		Parkinson disease 19a, juvenile-onset	Likely benign(Last reviewed: Dec 3, 2021)	criteria provided, single submitter	VCV001618322	1	65860569	1	65394886	1618322	1527644		NC_000001.11:65394885:A:G
NM_001256864.2(DNAJC6):c.2463C>T (p.Asn821=)	DNAJC6		Parkinson disease 19a, juvenile-onset	Likely benign(Last reviewed: Oct 4, 2021)	criteria provided, single submitter	VCV001604566	1	65871788	1	65406105	1604566	1623721		NC_000001.11:65406104:C:T
NM_001256864.2(DNAJC6):c.2228-17T>A	DNAJC6		Parkinson disease 19a, juvenile-onset	Likely benign(Last reviewed: Sep 21, 2021)	criteria provided, single submitter	VCV001598421	1	65871536	1	65405853	1598421	1630420		NC_000001.11:65405852:T:A
NM_001256864.2(DNAJC6):c.194-17T>G	DNAJC6		Parkinson disease 19a, juvenile-onset	Benign(Last reviewed: Oct 5, 2021)	criteria provided, single submitter	VCV001595879	1	65830301	1	65364618	1595879	1569455		NC_000001.11:65364617:T:G
NM_001256864.2(DNAJC6):c.666+10C>G	DNAJC6		Parkinson disease 19a, juvenile-onset	Likely benign(Last reviewed: Mar 23, 2021)	criteria provided, single submitter	VCV001575180	1	65845217	1	65379534	1575180	1638465		NC_000001.11:65379533:C:G
NM_001256864.2(DNAJC6):c.897C>G (p.Pro299=)	DNAJC6		Parkinson disease 19a, juvenile-onset	Likely benign(Last reviewed: Oct 26, 2021)	criteria provided, single submitter	VCV001571616	1	65851491	1	65385808	1571616	1624940		NC_000001.11:65385807:C:G
NM_001256864.2(DNAJC6):c.2331C>T (p.Gly777=)	DNAJC6		Parkinson disease 19a, juvenile-onset	Benign(Last reviewed: May 5, 2021)	criteria provided, single submitter	VCV001565953	1	65871656	1	65405973	1565953	1590542		NC_000001.11:65405972:C:T
NM_001256864.2(DNAJC6):c.194-13T>G	DNAJC6		Parkinson disease 19a, juvenile-onset	Likely benign(Last reviewed: Jun 6, 2021)	criteria provided, single submitter	VCV001554713	1	65830305	1	65364622	1554713	1652149		NC_000001.11:65364621:T:G
NM_001256864.2(DNAJC6):c.194-16T>G	DNAJC6		Parkinson disease 19a, juvenile-onset	Likely benign(Last reviewed: Jul 26, 2021)	criteria provided, single submitter	VCV001554517	1	65830302	1	65364619	1554517	1651953		NC_000001.11:65364618:T:G
NM_001256864.2(DNAJC6):c.801-14A>C	DNAJC6		Parkinson disease 19a, juvenile-onset	Likely benign(Last reviewed: Nov 1, 2021)	criteria provided, single submitter	VCV001544023	1	65851381	1	65385698	1544023	1611561		NC_000001.11:65385697:A:C
NM_001256864.2(DNAJC6):c.995+16T>C	DNAJC6		Parkinson disease 19a, juvenile-onset	Likely benign(Last reviewed: Aug 4, 2021)	criteria provided, single submitter	VCV001528955	1	65851605	1	65385922	1528955	1634724		NC_000001.11:65385921:T:C
NM_001256864.2(DNAJC6):c.1832C>T (p.Ala611Val)	DNAJC6	A611V, A554V, A541V	Parkinson disease 19a, juvenile-onset	Uncertain significance(Last reviewed: Oct 17, 2021)	criteria provided, single submitter	VCV001522190	1	65858477	1	65392794	1522190	1344204		NC_000001.11:65392793:C:T
NM_001256864.2(DNAJC6):c.2107+8_2107+10del	DNAJC6		Parkinson disease 19a, juvenile-onset	Uncertain significance(Last reviewed: Oct 15, 2021)	criteria provided, single submitter	VCV001509579	1	65864570 - 65864572	1	65398887 - 65398889	1509579	1365199		NC_000001.11:65398886:AGCAG:AG
NM_001256864.2(DNAJC6):c.973T>C (p.Cys325Arg)	DNAJC6	C255R, C268R, C325R	Parkinson disease 19a, juvenile-onset	Uncertain significance(Last reviewed: Nov 22, 2021)	criteria provided, single submitter	VCV001500680	1	65851567	1	65385884	1500680	1501603		NC_000001.11:65385883:T:C
NM_001256864.2(DNAJC6):c.2443G>T (p.Ala815Ser)	DNAJC6	A815S, A745S, A758S	Parkinson disease 19a, juvenile-onset	Uncertain significance(Last reviewed: Sep 17, 2021)	criteria provided, single submitter	VCV001493001	1	65871768	1	65406085	1493001	1515837		NC_000001.11:65406084:G:T
NM_001256864.2(DNAJC6):c.2003T>A (p.Leu668His)	DNAJC6	L668H, L598H, L611H	Parkinson disease 19a, juvenile-onset	Uncertain significance(Last reviewed: Nov 10, 2021)	criteria provided, single submitter	VCV001491251	1	65860680	1	65394997	1491251	1508486		NC_000001.11:65394996:T:A
NM_001256864.2(DNAJC6):c.1794G>C (p.Gln598His)	DNAJC6	Q541H, Q528H, Q598H	Parkinson disease 19a, juvenile-onset	Uncertain significance(Last reviewed: Nov 18, 2021)	criteria provided, single submitter	VCV001489629	1	65858439	1	65392756	1489629	1495235		NC_000001.11:65392755:G:C
NM_001256864.2(DNAJC6):c.344+4C>T	DNAJC6		Parkinson disease 19a, juvenile-onset	Uncertain significance(Last reviewed: Aug 28, 2021)	criteria provided, single submitter	VCV001484761	1	65830472	1	65364789	1484761	1478299		NC_000001.11:65364788:C:T
NM_001256864.2(DNAJC6):c.2873G>T (p.Trp958Leu)	DNAJC6	W901L, W888L, W958L	Parkinson disease 19a, juvenile-onset	Uncertain significance(Last reviewed: Sep 20, 2021)	criteria provided, single submitter	VCV001481601	1	65878668	1	65412985	1481601	1367119		NC_000001.11:65412984:G:T
NM_001256864.2(DNAJC6):c.2255C>T (p.Thr752Ile)	DNAJC6	T682I, T752I, T695I	Parkinson disease 19a, juvenile-onset	Uncertain significance(Last reviewed: Jul 28, 2021)	criteria provided, single submitter	VCV001478736	1	65871580	1	65405897	1478736	1429971		NC_000001.11:65405896:C:T
NM_001256864.2(DNAJC6):c.2456dup (p.Gln820fs)	DNAJC6	Q820fs, Q750fs, Q763fs	Parkinson disease 19a, juvenile-onset	Pathogenic(Last reviewed: Oct 4, 2021)	criteria provided, single submitter	VCV001451316	1	65871776 - 65871777	1	65406093 - 65406094	1451316	1429570		NC_000001.11:65406093:GGGGG:GGGGGG
NM_001256864.2(DNAJC6):c.32C>T (p.Thr11Ile)	DNAJC6	T11I	Parkinson disease 19a, juvenile-onset	Uncertain significance(Last reviewed: Sep 24, 2021)	criteria provided, single submitter	VCV001447596	1	65775460	1	65309777	1447596	1403483		NC_000001.11:65309776:C:T
NM_001256864.2(DNAJC6):c.164C>A (p.Pro55Gln)	DNAJC6	P55Q	Parkinson disease 19a, juvenile-onset	Uncertain significance(Last reviewed: Oct 18, 2021)	criteria provided, single submitter	VCV001446499	1	65775592	1	65309909	1446499	1387450		NC_000001.11:65309908:C:A
NM_001256864.2(DNAJC6):c.119G>T (p.Arg40Ile)	DNAJC6	R40I	Parkinson disease 19a, juvenile-onset	Uncertain significance(Last reviewed: Nov 8, 2021)	criteria provided, single submitter	VCV001445553	1	65775547	1	65309864	1445553	1490424		NC_000001.11:65309863:G:T
NM_001256864.2(DNAJC6):c.1666C>T (p.Leu556Phe)	DNAJC6	L499F, L556F, L486F	Parkinson disease 19a, juvenile-onset	Uncertain significance(Last reviewed: Nov 27, 2021)	criteria provided, single submitter	VCV001444657	1	65858311	1	65392628	1444657	1384747		NC_000001.11:65392627:C:T
NM_001256864.2(DNAJC6):c.809G>A (p.Gly270Asp)	DNAJC6	G200D, G270D, G213D	Parkinson disease 19a, juvenile-onset	Uncertain significance(Last reviewed: Sep 15, 2021)	criteria provided, single submitter	VCV001444053	1	65851403	1	65385720	1444053	1488051		NC_000001.11:65385719:G:A
NM_001256864.2(DNAJC6):c.2839G>A (p.Ala947Thr)	DNAJC6	A947T, A890T, A877T	Parkinson disease 19a, juvenile-onset	Uncertain significance(Last reviewed: Oct 8, 2021)	criteria provided, single submitter	VCV001432952	1	65878634	1	65412951	1432952	1493526		NC_000001.11:65412950:G:A
NM_001256864.2(DNAJC6):c.1982G>A (p.Ser661Asn)	DNAJC6	S604N, S661N, S591N	Parkinson disease 19a, juvenile-onset	Uncertain significance(Last reviewed: Sep 1, 2021)	criteria provided, single submitter	VCV001426533	1	65860659	1	65394976	1426533	1366206		NC_000001.11:65394975:G:A
NM_001256864.2(DNAJC6):c.1852C>T (p.Arg618Cys)	DNAJC6	R561C, R618C, R548C	Parkinson disease 19a, juvenile-onset	Uncertain significance(Last reviewed: Sep 30, 2021)	criteria provided, single submitter	VCV001425297	1	65858497	1	65392814	1425297	1431536		NC_000001.11:65392813:C:T
NM_001256864.2(DNAJC6):c.1877C>T (p.Ala626Val)	DNAJC6	A569V, A556V, A626V	Parkinson disease 19a, juvenile-onset	Uncertain significance(Last reviewed: Dec 11, 2021)	criteria provided, single submitter	VCV001423966	1	65858522	1	65392839	1423966	1415150		NC_000001.11:65392838:C:T
NM_001256864.2(DNAJC6):c.1646C>T (p.Pro549Leu)	DNAJC6	P492L, P479L, P549L	Parkinson disease 19a, juvenile-onset	Uncertain significance(Last reviewed: Sep 17, 2021)	criteria provided, single submitter	VCV001418472	1	65858291	1	65392608	1418472	1490068		NC_000001.11:65392607:C:T
NM_001256864.2(DNAJC6):c.2715G>C (p.Glu905Asp)	DNAJC6	E835D, E848D, E905D	Parkinson disease 19a, juvenile-onset	Uncertain significance(Last reviewed: Sep 24, 2021)	criteria provided, single submitter	VCV001416440	1	65877013	1	65411330	1416440	1383262		NC_000001.11:65411329:G:C
NM_001256864.2(DNAJC6):c.992T>C (p.Met331Thr)	DNAJC6	M274T, M331T, M261T	Parkinson disease 19a, juvenile-onset	Uncertain significance(Last reviewed: Sep 24, 2021)	criteria provided, single submitter	VCV001416337	1	65851586	1	65385903	1416337	1383160		NC_000001.11:65385902:T:C
NM_001256864.2(DNAJC6):c.1709C>T (p.Pro570Leu)	DNAJC6	P500L, P570L, P513L	Parkinson disease 19a, juvenile-onset	Uncertain significance(Last reviewed: Aug 27, 2021)	criteria provided, single submitter	VCV001414996	1	65858354	1	65392671	1414996	1474609		NC_000001.11:65392670:C:T
NM_001256864.2(DNAJC6):c.1446C>A (p.Phe482Leu)	DNAJC6	F412L, F482L, F425L	Parkinson disease 19a, juvenile-onset	Uncertain significance(Last reviewed: Aug 4, 2021)	criteria provided, single submitter	VCV001409187	1	65855288	1	65389605	1409187	1496976		NC_000001.11:65389604:C:A
NM_001256864.2(DNAJC6):c.2107+3A>G	DNAJC6		Parkinson disease 19a, juvenile-onset	Uncertain significance(Last reviewed: Apr 28, 2021)	criteria provided, single submitter	VCV001408118	1	65864567	1	65398884	1408118	1421765		NC_000001.11:65398883:A:G
NM_001256864.2(DNAJC6):c.1716G>A (p.Ala572=)	DNAJC6		Parkinson disease 19a, juvenile-onset	Uncertain significance(Last reviewed: Oct 14, 2021)	criteria provided, single submitter	VCV001407794	1	65858361	1	65392678	1407794	1506673		NC_000001.11:65392677:G:A
NM_001256864.2(DNAJC6):c.2762A>T (p.Gln921Leu)	DNAJC6	Q864L, Q851L, Q921L	Parkinson disease 19a, juvenile-onset	Uncertain significance(Last reviewed: Aug 26, 2021)	criteria provided, single submitter	VCV001407142	1	65877060	1	65411377	1407142	1483352		NC_000001.11:65411376:A:T
NM_001256864.2(DNAJC6):c.1990A>G (p.Ser664Gly)	DNAJC6	S607G, S664G, S594G	Parkinson disease 19a, juvenile-onset	Uncertain significance(Last reviewed: Oct 24, 2021)	criteria provided, single submitter	VCV001401860	1	65860667	1	65394984	1401860	1457519		NC_000001.11:65394983:A:G
NM_001256864.2(DNAJC6):c.677_678dup (p.Ala227fs)	DNAJC6	A157fs, A170fs, A227fs	Parkinson disease 19a, juvenile-onset	Pathogenic(Last reviewed: Nov 29, 2021)	criteria provided, single submitter	VCV001399200	1	65849884 - 65849885	1	65384201 - 65384202	1399200	1450495		NC_000001.11:65384201:GCG:GCGCG
NM_001256864.2(DNAJC6):c.2212G>A (p.Asp738Asn)	DNAJC6	D668N, D681N, D738N	Parkinson disease 19a, juvenile-onset	Uncertain significance(Last reviewed: Oct 14, 2021)	criteria provided, single submitter	VCV001398584	1	65867548	1	65401865	1398584	1427651		NC_000001.11:65401864:G:A
NM_001256864.2(DNAJC6):c.839C>T (p.Pro280Leu)	DNAJC6	P223L, P210L, P280L	Parkinson disease 19a, juvenile-onset	Uncertain significance(Last reviewed: Nov 29, 2021)	criteria provided, single submitter	VCV001394692	1	65851433	1	65385750	1394692	1415581		NC_000001.11:65385749:C:T
NM_001256864.2(DNAJC6):c.518A>G (p.Tyr173Cys)	DNAJC6	Y116C, Y173C, Y103C	Parkinson disease 19a, juvenile-onset	Uncertain significance(Last reviewed: Aug 31, 2021)	criteria provided, single submitter	VCV001382772	1	65831854	1	65366171	1382772	1513246		NC_000001.11:65366170:A:G
NM_001256864.2(DNAJC6):c.1856G>A (p.Arg619His)	DNAJC6	R549H, R562H, R619H	Parkinson disease 19a, juvenile-onset	Uncertain significance(Last reviewed: Nov 22, 2021)	criteria provided, single submitter	VCV001380743	1	65858501	1	65392818	1380743	1421565		NC_000001.11:65392817:G:A
NM_001256864.2(DNAJC6):c.1607A>G (p.Lys536Arg)	DNAJC6	K479R, K536R, K466R	Parkinson disease 19a, juvenile-onset	Uncertain significance(Last reviewed: Aug 20, 2021)	criteria provided, single submitter	VCV001379214	1	65858252	1	65392569	1379214	1486443		NC_000001.11:65392568:A:G
NM_001256864.2(DNAJC6):c.1715C>T (p.Ala572Val)	DNAJC6	A502V, A515V, A572V	Parkinson disease 19a, juvenile-onset	Uncertain significance(Last reviewed: Oct 18, 2021)	criteria provided, single submitter	VCV001378591	1	65858360	1	65392677	1378591	1493021		NC_000001.11:65392676:C:T
NM_001256864.2(DNAJC6):c.2072A>G (p.Asp691Gly)	DNAJC6	D634G, D621G, D691G	Parkinson disease 19a, juvenile-onset	Uncertain significance(Last reviewed: Nov 14, 2021)	criteria provided, single submitter	VCV001376516	1	65864529	1	65398846	1376516	1479381		NC_000001.11:65398845:A:G
NM_001256864.2(DNAJC6):c.1651C>A (p.Pro551Thr)	DNAJC6	P481T, P494T, P551T	Parkinson disease 19a, juvenile-onset	Uncertain significance(Last reviewed: Sep 24, 2021)	criteria provided, single submitter	VCV001374640	1	65858296	1	65392613	1374640	1453609		NC_000001.11:65392612:C:A
NM_001256864.2(DNAJC6):c.1348T>G (p.Ser450Ala)	DNAJC6	S380A, S393A, S450A	Parkinson disease 19a, juvenile-onset	Uncertain significance(Last reviewed: Aug 12, 2021)	criteria provided, single submitter	VCV001374469	1	65855093	1	65389410	1374469	1453438		NC_000001.11:65389409:T:G
NM_001256864.2(DNAJC6):c.224A>G (p.Tyr75Cys)	DNAJC6	Y18C, Y75C, Y5C	Parkinson disease 19a, juvenile-onset	Uncertain significance(Last reviewed: Oct 23, 2021)	criteria provided, single submitter	VCV001364685	1	65830348	1	65364665	1364685	1409166		NC_000001.11:65364664:A:G
NM_001256864.2(DNAJC6):c.154C>G (p.Arg52Gly)	DNAJC6	R52G	Parkinson disease 19a, juvenile-onset	Uncertain significance(Last reviewed: Aug 27, 2021)	criteria provided, single submitter	VCV001363460	1	65775582	1	65309899	1363460	1489320		NC_000001.11:65309898:C:G
NM_001256864.2(DNAJC6):c.1113G>A (p.Lys371=)	DNAJC6		Parkinson disease 19a, juvenile-onset	Uncertain significance(Last reviewed: Oct 2, 2021)	criteria provided, single submitter	VCV001358065	1	65852612	1	65386929	1358065	1460364		NC_000001.11:65386928:G:A
NM_001256864.2(DNAJC6):c.844C>T (p.Arg282Cys)	DNAJC6	R282C, R225C, R212C	Parkinson disease 19a, juvenile-onset	Uncertain significance(Last reviewed: Sep 20, 2021)	criteria provided, single submitter	VCV001345716	1	65851438	1	65385755	1345716	1452583		NC_000001.11:65385754:C:T
NM_001256864.2(DNAJC6):c.829G>A (p.Ala277Thr)	DNAJC6	A207T, A220T, A277T	not provided|Parkinson disease 19a, juvenile-onset	Uncertain significance(Last reviewed: Dec 2, 2021)	criteria provided, multiple submitters, no conflicts	VCV001298426	1	65851423	1	65385740	1298426	1288288		NC_000001.11:65385739:G:A
NM_001256864.2(DNAJC6):c.194-19T>G	DNAJC6		not provided|Parkinson disease 19a, juvenile-onset	Benign(Last reviewed: Dec 11, 2021)	criteria provided, multiple submitters, no conflicts	VCV001277678	1	65830299	1	65364616	1277678	1269011		NC_000001.11:65364615:T:G
NM_001256864.2(DNAJC6):c.194-20_194-19insG	DNAJC6		Parkinson disease 19a, juvenile-onset|not provided	Benign/Likely benign(Last reviewed: Nov 25, 2021)	criteria provided, multiple submitters, no conflicts	VCV001260451	1	65830298 - 65830299	1	65364615 - 65364616	1260451	1248659		NC_000001.11:65364615::G
NM_001256864.2(DNAJC6):c.194-21G>T	DNAJC6		Parkinson disease 19a, juvenile-onset|not provided	Benign(Last reviewed: Dec 18, 2021)	criteria provided, multiple submitters, no conflicts	VCV001258041	1	65830297	1	65364614	1258041	1248811		NC_000001.11:65364613:G:T
NM_001256864.2(DNAJC6):c.194-18T>G	DNAJC6		not provided|Parkinson disease 19a, juvenile-onset	Benign/Likely benign(Last reviewed: Dec 18, 2021)	criteria provided, multiple submitters, no conflicts	VCV001215186	1	65830300	1	65364617	1215186	1205169		NC_000001.11:65364616:T:G
NM_001256864.2(DNAJC6):c.2159C>T (p.Ser720Leu)	DNAJC6	S650L, S663L, S720L	Parkinson disease 19a, juvenile-onset|not provided	Likely benign(Last reviewed: Aug 3, 2021)	criteria provided, multiple submitters, no conflicts	VCV001196512	1	65867495	1	65401812	1196512	1186231		NC_000001.11:65401811:C:T
NM_001256864.2(DNAJC6):c.194-6del	DNAJC6		Parkinson disease 19a, juvenile-onset|not provided	Benign(Last reviewed: Dec 18, 2021)	criteria provided, multiple submitters, no conflicts	VCV001178033	1	65830298	1	65364615	1178033	1167206		NC_000001.11:65364614:TTTTTTTTTTTTTTT:TTTTTTTTTTTTTT
NM_001256864.2(DNAJC6):c.1070T>C (p.Met357Thr)	DNAJC6	M287T, M300T, M357T	Parkinson disease 19a, juvenile-onset|not provided	Uncertain significance(Last reviewed: Oct 24, 2021)	criteria provided, multiple submitters, no conflicts	VCV001176504	1	65852569	1	65386886	1176504	1165522		NC_000001.11:65386885:T:C
NM_001256864.2(DNAJC6):c.2010A>C (p.Pro670=)	DNAJC6		not provided|not specified|Parkinson disease 19a, juvenile-onset	Benign(Last reviewed: Dec 8, 2020)	criteria provided, multiple submitters, no conflicts	VCV001170300	1	65860687	1	65395004	1170300	1153667		NC_000001.11:65395003:A:C
NM_001256864.2(DNAJC6):c.1500G>A (p.Glu500=)	DNAJC6		not provided|not specified|Parkinson disease 19a, juvenile-onset	Benign(Last reviewed: Dec 8, 2020)	criteria provided, multiple submitters, no conflicts	VCV001170299	1	65858145	1	65392462	1170299	1153664		NC_000001.11:65392461:G:A
NM_001256864.2(DNAJC6):c.544-9C>T	DNAJC6		not provided|not specified|Parkinson disease 19a, juvenile-onset	Benign(Last reviewed: Dec 4, 2020)	criteria provided, multiple submitters, no conflicts	VCV001170298	1	65845076	1	65379393	1170298	1153663		NC_000001.11:65379392:C:T
NM_001256864.2(DNAJC6):c.2183G>A (p.Ser728Asn)	DNAJC6	S658N, S671N, S728N	not specified|not provided|Parkinson disease 19a, juvenile-onset	Benign(Last reviewed: Dec 6, 2020)	criteria provided, multiple submitters, no conflicts	VCV001167138	1	65867519	1	65401836	1167138	1153668		NC_000001.11:65401835:G:A
NM_001256864.2(DNAJC6):c.1983T>C (p.Ser661=)	DNAJC6		Parkinson disease 19a, juvenile-onset|not specified|not provided	Benign(Last reviewed: Dec 6, 2020)	criteria provided, multiple submitters, no conflicts	VCV001167137	1	65860660	1	65394977	1167137	1153666		NC_000001.11:65394976:T:C
NM_001256864.2(DNAJC6):c.1506C>T (p.His502=)	DNAJC6		Parkinson disease 19a, juvenile-onset|not provided|not specified	Benign(Last reviewed: Dec 6, 2020)	criteria provided, multiple submitters, no conflicts	VCV001167136	1	65858151	1	65392468	1167136	1153665		NC_000001.11:65392467:C:T
NM_001256864.2(DNAJC6):c.2799G>A (p.Val933=)	DNAJC6		Parkinson disease 19a, juvenile-onset	Likely benign(Last reviewed: Oct 8, 2019)	criteria provided, single submitter	VCV001157160	1	65877097	1	65411414	1157160	1131684		NC_000001.11:65411413:G:A
NM_001256864.2(DNAJC6):c.507A>G (p.Ser169=)	DNAJC6		Parkinson disease 19a, juvenile-onset	Likely benign(Last reviewed: Dec 13, 2019)	criteria provided, single submitter	VCV001138490	1	65831843	1	65366160	1138490	1110820		NC_000001.11:65366159:A:G
NM_001256864.2(DNAJC6):c.2687C>T (p.Thr896Met)	DNAJC6	T826M, T839M, T896M	Parkinson disease 19a, juvenile-onset	Pathogenic(Last reviewed: May 11, 2021)	no assertion criteria provided	VCV001098747	1	65876985	1	65411302	1098747	1087475		NC_000001.11:65411301:C:T
NM_001256864.2(DNAJC6):c.2038+3A>G	DNAJC6		Parkinson disease 19a, juvenile-onset	Pathogenic(Last reviewed: May 11, 2021)	no assertion criteria provided	VCV001098746	1	65860718	1	65395035	1098746	1087472		NC_000001.11:65395034:A:G
NM_001256864.2(DNAJC6):c.2365C>T (p.Gln789Ter)	DNAJC6	Q719*, Q732*, Q789*	Parkinson disease 19a, juvenile-onset	Pathogenic(Last reviewed: May 11, 2021)	no assertion criteria provided	VCV001098745	1	65871690	1	65406007	1098745	1087473		NC_000001.11:65406006:C:T
NM_001256864.2(DNAJC6):c.2416C>T (p.Arg806Ter)	DNAJC6	R736*, R749*, R806*	Parkinson disease 19a, juvenile-onset	Pathogenic(Last reviewed: May 11, 2021)	no assertion criteria provided	VCV001098744	1	65871741	1	65406058	1098744	1087474		NC_000001.11:65406057:C:T
NM_001256864.2(DNAJC6):c.766C>T (p.Arg256Ter)	DNAJC6	R186*, R199*, R256*	Parkinson disease 19a, juvenile-onset	Pathogenic(Last reviewed: May 11, 2021)	no assertion criteria provided	VCV001098743	1	65849975	1	65384292	1098743	1087471		NC_000001.11:65384291:C:T
NM_001256864.2(DNAJC6):c.750A>T (p.Arg250=)	DNAJC6		Parkinson disease 19a, juvenile-onset	Likely benign(Last reviewed: Feb 21, 2019)	criteria provided, single submitter	VCV001081918	1	65849959	1	65384276	1081918	1067546		NC_000001.11:65384275:A:T
NM_001256864.2(DNAJC6):c.1831G>A (p.Ala611Thr)	DNAJC6	A541T, A554T, A611T	Parkinson disease 19a, juvenile-onset	Uncertain significance(Last reviewed: Aug 31, 2020)	criteria provided, single submitter	VCV001024855	1	65858476	1	65392793	1024855	1002989	rs1015326337	NC_000001.11:65392792:G:A
NM_001256864.2(DNAJC6):c.101G>C (p.Gly34Ala)	DNAJC6	G34A	Parkinson disease 19a, juvenile-onset	Uncertain significance(Last reviewed: Sep 24, 2020)	criteria provided, single submitter	VCV001004818	1	65775529	1	65309846	1004818	987742	rs956622990	NC_000001.11:65309845:G:C
NM_001256864.2(DNAJC6):c.988C>T (p.Arg330Ter)	DNAJC6	R260*, R273*, R330*	Parkinson disease 19a, juvenile-onset	Pathogenic(Last reviewed: Jul 1, 2020)	criteria provided, multiple submitters, no conflicts	VCV000976692	1	65851582	1	65385899	976692	964803	rs1645867120	NC_000001.11:65385898:C:T
NM_001256864.2(DNAJC6):c.674G>A (p.Arg225Gln)	DNAJC6	R155Q, R168Q, R225Q	Parkinson disease 19a, juvenile-onset	Uncertain significance(Last reviewed: Aug 13, 2019)	criteria provided, single submitter	VCV000969368	1	65849883	1	65384200	969368	952507	rs772437036	NC_000001.11:65384199:G:A
NM_001256864.2(DNAJC6):c.2020C>T (p.Pro674Ser)	DNAJC6	P617S, P674S, P604S	Parkinson disease 19a, juvenile-onset	Uncertain significance(Last reviewed: Oct 25, 2019)	criteria provided, single submitter	VCV000953330	1	65860697	1	65395014	953330	942092	rs749594846	NC_000001.11:65395013:C:T
NM_001256864.2(DNAJC6):c.677C>T (p.Ala226Val)	DNAJC6	A169V, A156V, A226V	Parkinson disease 19a, juvenile-onset	Uncertain significance(Last reviewed: Aug 29, 2019)	criteria provided, single submitter	VCV000935514	1	65849886	1	65384203	935514	930653	rs776225529	NC_000001.11:65384202:C:T
NM_001256864.2(DNAJC6):c.2468G>A (p.Arg823His)	DNAJC6	R823H, R753H, R766H	Parkinson disease 19a, juvenile-onset	Uncertain significance(Last reviewed: Jun 5, 2019)	criteria provided, single submitter	VCV000861071	1	65871793	1	65406110	861071	824387	rs201984806	NC_000001.11:65406109:G:A
NM_001256864.2(DNAJC6):c.2044A>G (p.Ser682Gly)	DNAJC6	S682G, S625G, S612G	Parkinson disease 19a, juvenile-onset	Uncertain significance(Last reviewed: Jan 3, 2019)	criteria provided, single submitter	VCV000851922	1	65864501	1	65398818	851922	824386	rs145175543	NC_000001.11:65398817:A:G
NM_001256864.2(DNAJC6):c.521G>A (p.Arg174Gln)	DNAJC6	R117Q, R104Q, R174Q	Parkinson disease 19a, juvenile-onset	Uncertain significance(Last reviewed: Jan 14, 2019)	criteria provided, single submitter	VCV000845295	1	65831857	1	65366174	845295	824384	rs895749847	NC_000001.11:65366173:G:A
NM_001256864.2(DNAJC6):c.926G>A (p.Arg309His)	DNAJC6	R239H, R252H, R309H	Parkinson disease 19a, juvenile-onset	Uncertain significance(Last reviewed: May 30, 2019)	criteria provided, single submitter	VCV000844109	1	65851520	1	65385837	844109	824385	rs757458350	NC_000001.11:65385836:G:A
NC_000001.11:g.(?_65388326)_(65413035_?)dup	DNAJC6		Parkinson disease 19a, juvenile-onset	Uncertain significance(Last reviewed: Mar 21, 2019)	criteria provided, single submitter	VCV000830927	1	65854009 - 65878718			830927	818991		
NM_001256864.2(DNAJC6):c.2310G>A (p.Ala770=)	DNAJC6		not provided|Parkinson disease 19a, juvenile-onset	Likely benign(Last reviewed: Jan 8, 2018)	criteria provided, single submitter	VCV000766835	1	65871635	1	65405952	766835	696843	rs113490907	NC_000001.11:65405951:G:A
NM_001256864.2(DNAJC6):c.2298G>A (p.Ser766=)	DNAJC6		Parkinson disease 19a, juvenile-onset|not provided	Likely benign(Last reviewed: Jun 11, 2018)	criteria provided, single submitter	VCV000745392	1	65871623	1	65405940	745392	746628	rs540477402	NC_000001.11:65405939:G:A
NM_001256864.2(DNAJC6):c.264G>A (p.Gly88=)	DNAJC6		Parkinson disease 19a, juvenile-onset|not provided	Likely benign(Last reviewed: Jan 22, 2018)	criteria provided, single submitter	VCV000729926	1	65830388	1	65364705	729926	732562	rs139946043	NC_000001.11:65364704:G:A
NM_001256864.2(DNAJC6):c.2151C>T (p.Thr717=)	DNAJC6		Parkinson disease 19a, juvenile-onset|not provided	Likely benign(Last reviewed: Dec 26, 2018)	criteria provided, single submitter	VCV000710532	1	65867487	1	65401804	710532	719054	rs145501615	NC_000001.11:65401803:C:T
NM_001256864.2(DNAJC6):c.1194-9C>G	DNAJC6		Parkinson disease 19a, juvenile-onset|not provided	Likely benign(Last reviewed: Mar 27, 2020)	criteria provided, single submitter	VCV000706857	1	65854930	1	65389247	706857	695062	rs370864885	NC_000001.11:65389246:C:G
NM_001256864.2(DNAJC6):c.1182A>G (p.Leu394=)	DNAJC6		Parkinson disease 19a, juvenile-onset	Likely benign(Last reviewed: Dec 31, 2019)	criteria provided, single submitter	VCV000706823	1	65854087	1	65388404	706823	690665	rs148145327	NC_000001.11:65388403:A:G
NM_001256864.2(DNAJC6):c.1577A>G (p.Asn526Ser)	DNAJC6	N456S, N526S, N469S	Parkinson disease 19a, juvenile-onset	Likely benign(Last reviewed: Nov 6, 2020)	criteria provided, single submitter	VCV000706821	1	65858222	1	65392539	706821	690671	rs191459935	NC_000001.11:65392538:A:G
NM_001256864.2(DNAJC6):c.1350T>C (p.Ser450=)	DNAJC6		Parkinson disease 19a, juvenile-onset	Likely benign(Last reviewed: Nov 18, 2019)	criteria provided, single submitter	VCV000706557	1	65855095	1	65389412	706557	690668	rs202109326	NC_000001.11:65389411:T:C
NM_001256864.2(DNAJC6):c.513G>A (p.Lys171=)	DNAJC6		Parkinson disease 19a, juvenile-onset	Benign(Last reviewed: Dec 31, 2019)	criteria provided, single submitter	VCV000705664	1	65831849	1	65366166	705664	690664	rs148204207	NC_000001.11:65366165:G:A
NM_001256864.2(DNAJC6):c.1374G>A (p.Thr458=)	DNAJC6		Parkinson disease 19a, juvenile-onset	Likely benign(Last reviewed: Sep 19, 2019)	criteria provided, single submitter	VCV000705046	1	65855119	1	65389436	705046	690669	rs148673423	NC_000001.11:65389435:G:A
NM_001256864.2(DNAJC6):c.186C>T (p.Asp62=)	DNAJC6		Parkinson disease 19a, juvenile-onset	Likely benign(Last reviewed: Dec 27, 2019)	criteria provided, single submitter	VCV000705033	1	65775614	1	65309931	705033	690662	rs371984320	NC_000001.11:65309930:C:T
NM_001256864.2(DNAJC6):c.1266A>T (p.Leu422=)	DNAJC6		Parkinson disease 19a, juvenile-onset|not provided	Benign(Last reviewed: Aug 29, 2021)	criteria provided, single submitter	VCV000704469	1	65855011	1	65389328	704469	690666	rs61758427	NC_000001.11:65389327:A:T
NM_001256864.2(DNAJC6):c.2254A>T (p.Thr752Ser)	DNAJC6	T682S, T695S, T752S	Parkinson disease 19a, juvenile-onset	Likely benign(Last reviewed: Dec 31, 2019)	criteria provided, single submitter	VCV000704007	1	65871579	1	65405896	704007	690673	rs113143702	NC_000001.11:65405895:A:T
NM_001256864.2(DNAJC6):c.1492T>A (p.Cys498Ser)	DNAJC6	C441S, C428S, C498S	not provided|Parkinson disease 19a, juvenile-onset	Conflicting interpretations of pathogenicity(Last reviewed: Nov 11, 2020)	criteria provided, conflicting interpretations	VCV000703945	1	65858137	1	65392454	703945	690670	rs145329294	NC_000001.11:65392453:T:A
NM_001256864.2(DNAJC6):c.1710G>A (p.Pro570=)	DNAJC6		not provided|Parkinson disease 19a, juvenile-onset	Benign/Likely benign(Last reviewed: Feb 25, 2021)	criteria provided, multiple submitters, no conflicts	VCV000703807	1	65858355	1	65392672	703807	690672	rs7551930	NC_000001.11:65392671:G:A
NM_001256864.2(DNAJC6):c.1320A>T (p.Thr440=)	DNAJC6		Parkinson disease 19a, juvenile-onset|not provided	Benign/Likely benign(Last reviewed: Jun 11, 2021)	criteria provided, multiple submitters, no conflicts	VCV000702187	1	65855065	1	65389382	702187	690667	rs142136708	NC_000001.11:65389381:A:T
NM_001256864.2(DNAJC6):c.170G>T (p.Arg57Leu)	DNAJC6	R57L	Parkinson disease 19a, juvenile-onset	Uncertain significance(Last reviewed: Oct 19, 2019)	criteria provided, single submitter	VCV000664983	1	65775598	1	65309915	664983	628246	rs747115530	NC_000001.11:65309914:G:T
NM_001256864.2(DNAJC6):c.397A>T (p.Met133Leu)	DNAJC6	M63L, M76L, M133L	Parkinson disease 19a, juvenile-onset	Uncertain significance(Last reviewed: Oct 10, 2020)	criteria provided, single submitter	VCV000663145	1	65831733	1	65366050	663145	628248	rs61757223	NC_000001.11:65366049:A:T
NM_001256864.2(DNAJC6):c.2228-3T>C	DNAJC6		Parkinson disease 19a, juvenile-onset	Uncertain significance(Last reviewed: Sep 24, 2018)	criteria provided, single submitter	VCV000648740	1	65871550	1	65405867	648740	650698	rs753885398	NC_000001.11:65405866:T:C
NM_001256864.2(DNAJC6):c.175A>G (p.Ser59Gly)	DNAJC6	S59G	Parkinson disease 19a, juvenile-onset	Uncertain significance(Last reviewed: Jul 26, 2018)	criteria provided, single submitter	VCV000641135	1	65775603	1	65309920	641135	628247	rs1296532855	NC_000001.11:65309919:A:G
NM_001256864.2(DNAJC6):c.1039A>G (p.Ile347Val)	DNAJC6	I277V, I347V, I290V	not provided|Parkinson disease 19a, juvenile-onset	Uncertain significance(Last reviewed: Dec 5, 2018)	criteria provided, multiple submitters, no conflicts	VCV000623687	1	65852538	1	65386855	623687	612540	rs200712827	NC_000001.11:65386854:A:G
NM_001256864.2(DNAJC6):c.2468G>C (p.Arg823Pro)	DNAJC6	R823P, R753P, R766P	Parkinson disease 19a, juvenile-onset	Uncertain significance(Last reviewed: May 29, 2018)	criteria provided, single submitter	VCV000569095	1	65871793	1	65406110	569095	557423	rs201984806	NC_000001.11:65406109:G:C
NM_001256864.2(DNAJC6):c.996-9T>C	DNAJC6		Parkinson disease 19a, juvenile-onset	Benign(Last reviewed: Aug 29, 2017)	criteria provided, single submitter	VCV000541545	1	65852486	1	65386803	541545	516230	rs187965193	NC_000001.11:65386802:T:C
NM_001256864.2(DNAJC6):c.745A>G (p.Ile249Val)	DNAJC6	I249V, I179V, I192V	not provided|Parkinson disease 19a, juvenile-onset	Benign(Last reviewed: Nov 28, 2020)	criteria provided, multiple submitters, no conflicts	VCV000541544	1	65849954	1	65384271	541544	516227	rs149588872	NC_000001.11:65384270:A:G
NM_001256864.2(DNAJC6):c.833A>G (p.Asp278Gly)	DNAJC6	D278G, D208G, D221G	Parkinson disease 19a, juvenile-onset	Uncertain significance(Last reviewed: Sep 15, 2017)	criteria provided, single submitter	VCV000541543	1	65851427	1	65385744	541543	516077	rs368290134	NC_000001.11:65385743:A:G
NM_001256864.2(DNAJC6):c.678G>A (p.Ala226=)	DNAJC6		not provided|Parkinson disease 19a, juvenile-onset|not specified	Benign/Likely benign(Last reviewed: Dec 1, 2020)	criteria provided, multiple submitters, no conflicts	VCV000474681	1	65849887	1	65384204	474681	448350	rs61753391	NC_000001.11:65384203:G:A
NM_001256864.2(DNAJC6):c.2838C>T (p.Tyr946=)	DNAJC6		Parkinson disease 19a, juvenile-onset	Likely benign(Last reviewed: Aug 7, 2017)	criteria provided, single submitter	VCV000474680	1	65878633	1	65412950	474680	448222	rs148209150	NC_000001.11:65412949:C:T
NM_001256864.2(DNAJC6):c.2290C>T (p.Leu764Phe)	DNAJC6	L694F, L764F, L707F	Parkinson disease 19a, juvenile-onset	Uncertain significance(Last reviewed: Jul 25, 2017)	criteria provided, single submitter	VCV000474679	1	65871615	1	65405932	474679	448427	rs917235831	NC_000001.11:65405931:C:T
NM_001256864.2(DNAJC6):c.2086T>C (p.Trp696Arg)	DNAJC6	W626R, W696R, W639R	Parkinson disease 19a, juvenile-onset	Uncertain significance(Last reviewed: Jul 30, 2019)	criteria provided, single submitter	VCV000474678	1	65864543	1	65398860	474678	448369	rs1462099424	NC_000001.11:65398859:T:C
NM_001256864.2(DNAJC6):c.2025G>T (p.Ser675=)	DNAJC6		not provided|Parkinson disease 19a, juvenile-onset	Likely benign(Last reviewed: Nov 10, 2016)	criteria provided, single submitter	VCV000474677	1	65860702	1	65395019	474677	448363	rs185245369	NC_000001.11:65395018:G:T
NM_001256864.2(DNAJC6):c.194-5G>T	DNAJC6		not provided|Parkinson disease 19a, juvenile-onset	Likely benign(Last reviewed: Oct 25, 2020)	criteria provided, multiple submitters, no conflicts	VCV000474676	1	65830313	1	65364630	474676	448345	rs753576283	NC_000001.11:65364629:G:T
NM_001256864.2(DNAJC6):c.1456C>T (p.Leu486Phe)	DNAJC6	L416F, L486F, L429F	Parkinson disease 19a, juvenile-onset|not provided	Benign/Likely benign(Last reviewed: Oct 27, 2020)	criteria provided, multiple submitters, no conflicts	VCV000445731	1	65855298	1	65389615	445731	439003	rs78141380	NC_000001.11:65389614:C:T
NM_001256864.2(DNAJC6):c.2536C>T (p.Gln846Ter)	DNAJC6	Q789*, Q776*, Q846*	Parkinson disease 19a, juvenile-onset	Pathogenic(Last reviewed: Oct 13, 2016)	no assertion criteria provided	VCV000265964	1	65874368	1	65408685	265964	260693	rs886039854	NC_000001.11:65408684:C:T
NM_001256864.2(DNAJC6):c.2223A>T (p.Thr741=)	DNAJC6		Parkinson disease 19b, early-onset|Parkinson disease 19a, juvenile-onset	Pathogenic(Last reviewed: May 11, 2021)	no assertion criteria provided	VCV000253095	1	65867559	1	65401876	253095	247506	rs879255554	NC_000001.11:65401875:A:T
NM_001256864.2(DNAJC6):c.2779A>G (p.Arg927Gly)	DNAJC6	R927G, R857G, R870G	Parkinson disease 19b, early-onset|Parkinson disease 19a, juvenile-onset	Pathogenic(Last reviewed: May 11, 2021)	no assertion criteria provided	VCV000253094	1	65877077	1	65411394	253094	247505	rs879255630	NC_000001.11:65411393:A:G
NM_001256864.2(DNAJC6):c.454C>T (p.Arg152Ter)	DNAJC6	R82*, R152*, R95*	Malignant tumor of prostate|Parkinson disease 19a, juvenile-onset	Pathogenic(Last reviewed: Dec 3, 2018)	criteria provided, single submitter	VCV000219301	1	65831790	1	65366107	219301	220990	rs864622011	NC_000001.11:65366106:C:T
NM_001256864.2(DNAJC6):c.2410C>T (p.Gln804Ter)	DNAJC6	Q734*, Q747*, Q804*	Parkinson disease 19a, juvenile-onset	Pathogenic(Last reviewed: May 11, 2021)	no assertion criteria provided	VCV000088855	1	65871735	1	65406052	88855	94424	rs398122405	NC_000001.11:65406051:C:T
NM_001256864.2(DNAJC6):c.801-2A>G	DNAJC6		Parkinson disease 19a, juvenile-onset|Ataxia, combined cerebellar and peripheral, with hearing loss and diabetes mellitus	Pathogenic(Last reviewed: May 11, 2021)	no assertion criteria provided	VCV000088854	1	65851393	1	65385710	88854	94423	rs398122404	NC_000001.11:65385709:A:G
NM_130797.4(DPP6):c.1154T>C (p.Met385Thr)	DPP6	M321T, M278T, M323T, M324T, M385T	Wolff-Parkinson-White pattern	Uncertain significance(Last reviewed: Jul 14, 2017)	no assertion criteria provided	VCV000487614	7	154585806	7	154794096	487614	480698	rs369128533	NC_000007.14:154794095:T:C
NM_130797.4(DPP6):c.1091C>G (p.Pro364Arg)	DPP6	P300R, P257R, P303R, P302R, P364R	Wolff-Parkinson-White pattern	Uncertain significance(Last reviewed: Jul 14, 2017)	no assertion criteria provided	VCV000487598	7	154564607	7	154772897	487598	480697	rs756673341	NC_000007.14:154772896:C:G
DRD4, 120-BP INS	DRD4		Attention deficit-hyperactivity disorder, susceptibility to	risk factor(Last reviewed: Nov 1, 2006)	no assertion criteria provided	VCV000016769					16769	31808		
NM_004415.4(DSP):c.3754G>A (p.Glu1252Lys)	DSP	E1252K	Cardiomyopathy|not provided|Wolff-Parkinson-White pattern|Arrhythmogenic right ventricular dysplasia 8|Dilated cardiomyopathy with woolly hair and keratoderma	Uncertain significance(Last reviewed: Aug 22, 2020)	criteria provided, multiple submitters, no conflicts	VCV000487613	6	7580177	6	7579944	487613	480692	rs1262533485	NC_000006.12:7579943:G:A
NM_004415.4(DSP):c.193C>T (p.His65Tyr)	DSP	H65Y	Wolff-Parkinson-White pattern	Uncertain significance(Last reviewed: Jul 14, 2017)	no assertion criteria provided	VCV000487612	6	7555973	6	7555740	487612	480691	rs1554105605	NC_000006.12:7555739:C:T
NC_000014.9:g.(31394019_31414809)_(31654321_31655889)del	DTD2|GPR33|HEATR5A|HEATR5A-DT|NUBPL|NUBPL-DT		Parkinson disease, late-onset|Mitochondrial complex 1 deficiency, nuclear type 21	Pathogenic(Last reviewed: May 26, 2020)	criteria provided, single submitter	VCV000929501	14	31867179 - 32280475	14	31394019 - 31655889	929501	917820		
NM_198241.3(EIF4G1):c.536C>T (p.Thr179Met)	EIF4G1	T139M, T15M, T179M, T186M, T92M	Parkinson disease 18	Uncertain significance(Last reviewed: Jan 7, 2022)	criteria provided, single submitter	VCV001334462	3	184037588	3	184319800	1334462	1325357		NC_000003.12:184319799:C:T
NM_198241.3(EIF4G1):c.3824T>A (p.Leu1275His)	EIF4G1	L1275H, L1276H, L1080H, L1111H, L1188H, L1235H, L1282H	Parkinson disease 18	Uncertain significance(Last reviewed: Jun 9, 2020)	criteria provided, single submitter	VCV001030449	3	184045661	3	184327873	1030449	1016210	rs550525876	NC_000003.12:184327872:T:A
NM_198241.3(EIF4G1):c.3953+9A>G	EIF4G1		Parkinson disease 18|not provided|not specified	Benign(Last reviewed: Jun 18, 2021)	criteria provided, single submitter	VCV000518346	3	184045799	3	184328011	518346	508787	rs939317	NC_000003.12:184328010:A:G
NM_198241.3(EIF4G1):c.3325+16C>T	EIF4G1		Parkinson disease 18|not provided|not specified	Benign(Last reviewed: Jun 19, 2021)	criteria provided, single submitter	VCV000518345	3	184044433	3	184326645	518345	508786	rs2293605	NC_000003.12:184326644:C:T
NM_198241.3(EIF4G1):c.1294A>G (p.Met432Val)	EIF4G1	M432V, M236V, M345V, M392V, M268V, M439V	Parkinson disease 18|not provided|not specified	Benign(Last reviewed: Jun 9, 2021)	criteria provided, single submitter	VCV000518344	3	184039666	3	184321878	518344	508785	rs2178403	NC_000003.12:184321877:A:G
NM_198241.3(EIF4G1):c.1505C>T (p.Ala502Val)	EIF4G1	A502V, A306V, A338V, A415V, A462V, A509V	Parkinson disease 18	risk factor(Last reviewed: Jan 1, 2015)	no assertion criteria provided	VCV000030073	3	184039877	3	184322089	30073	39028	rs111290936	NC_000003.12:184322088:C:T
NM_198241.3(EIF4G1):c.3614G>A (p.Arg1205His)	EIF4G1	R1205H, R1206H, R1165H, R1010H, R1041H, R1118H, R1212H	Parkinson disease 18	risk factor(Last reviewed: Jan 1, 2015)	no assertion criteria provided	VCV000030072	3	184045189	3	184327401	30072	39027	rs112176450	NC_000003.12:184327400:G:A
NM_012179.4(FBXO7):c.110C>G (p.Thr37Ser)	FBXO7	T37S	Parkinson disease 15	Likely benign(Last reviewed: Aug 7, 2021)	criteria provided, single submitter	VCV001667967	22	32871099	22	32475112	1667967	1569832		NC_000022.11:32475111:C:G
NM_012179.4(FBXO7):c.1183-15T>G	FBXO7		Parkinson disease 15	Likely benign(Last reviewed: Sep 1, 2021)	criteria provided, single submitter	VCV001618198	22	32894116	22	32498129	1618198	1527520		NC_000022.11:32498128:T:G
NM_012179.4(FBXO7):c.1182+18T>G	FBXO7		Parkinson disease 15	Likely benign(Last reviewed: Oct 27, 2021)	criteria provided, single submitter	VCV001583790	22	32891535	22	32495548	1583790	1528236		NC_000022.11:32495547:T:G
NM_012179.4(FBXO7):c.871+15_871+17del	FBXO7		Parkinson disease 15	Likely benign(Last reviewed: Apr 5, 2021)	criteria provided, single submitter	VCV001562162	22	32883827 - 32883829	22	32487840 - 32487842	1562162	1577226		NC_000022.11:32487839:ATTATT:ATT
NM_012179.4(FBXO7):c.306G>A (p.Glu102=)	FBXO7		Parkinson disease 15	Likely benign(Last reviewed: Aug 2, 2021)	criteria provided, single submitter	VCV001546560	22	32875151	22	32479164	1546560	1526409		NC_000022.11:32479163:G:A
NM_012179.4(FBXO7):c.1100A>G (p.Asn367Ser)	FBXO7	N367S, N253S, N288S	Parkinson disease 15	Uncertain significance(Last reviewed: Sep 15, 2021)	criteria provided, single submitter	VCV001522156	22	32889224	22	32493237	1522156	1344170		NC_000022.11:32493236:A:G
NM_012179.4(FBXO7):c.1386T>G (p.Ser462Arg)	FBXO7	S383R, S462R, S348R	Parkinson disease 15	Uncertain significance(Last reviewed: Oct 11, 2021)	criteria provided, single submitter	VCV001503061	22	32894334	22	32498347	1503061	1404654		NC_000022.11:32498346:T:G
NM_012179.4(FBXO7):c.899A>T (p.Asp300Val)	FBXO7	D221V, D300V, D186V	Parkinson disease 15	Uncertain significance(Last reviewed: Nov 28, 2021)	criteria provided, single submitter	VCV001500537	22	32887100	22	32491113	1500537	1408899		NC_000022.11:32491112:A:T
NM_012179.4(FBXO7):c.430C>G (p.Gln144Glu)	FBXO7	Q65E, Q144E, Q30E	Parkinson disease 15	Uncertain significance(Last reviewed: Nov 14, 2021)	criteria provided, single submitter	VCV001498910	22	32879896	22	32483909	1498910	1488657		NC_000022.11:32483908:C:G
NM_012179.4(FBXO7):c.917G>A (p.Arg306His)	FBXO7	R227H, R306H, R192H	Parkinson disease 15	Uncertain significance(Last reviewed: Sep 24, 2021)	criteria provided, single submitter	VCV001484666	22	32887118	22	32491131	1484666	1478204		NC_000022.11:32491130:G:A
NM_012179.4(FBXO7):c.1490G>C (p.Gly497Ala)	FBXO7	G383A, G418A, G497A	Parkinson disease 15	Uncertain significance(Last reviewed: Dec 6, 2021)	criteria provided, single submitter	VCV001483160	22	32894438	22	32498451	1483160	1465143		NC_000022.11:32498450:G:C
NM_012179.4(FBXO7):c.114G>C (p.Trp38Cys)	FBXO7	W38C	Parkinson disease 15	Uncertain significance(Last reviewed: Nov 29, 2021)	criteria provided, single submitter	VCV001478274	22	32871103	22	32475116	1478274	1351781		NC_000022.11:32475115:G:C
NM_012179.4(FBXO7):c.284A>T (p.His95Leu)	FBXO7	H95L, H16L	Parkinson disease 15	Uncertain significance(Last reviewed: Nov 24, 2021)	criteria provided, single submitter	VCV001464858	22	32875129	22	32479142	1464858	1514569		NC_000022.11:32479141:A:T
NM_012179.4(FBXO7):c.1541del (p.Pro514fs)	FBXO7	P435fs, P400fs, P514fs	Parkinson disease 15	Uncertain significance(Last reviewed: Apr 10, 2021)	criteria provided, single submitter	VCV001463711	22	32894488	22	32498501	1463711	1342067		NC_000022.11:32498500:CC:C
NM_012179.4(FBXO7):c.1213G>T (p.Glu405Ter)	FBXO7	E291*, E326*, E405*	Parkinson disease 15	Pathogenic(Last reviewed: Aug 28, 2021)	criteria provided, single submitter	VCV001455741	22	32894161	22	32498174	1455741	1380001		NC_000022.11:32498173:G:T
NM_012179.4(FBXO7):c.521C>T (p.Ser174Leu)	FBXO7	S174L, S60L, S95L	Parkinson disease 15	Uncertain significance(Last reviewed: Sep 24, 2021)	criteria provided, single submitter	VCV001444906	22	32879987	22	32484000	1444906	1384996		NC_000022.11:32483999:C:T
NM_012179.4(FBXO7):c.661G>C (p.Ala221Pro)	FBXO7	A142P, A221P, A107P	Parkinson disease 15	Uncertain significance(Last reviewed: Sep 17, 2021)	criteria provided, single submitter	VCV001443844	22	32881070	22	32485083	1443844	1487843		NC_000022.11:32485082:G:C
NM_012179.4(FBXO7):c.1388C>T (p.Ser463Leu)	FBXO7	S384L, S349L, S463L	Parkinson disease 15	Uncertain significance(Last reviewed: Sep 24, 2021)	criteria provided, single submitter	VCV001433610	22	32894336	22	32498349	1433610	1419283		NC_000022.11:32498348:C:T
NC_000022.10:g.(?_32870990)_(32875282_?)dup	FBXO7		Parkinson disease 15	Uncertain significance(Last reviewed: Jun 23, 2021)	criteria provided, single submitter	VCV001429863	22	32870990 - 32875282			1429863	1477596		
NM_012179.4(FBXO7):c.1453G>C (p.Val485Leu)	FBXO7	V406L, V485L, V371L	Parkinson disease 15	Uncertain significance(Last reviewed: Sep 20, 2021)	criteria provided, single submitter	VCV001423862	22	32894401	22	32498414	1423862	1418921		NC_000022.11:32498413:G:C
NM_012179.4(FBXO7):c.364G>A (p.Asp122Asn)	FBXO7	D43N, D122N, D8N	Parkinson disease 15	Uncertain significance(Last reviewed: Nov 17, 2021)	criteria provided, single submitter	VCV001391125	22	32875209	22	32479222	1391125	1489843		NC_000022.11:32479221:G:A
NM_012179.4(FBXO7):c.571G>C (p.Asp191His)	FBXO7	D112H, D191H, D77H	Parkinson disease 15	Uncertain significance(Last reviewed: Nov 11, 2021)	criteria provided, single submitter	VCV001361891	22	32880037	22	32484050	1361891	1376517		NC_000022.11:32484049:G:C
NM_012179.4(FBXO7):c.1553G>A (p.Arg518Gln)	FBXO7	R404Q, R518Q, R439Q	Parkinson disease 15	Uncertain significance(Last reviewed: Sep 4, 2021)	criteria provided, single submitter	VCV001361456	22	32894501	22	32498514	1361456	1476180		NC_000022.11:32498513:G:A
NM_012179.4(FBXO7):c.674C>G (p.Pro225Arg)	FBXO7	P111R, P225R, P146R	Parkinson disease 15	Uncertain significance(Last reviewed: Jul 28, 2021)	criteria provided, single submitter	VCV001347968	22	32881083	22	32485096	1347968	1391884		NC_000022.11:32485095:C:G
NM_012179.4(FBXO7):c.803A>G (p.Asn268Ser)	FBXO7	N154S, N189S, N268S	not provided|Parkinson disease 15	Uncertain significance(Last reviewed: Sep 17, 2021)	criteria provided, multiple submitters, no conflicts	VCV001302395	22	32883747	22	32487760	1302395	1292676		NC_000022.11:32487759:A:G
NM_012179.4(FBXO7):c.674C>T (p.Pro225Leu)	FBXO7	P111L, P146L, P225L	Parkinson disease 15	Uncertain significance(Last reviewed: Sep 13, 2020)	criteria provided, single submitter	VCV001301697	22	32881083	22	32485096	1301697	1291980		NC_000022.11:32485095:C:T
NM_012179.4(FBXO7):c.1312C>T (p.Arg438Cys)	FBXO7	R324C, R359C, R438C	not provided|Parkinson disease 15	Uncertain significance(Last reviewed: Aug 27, 2021)	criteria provided, multiple submitters, no conflicts	VCV001182452	22	32894260	22	32498273	1182452	1173481		NC_000022.11:32498272:C:T
NM_012179.4(FBXO7):c.1495G>A (p.Gly499Ser)	FBXO7	G385S, G420S, G499S	Parkinson disease 15	Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV001153556	22	32894443	22	32498456	1153556	1150108		NC_000022.11:32498455:G:A
NM_012179.4(FBXO7):c.123-10T>G	FBXO7		Parkinson disease 15	Likely benign(Last reviewed: Aug 14, 2019)	criteria provided, single submitter	VCV001144336	22	32874958	22	32478971	1144336	1150107		NC_000022.11:32478970:T:G
NM_012179.4(FBXO7):c.1145-8C>T	FBXO7		Parkinson disease 15	Likely benign(Last reviewed: Sep 15, 2020)	criteria provided, single submitter	VCV001137746	22	32891472	22	32495485	1137746	1129119		NC_000022.11:32495484:C:T
NM_012179.4(FBXO7):c.993G>T (p.Gly331=)	FBXO7		Parkinson disease 15	Likely benign(Last reviewed: Sep 21, 2020)	criteria provided, single submitter	VCV001129864	22	32889117	22	32493130	1129864	1129118		NC_000022.11:32493129:G:T
NM_012179.4(FBXO7):c.418-7T>C	FBXO7		Parkinson disease 15	Likely benign(Last reviewed: Dec 12, 2019)	criteria provided, single submitter	VCV001125930	22	32879877	22	32483890	1125930	1129116		NC_000022.11:32483889:T:C
NM_012179.4(FBXO7):c.646-10C>T	FBXO7		Parkinson disease 15	Likely benign(Last reviewed: Apr 10, 2019)	criteria provided, single submitter	VCV001121992	22	32881045	22	32485058	1121992	1129117		NC_000022.11:32485057:C:T
NM_012179.4(FBXO7):c.1086C>T (p.Leu362=)	FBXO7		Parkinson disease 15	Likely benign(Last reviewed: Nov 11, 2019)	criteria provided, single submitter	VCV001084805	22	32889210	22	32493223	1084805	1085983		NC_000022.11:32493222:C:T
NM_012179.4(FBXO7):c.1546G>T (p.Asp516Tyr)	FBXO7	D437Y, D402Y, D516Y	Parkinson disease 15	Uncertain significance(Last reviewed: Jul 24, 2020)	criteria provided, single submitter	VCV001036996	22	32894494	22	32498507	1036996	1035178	rs34316445	NC_000022.11:32498506:G:T
NM_012179.4(FBXO7):c.1181_1182+1del	FBXO7		Parkinson disease 15	Uncertain significance(Last reviewed: Aug 21, 2020)	criteria provided, single submitter	VCV000971885	22	32891513 - 32891515	22	32495526 - 32495528	971885	959085	rs2057568606	NC_000022.11:32495525:AAGAAG:AAG
NM_012179.4(FBXO7):c.1264A>T (p.Ile422Phe)	FBXO7	I308F, I343F, I422F	Parkinson disease 15	Uncertain significance(Last reviewed: Jun 17, 2020)	criteria provided, single submitter	VCV000971129	22	32894212	22	32498225	971129	959086	rs1555884880	NC_000022.11:32498224:A:T
NM_012179.4(FBXO7):c.1497C>T (p.Gly499=)	FBXO7		Parkinson disease 15	Uncertain significance(Last reviewed: Aug 24, 2019)	criteria provided, single submitter	VCV000962864	22	32894445	22	32498458	962864	951460	rs373124830	NC_000022.11:32498457:C:T
NM_012179.4(FBXO7):c.593C>G (p.Ala198Gly)	FBXO7	A119G, A198G, A84G	Parkinson disease 15	Uncertain significance(Last reviewed: Oct 29, 2019)	criteria provided, single submitter	VCV000962045	22	32880059	22	32484072	962045	951459	rs2057482701	NC_000022.11:32484071:C:G
NM_012179.4(FBXO7):c.464C>A (p.Ala155Glu)	FBXO7	A155E, A76E, A41E	Parkinson disease 15	Uncertain significance(Last reviewed: Oct 26, 2019)	criteria provided, single submitter	VCV000953199	22	32879930	22	32483943	953199	951458	rs61730784	NC_000022.11:32483942:C:A
NM_012179.4(FBXO7):c.32C>T (p.Thr11Ile)	FBXO7	T11I	Parkinson disease 15	Uncertain significance(Last reviewed: May 30, 2019)	criteria provided, single submitter	VCV000934590	22	32871021	22	32475034	934590	939300	rs1233525301	NC_000022.11:32475033:C:T
NM_012179.4(FBXO7):c.968-14T>G	FBXO7		not provided|Parkinson disease 15	Benign(Last reviewed: Nov 8, 2021)	criteria provided, multiple submitters, no conflicts	VCV000903533	22	32889078	22	32493091	903533	891820	rs77327421	NC_000022.11:32493090:T:G
NM_012179.4(FBXO7):c.957T>C (p.Phe319=)	FBXO7		Parkinson disease 15	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000903532	22	32887158	22	32491171	903532	891141	rs2057532824	NC_000022.11:32491170:T:C
NM_012179.4(FBXO7):c.447G>A (p.Glu149=)	FBXO7		Parkinson disease 15	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000901600	22	32879913	22	32483926	901600	891140	rs1012166328	NC_000022.11:32483925:G:A
NM_012179.4(FBXO7):c.367T>G (p.Ser123Ala)	FBXO7	S44A, S9A, S123A	Parkinson disease 15	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000901599	22	32875212	22	32479225	901599	891139	rs2057448381	NC_000022.11:32479224:T:G
NM_012179.4(FBXO7):c.277T>G (p.Ser93Ala)	FBXO7	S93A, S14A	Parkinson disease 15	Conflicting interpretations of pathogenicity(Last reviewed: Nov 24, 2021)	criteria provided, conflicting interpretations	VCV000901598	22	32875122	22	32479135	901598	891138	rs143041875	NC_000022.11:32479134:T:G
NM_012179.4(FBXO7):c.155A>G (p.Tyr52Cys)	FBXO7	Y52C	Parkinson disease 15	Likely benign(Last reviewed: Jan 29, 2020)	criteria provided, multiple submitters, no conflicts	VCV000901597	22	32875000	22	32479013	901597	891137	rs550610502	NC_000022.11:32479012:A:G
NM_012179.4(FBXO7):c.*198T>G	FBXO7		Parkinson disease 15	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000901103	22	32894715	22	32498728	901103	891148	rs951733600	NC_000022.11:32498727:T:G
NM_012179.4(FBXO7):c.*104T>C	FBXO7		Parkinson disease 15	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000901102	22	32894621	22	32498634	901102	891147	rs1601521158	NC_000022.11:32498633:T:C
NM_012179.4(FBXO7):c.*82G>A	FBXO7		Parkinson disease 15	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000901101	22	32894599	22	32498612	901101	891146	rs147661976	NC_000022.11:32498611:G:A
NM_012179.4(FBXO7):c.1552C>T (p.Arg518Trp)	FBXO7	R404W, R439W, R518W	Parkinson disease 15	Uncertain significance(Last reviewed: Aug 9, 2021)	criteria provided, multiple submitters, no conflicts	VCV000901100	22	32894500	22	32498513	901100	891145	rs374363283	NC_000022.11:32498512:C:T
NM_012179.4(FBXO7):c.-97C>T	FBXO7		Parkinson disease 15	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000901045	22	32870893	22	32474906	901045	891136	rs531209490	NC_000022.11:32474905:C:T
NM_012179.4(FBXO7):c.-130C>T	FBXO7		Parkinson disease 15	Uncertain significance(Last reviewed: Apr 28, 2017)	criteria provided, single submitter	VCV000901044	22	32870860	22	32474873	901044	891135	rs1399012413	NC_000022.11:32474872:C:T
NM_012179.4(FBXO7):c.1506T>C (p.Asn502=)	FBXO7		Parkinson disease 15	Conflicting interpretations of pathogenicity(Last reviewed: Oct 27, 2019)	criteria provided, conflicting interpretations	VCV000899932	22	32894454	22	32498467	899932	891144	rs765344006	NC_000022.11:32498466:T:C
NM_012179.4(FBXO7):c.1332C>G (p.Ile444Met)	FBXO7	I330M, I365M, I444M	Parkinson disease 15	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000899931	22	32894280	22	32498293	899931	891143	rs755248108	NC_000022.11:32498292:C:G
NM_012179.4(FBXO7):c.1266T>G (p.Ile422Met)	FBXO7	I343M, I422M, I308M	Parkinson disease 15	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000899930	22	32894214	22	32498227	899930	891142	rs2057588908	NC_000022.11:32498226:T:G
NM_012179.4(FBXO7):c.1198C>A (p.His400Asn)	FBXO7	H321N, H400N, H286N	Parkinson disease 15	Uncertain significance(Last reviewed: Jan 30, 2019)	criteria provided, single submitter	VCV000860252	22	32894146	22	32498159	860252	849298	rs2057587664	NC_000022.11:32498158:C:A
NM_012179.4(FBXO7):c.1221G>A (p.Pro407=)	FBXO7		Parkinson disease 15|not provided	Likely benign(Last reviewed: Sep 24, 2020)	criteria provided, single submitter	VCV000776097	22	32894169	22	32498182	776097	705900	rs201127594	NC_000022.11:32498181:G:A
NM_012179.4(FBXO7):c.303T>C (p.Asn101=)	FBXO7		Parkinson disease 15|not provided	Likely benign(Last reviewed: Jul 31, 2021)	criteria provided, single submitter	VCV000771234	22	32875148	22	32479161	771234	705898	rs373293691	NC_000022.11:32479160:T:C
NM_012179.4(FBXO7):c.1441C>T (p.Arg481Cys)	FBXO7	R367C, R402C, R481C	Parkinson disease 15	Likely benign(Last reviewed: Oct 18, 2020)	criteria provided, single submitter	VCV000767123	22	32894389	22	32498402	767123	705903	rs148272407	NC_000022.11:32498401:C:T
NM_012179.4(FBXO7):c.1089T>C (p.Phe363=)	FBXO7		not provided|Parkinson disease 15	Likely benign(Last reviewed: Jul 26, 2018)	criteria provided, single submitter	VCV000763225	22	32889213	22	32493226	763225	773526	rs1250777790	NC_000022.11:32493225:T:C
NM_012179.4(FBXO7):c.999C>T (p.Val333=)	FBXO7		Parkinson disease 15|not provided	Likely benign(Last reviewed: Oct 1, 2018)	criteria provided, single submitter	VCV000755172	22	32889123	22	32493136	755172	773525	rs1191841298	NC_000022.11:32493135:C:T
NM_012179.4(FBXO7):c.319G>A (p.Ala107Thr)	FBXO7	A28T, A107T	Parkinson disease 15|not provided	Likely benign(Last reviewed: Jan 24, 2020)	criteria provided, single submitter	VCV000716472	22	32875164	22	32479177	716472	729149	rs138222812	NC_000022.11:32479176:G:A
NM_012179.4(FBXO7):c.1535G>A (p.Gly512Asp)	FBXO7	G433D, G398D, G512D	Parkinson disease 15|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Dec 7, 2018)	criteria provided, conflicting interpretations	VCV000706329	22	32894483	22	32498496	706329	694718	rs142471722	NC_000022.11:32498495:G:A
NM_012179.4(FBXO7):c.291A>C (p.Ser97=)	FBXO7		not provided|Parkinson disease 15	Likely benign(Last reviewed: Mar 27, 2018)	criteria provided, single submitter	VCV000705692	22	32875136	22	32479149	705692	694716	rs369892815	NC_000022.11:32479148:A:C
NM_012179.4(FBXO7):c.1183-4del	FBXO7		Parkinson disease 15|not provided	Likely benign(Last reviewed: Sep 10, 2018)	criteria provided, single submitter	VCV000705190	22	32894127	22	32498140	705190	695874	rs1399849415	NC_000022.11:32498139:A:
NM_012179.4(FBXO7):c.1271_1272delinsAT (p.Phe424Tyr)	FBXO7	F310Y, F345Y, F424Y	Parkinson disease 15	Benign(Last reviewed: Oct 3, 2020)	criteria provided, single submitter	VCV000704113	22	32894219 - 32894220	22	32498232 - 32498233	704113	694717	rs1601520476	NC_000022.11:32498231:TC:AT
NM_012179.4(FBXO7):c.213G>A (p.Gly71=)	FBXO7		Parkinson disease 15|not provided	Likely benign(Last reviewed: Oct 27, 2021)	criteria provided, single submitter	VCV000704085	22	32875058	22	32479071	704085	694715	rs149180516	NC_000022.11:32479070:G:A
NM_012179.4(FBXO7):c.1385G>T (p.Ser462Ile)	FBXO7	S348I, S383I, S462I	not provided|Parkinson disease 15	Uncertain significance(Last reviewed: Oct 11, 2019)	criteria provided, multiple submitters, no conflicts	VCV000655787	22	32894333	22	32498346	655787	649458	rs149552421	NC_000022.11:32498345:G:T
NM_012179.4(FBXO7):c.1070C>T (p.Ala357Val)	FBXO7	A243V, A357V, A278V	Parkinson disease 15	Uncertain significance(Last reviewed: Oct 1, 2018)	criteria provided, single submitter	VCV000652909	22	32889194	22	32493207	652909	649456	rs141068487	NC_000022.11:32493206:C:T
NM_012179.4(FBXO7):c.697G>A (p.Val233Met)	FBXO7	V154M, V119M, V233M	Parkinson disease 15	Uncertain significance(Last reviewed: Jul 10, 2018)	criteria provided, single submitter	VCV000648239	22	32881106	22	32485119	648239	649455	rs1388222868	NC_000022.11:32485118:G:A
NM_012179.4(FBXO7):c.1206_1207dup (p.Arg403fs)	FBXO7	R289fs, R324fs, R403fs	Parkinson disease 15	Pathogenic(Last reviewed: Oct 17, 2018)	criteria provided, single submitter	VCV000641981	22	32894152 - 32894153	22	32498165 - 32498166	641981	649457	rs749019340	NC_000022.11:32498165:AAA:AAAAA
NM_012179.4(FBXO7):c.1536_1539del (p.Arg513fs)	FBXO7	R399fs, R513fs, R434fs	Parkinson disease 15	Uncertain significance(Last reviewed: Nov 30, 2018)	criteria provided, single submitter	VCV000640811	22	32894482 - 32894485	22	32498495 - 32498498	640811	649459	rs772175765	NC_000022.11:32498494:GGTCGG:GG
NM_012179.4(FBXO7):c.169A>G (p.Thr57Ala)	FBXO7	T57A	Parkinson disease 15	Uncertain significance(Last reviewed: Dec 3, 2018)	criteria provided, single submitter	VCV000640301	22	32875014	22	32479027	640301	649454	rs760306475	NC_000022.11:32479026:A:G
NM_012179.4(FBXO7):c.1268_1272dup (p.Tyr425fs)	FBXO7	Y311fs, Y346fs, Y425fs	Parkinson disease 15|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Jun 30, 2021)	criteria provided, conflicting interpretations	VCV000631891	22	32894209 - 32894210	22	32498222 - 32498223	631891	620687	rs749534144	NC_000022.11:32498222:CCATTCCATTC:CCATTCCATTCCATTC
NM_012179.4(FBXO7):c.726_727del (p.Cys243fs)	FBXO7	C164fs, C129fs, C243fs	Parkinson disease 15	Uncertain significance(Last reviewed: Oct 10, 2018)	criteria provided, single submitter	VCV000631890	22	32881131 - 32881132	22	32485144 - 32485145	631890	620686	rs1290655316	NC_000022.11:32485143:CTCTCT:CTCT
NM_012179.4(FBXO7):c.1453G>A (p.Val485Ile)	FBXO7	V485I, V406I, V371I	Parkinson disease 15|not provided	Uncertain significance(Last reviewed: Oct 29, 2019)	criteria provided, multiple submitters, no conflicts	VCV000597905	22	32894401	22	32498414	597905	588966	rs141286570	NC_000022.11:32498413:G:A
NM_012179.4(FBXO7):c.601G>A (p.Val201Met)	FBXO7	V201M, V87M, V122M	Parkinson disease 15|not provided	Likely benign(Last reviewed: Dec 31, 2019)	criteria provided, multiple submitters, no conflicts	VCV000533897	22	32880067	22	32484080	533897	534312	rs61730783	NC_000022.11:32484079:G:A
NM_012179.4(FBXO7):c.122+272T>G	FBXO7	L12R	not provided|Parkinson disease 15	Benign(Last reviewed: Aug 25, 2018)	criteria provided, single submitter	VCV000518326	22	32871383	22	32475396	518326	508941	rs8137714	NC_000022.11:32475395:T:G
NM_012179.4(FBXO7):c.152del (p.Asn51fs)	FBXO7	N51fs	Parkinson disease 15	Pathogenic(Last reviewed: Nov 16, 2017)	criteria provided, single submitter	VCV000488517	22	32874996	22	32479009	488517	481385	rs1228608709	NC_000022.11:32479008:AA:A
NM_012179.4(FBXO7):c.839T>C (p.Leu280Pro)	FBXO7	L280P, L201P, L166P	not provided|Parkinson disease 15	Uncertain significance(Last reviewed: Aug 12, 2021)	criteria provided, multiple submitters, no conflicts	VCV000452085	22	32883783	22	32487796	452085	446406	rs776439796	NC_000022.11:32487795:T:C
NM_012179.4(FBXO7):c.1546G>C (p.Asp516His)	FBXO7	D516H, D437H, D402H	Parkinson disease 15|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Jan 1, 2021)	criteria provided, conflicting interpretations	VCV000444586	22	32894494	22	32498507	444586	438226	rs34316445	NC_000022.11:32498506:G:C
NM_001033024.1(FBXO7):c.*301A>G	FBXO7		Parkinson Disease, Recessive	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000341324	22	32894818	22	32498831	341324	352435	rs757675819	NC_000022.11:32498830:A:G
NM_012179.4(FBXO7):c.*282A>T	FBXO7		Parkinson disease 15	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000341323	22	32894799	22	32498812	341323	352434	rs886057423	NC_000022.11:32498811:A:T
NM_012179.4(FBXO7):c.*263A>G	FBXO7		Parkinson disease 15	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000341322	22	32894780	22	32498793	341322	351428	rs886057422	NC_000022.11:32498792:A:G
NM_012179.4(FBXO7):c.*170C>G	FBXO7		Parkinson disease 15	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000341321	22	32894687	22	32498700	341321	352433	rs186797068	NC_000022.11:32498699:C:G
NM_012179.4(FBXO7):c.*47A>T	FBXO7		Parkinson disease 15	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000341320	22	32894564	22	32498577	341320	337913	rs367714958	NC_000022.11:32498576:A:T
NM_012179.4(FBXO7):c.1527C>A (p.Pro509=)	FBXO7		Parkinson disease 15	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000341319	22	32894475	22	32498488	341319	352426	rs758609287	NC_000022.11:32498487:C:A
NM_012179.4(FBXO7):c.1505A>G (p.Asn502Ser)	FBXO7	N502S, N423S, N388S	Parkinson disease 15|not provided	Uncertain significance(Last reviewed: Sep 30, 2021)	criteria provided, multiple submitters, no conflicts	VCV000341318	22	32894453	22	32498466	341318	337910	rs144538200	NC_000022.11:32498465:A:G
NM_012179.4(FBXO7):c.1144+9C>T	FBXO7		Parkinson disease 15|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Dec 31, 2019)	criteria provided, conflicting interpretations	VCV000341317	22	32889277	22	32493290	341317	337907	rs199954341	NC_000022.11:32493289:C:T
NM_012179.4(FBXO7):c.1125A>G (p.Leu375=)	FBXO7		Parkinson disease 15	Benign/Likely benign(Last reviewed: Dec 31, 2019)	criteria provided, multiple submitters, no conflicts	VCV000341316	22	32889249	22	32493262	341316	351426	rs147911892	NC_000022.11:32493261:A:G
NM_012179.4(FBXO7):c.1054G>A (p.Val352Ile)	FBXO7	V352I, V273I, V238I	Parkinson disease 15	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000341315	22	32889178	22	32493191	341315	352421	rs762037477	NC_000022.11:32493190:G:A
NM_012179.4(FBXO7):c.949C>T (p.Leu317=)	FBXO7		Parkinson disease 15|not provided	Benign(Last reviewed: Dec 8, 2020)	criteria provided, multiple submitters, no conflicts	VCV000341314	22	32887150	22	32491163	341314	347523	rs9726	NC_000022.11:32491162:C:T
NM_012179.4(FBXO7):c.745A>G (p.Thr249Ala)	FBXO7	T249A, T170A, T135A	Parkinson disease 15	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000341313	22	32881154	22	32485167	341313	337906	rs749742547	NC_000022.11:32485166:A:G
NM_012179.4(FBXO7):c.693C>T (p.Ser231=)	FBXO7		not specified|Parkinson disease 15|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Feb 1, 2022)	criteria provided, conflicting interpretations	VCV000341312	22	32881102	22	32485115	341312	352420	rs61752254	NC_000022.11:32485114:C:T
NM_012179.4(FBXO7):c.540A>G (p.Pro180=)	FBXO7		Parkinson disease 15|not provided	Benign/Likely benign(Last reviewed: Dec 1, 2020)	criteria provided, multiple submitters, no conflicts	VCV000341311	22	32880006	22	32484019	341311	351423	rs41311141	NC_000022.11:32484018:A:G
NM_012179.4(FBXO7):c.425C>G (p.Pro142Arg)	FBXO7	P142R, P28R, P63R	Parkinson Disease, Recessive	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000341310	22	32879891	22	32483904	341310	351422	rs886057421	NC_000022.11:32483903:C:G
NM_012179.4(FBXO7):c.358C>T (p.Pro120Ser)	FBXO7	P120S, P6S, P41S	Parkinson disease 15	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000341309	22	32875203	22	32479216	341309	351420	rs191469599	NC_000022.11:32479215:C:T
NM_012179.4(FBXO7):c.274G>C (p.Asp92His)	FBXO7	D92H	Parkinson disease 15|not provided	Uncertain significance(Last reviewed: Dec 13, 2021)	criteria provided, multiple submitters, no conflicts	VCV000341308	22	32875119	22	32479132	341308	347522	rs139135860	NC_000022.11:32479131:G:C
NM_012179.4(FBXO7):c.122+9G>A	FBXO7		not specified|Parkinson disease 15	Conflicting interpretations of pathogenicity(Last reviewed: Nov 13, 2020)	criteria provided, conflicting interpretations	VCV000341307	22	32871120	22	32475133	341307	347519	rs192327462	NC_000022.11:32475132:G:A
NM_012179.4(FBXO7):c.49C>G (p.Pro17Ala)	FBXO7	P17A	Parkinson disease 15	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000341306	22	32871038	22	32475051	341306	347518	rs886057420	NC_000022.11:32475050:C:G
NM_012179.4(FBXO7):c.-93G>A	FBXO7		Parkinson disease 15	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000341305	22	32870897	22	32474910	341305	337905	rs886057419	NC_000022.11:32474909:G:A
NM_012179.4(FBXO7):c.-118T>G	FBXO7		Parkinson disease 15	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000341304	22	32870872	22	32474885	341304	352419	rs886057418	NC_000022.11:32474884:T:G
NM_012179.4(FBXO7):c.-168A>G	FBXO7		Parkinson disease 15	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000341303	22	32870822	22	32474835	341303	351419	rs886057417	NC_000022.11:32474834:A:G
NM_012179.4(FBXO7):c.-184C>T	FBXO7		Parkinson disease 15|not provided	Benign(Last reviewed: Aug 21, 2018)	criteria provided, multiple submitters, no conflicts	VCV000341302	22	32870806	22	32474819	341302	347516	rs11538371	NC_000022.11:32474818:C:T
NM_012179.3(FBXO7):c.-197C>T	FBXO7		Parkinson Disease, Recessive	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000341301	22	32870793	22	32474806	341301	347512	rs886057416	NC_000022.11:32474805:C:T
NM_012179.3(FBXO7):c.-200G>A	FBXO7		Parkinson Disease, Recessive	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000341300	22	32870790	22	32474803	341300	351415	rs886057415	NC_000022.11:32474802:G:A
NM_012179.3(FBXO7):c.-221C>T	FBXO7		not provided|Parkinson Disease, Recessive	Benign(Last reviewed: Jul 5, 2018)	criteria provided, multiple submitters, no conflicts	VCV000341299	22	32870769	22	32474782	341299	352418	rs2072814	NC_000022.11:32474781:C:T
NM_012179.3(FBXO7):c.-232G>C	FBXO7		Parkinson Disease, Recessive	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000341298	22	32870758	22	32474771	341298	337898	rs886057414	NC_000022.11:32474770:G:C
NM_012179.3(FBXO7):c.-268C>G	FBXO7		Parkinson Disease, Recessive	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000341297	22	32870722	22	32474735	341297	347509	rs540551581	NC_000022.11:32474734:C:G
NM_012179.4(FBXO7):c.260T>C (p.Ile87Thr)	FBXO7	I87T	Parkinson disease 15	Uncertain significance(Last reviewed: Mar 18, 2016)	criteria provided, single submitter	VCV000225358	22	32875105	22	32479118	225358	227415	rs780055842	NC_000022.11:32479117:T:C
NM_012179.4(FBXO7):c.345G>A (p.Met115Ile)	FBXO7	M115I, M1I, M36I	Parkinson disease 15|not specified|not provided	Benign(Last reviewed: Dec 8, 2020)	criteria provided, multiple submitters, no conflicts	VCV000195275	22	32875190	22	32479203	195275	192436	rs11107	NC_000022.11:32479202:G:A
NM_012179.4(FBXO7):c.65C>T (p.Thr22Met)	FBXO7	T22M	Parkinson disease 15	Pathogenic(Last reviewed: Jan 20, 2009)	no assertion criteria provided	VCV000004811	22	32871054	22	32475067	4811	19850	rs121918305	NC_000022.11:32475066:C:T
NM_012179.4(FBXO7):c.1144+1G>T	FBXO7		Parkinson disease 15	Pathogenic(Last reviewed: Nov 16, 2017)	criteria provided, single submitter	VCV000004810	22	32889269	22	32493282	4810	19849	rs730880272	NC_000022.11:32493281:G:T
NM_012179.4(FBXO7):c.1492C>T (p.Arg498Ter)	FBXO7	R498*, R419*, R384*	Parkinson disease 15	Pathogenic(Last reviewed: Jan 20, 2009)	no assertion criteria provided	VCV000004809	22	32894440	22	32498453	4809	19848	rs121918304	NC_000022.11:32498452:C:T
NM_012179.4(FBXO7):c.1132C>G (p.Arg378Gly)	FBXO7	R378G, R264G, R299G	Parkinson disease 15	Pathogenic(Last reviewed: Jun 1, 2008)	no assertion criteria provided	VCV000004808	22	32889256	22	32493269	4808	19847	rs71799110	NC_000022.11:32493268:C:G
NM_019851.3(FGF20):c.*182C>T	FGF20		not provided|Parkinson disease, late-onset	Benign(Last reviewed: Jun 19, 2021)	criteria provided, single submitter	VCV000004885	8	16850399	8	16992890	4885	19924	rs12720208	NC_000008.11:16992889:G:A
NM_001110556.2(FLNA):c.6268G>C (p.Val2090Leu)	FLNA	V2082L, V2090L	Periventricular nodular heterotopia 1|Oto-palato-digital syndrome, type II|Melnick-Needles syndrome|Frontometaphyseal dysplasia 1|Wolff-Parkinson-White pattern	Uncertain significance(Last reviewed: Nov 20, 2018)	criteria provided, single submitter	VCV000465010	X	153581251	X	154352883	465010	471375	rs968230475	NC_000023.11:154352882:C:G
NM_001458.5(FLNC):c.6748A>C (p.Met2250Leu)	FLNC|FLNC-AS1	M2250L, M2217L	Wolff-Parkinson-White pattern|Myopathy, distal, 4|Myofibrillar myopathy, filamin C-related|Cardiomyopathy, familial hypertrophic, 26|Dilated Cardiomyopathy, Dominant	Uncertain significance(Last reviewed: Apr 25, 2019)	criteria provided, single submitter	VCV000487622	7	128494487	7	128854433	487622	480694	rs923795184	NC_000007.14:128854432:A:C
NM_001458.5(FLNC):c.3014C>T (p.Ser1005Leu)	FLNC	S1005L	Myofibrillar myopathy, filamin C-related|Dilated Cardiomyopathy, Dominant|Myopathy, distal, 4|Cardiomyopathy, familial hypertrophic, 26|Wolff-Parkinson-White pattern	Uncertain significance(Last reviewed: Aug 20, 2021)	criteria provided, single submitter	VCV000487593	7	128484142	7	128844088	487593	480693	rs752448040	NC_000007.14:128844087:C:T
NM_133372.3(FNIP1):c.2753_2756del (p.Lys918fs)	FNIP1	K873fs, K890fs, K918fs	Wolff-Parkinson-White pattern	Uncertain significance(Last reviewed: Jul 14, 2017)	no assertion criteria provided	VCV000487638	5	131007381 - 131007384	5	131671688 - 131671691	487638	480688	rs1554092867	NC_000005.10:131671687:TCTTT:T
NM_133372.3(FNIP1):c.455+1G>A	FNIP1		Wolff-Parkinson-White pattern	Uncertain significance(Last reviewed: Jul 14, 2017)	no assertion criteria provided	VCV000487589	5	131055009	5	131719316	487589	480689	rs1554096246	NC_000005.10:131719315:C:T
NM_000157.4(GBA):c.1586A>G (p.His529Arg)	GBA|LOC106627981	H442R, H480R, H529R	Parkinson disease, late-onset	Uncertain significance(Last reviewed: Mar 18, 2020)	criteria provided, single submitter	VCV001333747	1	155204811	1	155235020	1333747	1324517		NC_000001.11:155235019:T:C
NM_000157.4(GBA):c.355G>C (p.Gly119Arg)	GBA|LOC106627981	G119R, G32R	not provided	Uncertain significance(Last reviewed: Nov 6, 2020)	criteria provided, single submitter	VCV001330880	1	155209506	1	155239715	1330880	1321557		NC_000001.11:155239714:C:G
NM_000157.4(GBA):c.1312G>C (p.Asp438His)	GBA|LOC106627981	D351H, D389H, D438H	Parkinson disease, late-onset	Likely pathogenic(Last reviewed: Jul 26, 2021)	no assertion criteria provided	VCV001319931	1	155205548	1	155235757	1319931	1310179		NC_000001.11:155235756:C:G
NM_000157.4(GBA):c.901C>T (p.Arg301Cys)	GBA|LOC106627981	R214C, R252C, R301C	not provided	Uncertain significance(Last reviewed: Aug 15, 2019)	criteria provided, single submitter	VCV001303549	1	155207230	1	155237439	1303549	1293826		NC_000001.11:155237438:G:A
NM_000157.4(GBA):c.644C>A (p.Ala215Asp)	GBA|LOC106627981	A128D, A166D, A215D	not provided	Uncertain significance(Last reviewed: Sep 28, 2020)	criteria provided, single submitter	VCV001303174	1	155208042	1	155238251	1303174	1293452		NC_000001.11:155238250:G:T
NM_000157.4(GBA):c.1000G>A (p.Val334Ile)	GBA|LOC106627981	V247I, V285I, V334I	not provided	Uncertain significance(Last reviewed: Mar 2, 2021)	criteria provided, single submitter	VCV001302744	1	155206260	1	155236469	1302744	1293025		NC_000001.11:155236468:C:T
NM_000157.4(GBA):c.1249T>G (p.Trp417Gly)	GBA|LOC106627981	W330G, W368G, W417G	not provided|Gaucher disease	Likely pathogenic(Last reviewed: Feb 22, 2021)	criteria provided, single submitter	VCV001211295	1	155205611	1	155235820	1211295	1201292		NC_000001.11:155235819:A:C
NM_000157.4(GBA):c.604C>T (p.Arg202Ter)	GBA|LOC106627981	R115*, R153*, R202*	Gaucher disease|Parkinson disease, late-onset|not provided	Pathogenic(Last reviewed: Sep 24, 2021)	criteria provided, multiple submitters, no conflicts	VCV001119997	1	155208082	1	155238291	1119997	1108785		NC_000001.11:155238290:G:A
NM_000157.4(GBA):c.635C>G (p.Ser212Ter)	GBA|LOC106627981	S125*, S163*, S212*	not provided|Parkinson disease, late-onset|Gaucher disease	Pathogenic(Last reviewed: May 3, 2021)	criteria provided, multiple submitters, no conflicts	VCV000996254	1	155208051	1	155238260	996254	983940	rs1671872221	NC_000001.11:155238259:G:C
NM_000157.4(GBA):c.706C>T (p.Leu236Phe)	GBA|LOC106627981	L149F, L187F, L236F	not specified|not provided|Gaucher disease	Conflicting interpretations of pathogenicity(Last reviewed: Feb 2, 2022)	criteria provided, conflicting interpretations	VCV000929061	1	155207980	1	155238189	929061	916794	rs1671865905	NC_000001.11:155238188:G:A
NM_000157.4(GBA):c.946C>T (p.Arg316Cys)	GBA|LOC106627981	R229C, R267C, R316C	Gaucher disease type III|Gaucher disease type I|Gaucher disease type II|Gaucher disease type 3C|not specified|Parkinson disease, late-onset|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Dec 15, 2021)	criteria provided, conflicting interpretations	VCV000813338	1	155207185	1	155237394	813338	801584	rs1264734195	NC_000001.11:155237393:G:A
GRCh37/hg19 1q22(chr1:155188179-155209868)	GBA		Parkinson disease, late-onset	Pathogenic(Last reviewed: Apr 26, 2019)	criteria provided, single submitter	VCV000813310	1	155188179 - 155209868			813310	801562		
NM_000157.4(GBA):c.247C>T (p.Arg83Cys)	GBA|LOC106627981	R83C	not provided|not specified|Gaucher disease	Uncertain significance(Last reviewed: Oct 18, 2021)	criteria provided, multiple submitters, no conflicts	VCV000806230	1	155209737	1	155239946	806230	794438	rs1141812	NC_000001.11:155239945:G:A
NM_000157.4(GBA):c.1503C>G (p.Asn501Lys)	GBA|LOC106627981	N414K, N452K, N501K	Gaucher disease type II|not provided	Likely pathogenic(Last reviewed: May 31, 2017)	criteria provided, single submitter	VCV000691989	1	155204988	1	155235197	691989	679732	rs755265316	NC_000001.11:155235196:G:C
NM_000157.4(GBA):c.1495G>C (p.Val499Leu)	GBA|LOC106627981	V499L, V450L, V412L	Gaucher disease type I|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Jul 22, 2021)	criteria provided, conflicting interpretations	VCV000634558	1	155204996	1	155235205	634558	622301	rs369068553	NC_000001.11:155235204:C:G
NM_000157.4(GBA):c.762-1G>C	GBA|LOC106627981		Gaucher disease|Parkinson disease, late-onset	Pathogenic(Last reviewed: Jun 7, 2019)	criteria provided, multiple submitters, no conflicts	VCV000633240	1	155207370	1	155237579	633240	621703	rs1237637353	NC_000001.11:155237578:C:G
NM_000157.4(GBA):c.653G>A (p.Trp218Ter)	GBA|LOC106627981	W218*, W169*, W131*	Parkinson disease, late-onset|Gaucher disease|Thrombocytopenia|Abnormal bleeding	Pathogenic(Last reviewed: May 3, 2021)	criteria provided, multiple submitters, no conflicts	VCV000632834	1	155208033	1	155238242	632834	621059	rs867929413	NC_000001.11:155238241:C:T
NM_000157.4(GBA):c.1294T>A (p.Trp432Arg)	GBA|LOC106627981	W432R, W383R, W345R	Parkinson disease, late-onset	Pathogenic	no assertion criteria provided	VCV000599275	1	155205566	1	155235775	599275	590519	rs1557901552	NC_000001.11:155235774:A:T
NM_000157.4(GBA):c.902G>A (p.Arg301His)	GBA|LOC106627981	R301H, R252H, R214H	not provided	Uncertain significance(Last reviewed: Mar 31, 2021)	criteria provided, multiple submitters, no conflicts	VCV000592663	1	155207229	1	155237438	592663	583728	rs140955685	NC_000001.11:155237437:C:T
NM_000157.4(GBA):c.1224G>A (p.Thr408=)	GBA|LOC106627981		Gaucher disease|Gaucher disease type II|Gaucher disease type I|not provided	Uncertain significance(Last reviewed: Jul 14, 2021)	criteria provided, multiple submitters, no conflicts	VCV000503740	1	155206036	1	155236245	503740	495063	rs138498426	NC_000001.11:155236244:C:T
NM_000157.4(GBA):c.1279G>A (p.Glu427Lys)	GBA|LOC106627981	E427K, E378K, E340K	Resting tremor|Cogwheel rigidity|Parkinsonism|not provided	Uncertain significance(Last reviewed: Nov 10, 2021)	criteria provided, multiple submitters, no conflicts	VCV000493050	1	155205581	1	155235790	493050	486013	rs149171124	NC_000001.11:155235789:C:T
NM_000157.4(GBA):c.1296G>A (p.Trp432Ter)	GBA|LOC106627981	W432*, W345*, W383*	not provided|Gaucher disease	Conflicting interpretations of pathogenicity(Last reviewed: Jan 22, 2020)	criteria provided, conflicting interpretations	VCV000493049	1	155205564	1	155235773	493049	486012	rs1484043383	NC_000001.11:155235772:C:T
NM_000157.4(GBA):c.1102C>T (p.Arg368Cys)	GBA|LOC106627981	R368C, R281C, R319C	Gaucher disease type I|Gaucher disease type II|Gaucher disease type III|Gaucher disease type 3C|not provided|Gaucher disease|not specified	Conflicting interpretations of pathogenicity(Last reviewed: Aug 22, 2021)	criteria provided, conflicting interpretations	VCV000420153	1	155206158	1	155236367	420153	404945	rs374306700	NC_000001.11:155236366:G:A
NM_000157.4(GBA):c.1220T>C (p.Ile407Thr)	GBA|LOC106627981	I407T, I358T, I320T	Parkinson disease, late-onset	Uncertain significance(Last reviewed: Oct 5, 2015)	no assertion criteria provided	VCV000212789	1	155206040	1	155236249	212789	209422	rs1057519358	NC_000001.11:155236248:A:G
NM_000157.4(GBA):c.1277C>T (p.Pro426Leu)	GBA|LOC106627981	P426L, P339L, P377L	Parkinson disease, late-onset	Uncertain significance(Last reviewed: Sep 8, 2015)	no assertion criteria provided	VCV000209104	1	155205583	1	155235792	209104	205700	rs1057519357	NC_000001.11:155235791:G:A
NM_000157.4(GBA):c.221G>C (p.Gly74Ala)	GBA|LOC106627981	G74A	Parkinson disease, late-onset	Uncertain significance(Last reviewed: Sep 8, 2015)	no assertion criteria provided	VCV000209102	1	155209763	1	155239972	209102	205701	rs371592589	NC_000001.11:155239971:C:G
NM_000157.4(GBA):c.1093G>A (p.Glu365Lys)	GBA|LOC106627981	E365K, E278K, E316K	Lower limb muscle weakness|Hypertensive disorder|Neurological speech impairment|Hyperlipidemia|Parkinsonism|Dementia|Gaucher disease|Parkinson disease, late-onset|Gaucher disease, perinatal lethal|not specified|Parkinsonism|Rigidity|Cogwheel rigidity|Parkinsonism|Tremor|not provided	Conflicting interpretations of pathogenicity; risk factor(Last reviewed: Sep 28, 2021)	criteria provided, conflicting interpretations	VCV000199044	1	155206167	1	155236376	199044	38432	rs2230288	NC_000001.11:155236375:C:T
NM_000157.4(GBA):c.605G>A (p.Arg202Gln)	GBA|LOC106627981	R202Q, R153Q, R115Q	not specified	Conflicting interpretations of pathogenicity(Last reviewed: Oct 8, 2021)	criteria provided, conflicting interpretations	VCV000093454	1	155208081	1	155238290	93454	99359	rs398123531	NC_000001.11:155238289:C:T
NM_000157.4(GBA):c.1448T>G (p.Leu483Arg)	GBA|LOC106627981	L483R, L434R, L396R	Gaucher disease type II|Gaucher disease type III|Gaucher disease type I|Gaucher disease type II|Gaucher disease type III|Gaucher disease type 3C|Gaucher disease|Gaucher disease type I|not provided	Pathogenic/Likely pathogenic(Last reviewed: Feb 1, 2022)	criteria provided, multiple submitters, no conflicts	VCV000093449	1	155205043	1	155235252	93449	99356	rs421016	NC_000001.11:155235251:A:C
NM_000157.4(GBA):c.1223C>T (p.Thr408Met)	GBA|LOC106627981	T408M, T359M, T321M	Gaucher disease|Parkinson disease, late-onset|Gaucher disease, perinatal lethal|not provided|not specified	Conflicting interpretations of pathogenicity(Last reviewed: May 18, 2021)	criteria provided, conflicting interpretations	VCV000093447	1	155206037	1	155236246	93447	99354	rs75548401	NC_000001.11:155236245:G:A
NM_000157.4(GBA):c.115+1G>A	GBA		not provided|Gaucher disease, perinatal lethal|Lewy body dementia|Parkinson disease, late-onset|Gaucher disease type I|Gaucher disease type II|Gaucher disease type III|Gaucher disease type 3C|Gaucher disease type I|Gaucher disease type II|Gaucher disease type III|Gaucher disease type 3C|Gaucher disease|Parkinson disease, late-onset|Gaucher disease type II|Gaucher disease type I	Pathogenic/Likely pathogenic(Last reviewed: Oct 18, 2021)	criteria provided, multiple submitters, no conflicts	VCV000093445	1	155210420	1	155240629	93445	99352	rs104886460	NC_000001.11:155240628:C:T
NM_000157.4(GBA):c.1444G>A (p.Asp482Asn)	GBA|LOC106627981	D395N, D433N, D482N	Gaucher disease|not provided|not specified|Parkinson disease, late-onset	Likely benign(Last reviewed: Sep 23, 2020)	criteria provided, multiple submitters, no conflicts	VCV000004335	1	155205047	1	155235256	4335	19374	rs75671029	NC_000001.11:155235255:C:T
NM_001005741.2(GBA):c.[880T>G;1342G>C]	GBA|LOC106627981	D448H, D361H, D399H, H294Q, H245Q, H207Q	Gaucher disease type II|Gaucher disease type III	Pathogenic(Last reviewed: Apr 1, 2005)	no assertion criteria provided	VCV000004334	1|1	155205518	1|1	155235727	4334	19332|19373	rs1064651|rs367968666	NC_000001.11:155235726:C:G|NC_000001.11:155237457:A:C
NM_000157.4(GBA):c.887G>A (p.Arg296Gln)	GBA|LOC106627981	R296Q, R209Q, R247Q	Gaucher disease type 3C|Gaucher disease type I|Gaucher disease type II|Gaucher disease type III|not provided|Gaucher disease|Gaucher disease type 3C|Gaucher disease type I|Gaucher disease type II|Gaucher disease type III|Gaucher disease, perinatal lethal|Lewy body dementia|Parkinson disease, late-onset|Parkinson disease, late-onset|Gaucher disease, perinatal lethal	Pathogenic(Last reviewed: Sep 23, 2021)	criteria provided, multiple submitters, no conflicts	VCV000004328	1	155207244	1	155237453	4328	19367	rs78973108	NC_000001.11:155237452:C:T
NM_000157.4(GBA):c.1604G>A (p.Arg535His)	GBA|LOC106627981	R535H, R486H, R448H	Gaucher disease type 3C|Gaucher disease type I|Gaucher disease type II|Gaucher disease type III|Parkinson disease, late-onset|Gaucher disease type I|Gaucher disease|Gaucher disease type 3C|Gaucher disease type I|Gaucher disease type II|Gaucher disease type III|Gaucher disease, perinatal lethal|Lewy body dementia|Parkinson disease, late-onset|not provided	Pathogenic(Last reviewed: May 3, 2021)	criteria provided, multiple submitters, no conflicts	VCV000004311	1	155204793	1	155235002	4311	19350	rs75822236	NC_000001.11:155235001:C:T
NM_000157.4(GBA):c.84dup (p.Leu29fs)	GBA	L29fs	Gaucher disease type 3C|Gaucher disease type I|Gaucher disease type II|Gaucher disease type III|Gaucher disease type I|Parkinson disease, late-onset|not provided|Gaucher disease	Pathogenic(Last reviewed: Feb 8, 2022)	criteria provided, multiple submitters, no conflicts	VCV000004302	1	155210451 - 155210452	1	155240660 - 155240661	4302	19341	rs387906315	NC_000001.11:155240660:C:CC
NM_001005741.2(GBA):c.[535G>C;c.1093G>A]	GBA|LOC106627981	E365K, E278K, E316K, D179H, D130H, D92H	Gaucher disease type I	Pathogenic(Last reviewed: Jun 1, 2004)	no assertion criteria provided	VCV000004299	1|1	155206167	1|1	155236376	4299	38432|19338	rs2230288|rs147138516	NC_000001.11:155236375:C:T|NC_000001.11:155238569:C:G
NM_000157.4(GBA):c.764T>A (p.Phe255Tyr)	GBA|LOC106627981	F255Y, F168Y, F206Y	Gaucher disease type 3C|Gaucher disease type I|Gaucher disease type II|Gaucher disease type III|Parkinson disease, late-onset|Gaucher disease|Gaucher disease type I|not provided	Pathogenic/Likely pathogenic(Last reviewed: Feb 1, 2022)	criteria provided, multiple submitters, no conflicts	VCV000004298	1	155207367	1	155237576	4298	19337	rs74500255	NC_000001.11:155237575:A:T
NM_001005741.2(GBA):c.[1448T>C;1483G>C;1497G>C]	GBA|LOC106627981	L483P, L396P, L434P, A495P, A408P, A446P	Gaucher disease, perinatal lethal|Gaucher disease type II|Gaucher disease type III|Gaucher disease type I|Parkinson disease, late-onset|not provided	Pathogenic(Last reviewed: May 3, 2021)	criteria provided, single submitter	VCV000004297	1|1|1	155205043	1|1|1	155235252	4297	19327|38384|38385	rs421016|rs368060|rs1135675	NC_000001.11:155235251:A:G|NC_000001.11:155235216:C:G|NC_000001.11:155235202:C:G
NM_000157.4(GBA):c.1504C>T (p.Arg502Cys)	GBA|LOC106627981	R502C, R415C, R453C	Gaucher disease type 3C|Gaucher disease type I|Gaucher disease type II|Gaucher disease type III|Gaucher disease type II|Gaucher disease type III|Parkinson disease, late-onset|Gaucher disease type I|not provided|Gaucher disease|Gaucher disease type 3C|Gaucher disease type I|Gaucher disease type II|Gaucher disease type III|Gaucher disease, perinatal lethal|Lewy body dementia|Parkinson disease, late-onset	Pathogenic(Last reviewed: Nov 26, 2021)	criteria provided, multiple submitters, no conflicts	VCV000004295	1	155204987	1	155235196	4295	19334	rs80356771	NC_000001.11:155235195:G:A
NM_000157.4(GBA):c.1342G>C (p.Asp448His)	GBA|LOC106627981	D448H, D361H, D399H	Gaucher disease type 3C|Gaucher disease type I|Gaucher disease type II|Gaucher disease type III|Parkinson disease, late-onset|Gaucher disease type III|not provided|Gaucher disease type II|Gaucher disease type 3C|Gaucher disease type I|Gaucher disease, perinatal lethal|Gaucher disease|Gaucher disease type 3C|Gaucher disease type I|Gaucher disease type II|Gaucher disease type III|Gaucher disease, perinatal lethal|Lewy body dementia|Parkinson disease, late-onset	Pathogenic/Likely pathogenic(Last reviewed: Aug 17, 2021)	criteria provided, multiple submitters, no conflicts	VCV000004293	1	155205518	1	155235727	4293	19332	rs1064651	NC_000001.11:155235726:C:G
NM_000157.4(GBA):c.1297G>T (p.Val433Leu)	GBA|LOC106627981	V433L, V384L, V346L	Gaucher disease type 3C|Gaucher disease type I|Gaucher disease type II|Gaucher disease type III|not provided|Gaucher disease type I|Gaucher disease|Gaucher disease type 3C|Gaucher disease type I|Gaucher disease type II|Gaucher disease type III|Gaucher disease, perinatal lethal|Lewy body dementia|Parkinson disease, late-onset|Gaucher disease type III|Parkinson disease, late-onset	Pathogenic/Likely pathogenic(Last reviewed: May 3, 2021)	criteria provided, multiple submitters, no conflicts	VCV000004292	1	155205563	1	155235772	4292	19331	rs80356769	NC_000001.11:155235771:C:A
NM_000157.4(GBA):c.1226A>G (p.Asn409Ser)	GBA|LOC106627981	N409S, N322S, N360S	Gaucher disease type 3C|Gaucher disease type I|Gaucher disease type II|Gaucher disease type III|Parkinson disease|Thrombocytopenia|Abnormal bleeding|Gaucher disease type 3C|Gaucher disease type I|Gaucher disease type II|Gaucher disease type III|Gaucher disease, perinatal lethal|Lewy body dementia|Parkinson disease, late-onset|Parkinson disease, late-onset|Dementia, Lewy body, susceptibility to|Gaucher disease type I|Akinesia|Rigidity|Gaucher disease, perinatal lethal|not provided|Gaucher disease	Pathogenic/Likely pathogenic; risk factor(Last reviewed: Mar 25, 2022)	criteria provided, multiple submitters, no conflicts	VCV000004290	1	155205634	1	155235843	4290	19329	rs76763715	NC_000001.11:155235842:T:C
NM_000157.3(GBA):c.1448T>C	GBA|LOC106627981	L483P, L396P, L434P	Gaucher disease type 3C|Gaucher disease type I|Gaucher disease type II|Gaucher disease type III|Gaucher disease type III|Gaucher disease type I|Parkinson disease, late-onset|Gaucher disease, perinatal lethal|Dementia, Lewy body, susceptibility to|Thoracolumbar scoliosis|Parkinsonism|Hypomimic face|Abnormality of movement|Resting tremor|Gaucher disease|Gaucher disease type II|not provided	Pathogenic; risk factor(Last reviewed: Mar 5, 2022)	criteria provided, multiple submitters, no conflicts	VCV000004288	1	155205043	1	155235252	4288	19327	rs421016	NC_000001.11:155235251:A:G
NM_000161.3(GCH1):c.695G>A (p.Gly232Asp)	GCH1	G232D	Dystonia 5|GTP cyclohydrolase I deficiency	Uncertain significance(Last reviewed: Nov 26, 2021)	criteria provided, single submitter	VCV001407807	14	55310793	14	54844075	1407807	1506686		NC_000014.9:54844074:C:T
NM_001001557.4(GDF6):c.1271A>G (p.Lys424Arg)	GDF6	K424R	Klippel-Feil syndrome 1, autosomal dominant|Microphthalmia, isolated, with coloboma 6|Leber congenital amaurosis 17|Microphthalmia, isolated 4|Cervical C2/C3 vertebral fusion|Parkinson disease 8, autosomal dominant|Klippel-Feil syndrome 1, autosomal dominant|Klippel-Feil syndrome 1, autosomal dominant	Likely benign(Last reviewed: Mar 3, 2020)	criteria provided, multiple submitters, no conflicts	VCV000008373	8	97156888	8	96144660	8373	23412	rs121909353	NC_000008.11:96144659:T:C
NM_001103146.3(GIGYF2):c.2146A>G (p.Thr716Ala)	GIGYF2	T737A, T710A, T716A	Parkinson disease 11	Uncertain significance(Last reviewed: Jun 3, 2020)	criteria provided, single submitter	VCV001030144	2	233680385	2	232815675	1030144	1016024	rs1700885234	NC_000002.12:232815674:A:G
NM_001103146.3(GIGYF2):c.2489A>T (p.Glu830Val)	GIGYF2	E830V, E851V, E824V	Parkinson disease 11	Uncertain significance(Last reviewed: Mar 29, 2020)	criteria provided, single submitter	VCV000931848	2	233684655	2	232819945	931848	918754	rs1327472255	NC_000002.12:232819944:A:T
NM_001103146.3(GIGYF2):c.1554G>A (p.Glu518=)	GIGYF2		not provided|Parkinson disease 11	Benign(Last reviewed: Jun 9, 2021)	criteria provided, multiple submitters, no conflicts	VCV000522283	2	233660846	2	232796136	522283	512894	rs2305138	NC_000002.12:232796135:G:A
NM_001103146.3(GIGYF2):c.3684+15G>A	GIGYF2		not provided|Parkinson disease 11	Benign(Last reviewed: Jun 19, 2021)	criteria provided, multiple submitters, no conflicts	VCV000518340	2	233712296	2	232847586	518340	508781	rs6437074	NC_000002.12:232847585:G:A
NM_001103146.3(GIGYF2):c.3651G>A (p.Pro1217=)	GIGYF2		not provided|Parkinson disease 11	Benign(Last reviewed: Jun 9, 2021)	criteria provided, multiple submitters, no conflicts	VCV000518339	2	233712248	2	232847538	518339	508780	rs12328151	NC_000002.12:232847537:G:A
NM_001103146.3(GIGYF2):c.3630_3632del (p.Gln1216del)	GIGYF2	Q1216del, Q1237del, Q1210del	not provided|Parkinson disease 11	Benign(Last reviewed: Jun 9, 2021)	criteria provided, single submitter	VCV000518338	2	233712227 - 233712229	2	232847517 - 232847519	518338	508779	rs10555297	NC_000002.12:232847516:ACA:
NM_001103146.3(GIGYF2):c.3461-9G>A	GIGYF2		not provided|Parkinson disease 11	Benign(Last reviewed: Jun 9, 2021)	criteria provided, multiple submitters, no conflicts	VCV000518337	2	233712049	2	232847339	518337	508778	rs2305137	NC_000002.12:232847338:G:A
NM_001103146.3(GIGYF2):c.2940A>G (p.Gln980=)	GIGYF2		Parkinson disease 11|not provided	Benign(Last reviewed: Mar 3, 2020)	criteria provided, multiple submitters, no conflicts	VCV000518336	2	233708806	2	232844096	518336	508777	rs3816334	NC_000002.12:232844095:A:G
NM_001103146.3(GIGYF2):c.3629_3630insGC (p.Gln1211fs)	GIGYF2	Q1211fs, Q1205fs, Q1232fs	Parkinson disease 11|not provided|not specified	Benign/Likely benign(Last reviewed: Jun 9, 2021)	criteria provided, multiple submitters, no conflicts	VCV000402899	2	233712226 - 233712227	2	232847515 - 232847516	402899	389487	rs371622656	NC_000002.12:232847515:C:CGC
NM_001103146.3(GIGYF2):c.2378C>T (p.Ala793Val)	GIGYF2	A793V, A814V, A787V	Parkinson disease 11	Conflicting interpretations of pathogenicity(Last reviewed: Feb 11, 2020)	criteria provided, conflicting interpretations	VCV000216934	2	233684544	2	232819834	216934	213536	rs748538823	NC_000002.12:232819833:C:T
NM_001103146.3(GIGYF2):c.1262A>G (p.Lys421Arg)	GIGYF2	K421R, K415R, K442R	Parkinson disease 11	risk factor(Last reviewed: Sep 1, 2009)	no assertion criteria provided	VCV000000757	2	233656136	2	232791426	757	15796	rs115735611	NC_000002.12:232791425:A:G
NM_001103146.3(GIGYF2):c.832A>G (p.Ile278Val)	GIGYF2	I278V, I272V, I300V	Parkinson disease 11	risk factor(Last reviewed: Apr 1, 2008)	no assertion criteria provided	VCV000000756	2	233655527	2	232790817	756	15795	rs118203904	NC_000002.12:232790816:A:G
NM_001103146.3(GIGYF2):c.1818C>G (p.Asp606Glu)	GIGYF2	D606E, D627E, D600E	Parkinson disease 11	risk factor(Last reviewed: Apr 1, 2008)	no assertion criteria provided	VCV000000755	2	233674441	2	232809731	755	15794	rs118203903	NC_000002.12:232809730:C:G
NM_001103146.3(GIGYF2):c.1370A>C (p.Asn457Thr)	GIGYF2	N457T, N451T, N478T	Parkinson disease 11	risk factor(Last reviewed: Aug 1, 2009)	no assertion criteria provided	VCV000000754	2	233659545	2	232794835	754	15793	rs116074753	NC_000002.12:232794834:A:C
NM_001103146.3(GIGYF2):c.167A>G (p.Asn56Ser)	GIGYF2	N56S	Parkinson disease 11	risk factor(Last reviewed: Aug 1, 2009)	no assertion criteria provided	VCV000000753	2	233612450	2	232747740	753	15792	rs72554080	NC_000002.12:232747739:A:G
NM_181703.4(GJA5):c.895G>A (p.Glu299Lys)	GJA5	E299K	Wolff-Parkinson-White pattern	Uncertain significance(Last reviewed: Jul 14, 2017)	no assertion criteria provided	VCV000487608	1	147230452	1	147758344	487608	480667	rs1553226803	NC_000001.11:147758343:C:T
NM_000404.2(GLB1):c.245C>T	GLB1	T82M, T130M, T52M, T82I	not provided|GM1 gangliosidosis|Mucopolysaccharidosis, MPS-IV-B|GM1 gangliosidosis type 3|GM1 gangliosidosis type 2|Mucopolysaccharidosis, MPS-IV-B|Infantile GM1 gangliosidosis|GM1 gangliosidosis type 2|GM1 gangliosidosis type 3|Inborn genetic diseases	Conflicting interpretations of pathogenicity(Last reviewed: Oct 25, 2021)	criteria provided, conflicting interpretations	VCV000000935	3	33114036	3	33072544	935	15974	rs72555393	NC_000003.12:33072543:G:A
NM_012084.4(GLUD2):c.1492T>G (p.Ser498Ala)	GLUD2	S498A	Parkinson disease, late-onset	Pathogenic(Last reviewed: Mar 1, 2010)	no assertion criteria provided	VCV000029936	X	120183030	X	121049176	29936	38891	rs9697983	NC_000023.11:121049175:T:G
NM_015141.4(GPD1L):c.775G>A (p.Gly259Arg)	GPD1L	G259R	Wolff-Parkinson-White pattern|Brugada syndrome	Uncertain significance(Last reviewed: Aug 27, 2020)	criteria provided, single submitter	VCV000487599	3	32200524	3	32159032	487599	480683	rs146477959	NC_000003.12:32159031:G:A
NM_002087.4(GRN):c.1540G>A (p.Val514Met)	GRN	V514M	Seizure|Ceroid lipofuscinosis, neuronal, 11|Grn-related frontotemporal lobar degeneration with Tdp43 inclusions|Grn-related frontotemporal lobar degeneration with Tdp43 inclusions	Uncertain significance(Last reviewed: Nov 26, 2021)	criteria provided, multiple submitters, no conflicts	VCV000587957	17	42429835	17	44352467	587957	580346	rs142926942	NC_000017.11:44352466:G:A
NM_002087.4(GRN):c.970G>A (p.Ala324Thr)	GRN	A324T	Ceroid lipofuscinosis, neuronal, 11|Grn-related frontotemporal lobar degeneration with Tdp43 inclusions|not specified|not provided|Grn-related frontotemporal lobar degeneration with Tdp43 inclusions	Conflicting interpretations of pathogenicity(Last reviewed: Jul 29, 2020)	criteria provided, conflicting interpretations	VCV000098165	17	42428954	17	44351586	98165	104057	rs63750541	NC_000017.11:44351585:G:A
NM_002087.4(GRN):c.-8+5G>C	GRN		Grn-related frontotemporal lobar degeneration with Tdp43 inclusions|not provided	Pathogenic(Last reviewed: Feb 3, 2020)	no assertion criteria provided	VCV000098119	17	42422707	17	44345339	98119	104011	rs63750313	NC_000017.11:44345338:G:C
NM_032620.4(GTPBP3):c.32_33delinsGTG (p.Gln11fs)	GTPBP3	Q11fs	Combined oxidative phosphorylation deficiency 23	Pathogenic(Last reviewed: Dec 4, 2014)	no assertion criteria provided	VCV000180619	19	17448452 - 17448453	19	17337643 - 17337644	180619	178785	rs886037736	NC_000019.10:17337642:AA:GTG
NM_031157.4(HNRNPA1):c.240_243del (p.Asp80fs)	HNRNPA1	D80fs	Inclusion body myopathy with early-onset paget disease with or without frontotemporal dementia 3	Uncertain significance(Last reviewed: Jan 3, 2022)	criteria provided, single submitter	VCV001333611	12	54675682 - 54675685	12	54281898 - 54281901	1333611	1324382		NC_000012.12:54281897:TGGATGGA:TGGA
NM_031157.4(HNRNPA1):c.1018C>G (p.Pro340Ala)	HNRNPA1	P288A, P340A	Inclusion body myopathy with early-onset paget disease with or without frontotemporal dementia 3	Likely pathogenic(Last reviewed: Jun 12, 2018)	criteria provided, single submitter	VCV000637023	12	54677706	12	54283922	637023	624860	rs1592173638	NC_000012.12:54283921:C:G
NM_031157.4(HNRNPA1):c.941A>T (p.Asp314Val)	HNRNPA1	D314V, D262V	Inclusion body myopathy with early-onset paget disease with or without frontotemporal dementia 3|not provided	Pathogenic/Likely pathogenic(Last reviewed: May 25, 2020)	no assertion criteria provided	VCV000065451	12	54677629	12	54283845	65451	76368	rs397518452	NC_000012.12:54283844:A:T
NM_002137.4(HNRNPA2B1):c.264+17T>G	HNRNPA2B1		Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 2	Likely benign(Last reviewed: Jun 4, 2021)	criteria provided, single submitter	VCV001669943	7	26236918	7	26197298	1669943	1582621		NC_000007.14:26197297:A:C
NM_002137.4(HNRNPA2B1):c.7-137dup	HNRNPA2B1		Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 2	Likely benign(Last reviewed: Nov 19, 2021)	criteria provided, single submitter	VCV001669039	7	26237488 - 26237489	7	26197868 - 26197869	1669039	1602925		NC_000007.14:26197868:GGGGGG:GGGGGGG
NM_002137.4(HNRNPA2B1):c.135A>C (p.Ala45=)	HNRNPA2B1		Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 2	Likely benign(Last reviewed: Oct 31, 2021)	criteria provided, single submitter	VCV001667067	7	26237064	7	26197444	1667067	1622491		NC_000007.14:26197443:T:G
NM_002137.4(HNRNPA2B1):c.577+13_577+14del	HNRNPA2B1		Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 2	Likely benign(Last reviewed: Dec 17, 2021)	criteria provided, single submitter	VCV001663277	7	26236163 - 26236164	7	26196543 - 26196544	1663277	1619586		NC_000007.14:26196542:AGA:A
NM_002137.4(HNRNPA2B1):c.118-14C>T	HNRNPA2B1		Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 2	Likely benign(Last reviewed: Jun 11, 2021)	criteria provided, single submitter	VCV001661544	7	26237095	7	26197475	1661544	1607905		NC_000007.14:26197474:G:A
NM_002137.4(HNRNPA2B1):c.658+18C>T	HNRNPA2B1		Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 2	Benign(Last reviewed: Dec 9, 2021)	criteria provided, single submitter	VCV001659025	7	26236003	7	26196383	1659025	1640570		NC_000007.14:26196382:G:A
NM_002137.4(HNRNPA2B1):c.264+14G>A	HNRNPA2B1		Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 2	Likely benign(Last reviewed: Nov 11, 2021)	criteria provided, single submitter	VCV001655353	7	26236921	7	26197301	1655353	1615703		NC_000007.14:26197300:C:T
NM_002137.4(HNRNPA2B1):c.658+15C>A	HNRNPA2B1		Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 2	Likely benign(Last reviewed: Oct 8, 2021)	criteria provided, single submitter	VCV001650547	7	26236006	7	26196386	1650547	1602259		NC_000007.14:26196385:G:T
NM_002137.4(HNRNPA2B1):c.475+13C>T	HNRNPA2B1		Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 2	Likely benign(Last reviewed: Mar 24, 2021)	criteria provided, single submitter	VCV001645613	7	26236414	7	26196794	1645613	1652912		NC_000007.14:26196793:G:A
NM_002137.4(HNRNPA2B1):c.577+15G>C	HNRNPA2B1		Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 2	Likely benign(Last reviewed: Sep 2, 2021)	criteria provided, single submitter	VCV001643789	7	26236162	7	26196542	1643789	1651527		NC_000007.14:26196541:C:G
NM_002137.4(HNRNPA2B1):c.659-10C>T	HNRNPA2B1		Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 2	Likely benign(Last reviewed: Feb 21, 2021)	criteria provided, single submitter	VCV001642559	7	26235539	7	26195919	1642559	1552657		NC_000007.14:26195918:G:A
NM_002137.4(HNRNPA2B1):c.658+19G>A	HNRNPA2B1		Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 2	Likely benign(Last reviewed: Jul 9, 2021)	criteria provided, single submitter	VCV001639419	7	26236002	7	26196382	1639419	1647007		NC_000007.14:26196381:C:T
NM_002137.4(HNRNPA2B1):c.348T>C (p.Leu116=)	HNRNPA2B1		Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 2	Likely benign(Last reviewed: Apr 28, 2021)	criteria provided, single submitter	VCV001635264	7	26236554	7	26196934	1635264	1610990		NC_000007.14:26196933:A:G
NM_002137.4(HNRNPA2B1):c.721+19T>C	HNRNPA2B1		Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 2	Benign(Last reviewed: Dec 6, 2021)	criteria provided, single submitter	VCV001633968	7	26235448	7	26195828	1633968	1661369		NC_000007.14:26195827:A:G
NM_002137.4(HNRNPA2B1):c.964+16T>C	HNRNPA2B1		Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 2	Likely benign(Last reviewed: Oct 2, 2021)	criteria provided, single submitter	VCV001625998	7	26232855	7	26193235	1625998	1575213		NC_000007.14:26193234:A:G
NM_002137.4(HNRNPA2B1):c.475+9C>T	HNRNPA2B1		Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 2	Benign(Last reviewed: Jul 21, 2021)	criteria provided, single submitter	VCV001622851	7	26236418	7	26196798	1622851	1627477		NC_000007.14:26196797:G:A
NM_002137.4(HNRNPA2B1):c.27T>G (p.Arg9=)	HNRNPA2B1		Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 2	Likely benign(Last reviewed: Jul 7, 2021)	criteria provided, single submitter	VCV001617706	7	26237332	7	26197712	1617706	1614559		NC_000007.14:26197711:A:C
NM_002137.4(HNRNPA2B1):c.659-14_659-13del	HNRNPA2B1		Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 2	Benign(Last reviewed: Aug 25, 2021)	criteria provided, single submitter	VCV001617525	7	26235542 - 26235543	7	26195922 - 26195923	1617525	1614378		NC_000007.14:26195921:AAAAAAA:AAAAA
NM_002137.4(HNRNPA2B1):c.475+17A>G	HNRNPA2B1		Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 2	Likely benign(Last reviewed: Dec 3, 2021)	criteria provided, single submitter	VCV001616485	7	26236410	7	26196790	1616485	1526675		NC_000007.14:26196789:T:C
NM_002137.4(HNRNPA2B1):c.939G>A (p.Arg313=)	HNRNPA2B1		Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 2	Likely benign(Last reviewed: Aug 28, 2021)	criteria provided, single submitter	VCV001612413	7	26232896	7	26193276	1612413	1601496		NC_000007.14:26193275:C:T
NM_002137.4(HNRNPA2B1):c.964+9del	HNRNPA2B1		Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 2	Likely benign(Last reviewed: Oct 20, 2021)	criteria provided, single submitter	VCV001611021	7	26232862	7	26193242	1611021	1640097		NC_000007.14:26193241:A:
NM_002137.4(HNRNPA2B1):c.843A>C (p.Gly281=)	HNRNPA2B1		Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 2	Likely benign(Last reviewed: Nov 9, 2021)	criteria provided, single submitter	VCV001610080	7	26232992	7	26193372	1610080	1551036		NC_000007.14:26193371:T:G
NM_002137.4(HNRNPA2B1):c.577+19C>T	HNRNPA2B1		Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 2	Likely benign(Last reviewed: Aug 3, 2021)	criteria provided, single submitter	VCV001606061	7	26236158	7	26196538	1606061	1560556		NC_000007.14:26196537:G:A
NM_002137.4(HNRNPA2B1):c.117+13C>T	HNRNPA2B1		Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 2	Benign(Last reviewed: Dec 2, 2021)	criteria provided, single submitter	VCV001605397	7	26237229	7	26197609	1605397	1646451		NC_000007.14:26197608:G:A
NM_002137.4(HNRNPA2B1):c.659-19T>C	HNRNPA2B1		Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 2	Benign(Last reviewed: Oct 29, 2021)	criteria provided, single submitter	VCV001602535	7	26235548	7	26195928	1602535	1557492		NC_000007.14:26195927:A:G
NM_002137.4(HNRNPA2B1):c.906T>A (p.Gly302=)	HNRNPA2B1		Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 2	Benign(Last reviewed: Sep 15, 2021)	criteria provided, single submitter	VCV001599601	7	26232929	7	26193309	1599601	1609683		NC_000007.14:26193308:A:T
NM_002137.4(HNRNPA2B1):c.264+12A>G	HNRNPA2B1		Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 2	Likely benign(Last reviewed: Jun 15, 2021)	criteria provided, single submitter	VCV001595037	7	26236923	7	26197303	1595037	1590677		NC_000007.14:26197302:T:C
NM_002137.4(HNRNPA2B1):c.118-13T>C	HNRNPA2B1		Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 2	Likely benign(Last reviewed: Oct 23, 2021)	criteria provided, single submitter	VCV001593114	7	26237094	7	26197474	1593114	1620668		NC_000007.14:26197473:A:G
NM_002137.4(HNRNPA2B1):c.486C>T (p.Tyr162=)	HNRNPA2B1		Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 2	Likely benign(Last reviewed: Apr 22, 2021)	criteria provided, single submitter	VCV001593089	7	26236268	7	26196648	1593089	1620644		NC_000007.14:26196647:G:A
NM_002137.4(HNRNPA2B1):c.234A>G (p.Val78=)	HNRNPA2B1		Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 2	Likely benign(Last reviewed: Jan 25, 2021)	criteria provided, single submitter	VCV001591427	7	26236965	7	26197345	1591427	1609020		NC_000007.14:26197344:T:C
NM_002137.4(HNRNPA2B1):c.525_526delinsGC (p.Ala175_Leu176=)	HNRNPA2B1		Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 2	Likely benign(Last reviewed: Sep 29, 2021)	criteria provided, single submitter	VCV001584929	7	26236228 - 26236229	7	26196608 - 26196609	1584929	1561080		NC_000007.14:26196607:AA:GC
NM_002137.4(HNRNPA2B1):c.842-12A>T	HNRNPA2B1		Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 2	Likely benign(Last reviewed: Sep 25, 2021)	criteria provided, single submitter	VCV001583205	7	26233005	7	26193385	1583205	1535443		NC_000007.14:26193384:T:A
NM_002137.4(HNRNPA2B1):c.118-16C>T	HNRNPA2B1		Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 2	Likely benign(Last reviewed: Sep 1, 2021)	criteria provided, single submitter	VCV001582732	7	26237097	7	26197477	1582732	1567001		NC_000007.14:26197476:G:A
NM_002137.4(HNRNPA2B1):c.476-16G>A	HNRNPA2B1		Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 2	Benign(Last reviewed: Nov 6, 2021)	criteria provided, single submitter	VCV001578241	7	26236294	7	26196674	1578241	1587709		NC_000007.14:26196673:C:T
NM_002137.4(HNRNPA2B1):c.84C>T (p.Tyr28=)	HNRNPA2B1		Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 2	Likely benign(Last reviewed: Sep 29, 2021)	criteria provided, single submitter	VCV001577062	7	26237275	7	26197655	1577062	1639919		NC_000007.14:26197654:G:A
NM_002137.4(HNRNPA2B1):c.696T>C (p.Tyr232=)	HNRNPA2B1		Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 2	Likely benign(Last reviewed: Jul 31, 2021)	criteria provided, single submitter	VCV001573599	7	26235492	7	26195872	1573599	1637314		NC_000007.14:26195871:A:G
NM_002137.4(HNRNPA2B1):c.475+14C>T	HNRNPA2B1		Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 2	Likely benign(Last reviewed: Nov 10, 2021)	criteria provided, single submitter	VCV001572379	7	26236413	7	26196793	1572379	1538448		NC_000007.14:26196792:G:A
NM_002137.4(HNRNPA2B1):c.659-13dup	HNRNPA2B1		Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 2	Benign(Last reviewed: Aug 4, 2021)	criteria provided, single submitter	VCV001571027	7	26235541 - 26235542	7	26195921 - 26195922	1571027	1646255		NC_000007.14:26195921:AAAAAAA:AAAAAAAA
NM_002137.4(HNRNPA2B1):c.987T>C (p.Ser329=)	HNRNPA2B1		Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 2	Likely benign(Last reviewed: Sep 23, 2021)	criteria provided, single submitter	VCV001568882	7	26232175	7	26192555	1568882	1634483		NC_000007.14:26192554:A:G
NM_002137.4(HNRNPA2B1):c.405G>A (p.Arg135=)	HNRNPA2B1		Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 2	Likely benign(Last reviewed: Jul 27, 2021)	criteria provided, single submitter	VCV001567742	7	26236497	7	26196877	1567742	1657250		NC_000007.14:26196876:C:T
NM_002137.4(HNRNPA2B1):c.66A>G (p.Glu22=)	HNRNPA2B1		Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 2	Likely benign(Last reviewed: Jun 27, 2021)	criteria provided, single submitter	VCV001566935	7	26237293	7	26197673	1566935	1622578		NC_000007.14:26197672:T:C
NM_002137.4(HNRNPA2B1):c.7-137del	HNRNPA2B1		Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 2	Benign(Last reviewed: Oct 22, 2021)	criteria provided, single submitter	VCV001559822	7	26237489	7	26197869	1559822	1542412		NC_000007.14:26197868:GGGGGG:GGGGG
NM_002137.4(HNRNPA2B1):c.384C>T (p.Thr128=)	HNRNPA2B1		Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 2	Likely benign(Last reviewed: Apr 20, 2021)	criteria provided, single submitter	VCV001549153	7	26236518	7	26196898	1549153	1626230		NC_000007.14:26196897:G:A
NM_002137.4(HNRNPA2B1):c.357C>T (p.Tyr119=)	HNRNPA2B1		Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 2	Likely benign(Last reviewed: Aug 23, 2021)	criteria provided, single submitter	VCV001537375	7	26236545	7	26196925	1537375	1596968		NC_000007.14:26196924:G:A
NM_002137.4(HNRNPA2B1):c.658+16T>G	HNRNPA2B1		Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 2	Likely benign(Last reviewed: Oct 23, 2021)	criteria provided, single submitter	VCV001532689	7	26236005	7	26196385	1532689	1636300		NC_000007.14:26196384:A:C
NM_002137.4(HNRNPA2B1):c.375A>G (p.Lys125=)	HNRNPA2B1		Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 2	Likely benign(Last reviewed: Feb 21, 2021)	criteria provided, single submitter	VCV001532140	7	26236527	7	26196907	1532140	1583060		NC_000007.14:26196906:T:C
NM_002137.4(HNRNPA2B1):c.264+15A>C	HNRNPA2B1		Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 2	Likely benign(Last reviewed: Jun 11, 2021)	criteria provided, single submitter	VCV001531921	7	26236920	7	26197300	1531921	1582841		NC_000007.14:26197299:T:G
NM_002137.4(HNRNPA2B1):c.476-3del	HNRNPA2B1		Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 2	Uncertain significance(Last reviewed: Jul 4, 2021)	criteria provided, single submitter	VCV001516950	7	26236281	7	26196661	1516950	1495723		NC_000007.14:26196660:GG:G
NM_002137.4(HNRNPA2B1):c.779G>C (p.Gly260Ala)	HNRNPA2B1	G272A, G260A	Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 2	Uncertain significance(Last reviewed: Sep 24, 2021)	criteria provided, single submitter	VCV001515178	7	26233257	7	26193637	1515178	1482367		NC_000007.14:26193636:C:G
NM_002137.4(HNRNPA2B1):c.322_324del (p.Lys108del)	HNRNPA2B1	K120del, K108del	Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 2	Uncertain significance(Last reviewed: Aug 14, 2021)	criteria provided, single submitter	VCV001512625	7	26236578 - 26236580	7	26196958 - 26196960	1512625	1478875		NC_000007.14:26196957:TTT:
NM_002137.4(HNRNPA2B1):c.625CCAGGA[1] (p.209PG[1])	HNRNPA2B1		Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 2	Uncertain significance(Last reviewed: Aug 31, 2021)	criteria provided, single submitter	VCV001512360	7	26236043 - 26236048	7	26196423 - 26196428	1512360	1478610		NC_000007.14:26196422:TCCTGGTCCTGGTCC:TCCTGGTCC
NM_002137.4(HNRNPA2B1):c.893C>T (p.Pro298Leu)	HNRNPA2B1	P310L, P298L	Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 2	Likely pathogenic(Last reviewed: Sep 2, 2021)	criteria provided, single submitter	VCV001501742	7	26232942	7	26193322	1501742	1398610		NC_000007.14:26193321:G:A
NM_002137.4(HNRNPA2B1):c.745G>A (p.Gly249Ser)	HNRNPA2B1	G261S, G249S	Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 2	Uncertain significance(Last reviewed: Sep 1, 2021)	criteria provided, single submitter	VCV001500986	7	26233291	7	26193671	1500986	1501908		NC_000007.14:26193670:C:T
NM_002137.4(HNRNPA2B1):c.203C>G (p.Ala68Gly)	HNRNPA2B1	A80G, A68G	Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 2	Uncertain significance(Last reviewed: Sep 17, 2021)	criteria provided, single submitter	VCV001497669	7	26236996	7	26197376	1497669	1376190		NC_000007.14:26197375:G:C
NM_002137.4(HNRNPA2B1):c.700G>A (p.Gly234Arg)	HNRNPA2B1	G246R, G234R	Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 2	Uncertain significance(Last reviewed: Aug 27, 2021)	criteria provided, single submitter	VCV001485729	7	26235488	7	26195868	1485729	1472076		NC_000007.14:26195867:C:T
NM_002137.4(HNRNPA2B1):c.853A>G (p.Ser285Gly)	HNRNPA2B1	S285G, S297G	Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 2	Uncertain significance(Last reviewed: Aug 28, 2021)	criteria provided, single submitter	VCV001478408	7	26232982	7	26193362	1478408	1351915		NC_000007.14:26193361:T:C
NM_002137.4(HNRNPA2B1):c.7-128_7-127del	HNRNPA2B1	L5fs	Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 2	Uncertain significance(Last reviewed: Sep 26, 2021)	criteria provided, single submitter	VCV001477813	7	26237479 - 26237480	7	26197859 - 26197860	1477813	1436692		NC_000007.14:26197858:AAA:A
NM_002137.4(HNRNPA2B1):c.763GGA[1] (p.Gly256del)	HNRNPA2B1	G268del, G256del	Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 2	Uncertain significance(Last reviewed: Sep 24, 2021)	criteria provided, single submitter	VCV001469236	7	26233268 - 26233270	7	26193648 - 26193650	1469236	1370345		NC_000007.14:26193647:TCCTCCTC:TCCTC
NM_002137.4(HNRNPA2B1):c.233T>C (p.Val78Ala)	HNRNPA2B1	V78A, V90A	Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 2	Uncertain significance(Last reviewed: Aug 23, 2021)	criteria provided, single submitter	VCV001447922	7	26236966	7	26197346	1447922	1403808		NC_000007.14:26197345:A:G
NM_002137.4(HNRNPA2B1):c.7-9C>G	HNRNPA2B1		Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 2	Uncertain significance(Last reviewed: Aug 13, 2021)	criteria provided, single submitter	VCV001447402	7	26237361	7	26197741	1447402	1503457		NC_000007.14:26197740:G:C
NC_000007.13:g.(?_26232136)_(26240197_?)dup	HNRNPA2B1		Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 2	Uncertain significance(Last reviewed: Sep 15, 2021)	criteria provided, single submitter	VCV001445121	7	26232136 - 26240197			1445121	1397447		
NM_002137.4(HNRNPA2B1):c.902A>T (p.Tyr301Phe)	HNRNPA2B1	Y301F, Y313F	Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 2	Uncertain significance(Last reviewed: Nov 30, 2021)	criteria provided, single submitter	VCV001441499	7	26232933	7	26193313	1441499	1358767		NC_000007.14:26193312:T:A
NM_002137.4(HNRNPA2B1):c.581A>G (p.Asn194Ser)	HNRNPA2B1	N206S, N194S	Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 2	Uncertain significance(Last reviewed: Aug 27, 2021)	criteria provided, single submitter	VCV001424612	7	26236098	7	26196478	1424612	1438488		NC_000007.14:26196477:T:C
NM_002137.4(HNRNPA2B1):c.676C>T (p.Arg226Cys)	HNRNPA2B1	R226C, R238C	Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 2	Uncertain significance(Last reviewed: Sep 29, 2021)	criteria provided, single submitter	VCV001420980	7	26235512	7	26195892	1420980	1399707		NC_000007.14:26195891:G:A
NM_002137.4(HNRNPA2B1):c.7-115C>A	HNRNPA2B1	P9H	Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 2	Uncertain significance(Last reviewed: Sep 1, 2021)	criteria provided, single submitter	VCV001419235	7	26237467	7	26197847	1419235	1386914		NC_000007.14:26197846:G:T
NM_002137.4(HNRNPA2B1):c.965-3T>C	HNRNPA2B1		Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 2	Uncertain significance(Last reviewed: Sep 8, 2021)	criteria provided, single submitter	VCV001406853	7	26232200	7	26192580	1406853	1486911		NC_000007.14:26192579:A:G
NM_002137.4(HNRNPA2B1):c.715C>T (p.Pro239Ser)	HNRNPA2B1	P239S, P251S	Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 2	Uncertain significance(Last reviewed: Aug 14, 2021)	criteria provided, single submitter	VCV001404442	7	26235473	7	26195853	1404442	1480138		NC_000007.14:26195852:G:A
NM_002137.4(HNRNPA2B1):c.948_950del (p.Gly317del)	HNRNPA2B1	G317del, G329del	Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 2	Uncertain significance(Last reviewed: Dec 8, 2021)	criteria provided, single submitter	VCV001402601	7	26232885 - 26232887	7	26193265 - 26193267	1402601	1477028		NC_000007.14:26193264:CCCCCC:CCC
NM_002137.4(HNRNPA2B1):c.721+16C>A	HNRNPA2B1		Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 2	Uncertain significance(Last reviewed: Aug 3, 2021)	criteria provided, single submitter	VCV001398576	7	26235451	7	26195831	1398576	1427643		NC_000007.14:26195830:G:T
NM_002137.4(HNRNPA2B1):c.205_206delinsCT (p.Ala69Leu)	HNRNPA2B1	A69L, A81L	Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 2	Uncertain significance(Last reviewed: Aug 30, 2021)	criteria provided, single submitter	VCV001396081	7	26236993 - 26236994	7	26197373 - 26197374	1396081	1350860		NC_000007.14:26197372:GC:AG
NM_002137.4(HNRNPA2B1):c.7-93C>T	HNRNPA2B1		Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 2	Uncertain significance(Last reviewed: Jun 19, 2021)	criteria provided, single submitter	VCV001394313	7	26237445	7	26197825	1394313	1338336		NC_000007.14:26197824:G:A
NM_002137.4(HNRNPA2B1):c.475T>C (p.Leu159=)	HNRNPA2B1		Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 2	Uncertain significance(Last reviewed: Oct 27, 2021)	criteria provided, single submitter	VCV001393154	7	26236427	7	26196807	1393154	1402881		NC_000007.14:26196806:A:G
NM_002137.4(HNRNPA2B1):c.475+18A>G	HNRNPA2B1		Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 2	Uncertain significance(Last reviewed: Aug 20, 2021)	criteria provided, single submitter	VCV001387778	7	26236409	7	26196789	1387778	1374399		NC_000007.14:26196788:T:C
NM_002137.4(HNRNPA2B1):c.621C>T (p.Phe207=)	HNRNPA2B1		Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 2	Likely benign(Last reviewed: Mar 23, 2021)	criteria provided, single submitter	VCV001368974	7	26236058	7	26196438	1368974	1417864		NC_000007.14:26196437:G:A
NM_002137.4(HNRNPA2B1):c.475+6T>A	HNRNPA2B1		Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 2	Uncertain significance(Last reviewed: Nov 4, 2021)	criteria provided, single submitter	VCV001349339	7	26236421	7	26196801	1349339	1479350		NC_000007.14:26196800:A:T
NM_002137.4(HNRNPA2B1):c.7-143del	HNRNPA2B1		Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 2	Benign(Last reviewed: Jun 1, 2020)	criteria provided, single submitter	VCV001170361	7	26237495	7	26197875	1170361	1155684		NC_000007.14:26197874:AAAAAAAAAA:AAAAAAAAA
NM_002137.4(HNRNPA2B1):c.852A>G (p.Gly284=)	HNRNPA2B1		Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 2	Likely benign(Last reviewed: Sep 15, 2020)	criteria provided, single submitter	VCV001161696	7	26232983	7	26193363	1161696	1138705		NC_000007.14:26193362:T:C
NM_002137.4(HNRNPA2B1):c.189T>C (p.Val63=)	HNRNPA2B1		Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 2	Likely benign(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV001155590	7	26237010	7	26197390	1155590	1138709		NC_000007.14:26197389:A:G
NM_002137.4(HNRNPA2B1):c.255A>T (p.Val85=)	HNRNPA2B1		Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 2	Likely benign(Last reviewed: Apr 23, 2019)	criteria provided, single submitter	VCV001150367	7	26236944	7	26197324	1150367	1138708		NC_000007.14:26197323:T:A
NM_002137.4(HNRNPA2B1):c.659-5A>G	HNRNPA2B1		Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 2	Likely benign(Last reviewed: Sep 15, 2020)	criteria provided, single submitter	VCV001144709	7	26235534	7	26195914	1144709	1138706		NC_000007.14:26195913:T:C
NM_002137.4(HNRNPA2B1):c.577+9A>C	HNRNPA2B1		Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 2	Likely benign(Last reviewed: Oct 21, 2019)	criteria provided, single submitter	VCV001143376	7	26236168	7	26196548	1143376	1138707		NC_000007.14:26196547:T:G
NM_002137.4(HNRNPA2B1):c.7-8C>T	HNRNPA2B1		Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 2	Likely benign(Last reviewed: Nov 17, 2020)	criteria provided, single submitter	VCV001140282	7	26237360	7	26197740	1140282	1117805		NC_000007.14:26197739:G:A
NM_002137.4(HNRNPA2B1):c.659-9C>T	HNRNPA2B1		Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 2	Likely benign(Last reviewed: Oct 9, 2020)	criteria provided, single submitter	VCV001135005	7	26235538	7	26195918	1135005	1117802		NC_000007.14:26195917:G:A
NM_002137.4(HNRNPA2B1):c.738T>C (p.Gly246=)	HNRNPA2B1		Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 2	Likely benign(Last reviewed: Jul 22, 2020)	criteria provided, single submitter	VCV001132450	7	26233298	7	26193678	1132450	1117801		NC_000007.14:26193677:A:G
NM_002137.4(HNRNPA2B1):c.265-7A>G	HNRNPA2B1		Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 2	Likely benign(Last reviewed: Nov 19, 2020)	criteria provided, single submitter	VCV001130792	7	26236644	7	26197024	1130792	1117803		NC_000007.14:26197023:T:C
NM_002137.4(HNRNPA2B1):c.240G>A (p.Glu80=)	HNRNPA2B1		Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 2	Likely benign(Last reviewed: Jan 11, 2020)	criteria provided, single submitter	VCV001123541	7	26236959	7	26197339	1123541	1117804		NC_000007.14:26197338:C:T
NM_002137.4(HNRNPA2B1):c.842-8T>C	HNRNPA2B1		Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 2	Likely benign(Last reviewed: Jan 8, 2020)	criteria provided, single submitter	VCV001119401	7	26233001	7	26193381	1119401	1096266		NC_000007.14:26193380:A:G
NM_002137.4(HNRNPA2B1):c.528G>A (p.Leu176=)	HNRNPA2B1		Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 2	Likely benign(Last reviewed: Feb 5, 2019)	criteria provided, single submitter	VCV001119002	7	26236226	7	26196606	1119002	1096267		NC_000007.14:26196605:C:T
NM_002137.4(HNRNPA2B1):c.475+7G>A	HNRNPA2B1		Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 2	Likely benign(Last reviewed: Jun 7, 2019)	criteria provided, single submitter	VCV001105386	7	26236420	7	26196800	1105386	1096268		NC_000007.14:26196799:C:T
NM_002137.4(HNRNPA2B1):c.45C>T (p.Gly15=)	HNRNPA2B1		Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 2	Likely benign(Last reviewed: Jun 22, 2020)	criteria provided, single submitter	VCV001097353	7	26237314	7	26197694	1097353	1074636		NC_000007.14:26197693:G:A
NM_002137.4(HNRNPA2B1):c.601C>T (p.Arg201Cys)	HNRNPA2B1	R201C, R213C	Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 2	Uncertain significance(Last reviewed: Feb 10, 2020)	criteria provided, single submitter	VCV001060923	7	26236078	7	26196458	1060923	1044909		NC_000007.14:26196457:G:A
NM_002137.4(HNRNPA2B1):c.505A>G (p.Asn169Asp)	HNRNPA2B1	N169D, N181D	Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 2	Uncertain significance(Last reviewed: Mar 8, 2020)	criteria provided, single submitter	VCV001021688	7	26236249	7	26196629	1021688	1007421	rs1353165662	NC_000007.14:26196628:T:C
NM_002137.4(HNRNPA2B1):c.14A>G (p.Lys5Arg)	HNRNPA2B1	K17R, K5R	Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 2	Uncertain significance(Last reviewed: Jul 31, 2020)	criteria provided, single submitter	VCV001010666	7	26237345	7	26197725	1010666	992287	rs751281272	NC_000007.14:26197724:T:C
NM_002137.4(HNRNPA2B1):c.657T>A (p.Ser219=)	HNRNPA2B1		Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 2	Uncertain significance(Last reviewed: Oct 31, 2019)	criteria provided, single submitter	VCV000967904	7	26236022	7	26196402	967904	955136	rs370050080	NC_000007.14:26196401:A:T
NM_002137.4(HNRNPA2B1):c.964+5T>G	HNRNPA2B1		Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 2	Uncertain significance(Last reviewed: Aug 16, 2020)	criteria provided, single submitter	VCV000858196	7	26232866	7	26193246	858196	852084	rs878989290	NC_000007.14:26193245:A:C
NC_000007.14:g.(?_26200562)_(26200587_?)dup	HNRNPA2B1		Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 2	Uncertain significance(Last reviewed: Nov 26, 2019)	criteria provided, single submitter	VCV000830531	7	26240182 - 26240207			830531	819866		
NM_002137.4(HNRNPA2B1):c.928GGT[1] (p.Gly311del)	HNRNPA2B1	G311del, G323del	Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 2|not provided	Uncertain significance(Last reviewed: Aug 26, 2020)	criteria provided, multiple submitters, no conflicts	VCV000810077	7	26232902 - 26232904	7	26193282 - 26193284	810077	796027	rs776731510	NC_000007.14:26193281:ACCACCA:ACCA
NM_002137.4(HNRNPA2B1):c.330T>C (p.Asp110=)	HNRNPA2B1		Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 2	Likely benign(Last reviewed: Jul 30, 2020)	criteria provided, single submitter	VCV000772754	7	26236572	7	26196952	772754	700021	rs191937523	NC_000007.14:26196951:A:G
NM_002137.4(HNRNPA2B1):c.147A>G (p.Ser49=)	HNRNPA2B1		Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 2	Likely benign(Last reviewed: Aug 22, 2019)	criteria provided, single submitter	VCV000763430	7	26237052	7	26197432	763430	766244	rs773260084	NC_000007.14:26197431:T:C
NM_002137.4(HNRNPA2B1):c.658+9C>T	HNRNPA2B1		Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 2|not provided	Likely benign(Last reviewed: Nov 13, 2018)	criteria provided, single submitter	VCV000758964	7	26236012	7	26196392	758964	775308	rs760373015	NC_000007.14:26196391:G:A
NM_002137.4(HNRNPA2B1):c.842-11dup	HNRNPA2B1		Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 2|not provided	Benign(Last reviewed: Aug 20, 2018)	criteria provided, single submitter	VCV000750886	7	26232998 - 26232999	7	26193378 - 26193379	750886	775372	rs1465279377	NC_000007.14:26193378:AAAAAA:AAAAAAA
NM_002137.4(HNRNPA2B1):c.7-143T>C	HNRNPA2B1		Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 2	Likely benign(Last reviewed: Dec 31, 2019)	criteria provided, single submitter	VCV000733173	7	26237495	7	26197875	733173	744331	rs773972068	NC_000007.14:26197874:A:G
NM_002137.4(HNRNPA2B1):c.246A>G (p.Lys82=)	HNRNPA2B1		Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 2|not provided	Likely benign(Last reviewed: Mar 3, 2020)	criteria provided, single submitter	VCV000706799	7	26236953	7	26197333	706799	692221	rs1428232126	NC_000007.14:26197332:T:C
NM_002137.4(HNRNPA2B1):c.984C>A (p.Gly328=)	HNRNPA2B1		Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 2|not provided	Likely benign(Last reviewed: May 12, 2020)	criteria provided, single submitter	VCV000705959	7	26232178	7	26192558	705959	692218	rs768943063	NC_000007.14:26192557:G:T
NM_002137.4(HNRNPA2B1):c.243A>G (p.Pro81=)	HNRNPA2B1		Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 2	Benign(Last reviewed: Sep 15, 2020)	criteria provided, single submitter	VCV000704997	7	26236956	7	26197336	704997	692222	rs143134057	NC_000007.14:26197335:T:C
NM_002137.4(HNRNPA2B1):c.964+10A>G	HNRNPA2B1		not provided|Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 2	Benign(Last reviewed: Oct 14, 2020)	criteria provided, single submitter	VCV000704601	7	26232861	7	26193241	704601	695361	rs181705411	NC_000007.14:26193240:T:C
NM_002137.4(HNRNPA2B1):c.610G>A (p.Gly204Ser)	HNRNPA2B1	G204S, G216S	Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 2	Likely benign(Last reviewed: Dec 3, 2020)	criteria provided, single submitter	VCV000704292	7	26236069	7	26196449	704292	692220	rs200929422	NC_000007.14:26196448:C:T
NM_002137.4(HNRNPA2B1):c.756A>C (p.Gly252=)	HNRNPA2B1		not provided|Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 2	Benign/Likely benign(Last reviewed: Dec 18, 2020)	criteria provided, multiple submitters, no conflicts	VCV000704090	7	26233280	7	26193660	704090	692219	rs199909637	NC_000007.14:26193659:T:G
NM_002137.4(HNRNPA2B1):c.659-7C>G	HNRNPA2B1		Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 2|not provided	Benign(Last reviewed: Jun 30, 2021)	criteria provided, multiple submitters, no conflicts	VCV000703967	7	26235536	7	26195916	703967	695362	rs199606705	NC_000007.14:26195915:G:C
NM_002137.4(HNRNPA2B1):c.657T>C (p.Ser219=)	HNRNPA2B1		Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 2	Uncertain significance(Last reviewed: Nov 27, 2018)	criteria provided, single submitter	VCV000662036	7	26236022	7	26196402	662036	636094	rs370050080	NC_000007.14:26196401:A:G
NM_002137.4(HNRNPA2B1):c.476-3C>T	HNRNPA2B1		Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 2	Uncertain significance(Last reviewed: Aug 20, 2018)	criteria provided, single submitter	VCV000659107	7	26236281	7	26196661	659107	651731	rs370807816	NC_000007.14:26196660:G:A
NM_002137.4(HNRNPA2B1):c.578-10T>C	HNRNPA2B1		Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 2	Uncertain significance(Last reviewed: Mar 7, 2020)	criteria provided, single submitter	VCV000646482	7	26236111	7	26196491	646482	651725	rs199915606	NC_000007.14:26196490:A:G
NM_002137.4(HNRNPA2B1):c.659-4A>G	HNRNPA2B1		Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 2	Uncertain significance(Last reviewed: May 8, 2018)	criteria provided, single submitter	VCV000571200	7	26235533	7	26195913	571200	564276	rs1562711082	NC_000007.14:26195912:T:C
NM_002137.4(HNRNPA2B1):c.288T>C (p.His96=)	HNRNPA2B1		Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 2|not provided	Benign(Last reviewed: Nov 11, 2020)	criteria provided, multiple submitters, no conflicts	VCV000541430	7	26236614	7	26196994	541430	523021	rs142061533	NC_000007.14:26196993:A:G
NM_002137.4(HNRNPA2B1):c.841+6A>G	HNRNPA2B1		Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 2|not provided	Benign(Last reviewed: Nov 21, 2020)	criteria provided, multiple submitters, no conflicts	VCV000541429	7	26233189	7	26193569	541429	523261	rs144309126	NC_000007.14:26193568:T:C
NM_002137.4(HNRNPA2B1):c.633A>G (p.Pro211=)	HNRNPA2B1		Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 2	Likely benign(Last reviewed: Oct 26, 2017)	criteria provided, single submitter	VCV000541428	7	26236046	7	26196426	541428	523264	rs752086550	NC_000007.14:26196425:T:C
NM_002137.4(HNRNPA2B1):c.984_992del (p.329_331SGG[1])	HNRNPA2B1		Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 2	Uncertain significance(Last reviewed: Sep 17, 2017)	criteria provided, single submitter	VCV000541427	7	26232170 - 26232178	7	26192550 - 26192558	541427	522884	rs754021381	NC_000007.14:26192549:CCTCCACTGCCTCC:CCTCC
NM_002137.4(HNRNPA2B1):c.669C>T (p.Gly223=)	HNRNPA2B1		Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 2	Uncertain significance(Last reviewed: Nov 28, 2017)	criteria provided, single submitter	VCV000541426	7	26235519	7	26195899	541426	522885	rs767263210	NC_000007.14:26195898:G:A
NM_002137.4(HNRNPA2B1):c.797A>G (p.Asn266Ser)	HNRNPA2B1	N278S, N266S	not provided|Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 2	Uncertain significance(Last reviewed: Feb 18, 2021)	criteria provided, multiple submitters, no conflicts	VCV000474504	7	26233239	7	26193619	474504	457114	rs1554331125	NC_000007.14:26193618:T:C
NM_002137.4(HNRNPA2B1):c.744C>T (p.Pro248=)	HNRNPA2B1		Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 2	Likely benign(Last reviewed: Nov 10, 2020)	criteria provided, single submitter	VCV000474503	7	26233292	7	26193672	474503	457301	rs141885504	NC_000007.14:26193671:G:A
NM_002137.4(HNRNPA2B1):c.721+10C>T	HNRNPA2B1		not provided|Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 2	Likely benign(Last reviewed: Jun 9, 2018)	criteria provided, single submitter	VCV000474502	7	26235457	7	26195837	474502	457124	rs768374617	NC_000007.14:26195836:G:A
NM_002137.4(HNRNPA2B1):c.33C>G (p.Leu11=)	HNRNPA2B1		Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 2	Likely benign(Last reviewed: Aug 9, 2017)	criteria provided, single submitter	VCV000474501	7	26237326	7	26197706	474501	457125	rs774999756	NC_000007.14:26197705:G:C
NM_002137.4(HNRNPA2B1):c.315C>T (p.Gly105=)	HNRNPA2B1		Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 2	Likely benign(Last reviewed: Mar 12, 2020)	criteria provided, single submitter	VCV000474500	7	26236587	7	26196967	474500	456681	rs766409233	NC_000007.14:26196966:G:A
NM_002137.4(HNRNPA2B1):c.645T>C (p.Phe215=)	HNRNPA2B1		Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 2|not provided|not specified	Benign(Last reviewed: Nov 30, 2020)	criteria provided, multiple submitters, no conflicts	VCV000261955	7	26236034	7	26196414	261955	252783	rs117082250	NC_000007.14:26196413:A:G
NM_002137.4(HNRNPA2B1):c.519A>G (p.Arg173=)	HNRNPA2B1		not specified|not provided|Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 2	Benign(Last reviewed: Dec 3, 2020)	criteria provided, multiple submitters, no conflicts	VCV000261954	7	26236235	7	26196615	261954	252784	rs34317198	NC_000007.14:26196614:T:C
NM_002137.4(HNRNPA2B1):c.117+4T>C	HNRNPA2B1		Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 2|not provided|not specified	Benign(Last reviewed: Nov 25, 2020)	criteria provided, multiple submitters, no conflicts	VCV000261953	7	26237238	7	26197618	261953	252785	rs41275982	NC_000007.14:26197617:A:G
NM_002137.4(HNRNPA2B1):c.869A>T (p.Asp290Val)	HNRNPA2B1	D290V, D302V	Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 2	Pathogenic(Last reviewed: Mar 28, 2013)	no assertion criteria provided	VCV000065454	7	26232966	7	26193346	65454	76371	rs397515326	NC_000007.14:26193345:T:A
NM_004134.7(HSPA9):c.1426G>A (p.Ala476Thr)	HSPA9	A476T	Anemia, sideroblastic, 4|not provided	Uncertain significance(Last reviewed: Nov 3, 2021)	criteria provided, single submitter	VCV000430651	5	137894331	5	138558642	430651	424181	rs145860531	NC_000005.10:138558641:C:T
NM_013247.5(HTRA2):c.77G>A (p.Gly26Glu)	HTRA2	G26E	Parkinson disease 13	Uncertain significance(Last reviewed: Apr 28, 2017)	criteria provided, single submitter	VCV000898769	2	74757210	2	74530083	898769	885479	rs145946172	NC_000002.12:74530082:G:A
NM_013247.5(HTRA2):c.*267C>T	HTRA2|LOXL3		Parkinson disease 13	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000897673	2	74760379	2	74533252	897673	885484	rs184230827	NC_000002.12:74533251:C:T
NM_145074.2(HTRA2):c.-136C>T	HTRA2		Parkinson disease 13	Uncertain significance(Last reviewed: Jan 19, 2018)	criteria provided, single submitter	VCV000897610	2	74756998	2	74529871	897610	885478	rs886056343	NC_000002.12:74529870:C:T
NM_013247.5(HTRA2):c.*265C>T	HTRA2|LOXL3		Parkinson disease 13	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000896084	2	74760377	2	74533250	896084	885483	rs1016550488	NC_000002.12:74533249:C:T
NM_013247.5(HTRA2):c.1079G>A (p.Arg360His)	HTRA2	R295H, R360H, R370H	Parkinson disease 13	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000896083	2	74759016	2	74531889	896083	885482	rs1475151932	NC_000002.12:74531888:G:A
NM_013247.5(HTRA2):c.1056C>T (p.Ser352=)	HTRA2		not provided|Parkinson disease 13	Conflicting interpretations of pathogenicity(Last reviewed: Oct 20, 2021)	criteria provided, conflicting interpretations	VCV000895799	2	74758993	2	74531866	895799	885481	rs781540048	NC_000002.12:74531865:C:T
NM_013247.5(HTRA2):c.1046-5C>G	HTRA2		Parkinson disease 13	Likely benign(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000895798	2	74758978	2	74531851	895798	887401	rs374529449	NC_000002.12:74531850:C:G
NM_013247.5(HTRA2):c.937C>T (p.Leu313=)	HTRA2		Parkinson disease 13	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000895797	2	74758496	2	74531369	895797	885480	rs766035905	NC_000002.12:74531368:C:T
NM_013247.5(HTRA2):c.510C>T (p.His170=)	HTRA2		not provided|Parkinson disease 13	Likely benign(Last reviewed: Jul 13, 2018)	criteria provided, multiple submitters, no conflicts	VCV000741628	2	74757747	2	74530620	741628	747788	rs200747610	NC_000002.12:74530619:C:T
NM_013247.5(HTRA2):c.354G>A (p.Leu118=)	HTRA2		Parkinson disease 13|not provided	Likely benign(Last reviewed: Oct 1, 2021)	criteria provided, multiple submitters, no conflicts	VCV000727861	2	74757487	2	74530360	727861	733580	rs199735424	NC_000002.12:74530359:G:A
NM_032603.5(LOXL3):c.*84C>T	HTRA2|LOXL3		Parkinson disease 13	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000337146	2	74760649	2	74533522	337146	290952	rs886056349	NC_000002.12:74533521:G:A
NM_032603.5(LOXL3):c.*90T>C	HTRA2|LOXL3		Parkinson disease 13	Benign(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000337145	2	74760643	2	74533516	337145	290732	rs114661282	NC_000002.12:74533515:A:G
NM_032603.5(LOXL3):c.*237G>T	HTRA2|LOXL3		Parkinson disease 13	Benign(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000337142	2	74760496	2	74533369	337142	290720	rs71640295	NC_000002.12:74533368:C:A
NM_013247.5(HTRA2):c.*291G>A	HTRA2|LOXL3		Parkinson disease 13	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000337141	2	74760403	2	74533276	337141	287311	rs886056347	NC_000002.12:74533275:G:A
NM_013247.5(HTRA2):c.*249G>C	HTRA2|LOXL3		Parkinson disease 13	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000337140	2	74760361	2	74533234	337140	290718	rs775428682	NC_000002.12:74533233:G:C
NM_013247.5(HTRA2):c.*94C>T	HTRA2|LOXL3		Parkinson disease 13|not provided	Benign(Last reviewed: Jul 15, 2018)	criteria provided, multiple submitters, no conflicts	VCV000337139	2	74760206	2	74533079	337139	288038	rs79220020	NC_000002.12:74533078:C:T
NM_013247.5(HTRA2):c.1346C>T (p.Thr449Ile)	HTRA2|LOXL3	T449I, T427I, T352I, T417I	Parkinson disease 13|not provided	Uncertain significance(Last reviewed: Aug 26, 2021)	criteria provided, multiple submitters, no conflicts	VCV000337138	2	74760081	2	74532954	337138	290950	rs886056346	NC_000002.12:74532953:C:T
NM_013247.5(HTRA2):c.1155C>T (p.Pro385=)	HTRA2|LOXL3		Parkinson disease 13|not provided	Likely benign(Last reviewed: Dec 31, 2019)	criteria provided, multiple submitters, no conflicts	VCV000337137	2	74759785	2	74532658	337137	290715	rs150357486	NC_000002.12:74532657:C:T
NM_013247.5(HTRA2):c.1131A>G (p.Leu377=)	HTRA2|LOXL3		Parkinson disease 13|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Dec 5, 2020)	criteria provided, conflicting interpretations	VCV000337136	2	74759761	2	74532634	337136	290714	rs758108369	NC_000002.12:74532633:A:G
NM_013247.5(HTRA2):c.1046-13C>T	HTRA2		Parkinson disease 13|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Sep 7, 2021)	criteria provided, conflicting interpretations	VCV000337135	2	74758970	2	74531843	337135	287303	rs542851656	NC_000002.12:74531842:C:T
NM_013247.5(HTRA2):c.873T>C (p.Asn291=)	HTRA2		Parkinson disease 13	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000337134	2	74758199	2	74531072	337134	287302	rs775948550	NC_000002.12:74531071:T:C
NM_013247.5(HTRA2):c.825T>C (p.Val275=)	HTRA2		Parkinson disease 13|not provided	Uncertain significance(Last reviewed: Sep 7, 2021)	criteria provided, multiple submitters, no conflicts	VCV000337133	2	74758151	2	74531024	337133	290711	rs777650346	NC_000002.12:74531023:T:C
NM_013247.5(HTRA2):c.627A>G (p.Arg209=)	HTRA2		Parkinson disease 13|not provided	Likely benign(Last reviewed: Apr 17, 2021)	criteria provided, multiple submitters, no conflicts	VCV000337132	2	74757864	2	74530737	337132	288035	rs149169879	NC_000002.12:74530736:A:G
NM_013247.5(HTRA2):c.507-9C>A	HTRA2		Parkinson disease 13	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000337131	2	74757735	2	74530608	337131	290709	rs151291127	NC_000002.12:74530607:C:A
NM_013247.5(HTRA2):c.507-10T>A	HTRA2		Parkinson disease 13	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000337130	2	74757734	2	74530607	337130	290701	rs747756166	NC_000002.12:74530606:T:A
NM_013247.5(HTRA2):c.480C>G (p.Ala160=)	HTRA2		Parkinson disease 13|not provided	Benign(Last reviewed: Nov 20, 2020)	criteria provided, multiple submitters, no conflicts	VCV000337129	2	74757613	2	74530486	337129	290947	rs2231248	NC_000002.12:74530485:C:G
NM_013247.5(HTRA2):c.241G>A (p.Ala81Thr)	HTRA2	A81T	Parkinson disease 13	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000337128	2	74757374	2	74530247	337128	287301	rs886056345	NC_000002.12:74530246:G:A
NM_013247.5(HTRA2):c.215T>C (p.Leu72Pro)	HTRA2	L72P	Parkinson disease 13|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Dec 7, 2020)	criteria provided, conflicting interpretations	VCV000337127	2	74757348	2	74530221	337127	288021	rs150047108	NC_000002.12:74530220:T:C
NM_145074.2(HTRA2):c.-86G>C	HTRA2		Parkinson disease 13	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000337126	2	74757048	2	74529921	337126	290700	rs886056344	NC_000002.12:74529920:G:C
NM_145074.2(HTRA2):c.-136C>G	HTRA2		Parkinson disease 13	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000337125	2	74756998	2	74529871	337125	290668	rs886056343	NC_000002.12:74529870:C:G
NM_145074.2(HTRA2):c.-146G>A	HTRA2		Parkinson disease 13	Benign(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000337124	2	74756988	2	74529861	337124	288016	rs569404179	NC_000002.12:74529860:G:A
NM_145074.2(HTRA2):c.-216G>A	HTRA2		Parkinson disease 13	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000337123	2	74756918	2	74529791	337123	290946	rs886056342	NC_000002.12:74529790:G:A
NM_145074.2(HTRA2):c.-236G>C	HTRA2		Parkinson disease 13	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000337122	2	74756898	2	74529771	337122	287298	rs886056341	NC_000002.12:74529770:G:C
NM_181575.5(AUP1):c.-19C>T	HTRA2|AUP1		Parkinson disease 13	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000337120	2	74756775	2	74529648	337120	288014	rs886056340	NC_000002.12:74529647:G:A
NM_181575.5(AUP1):c.-15C>T	HTRA2|AUP1		Parkinson disease 13	Likely benign(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000337119	2	74756771	2	74529644	337119	290667	rs371791263	NC_000002.12:74529643:G:A
NM_013247.5(HTRA2):c.427C>G (p.Pro143Ala)	HTRA2	P143A	Parkinson disease 13	risk factor(Last reviewed: Dec 1, 2011)	no assertion criteria provided	VCV000030583	2	74757560	2	74530433	30583	39540	rs387906942	NC_000002.12:74530432:C:G
NM_013247.5(HTRA2):c.421G>T (p.Ala141Ser)	HTRA2	A141S	not provided|Parkinson disease 13	Benign(Last reviewed: Dec 7, 2020)	criteria provided, multiple submitters, no conflicts	VCV000004342	2	74757554	2	74530427	4342	19381	rs72470544	NC_000002.12:74530426:G:T
NM_013247.5(HTRA2):c.1195G>A (p.Gly399Ser)	HTRA2|LOXL3	G399S	not provided|Parkinson disease 13	Benign/Likely benign(Last reviewed: Dec 7, 2020)	criteria provided, multiple submitters, no conflicts	VCV000004341	2	74759825	2	74532698	4341	19380	rs72470545	NC_000002.12:74532697:G:A
NM_000202.8(IDS):c.238C>T (p.Gln80Ter)	IDS	Q80*	Mucopolysaccharidosis, MPS-II	Pathogenic(Last reviewed: Sep 5, 2021)	criteria provided, multiple submitters, no conflicts	VCV000633269	X	148585689	X	149504159	633269	621680	rs1569560527	NC_000023.11:149504158:G:A
NM_000202.8(IDS):c.262C>T (p.Arg88Cys)	IDS	R88C	Mucopolysaccharidosis, MPS-II|not provided	Pathogenic(Last reviewed: Feb 23, 2022)	criteria provided, multiple submitters, no conflicts	VCV000092618	X	148584998	X	149503468	92618	98526	rs398123249	NC_000023.11:149503467:G:A
NC_000011.9:g.(?_2181023)_(2193087_?)del	INS|INS-IGF2|TH		Autosomal recessive DOPA responsive dystonia	Pathogenic(Last reviewed: Oct 5, 2021)	criteria provided, single submitter	VCV001457228	11	2181023 - 2193087			1457228	1477963		
NM_002230.4(JUP):c.251G>A (p.Arg84Gln)	JUP	R84Q	not provided|Wolff-Parkinson-White pattern|Arrhythmogenic right ventricular cardiomyopathy, type 12|Naxos disease	Uncertain significance(Last reviewed: Oct 3, 2020)	criteria provided, multiple submitters, no conflicts	VCV000487584	17	39925887	17	41769635	487584	480722	rs782061304	NC_000017.11:41769634:C:T
NM_002230.4(JUP):c.578T>C (p.Met193Thr)	JUP	M193T	Wolff-Parkinson-White pattern|Naxos disease|Arrhythmogenic right ventricular cardiomyopathy, type 12|not provided|Primary dilated cardiomyopathy	Uncertain significance(Last reviewed: Oct 19, 2020)	criteria provided, multiple submitters, no conflicts	VCV000222661	17	39925350	17	41769098	222661	224519	rs139496777	NC_000017.11:41769097:A:G
NM_002230.4(JUP):c.773A>G (p.Glu258Gly)	JUP	E258G	Wolff-Parkinson-White pattern|not provided	Uncertain significance(Last reviewed: Nov 17, 2021)	criteria provided, single submitter	VCV000201830	17	39923767	17	41767515	201830	198498	rs794729052	NC_000017.11:41767514:T:C
NM_000238.4(KCNH2):c.2046G>C (p.Glu682Asp)	KCNH2	E342D, E682D	not provided|Cardiac arrhythmia|Wolff-Parkinson-White pattern	Uncertain significance(Last reviewed: Nov 25, 2020)	criteria provided, multiple submitters, no conflicts	VCV000487626	7	150648108	7	150951020	487626	480695	rs1338579153	NC_000007.14:150951019:C:G
NM_000238.4(KCNH2):c.1225G>A (p.Val409Met)	KCNH2	V69M, V409M	Long QT syndrome|Wolff-Parkinson-White pattern|Cardiac arrhythmia	Uncertain significance(Last reviewed: Oct 27, 2020)	criteria provided, multiple submitters, no conflicts	VCV000456884	7	150649845	7	150952757	456884	457546	rs539146547	NC_000007.14:150952756:C:T
NM_000891.3(KCNJ2):c.49G>A (p.Asp17Asn)	KCNJ2	D17N	Wolff-Parkinson-White pattern	Uncertain significance(Last reviewed: Jul 14, 2017)	no assertion criteria provided	VCV000487624	17	68171229	17	70175088	487624	480723	rs1331601602	NC_000017.11:70175087:G:A
NM_000218.3(KCNQ1):c.1621G>A (p.Val541Ile)	KCNQ1	V541I, V414I	Congenital long QT syndrome|Long QT syndrome|not provided|Wolff-Parkinson-White pattern|not specified|Long QT syndrome 1|Cardiac arrhythmia	Conflicting interpretations of pathogenicity(Last reviewed: Nov 25, 2020)	criteria provided, conflicting interpretations	VCV000067043	11	2797220	11	2775990	67043	77939	rs199472796	NC_000011.10:2775989:G:A
NM_000218.3(KCNQ1):c.724G>A (p.Asp242Asn)	KCNQ1	D242N, D115N	Wolff-Parkinson-White pattern|Congenital long QT syndrome|Long QT syndrome|not provided	Pathogenic(Last reviewed: Jul 8, 2020)	criteria provided, multiple submitters, no conflicts	VCV000053090	11	2593283	11	2572053	53090	67758	rs199472712	NC_000011.10:2572052:G:A
NM_000218.3(KCNQ1):c.1189C>T (p.Arg397Trp)	KCNQ1	R397W, R270W	Long QT syndrome 1|Jervell and Lange-Nielsen syndrome|not specified|Wolff-Parkinson-White pattern|not provided|Familial atrial fibrillation|Cardiovascular phenotype|Cardiac arrhythmia|Congenital long QT syndrome|Long QT syndrome|short QT syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Apr 29, 2021)	criteria provided, conflicting interpretations	VCV000052970	11	2608860	11	2587630	52970	67638	rs199472776	NC_000011.10:2587629:C:T
NM_001105206.3(LAMA4):c.1420G>T (p.Val474Phe)	LAMA4	V467F, V474F	Wolff-Parkinson-White pattern	Uncertain significance(Last reviewed: Jul 14, 2017)	no assertion criteria provided	VCV000487609	6	112493944	6	112172742	487609	480690	rs375981026	NC_000006.12:112172741:C:A
NM_001105206.3(LAMA4):c.2398C>T (p.Arg800Cys)	LAMA4	R793C, R800C	Wolff-Parkinson-White pattern|Dilated cardiomyopathy 1JJ|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Jul 22, 2021)	criteria provided, conflicting interpretations	VCV000192119	6	112466091	6	112144889	192119	189798	rs202184174	NC_000006.12:112144888:G:A
NM_002293.4(LAMC1):c.3304C>T (p.Arg1102Cys)	LAMC1	R1102C	Wolff-Parkinson-White pattern	Uncertain significance(Last reviewed: Jul 14, 2017)	no assertion criteria provided	VCV000487617	1	183099502	1	183130367	487617	480670	rs142883085	NC_000001.11:183130366:C:T
NM_002294.3(LAMP2):c.718C>T (p.Gln240Ter)	LAMP2	Q240*	not provided|Danon disease	Pathogenic(Last reviewed: Sep 27, 2017)	criteria provided, single submitter	VCV000488987	X	119581719	X	120447864	488987	482232	rs1556101420	NC_000023.11:120447863:G:A
NM_002294.3(LAMP2):c.1075C>T (p.Gln359Ter)	LAMP2	Q359*	Danon disease|not provided	Likely pathogenic(Last reviewed: Aug 19, 2016)	criteria provided, single submitter	VCV000372712	X	119575603	X	120441748	372712	360562	rs1057517940	NC_000023.11:120441747:G:A
NM_002294.3(LAMP2):c.293G>A (p.Trp98Ter)	LAMP2	W98*	Danon disease|not provided	Pathogenic(Last reviewed: Aug 28, 2021)	criteria provided, multiple submitters, no conflicts	VCV000044423	X	119589316	X	120455461	44423	53590	rs397516740	NC_000023.11:120455460:C:T
NM_002294.3(LAMP2):c.520C>T (p.Gln174Ter)	LAMP2	Q174*	Danon disease	Pathogenic(Last reviewed: Aug 17, 2017)	criteria provided, single submitter	VCV000009981	X	119582861	X	120449006	9981	25020	rs104894857	NC_000023.11:120449005:G:A
NM_007078.3(LDB3):c.2017G>A (p.Asp673Asn)	LDB3	D626N, D673N, D678N, D610N, D563N	Dilated cardiomyopathy 1C|Myofibrillar myopathy, ZASP-related|Left ventricular noncompaction 3|not provided	Uncertain significance(Last reviewed: Dec 30, 2020)	criteria provided, multiple submitters, no conflicts	VCV000004735	10	88485932	10	86726175	4735	19774	rs45514002	NC_000010.11:86726174:G:A
NM_170707.4(LMNA):c.1756G>A (p.Val586Met)	LMNA	V474M, V556M, V586M	not specified|Benign scapuloperoneal muscular dystrophy with cardiomyopathy|Heart-hand syndrome, Slovenian type|Hutchinson-Gilford syndrome|Dilated cardiomyopathy-hypergonadotropic hypogonadism syndrome|Dilated cardiomyopathy 1A|Mandibuloacral dysplasia with type A lipodystrophy|Charcot-Marie-Tooth disease type 2B1|Familial partial lipodystrophy 2|Lethal tight skin contracture syndrome|Congenital muscular dystrophy, LMNA-related|Emery-Dreifuss muscular dystrophy 3, autosomal recessive|Charcot-Marie-Tooth disease, type 2|not provided|Wolff-Parkinson-White pattern	Uncertain significance(Last reviewed: Jul 20, 2020)	criteria provided, multiple submitters, no conflicts	VCV000487635	1	156108336	1	156138545	487635	480668	rs758048062	NC_000001.11:156138544:G:A
NC_000006.11:g.(?_161768590)_(162475206_?)dup	LOC105378098|LOC121132714|LOC123881358|PRKN		Parkinson disease 2	Uncertain significance(Last reviewed: Aug 5, 2016)	criteria provided, single submitter	VCV000417462	6	161768590 - 162475206	6	161347558 - 162054174	417462	394996		
NM_000157.4(GBA):c.1440G>C (p.Lys480Asn)	LOC106627981|GBA	K480N, K431N, K393N	Parkinson disease, late-onset	Uncertain significance(Last reviewed: Sep 8, 2015)	no assertion criteria provided	VCV000209103	1	155205051	1	155235260	209103	205699	rs1057519356	NC_000001.11:155235259:C:G
NG_008165.1:g.12526CAR[(46_?)]	LOC108663996|TBP		Parkinson disease, late-onset|Spinocerebellar ataxia type 17	Pathogenic; risk factor(Last reviewed: Dec 1, 2004)	no assertion criteria provided	VCV000562072			6	170561908	562072	553248		
NM_002471.4(MYH6):c.635C>T (p.Ala212Val)	LOC114827851|MYH6	A212V	Cardiovascular phenotype|Familial hypertrophic cardiomyopathy 14|not specified	Conflicting interpretations of pathogenicity(Last reviewed: Aug 2, 2019)	criteria provided, conflicting interpretations	VCV000519020	14	23873927	14	23404718	519020	510455	rs780456381	NC_000014.9:23404717:G:A
NM_002471.4(MYH6):c.292G>A (p.Glu98Lys)	LOC114827851|MYH6	E98K	not provided|Familial hypertrophic cardiomyopathy 1|Familial hypertrophic cardiomyopathy 14|Atrial septal defect 3|Sick sinus syndrome 3, susceptibility to|Dilated cardiomyopathy 1EE|not specified|Familial hypertrophic cardiomyopathy 14|Cardiovascular phenotype|Cardiomyopathy|Familial hypertrophic cardiomyopathy 1	Conflicting interpretations of pathogenicity(Last reviewed: Sep 24, 2020)	criteria provided, conflicting interpretations	VCV000044474	14	23874889	14	23405680	44474	53641	rs140596256	NC_000014.9:23405679:C:T
NM_032603.5(LOXL3):c.*108A>T	LOXL3|HTRA2		Parkinson disease 13	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000337144	2	74760625	2	74533498	337144	290951	rs886056348	NC_000002.12:74533497:T:A
NM_032603.5(LOXL3):c.*178A>T	LOXL3|HTRA2		Parkinson disease 13	Benign(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000337143	2	74760555	2	74533428	337143	290725	rs71640296	NC_000002.12:74533427:T:A
NM_198578.4(LRRK2):c.319A>G (p.Asn107Asp)	LRRK2	N107D	Parkinson disease 8, autosomal dominant	Likely benign(Last reviewed: Sep 25, 2021)	criteria provided, single submitter	VCV001673293	12	40626157	12	40232355	1673293	1595480		NC_000012.12:40232354:A:G
NM_198578.4(LRRK2):c.2689+12A>G	LRRK2		Parkinson disease 8, autosomal dominant	Likely benign(Last reviewed: May 7, 2021)	criteria provided, single submitter	VCV001671257	12	40681353	12	40287551	1671257	1530147		NC_000012.12:40287550:A:G
NM_198578.4(LRRK2):c.2191T>C (p.Leu731=)	LRRK2		Parkinson disease 8, autosomal dominant	Likely benign(Last reviewed: Aug 23, 2021)	criteria provided, single submitter	VCV001671237	12	40672013	12	40278211	1671237	1530127		NC_000012.12:40278210:T:C
NM_198578.4(LRRK2):c.5217C>T (p.Tyr1739=)	LRRK2		Parkinson disease 8, autosomal dominant	Likely benign(Last reviewed: Sep 8, 2021)	criteria provided, single submitter	VCV001665094	12	40715883	12	40322081	1665094	1620963		NC_000012.12:40322080:C:T
NM_198578.4(LRRK2):c.2878+14T>C	LRRK2		Parkinson disease 8, autosomal dominant	Likely benign(Last reviewed: Oct 8, 2021)	criteria provided, single submitter	VCV001663302	12	40688730	12	40294928	1663302	1619611		NC_000012.12:40294927:T:C
NM_198578.4(LRRK2):c.2382G>T (p.Leu794=)	LRRK2		Parkinson disease 8, autosomal dominant	Likely benign(Last reviewed: Nov 24, 2021)	criteria provided, single submitter	VCV001659351	12	40677817	12	40284015	1659351	1543080		NC_000012.12:40284014:G:T
NM_198578.4(LRRK2):c.3741A>G (p.Val1247=)	LRRK2		Parkinson disease 8, autosomal dominant	Likely benign(Last reviewed: Jul 4, 2021)	criteria provided, single submitter	VCV001658253	12	40697900	12	40304098	1658253	1594254		NC_000012.12:40304097:A:G
NM_198578.4(LRRK2):c.2809-19A>G	LRRK2		Parkinson disease 8, autosomal dominant	Likely benign(Last reviewed: Sep 29, 2021)	criteria provided, single submitter	VCV001647739	12	40688628	12	40294826	1647739	1566467		NC_000012.12:40294825:A:G
NM_198578.4(LRRK2):c.5385G>A (p.Leu1795=)	LRRK2		Parkinson disease 8, autosomal dominant	Benign(Last reviewed: Oct 5, 2021)	criteria provided, single submitter	VCV001646231	12	40716188	12	40322386	1646231	1533801		NC_000012.12:40322385:G:A
NM_198578.4(LRRK2):c.2879-9del	LRRK2		Parkinson disease 8, autosomal dominant	Benign(Last reviewed: Dec 2, 2021)	criteria provided, single submitter	VCV001645846	12	40689216	12	40295414	1645846	1565450		NC_000012.12:40295413:TTTTT:TTTT
NM_198578.4(LRRK2):c.5691C>T (p.Ala1897=)	LRRK2		Parkinson disease 8, autosomal dominant	Likely benign(Last reviewed: Apr 30, 2021)	criteria provided, single submitter	VCV001642845	12	40722196	12	40328394	1642845	1521337		NC_000012.12:40328393:C:T
NM_198578.4(LRRK2):c.6109+19C>T	LRRK2		Parkinson disease 8, autosomal dominant	Likely benign(Last reviewed: Oct 6, 2021)	criteria provided, single submitter	VCV001640588	12	40734275	12	40340473	1640588	1539871		NC_000012.12:40340472:C:T
NM_198578.4(LRRK2):c.66G>A (p.Arg22=)	LRRK2		Parkinson disease 8, autosomal dominant	Likely benign(Last reviewed: Jun 20, 2021)	criteria provided, single submitter	VCV001629454	12	40618999	12	40225197	1629454	1532238		NC_000012.12:40225196:G:A
NM_198578.4(LRRK2):c.4831T>C (p.Leu1611=)	LRRK2		Parkinson disease 8, autosomal dominant	Likely benign(Last reviewed: Jul 19, 2021)	criteria provided, single submitter	VCV001627924	12	40713793	12	40319991	1627924	1531141		NC_000012.12:40319990:T:C
NM_198578.4(LRRK2):c.3906G>A (p.Leu1302=)	LRRK2		Parkinson disease 8, autosomal dominant	Likely benign(Last reviewed: Aug 3, 2021)	criteria provided, single submitter	VCV001627372	12	40699715	12	40305913	1627372	1616397		NC_000012.12:40305912:G:A
NM_198578.4(LRRK2):c.7462+15G>C	LRRK2		Parkinson disease 8, autosomal dominant	Benign(Last reviewed: Sep 4, 2021)	criteria provided, single submitter	VCV001626315	12	40760894	12	40367092	1626315	1583320		NC_000012.12:40367091:G:C
NM_198578.4(LRRK2):c.5657-9T>C	LRRK2		Parkinson disease 8, autosomal dominant	Likely benign(Last reviewed: Aug 11, 2021)	criteria provided, single submitter	VCV001623117	12	40722153	12	40328351	1623117	1627743		NC_000012.12:40328350:T:C
NM_198578.4(LRRK2):c.45T>C (p.Thr15=)	LRRK2		Parkinson disease 8, autosomal dominant	Likely benign(Last reviewed: Sep 24, 2021)	criteria provided, single submitter	VCV001622963	12	40618978	12	40225176	1622963	1627589		NC_000012.12:40225175:T:C
NM_198578.4(LRRK2):c.5166G>A (p.Gly1722=)	LRRK2		Parkinson disease 8, autosomal dominant	Likely benign(Last reviewed: Sep 14, 2021)	criteria provided, single submitter	VCV001622565	12	40714986	12	40321184	1622565	1561411		NC_000012.12:40321183:G:A
NM_198578.4(LRRK2):c.2689+17A>G	LRRK2		Parkinson disease 8, autosomal dominant	Likely benign(Last reviewed: Apr 13, 2021)	criteria provided, single submitter	VCV001621981	12	40681358	12	40287556	1621981	1593184		NC_000012.12:40287555:A:G
NM_198578.4(LRRK2):c.2690-14C>A	LRRK2		Parkinson disease 8, autosomal dominant	Likely benign(Last reviewed: Oct 18, 2021)	criteria provided, single submitter	VCV001621382	12	40687333	12	40293531	1621382	1615629		NC_000012.12:40293530:C:A
NM_198578.4(LRRK2):c.151+19A>G	LRRK2		Parkinson disease 8, autosomal dominant	Likely benign(Last reviewed: Sep 15, 2021)	criteria provided, single submitter	VCV001621333	12	40619103	12	40225301	1621333	1615580		NC_000012.12:40225300:A:G
NM_198578.4(LRRK2):c.2697A>C (p.Glu899Asp)	LRRK2	E899D	Parkinson disease 8, autosomal dominant	Likely benign(Last reviewed: Dec 10, 2021)	criteria provided, single submitter	VCV001620419	12	40687354	12	40293552	1620419	1581245		NC_000012.12:40293551:A:C
NM_198578.4(LRRK2):c.3435A>G (p.Ser1145=)	LRRK2		Parkinson disease 8, autosomal dominant	Likely benign(Last reviewed: Aug 26, 2021)	criteria provided, single submitter	VCV001618722	12	40692998	12	40299196	1618722	1580855		NC_000012.12:40299195:A:G
NM_198578.4(LRRK2):c.5949-2490G>A	LRRK2		Parkinson disease 8, autosomal dominant	Benign(Last reviewed: Dec 10, 2021)	criteria provided, single submitter	VCV001616783	12	40731606	12	40337804	1616783	1579786		NC_000012.12:40337803:G:A
NM_198578.4(LRRK2):c.3028T>C (p.Leu1010=)	LRRK2		Parkinson disease 8, autosomal dominant	Likely benign(Last reviewed: Oct 17, 2021)	criteria provided, single submitter	VCV001616565	12	40689378	12	40295576	1616565	1526755		NC_000012.12:40295575:T:C
NM_198578.4(LRRK2):c.4447C>A (p.Arg1483=)	LRRK2		Parkinson disease 8, autosomal dominant	Likely benign(Last reviewed: Oct 18, 2021)	criteria provided, single submitter	VCV001610720	12	40704362	12	40310560	1610720	1585538		NC_000012.12:40310559:C:A
NM_198578.4(LRRK2):c.2689+19_2689+20dup	LRRK2		Parkinson disease 8, autosomal dominant	Benign(Last reviewed: Oct 14, 2021)	criteria provided, single submitter	VCV001610647	12	40681352 - 40681353	12	40287550 - 40287551	1610647	1585465		NC_000012.12:40287550:AAAAAAAAA:AAAAAAAAAAA
NM_198578.4(LRRK2):c.4828-11G>A	LRRK2		Parkinson disease 8, autosomal dominant	Likely benign(Last reviewed: Oct 7, 2021)	criteria provided, single submitter	VCV001603043	12	40713779	12	40319977	1603043	1611382		NC_000012.12:40319976:G:A
NM_198578.4(LRRK2):c.4077A>G (p.Lys1359=)	LRRK2		Parkinson disease 8, autosomal dominant	Likely benign(Last reviewed: Oct 17, 2021)	criteria provided, single submitter	VCV001601933	12	40702386	12	40308584	1601933	1633059		NC_000012.12:40308583:A:G
NM_198578.4(LRRK2):c.436+15T>C	LRRK2		Parkinson disease 8, autosomal dominant	Likely benign(Last reviewed: Dec 8, 2021)	criteria provided, single submitter	VCV001601840	12	40629531	12	40235729	1601840	1523783		NC_000012.12:40235728:T:C
NM_198578.4(LRRK2):c.1802-11del	LRRK2		Parkinson disease 8, autosomal dominant	Benign(Last reviewed: Nov 16, 2021)	criteria provided, single submitter	VCV001600630	12	40668637	12	40274835	1600630	1546057		NC_000012.12:40274834:TTTTTTTTT:TTTTTTTT
NM_198578.4(LRRK2):c.834A>G (p.Thr278=)	LRRK2		Parkinson disease 8, autosomal dominant	Benign(Last reviewed: May 19, 2021)	criteria provided, single submitter	VCV001599852	12	40637479	12	40243677	1599852	1662025		NC_000012.12:40243676:A:G
NM_198578.4(LRRK2):c.5178A>G (p.Ala1726=)	LRRK2		Parkinson disease 8, autosomal dominant	Likely benign(Last reviewed: Jul 22, 2021)	criteria provided, single submitter	VCV001595646	12	40715844	12	40322042	1595646	1656636		NC_000012.12:40322041:A:G
NM_198578.4(LRRK2):c.5015+13T>A	LRRK2		Parkinson disease 8, autosomal dominant	Benign(Last reviewed: Nov 19, 2021)	criteria provided, single submitter	VCV001592399	12	40713990	12	40320188	1592399	1556447		NC_000012.12:40320187:T:A
NM_198578.4(LRRK2):c.4473C>T (p.Thr1491=)	LRRK2		Parkinson disease 8, autosomal dominant	Likely benign(Last reviewed: Aug 7, 2021)	criteria provided, single submitter	VCV001591992	12	40704388	12	40310586	1591992	1643455		NC_000012.12:40310585:C:T
NM_198578.4(LRRK2):c.1092G>A (p.Lys364=)	LRRK2		Parkinson disease 8, autosomal dominant	Likely benign(Last reviewed: Oct 28, 2021)	criteria provided, single submitter	VCV001590745	12	40645167	12	40251365	1590745	1555224		NC_000012.12:40251364:G:A
NM_198578.4(LRRK2):c.707-14C>T	LRRK2		Parkinson disease 8, autosomal dominant	Likely benign(Last reviewed: Aug 14, 2021)	criteria provided, single submitter	VCV001590173	12	40637338	12	40243536	1590173	1576718		NC_000012.12:40243535:C:T
NM_198578.4(LRRK2):c.6012A>G (p.Thr2004=)	LRRK2		Parkinson disease 8, autosomal dominant	Likely benign(Last reviewed: Jun 20, 2021)	criteria provided, single submitter	VCV001589895	12	40734159	12	40340357	1589895	1576441		NC_000012.12:40340356:A:G
NM_198578.4(LRRK2):c.347+11T>C	LRRK2		Parkinson disease 8, autosomal dominant	Likely benign(Last reviewed: Oct 7, 2021)	criteria provided, single submitter	VCV001589168	12	40626196	12	40232394	1589168	1554076		NC_000012.12:40232393:T:C
NM_198578.4(LRRK2):c.5163A>C (p.Ser1721=)	LRRK2		Parkinson disease 8, autosomal dominant	Likely benign(Last reviewed: Dec 8, 2021)	criteria provided, single submitter	VCV001584314	12	40714983	12	40321181	1584314	1591951		NC_000012.12:40321180:A:C
NM_198578.4(LRRK2):c.3867G>A (p.Gly1289=)	LRRK2		Parkinson disease 8, autosomal dominant	Likely benign(Last reviewed: Sep 21, 2021)	criteria provided, single submitter	VCV001581851	12	40699676	12	40305874	1581851	1600410		NC_000012.12:40305873:G:A
NM_198578.4(LRRK2):c.4845G>A (p.Val1615=)	LRRK2		Parkinson disease 8, autosomal dominant	Likely benign(Last reviewed: Jul 29, 2021)	criteria provided, single submitter	VCV001581038	12	40713807	12	40320005	1581038	1566165		NC_000012.12:40320004:G:A
NM_198578.4(LRRK2):c.2501-13C>T	LRRK2		Parkinson disease 8, autosomal dominant	Likely benign(Last reviewed: Sep 26, 2021)	criteria provided, single submitter	VCV001580292	12	40681140	12	40287338	1580292	1653115		NC_000012.12:40287337:C:T
NM_198578.4(LRRK2):c.5454T>C (p.Asp1818=)	LRRK2		Parkinson disease 8, autosomal dominant	Likely benign(Last reviewed: Nov 29, 2021)	criteria provided, single submitter	VCV001575832	12	40716257	12	40322455	1575832	1551860		NC_000012.12:40322454:T:C
NM_198578.4(LRRK2):c.4101C>T (p.Ala1367=)	LRRK2		Parkinson disease 8, autosomal dominant	Likely benign(Last reviewed: Aug 10, 2021)	criteria provided, single submitter	VCV001575111	12	40702410	12	40308608	1575111	1638396		NC_000012.12:40308607:C:T
NM_198578.4(LRRK2):c.3497-8dup	LRRK2		Parkinson disease 8, autosomal dominant	Benign(Last reviewed: Oct 29, 2021)	criteria provided, single submitter	VCV001573823	12	40696575 - 40696576	12	40302773 - 40302774	1573823	1539027		NC_000012.12:40302773:TTTTTTTT:TTTTTTTTT
NM_198578.4(LRRK2):c.3348-20A>T	LRRK2		Parkinson disease 8, autosomal dominant	Likely benign(Last reviewed: Aug 19, 2021)	criteria provided, single submitter	VCV001572754	12	40692891	12	40299089	1572754	1658373		NC_000012.12:40299088:A:T
NM_198578.4(LRRK2):c.2689+12A>T	LRRK2		Parkinson disease 8, autosomal dominant	Likely benign(Last reviewed: Oct 14, 2021)	criteria provided, single submitter	VCV001565573	12	40681353	12	40287551	1565573	1590163		NC_000012.12:40287550:A:T
NM_198578.4(LRRK2):c.1299A>G (p.Arg433=)	LRRK2		Parkinson disease 8, autosomal dominant	Likely benign(Last reviewed: Dec 2, 2021)	criteria provided, single submitter	VCV001564858	12	40651060	12	40257258	1564858	1567812		NC_000012.12:40257257:A:G
NM_198578.4(LRRK2):c.2880G>A (p.Arg960=)	LRRK2		Parkinson disease 8, autosomal dominant	Likely benign(Last reviewed: Nov 26, 2021)	criteria provided, single submitter	VCV001564505	12	40689230	12	40295428	1564505	1654874		NC_000012.12:40295427:G:A
NM_198578.4(LRRK2):c.4401T>C (p.Ser1467=)	LRRK2		Parkinson disease 8, autosomal dominant	Likely benign(Last reviewed: Nov 24, 2021)	criteria provided, single submitter	VCV001562934	12	40704316	12	40310514	1562934	1643345		NC_000012.12:40310513:T:C
NM_198578.4(LRRK2):c.2874A>T (p.Ser958=)	LRRK2		Parkinson disease 8, autosomal dominant	Likely benign(Last reviewed: Jun 21, 2021)	criteria provided, single submitter	VCV001553757	12	40688712	12	40294910	1553757	1521937		NC_000012.12:40294909:A:T
NM_198578.4(LRRK2):c.6702G>A (p.Lys2234=)	LRRK2		Parkinson disease 8, autosomal dominant	Likely benign(Last reviewed: Jun 14, 2021)	criteria provided, single submitter	VCV001546186	12	40748226	12	40354424	1546186	1526036		NC_000012.12:40354423:G:A
NM_198578.4(LRRK2):c.2229T>G (p.Ser743=)	LRRK2		Parkinson disease 8, autosomal dominant	Likely benign(Last reviewed: May 8, 2021)	criteria provided, single submitter	VCV001545347	12	40672051	12	40278249	1545347	1559068		NC_000012.12:40278248:T:G
NM_198578.4(LRRK2):c.201C>T (p.Val67=)	LRRK2		Parkinson disease 8, autosomal dominant	Likely benign(Last reviewed: May 8, 2021)	criteria provided, single submitter	VCV001543027	12	40619406	12	40225604	1543027	1523302		NC_000012.12:40225603:C:T
NM_198578.4(LRRK2):c.237+20T>A	LRRK2		Parkinson disease 8, autosomal dominant	Likely benign(Last reviewed: Nov 5, 2021)	criteria provided, single submitter	VCV001542328	12	40619462	12	40225660	1542328	1609865		NC_000012.12:40225659:T:A
NM_198578.4(LRRK2):c.5170+14_5170+28del	LRRK2		Parkinson disease 8, autosomal dominant	Likely benign(Last reviewed: Nov 18, 2021)	criteria provided, single submitter	VCV001541790	12	40715002 - 40715016	12	40321200 - 40321214	1541790	1631673		NC_000012.12:40321199:ATGAAGACTTATTAGAT:AT
NM_198578.4(LRRK2):c.1891C>T (p.Leu631=)	LRRK2		Parkinson disease 8, autosomal dominant	Likely benign(Last reviewed: Aug 7, 2021)	criteria provided, single submitter	VCV001540914	12	40668745	12	40274943	1540914	1609316		NC_000012.12:40274942:C:T
NM_198578.4(LRRK2):c.5948+8G>C	LRRK2		Parkinson disease 8, autosomal dominant	Likely benign(Last reviewed: Dec 11, 2021)	criteria provided, single submitter	VCV001535918	12	40728967	12	40335165	1535918	1648622		NC_000012.12:40335164:G:C
NM_198578.4(LRRK2):c.4189+14T>C	LRRK2		Parkinson disease 8, autosomal dominant	Likely benign(Last reviewed: Aug 13, 2021)	criteria provided, single submitter	VCV001533270	12	40702512	12	40308710	1533270	1530410		NC_000012.12:40308709:T:C
NM_198578.4(LRRK2):c.707-13T>C	LRRK2		Parkinson disease 8, autosomal dominant	Likely benign(Last reviewed: Nov 8, 2021)	criteria provided, single submitter	VCV001532339	12	40637339	12	40243537	1532339	1635950		NC_000012.12:40243536:T:C
NM_198578.4(LRRK2):c.2809-18T>C	LRRK2		Parkinson disease 8, autosomal dominant	Likely benign(Last reviewed: Nov 17, 2021)	criteria provided, single submitter	VCV001529649	12	40688629	12	40294827	1529649	1604363		NC_000012.12:40294826:T:C
NM_198578.4(LRRK2):c.2906G>A (p.Arg969Lys)	LRRK2	R969K	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Sep 1, 2021)	criteria provided, single submitter	VCV001523683	12	40689256	12	40295454	1523683	1346979		NC_000012.12:40295453:G:A
NM_198578.4(LRRK2):c.4536+20G>A	LRRK2		Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Dec 13, 2021)	criteria provided, single submitter	VCV001520030	12	40704471	12	40310669	1520030	1516026		NC_000012.12:40310668:G:A
NM_198578.4(LRRK2):c.5182C>T (p.Arg1728Cys)	LRRK2	R1728C	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Sep 24, 2021)	criteria provided, single submitter	VCV001516364	12	40715848	12	40322046	1516364	1499018		NC_000012.12:40322045:C:T
NM_198578.4(LRRK2):c.5684G>A (p.Arg1895Gln)	LRRK2	R1895Q	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Aug 24, 2021)	criteria provided, single submitter	VCV001516242	12	40722189	12	40328387	1516242	1498896		NC_000012.12:40328386:G:A
NM_198578.4(LRRK2):c.3443T>C (p.Phe1148Ser)	LRRK2	F1148S	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Aug 27, 2021)	criteria provided, single submitter	VCV001515850	12	40693006	12	40299204	1515850	1407128		NC_000012.12:40299203:T:C
NM_198578.4(LRRK2):c.959-5T>C	LRRK2		Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Oct 15, 2021)	criteria provided, single submitter	VCV001513173	12	40645029	12	40251227	1513173	1472228		NC_000012.12:40251226:T:C
NM_198578.4(LRRK2):c.3368G>T (p.Cys1123Phe)	LRRK2	C1123F	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Sep 24, 2021)	criteria provided, single submitter	VCV001509829	12	40692931	12	40299129	1509829	1445748		NC_000012.12:40299128:G:T
NM_198578.4(LRRK2):c.2200G>A (p.Asp734Asn)	LRRK2	D734N	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Oct 11, 2021)	criteria provided, single submitter	VCV001506447	12	40672022	12	40278220	1506447	1430372		NC_000012.12:40278219:G:A
NM_198578.4(LRRK2):c.5509G>A (p.Gly1837Arg)	LRRK2	G1837R	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Sep 17, 2021)	criteria provided, single submitter	VCV001504124	12	40716312	12	40322510	1504124	1337000		NC_000012.12:40322509:G:A
NM_198578.4(LRRK2):c.4821G>A (p.Met1607Ile)	LRRK2	M1607I	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Oct 14, 2021)	criteria provided, single submitter	VCV001502737	12	40709096	12	40315294	1502737	1404331		NC_000012.12:40315293:G:A
NM_198578.4(LRRK2):c.570A>T (p.Arg190Ser)	LRRK2	R190S	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Aug 25, 2021)	criteria provided, single submitter	VCV001501799	12	40631904	12	40238102	1501799	1398667		NC_000012.12:40238101:A:T
NM_198578.4(LRRK2):c.2653A>G (p.Ser885Gly)	LRRK2	S885G	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Aug 28, 2021)	criteria provided, single submitter	VCV001499536	12	40681305	12	40287503	1499536	1389239		NC_000012.12:40287502:A:G
NM_198578.4(LRRK2):c.572-14C>T	LRRK2		Parkinson disease 8, autosomal dominant	Likely benign(Last reviewed: Sep 25, 2021)	criteria provided, single submitter	VCV001497845	12	40634271	12	40240469	1497845	1376365		NC_000012.12:40240468:C:T
NM_198578.4(LRRK2):c.1324C>T (p.His442Tyr)	LRRK2	H442Y	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Oct 14, 2021)	criteria provided, single submitter	VCV001493722	12	40651085	12	40257283	1493722	1449225		NC_000012.12:40257282:C:T
NM_198578.4(LRRK2):c.6806A>G (p.Asp2269Gly)	LRRK2	D2269G	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Sep 29, 2021)	criteria provided, single submitter	VCV001492559	12	40749952	12	40356150	1492559	1516697		NC_000012.12:40356149:A:G
NM_198578.4(LRRK2):c.1477C>T (p.Arg493Cys)	LRRK2	R493C	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Sep 17, 2021)	criteria provided, single submitter	VCV001492558	12	40653340	12	40259538	1492558	1516696		NC_000012.12:40259537:C:T
NM_198578.4(LRRK2):c.4391C>G (p.Ala1464Gly)	LRRK2	A1464G	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Dec 3, 2021)	criteria provided, single submitter	VCV001491788	12	40704306	12	40310504	1491788	1342825		NC_000012.12:40310503:C:G
NM_198578.4(LRRK2):c.1874A>G (p.His625Arg)	LRRK2	H625R	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Sep 17, 2021)	criteria provided, single submitter	VCV001490259	12	40668728	12	40274926	1490259	1433328		NC_000012.12:40274925:A:G
NM_198578.4(LRRK2):c.7366A>G (p.Arg2456Gly)	LRRK2	R2456G	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Aug 14, 2021)	criteria provided, single submitter	VCV001488301	12	40758828	12	40365026	1488301	1505009		NC_000012.12:40365025:A:G
NM_198578.4(LRRK2):c.212A>G (p.Tyr71Cys)	LRRK2	Y71C	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Oct 28, 2021)	criteria provided, single submitter	VCV001487608	12	40619417	12	40225615	1487608	1481642		NC_000012.12:40225614:A:G
NM_198578.4(LRRK2):c.350T>G (p.Leu117Trp)	LRRK2	L117W	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Sep 1, 2021)	criteria provided, single submitter	VCV001485185	12	40629430	12	40235628	1485185	1393911		NC_000012.12:40235627:T:G
NM_198578.4(LRRK2):c.851A>G (p.Asn284Ser)	LRRK2	N284S	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Aug 2, 2021)	criteria provided, single submitter	VCV001483305	12	40643640	12	40249838	1483305	1380424		NC_000012.12:40249837:A:G
NM_198578.4(LRRK2):c.7382C>T (p.Ala2461Val)	LRRK2	A2461V	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Aug 31, 2021)	criteria provided, single submitter	VCV001482826	12	40758844	12	40365042	1482826	1464809		NC_000012.12:40365041:C:T
NM_198578.4(LRRK2):c.7146A>C (p.Lys2382Asn)	LRRK2	K2382N	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Sep 9, 2021)	criteria provided, single submitter	VCV001475709	12	40757321	12	40363519	1475709	1400740		NC_000012.12:40363518:A:C
NM_198578.4(LRRK2):c.1015G>C (p.Asp339His)	LRRK2	D339H	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Oct 27, 2021)	criteria provided, single submitter	VCV001474746	12	40645090	12	40251288	1474746	1503833		NC_000012.12:40251287:G:C
NM_198578.4(LRRK2):c.93_94del (p.Gln31fs)	LRRK2	Q31fs	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: May 20, 2021)	criteria provided, single submitter	VCV001473783	12	40619025 - 40619026	12	40225223 - 40225224	1473783	1387779		NC_000012.12:40225222:AGA:A
NM_198578.4(LRRK2):c.2714A>T (p.Lys905Ile)	LRRK2	K905I	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Dec 17, 2021)	criteria provided, single submitter	VCV001472718	12	40687371	12	40293569	1472718	1398099		NC_000012.12:40293568:A:T
NM_198578.4(LRRK2):c.158A>G (p.Lys53Arg)	LRRK2	K53R	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Aug 27, 2021)	criteria provided, single submitter	VCV001466715	12	40619363	12	40225561	1466715	1348073		NC_000012.12:40225560:A:G
NM_198578.4(LRRK2):c.2384C>T (p.Ala795Val)	LRRK2	A795V	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Nov 24, 2021)	criteria provided, single submitter	VCV001464083	12	40677819	12	40284017	1464083	1342439		NC_000012.12:40284016:C:T
NM_198578.4(LRRK2):c.368C>T (p.Thr123Ile)	LRRK2	T123I	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Sep 24, 2021)	criteria provided, single submitter	VCV001463682	12	40629448	12	40235646	1463682	1508245		NC_000012.12:40235645:C:T
NM_198578.4(LRRK2):c.1787A>G (p.Tyr596Cys)	LRRK2	Y596C	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Aug 31, 2021)	criteria provided, single submitter	VCV001461932	12	40668515	12	40274713	1461932	1494875		NC_000012.12:40274712:A:G
NM_198578.4(LRRK2):c.5402G>T (p.Cys1801Phe)	LRRK2	C1801F	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Aug 26, 2021)	criteria provided, single submitter	VCV001447875	12	40716205	12	40322403	1447875	1403761		NC_000012.12:40322402:G:T
NM_198578.4(LRRK2):c.5817G>T (p.Gly1939=)	LRRK2		Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Oct 14, 2021)	criteria provided, single submitter	VCV001445922	12	40728828	12	40335026	1445922	1390753		NC_000012.12:40335025:G:T
NM_198578.4(LRRK2):c.539G>C (p.Gly180Ala)	LRRK2	G180A	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Oct 3, 2021)	criteria provided, single submitter	VCV001444528	12	40631873	12	40238071	1444528	1388492		NC_000012.12:40238070:G:C
NM_198578.4(LRRK2):c.1735A>G (p.Met579Val)	LRRK2	M579V	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Sep 19, 2021)	criteria provided, single submitter	VCV001443453	12	40668463	12	40274661	1443453	1384399		NC_000012.12:40274660:A:G
NM_198578.4(LRRK2):c.4046C>T (p.Thr1349Ile)	LRRK2	T1349I	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Aug 5, 2021)	criteria provided, single submitter	VCV001439705	12	40702355	12	40308553	1439705	1346233		NC_000012.12:40308552:C:T
NM_198578.4(LRRK2):c.3595C>T (p.Arg1199Trp)	LRRK2	R1199W	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Sep 17, 2021)	criteria provided, single submitter	VCV001439609	12	40697754	12	40303952	1439609	1346137		NC_000012.12:40303951:C:T
NM_198578.4(LRRK2):c.2234T>C (p.Ile745Thr)	LRRK2	I745T	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Aug 16, 2021)	criteria provided, single submitter	VCV001438711	12	40672056	12	40278254	1438711	1448437		NC_000012.12:40278253:T:C
NM_198578.4(LRRK2):c.7226C>G (p.Ser2409Cys)	LRRK2	S2409C	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Sep 17, 2021)	criteria provided, single submitter	VCV001432911	12	40758688	12	40364886	1432911	1481166		NC_000012.12:40364885:C:G
NM_198578.4(LRRK2):c.7028+2T>C	LRRK2		Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Oct 27, 2021)	criteria provided, single submitter	VCV001428944	12	40753248	12	40359446	1428944	1457908		NC_000012.12:40359445:T:C
NM_198578.4(LRRK2):c.2821G>T (p.Asp941Tyr)	LRRK2	D941Y	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Oct 31, 2021)	criteria provided, single submitter	VCV001427778	12	40688659	12	40294857	1427778	1463934		NC_000012.12:40294856:G:T
NM_198578.4(LRRK2):c.1310T>C (p.Leu437Ser)	LRRK2	L437S	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Aug 30, 2021)	criteria provided, single submitter	VCV001427431	12	40651071	12	40257269	1427431	1440966		NC_000012.12:40257268:T:C
NM_198578.4(LRRK2):c.3391C>A (p.Leu1131Met)	LRRK2	L1131M	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Aug 27, 2021)	criteria provided, single submitter	VCV001427178	12	40692954	12	40299152	1427178	1444580		NC_000012.12:40299151:C:A
NM_198578.4(LRRK2):c.1937_1940del (p.Thr646fs)	LRRK2	T646fs	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Jun 9, 2021)	criteria provided, single submitter	VCV001424812	12	40668790 - 40668793	12	40274988 - 40274991	1424812	1353319		NC_000012.12:40274987:ACTAA:A
NM_198578.4(LRRK2):c.6928A>G (p.Thr2310Ala)	LRRK2	T2310A	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Aug 27, 2021)	criteria provided, single submitter	VCV001420340	12	40753146	12	40359344	1420340	1503119		NC_000012.12:40359343:A:G
NM_198578.4(LRRK2):c.2050A>G (p.Met684Val)	LRRK2	M684V	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Nov 5, 2021)	criteria provided, single submitter	VCV001418638	12	40671798	12	40277996	1418638	1490234		NC_000012.12:40277995:A:G
NM_198578.4(LRRK2):c.531G>C (p.Gln177His)	LRRK2	Q177H	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Aug 14, 2021)	criteria provided, single submitter	VCV001417269	12	40631865	12	40238063	1417269	1377636		NC_000012.12:40238062:G:C
NM_198578.4(LRRK2):c.3347+6A>T	LRRK2		Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Aug 7, 2021)	criteria provided, single submitter	VCV001414245	12	40692301	12	40298499	1414245	1358268		NC_000012.12:40298498:A:T
NM_198578.4(LRRK2):c.334C>T (p.Leu112Phe)	LRRK2	L112F	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Nov 8, 2021)	criteria provided, single submitter	VCV001412581	12	40626172	12	40232370	1412581	1344562		NC_000012.12:40232369:C:T
NM_198578.4(LRRK2):c.868G>A (p.Glu290Lys)	LRRK2	E290K	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Sep 24, 2021)	criteria provided, single submitter	VCV001412461	12	40643657	12	40249855	1412461	1344442		NC_000012.12:40249854:G:A
NM_198578.4(LRRK2):c.5554A>G (p.Ile1852Val)	LRRK2	I1852V	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Nov 9, 2021)	criteria provided, single submitter	VCV001407912	12	40717006	12	40323204	1407912	1506790		NC_000012.12:40323203:A:G
NM_198578.4(LRRK2):c.4306T>C (p.Phe1436Leu)	LRRK2	F1436L	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Oct 6, 2021)	criteria provided, single submitter	VCV001407160	12	40703024	12	40309222	1407160	1483370		NC_000012.12:40309221:T:C
NM_198578.4(LRRK2):c.1546A>G (p.Met516Val)	LRRK2	M516V	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Sep 17, 2021)	criteria provided, single submitter	VCV001406544	12	40657593	12	40263791	1406544	1408565		NC_000012.12:40263790:A:G
NM_198578.4(LRRK2):c.3199C>A (p.Arg1067=)	LRRK2		Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Nov 13, 2021)	criteria provided, single submitter	VCV001404747	12	40692147	12	40298345	1404747	1405508		NC_000012.12:40298344:C:A
NM_198578.4(LRRK2):c.4617A>T (p.Lys1539Asn)	LRRK2	K1539N	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Nov 24, 2021)	criteria provided, single submitter	VCV001404013	12	40707854	12	40314052	1404013	1467379		NC_000012.12:40314051:A:T
NM_198578.4(LRRK2):c.5417C>T (p.Thr1806Ile)	LRRK2	T1806I	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Sep 29, 2021)	criteria provided, single submitter	VCV001401497	12	40716220	12	40322418	1401497	1379482		NC_000012.12:40322417:C:T
NM_198578.4(LRRK2):c.3999C>A (p.Asn1333Lys)	LRRK2	N1333K	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Nov 27, 2021)	criteria provided, single submitter	VCV001401162	12	40702308	12	40308506	1401162	1379150		NC_000012.12:40308505:C:A
NM_198578.4(LRRK2):c.6752A>C (p.Asn2251Thr)	LRRK2	N2251T	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Oct 14, 2021)	criteria provided, single submitter	VCV001399273	12	40748276	12	40354474	1399273	1450567		NC_000012.12:40354473:A:C
NM_198578.4(LRRK2):c.3812C>T (p.Thr1271Ile)	LRRK2	T1271I	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Aug 26, 2021)	criteria provided, single submitter	VCV001397544	12	40699621	12	40305819	1397544	1438110		NC_000012.12:40305818:C:T
NM_198578.4(LRRK2):c.137C>T (p.Thr46Met)	LRRK2	T46M	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Sep 15, 2021)	criteria provided, single submitter	VCV001397201	12	40619070	12	40225268	1397201	1437768		NC_000012.12:40225267:C:T
NM_198578.4(LRRK2):c.1910G>A (p.Arg637Gln)	LRRK2	R637Q	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Oct 9, 2021)	criteria provided, single submitter	VCV001396128	12	40668764	12	40274962	1396128	1350907		NC_000012.12:40274961:G:A
NM_198578.4(LRRK2):c.3087G>T (p.Gln1029His)	LRRK2	Q1029H	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Nov 13, 2021)	criteria provided, single submitter	VCV001392541	12	40689437	12	40295635	1392541	1502444		NC_000012.12:40295634:G:T
NM_198578.4(LRRK2):c.784A>G (p.Met262Val)	LRRK2	M262V	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Oct 19, 2021)	criteria provided, single submitter	VCV001392440	12	40637429	12	40243627	1392440	1502343		NC_000012.12:40243626:A:G
NM_198578.4(LRRK2):c.7315C>A (p.Leu2439Ile)	LRRK2	L2439I	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Aug 15, 2021)	criteria provided, single submitter	VCV001390927	12	40758777	12	40364975	1390927	1489645		NC_000012.12:40364974:C:A
NM_198578.4(LRRK2):c.1825C>G (p.Leu609Val)	LRRK2	L609V	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Sep 20, 2021)	criteria provided, single submitter	VCV001390629	12	40668679	12	40274877	1390629	1396802		NC_000012.12:40274876:C:G
NM_198578.4(LRRK2):c.4117G>A (p.Val1373Met)	LRRK2	V1373M	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Aug 7, 2021)	criteria provided, single submitter	VCV001388424	12	40702426	12	40308624	1388424	1371165		NC_000012.12:40308623:G:A
NM_198578.4(LRRK2):c.5764G>A (p.Val1922Met)	LRRK2	V1922M	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Sep 24, 2021)	criteria provided, single submitter	VCV001386749	12	40728775	12	40334973	1386749	1357876		NC_000012.12:40334972:G:A
NM_198578.4(LRRK2):c.3846A>T (p.Arg1282Ser)	LRRK2	R1282S	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Aug 26, 2021)	criteria provided, single submitter	VCV001386227	12	40699655	12	40305853	1386227	1361235		NC_000012.12:40305852:A:T
NM_198578.4(LRRK2):c.2964C>A (p.Asp988Glu)	LRRK2	D988E	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Oct 14, 2021)	criteria provided, single submitter	VCV001383393	12	40689314	12	40295512	1383393	1354534		NC_000012.12:40295511:C:A
NM_198578.4(LRRK2):c.500T>G (p.Met167Arg)	LRRK2	M167R	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Sep 24, 2021)	criteria provided, single submitter	VCV001381407	12	40631834	12	40238032	1381407	1496370		NC_000012.12:40238031:T:G
NM_198578.4(LRRK2):c.4738+3_4738+6del	LRRK2		Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Sep 11, 2021)	criteria provided, single submitter	VCV001380698	12	40707976 - 40707979	12	40314174 - 40314177	1380698	1421520		NC_000012.12:40314173:GTTTGT:GT
NM_198578.4(LRRK2):c.3946A>G (p.Lys1316Glu)	LRRK2	K1316E	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Sep 8, 2021)	criteria provided, single submitter	VCV001379965	12	40699755	12	40305953	1379965	1506014		NC_000012.12:40305952:A:G
NM_198578.4(LRRK2):c.7324C>T (p.Arg2442Cys)	LRRK2	R2442C	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Sep 1, 2021)	criteria provided, single submitter	VCV001376743	12	40758786	12	40364984	1376743	1479607		NC_000012.12:40364983:C:T
NM_198578.4(LRRK2):c.2500+5_2500+8del	LRRK2		Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Oct 14, 2021)	criteria provided, single submitter	VCV001375165	12	40677934 - 40677937	12	40284132 - 40284135	1375165	1466451		NC_000012.12:40284131:AAGTAAGTAA:AAGTAA
NM_198578.4(LRRK2):c.3823G>A (p.Val1275Ile)	LRRK2	V1275I	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Oct 2, 2021)	criteria provided, single submitter	VCV001374404	12	40699632	12	40305830	1374404	1453374		NC_000012.12:40305829:G:A
NM_198578.4(LRRK2):c.1154A>G (p.His385Arg)	LRRK2	H385R	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Oct 15, 2021)	criteria provided, single submitter	VCV001367291	12	40645319	12	40251517	1367291	1405012		NC_000012.12:40251516:A:G
NM_198578.4(LRRK2):c.2124A>T (p.Leu708Phe)	LRRK2	L708F	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Aug 14, 2021)	criteria provided, single submitter	VCV001364095	12	40671946	12	40278144	1364095	1386034		NC_000012.12:40278143:A:T
NM_198578.4(LRRK2):c.1975T>A (p.Ser659Thr)	LRRK2	S659T	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Sep 24, 2021)	criteria provided, single submitter	VCV001362742	12	40671723	12	40277921	1362742	1396062		NC_000012.12:40277920:T:A
NM_198578.4(LRRK2):c.5896C>T (p.Leu1966Phe)	LRRK2	L1966F	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Oct 23, 2021)	criteria provided, single submitter	VCV001362259	12	40728907	12	40335105	1362259	1376884		NC_000012.12:40335104:C:T
NM_198578.4(LRRK2):c.2159A>G (p.Asn720Ser)	LRRK2	N720S	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Sep 29, 2021)	criteria provided, single submitter	VCV001360689	12	40671981	12	40278179	1360689	1360255		NC_000012.12:40278178:A:G
NM_198578.4(LRRK2):c.526G>C (p.Val176Leu)	LRRK2	V176L	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Aug 7, 2021)	criteria provided, single submitter	VCV001360508	12	40631860	12	40238058	1360508	1363950		NC_000012.12:40238057:G:C
NM_198578.4(LRRK2):c.3091T>C (p.Cys1031Arg)	LRRK2	C1031R	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Aug 31, 2021)	criteria provided, single submitter	VCV001359114	12	40689441	12	40295639	1359114	1357391		NC_000012.12:40295638:T:C
NM_198578.4(LRRK2):c.3071C>T (p.Thr1024Met)	LRRK2	T1024M	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Aug 14, 2021)	criteria provided, single submitter	VCV001357646	12	40689421	12	40295619	1357646	1367543		NC_000012.12:40295618:C:T
NM_198578.4(LRRK2):c.1379_1388del (p.Glu460fs)	LRRK2	E460fs	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Sep 3, 2021)	criteria provided, single submitter	VCV001353381	12	40651131 - 40651140	12	40257329 - 40257338	1353381	1499380		NC_000012.12:40257328:AAGTGGCTGAAAGTGGCTG:AAGTGGCTG
NM_198578.4(LRRK2):c.269_280del (p.Glu90_Pro93del)	LRRK2		Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Sep 10, 2021)	criteria provided, single submitter	VCV001351737	12	40626105 - 40626116	12	40232303 - 40232314	1351737	1486125		NC_000012.12:40232302:AGAAGTCTGTCCAG:AG
NM_198578.4(LRRK2):c.4985T>C (p.Ile1662Thr)	LRRK2	I1662T	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Sep 1, 2021)	criteria provided, single submitter	VCV001351657	12	40713947	12	40320145	1351657	1486045		NC_000012.12:40320144:T:C
NM_198578.4(LRRK2):c.2204C>A (p.Ala735Asp)	LRRK2	A735D	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Aug 27, 2021)	criteria provided, single submitter	VCV001350386	12	40672026	12	40278224	1350386	1469346		NC_000012.12:40278223:C:A
NM_198578.4(LRRK2):c.6220G>A (p.Val2074Ile)	LRRK2	V2074I	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Aug 27, 2021)	criteria provided, single submitter	VCV001345066	12	40740665	12	40346863	1345066	1443032		NC_000012.12:40346862:G:A
NM_198578.4(LRRK2):c.491T>C (p.Phe164Ser)	LRRK2	F164S	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Jan 7, 2022)	criteria provided, single submitter	VCV001334457	12	40631825	12	40238023	1334457	1325352		NC_000012.12:40238022:T:C
NM_198578.4(LRRK2):c.478T>A (p.Phe160Ile)	LRRK2	F160I	Parkinson disease 8, autosomal dominant|not provided	Uncertain significance(Last reviewed: Aug 4, 2021)	criteria provided, multiple submitters, no conflicts	VCV001313483	12	40631812	12	40238010	1313483	1303744		NC_000012.12:40238009:T:A
NM_198578.4(LRRK2):c.7328G>A (p.Arg2443Gln)	LRRK2	R2443Q	Parkinson disease 8, autosomal dominant|not provided	Uncertain significance(Last reviewed: Aug 3, 2021)	criteria provided, multiple submitters, no conflicts	VCV001309739	12	40758790	12	40364988	1309739	1299114		NC_000012.12:40364987:G:A
NM_198578.4(LRRK2):c.4943A>G (p.Gln1648Arg)	LRRK2	Q1648R	not provided|Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Sep 24, 2021)	criteria provided, multiple submitters, no conflicts	VCV001306222	12	40713905	12	40320103	1306222	1297491		NC_000012.12:40320102:A:G
NM_198578.4(LRRK2):c.347A>G (p.Gln116Arg)	LRRK2	Q116R	Parkinson disease 8, autosomal dominant|not provided	Benign/Likely benign(Last reviewed: Dec 17, 2021)	criteria provided, multiple submitters, no conflicts	VCV001296540	12	40626185	12	40232383	1296540	1286332		NC_000012.12:40232382:A:G
NM_198578.4(LRRK2):c.6054C>T (p.Tyr2018=)	LRRK2		Parkinson disease 8, autosomal dominant|not specified	Benign/Likely benign(Last reviewed: Nov 24, 2021)	criteria provided, multiple submitters, no conflicts	VCV001256386	12	40734201	12	40340399	1256386	1246315		NC_000012.12:40340398:C:T
NM_198578.4(LRRK2):c.1802-11dup	LRRK2		Parkinson disease 8, autosomal dominant|not provided	Benign(Last reviewed: Dec 16, 2021)	criteria provided, multiple submitters, no conflicts	VCV001242954	12	40668636 - 40668637	12	40274834 - 40274835	1242954	1231209		NC_000012.12:40274834:TTTTTTTTT:TTTTTTTTTT
NM_198578.4(LRRK2):c.1740A>T (p.Leu580Phe)	LRRK2	L580F	Parkinson disease 8, autosomal dominant|not provided	Benign(Last reviewed: Sep 2, 2021)	criteria provided, multiple submitters, no conflicts	VCV001238571	12	40668468	12	40274666	1238571	1227699		NC_000012.12:40274665:A:T
NM_198578.4(LRRK2):c.5509+20A>C	LRRK2		not provided|Parkinson disease 8, autosomal dominant	Benign/Likely benign(Last reviewed: Dec 17, 2021)	criteria provided, multiple submitters, no conflicts	VCV001213043	12	40716332	12	40322530	1213043	1203037		NC_000012.12:40322529:A:C
NM_198578.4(LRRK2):c.4453T>G (p.Tyr1485Asp)	LRRK2	Y1485D	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Jan 11, 2021)	criteria provided, single submitter	VCV001199187	12	40704368	12	40310566	1199187	1189225		NC_000012.12:40310565:T:G
NM_198578.4(LRRK2):c.6844-9_6844-8dup	LRRK2		not provided|Parkinson disease 8, autosomal dominant	Benign/Likely benign(Last reviewed: Oct 27, 2021)	criteria provided, multiple submitters, no conflicts	VCV001198506	12	40753044 - 40753045	12	40359242 - 40359243	1198506	1187904		NC_000012.12:40359242:TTTTTTTTTT:TTTTTTTTTTTT
NM_198578.4(LRRK2):c.6844-8dup	LRRK2		not specified|Parkinson disease 8, autosomal dominant|not provided	Benign(Last reviewed: Dec 18, 2021)	criteria provided, multiple submitters, no conflicts	VCV001174992	12	40753044 - 40753045	12	40359242 - 40359243	1174992	1164417		NC_000012.12:40359242:TTTTTTTTTT:TTTTTTTTTTT
NM_198578.4(LRRK2):c.7029-9del	LRRK2		Parkinson disease 8, autosomal dominant|not specified|not provided	Benign(Last reviewed: Dec 18, 2021)	criteria provided, multiple submitters, no conflicts	VCV001174905	12	40757187	12	40363385	1174905	1164418		NC_000012.12:40363384:TTTTTTTTT:TTTTTTTT
NM_198578.4(LRRK2):c.5080C>T (p.Leu1694=)	LRRK2		Parkinson disease 8, autosomal dominant	Benign(Last reviewed: Feb 1, 2020)	criteria provided, single submitter	VCV001169460	12	40714900	12	40321098	1169460	1156982		NC_000012.12:40321097:C:T
NM_198578.4(LRRK2):c.149G>A (p.Arg50His)	LRRK2	R50H	not specified|Parkinson disease 8, autosomal dominant	Benign(Last reviewed: Dec 8, 2020)	criteria provided, single submitter	VCV001169383	12	40619082	12	40225280	1169383	1156981		NC_000012.12:40225279:G:A
NM_198578.4(LRRK2):c.7320A>G (p.Ser2440=)	LRRK2		Parkinson disease 8, autosomal dominant	Benign(Last reviewed: Aug 30, 2020)	criteria provided, single submitter	VCV001164630	12	40758782	12	40364980	1164630	1156983		NC_000012.12:40364979:A:G
NM_198578.4(LRRK2):c.3993T>G (p.Pro1331=)	LRRK2		Parkinson disease 8, autosomal dominant	Likely benign(Last reviewed: Jul 31, 2019)	criteria provided, single submitter	VCV001160689	12	40702302	12	40308500	1160689	1143453		NC_000012.12:40308499:T:G
NM_198578.4(LRRK2):c.1404T>C (p.His468=)	LRRK2		Parkinson disease 8, autosomal dominant	Likely benign(Last reviewed: Jun 18, 2019)	criteria provided, single submitter	VCV001154739	12	40651165	12	40257363	1154739	1143452		NC_000012.12:40257362:T:C
NM_198578.4(LRRK2):c.4162C>A (p.Leu1388Ile)	LRRK2	L1388I	Parkinson disease 8, autosomal dominant	Likely benign(Last reviewed: Dec 31, 2019)	criteria provided, single submitter	VCV001152814	12	40702471	12	40308669	1152814	1143454		NC_000012.12:40308668:C:A
NM_198578.4(LRRK2):c.1288+9T>A	LRRK2		Parkinson disease 8, autosomal dominant	Likely benign(Last reviewed: Oct 11, 2020)	criteria provided, single submitter	VCV001150013	12	40646827	12	40253025	1150013	1143451		NC_000012.12:40253024:T:A
NM_198578.4(LRRK2):c.6382-8T>C	LRRK2		Parkinson disease 8, autosomal dominant	Likely benign(Last reviewed: Oct 12, 2019)	criteria provided, single submitter	VCV001149733	12	40745333	12	40351531	1149733	1143455		NC_000012.12:40351530:T:C
NM_198578.4(LRRK2):c.6714A>T (p.Leu2238=)	LRRK2		Parkinson disease 8, autosomal dominant	Likely benign(Last reviewed: Mar 14, 2020)	criteria provided, single submitter	VCV001148495	12	40748238	12	40354436	1148495	1143456		NC_000012.12:40354435:A:T
NM_198578.4(LRRK2):c.5838G>A (p.Val1946=)	LRRK2		Parkinson disease 8, autosomal dominant	Likely benign(Last reviewed: Nov 14, 2019)	criteria provided, single submitter	VCV001115510	12	40728849	12	40335047	1115510	1101132		NC_000012.12:40335046:G:A
NM_198578.4(LRRK2):c.1980A>G (p.Ala660=)	LRRK2		Parkinson disease 8, autosomal dominant	Likely benign(Last reviewed: Aug 27, 2019)	criteria provided, single submitter	VCV001114859	12	40671728	12	40277926	1114859	1101131		NC_000012.12:40277925:A:G
NM_198578.4(LRRK2):c.5550T>C (p.Ile1850=)	LRRK2		Parkinson disease 8, autosomal dominant	Likely benign(Last reviewed: Aug 29, 2020)	criteria provided, single submitter	VCV001096218	12	40717002	12	40323200	1096218	1079382		NC_000012.12:40323199:T:C
NM_198578.4(LRRK2):c.4203C>T (p.Phe1401=)	LRRK2		Parkinson disease 8, autosomal dominant	Likely benign(Last reviewed: Oct 12, 2019)	criteria provided, single submitter	VCV001093539	12	40702921	12	40309119	1093539	1079381		NC_000012.12:40309118:C:T
NM_198578.4(LRRK2):c.6584_6586del (p.Ala2195del)	LRRK2	A2195del	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Sep 9, 2020)	criteria provided, single submitter	VCV001051669	12	40748106 - 40748108	12	40354304 - 40354306	1051669	1047926		NC_000012.12:40354303:TGCTG:TG
NM_198578.4(LRRK2):c.4132A>G (p.Ile1378Val)	LRRK2	I1378V	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Apr 13, 2020)	criteria provided, single submitter	VCV001045094	12	40702441	12	40308639	1045094	1030917	rs1447241100	NC_000012.12:40308638:A:G
NM_198578.4(LRRK2):c.7430G>A (p.Arg2477Gln)	LRRK2	R2477Q	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Mar 6, 2020)	criteria provided, single submitter	VCV001044075	12	40760847	12	40367045	1044075	1030918	rs146428335	NC_000012.12:40367044:G:A
NM_198578.4(LRRK2):c.7570A>G (p.Thr2524Ala)	LRRK2	T2524A	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Feb 5, 2020)	criteria provided, single submitter	VCV001043048	12	40761553	12	40367751	1043048	1030919	rs748739318	NC_000012.12:40367750:A:G
NM_198578.4(LRRK2):c.605A>G (p.Asn202Ser)	LRRK2	N202S	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Jun 30, 2020)	criteria provided, single submitter	VCV001042541	12	40634318	12	40240516	1042541	1030916	rs377550083	NC_000012.12:40240515:A:G
NM_198578.4(LRRK2):c.3184A>C (p.Asn1062His)	LRRK2	N1062H	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Jan 31, 2020)	criteria provided, single submitter	VCV001015784	12	40692132	12	40298330	1015784	1010420	rs201935017	NC_000012.12:40298329:A:C
NM_198578.4(LRRK2):c.3901G>A (p.Glu1301Lys)	LRRK2	E1301K	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: May 5, 2020)	criteria provided, single submitter	VCV001015545	12	40699710	12	40305908	1015545	1010421	rs1944805160	NC_000012.12:40305907:G:A
NM_198578.4(LRRK2):c.6589A>G (p.Ser2197Gly)	LRRK2	S2197G	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Oct 26, 2020)	criteria provided, single submitter	VCV001011348	12	40748113	12	40354311	1011348	995182	rs1946461955	NC_000012.12:40354310:A:G
NM_198578.4(LRRK2):c.4468G>A (p.Ala1490Thr)	LRRK2	A1490T	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Jan 15, 2020)	criteria provided, single submitter	VCV001007154	12	40704383	12	40310581	1007154	995181	rs201154630	NC_000012.12:40310580:G:A
NM_198578.4(LRRK2):c.1030G>A (p.Glu344Lys)	LRRK2	E344K	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Sep 9, 2019)	criteria provided, single submitter	VCV000963191	12	40645105	12	40251303	963191	948001	rs1942259532	NC_000012.12:40251302:G:A
NM_198578.4(LRRK2):c.3935G>A (p.Gly1312Glu)	LRRK2	G1312E	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Sep 2, 2019)	criteria provided, single submitter	VCV000963111	12	40699744	12	40305942	963111	948003	rs758688913	NC_000012.12:40305941:G:A
NM_198578.4(LRRK2):c.6175T>C (p.Phe2059Leu)	LRRK2	F2059L	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Aug 20, 2019)	criteria provided, single submitter	VCV000961639	12	40740620	12	40346818	961639	948004	rs528838140	NC_000012.12:40346817:T:C
NM_198578.4(LRRK2):c.1382G>T (p.Ser461Ile)	LRRK2	S461I	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Nov 4, 2019)	criteria provided, single submitter	VCV000957338	12	40651143	12	40257341	957338	948002	rs372415323	NC_000012.12:40257340:G:T
NM_198578.4(LRRK2):c.5827C>T (p.Arg1943Trp)	LRRK2	R1943W	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Sep 2, 2019)	criteria provided, single submitter	VCV000950727	12	40728838	12	40335036	950727	926615	rs756387719	NC_000012.12:40335035:C:T
NM_198578.4(LRRK2):c.1211C>T (p.Ser404Phe)	LRRK2	S404F	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Aug 4, 2019)	criteria provided, single submitter	VCV000938921	12	40646741	12	40252939	938921	936109	rs1942343374	NC_000012.12:40252938:C:T
NM_198578.4(LRRK2):c.2500+6T>C	LRRK2		Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Feb 17, 2020)	criteria provided, single submitter	VCV000937316	12	40677941	12	40284139	937316	940267	rs1943818293	NC_000012.12:40284138:T:C
NM_198578.4(LRRK2):c.6087A>G (p.Ile2029Met)	LRRK2	I2029M	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Jun 2, 2019)	criteria provided, single submitter	VCV000935665	12	40734234	12	40340432	935665	936111	rs761177119	NC_000012.12:40340431:A:G
NM_198578.4(LRRK2):c.2333G>A (p.Ser778Asn)	LRRK2	S778N	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Sep 25, 2019)	criteria provided, single submitter	VCV000934690	12	40677768	12	40283966	934690	936110	rs1356461363	NC_000012.12:40283965:G:A
NM_198578.4(LRRK2):c.7475G>T (p.Cys2492Phe)	LRRK2	C2492F	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Mar 26, 2020)	criteria provided, single submitter	VCV000931900	12	40761458	12	40367656	931900	919431	rs774904977	NC_000012.12:40367655:G:T
NM_198578.4(LRRK2):c.6448G>C (p.Val2150Leu)	LRRK2	V2150L	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Aug 12, 2019)	criteria provided, single submitter	VCV000931534	12	40745407	12	40351605	931534	919430	rs755564073	NC_000012.12:40351604:G:C
NM_198578.4(LRRK2):c.2842C>T (p.Arg948Ter)	LRRK2	R948*	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Oct 23, 2018)	criteria provided, single submitter	VCV000930929	12	40688680	12	40294878	930929	919429	rs766809708	NC_000012.12:40294877:C:T
NM_198578.4(LRRK2):c.1721del (p.Pro574fs)	LRRK2	P574fs	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Dec 19, 2019)	criteria provided, single submitter	VCV000930781	12	40668448	12	40274646	930781	919428	rs1943372260	NC_000012.12:40274645:CC:C
NM_198578.4(LRRK2):c.*1429C>G	LRRK2		Parkinson disease 8, autosomal dominant	Likely benign(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000883735	12	40762996	12	40369194	883735	869800	rs142051987	NC_000012.12:40369193:C:G
NM_198578.4(LRRK2):c.*1402G>T	LRRK2		Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000883734	12	40762969	12	40369167	883734	869799	rs201559861	NC_000012.12:40369166:G:T
NM_198578.4(LRRK2):c.*308A>C	LRRK2		Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000883687	12	40761875	12	40368073	883687	869790	rs1946932213	NC_000012.12:40368072:A:C
NM_198578.4(LRRK2):c.*277A>G	LRRK2		Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Mar 30, 2018)	criteria provided, single submitter	VCV000883686	12	40761844	12	40368042	883686	869789	rs1946931443	NC_000012.12:40368041:A:G
NM_198578.4(LRRK2):c.5799A>T (p.Ile1933=)	LRRK2		not provided|Parkinson disease 8, autosomal dominant	Conflicting interpretations of pathogenicity(Last reviewed: Apr 1, 2021)	criteria provided, conflicting interpretations	VCV000883636	12	40728810	12	40335008	883636	869782	rs139746572	NC_000012.12:40335007:A:T
NM_198578.4(LRRK2):c.3615C>G (p.Ser1205Arg)	LRRK2	S1205R	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Apr 27, 2017)	criteria provided, single submitter	VCV000883595	12	40697774	12	40303972	883595	869780	rs1944717503	NC_000012.12:40303971:C:G
NM_198578.4(LRRK2):c.1473G>T (p.Met491Ile)	LRRK2	M491I	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000883552	12	40653336	12	40259534	883552	869773	rs200955457	NC_000012.12:40259533:G:T
NM_198578.4(LRRK2):c.1260T>C (p.Asn420=)	LRRK2		Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000883551	12	40646790	12	40252988	883551	869772	rs1942345799	NC_000012.12:40252987:T:C
NM_198578.4(LRRK2):c.1224T>G (p.His408Gln)	LRRK2	H408Q	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000883550	12	40646754	12	40252952	883550	869771	rs1161551642	NC_000012.12:40252951:T:G
NM_198578.4(LRRK2):c.-91C>T	LRRK2		Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000883497	12	40618843	12	40225041	883497	869764	rs957511525	NC_000012.12:40225040:C:T
NM_198578.4(LRRK2):c.*1165C>T	LRRK2		Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Apr 20, 2018)	criteria provided, single submitter	VCV000882942	12	40762732	12	40368930	882942	869798	rs200135922	NC_000012.12:40368929:C:T
NM_198578.4(LRRK2):c.*1095C>T	LRRK2		Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Jan 17, 2018)	criteria provided, single submitter	VCV000882941	12	40762662	12	40368860	882941	869797	rs1204413722	NC_000012.12:40368859:C:T
NM_198578.4(LRRK2):c.*1042A>G	LRRK2		Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Apr 27, 2017)	criteria provided, single submitter	VCV000882940	12	40762609	12	40368807	882940	869796	rs1356131541	NC_000012.12:40368806:A:G
NM_198578.4(LRRK2):c.7573T>C (p.Ser2525Pro)	LRRK2	S2525P	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000882889	12	40761556	12	40367754	882889	869788	rs200418197	NC_000012.12:40367753:T:C
NM_198578.4(LRRK2):c.921A>G (p.Ala307=)	LRRK2		Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000882757	12	40643710	12	40249908	882757	869770	rs1942177952	NC_000012.12:40249907:A:G
NM_198578.4(LRRK2):c.839-4T>G	LRRK2		Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000882756	12	40643624	12	40249822	882756	872237	rs748213808	NC_000012.12:40249821:T:G
NM_198578.4(LRRK2):c.*942T>C	LRRK2		Parkinson disease 8, autosomal dominant	Likely benign(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000881792	12	40762509	12	40368707	881792	869795	rs182229935	NC_000012.12:40368706:T:C
NM_198578.4(LRRK2):c.*908A>C	LRRK2		Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Apr 28, 2017)	criteria provided, single submitter	VCV000881791	12	40762475	12	40368673	881791	869794	rs1946946858	NC_000012.12:40368672:A:C
NM_198578.4(LRRK2):c.*769T>G	LRRK2		Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Apr 27, 2017)	criteria provided, single submitter	VCV000881790	12	40762336	12	40368534	881790	869793	rs201106361	NC_000012.12:40368533:T:G
NM_198578.4(LRRK2):c.*751C>A	LRRK2		Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Apr 27, 2017)	criteria provided, single submitter	VCV000881789	12	40762318	12	40368516	881789	869792	rs199692050	NC_000012.12:40368515:C:A
NM_198578.4(LRRK2):c.7036T>C (p.Tyr2346His)	LRRK2	Y2346H	Parkinson disease 8, autosomal dominant	Likely benign(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000881738	12	40757211	12	40363409	881738	869787	rs138264225	NC_000012.12:40363408:T:C
NM_198578.4(LRRK2):c.6583G>T (p.Ala2195Ser)	LRRK2	A2195S	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000881737	12	40748107	12	40354305	881737	869786	rs1946461726	NC_000012.12:40354304:G:T
NM_198578.4(LRRK2):c.2864C>T (p.Ser955Leu)	LRRK2	S955L	Parkinson disease 8, autosomal dominant	Likely benign(Last reviewed: Apr 27, 2017)	criteria provided, single submitter	VCV000881647	12	40688702	12	40294900	881647	869779	rs189460764	NC_000012.12:40294899:C:T
NM_198578.4(LRRK2):c.2758G>A (p.Ala920Thr)	LRRK2	A920T	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000881646	12	40687415	12	40293613	881646	869778	rs201184634	NC_000012.12:40293612:G:A
NM_198578.4(LRRK2):c.2579G>A (p.Ser860Asn)	LRRK2	S860N	Parkinson disease 8, autosomal dominant	Likely benign(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000881645	12	40681231	12	40287429	881645	869777	rs747546304	NC_000012.12:40287428:G:A
NM_198578.4(LRRK2):c.2443C>A (p.Pro815Thr)	LRRK2	P815T	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Apr 28, 2017)	criteria provided, single submitter	VCV000881644	12	40677878	12	40284076	881644	869776	rs1484372271	NC_000012.12:40284075:C:A
NM_198578.4(LRRK2):c.606C>T (p.Asn202=)	LRRK2		Parkinson disease 8, autosomal dominant	Conflicting interpretations of pathogenicity(Last reviewed: Nov 2, 2021)	criteria provided, conflicting interpretations	VCV000881601	12	40634319	12	40240517	881601	869769	rs199854074	NC_000012.12:40240516:C:T
NM_198578.4(LRRK2):c.*497C>T	LRRK2		Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000881346	12	40762064	12	40368262	881346	869791	rs775191024	NC_000012.12:40368261:C:T
NM_198578.4(LRRK2):c.6004C>G (p.Leu2002Val)	LRRK2	L2002V	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000881285	12	40734151	12	40340349	881285	869785	rs1946002614	NC_000012.12:40340348:C:G
NM_198578.4(LRRK2):c.5982C>T (p.Asp1994=)	LRRK2		Parkinson disease 8, autosomal dominant	Likely benign(Last reviewed: Apr 27, 2017)	criteria provided, single submitter	VCV000881284	12	40734129	12	40340327	881284	869784	rs1329710738	NC_000012.12:40340326:C:T
NM_198578.4(LRRK2):c.5828G>A (p.Arg1943Gln)	LRRK2	R1943Q	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000881283	12	40728839	12	40335037	881283	869783	rs780057140	NC_000012.12:40335036:G:A
NM_198578.4(LRRK2):c.4317+3G>A	LRRK2		Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000881231	12	40703038	12	40309236	881231	872239	rs747703290	NC_000012.12:40309235:G:A
NM_198578.4(LRRK2):c.4165G>A (p.Val1389Ile)	LRRK2	V1389I	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Sep 24, 2021)	criteria provided, multiple submitters, no conflicts	VCV000881230	12	40702474	12	40308672	881230	869781	rs140743795	NC_000012.12:40308671:G:A
NM_198578.4(LRRK2):c.2282T>C (p.Leu761Ser)	LRRK2	L761S	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000881178	12	40677717	12	40283915	881178	869775	rs1276618177	NC_000012.12:40283914:T:C
NM_198578.4(LRRK2):c.1656+6T>C	LRRK2		Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000881177	12	40657709	12	40263907	881177	872238	rs1490357320	NC_000012.12:40263906:T:C
NM_198578.4(LRRK2):c.1655G>A (p.Arg552Lys)	LRRK2	R552K	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Apr 27, 2017)	criteria provided, single submitter	VCV000881176	12	40657702	12	40263900	881176	869774	rs1942888332	NC_000012.12:40263899:G:A
NM_198578.4(LRRK2):c.228T>C (p.Ser76=)	LRRK2		Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Mar 30, 2018)	criteria provided, single submitter	VCV000881131	12	40619433	12	40225631	881131	869768	rs1940834579	NC_000012.12:40225630:T:C
NM_198578.4(LRRK2):c.215T>C (p.Met72Thr)	LRRK2	M72T	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Apr 28, 2017)	criteria provided, single submitter	VCV000881130	12	40619420	12	40225618	881130	869767	rs750946093	NC_000012.12:40225617:T:C
NM_198578.4(LRRK2):c.102G>C (p.Thr34=)	LRRK2		Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000881129	12	40619035	12	40225233	881129	869766	rs1179163564	NC_000012.12:40225232:G:C
NM_198578.4(LRRK2):c.-74C>A	LRRK2		Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000881128	12	40618860	12	40225058	881128	869765	rs1422910994	NC_000012.12:40225057:C:A
NM_198578.4(LRRK2):c.620T>C (p.Ile207Thr)	LRRK2	I207T	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Jan 27, 2019)	criteria provided, single submitter	VCV000863118	12	40634333	12	40240531	863118	839882	rs1458896948	NC_000012.12:40240530:T:C
NM_198578.4(LRRK2):c.309G>C (p.Gln103His)	LRRK2	Q103H	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Nov 26, 2019)	criteria provided, single submitter	VCV000859873	12	40626147	12	40232345	859873	839880	rs200926937	NC_000012.12:40232344:G:C
NM_198578.4(LRRK2):c.2025A>G (p.Ile675Met)	LRRK2	I675M	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Feb 21, 2019)	criteria provided, single submitter	VCV000847711	12	40671773	12	40277971	847711	839883	rs201162329	NC_000012.12:40277970:A:G
NM_198578.4(LRRK2):c.2513C>A (p.Thr838Lys)	LRRK2	T838K	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Sep 5, 2019)	criteria provided, single submitter	VCV000846772	12	40681165	12	40287363	846772	839884	rs1943969628	NC_000012.12:40287362:C:A
NM_198578.4(LRRK2):c.6563G>C (p.Gly2188Ala)	LRRK2	G2188A	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Nov 22, 2019)	criteria provided, single submitter	VCV000846126	12	40745522	12	40351720	846126	839886	rs202072135	NC_000012.12:40351719:G:C
NM_198578.4(LRRK2):c.4327T>G (p.Ser1443Ala)	LRRK2	S1443A	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Jan 14, 2020)	criteria provided, single submitter	VCV000844650	12	40704242	12	40310440	844650	839885	rs763128299	NC_000012.12:40310439:T:G
NM_198578.4(LRRK2):c.382A>G (p.Ser128Gly)	LRRK2	S128G	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Jan 3, 2019)	criteria provided, single submitter	VCV000840701	12	40629462	12	40235660	840701	839881	rs187299177	NC_000012.12:40235659:A:G
NM_198578.4(LRRK2):c.825T>C (p.His275=)	LRRK2		Parkinson disease 8, autosomal dominant|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Feb 1, 2022)	criteria provided, conflicting interpretations	VCV000804996	12	40637470	12	40243668	804996	793420	rs72546315	NC_000012.12:40243667:T:C
NM_198578.4(LRRK2):c.2771G>A (p.Arg924His)	LRRK2	R924H	Parkinson disease 8, autosomal dominant|not provided	Uncertain significance(Last reviewed: Aug 31, 2021)	criteria provided, multiple submitters, no conflicts	VCV000804995	12	40687428	12	40293626	804995	793421	rs200795874	NC_000012.12:40293625:G:A
NM_198578.4(LRRK2):c.4827+6T>A	LRRK2		Parkinson disease 8, autosomal dominant|not provided	Likely benign(Last reviewed: Nov 5, 2018)	criteria provided, single submitter	VCV000800181	12	40709108	12	40315306	800181	787873	rs550610903	NC_000012.12:40315305:T:A
NM_198578.4(LRRK2):c.3496+9T>G	LRRK2		not provided|Parkinson disease 8, autosomal dominant	Benign(Last reviewed: Jun 21, 2018)	criteria provided, multiple submitters, no conflicts	VCV000767350	12	40693068	12	40299266	767350	778090	rs560559629	NC_000012.12:40299265:T:G
NM_198578.4(LRRK2):c.693C>T (p.Ser231=)	LRRK2		not provided|Parkinson disease 8, autosomal dominant	Likely benign(Last reviewed: Jul 2, 2018)	criteria provided, single submitter	VCV000766224	12	40634406	12	40240604	766224	769103	rs1592146379	NC_000012.12:40240603:C:T
NM_198578.4(LRRK2):c.4537-6T>C	LRRK2		not provided|Parkinson disease 8, autosomal dominant	Benign(Last reviewed: Jan 31, 2020)	criteria provided, single submitter	VCV000765623	12	40707768	12	40313966	765623	776033	rs779382508	NC_000012.12:40313965:T:C
NM_198578.4(LRRK2):c.5412A>G (p.Gly1804=)	LRRK2		Parkinson disease 8, autosomal dominant|not provided	Likely benign(Last reviewed: Aug 27, 2020)	criteria provided, single submitter	VCV000761200	12	40716215	12	40322413	761200	769106	rs200951081	NC_000012.12:40322412:A:G
NM_198578.4(LRRK2):c.2517A>G (p.Leu839=)	LRRK2		Parkinson disease 8, autosomal dominant	Likely benign(Last reviewed: Dec 31, 2019)	criteria provided, single submitter	VCV000752449	12	40681169	12	40287367	752449	769104	rs1592226567	NC_000012.12:40287366:A:G
NM_198578.4(LRRK2):c.114C>A (p.Ile38=)	LRRK2		Parkinson disease 8, autosomal dominant|not provided	Likely benign(Last reviewed: Feb 20, 2018)	criteria provided, single submitter	VCV000749146	12	40619047	12	40225245	749146	753349	rs1592124610	NC_000012.12:40225244:C:A
NM_198578.4(LRRK2):c.2778A>G (p.Ser926=)	LRRK2		Parkinson disease 8, autosomal dominant|not provided	Likely benign(Last reviewed: Jan 16, 2018)	criteria provided, single submitter	VCV000743537	12	40687435	12	40293633	743537	753353	rs937911118	NC_000012.12:40293632:A:G
NM_198578.4(LRRK2):c.75T>C (p.Asn25=)	LRRK2		Parkinson disease 8, autosomal dominant	Likely benign(Last reviewed: Jun 27, 2019)	criteria provided, single submitter	VCV000738486	12	40619008	12	40225206	738486	753348	rs1592124542	NC_000012.12:40225205:T:C
NM_198578.4(LRRK2):c.1182-5G>A	LRRK2		not provided|Parkinson disease 8, autosomal dominant	Likely benign(Last reviewed: Jul 16, 2021)	criteria provided, single submitter	VCV000736961	12	40646707	12	40252905	736961	760010	rs898586557	NC_000012.12:40252904:G:A
NM_198578.4(LRRK2):c.6384C>G (p.Val2128=)	LRRK2		not provided|Parkinson disease 8, autosomal dominant	Likely benign(Last reviewed: Apr 5, 2021)	criteria provided, single submitter	VCV000736126	12	40745343	12	40351541	736126	753354	rs145225800	NC_000012.12:40351540:C:G
NM_198578.4(LRRK2):c.4611G>A (p.Glu1537=)	LRRK2		Parkinson disease 8, autosomal dominant	Benign(Last reviewed: Dec 31, 2019)	criteria provided, single submitter	VCV000735024	12	40707848	12	40314046	735024	738633	rs575429866	NC_000012.12:40314045:G:A
NM_198578.4(LRRK2):c.1476A>G (p.Lys492=)	LRRK2		not provided|Parkinson disease 8, autosomal dominant	Likely benign(Last reviewed: Jan 13, 2018)	criteria provided, multiple submitters, no conflicts	VCV000722201	12	40653339	12	40259537	722201	738632	rs748115010	NC_000012.12:40259536:A:G
NM_198578.4(LRRK2):c.6900G>A (p.Leu2300=)	LRRK2		Parkinson disease 8, autosomal dominant|not provided	Likely benign(Last reviewed: Aug 10, 2018)	criteria provided, single submitter	VCV000716263	12	40753118	12	40359316	716263	725086	rs906855468	NC_000012.12:40359315:G:A
NM_198578.4(LRRK2):c.2322G>A (p.Ala774=)	LRRK2		Parkinson disease 8, autosomal dominant	Benign(Last reviewed: Nov 10, 2020)	criteria provided, single submitter	VCV000707538	12	40677757	12	40283955	707538	693198	rs146103273	NC_000012.12:40283954:G:A
NM_198578.4(LRRK2):c.5171-9A>G	LRRK2		not provided|Parkinson disease 8, autosomal dominant	Likely benign(Last reviewed: Feb 12, 2020)	criteria provided, single submitter	VCV000707077	12	40715828	12	40322026	707077	695567	rs78243554	NC_000012.12:40322025:A:G
NM_198578.4(LRRK2):c.750T>C (p.Tyr250=)	LRRK2		not provided|Parkinson disease 8, autosomal dominant	Likely benign(Last reviewed: Sep 12, 2018)	criteria provided, single submitter	VCV000706954	12	40637395	12	40243593	706954	693197	rs139971538	NC_000012.12:40243592:T:C
NM_198578.4(LRRK2):c.364C>T (p.Leu122=)	LRRK2		not provided|Parkinson disease 8, autosomal dominant	Benign/Likely benign(Last reviewed: Nov 1, 2020)	criteria provided, multiple submitters, no conflicts	VCV000706229	12	40629444	12	40235642	706229	693195	rs41286468	NC_000012.12:40235641:C:T
NM_198578.4(LRRK2):c.2594C>T (p.Ser865Phe)	LRRK2	S865F	not provided|Parkinson disease 8, autosomal dominant	Benign/Likely benign(Last reviewed: Mar 18, 2021)	criteria provided, multiple submitters, no conflicts	VCV000705830	12	40681246	12	40287444	705830	693199	rs142700458	NC_000012.12:40287443:C:T
NM_198578.4(LRRK2):c.4827+9C>A	LRRK2		not provided|Parkinson disease 8, autosomal dominant	Benign(Last reviewed: Aug 21, 2021)	criteria provided, multiple submitters, no conflicts	VCV000704499	12	40709111	12	40315309	704499	695566	rs113735323	NC_000012.12:40315308:C:A
NM_198578.4(LRRK2):c.4536+3A>G	LRRK2		Parkinson disease 8, autosomal dominant|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Aug 19, 2021)	criteria provided, conflicting interpretations	VCV000703922	12	40704454	12	40310652	703922	695565	rs41286476	NC_000012.12:40310651:A:G
NM_198578.4(LRRK2):c.699G>A (p.Ala233=)	LRRK2		Parkinson disease 8, autosomal dominant	Likely benign(Last reviewed: Nov 15, 2020)	criteria provided, single submitter	VCV000702314	12	40634412	12	40240610	702314	693196	rs577327683	NC_000012.12:40240609:G:A
NM_198578.4(LRRK2):c.6423G>A (p.Thr2141=)	LRRK2		Parkinson disease 8, autosomal dominant|not provided	Likely benign(Last reviewed: Aug 25, 2018)	criteria provided, single submitter	VCV000702228	12	40745382	12	40351580	702228	693203	rs369306296	NC_000012.12:40351579:G:A
NM_198578.4(LRRK2):c.1383T>C (p.Ser461=)	LRRK2		Parkinson disease 8, autosomal dominant|not provided	Likely benign(Last reviewed: Dec 8, 2021)	criteria provided, multiple submitters, no conflicts	VCV000695715	12	40651144	12	40257342	695715	684325	rs35847451	NC_000012.12:40257341:T:C
NM_198578.4(LRRK2):c.4881G>A (p.Ser1627=)	LRRK2		Parkinson disease 8, autosomal dominant	Likely benign(Last reviewed: Dec 31, 2019)	criteria provided, single submitter	VCV000695696	12	40713843	12	40320041	695696	684326	rs767307387	NC_000012.12:40320040:G:A
NM_198578.4(LRRK2):c.4318-6C>T	LRRK2		Parkinson disease 8, autosomal dominant|not provided	Benign/Likely benign(Last reviewed: May 25, 2021)	criteria provided, multiple submitters, no conflicts	VCV000695341	12	40704227	12	40310425	695341	685380	rs56082834	NC_000012.12:40310424:C:T
NM_198578.4(LRRK2):c.7429C>T (p.Arg2477Trp)	LRRK2	R2477W	Parkinson disease 8, autosomal dominant|not provided	Benign(Last reviewed: Feb 24, 2021)	criteria provided, multiple submitters, no conflicts	VCV000695315	12	40760846	12	40367044	695315	684327	rs138780308	NC_000012.12:40367043:C:T
NM_198578.4(LRRK2):c.1289-6del	LRRK2		Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Jul 15, 2019)	criteria provided, single submitter	VCV000664397	12	40651044	12	40257242	664397	652698	rs758855054	NC_000012.12:40257241:T:
NM_198578.4(LRRK2):c.1073C>T (p.Thr358Met)	LRRK2	T358M	Parkinson disease 8, autosomal dominant	Conflicting interpretations of pathogenicity(Last reviewed: Nov 30, 2018)	criteria provided, conflicting interpretations	VCV000663402	12	40645148	12	40251346	663402	641104	rs141262110	NC_000012.12:40251345:C:T
NM_198578.4(LRRK2):c.1865G>C (p.Gly622Ala)	LRRK2	G622A	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Nov 8, 2018)	criteria provided, single submitter	VCV000662235	12	40668719	12	40274917	662235	641106	rs1592203496	NC_000012.12:40274916:G:C
NM_198578.4(LRRK2):c.2357T>C (p.Ile786Thr)	LRRK2	I786T	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Sep 10, 2018)	criteria provided, single submitter	VCV000661611	12	40677792	12	40283990	661611	641107	rs1592220766	NC_000012.12:40283989:T:C
NM_198578.4(LRRK2):c.4894G>C (p.Glu1632Gln)	LRRK2	E1632Q	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Dec 14, 2018)	criteria provided, single submitter	VCV000652400	12	40713856	12	40320054	652400	641109	rs200580973	NC_000012.12:40320053:G:C
NM_198578.4(LRRK2):c.6347A>G (p.Lys2116Arg)	LRRK2	K2116R	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Dec 24, 2018)	criteria provided, single submitter	VCV000649401	12	40742277	12	40348475	649401	641111	rs1592321778	NC_000012.12:40348474:A:G
NM_198578.4(LRRK2):c.3184A>G (p.Asn1062Asp)	LRRK2	N1062D	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Oct 16, 2018)	criteria provided, single submitter	VCV000647579	12	40692132	12	40298330	647579	641108	rs201935017	NC_000012.12:40298329:A:G
NM_198578.4(LRRK2):c.1352A>G (p.Lys451Arg)	LRRK2	K451R	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Aug 7, 2018)	criteria provided, single submitter	VCV000647525	12	40651113	12	40257311	647525	641105	rs1592172389	NC_000012.12:40257310:A:G
NM_198578.4(LRRK2):c.5363T>C (p.Met1788Thr)	LRRK2	M1788T	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Oct 19, 2020)	criteria provided, single submitter	VCV000641128	12	40716166	12	40322364	641128	641110	rs376533552	NC_000012.12:40322363:T:C
NM_198578.4(LRRK2):c.4037del (p.Gly1346fs)	LRRK2	G1346fs	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Oct 18, 2018)	criteria provided, single submitter	VCV000632191	12	40702345	12	40308543	632191	620442	rs1565737297	NC_000012.12:40308542:GG:G
NM_198578.4(LRRK2):c.2752C>T (p.Arg918Ter)	LRRK2	R918*	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Apr 5, 2019)	criteria provided, single submitter	VCV000631544	12	40687409	12	40293607	631544	619925	rs957794216	NC_000012.12:40293606:C:T
NM_198578.4(LRRK2):c.736A>C (p.Asn246His)	LRRK2	N246H	not provided|Parkinson disease 8, autosomal dominant	Benign(Last reviewed: Dec 31, 2019)	criteria provided, multiple submitters, no conflicts	VCV000586130	12	40637381	12	40243579	586130	577259	rs150050676	NC_000012.12:40243578:A:C
NM_198578.4(LRRK2):c.6382-2A>G	LRRK2		Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: May 21, 2018)	criteria provided, single submitter	VCV000583272	12	40745339	12	40351537	583272	568030	rs1565772858	NC_000012.12:40351536:A:G
NM_198578.4(LRRK2):c.1093C>A (p.His365Asn)	LRRK2	H365N	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Jun 20, 2018)	criteria provided, single submitter	VCV000580102	12	40645168	12	40251366	580102	571834	rs765509204	NC_000012.12:40251365:C:A
NM_198578.4(LRRK2):c.1240G>A (p.Val414Ile)	LRRK2	V414I	not provided|Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Oct 1, 2019)	criteria provided, multiple submitters, no conflicts	VCV000579293	12	40646770	12	40252968	579293	568026	rs1565682626	NC_000012.12:40252967:G:A
NM_198578.4(LRRK2):c.3033G>T (p.Glu1011Asp)	LRRK2	E1011D	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Aug 23, 2019)	criteria provided, single submitter	VCV000578792	12	40689383	12	40295581	578792	571841	rs141252946	NC_000012.12:40295580:G:T
NM_198578.4(LRRK2):c.2818T>G (p.Phe940Val)	LRRK2	F940V	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: May 14, 2018)	criteria provided, single submitter	VCV000577777	12	40688656	12	40294854	577777	566828	rs953836925	NC_000012.12:40294853:T:G
NM_198578.4(LRRK2):c.368C>G (p.Thr123Arg)	LRRK2	T123R	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Jan 19, 2018)	criteria provided, single submitter	VCV000573487	12	40629448	12	40235646	573487	568025	rs1182341950	NC_000012.12:40235645:C:G
NM_198578.4(LRRK2):c.5594C>G (p.Pro1865Arg)	LRRK2	P1865R	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Nov 20, 2019)	criteria provided, single submitter	VCV000571682	12	40717046	12	40323244	571682	565444	rs905690564	NC_000012.12:40323243:C:G
NM_198578.4(LRRK2):c.3721G>A (p.Ala1241Thr)	LRRK2	A1241T	not provided|Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: May 21, 2019)	criteria provided, multiple submitters, no conflicts	VCV000566690	12	40697880	12	40304078	566690	571842	rs767609721	NC_000012.12:40304077:G:A
NM_198578.4(LRRK2):c.4883G>A (p.Arg1628His)	LRRK2	R1628H	Parkinson disease 8, autosomal dominant|not provided	Uncertain significance(Last reviewed: May 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000546702	12	40713845	12	40320043	546702	537191	rs33949390	NC_000012.12:40320042:G:A
NM_198578.4(LRRK2):c.3960-5A>G	LRRK2		Parkinson disease 8, autosomal dominant	Likely benign(Last reviewed: Dec 28, 2017)	criteria provided, single submitter	VCV000533779	12	40702264	12	40308462	533779	527162	rs764870651	NC_000012.12:40308461:A:G
NM_198578.4(LRRK2):c.177T>A (p.Asn59Lys)	LRRK2	N59K	Parkinson disease 8, autosomal dominant	Conflicting interpretations of pathogenicity(Last reviewed: Jan 13, 2018)	criteria provided, conflicting interpretations	VCV000533778	12	40619382	12	40225580	533778	527134	rs150422099	NC_000012.12:40225579:T:A
NM_198578.4(LRRK2):c.2915A>G (p.Asp972Gly)	LRRK2	D972G	not provided|Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Aug 2, 2019)	criteria provided, multiple submitters, no conflicts	VCV000533777	12	40689265	12	40295463	533777	527161	rs201718451	NC_000012.12:40295462:A:G
NM_198578.4(LRRK2):c.7384C>T (p.Gln2462Ter)	LRRK2	Q2462*	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Oct 25, 2017)	criteria provided, single submitter	VCV000533776	12	40758846	12	40365044	533776	527165	rs765894452	NC_000012.12:40365043:C:T
NM_198578.4(LRRK2):c.4608G>A (p.Ser1536=)	LRRK2		Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Sep 18, 2017)	criteria provided, single submitter	VCV000533775	12	40707845	12	40314043	533775	527135	rs202073944	NC_000012.12:40314042:G:A
NM_198578.4(LRRK2):c.4417C>T (p.Leu1473Phe)	LRRK2	L1473F	not provided|Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Oct 19, 2020)	criteria provided, multiple submitters, no conflicts	VCV000533774	12	40704332	12	40310530	533774	527626	rs1555187766	NC_000012.12:40310529:C:T
NM_198578.4(LRRK2):c.3939T>A (p.Cys1313Ter)	LRRK2	C1313*	not specified|Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Aug 10, 2021)	criteria provided, multiple submitters, no conflicts	VCV000503625	12	40699748	12	40305946	503625	495294	rs183902574	NC_000012.12:40305945:T:A
NM_198578.4(LRRK2):c.347+2T>C	LRRK2		not provided|Parkinson disease 8, autosomal dominant	Conflicting interpretations of pathogenicity(Last reviewed: Dec 17, 2021)	criteria provided, conflicting interpretations	VCV000496937	12	40626187	12	40232385	496937	488361	rs141221000	NC_000012.12:40232384:T:C
NM_198578.4(LRRK2):c.7296C>G (p.Gly2432=)	LRRK2		Parkinson disease 8, autosomal dominant|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Aug 25, 2020)	criteria provided, conflicting interpretations	VCV000465217	12	40758758	12	40364956	465217	463050	rs199964631	NC_000012.12:40364955:C:G
NM_198578.4(LRRK2):c.5870G>T (p.Arg1957Leu)	LRRK2	R1957L	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Feb 21, 2017)	criteria provided, single submitter	VCV000465216	12	40728881	12	40335079	465216	462146	rs201012950	NC_000012.12:40335078:G:T
NM_198578.4(LRRK2):c.2701_2702delinsCT (p.Ser901Leu)	LRRK2	S901L	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Jun 27, 2017)	criteria provided, single submitter	VCV000465215	12	40687358 - 40687359	12	40293556 - 40293557	465215	462432	rs1555184069	NC_000012.12:40293555:TC:CT
NM_198578.4(LRRK2):c.1201G>A (p.Val401Met)	LRRK2	V401M	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Jul 14, 2017)	criteria provided, single submitter	VCV000465214	12	40646731	12	40252929	465214	462143	rs1479574336	NC_000012.12:40252928:G:A
NM_198578.4(LRRK2):c.5105T>C (p.Met1702Thr)	LRRK2	M1702T	not specified|Parkinson disease 8, autosomal dominant|not provided	Uncertain significance(Last reviewed: Oct 15, 2021)	criteria provided, multiple submitters, no conflicts	VCV000447705	12	40714925	12	40321123	447705	441539	rs200008981	NC_000012.12:40321122:T:C
NM_198578.4(LRRK2):c.3643G>A (p.Ala1215Thr)	LRRK2	A1215T	Parkinson disease 8, autosomal dominant|not provided	Uncertain significance(Last reviewed: Mar 1, 2018)	criteria provided, multiple submitters, no conflicts	VCV000444287	12	40697802	12	40304000	444287	437927	rs143710836	NC_000012.12:40303999:G:A
NM_198578.4(LRRK2):c.-124G>C	LRRK2		Parkinson disease 8, autosomal dominant|not provided	Benign/Likely benign(Last reviewed: Aug 17, 2018)	criteria provided, multiple submitters, no conflicts	VCV000369016	12	40618810	12	40225008	369016	353245	rs112643657	NC_000012.12:40225007:G:C
NM_198578.4(LRRK2):c.*1482A>G	LRRK2		Parkinson disease 8, autosomal dominant	Benign(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000308680	12	40763049	12	40369247	308680	324765	rs17491835	NC_000012.12:40369246:A:G
NM_198578.4(LRRK2):c.*1464T>G	LRRK2		Parkinson disease 8, autosomal dominant	Benign(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000308679	12	40763031	12	40369229	308679	324764	rs17491828	NC_000012.12:40369228:T:G
NM_198578.4(LRRK2):c.*1446T>A	LRRK2		Parkinson disease 8, autosomal dominant	Benign(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000308678	12	40763013	12	40369211	308678	330898	rs12422278	NC_000012.12:40369210:T:A
NM_198578.4(LRRK2):c.*1388T>C	LRRK2		Parkinson disease 8, autosomal dominant	Likely benign(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000308677	12	40762955	12	40369153	308677	324760	rs200410756	NC_000012.12:40369152:T:C
NM_198578.4(LRRK2):c.*1279T>C	LRRK2		Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000308676	12	40762846	12	40369044	308676	324759	rs886049369	NC_000012.12:40369043:T:C
NM_198578.4(LRRK2):c.*1186C>T	LRRK2		Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000308675	12	40762753	12	40368951	308675	324757	rs886049368	NC_000012.12:40368950:C:T
NM_198578.4(LRRK2):c.*1182C>T	LRRK2		Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000308674	12	40762749	12	40368947	308674	330897	rs376228552	NC_000012.12:40368946:C:T
NM_198578.4(LRRK2):c.*1181C>T	LRRK2		Parkinson disease 8, autosomal dominant	Benign(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000308673	12	40762748	12	40368946	308673	332404	rs147956597	NC_000012.12:40368945:C:T
NM_198578.4(LRRK2):c.*1140A>T	LRRK2		Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000308672	12	40762707	12	40368905	308672	317049	rs886049367	NC_000012.12:40368904:A:T
NM_198578.4(LRRK2):c.*1069A>G	LRRK2		Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000308671	12	40762636	12	40368834	308671	332397	rs199823070	NC_000012.12:40368833:A:G
NM_198578.4(LRRK2):c.*1035T>C	LRRK2		Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000308670	12	40762602	12	40368800	308670	332396	rs201488873	NC_000012.12:40368799:T:C
NM_198578.4(LRRK2):c.*1018G>T	LRRK2		Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000308669	12	40762585	12	40368783	308669	317047	rs200782338	NC_000012.12:40368782:G:T
NM_198578.4(LRRK2):c.*979T>C	LRRK2		Parkinson disease 8, autosomal dominant	Benign(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000308668	12	40762546	12	40368744	308668	330896	rs10784548	NC_000012.12:40368743:T:C
NM_198578.4(LRRK2):c.*971C>A	LRRK2		Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000308667	12	40762538	12	40368736	308667	317043	rs200935645	NC_000012.12:40368735:C:A
NM_198578.4(LRRK2):c.*936del	LRRK2		Parkinson disease 8, autosomal dominant	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000308666	12	40762493	12	40368691	308666	324748	rs367772598	NC_000012.12:40368690:TTTTTTTTTTT:TTTTTTTTTT
NM_198578.4(LRRK2):c.*934_*936dup	LRRK2		Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000308665	12	40762492 - 40762493	12	40368690 - 40368691	308665	330877	rs367772598	NC_000012.12:40368690:TTTTTTTTTTT:TTTTTTTTTTTTTT
NM_198578.4(LRRK2):c.*935_*936dup	LRRK2		Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000308664	12	40762492 - 40762493	12	40368690 - 40368691	308664	317038	rs367772598	NC_000012.12:40368690:TTTTTTTTTTT:TTTTTTTTTTTTT
NM_198578.4(LRRK2):c.*936dup	LRRK2		Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000308663	12	40762492 - 40762493	12	40368690 - 40368691	308663	332395	rs367772598	NC_000012.12:40368690:TTTTTTTTTTT:TTTTTTTTTTTT
NM_198578.4(LRRK2):c.*736G>C	LRRK2		Parkinson disease 8, autosomal dominant	Benign(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000308662	12	40762303	12	40368501	308662	317036	rs1365770	NC_000012.12:40368500:G:C
NM_198578.4(LRRK2):c.*721G>T	LRRK2		Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000308661	12	40762288	12	40368486	308661	332390	rs886049365	NC_000012.12:40368485:G:T
NM_198578.4(LRRK2):c.*615T>A	LRRK2		Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000308660	12	40762182	12	40368380	308660	332388	rs201422404	NC_000012.12:40368379:T:A
NM_198578.4(LRRK2):c.*470G>T	LRRK2		Parkinson disease 8, autosomal dominant	Benign(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000308659	12	40762037	12	40368235	308659	324746	rs200678400	NC_000012.12:40368234:G:T
NM_198578.4(LRRK2):c.*405C>T	LRRK2		Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000308658	12	40761972	12	40368170	308658	324745	rs200503610	NC_000012.12:40368169:C:T
NM_198578.4(LRRK2):c.*384C>T	LRRK2		Parkinson disease 8, autosomal dominant	Benign(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000308657	12	40761951	12	40368149	308657	332384	rs3886747	NC_000012.12:40368148:C:T
NM_198578.4(LRRK2):c.*364A>C	LRRK2		Parkinson disease 8, autosomal dominant	Benign(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000308656	12	40761931	12	40368129	308656	317030	rs10878441	NC_000012.12:40368128:A:C
NM_198578.4(LRRK2):c.*346A>G	LRRK2		Parkinson disease 8, autosomal dominant	Benign(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000308655	12	40761913	12	40368111	308655	324744	rs17520676	NC_000012.12:40368110:A:G
NM_198578.4(LRRK2):c.*223C>T	LRRK2		Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000308654	12	40761790	12	40367988	308654	317029	rs886049364	NC_000012.12:40367987:C:T
NM_198578.4(LRRK2):c.*148T>C	LRRK2		Parkinson disease 8, autosomal dominant	Benign(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000308653	12	40761715	12	40367913	308653	324729	rs202205832	NC_000012.12:40367912:T:C
NM_198578.4(LRRK2):c.*131del	LRRK2		Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000308652	12	40761697	12	40367895	308652	317028	rs572544182	NC_000012.12:40367894:TT:T
NM_198578.4(LRRK2):c.*123A>C	LRRK2		Parkinson disease 8, autosomal dominant	Benign(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000308651	12	40761690	12	40367888	308651	330873	rs73277568	NC_000012.12:40367887:A:C
NM_198578.4(LRRK2):c.*96T>C	LRRK2		Parkinson disease 8, autosomal dominant|not provided	Benign(Last reviewed: Aug 17, 2018)	criteria provided, multiple submitters, no conflicts	VCV000308650	12	40761663	12	40367861	308650	330872	rs66737902	NC_000012.12:40367860:T:C
NM_198578.4(LRRK2):c.*84G>A	LRRK2		Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000308649	12	40761651	12	40367849	308649	332383	rs201671072	NC_000012.12:40367848:G:A
NM_198578.4(LRRK2):c.7483G>A (p.Val2495Ile)	LRRK2	V2495I	Parkinson disease 8, autosomal dominant	Benign(Last reviewed: Mar 18, 2020)	criteria provided, multiple submitters, no conflicts	VCV000308648	12	40761466	12	40367664	308648	324728	rs150062967	NC_000012.12:40367663:G:A
NM_198578.4(LRRK2):c.7190T>C (p.Met2397Thr)	LRRK2	M2397T	not specified|not provided|Parkinson disease 8, autosomal dominant	Benign(Last reviewed: Dec 8, 2020)	criteria provided, multiple submitters, no conflicts	VCV000308647	12	40758652	12	40364850	308647	324716	rs3761863	NC_000012.12:40364849:T:C
NM_198578.4(LRRK2):c.7062C>T (p.Ile2354=)	LRRK2		Parkinson disease 8, autosomal dominant	Likely benign(Last reviewed: Aug 14, 2019)	criteria provided, multiple submitters, no conflicts	VCV000308646	12	40757237	12	40363435	308646	324713	rs768811495	NC_000012.12:40363434:C:T
NM_198578.4(LRRK2):c.6844-14_6844-13insA	LRRK2		not provided|Parkinson disease 8, autosomal dominant	Benign/Likely benign(Last reviewed: Dec 9, 2021)	criteria provided, multiple submitters, no conflicts	VCV000308645	12	40753048 - 40753049	12	40359246 - 40359247	308645	332380	rs150964683	NC_000012.12:40359246::A
NM_198578.4(LRRK2):c.6801C>T (p.Thr2267=)	LRRK2		Parkinson disease 8, autosomal dominant	Conflicting interpretations of pathogenicity(Last reviewed: Nov 12, 2019)	criteria provided, conflicting interpretations	VCV000308644	12	40749947	12	40356145	308644	324707	rs148143226	NC_000012.12:40356144:C:T
NM_198578.4(LRRK2):c.6688G>A (p.Glu2230Lys)	LRRK2	E2230K	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000308643	12	40748212	12	40354410	308643	324706	rs201317931	NC_000012.12:40354409:G:A
NM_198578.4(LRRK2):c.6582T>C (p.Val2194=)	LRRK2		Parkinson disease 8, autosomal dominant	Conflicting interpretations of pathogenicity(Last reviewed: Oct 25, 2021)	criteria provided, conflicting interpretations	VCV000308642	12	40748106	12	40354304	308642	332370	rs773085638	NC_000012.12:40354303:T:C
NM_198578.4(LRRK2):c.6281-3dup	LRRK2		Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000308641	12	40742204 - 40742205	12	40348402 - 40348403	308641	332364	rs780258764	NC_000012.12:40348402:TTTT:TTTTT
NM_198578.4(LRRK2):c.5713G>C (p.Val1905Leu)	LRRK2	V1905L	Parkinson disease 8, autosomal dominant	Conflicting interpretations of pathogenicity(Last reviewed: Nov 13, 2018)	criteria provided, conflicting interpretations	VCV000308640	12	40722218	12	40328416	308640	324704	rs754436306	NC_000012.12:40328415:G:C
NM_198578.4(LRRK2):c.5510-9A>G	LRRK2		not specified|not provided|Parkinson Disease, Dominant|Parkinson disease 8, autosomal dominant	Benign/Likely benign(Last reviewed: Dec 31, 2019)	criteria provided, multiple submitters, no conflicts	VCV000308639	12	40716953	12	40323151	308639	332363	rs41286460	NC_000012.12:40323150:A:G
NM_198578.4(LRRK2):c.5270A>G (p.Asn1757Ser)	LRRK2	N1757S	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000308638	12	40715936	12	40322134	308638	332354	rs368762897	NC_000012.12:40322133:A:G
NM_198578.4(LRRK2):c.4934A>G (p.Tyr1645Cys)	LRRK2	Y1645C	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000308637	12	40713896	12	40320094	308637	317022	rs759886320	NC_000012.12:40320093:A:G
NM_198578.4(LRRK2):c.4930A>G (p.Asn1644Asp)	LRRK2	N1644D	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000308636	12	40713892	12	40320090	308636	332353	rs886049361	NC_000012.12:40320089:A:G
NM_198578.4(LRRK2):c.4828-9A>T	LRRK2		Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000308635	12	40713781	12	40319979	308635	324698	rs199843206	NC_000012.12:40319978:A:T
NM_198578.4(LRRK2):c.4627A>G (p.Ile1543Val)	LRRK2	I1543V	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Dec 6, 2021)	criteria provided, multiple submitters, no conflicts	VCV000308634	12	40707864	12	40314062	308634	324697	rs201540075	NC_000012.12:40314061:A:G
NM_198578.4(LRRK2):c.4317+12del	LRRK2		not provided|Parkinson disease 8, autosomal dominant	Benign/Likely benign(Last reviewed: Dec 18, 2021)	criteria provided, multiple submitters, no conflicts	VCV000308633	12	40703047	12	40309245	308633	324696	rs200829235	NC_000012.12:40309244:T:
NM_198578.4(LRRK2):c.3969A>G (p.Gln1323=)	LRRK2		Parkinson disease 8, autosomal dominant	Conflicting interpretations of pathogenicity(Last reviewed: Aug 27, 2019)	criteria provided, conflicting interpretations	VCV000308632	12	40702278	12	40308476	308632	332351	rs372245035	NC_000012.12:40308475:A:G
NM_198578.4(LRRK2):c.3864G>A (p.Met1288Ile)	LRRK2	M1288I	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000308631	12	40699673	12	40305871	308631	324695	rs747301221	NC_000012.12:40305870:G:A
NM_198578.4(LRRK2):c.3778-9C>T	LRRK2		Parkinson disease 8, autosomal dominant|not provided	Benign/Likely benign(Last reviewed: Mar 19, 2021)	criteria provided, multiple submitters, no conflicts	VCV000308630	12	40699578	12	40305776	308630	332342	rs114948984	NC_000012.12:40305775:C:T
NM_198578.4(LRRK2):c.3777+7C>T	LRRK2		not specified|Parkinson disease 8, autosomal dominant	Conflicting interpretations of pathogenicity(Last reviewed: May 28, 2021)	criteria provided, conflicting interpretations	VCV000308629	12	40697943	12	40304141	308629	324694	rs41286480	NC_000012.12:40304140:C:T
NM_198578.4(LRRK2):c.3678A>C (p.Leu1226Phe)	LRRK2	L1226F	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000308628	12	40697837	12	40304035	308628	330868	rs746701556	NC_000012.12:40304034:A:C
NM_198578.4(LRRK2):c.3595C>A (p.Arg1199=)	LRRK2		Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000308627	12	40697754	12	40303952	308627	324690	rs746433333	NC_000012.12:40303951:C:A
NM_198578.4(LRRK2):c.3497-8del	LRRK2		Parkinson disease 8, autosomal dominant|not provided	Benign/Likely benign(Last reviewed: Dec 17, 2021)	criteria provided, multiple submitters, no conflicts	VCV000308626	12	40696576	12	40302774	308626	332341	rs201739149	NC_000012.12:40302773:TTTTTTTT:TTTTTTT
NM_198578.4(LRRK2):c.3435A>C (p.Ser1145=)	LRRK2		Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000308625	12	40692998	12	40299196	308625	332335	rs886049359	NC_000012.12:40299195:A:C
NM_198578.4(LRRK2):c.3429C>T (p.Ser1143=)	LRRK2		Parkinson disease 8, autosomal dominant	Benign/Likely benign(Last reviewed: Oct 19, 2020)	criteria provided, multiple submitters, no conflicts	VCV000308624	12	40692992	12	40299190	308624	330863	rs142989436	NC_000012.12:40299189:C:T
NM_198578.4(LRRK2):c.3026A>C (p.His1009Pro)	LRRK2	H1009P	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000308623	12	40689376	12	40295574	308623	324688	rs375146075	NC_000012.12:40295573:A:C
NM_198578.4(LRRK2):c.2987A>T (p.Asp996Val)	LRRK2	D996V	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000308622	12	40689337	12	40295535	308622	332334	rs886049358	NC_000012.12:40295534:A:T
NM_198578.4(LRRK2):c.2900A>G (p.His967Arg)	LRRK2	H967R	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Nov 16, 2021)	criteria provided, multiple submitters, no conflicts	VCV000308621	12	40689250	12	40295448	308621	317020	rs533409083	NC_000012.12:40295447:A:G
NM_198578.4(LRRK2):c.2826T>C (p.His942=)	LRRK2		Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000308620	12	40688664	12	40294862	308620	330854	rs886049357	NC_000012.12:40294861:T:C
NM_198578.4(LRRK2):c.2689+20dup	LRRK2		Parkinson disease 8, autosomal dominant|not specified|not provided	Benign/Likely benign(Last reviewed: Dec 18, 2021)	criteria provided, multiple submitters, no conflicts	VCV000308619	12	40681352 - 40681353	12	40287550 - 40287551	308619	332330	rs66810434	NC_000012.12:40287550:AAAAAAAAA:AAAAAAAAAA
NM_198578.4(LRRK2):c.2588A>G (p.Asn863Ser)	LRRK2	N863S	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000308618	12	40681240	12	40287438	308618	324686	rs555679009	NC_000012.12:40287437:A:G
NM_198578.4(LRRK2):c.2501-9dup	LRRK2		Parkinson disease 8, autosomal dominant|not specified|not provided	Benign(Last reviewed: Dec 8, 2020)	criteria provided, multiple submitters, no conflicts	VCV000308617	12	40681142 - 40681143	12	40287340 - 40287341	308617	330850	rs36220740	NC_000012.12:40287340:TT:TTT
NM_198578.4(LRRK2):c.2070+9T>A	LRRK2		Parkinson disease 8, autosomal dominant	Conflicting interpretations of pathogenicity(Last reviewed: Oct 18, 2021)	criteria provided, conflicting interpretations	VCV000308616	12	40671827	12	40278025	308616	332321	rs201389324	NC_000012.12:40278024:T:A
NM_198578.4(LRRK2):c.1446A>G (p.Ala482=)	LRRK2		Parkinson disease 8, autosomal dominant	Conflicting interpretations of pathogenicity(Last reviewed: May 8, 2021)	criteria provided, conflicting interpretations	VCV000308615	12	40653309	12	40259507	308615	324685	rs757454147	NC_000012.12:40259506:A:G
NM_198578.4(LRRK2):c.1182-4A>G	LRRK2		not provided|Parkinson disease 8, autosomal dominant	Benign/Likely benign(Last reviewed: Feb 6, 2020)	criteria provided, multiple submitters, no conflicts	VCV000308614	12	40646708	12	40252906	308614	332320	rs7135747	NC_000012.12:40252905:A:G
NM_198578.4(LRRK2):c.1102-10C>A	LRRK2		not specified|not provided|Parkinson disease 8, autosomal dominant	Benign(Last reviewed: Dec 8, 2020)	criteria provided, multiple submitters, no conflicts	VCV000308613	12	40645257	12	40251455	308613	324683	rs7955902	NC_000012.12:40251454:C:A
NM_198578.4(LRRK2):c.867C>T (p.Asn289=)	LRRK2		Parkinson disease 8, autosomal dominant|not provided	Benign/Likely benign(Last reviewed: May 10, 2021)	criteria provided, multiple submitters, no conflicts	VCV000308612	12	40643656	12	40249854	308612	332319	rs17490713	NC_000012.12:40249853:C:T
NM_198578.4(LRRK2):c.709AAT[1] (p.Asn238del)	LRRK2	N238del	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000308611	12	40637354 - 40637356	12	40243552 - 40243554	308611	332317	rs886049355	NC_000012.12:40243551:AATAAT:AAT
NM_198578.4(LRRK2):c.344A>C (p.His115Pro)	LRRK2	H115P	not provided|Parkinson disease 8, autosomal dominant	Benign/Likely benign(Last reviewed: Apr 21, 2021)	criteria provided, multiple submitters, no conflicts	VCV000308610	12	40626182	12	40232380	308610	317019	rs201439315	NC_000012.12:40232379:A:C
NM_198578.4(LRRK2):c.-44G>A	LRRK2		Parkinson disease 8, autosomal dominant	Likely benign(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000308609	12	40618890	12	40225088	308609	324682	rs765232448	NC_000012.12:40225087:G:A
NM_198578.4(LRRK2):c.7267A>T (p.Thr2423Ser)	LRRK2	T2423S	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Dec 11, 2014)	no assertion criteria provided	VCV000236298	12	40758729	12	40364927	236298	237853	rs1060499538	NC_000012.12:40364926:A:T
NM_198578.4(LRRK2):c.7006A>G (p.Ile2336Val)	LRRK2	I2336V	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Dec 11, 2014)	no assertion criteria provided	VCV000236297	12	40753224	12	40359422	236297	237851	rs878853311	NC_000012.12:40359421:A:G
NM_198578.4(LRRK2):c.6929C>T (p.Thr2310Met)	LRRK2	T2310M	not provided|Parkinson disease 8, autosomal dominant	Conflicting interpretations of pathogenicity(Last reviewed: Jun 1, 2021)	criteria provided, conflicting interpretations	VCV000236296	12	40753147	12	40359345	236296	237850	rs200002022	NC_000012.12:40359344:C:T
NM_198578.4(LRRK2):c.5273A>C (p.His1758Pro)	LRRK2	H1758P	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Dec 11, 2014)	no assertion criteria provided	VCV000236295	12	40715939	12	40322137	236295	237849	rs878853310	NC_000012.12:40322136:A:C
NM_198578.4(LRRK2):c.4441G>A (p.Ala1481Thr)	LRRK2	A1481T	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Dec 11, 2014)	no assertion criteria provided	VCV000236294	12	40704356	12	40310554	236294	237848	rs878853309	NC_000012.12:40310553:G:A
NM_198578.4(LRRK2):c.4358A>G (p.His1453Arg)	LRRK2	H1453R	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Dec 11, 2014)	no assertion criteria provided	VCV000236293	12	40704273	12	40310471	236293	237847	rs878853308	NC_000012.12:40310470:A:G
NM_198578.4(LRRK2):c.4314A>G (p.Ile1438Met)	LRRK2	I1438M	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Dec 11, 2014)	no assertion criteria provided	VCV000236292	12	40703032	12	40309230	236292	237852	rs878853307	NC_000012.12:40309229:A:G
NM_198578.4(LRRK2):c.3187C>T (p.Leu1063Phe)	LRRK2	L1063F	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Dec 11, 2014)	no assertion criteria provided	VCV000236291	12	40692135	12	40298333	236291	237846	rs878853306	NC_000012.12:40298332:C:T
NM_198578.4(LRRK2):c.2314C>T (p.Arg772Ter)	LRRK2	R772*	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Dec 11, 2014)	no assertion criteria provided	VCV000236290	12	40677749	12	40283947	236290	237845	rs376015112	NC_000012.12:40283946:C:T
NM_198578.4(LRRK2):c.1829T>C (p.Ile610Thr)	LRRK2	I610T	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Dec 11, 2014)	no assertion criteria provided	VCV000236289	12	40668683	12	40274881	236289	237844	rs566811888	NC_000012.12:40274880:T:C
NM_198578.4(LRRK2):c.1288G>A (p.Val430Ile)	LRRK2	V430I	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Dec 11, 2014)	no assertion criteria provided	VCV000236288	12	40646818	12	40253016	236288	237843	rs878853305	NC_000012.12:40253015:G:A
NM_198578.4(LRRK2):c.1132C>T (p.Leu378Phe)	LRRK2	L378F	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Dec 11, 2014)	no assertion criteria provided	VCV000236287	12	40645297	12	40251495	236287	237842	rs200870486	NC_000012.12:40251494:C:T
NM_198578.4(LRRK2):c.856C>G (p.Leu286Val)	LRRK2	L286V	Parkinson disease 8, autosomal dominant|not specified	Conflicting interpretations of pathogenicity(Last reviewed: Nov 12, 2020)	criteria provided, conflicting interpretations	VCV000236286	12	40643645	12	40249843	236286	237841	rs200437744	NC_000012.12:40249842:C:G
NM_198578.4(LRRK2):c.691T>C (p.Ser231Pro)	LRRK2	S231P	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Dec 11, 2014)	no assertion criteria provided	VCV000236285	12	40634404	12	40240602	236285	237840	rs201332859	NC_000012.12:40240601:T:C
NM_198578.4(LRRK2):c.4321C>A (p.Arg1441Ser)	LRRK2	R1441S	Parkinson disease, late-onset|Parkinson disease 8, autosomal dominant	Likely pathogenic(Last reviewed: Sep 24, 2018)	criteria provided, single submitter	VCV000225276	12	40704236	12	40310434	225276	227175	rs33939927	NC_000012.12:40310433:C:A
NM_198578.4(LRRK2):c.7300A>G (p.Ile2434Val)	LRRK2	I2434V	not provided|Parkinson disease, late-onset	Uncertain significance(Last reviewed: Jul 21, 2018)	criteria provided, single submitter	VCV000096731	12	40758762	12	40364960	96731	102617	rs398124661	NC_000012.12:40364959:A:G
NM_198578.4(LRRK2):c.2352C>A (p.Ser784Arg)	LRRK2	S784R	Parkinson disease, late-onset	Uncertain significance(Last reviewed: Jan 22, 2014)	no assertion criteria provided	VCV000096730	12	40677787	12	40283985	96730	102616	rs398124660	NC_000012.12:40283984:C:A
NM_198578.4(LRRK2):c.6523G>C (p.Asp2175His)	LRRK2	D2175H	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Sep 13, 2012)	no assertion criteria provided	VCV000039278	12	40745482	12	40351680	39278	47884	rs72547981	NC_000012.12:40351679:G:C
NM_198578.4(LRRK2):c.936G>T (p.Ala312=)	LRRK2		Parkinson disease 8, autosomal dominant	Benign(Last reviewed: Dec 1, 2020)	criteria provided, multiple submitters, no conflicts	VCV000039246	12	40643725	12	40249923	39246	47852	rs41286466	NC_000012.12:40249922:G:T
NM_198578.4(LRRK2):c.894T>C (p.Ala298=)	LRRK2		Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Sep 13, 2012)	no assertion criteria provided	VCV000039245	12	40643683	12	40249881	39245	47851	rs57355477	NC_000012.12:40249880:T:C
NM_198578.4(LRRK2):c.867= (p.Asn289=)	LRRK2		Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Sep 13, 2012)	no assertion criteria provided	VCV000039244	12	40643656	12	40249854	39244	47850	rs17490713	NC_000012.12:40249853:C:C
NM_198578.4(LRRK2):c.825= (p.His275=)	LRRK2		Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Sep 13, 2012)	no assertion criteria provided	VCV000039243	12	40637470	12	40243668	39243	47849	rs72546315	NC_000012.12:40243667:T:T
NM_198578.4(LRRK2):c.7468del (p.Gln2490fs)	LRRK2	Q2490fs	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Sep 13, 2012)	no assertion criteria provided	VCV000039242	12	40761451	12	40367649	39242	47848	rs281865058	NC_000012.12:40367648:C:
NM_198578.4(LRRK2):c.7435A>G (p.Asn2479Asp)	LRRK2	N2479D	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Sep 13, 2012)	no assertion criteria provided	VCV000039241	12	40760852	12	40367050	39241	47847	rs55633591	NC_000012.12:40367049:A:G
NM_198578.4(LRRK2):c.7397T>A (p.Leu2466His)	LRRK2	L2466H	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Aug 28, 2021)	criteria provided, single submitter	VCV000039240	12	40760814	12	40367012	39240	47846	rs281865057	NC_000012.12:40367011:T:A
NM_198578.4(LRRK2):c.7224G>A (p.Met2408Ile)	LRRK2	M2408I	Parkinson disease 8, autosomal dominant|not provided	Uncertain significance(Last reviewed: Sep 13, 2012)	no assertion criteria provided	VCV000039239	12	40758686	12	40364884	39239	47845	rs60545352	NC_000012.12:40364883:G:A
NM_198578.4(LRRK2):c.7190= (p.Met2397=)	LRRK2		Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Sep 13, 2012)	no assertion criteria provided	VCV000039238	12	40758652	12	40364850	39238	47844	rs3761863	NC_000012.12:40364849:T:T
NM_198578.4(LRRK2):c.7186_7187dup (p.Val2396_Met2397insTer)	LRRK2		Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Sep 13, 2012)	no assertion criteria provided	VCV000039237	12	40758647 - 40758648	12	40364845 - 40364846	39237	47843	rs281865056	NC_000012.12:40364845:GT:GTGT
NM_198578.4(LRRK2):c.7183G>A (p.Glu2395Lys)	LRRK2	E2395K	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Sep 13, 2012)	no assertion criteria provided	VCV000039236	12	40758645	12	40364843	39236	47842	rs78964014	NC_000012.12:40364842:G:A
NM_198578.4(LRRK2):c.7168G>A (p.Val2390Met)	LRRK2	V2390M	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Sep 13, 2012)	no assertion criteria provided	VCV000039235	12	40757343	12	40363541	39235	47841	rs79546190	NC_000012.12:40363540:G:A
NM_198578.4(LRRK2):c.7155A>G (p.Gly2385=)	LRRK2		not provided|not specified|Parkinson disease 8, autosomal dominant	Benign(Last reviewed: Dec 4, 2020)	criteria provided, multiple submitters, no conflicts	VCV000039234	12	40757330	12	40363528	39234	47840	rs33962975	NC_000012.12:40363527:A:G
NM_198578.4(LRRK2):c.713A>T (p.Asn238Ile)	LRRK2	N238I	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Sep 13, 2012)	no assertion criteria provided	VCV000039233	12	40637358	12	40243556	39233	47839	rs28365216	NC_000012.12:40243555:A:T
NM_198578.4(LRRK2):c.7067C>T (p.Thr2356Ile)	LRRK2	T2356I	not provided|Parkinson disease 8, autosomal dominant	Conflicting interpretations of pathogenicity(Last reviewed: Sep 29, 2021)	criteria provided, conflicting interpretations	VCV000039232	12	40757242	12	40363440	39232	47838	rs113511708	NC_000012.12:40363439:C:T
NM_198578.4(LRRK2):c.683G>C (p.Cys228Ser)	LRRK2	C228S	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Jul 11, 2019)	criteria provided, single submitter	VCV000039231	12	40634396	12	40240594	39231	47837	rs56108242	NC_000012.12:40240593:G:C
NM_198578.4(LRRK2):c.6782A>T (p.Asn2261Ile)	LRRK2	N2261I	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Sep 13, 2012)	no assertion criteria provided	VCV000039230	12	40749928	12	40356126	39230	47836	rs12581902	NC_000012.12:40356125:A:T
NM_198578.4(LRRK2):c.6566A>G (p.Tyr2189Cys)	LRRK2	Y2189C	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: May 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000039229	12	40745525	12	40351723	39229	47835	rs35658131	NC_000012.12:40351722:A:G
NM_198578.4(LRRK2):c.6510C>A (p.Gly2170=)	LRRK2		not provided|Parkinson disease 8, autosomal dominant	Benign/Likely benign(Last reviewed: Dec 3, 2020)	criteria provided, multiple submitters, no conflicts	VCV000039228	12	40745469	12	40351667	39228	47834	rs34869625	NC_000012.12:40351666:C:A
NM_198578.4(LRRK2):c.6428G>A (p.Arg2143His)	LRRK2	R2143H	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Apr 28, 2017)	criteria provided, single submitter	VCV000039227	12	40745387	12	40351585	39227	47833	rs201271001	NC_000012.12:40351584:G:A
NM_198578.4(LRRK2):c.6422C>T (p.Thr2141Met)	LRRK2	T2141M	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Sep 13, 2012)	no assertion criteria provided	VCV000039226	12	40745381	12	40351579	39226	47832	rs111691891	NC_000012.12:40351578:C:T
NM_198578.4(LRRK2):c.6415T>A (p.Cys2139Ser)	LRRK2	C2139S	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Sep 13, 2012)	no assertion criteria provided	VCV000039225	12	40745374	12	40351572	39225	47831	rs112048985	NC_000012.12:40351571:T:A
NM_198578.4(LRRK2):c.6356C>T (p.Pro2119Leu)	LRRK2	P2119L	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Sep 13, 2012)	no assertion criteria provided	VCV000039224	12	40742286	12	40348484	39224	47830	rs12423862	NC_000012.12:40348483:C:T
NM_198578.4(LRRK2):c.632C>T (p.Ala211Val)	LRRK2	A211V	Parkinson disease 8, autosomal dominant	Conflicting interpretations of pathogenicity(Last reviewed: May 28, 2019)	criteria provided, conflicting interpretations	VCV000039223	12	40634345	12	40240543	39223	47829	rs112794616	NC_000012.12:40240542:C:T
NM_198578.4(LRRK2):c.6324G>A (p.Glu2108=)	LRRK2		not specified|Parkinson disease 8, autosomal dominant|not provided	Benign(Last reviewed: Dec 7, 2020)	criteria provided, multiple submitters, no conflicts	VCV000039222	12	40742254	12	40348452	39222	47828	rs10878405	NC_000012.12:40348451:G:A
NM_198578.4(LRRK2):c.6241A>G (p.Asn2081Asp)	LRRK2	N2081D	not specified|not provided|Parkinson disease 8, autosomal dominant	Benign(Last reviewed: Nov 14, 2020)	criteria provided, multiple submitters, no conflicts	VCV000039221	12	40740686	12	40346884	39221	47827	rs33995883	NC_000012.12:40346883:A:G
NM_198578.4(LRRK2):c.6187_6191del (p.Leu2062_Leu2063insTer)	LRRK2		Parkinson disease 8, autosomal dominant|not provided	Uncertain significance(Last reviewed: Oct 10, 2019)	criteria provided, multiple submitters, no conflicts	VCV000039220	12	40740629 - 40740633	12	40346827 - 40346831	39220	47826	rs111739194	NC_000012.12:40346826:CTACTCTA:CTA
NM_198578.4(LRRK2):c.6091A>T (p.Thr2031Ser)	LRRK2	T2031S	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Sep 13, 2012)	no assertion criteria provided	VCV000039219	12	40734238	12	40340436	39219	47825	rs78029637	NC_000012.12:40340435:A:T
NM_198578.4(LRRK2):c.6035T>C (p.Ile2012Thr)	LRRK2	I2012T	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Sep 13, 2012)	no assertion criteria provided	VCV000039218	12	40734182	12	40340380	39218	47824	rs34015634	NC_000012.12:40340379:T:C
NM_198578.4(LRRK2):c.6016T>C (p.Tyr2006His)	LRRK2	Y2006H	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Sep 13, 2012)	no assertion criteria provided	VCV000039217	12	40734163	12	40340361	39217	47823	rs281865055	NC_000012.12:40340360:T:C
NM_198578.4(LRRK2):c.5822G>A (p.Arg1941His)	LRRK2	R1941H	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: May 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000039216	12	40728833	12	40335031	39216	47822	rs77428810	NC_000012.12:40335030:G:A
NM_198578.4(LRRK2):c.5620G>T (p.Glu1874Ter)	LRRK2	E1874*	Parkinson disease 8, autosomal dominant	Pathogenic(Last reviewed: Sep 13, 2012)	no assertion criteria provided	VCV000039215	12	40717072	12	40323270	39215	47821	rs281865054	NC_000012.12:40323269:G:T
NM_198578.4(LRRK2):c.5610G>T (p.Leu1870Phe)	LRRK2	L1870F	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Sep 13, 2012)	no assertion criteria provided	VCV000039214	12	40717062	12	40323260	39214	47820	rs281865053	NC_000012.12:40323259:G:T
NM_198578.4(LRRK2):c.5606T>C (p.Met1869Thr)	LRRK2	M1869T	Parkinson disease 8, autosomal dominant	Conflicting interpretations of pathogenicity(Last reviewed: Aug 1, 2021)	criteria provided, conflicting interpretations	VCV000039213	12	40717058	12	40323256	39213	47819	rs35602796	NC_000012.12:40323255:T:C
NM_198578.4(LRRK2):c.5605A>G (p.Met1869Val)	LRRK2	M1869V	Parkinson disease 8, autosomal dominant	Pathogenic(Last reviewed: Sep 13, 2012)	no assertion criteria provided	VCV000039212	12	40717057	12	40323255	39212	47818	rs281865052	NC_000012.12:40323254:A:G
NM_198578.4(LRRK2):c.546A>G (p.Lys182=)	LRRK2		Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Sep 13, 2012)	no assertion criteria provided	VCV000039211	12	40631880	12	40238078	39211	47817	rs35517158	NC_000012.12:40238077:A:G
NM_198578.4(LRRK2):c.5467C>A (p.Gln1823Lys)	LRRK2	Q1823K	Parkinson disease 8, autosomal dominant|not provided	Likely benign(Last reviewed: Jun 12, 2021)	criteria provided, single submitter	VCV000039210	12	40716270	12	40322468	39210	47816	rs72547980	NC_000012.12:40322467:C:A
NM_198578.4(LRRK2):c.5457T>C (p.Gly1819=)	LRRK2		not specified|not provided|Parkinson disease 8, autosomal dominant	Benign(Last reviewed: Dec 7, 2020)	criteria provided, multiple submitters, no conflicts	VCV000039209	12	40716260	12	40322458	39209	47815	rs10878371	NC_000012.12:40322457:T:C
NM_198578.4(LRRK2):c.5385G>T (p.Leu1795Phe)	LRRK2	L1795F	not provided|Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Aug 7, 2021)	criteria provided, multiple submitters, no conflicts	VCV000039208	12	40716188	12	40322386	39208	47814	rs111910483	NC_000012.12:40322385:G:T
NM_198578.4(LRRK2):c.5183G>T (p.Arg1728Leu)	LRRK2	R1728L	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Sep 13, 2012)	no assertion criteria provided	VCV000039207	12	40715849	12	40322047	39207	47813	rs145364431	NC_000012.12:40322046:G:T
NM_198578.4(LRRK2):c.5183G>A (p.Arg1728His)	LRRK2	R1728H	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Sep 13, 2012)	no assertion criteria provided	VCV000039206	12	40715849	12	40322047	39206	47812	rs145364431	NC_000012.12:40322046:G:A
NM_198578.4(LRRK2):c.5174G>A (p.Arg1725Gln)	LRRK2	R1725Q	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Sep 13, 2012)	no assertion criteria provided	VCV000039205	12	40715840	12	40322038	39205	47811	rs72547979	NC_000012.12:40322037:G:A
NM_198578.4(LRRK2):c.5173C>T (p.Arg1725Ter)	LRRK2	R1725*	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Sep 13, 2012)	no assertion criteria provided	VCV000039204	12	40715839	12	40322037	39204	47810	rs11564176	NC_000012.12:40322036:C:T
NM_198578.4(LRRK2):c.5163A>G (p.Ser1721=)	LRRK2		Parkinson disease 8, autosomal dominant|not provided	Benign/Likely benign(Last reviewed: May 4, 2021)	criteria provided, multiple submitters, no conflicts	VCV000039203	12	40714983	12	40321181	39203	47809	rs79909111	NC_000012.12:40321180:A:G
NM_198578.4(LRRK2):c.4959A>G (p.Leu1653=)	LRRK2		Parkinson disease 8, autosomal dominant	Benign(Last reviewed: Apr 27, 2017)	criteria provided, single submitter	VCV000039202	12	40713921	12	40320119	39202	47808	rs111503579	NC_000012.12:40320118:A:G
NM_198578.4(LRRK2):c.4939T>A (p.Ser1647Thr)	LRRK2	S1647T	Parkinson disease 8, autosomal dominant|not specified|not provided	Benign(Last reviewed: Oct 5, 2021)	criteria provided, multiple submitters, no conflicts	VCV000039201	12	40713901	12	40320099	39201	47807	rs11564148	NC_000012.12:40320098:T:A
NM_198578.4(LRRK2):c.4937T>C (p.Met1646Thr)	LRRK2	M1646T	Parkinson disease 8, autosomal dominant|not provided	Benign/Likely benign(Last reviewed: Sep 21, 2020)	criteria provided, multiple submitters, no conflicts	VCV000039200	12	40713899	12	40320097	39200	47806	rs35303786	NC_000012.12:40320096:T:C
NM_198578.4(LRRK2):c.4911A>G (p.Lys1637=)	LRRK2		not provided|not specified|Parkinson disease 8, autosomal dominant	Benign(Last reviewed: Dec 7, 2020)	criteria provided, multiple submitters, no conflicts	VCV000039199	12	40713873	12	40320071	39199	47805	rs11176013	NC_000012.12:40320070:A:G
NM_198578.4(LRRK2):c.4883G>C (p.Arg1628Pro)	LRRK2	R1628P	not provided|Spinocerebellar atrophy|Early onset Alzheimer disease with behavioral disturbance|Parkinson disease 8, autosomal dominant|Klippel-Feil syndrome 1, autosomal dominant|Parkinson disease 8, autosomal dominant	Conflicting interpretations of pathogenicity(Last reviewed: Sep 1, 2021)	criteria provided, conflicting interpretations	VCV000039198	12	40713845	12	40320043	39198	47804	rs33949390	NC_000012.12:40320042:G:C
NM_198578.4(LRRK2):c.4872C>A (p.Gly1624=)	LRRK2		not specified|not provided|Parkinson disease 8, autosomal dominant	Benign(Last reviewed: Dec 8, 2020)	criteria provided, multiple submitters, no conflicts	VCV000039197	12	40713834	12	40320032	39197	47803	rs1427263	NC_000012.12:40320031:C:A
NM_198578.4(LRRK2):c.4838T>C (p.Val1613Ala)	LRRK2	V1613A	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Sep 13, 2012)	no assertion criteria provided	VCV000039196	12	40713800	12	40319998	39196	47802	rs281865051	NC_000012.12:40319997:T:C
NM_198578.4(LRRK2):c.4793T>A (p.Val1598Glu)	LRRK2	V1598E	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Sep 13, 2012)	no assertion criteria provided	VCV000039195	12	40709068	12	40315266	39195	47801	rs721710	NC_000012.12:40315265:T:A
NM_198578.4(LRRK2):c.4666C>A (p.Leu1556Ile)	LRRK2	L1556I	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Sep 13, 2012)	no assertion criteria provided	VCV000039194	12	40707903	12	40314101	39194	47800	rs17491187	NC_000012.12:40314100:C:A
NM_198578.4(LRRK2):c.4624C>T (p.Pro1542Ser)	LRRK2	P1542S	not provided|not specified|Parkinson disease 8, autosomal dominant	Benign(Last reviewed: Dec 8, 2020)	criteria provided, multiple submitters, no conflicts	VCV000039193	12	40707861	12	40314059	39193	47799	rs33958906	NC_000012.12:40314058:C:T
NM_198578.4(LRRK2):c.457T>C (p.Leu153=)	LRRK2		Parkinson disease 8, autosomal dominant|not specified|not provided	Benign(Last reviewed: Dec 8, 2020)	criteria provided, multiple submitters, no conflicts	VCV000039192	12	40631791	12	40237989	39192	47798	rs10878245	NC_000012.12:40237988:T:C
NM_198578.4(LRRK2):c.4541G>A (p.Arg1514Gln)	LRRK2	R1514Q	Parkinson disease 8, autosomal dominant|not provided	Benign/Likely benign(Last reviewed: Dec 31, 2019)	criteria provided, multiple submitters, no conflicts	VCV000039191	12	40707778	12	40313976	39191	47797	rs35507033	NC_000012.12:40313975:G:A
NM_198578.4(LRRK2):c.4448G>A (p.Arg1483Gln)	LRRK2	R1483Q	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Oct 14, 2021)	criteria provided, single submitter	VCV000039190	12	40704363	12	40310561	39190	47796	rs113431708	NC_000012.12:40310560:G:A
NM_198578.4(LRRK2):c.4402A>G (p.Lys1468Glu)	LRRK2	K1468E	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Sep 13, 2012)	no assertion criteria provided	VCV000039189	12	40704317	12	40310515	39189	47795	rs281865050	NC_000012.12:40310514:A:G
NM_198578.4(LRRK2):c.4364_4365del (p.Asp1455fs)	LRRK2	D1455fs	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Sep 13, 2012)	no assertion criteria provided	VCV000039188	12	40704279 - 40704280	12	40310477 - 40310478	39188	47794	rs281865049	NC_000012.12:40310476:AT:
NM_198578.4(LRRK2):c.4348G>A (p.Val1450Ile)	LRRK2	V1450I	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Nov 24, 2021)	criteria provided, single submitter	VCV000039187	12	40704263	12	40310461	39187	47793	rs111501952	NC_000012.12:40310460:G:A
NM_198578.4(LRRK2):c.4337C>T (p.Pro1446Leu)	LRRK2	P1446L	not provided|Parkinson disease 8, autosomal dominant	Likely benign(Last reviewed: Feb 12, 2020)	criteria provided, multiple submitters, no conflicts	VCV000039186	12	40704252	12	40310450	39186	47792	rs74681492	NC_000012.12:40310449:C:T
NM_198578.4(LRRK2):c.4324G>C (p.Ala1442Pro)	LRRK2	A1442P	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Sep 13, 2012)	no assertion criteria provided	VCV000039185	12	40704239	12	40310437	39185	47791	rs281865048	NC_000012.12:40310436:G:C
NM_198578.4(LRRK2):c.4323C>T (p.Arg1441=)	LRRK2		Parkinson disease 8, autosomal dominant	Likely benign(Last reviewed: Dec 14, 2021)	criteria provided, single submitter	VCV000039184	12	40704238	12	40310436	39184	47790	rs112998035	NC_000012.12:40310435:C:T
NM_198578.4(LRRK2):c.4309A>C (p.Asn1437His)	LRRK2	N1437H	Parkinson disease 8, autosomal dominant	Pathogenic(Last reviewed: Sep 13, 2012)	no assertion criteria provided	VCV000039183	12	40703027	12	40309225	39183	47789	rs74163686	NC_000012.12:40309224:A:C
NM_198578.4(LRRK2):c.4290C>T (p.Ala1430=)	LRRK2		Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Sep 13, 2012)	no assertion criteria provided	VCV000039182	12	40703008	12	40309206	39182	47788	rs111435410	NC_000012.12:40309205:C:T
NM_198578.4(LRRK2):c.4269G>A (p.Lys1423=)	LRRK2		not specified|not provided|Parkinson disease 8, autosomal dominant	Benign(Last reviewed: Nov 27, 2020)	criteria provided, multiple submitters, no conflicts	VCV000039181	12	40702987	12	40309185	39181	47787	rs11175964	NC_000012.12:40309184:G:A
NM_198578.4(LRRK2):c.4258G>A (p.Asp1420Asn)	LRRK2	D1420N	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Sep 13, 2012)	no assertion criteria provided	VCV000039180	12	40702976	12	40309174	39180	47786	rs113589830	NC_000012.12:40309173:G:A
NM_198578.4(LRRK2):c.4229C>T (p.Thr1410Met)	LRRK2	T1410M	Parkinson disease 8, autosomal dominant|not provided	Benign/Likely benign(Last reviewed: Jun 2, 2020)	criteria provided, multiple submitters, no conflicts	VCV000039179	12	40702947	12	40309145	39179	47785	rs72546327	NC_000012.12:40309144:C:T
NM_198578.4(LRRK2):c.4193G>A (p.Arg1398His)	LRRK2	R1398H	not provided|not specified|Parkinson disease 8, autosomal dominant	Benign(Last reviewed: Nov 27, 2020)	criteria provided, multiple submitters, no conflicts	VCV000039178	12	40702911	12	40309109	39178	47784	rs7133914	NC_000012.12:40309108:G:A
NM_198578.4(LRRK2):c.4125C>A (p.Asp1375Glu)	LRRK2	D1375E	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Sep 13, 2012)	no assertion criteria provided	VCV000039177	12	40702434	12	40308632	39177	47783	rs28365226	NC_000012.12:40308631:C:A
NM_198578.4(LRRK2):c.4111A>G (p.Ile1371Val)	LRRK2	I1371V	Parkinson disease 8, autosomal dominant	Likely benign(Last reviewed: Dec 31, 2019)	criteria provided, multiple submitters, no conflicts	VCV000039176	12	40702420	12	40308618	39176	47782	rs17466213	NC_000012.12:40308617:A:G
NM_198578.4(LRRK2):c.3974G>A (p.Arg1325Gln)	LRRK2	R1325Q	Parkinson disease 8, autosomal dominant|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Oct 1, 2021)	criteria provided, conflicting interpretations	VCV000039175	12	40702283	12	40308481	39175	47781	rs72546338	NC_000012.12:40308480:G:A
NM_198578.4(LRRK2):c.3960G>T (p.Arg1320Ser)	LRRK2	R1320S	Parkinson disease 8, autosomal dominant|not provided	Likely benign(Last reviewed: Nov 30, 2020)	criteria provided, multiple submitters, no conflicts	VCV000039174	12	40702269	12	40308467	39174	47780	rs77018758	NC_000012.12:40308466:G:T
NM_198578.4(LRRK2):c.3784C>G (p.Pro1262Ala)	LRRK2	P1262A	not provided|Parkinson disease 8, autosomal dominant	Benign/Likely benign(Last reviewed: Jan 22, 2021)	criteria provided, multiple submitters, no conflicts	VCV000039173	12	40699593	12	40305791	39173	47779	rs4640000	NC_000012.12:40305790:C:G
NM_198578.4(LRRK2):c.3683G>T (p.Ser1228Ile)	LRRK2	S1228I	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Sep 13, 2012)	no assertion criteria provided	VCV000039172	12	40697842	12	40304040	39172	47778	rs60185966	NC_000012.12:40304039:G:T
NM_198578.4(LRRK2):c.3683G>C (p.Ser1228Thr)	LRRK2	S1228T	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Aug 27, 2018)	criteria provided, single submitter	VCV000039171	12	40697842	12	40304040	39171	47777	rs60185966	NC_000012.12:40304039:G:C
NM_198578.4(LRRK2):c.364= (p.Leu122=)	LRRK2		Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Sep 13, 2012)	no assertion criteria provided	VCV000039170	12	40629444	12	40235642	39170	47776	rs41286468	NC_000012.12:40235641:C:C
NM_198578.4(LRRK2):c.3647A>G (p.His1216Arg)	LRRK2	H1216R	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Sep 13, 2012)	no assertion criteria provided	VCV000039169	12	40697806	12	40304004	39169	47775	rs72546324	NC_000012.12:40304003:A:G
NM_198578.4(LRRK2):c.3574A>G (p.Ile1192Val)	LRRK2	I1192V	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Aug 9, 2018)	criteria provided, single submitter	VCV000039168	12	40696668	12	40302866	39168	47774	rs281865047	NC_000012.12:40302865:A:G
NM_198578.4(LRRK2):c.356T>C (p.Leu119Pro)	LRRK2	L119P	Parkinson disease 8, autosomal dominant|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Sep 3, 2021)	criteria provided, conflicting interpretations	VCV000039167	12	40629436	12	40235634	39167	47773	rs33995463	NC_000012.12:40235633:T:C
NM_198578.4(LRRK2):c.3494T>C (p.Leu1165Pro)	LRRK2	L1165P	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Sep 13, 2012)	no assertion criteria provided	VCV000039166	12	40693057	12	40299255	39166	47772	rs281865046	NC_000012.12:40299254:T:C
NM_198578.4(LRRK2):c.3451G>A (p.Ala1151Thr)	LRRK2	A1151T	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Sep 24, 2018)	criteria provided, single submitter	VCV000039165	12	40693014	12	40299212	39165	47771	rs74985840	NC_000012.12:40299211:G:A
NM_198578.4(LRRK2):c.3342A>G (p.Leu1114=)	LRRK2		not provided|Parkinson disease 8, autosomal dominant|not specified	Benign/Likely benign(Last reviewed: May 12, 2021)	criteria provided, multiple submitters, no conflicts	VCV000039164	12	40692290	12	40298488	39164	47770	rs35808389	NC_000012.12:40298487:A:G
NM_198578.4(LRRK2):c.3333G>T (p.Gln1111His)	LRRK2	Q1111H	not provided|Parkinson disease 8, autosomal dominant	Benign/Likely benign(Last reviewed: Oct 25, 2020)	criteria provided, multiple submitters, no conflicts	VCV000039163	12	40692281	12	40298479	39163	47769	rs78365431	NC_000012.12:40298478:G:T
NM_198578.4(LRRK2):c.3287C>G (p.Ser1096Cys)	LRRK2	S1096C	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Nov 18, 2021)	criteria provided, single submitter	VCV000039162	12	40692235	12	40298433	39162	47768	rs76535406	NC_000012.12:40298432:C:G
NM_198578.4(LRRK2):c.3200G>A (p.Arg1067Gln)	LRRK2	R1067Q	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Sep 13, 2012)	no assertion criteria provided	VCV000039161	12	40692148	12	40298346	39161	47767	rs111341148	NC_000012.12:40298345:G:A
NM_198578.4(LRRK2):c.3021= (p.Ser1007=)	LRRK2		Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Sep 13, 2012)	no assertion criteria provided	VCV000039160	12	40689371	12	40295569	39160	47766	rs55783828	NC_000012.12:40295568:T:T
NM_198578.4(LRRK2):c.3018A>G (p.Ile1006Met)	LRRK2	I1006M	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Nov 16, 2017)	criteria provided, multiple submitters, no conflicts	VCV000039159	12	40689368	12	40295566	39159	47765	rs113217062	NC_000012.12:40295565:A:G
NM_198578.4(LRRK2):c.2918G>A (p.Ser973Asn)	LRRK2	S973N	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Sep 13, 2012)	no assertion criteria provided	VCV000039158	12	40689268	12	40295466	39158	47764	rs75148313	NC_000012.12:40295465:G:A
NM_198578.4(LRRK2):c.28G>A (p.Glu10Lys)	LRRK2	E10K	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Nov 30, 2021)	criteria provided, single submitter	VCV000039157	12	40618961	12	40225159	39157	47763	rs281865040	NC_000012.12:40225158:G:A
NM_198578.4(LRRK2):c.2857T>C (p.Leu953=)	LRRK2		Parkinson disease 8, autosomal dominant|not provided|not specified	Benign(Last reviewed: Dec 7, 2020)	criteria provided, multiple submitters, no conflicts	VCV000039156	12	40688695	12	40294893	39156	47762	rs7966550	NC_000012.12:40294892:T:C
NM_198578.4(LRRK2):c.2830G>T (p.Asp944Tyr)	LRRK2	D944Y	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Sep 13, 2012)	no assertion criteria provided	VCV000039155	12	40688668	12	40294866	39155	47761	rs17519916	NC_000012.12:40294865:G:T
NM_198578.4(LRRK2):c.2789A>G (p.Gln930Arg)	LRRK2	Q930R	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Sep 13, 2012)	no assertion criteria provided	VCV000039154	12	40687446	12	40293644	39154	47760	rs281865045	NC_000012.12:40293643:A:G
NM_198578.4(LRRK2):c.2769G>C (p.Gln923His)	LRRK2	Q923H	Parkinson disease 8, autosomal dominant|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Jan 1, 2022)	criteria provided, conflicting interpretations	VCV000039153	12	40687426	12	40293624	39153	47759	rs58559150	NC_000012.12:40293623:G:C
NM_198578.4(LRRK2):c.2611A>G (p.Lys871Glu)	LRRK2	K871E	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Sep 13, 2012)	no assertion criteria provided	VCV000039152	12	40681263	12	40287461	39152	47758	rs281865044	NC_000012.12:40287460:A:G
NM_198578.4(LRRK2):c.2481T>C (p.Ser827=)	LRRK2		Parkinson disease 8, autosomal dominant	Likely benign(Last reviewed: Dec 1, 2019)	criteria provided, single submitter	VCV000039151	12	40677916	12	40284114	39151	47757	rs76890302	NC_000012.12:40284113:T:C
NM_198578.4(LRRK2):c.2428A>G (p.Ile810Val)	LRRK2	I810V	Parkinson disease 8, autosomal dominant|not provided	Uncertain significance(Last reviewed: Mar 15, 2017)	criteria provided, single submitter	VCV000039150	12	40677863	12	40284061	39150	47756	rs72546337	NC_000012.12:40284060:A:G
NM_198578.4(LRRK2):c.2378G>T (p.Arg793Met)	LRRK2	R793M	Parkinson disease 8, autosomal dominant|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Mar 15, 2021)	criteria provided, conflicting interpretations	VCV000039149	12	40677813	12	40284011	39149	47755	rs35173587	NC_000012.12:40284010:G:T
NM_198578.4(LRRK2):c.2264C>T (p.Pro755Leu)	LRRK2	P755L	Parkinson disease 8, autosomal dominant|not provided	Benign/Likely benign(Last reviewed: May 5, 2021)	criteria provided, multiple submitters, no conflicts	VCV000039148	12	40677699	12	40283897	39148	47754	rs34410987	NC_000012.12:40283896:C:T
NM_198578.4(LRRK2):c.225G>A (p.Ala75=)	LRRK2		Parkinson disease 8, autosomal dominant|not provided	Benign(Last reviewed: Oct 8, 2020)	criteria provided, multiple submitters, no conflicts	VCV000039147	12	40619430	12	40225628	39147	47753	rs75054132	NC_000012.12:40225627:G:A
NM_198578.4(LRRK2):c.2167A>G (p.Ile723Val)	LRRK2	I723V	Parkinson disease 8, autosomal dominant|not provided	Benign(Last reviewed: Dec 3, 2020)	criteria provided, multiple submitters, no conflicts	VCV000039146	12	40671989	12	40278187	39146	47752	rs10878307	NC_000012.12:40278186:A:G
NM_198578.4(LRRK2):c.2147C>T (p.Ala716Val)	LRRK2	A716V	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Sep 13, 2012)	no assertion criteria provided	VCV000039145	12	40671969	12	40278167	39145	47751	rs281865043	NC_000012.12:40278166:C:T
NM_198578.4(LRRK2):c.2134A>G (p.Met712Val)	LRRK2	M712V	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Sep 13, 2012)	no assertion criteria provided	VCV000039144	12	40671956	12	40278154	39144	47750	rs199566791	NC_000012.12:40278153:A:G
NM_198578.4(LRRK2):c.2022A>C (p.Val674=)	LRRK2		not specified|Parkinson disease 8, autosomal dominant	Benign(Last reviewed: Aug 19, 2019)	criteria provided, multiple submitters, no conflicts	VCV000039143	12	40671770	12	40277968	39143	47749	rs72546319	NC_000012.12:40277967:A:C
NM_198578.4(LRRK2):c.1987T>C (p.Ser663Pro)	LRRK2	S663P	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Sep 13, 2012)	no assertion criteria provided	VCV000039142	12	40671735	12	40277933	39142	47748	rs78154388	NC_000012.12:40277932:T:C
NM_198578.4(LRRK2):c.1847A>G (p.Lys616Arg)	LRRK2	K616R	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Sep 13, 2012)	no assertion criteria provided	VCV000039141	12	40668701	12	40274899	39141	47747	rs281865042	NC_000012.12:40274898:A:G
NM_198578.4(LRRK2):c.1674= (p.Gly558=)	LRRK2		Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Sep 13, 2012)	no assertion criteria provided	VCV000039140	12	40668402	12	40274600	39140	47746	rs77424631	NC_000012.12:40274599:G:G
NM_198578.4(LRRK2):c.1653C>G (p.Asn551Lys)	LRRK2	N551K	not provided|not specified|Parkinson disease 8, autosomal dominant	Benign(Last reviewed: Nov 27, 2020)	criteria provided, multiple submitters, no conflicts	VCV000039139	12	40657700	12	40263898	39139	47745	rs7308720	NC_000012.12:40263897:C:G
NM_198578.4(LRRK2):c.1630A>G (p.Lys544Glu)	LRRK2	K544E	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Aug 14, 2021)	criteria provided, single submitter	VCV000039138	12	40657677	12	40263875	39138	47744	rs79996249	NC_000012.12:40263874:A:G
NM_198578.4(LRRK2):c.1561A>G (p.Arg521Gly)	LRRK2	R521G	Parkinson disease 8, autosomal dominant|not specified	Conflicting interpretations of pathogenicity(Last reviewed: Sep 20, 2021)	criteria provided, conflicting interpretations	VCV000039137	12	40657608	12	40263806	39137	47743	rs35328937	NC_000012.12:40263805:A:G
NM_198578.4(LRRK2):c.155C>T (p.Ser52Phe)	LRRK2	S52F	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Sep 13, 2012)	no assertion criteria provided	VCV000039136	12	40619360	12	40225558	39136	47742	rs72546335	NC_000012.12:40225557:C:T
NM_198578.4(LRRK2):c.1517G>A (p.Arg506Gln)	LRRK2	R506Q	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Aug 20, 2021)	criteria provided, single submitter	VCV000039135	12	40653380	12	40259578	39135	47741	rs202009639	NC_000012.12:40259577:G:A
NM_198578.3(LRRK2):c.149A>G (p.His50Arg)	LRRK2		Parkinson disease 8, autosomal dominant|not specified	Benign(Last reviewed: Dec 27, 2019)	criteria provided, multiple submitters, no conflicts	VCV000039134	12	40619082	12	40225280	39134	47740	rs2256408	NC_000012.12:40225279:G:G
NM_198578.4(LRRK2):c.1464A>T (p.Leu488=)	LRRK2		Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Sep 13, 2012)	no assertion criteria provided	VCV000039133	12	40653327	12	40259525	39133	47739	rs75711334	NC_000012.12:40259524:A:T
NM_198578.4(LRRK2):c.1383= (p.Ser461=)	LRRK2		Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Sep 13, 2012)	no assertion criteria provided	VCV000039132	12	40651144	12	40257342	39132	47738	rs35847451	NC_000012.12:40257341:T:T
NM_198578.4(LRRK2):c.1256C>T (p.Ala419Val)	LRRK2	A419V	not provided|Parkinson disease 8, autosomal dominant	Benign(Last reviewed: Dec 1, 2020)	criteria provided, multiple submitters, no conflicts	VCV000039131	12	40646786	12	40252984	39131	47737	rs34594498	NC_000012.12:40252983:C:T
NM_198578.4(LRRK2):c.1096G>A (p.Val366Met)	LRRK2	V366M	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Sep 13, 2012)	no assertion criteria provided	VCV000039130	12	40645171	12	40251369	39130	47736	rs113065049	NC_000012.12:40251368:G:A
NM_198578.4(LRRK2):c.1088A>G (p.Asn363Ser)	LRRK2	N363S	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Sep 13, 2012)	no assertion criteria provided	VCV000039129	12	40645163	12	40251361	39129	47735	rs72546336	NC_000012.12:40251360:A:G
NM_198578.4(LRRK2):c.1000G>A (p.Glu334Lys)	LRRK2	E334K	not specified|not provided|Parkinson disease 8, autosomal dominant	Conflicting interpretations of pathogenicity(Last reviewed: Nov 11, 2020)	criteria provided, conflicting interpretations	VCV000039128	12	40645075	12	40251273	39128	47734	rs78501232	NC_000012.12:40251272:G:A
NM_198578.4(LRRK2):c.7153G>A (p.Gly2385Arg)	LRRK2	G2385R	Parkinson disease|Parkinson disease 8, autosomal dominant	Conflicting interpretations of pathogenicity; risk factor(Last reviewed: Nov 7, 2020)	criteria provided, conflicting interpretations	VCV000001943	12	40757328	12	40363526	1943	16982	rs34778348	NC_000012.12:40363525:G:A
NM_198578.4(LRRK2):c.4322G>A (p.Arg1441His)	LRRK2	R1441H	Parkinson disease 8, autosomal dominant	Pathogenic(Last reviewed: Sep 13, 2012)	no assertion criteria provided	VCV000001942	12	40704237	12	40310435	1942	16981	rs34995376	NC_000012.12:40310434:G:A
NM_198578.4(LRRK2):c.6059T>C (p.Ile2020Thr)	LRRK2	I2020T	not provided|Parkinson disease 8, autosomal dominant	Pathogenic(Last reviewed: Dec 1, 2020)	criteria provided, single submitter	VCV000001941	12	40734206	12	40340404	1941	16980	rs35870237	NC_000012.12:40340403:T:C
NM_198578.4(LRRK2):c.6055G>A (p.Gly2019Ser)	LRRK2	G2019S	Parkinson disease, late-onset|not provided|Young-onset Parkinson disease|Inborn genetic diseases|Parkinson disease 8, autosomal dominant	Pathogenic; risk factor(Last reviewed: Dec 3, 2021)	criteria provided, multiple submitters, no conflicts	VCV000001940	12	40734202	12	40340400	1940	16979	rs34637584	NC_000012.12:40340399:G:A
NM_198578.4(LRRK2):c.3364A>G (p.Ile1122Val)	LRRK2	I1122V	Parkinson disease 8, autosomal dominant	Pathogenic(Last reviewed: Sep 13, 2012)	no assertion criteria provided	VCV000001939	12	40692927	12	40299125	1939	16978	rs34805604	NC_000012.12:40299124:A:G
NM_198578.4(LRRK2):c.4321C>T (p.Arg1441Cys)	LRRK2	R1441C	Parkinson disease, late-onset|Parkinson disease 8, autosomal dominant	Pathogenic(Last reviewed: May 3, 2021)	criteria provided, multiple submitters, no conflicts	VCV000001938	12	40704236	12	40310434	1938	16977	rs33939927	NC_000012.12:40310433:C:T
NM_198578.4(LRRK2):c.5096A>G (p.Tyr1699Cys)	LRRK2	Y1699C	Parkinson disease 8, autosomal dominant	Pathogenic(Last reviewed: Sep 13, 2012)	no assertion criteria provided	VCV000001937	12	40714916	12	40321114	1937	16976	rs35801418	NC_000012.12:40321113:A:G
NM_198578.4(LRRK2):c.4321C>G (p.Arg1441Gly)	LRRK2	R1441G	Parkinson disease 8, autosomal dominant|not provided	Pathogenic(Last reviewed: Dec 16, 2020)	criteria provided, multiple submitters, no conflicts	VCV000001936	12	40704236	12	40310434	1936	16975	rs33939927	NC_000012.12:40310433:C:G
NM_001377265.1(MAPT):c.47G>T (p.Gly16Val)	MAPT	G16V	Parkinson disease, late-onset|Frontotemporal dementia|Progressive supranuclear ophthalmoplegia|Pick disease	Uncertain significance(Last reviewed: Feb 11, 2019)	criteria provided, multiple submitters, no conflicts	VCV000548576	17	44039750	17	45962384	548576	539073	rs755131800	NC_000017.11:45962383:G:T
NM_001377265.1(MAPT):c.1115C>T (p.Ala372Val)	MAPT	A297V, A372V	Frontotemporal dementia|Parkinson disease, late-onset|Parkinson-dementia syndrome|Pick disease|Progressive supranuclear ophthalmoplegia|not provided	Uncertain significance(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000429936	17	44061060	17	45983694	429936	422174	rs377402921	NC_000017.11:45983693:C:T
NM_001377265.1(MAPT):c.1630G>A (p.Ala544Thr)	MAPT	A152T, A469T, A123T, A94T, A478T, A544T	Frontotemporal dementia|MAPT-Related Spectrum Disorders|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Jun 1, 2021)	criteria provided, conflicting interpretations	VCV000323645	17	44068850	17	45991484	323645	338789	rs143624519	NC_000017.11:45991483:G:A
NM_001377265.1(MAPT):c.2060ATA[1] (p.Asn688del)	MAPT	N613del, N296del, N238del, N267del, N631del, N688del	Parkinson disease, late-onset|Parkinson-dementia syndrome|not provided	Pathogenic(Last reviewed: Jul 1, 2021)	criteria provided, single submitter	VCV000098243	17	44087737 - 44087739	17	46010371 - 46010373	98243	104135	rs63751392	NC_000017.11:46010370:ATAATA:ATA
NM_001377265.1(MAPT):c.1891G>A (p.Ala631Thr)	MAPT	A556T, A239T, A574T, A181T, A210T, A565T, A631T	Frontotemporal dementia|not provided|MAPT-Related Spectrum Disorders	Conflicting interpretations of pathogenicity(Last reviewed: Aug 25, 2020)	criteria provided, conflicting interpretations	VCV000098208	17	44073923	17	45996557	98208	104100	rs63750096	NC_000017.11:45996556:G:A
NM_001377265.1(MAPT):c.2013T>G (p.Asn671Lys)	MAPT	N279K, N221K, N250K, N596K, N614K, N671K	Frontotemporal dementia|Frontotemporal dementia|Parkinson disease, late-onset|Parkinson-dementia syndrome|Pick disease|Progressive supranuclear ophthalmoplegia|not provided	Pathogenic(Last reviewed: Mar 30, 2019)	criteria provided, multiple submitters, no conflicts	VCV000014253	17	44087690	17	46010324	14253	29292	rs63750756	NC_000017.11:46010323:T:G
NM_001377265.1(MAPT):c.2392C>T (p.Arg798Trp)	MAPT	R406W, R723W, R375W, R317W, R346W, R741W, R348W, R377W, R701W, R798W	Frontotemporal dementia|Frontotemporal dementia|Parkinson disease, late-onset|Parkinson-dementia syndrome|Pick disease|Progressive supranuclear ophthalmoplegia|not provided	Pathogenic(Last reviewed: Dec 1, 2021)	criteria provided, multiple submitters, no conflicts	VCV000014247	17	44101427	17	46024061	14247	29286	rs63750424	NC_000017.11:46024060:C:T
NM_001377265.1(MAPT):c.2078C>T (p.Pro693Leu)	MAPT	P301L, P243L, P272L, P618L, P636L, P693L	not provided|Progressive supranuclear ophthalmoplegia|Frontotemporal dementia|Frontotemporal dementia|Parkinson disease, late-onset|Parkinson-dementia syndrome|Pick disease|Progressive supranuclear ophthalmoplegia	Pathogenic(Last reviewed: Sep 1, 2021)	criteria provided, multiple submitters, no conflicts	VCV000014245	17	44087755	17	46010389	14245	29284	rs63751273	NC_000017.11:46010388:C:T
NM_002386.4(MC1R):c.451C>T (p.Arg151Cys)	MC1R	R151C	not provided|not specified|Increased analgesia from kappa-opioid receptor agonist, female-specific|OCULOCUTANEOUS ALBINISM, TYPE II, MODIFIER OF|Skin/hair/eye pigmentation 2, red hair/fair skin|Cutaneous malignant melanoma 5	Benign(Last reviewed: Dec 4, 2020)	criteria provided, multiple submitters, no conflicts	VCV000014312	16	89986117	16	89919709	14312	29351	rs1805007	NC_000016.10:89919708:C:T
NM_002386.4(MC1R):c.478C>T (p.Arg160Trp)	MC1R	R160W	not specified|not provided|Cutaneous malignant melanoma 5|Increased analgesia from kappa-opioid receptor agonist, female-specific|OCULOCUTANEOUS ALBINISM, TYPE II, MODIFIER OF|Skin/hair/eye pigmentation 2, red hair/fair skin|Malignant tumor of breast	Conflicting interpretations of pathogenicity(Last reviewed: Dec 4, 2020)	criteria provided, conflicting interpretations	VCV000014310	16	89986144	16	89919736	14310	29349	rs1805008	NC_000016.10:89919735:C:T
NM_005460.4(SNCAIP):c.*591A>T	MGC32805|SNCAIP		Parkinson Disease, Dominant/Recessive	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000907914	5	121799782	5	122464087	907914	896019	rs947102772	NC_000005.10:122464086:A:T
NM_005460.4(SNCAIP):c.*498A>G	MGC32805|SNCAIP		Parkinson Disease, Dominant/Recessive	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000907913	5	121799689	5	122463994	907913	892689	rs1399535393	NC_000005.10:122463993:A:G
NM_005460.4(SNCAIP):c.*343A>G	MGC32805|SNCAIP		Parkinson Disease, Dominant/Recessive	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000907912	5	121799534	5	122463839	907912	892688	rs952875545	NC_000005.10:122463838:A:G
NM_005460.4(SNCAIP):c.*287G>A	MGC32805|SNCAIP		Parkinson Disease, Dominant/Recessive	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000907911	5	121799478	5	122463783	907911	892687	rs536163171	NC_000005.10:122463782:G:A
NM_005460.4(SNCAIP):c.1817G>A (p.Arg606Gln)	MGC32805|SNCAIP	R202Q, R606Q, R653Q, R238Q, R240Q, R546Q, R300Q	Parkinson Disease, Dominant/Recessive	Uncertain significance(Last reviewed: Apr 28, 2017)	criteria provided, single submitter	VCV000907845	5	121786359	5	122450664	907845	892675	rs144492699	NC_000005.10:122450663:G:A
NM_005460.4(SNCAIP):c.1811C>G (p.Ser604Cys)	MGC32805|SNCAIP	S544C, S604C, S651C, S200C, S236C, S238C, S298C	Parkinson Disease, Dominant/Recessive	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000907844	5	121786353	5	122450658	907844	892674	rs1783529987	NC_000005.10:122450657:C:G
NM_005460.4(SNCAIP):c.1496G>A (p.Arg499Gln)	MGC32805|SNCAIP	R131Q, R439Q, R499Q, R95Q, R193Q, R546Q, R133Q	Parkinson Disease, Dominant/Recessive	Uncertain significance(Last reviewed: Apr 27, 2017)	criteria provided, single submitter	VCV000907843	5	121780331	5	122444636	907843	892673	rs373891275	NC_000005.10:122444635:G:A
NM_005460.4(SNCAIP):c.1448T>C (p.Val483Ala)	MGC32805|SNCAIP	V79A, V115A, V117A, V423A, V530A, V177A, V483A	Parkinson Disease, Dominant/Recessive	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000907842	5	121780283	5	122444588	907842	892672	rs150695297	NC_000005.10:122444587:T:C
NM_005460.4(SNCAIP):c.1297-3T>C	MGC32805|SNCAIP		Parkinson Disease, Dominant/Recessive	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000907841	5	121776321	5	122440626	907841	896018	rs374278026	NC_000005.10:122440625:T:C
NM_005460.4(SNCAIP):c.*247G>A	MGC32805|SNCAIP		Parkinson Disease, Dominant/Recessive	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000906929	5	121799438	5	122463743	906929	892685	rs1787041774	NC_000005.10:122463742:G:A
NM_005460.4(SNCAIP):c.*161A>G	MGC32805|SNCAIP		Parkinson Disease, Dominant/Recessive	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000906928	5	121799352	5	122463657	906928	892684	rs762790786	NC_000005.10:122463656:A:G
NM_005460.4(SNCAIP):c.*103C>T	MGC32805|SNCAIP		Parkinson Disease, Dominant/Recessive	Likely benign(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000906927	5	121799294	5	122463599	906927	892683	rs547306341	NC_000005.10:122463598:C:T
NM_005460.4(SNCAIP):c.2729C>A (p.Ser910Tyr)	MGC32805|SNCAIP	S506Y, S542Y, S957Y, S850Y, S604Y, S544Y, S910Y	Parkinson Disease, Dominant/Recessive	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000905322	5	121787271	5	122451576	905322	892682	rs1783693013	NC_000005.10:122451575:C:A
NM_005460.4(SNCAIP):c.2618G>A (p.Gly873Asp)	MGC32805|SNCAIP	G507D, G873D, G920D, G469D, G813D, G505D, G567D	Parkinson Disease, Dominant/Recessive	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000905320	5	121787160	5	122451465	905320	892680	rs1334883855	NC_000005.10:122451464:G:A
NM_005460.4(SNCAIP):c.2556A>G (p.Glu852=)	MGC32805|SNCAIP		Parkinson Disease, Dominant/Recessive	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000905319	5	121787098	5	122451403	905319	892679	rs761300214	NC_000005.10:122451402:A:G
NM_005460.4(SNCAIP):c.2291C>T (p.Pro764Leu)	MGC32805|SNCAIP	P396L, P704L, P764L, P811L, P360L, P398L, P458L	Parkinson Disease, Dominant/Recessive	Likely benign(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000905318	5	121786833	5	122451138	905318	892678	rs201185316	NC_000005.10:122451137:C:T
NM_005460.4(SNCAIP):c.2191C>T (p.Arg731Cys)	MGC32805|SNCAIP	R778C, R363C, R671C, R731C, R327C, R365C, R425C	Parkinson Disease, Dominant/Recessive	Likely benign(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000905317	5	121786733	5	122451038	905317	892677	rs755160196	NC_000005.10:122451037:C:T
NM_005460.4(SNCAIP):c.1939G>C (p.Ala647Pro)	MGC32805|SNCAIP	A243P, A694P, A281P, A647P, A279P, A341P, A587P	Parkinson Disease, Dominant/Recessive	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000904533	5	121786481	5	122450786	904533	892676	rs149789738	NC_000005.10:122450785:G:C
NM_005460.4(SNCAIP):c.*574dup	MGC32805|SNCAIP		Parkinson Disease, Dominant/Recessive	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000350511	5	121799761 - 121799762	5	122464066 - 122464067	350511	300497	rs574096351	NC_000005.10:122464066:GGGG:GGGGG
NM_005460.4(SNCAIP):c.*314T>C	MGC32805|SNCAIP		Parkinson Disease, Dominant/Recessive	Benign(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000350510	5	121799505	5	122463810	350510	300574	rs11326	NC_000005.10:122463809:T:C
NM_005460.4(SNCAIP):c.*202A>T	MGC32805|SNCAIP		Parkinson Disease, Dominant/Recessive	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000350509	5	121799393	5	122463698	350509	296780	rs886059828	NC_000005.10:122463697:A:T
NM_005460.4(SNCAIP):c.*170A>G	MGC32805|SNCAIP		Parkinson Disease, Dominant/Recessive	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000350508	5	121799361	5	122463666	350508	300496	rs886059827	NC_000005.10:122463665:A:G
NM_005460.4(SNCAIP):c.*102A>G	MGC32805|SNCAIP		Parkinson Disease, Dominant/Recessive	Likely benign(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000350507	5	121799293	5	122463598	350507	300495	rs567026967	NC_000005.10:122463597:A:G
NM_005460.4(SNCAIP):c.*70C>G	MGC32805|SNCAIP		Parkinson Disease, Dominant/Recessive	Benign(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000350506	5	121799261	5	122463566	350506	296767	rs149180835	NC_000005.10:122463565:C:G
NM_005460.4(SNCAIP):c.*46T>G	MGC32805|SNCAIP	I593M, I1006M	Parkinson Disease, Dominant/Recessive	Likely benign(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000350505	5	121799237	5	122463542	350505	295005	rs187197845	NC_000005.10:122463541:T:G
NM_005460.4(SNCAIP):c.2736C>G (p.Ser912Arg)	MGC32805|SNCAIP	S912R, S544R, S606R, S852R, S959R, S508R, S546R	Parkinson Disease, Dominant/Recessive	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000350504	5	121787278	5	122451583	350504	295003	rs886059826	NC_000005.10:122451582:C:G
NM_005460.4(SNCAIP):c.2710A>G (p.Lys904Glu)	MGC32805|SNCAIP	K904E, K536E, K844E, K951E, K500E, K538E, K598E	Parkinson Disease, Dominant/Recessive	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000350503	5	121787252	5	122451557	350503	300573	rs751412863	NC_000005.10:122451556:A:G
NM_005460.4(SNCAIP):c.2417G>A (p.Arg806His)	MGC32805|SNCAIP	R806H, R440H, R438H, R500H, R746H, R853H, R402H	Parkinson Disease, Dominant/Recessive|not provided	Benign(Last reviewed: Dec 31, 2019)	criteria provided, multiple submitters, no conflicts	VCV000350502	5	121786959	5	122451264	350502	300484	rs140850272	NC_000005.10:122451263:G:A
NM_005460.4(SNCAIP):c.2148C>T (p.Ser716=)	MGC32805|SNCAIP		Parkinson Disease, Dominant/Recessive	Likely benign(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000350501	5	121786690	5	122450995	350501	295001	rs536468779	NC_000005.10:122450994:C:T
NM_005460.4(SNCAIP):c.2140G>A (p.Ala714Thr)	MGC32805|SNCAIP	A714T, A310T, A348T, A654T, A346T, A408T, A761T	Parkinson Disease, Dominant/Recessive	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000350500	5	121786682	5	122450987	350500	300483	rs143468222	NC_000005.10:122450986:G:A
NM_005460.4(SNCAIP):c.2131A>G (p.Met711Val)	MGC32805|SNCAIP	M711V, M651V, M758V, M343V, M307V, M345V, M405V	Parkinson Disease, Dominant/Recessive|not provided	Benign(Last reviewed: Dec 31, 2019)	criteria provided, multiple submitters, no conflicts	VCV000350499	5	121786673	5	122450978	350499	296766	rs139256839	NC_000005.10:122450977:A:G
NM_005460.4(SNCAIP):c.2125G>C (p.Glu709Gln)	MGC32805|SNCAIP	E709Q, E649Q, E343Q, E305Q, E341Q, E403Q, E756Q	not provided|Parkinson Disease, Dominant/Recessive|not specified	Benign/Likely benign(Last reviewed: Dec 31, 2019)	criteria provided, multiple submitters, no conflicts	VCV000350498	5	121786667	5	122450972	350498	300482	rs55712196	NC_000005.10:122450971:G:C
NM_005460.4(SNCAIP):c.2022A>G (p.Ser674=)	MGC32805|SNCAIP		Parkinson Disease, Dominant/Recessive	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000350497	5	121786564	5	122450869	350497	300543	rs763683428	NC_000005.10:122450868:A:G
NM_005460.4(SNCAIP):c.1969C>T (p.Leu657=)	MGC32805|SNCAIP		Parkinson Disease, Dominant/Recessive	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000350496	5	121786511	5	122450816	350496	300542	rs376564775	NC_000005.10:122450815:C:T
NM_000257.4(MYH7):c.4377G>T (p.Lys1459Asn)	MHRT|MYH7	K1459N	Wolff-Parkinson-White pattern|Cardiomyopathy|Congenital myopathy with fiber type disproportion|not provided|Myopathy, distal, 1|Cardiovascular phenotype|Hypertrophic cardiomyopathy|Myosin storage myopathy|Familial hypertrophic cardiomyopathy 1|not specified|Primary familial hypertrophic cardiomyopathy	Likely benign(Last reviewed: Dec 15, 2016)	reviewed by expert panel	VCV000043012	14	23886504	14	23417295	43012	52182	rs201307101	NC_000014.9:23417294:C:A
NM_032409.3(PINK1):c.177C>T (p.Val59=)	MIR6084|PINK1		Parkinson disease 6, autosomal recessive early-onset	Likely benign(Last reviewed: Dec 8, 2021)	criteria provided, single submitter	VCV001644553	1	20960218	1	20633725	1644553	1522600		NC_000001.11:20633724:C:T
NM_032409.3(PINK1):c.141C>G (p.Gly47=)	MIR6084|PINK1		Parkinson disease 6, autosomal recessive early-onset	Uncertain significance(Last reviewed: Nov 1, 2021)	criteria provided, single submitter	VCV001510457	1	20960182	1	20633689	1510457	1442512		NC_000001.11:20633688:C:G
NM_032409.3(PINK1):c.199C>T (p.Leu67Phe)	MIR6084|PINK1	L67F	Parkinson disease 6, autosomal recessive early-onset	Uncertain significance(Last reviewed: Sep 1, 2021)	criteria provided, single submitter	VCV001416013	1	20960240	1	20633747	1416013	1371641		NC_000001.11:20633746:C:T
NM_032409.3(PINK1):c.161C>A (p.Ala54Glu)	MIR6084|PINK1	A54E	Parkinson disease 6, autosomal recessive early-onset	Uncertain significance(Last reviewed: Nov 4, 2019)	criteria provided, single submitter	VCV001030969	1	20960202	1	20633709	1030969	1015627	rs867771554	NC_000001.11:20633708:C:A
NM_032409.3(PINK1):c.218C>T (p.Ser73Leu)	MIR6084|PINK1	S73L	Parkinson disease 6, autosomal recessive early-onset	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000874873	1	20960259	1	20633766	874873	863341	rs202048763	NC_000001.11:20633765:C:T
NM_032409.3(PINK1):c.165G>A (p.Glu55=)	MIR6084|PINK1		Parkinson disease 6, autosomal recessive early-onset	Conflicting interpretations of pathogenicity(Last reviewed: Dec 31, 2019)	criteria provided, conflicting interpretations	VCV000294998	1	20960206	1	20633713	294998	278531	rs537679886	NC_000001.11:20633712:G:A
NM_032409.3(PINK1):c.189C>T (p.Leu63=)	MIR6084|PINK1		Parkinson disease 6, autosomal recessive early-onset|not provided|not specified	Benign(Last reviewed: Dec 4, 2020)	criteria provided, multiple submitters, no conflicts	VCV000262026	1	20960230	1	20633737	262026	249676	rs45530340	NC_000001.11:20633736:C:T
NC_012920.1:m.8969G>A	MT-ATP6	S148N	Myopathy, lactic acidosis, and sideroblastic anemia 3|Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Pathogenic(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000191364	MT	8969	MT	8969	191364	189167	rs794726857	NC_012920.1:8968:G:A
NC_012920.1:m.3548T>C	MT-ND1	I81T	Leigh syndrome|not specified	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000235006	MT	3548	MT	3548	235006	236826	rs876661353	NC_012920.1:3547:T:C
m.3796A>G	MT-ND1	T164A	not provided|Leigh syndrome|Dystonia, adult-onset	Benign(Last reviewed: Oct 17, 2019)	criteria provided, multiple submitters, no conflicts	VCV000009730	MT	3796	MT	3796	9730	24769	rs28357970	NC_012920.1:3795:A:G
m.3397A>G	MT-ND1	M31V	Alzheimer disease|Parkinson disease, late-onset|Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000009726	MT	3397	MT	3397	9726	24765	rs199476120	NC_012920.1:3396:A:G
m.10398A>G	MT-ND3	T114A	Leigh syndrome|Parkinson disease, resistance to	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000009713	MT	10398	MT	10398	9713	24752	rs2853826	NC_012920.1:10397:A:G
m.12397A>G	MT-ND5	T21A	Leigh syndrome|Parkinson disease 6, autosomal recessive early-onset	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000009705	MT	12397	MT	12397	9705	24744	rs1556424100	NC_012920.1:12396:A:G
m.13042G>A	MT-ND5	A236T	Leber optic atrophy|Leigh syndrome due to mitochondrial complex I deficiency|Juvenile myopathy, encephalopathy, lactic acidosis AND stroke|MERRF syndrome	Pathogenic(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000009703	MT	13042	MT	13042	9703	24742	rs267606898	NC_012920.1:13041:G:A
m.14319T>C	MT-ND6	N119D	Parkinson disease 6, autosomal recessive early-onset|Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000009695	MT	14319	MT	14319	9695	24734	rs199476110	NC_012920.1:14318:T:C
m.1095T>C	MT-RNR1		not specified|Auditory neuropathy|kanamycin response - Toxicity|streptomycin response - Toxicity|gentamicin response - Toxicity|aminoglycoside antibacterials response - Toxicity|Deafness, nonsyndromic sensorineural, mitochondrial|Aminoglycoside-induced deafness	drug response(Last reviewed: Jun 15, 2021)	reviewed by expert panel	VCV000009631	MT	1095	MT	1095	9631	24670	rs267606618	NC_012920.1:1094:T:C
m.611G>A	MT-TF		MERRF syndrome	Pathogenic(Last reviewed: Jan 29, 2015)	no assertion criteria provided	VCV000009574	MT	611	MT	611	9574	24613	rs118203886	NC_012920.1:610:G:A
m.8361G>A	MT-TK		MERRF syndrome	Pathogenic(Last reviewed: Jan 5, 2021)	no assertion criteria provided	VCV000009585	MT	8361	MT	8361	9585	24624	rs118192104	NC_012920.1:8360:G:A
m.8363G>A	MT-TK		Cardiomyopathy and Deafness|MERRF syndrome|Juvenile myopathy, encephalopathy, lactic acidosis AND stroke|Leigh syndrome	Pathogenic(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000009581	MT	8363	MT	8363	9581	24620	rs118192100	NC_012920.1:8362:G:A
m.8356T>C	MT-TK		MERRF syndrome|Juvenile myopathy, encephalopathy, lactic acidosis AND stroke|MERRF/MELAS overlap syndrome	Pathogenic(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000009580	MT	8356	MT	8356	9580	24619	rs118192099	NC_012920.1:8355:T:C
m.8344A>G	MT-TK		Mitochondrial disease|Juvenile myopathy, encephalopathy, lactic acidosis AND stroke|MERRF syndrome|Parkinson disease, mitochondrial|Leigh syndrome|not provided|MT-TK-related mitochondrial disorder	Pathogenic(Last reviewed: Nov 3, 2021)	reviewed by expert panel	VCV000009579	MT	8344	MT	8344	9579	24618	rs118192098	NC_012920.1:8343:A:G
m.3256C>T	MT-TL1		MERRF syndrome|Juvenile myopathy, encephalopathy, lactic acidosis AND stroke|Diabetes mellitus, noninsulin-dependent, maternally transmitted	Pathogenic(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000009591	MT	3256	MT	3256	9591	24630	rs199474659	NC_012920.1:3255:C:T
m.3271T>C	MT-TL1		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke|not specified|MERRF syndrome|Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Pathogenic(Last reviewed: Jul 12, 2019)	criteria provided, multiple submitters, no conflicts	VCV000009590	MT	3271	MT	3271	9590	24629	rs199474658	NC_012920.1:3270:T:C
NC_012920.1:m.3243A>G	MT-TL1		Stroke|Short stature|Glucose intolerance|Sensorineural hearing loss disorder|Cerebral palsy|Diabetes-deafness syndrome maternally transmitted|Muscle stiffness, painful|Age-related macular degeneration 2|Juvenile myopathy, encephalopathy, lactic acidosis AND stroke|MERRF/MELAS overlap syndrome|Juvenile myopathy, encephalopathy, lactic acidosis AND stroke|MERRF syndrome|not provided|Cyclical vomiting syndrome|3-Methylglutaconic aciduria type 1|Mitochondrial disease|Leigh syndrome|Mitochondrial complex IV deficiency	Pathogenic(Last reviewed: Nov 23, 2021)	criteria provided, multiple submitters, no conflicts	VCV000009589	MT	3243	MT	3243	9589	24628	rs199474657	NC_012920.1:3242:A:G
m.15965A>G	MT-TP		Parkinson disease, mitochondrial|Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Benign(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000009571	MT	15965	MT	15965	9571	24610	rs199474700	NC_012920.1:15964:A:G
m.4336T>C	MT-TQ		not specified|not provided|Sensorineural deafness and migraine|Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Conflicting interpretations of pathogenicity(Last reviewed: Aug 17, 2020)	criteria provided, conflicting interpretations	VCV000009615	MT	4336	MT	4336	9615	24654	rs41456348	NC_012920.1:4335:T:C
m.15950G>A	MT-TT		Parkinson disease, mitochondrial|Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Uncertain significance(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000009559	MT	15950	MT	15950	9559	24598	rs118203890	NC_012920.1:15949:G:A
NM_000256.3(MYBPC3):c.1219G>C (p.Gly407Arg)	MYBPC3	G407R	Wolff-Parkinson-White pattern	Uncertain significance(Last reviewed: Jul 14, 2017)	no assertion criteria provided	VCV000487636	11	47365047	11	47343496	487636	480708	rs727505266	NC_000011.10:47343495:C:G
NM_000256.3(MYBPC3):c.2603G>A (p.Gly868Asp)	MYBPC3	G868D	Wolff-Parkinson-White pattern	Uncertain significance(Last reviewed: Jul 14, 2017)	no assertion criteria provided	VCV000487610	11	47357562	11	47336011	487610	480707	rs886048376	NC_000011.10:47336010:C:T
NM_000256.3(MYBPC3):c.1591G>C (p.Gly531Arg)	MYBPC3	G531R	Cardiomyopathy|Hypertrophic cardiomyopathy|not provided|Wolff-Parkinson-White pattern|Hypertrophic cardiomyopathy	Likely pathogenic(Last reviewed: Nov 27, 2021)	criteria provided, multiple submitters, no conflicts	VCV000042550	11	47364162	11	47342611	42550	51720	rs397515912	NC_000011.10:47342610:C:G
NM_000256.3(MYBPC3):c.1321G>A (p.Glu441Lys)	MYBPC3	E441K	not specified|Primary familial hypertrophic cardiomyopathy|Hypertrophic cardiomyopathy|Wolff-Parkinson-White pattern|Cardiomyopathy|not provided|Cardiovascular phenotype|Arrhythmogenic right ventricular dysplasia, familial 1|Left ventricular noncompaction 10|Familial hypertrophic cardiomyopathy 4	Conflicting interpretations of pathogenicity(Last reviewed: Aug 1, 2021)	criteria provided, conflicting interpretations	VCV000036601	11	47364602	11	47343051	36601	45263	rs193922377	NC_000011.10:47343050:C:T
NM_002474.3(MYH11):c.5897A>G (p.Asn1966Ser)	MYH11|NDE1	N1973S, N1966S	Wolff-Parkinson-White pattern|Familial thoracic aortic aneurysm and aortic dissection	Uncertain significance(Last reviewed: Nov 24, 2018)	criteria provided, single submitter	VCV000487586	16	15797870	16	15704013	487586	480716	rs1317809527	NC_000016.10:15704012:T:C
NM_002471.4(MYH6):c.5653G>A (p.Glu1885Lys)	MYH6	E1885K	not provided|Familial hypertrophic cardiomyopathy 14|not specified	Uncertain significance(Last reviewed: Dec 14, 2020)	criteria provided, multiple submitters, no conflicts	VCV000537966	14	23852442	14	23383233	537966	528044	rs760353963	NC_000014.9:23383232:C:T
NM_002471.4(MYH6):c.4430G>T (p.Arg1477Leu)	MYH6	R1477L	Familial hypertrophic cardiomyopathy 14|Wolff-Parkinson-White pattern	Uncertain significance(Last reviewed: Dec 17, 2019)	criteria provided, single submitter	VCV000487615	14	23857062	14	23387853	487615	480712	rs147586142	NC_000014.9:23387852:C:A
NM_002471.4(MYH6):c.3010G>T (p.Ala1004Ser)	MYH6	A1004S	not specified|not provided|Primary familial hypertrophic cardiomyopathy|Primary dilated cardiomyopathy|Ventricular tachycardia|Cardiomyopathy|Wolff-Parkinson-White pattern|Cardiovascular phenotype|Sudden cardiac death|Familial hypertrophic cardiomyopathy 14|Primary dilated cardiomyopathy|Dilated cardiomyopathy 1EE|Familial hypertrophic cardiomyopathy 14	Conflicting interpretations of pathogenicity(Last reviewed: Dec 3, 2020)	criteria provided, conflicting interpretations	VCV000014151	14	23862646	14	23393437	14151	29190	rs143978652	NC_000014.9:23393436:C:A
NM_000257.4(MYH7):c.5779A>T (p.Ile1927Phe)	MYH7	I1927F	Cardiomyopathy|not provided|Primary familial hypertrophic cardiomyopathy|Wolff-Parkinson-White pattern|Hypertrophic cardiomyopathy	Uncertain significance(Last reviewed: Feb 11, 2022)	criteria provided, multiple submitters, no conflicts	VCV000487639	14	23882979	14	23413770	487639	480713	rs767300277	NC_000014.9:23413769:T:A
NM_000257.4(MYH7):c.2389G>A (p.Ala797Thr)	MYH7	A797T	Wolff-Parkinson-White pattern|Familial hypertrophic cardiomyopathy 1|Myopathy, myosin storage, autosomal recessive|Dilated cardiomyopathy 1S|Myosin storage myopathy|Myopathy, distal, 1|MYH7-related late-onset scapuloperoneal muscular dystrophy|Congenital myopathy with fiber type disproportion|MYH7-Related Disorders|Familial hypertrophic cardiomyopathy 1|Hypertrophic cardiomyopathy|not provided|Cardiovascular phenotype|Primary familial hypertrophic cardiomyopathy|Cardiomyopathy|Primary familial dilated cardiomyopathy|Abnormality of T cell physiology|Severe combined immunodeficiency disease|Immunodeficiency|Abnormal cellular immune system morphology|Combined T and B cell immunodeficiency|Lymphopenia	Pathogenic/Likely pathogenic(Last reviewed: Feb 1, 2022)	criteria provided, multiple submitters, no conflicts	VCV000042901	14	23894525	14	23425316	42901	52071	rs3218716	NC_000014.9:23425315:C:T
NM_000257.4(MYH7):c.728G>A (p.Arg243His)	MYH7	R243H	Familial hypertrophic cardiomyopathy 1|Cardiomyopathy|Hypertrophic cardiomyopathy|not provided|Wolff-Parkinson-White pattern|Left ventricular noncompaction 5	Uncertain significance(Last reviewed: Jun 16, 2021)	reviewed by expert panel	VCV000014126	14	23900798	14	23431589	14126	29165	rs267606910	NC_000014.9:23431588:C:T
NC_000016.9:g.(?_46694384)_(46782105_?)dup	MYLK3|ORC6|VPS35		not provided|Parkinson disease 17	Uncertain significance(Last reviewed: Nov 26, 2021)	criteria provided, single submitter	VCV001412147	16	46694384 - 46782105			1412147	1349286		
NM_001127392.3(MYRF):c.2358_2359del (p.Tyr787fs)	MYRF	Y778fs, Y787fs	Inborn genetic diseases	Pathogenic(Last reviewed: May 25, 2018)	criteria provided, single submitter	VCV000985076	11	61547714 - 61547715	11	61780242 - 61780243	985076	973799	rs2066505057	NC_000011.10:61780241:TGT:T
NM_016013.4(NDUFAF1):c.619A>C (p.Thr207Pro)	NDUFAF1	T207P	Mitochondrial complex 1 deficiency, nuclear type 11	Pathogenic(Last reviewed: Jul 11, 2007)	no assertion criteria provided	VCV000030622	15	41687197	15	41394999	30622	39579	rs387906956	NC_000015.10:41394998:T:G
NM_021074.5(NDUFV2):c.86T>C (p.Val29Ala)	NDUFV2	V29A	Parkinson disease, mitochondrial|not provided|Mitochondrial complex 1 deficiency, nuclear type 7|Mitochondrial complex I deficiency, nuclear type 1|not specified	Benign(Last reviewed: Nov 30, 2021)	criteria provided, multiple submitters, no conflicts	VCV000009054	18	9117867	18	9117869	9054	24093	rs906807	NC_000018.10:9117868:T:C
NM_006393.3(NEBL):c.2473C>T (p.His825Tyr)	NEBL	H162Y, H825Y, H126Y, H140Y, H143Y, H146Y	Wolff-Parkinson-White pattern	Uncertain significance(Last reviewed: Jul 14, 2017)	no assertion criteria provided	VCV000487585	10	21101743	10	20812814	487585	480703	rs1554774990	NC_000010.11:20812813:G:A
NM_018055.5(NODAL):c.778G>A (p.Gly260Arg)	NODAL	G260R, G127R	Visceral heterotaxy 5, autosomal|not provided|Heterotaxy syndrome|Inborn genetic diseases|Wolff-Parkinson-White pattern	Conflicting interpretations of pathogenicity(Last reviewed: Jan 20, 2021)	criteria provided, conflicting interpretations	VCV000008269	10	72195155	10	70435399	8269	23308	rs121909283	NC_000010.11:70435398:C:T
NM_001364012.2:c.-164GGC[(66_517)]	NOTCH2NLC		Oculopharyngodistal myopathy 3|Neuronal intranuclear inclusion disease|Tremor, hereditary essential, 6	Pathogenic(Last reviewed: Feb 16, 2022)	no assertion criteria provided	VCV000691867					691867	679582		
NM_000271.5(NPC1):c.2974G>C (p.Gly992Arg)	NPC1	G992R	not provided|Niemann-Pick disease type C1|Niemann-Pick disease, type C	Pathogenic/Likely pathogenic(Last reviewed: Sep 19, 2020)	criteria provided, multiple submitters, no conflicts	VCV000002969	18	21118573	18	23538609	2969	18008	rs80358254	NC_000018.10:23538608:C:G
NM_006432.5(NPC2):c.292A>C (p.Asn98His)	NPC2	N98H	not provided|Niemann-Pick disease, type C2	Uncertain significance(Last reviewed: Jun 29, 2020)	criteria provided, multiple submitters, no conflicts	VCV000377030	14	74951189	14	74484486	377030	363908	rs142858704	NC_000014.9:74484485:T:G
NM_006186.4(NR4A2):c.881dup (p.Asn294fs)	NR4A2	N231fs, N294fs	Parkinson disease, late-onset	Uncertain significance(Last reviewed: Nov 4, 2019)	criteria provided, single submitter	VCV000930579	2	157185028 - 157185029	2	156328516 - 156328517	930579	918675	rs1686760554	NC_000002.12:156328516:TTTTTTT:TTTTTTTT
NM_006186.4(NR4A2):c.325C>A (p.Gln109Lys)	NR4A2	Q109K, Q46K	Parkinson disease, late-onset	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000894762	2	157186374	2	156329862	894762	881259	rs747551776	NC_000002.12:156329861:G:T
NM_006186.4(NR4A2):c.325C>G (p.Gln109Glu)	NR4A2	Q109E, Q46E	Parkinson disease, late-onset	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000894761	2	157186374	2	156329862	894761	881258	rs747551776	NC_000002.12:156329861:G:C
NM_006186.4(NR4A2):c.360T>G (p.Val120=)	NR4A2		Parkinson disease, late-onset	Uncertain significance(Last reviewed: Mar 16, 2018)	criteria provided, single submitter	VCV000894760	2	157186339	2	156329827	894760	881257	rs201399912	NC_000002.12:156329826:A:C
NM_006186.4(NR4A2):c.372C>T (p.Pro124=)	NR4A2		Parkinson disease, late-onset	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000894759	2	157186327	2	156329815	894759	881256	rs943205037	NC_000002.12:156329814:G:A
NM_006186.4(NR4A2):c.591C>A (p.Pro197=)	NR4A2		Parkinson disease, late-onset	Uncertain significance(Last reviewed: Feb 2, 2018)	criteria provided, single submitter	VCV000894758	2	157186108	2	156329596	894758	881255	rs769738246	NC_000002.12:156329595:G:T
NM_006186.4(NR4A2):c.1163A>T (p.Gln388Leu)	NR4A2	Q325L, Q388L	Parkinson disease, late-onset	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000893841	2	157183428	2	156326916	893841	881254	rs767330388	NC_000002.12:156326915:T:A
NM_006186.4(NR4A2):c.1170C>A (p.Asn390Lys)	NR4A2	N390K, N327K	Parkinson disease, late-onset	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000893840	2	157183421	2	156326909	893840	881253	rs1486481129	NC_000002.12:156326908:G:T
NM_006186.4(NR4A2):c.1230G>A (p.Leu410=)	NR4A2		Parkinson disease, late-onset	Uncertain significance(Last reviewed: Apr 27, 2017)	criteria provided, single submitter	VCV000893839	2	157183361	2	156326849	893839	881252	rs139491338	NC_000002.12:156326848:C:T
NM_006186.4(NR4A2):c.1273C>T (p.Pro425Ser)	NR4A2	P362S, P425S	Parkinson disease, late-onset	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000893838	2	157183318	2	156326806	893838	881251	rs371624401	NC_000002.12:156326805:G:A
NM_006186.4(NR4A2):c.1548C>T (p.His516=)	NR4A2		Parkinson disease, late-onset	Uncertain significance(Last reviewed: Apr 27, 2017)	criteria provided, single submitter	VCV000893837	2	157182505	2	156325993	893837	881250	rs1343095735	NC_000002.12:156325992:G:A
NC_000002.12:g.156332790T>C	NR4A2		Parkinson disease, late-onset	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000893588	2	157189302	2	156332790	893588	882817	rs1686993973	NC_000002.12:156332789:T:C
NM_006186.4(NR4A2):c.1588A>C (p.Lys530Gln)	NR4A2	K467Q, K530Q	Parkinson disease, late-onset	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000893544	2	157182465	2	156325953	893544	881249	rs1686624142	NC_000002.12:156325952:T:G
NM_006186.4(NR4A2):c.1638G>A (p.Leu546=)	NR4A2		Parkinson disease, late-onset	Likely benign(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000893543	2	157182415	2	156325903	893543	881248	rs528222526	NC_000002.12:156325902:C:T
NM_006186.4(NR4A2):c.-339C>A	NR4A2		Parkinson disease, late-onset	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000892777	2	157189204	2	156332692	892777	881262	rs1055625772	NC_000002.12:156332691:G:T
NM_006186.4(NR4A2):c.-304C>T	NR4A2		Parkinson disease, late-onset	Uncertain significance(Last reviewed: Apr 27, 2017)	criteria provided, single submitter	VCV000892776	2	157189169	2	156332657	892776	881261	rs1003135527	NC_000002.12:156332656:G:A
NM_006186.4(NR4A2):c.-253C>T	NR4A2		Parkinson disease, late-onset	Uncertain significance(Last reviewed: Apr 27, 2017)	criteria provided, single submitter	VCV000892775	2	157189118	2	156332606	892775	881260	rs1242736877	NC_000002.12:156332605:G:A
NM_006186.4(NR4A2):c.*599T>G	NR4A2		Parkinson disease, late-onset	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000892747	2	157181657	2	156325145	892747	881247	rs1268567400	NC_000002.12:156325144:A:C
NM_006186.4(NR4A2):c.*1017T>C	NR4A2		Parkinson disease, late-onset	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000892746	2	157181239	2	156324727	892746	881246	rs986511917	NC_000002.12:156324726:A:G
NM_006186.4(NR4A2):c.*1249A>G	NR4A2		Parkinson disease, late-onset	Likely benign(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000892745	2	157181007	2	156324495	892745	881245	rs564495914	NC_000002.12:156324494:T:C
NM_006186.3(NR4A2):c.-387A>T	NR4A2		Parkinson Disease, Dominant/Recessive	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000331671	2	157189252	2	156332740	331671	284978	rs886054983	NC_000002.12:156332739:T:A
NM_006186.3(NR4A2):c.-384T>C	NR4A2		Parkinson disease, late-onset	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000331670	2	157189249	2	156332737	331670	284576	rs886054982	NC_000002.12:156332736:A:G
NM_006186.4(NR4A2):c.-325C>G	NR4A2		Parkinson disease, late-onset	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000331669	2	157189190	2	156332678	331669	282322	rs886054981	NC_000002.12:156332677:G:C
NM_006186.4(NR4A2):c.-241C>G	NR4A2		Parkinson disease, late-onset	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000331668	2	157189106	2	156332594	331668	284969	rs536532102	NC_000002.12:156332593:G:C
NM_006186.4(NR4A2):c.-227C>G	NR4A2		Parkinson disease, late-onset	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000331667	2	157189092	2	156332580	331667	284959	rs886054980	NC_000002.12:156332579:G:C
NM_006186.4(NR4A2):c.-223C>T	NR4A2		Parkinson disease, late-onset	Likely benign(Last reviewed: Apr 27, 2017)	criteria provided, single submitter	VCV000331666	2	157189088	2	156332576	331666	283008	rs114461423	NC_000002.12:156332575:G:A
NM_006186.4(NR4A2):c.-166C>G	NR4A2		Parkinson disease, late-onset	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000331665	2	157189031	2	156332519	331665	282318	rs755057457	NC_000002.12:156332518:G:C
NM_006186.4(NR4A2):c.-144G>A	NR4A2		Parkinson disease, late-onset	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000331664	2	157189009	2	156332497	331664	283007	rs886054979	NC_000002.12:156332496:C:T
NM_006186.4(NR4A2):c.585C>T (p.Asp195=)	NR4A2		Parkinson disease, late-onset	Likely benign(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000331663	2	157186114	2	156329602	331663	282317	rs143064317	NC_000002.12:156329601:G:A
NM_006186.4(NR4A2):c.657T>C (p.Ala219=)	NR4A2		Parkinson disease, late-onset	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000331662	2	157186042	2	156329530	331662	284563	rs769677341	NC_000002.12:156329529:A:G
NM_006186.4(NR4A2):c.732C>A (p.Leu244=)	NR4A2		Parkinson disease, late-onset|not provided	Benign/Likely benign(Last reviewed: Dec 31, 2019)	criteria provided, multiple submitters, no conflicts	VCV000331661	2	157185967	2	156329455	331661	284553	rs16840266	NC_000002.12:156329454:G:T
NM_006186.4(NR4A2):c.1158+13C>T	NR4A2		Parkinson disease, late-onset	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000331660	2	157184350	2	156327838	331660	284958	rs372468197	NC_000002.12:156327837:G:A
NM_006186.4(NR4A2):c.1635G>T (p.Gly545=)	NR4A2		Parkinson disease, late-onset	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000331659	2	157182418	2	156325906	331659	282316	rs886054978	NC_000002.12:156325905:C:A
NM_006186.4(NR4A2):c.1659C>G (p.Ser553=)	NR4A2		Parkinson disease, late-onset	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000331658	2	157182394	2	156325882	331658	284957	rs886054977	NC_000002.12:156325881:G:C
NM_006186.4(NR4A2):c.1746G>A (p.Val582=)	NR4A2		Parkinson disease, late-onset	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000331657	2	157182307	2	156325795	331657	282315	rs886054976	NC_000002.12:156325794:C:T
NM_006186.4(NR4A2):c.*192C>G	NR4A2		Parkinson disease, late-onset	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000331656	2	157182064	2	156325552	331656	284551	rs747113198	NC_000002.12:156325551:G:C
NM_006186.4(NR4A2):c.*331T>G	NR4A2		Parkinson disease, late-onset	Benign(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000331655	2	157181925	2	156325413	331655	283004	rs12803	NC_000002.12:156325412:A:C
NM_006186.4(NR4A2):c.*352C>A	NR4A2		Parkinson disease, late-onset	Benign(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000331654	2	157181904	2	156325392	331654	282313	rs115393922	NC_000002.12:156325391:G:T
NM_006186.4(NR4A2):c.*400CA[9]	NR4A2		Parkinson Disease, Dominant/Recessive	Benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000331653	2	157181837 - 157181838	2	156325325 - 156325326	331653	284954	rs3832066	NC_000002.12:156325324:TGTGTGTGTGTGTGTGTGTGT:TGTGTGTGTGTGTGTGTGT
NM_006186.4(NR4A2):c.*659_*661del	NR4A2		Parkinson Disease, Dominant/Recessive	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000331652	2	157181595 - 157181597	2	156325083 - 156325085	331652	282312	rs577936871	NC_000002.12:156325082:TTATT:TT
NM_006186.4(NR4A2):c.*822A>C	NR4A2		Parkinson disease, late-onset	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000331651	2	157181434	2	156324922	331651	282301	rs886054975	NC_000002.12:156324921:T:G
NM_006186.4(NR4A2):c.*933G>A	NR4A2		Parkinson disease, late-onset	Likely benign(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000331650	2	157181323	2	156324811	331650	284548	rs563505935	NC_000002.12:156324810:C:T
NM_006186.4(NR4A2):c.*1198C>T	NR4A2		Parkinson disease, late-onset	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000331649	2	157181058	2	156324546	331649	284952	rs577905348	NC_000002.12:156324545:G:A
NM_006186.3(NR4A2):c.*1311A>G	NR4A2		Parkinson disease, late-onset	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000331648	2	157180945	2	156324433	331648	282298	rs886054974	NC_000002.12:156324432:T:C
NM_006186.4(NR4A2):c.-245T>G	NR4A2		Parkinson disease, late-onset	Uncertain significance(Last reviewed: Jun 8, 2004)	no assertion criteria provided	VCV000007680	2	157189110	2	156332598	7680	22719		NC_000002.12:156332597:A:C
NR4A2, 1-BP DEL, -291T	NR4A2		Parkinson disease, late-onset	Uncertain significance(Last reviewed: Jun 8, 2004)	no assertion criteria provided	VCV000007679					7679	22718		
NM_018206.6(VPS35):c.-34G>A	ORC6|VPS35		Parkinson disease 17|Meier-Gorlin syndrome	Benign/Likely benign(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000319298	16	46723079	16	46689167	319298	343011	rs3743928	NC_000016.10:46689166:C:T
NC_000006.11:g.(?_162864322)_(163148700_?)dup	PACRG|PRKN		not provided	Uncertain significance(Last reviewed: Oct 1, 2021)	criteria provided, single submitter	VCV001411231	6	162864322 - 163148700			1411231	1343621		
NC_000006.11:g.(?_163148674)_(163148700_?)dup	PACRG|PRKN		not provided	Uncertain significance(Last reviewed: Jul 22, 2021)	criteria provided, single submitter	VCV001374896	6	163148674 - 163148700			1374896	1466183		
NM_004562.3(PRKN):c.-85G>A	PACRG|PRKN		Parkinson disease 2	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000906286	6	163148785	6	162727753	906286	895664	rs556535340	NC_000006.12:162727752:C:T
NM_004562.3(PRKN):c.-57G>C	PACRG|PRKN		Parkinson disease 2	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000906284	6	163148757	6	162727725	906284	895662	rs750626864	NC_000006.12:162727724:C:G
NM_004562.3(PRKN):c.2T>C (p.Met1Thr)	PACRG|PRKN	M1T	Parkinson disease 2|not provided	Pathogenic(Last reviewed: Jun 4, 2019)	criteria provided, single submitter	VCV000805243	6	163148699	6	162727667	805243	793179	rs771586218	NC_000006.12:162727666:A:G
NC_000006.11:g.(?_162622143)_(163148721_?)dup	PACRG|PRKN		not provided|Parkinson disease 2	Uncertain significance(Last reviewed: Aug 14, 2018)	criteria provided, single submitter	VCV000662856	6	162622143 - 163148721	6	162201111 - 162727689	662856	651583		
NM_004562.3(PRKN):c.4A>G (p.Ile2Val)	PACRG|PRKN	I2V	Parkinson disease 2|not provided	Uncertain significance(Last reviewed: Jan 19, 2018)	criteria provided, single submitter	VCV000579609	6	163148697	6	162727665	579609	563481	rs747682986	NC_000006.12:162727664:T:C
NM_004562.3(PRKN):c.7+5G>T	PACRG|PRKN		Parkinson disease 2|not provided	Uncertain significance(Last reviewed: May 24, 2018)	criteria provided, single submitter	VCV000573661	6	163148689	6	162727657	573661	560660	rs1204087943	NC_000006.12:162727656:C:A
NM_152410.3(PACRG):c.-76-385C>T	PACRG|PRKN		Parkinson Disease, Juvenile	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000356025	6	163148807	6	162727775	356025	306813	rs886061239	NC_000006.12:162727774:C:T
NM_004562.3(PRKN):c.-46C>T	PACRG|PRKN		Parkinson disease 2	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000356024	6	163148746	6	162727714	356024	306812	rs369389244	NC_000006.12:162727713:G:A
NM_004562.3(PRKN):c.-42T>C	PACRG|PRKN		Parkinson disease 2	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000356023	6	163148742	6	162727710	356023	302129	rs112850281	NC_000006.12:162727709:A:G
NM_004562.3(PRKN):c.-30T>C	PACRG|PRKN		not provided|Parkinson disease 2	Likely benign(Last reviewed: Jun 30, 2020)	criteria provided, multiple submitters, no conflicts	VCV000356022	6	163148730	6	162727698	356022	306811	rs200065081	NC_000006.12:162727697:A:G
NM_004562.3(PRKN):c.7+4C>T	PACRG|PRKN		Parkinson disease 2	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000356021	6	163148690	6	162727658	356021	306546	rs749081702	NC_000006.12:162727657:G:A
NM_004562.3(PRKN):c.7+1G>T	PACRG|PRKN		Parkinson disease 2	Pathogenic(Last reviewed: Mar 1, 2006)	no assertion criteria provided	VCV000007053	6	163148693	6	162727661	7053	22092	rs397518439	NC_000006.12:162727660:C:A
NM_007262.5(PARK7):c.322+12G>A	PARK7		Parkinson disease 7	Likely benign(Last reviewed: Dec 6, 2021)	criteria provided, single submitter	VCV001667228	1	8031035	1	7970975	1667228	1591166		NC_000001.11:7970974:G:A
NM_007262.5(PARK7):c.409+18TTTG[5]	PARK7		Parkinson disease 7	Likely benign(Last reviewed: Oct 11, 2021)	criteria provided, single submitter	VCV001649974	1	8037815 - 8037816	1	7977755 - 7977756	1649974	1536229		NC_000001.11:7977755:TTTGTTTGTTTGTTTGTTT:TTTGTTTGTTTGTTTGTTTGTTT
NM_007262.5(PARK7):c.193-13dup	PARK7		Parkinson disease 7	Benign(Last reviewed: Aug 6, 2021)	criteria provided, single submitter	VCV001581945	1	8029388 - 8029389	1	7969328 - 7969329	1581945	1600504		NC_000001.11:7969328:TTTT:TTTTT
NM_007262.5(PARK7):c.409+18TTTG[3]	PARK7		Parkinson disease 7	Likely benign(Last reviewed: Oct 25, 2021)	criteria provided, single submitter	VCV001551370	1	8037816 - 8037819	1	7977756 - 7977759	1551370	1551149		NC_000001.11:7977755:TTTGTTTGTTTGTTTGTTT:TTTGTTTGTTTGTTT
NM_007262.5(PARK7):c.193-17G>A	PARK7		Parkinson disease 7	Likely benign(Last reviewed: Aug 7, 2021)	criteria provided, single submitter	VCV001547969	1	8029388	1	7969328	1547969	1537787		NC_000001.11:7969327:G:A
NM_007262.5(PARK7):c.252+18A>G	PARK7		Parkinson disease 7	Benign(Last reviewed: Nov 13, 2021)	criteria provided, single submitter	VCV001535683	1	8029482	1	7969422	1535683	1596137		NC_000001.11:7969421:A:G
NM_007262.5(PARK7):c.328A>G (p.Thr110Ala)	PARK7	T110A	Parkinson disease 7	Uncertain significance(Last reviewed: Dec 17, 2021)	criteria provided, single submitter	VCV001519810	1	8037717	1	7977657	1519810	1517099		NC_000001.11:7977656:A:G
NM_007262.5(PARK7):c.198A>G (p.Pro66=)	PARK7		Parkinson disease 7	Uncertain significance(Last reviewed: Aug 3, 2021)	criteria provided, single submitter	VCV001510243	1	8029410	1	7969350	1510243	1442298		NC_000001.11:7969349:A:G
NM_007262.5(PARK7):c.271A>G (p.Ile91Val)	PARK7	I91V	Parkinson disease 7	Uncertain significance(Last reviewed: Nov 1, 2021)	criteria provided, single submitter	VCV001468432	1	8030972	1	7970912	1468432	1362676		NC_000001.11:7970911:A:G
NM_007262.5(PARK7):c.437T>G (p.Val146Gly)	PARK7	V146G	Parkinson disease 7	Uncertain significance(Last reviewed: Sep 20, 2021)	criteria provided, single submitter	VCV001425067	1	8044981	1	7984921	1425067	1353574		NC_000001.11:7984920:T:G
NM_007262.5(PARK7):c.395A>G (p.Lys132Arg)	PARK7	K132R	Parkinson disease 7	Uncertain significance(Last reviewed: Sep 1, 2021)	criteria provided, single submitter	VCV001419175	1	8037784	1	7977724	1419175	1386854		NC_000001.11:7977723:A:G
NM_007262.5(PARK7):c.82C>T (p.Arg28Ter)	PARK7	R28*	Parkinson disease 7	Pathogenic(Last reviewed: Jun 16, 2021)	criteria provided, single submitter	VCV001399835	1	8022927	1	7962867	1399835	1443925		NC_000001.11:7962866:C:T
NM_007262.5(PARK7):c.233G>A (p.Gly78Asp)	PARK7	G78D	Parkinson disease 7	Uncertain significance(Last reviewed: Aug 14, 2021)	criteria provided, single submitter	VCV001365948	1	8029445	1	7969385	1365948	1398938		NC_000001.11:7969384:G:A
NM_007262.5(PARK7):c.253T>C (p.Ser85Pro)	PARK7	S85P	Parkinson disease 7	Uncertain significance	criteria provided, single submitter	VCV001338986	1	8030954	1	7970894	1338986	1330029		NC_000001.11:7970893:T:C
NM_007262.5(PARK7):c.377A>G (p.His126Arg)	PARK7	H126R	Parkinson Disease, Juvenile|Motor neuron disease	Uncertain significance(Last reviewed: Jan 7, 2022)	criteria provided, single submitter	VCV001334461	1	8037766	1	7977706	1334461	1325356		NC_000001.11:7977705:A:G
NM_007262.5(PARK7):c.322G>A (p.Gly108Ser)	PARK7	G108S	Parkinson disease 7	Pathogenic(Last reviewed: Jan 7, 2022)	criteria provided, single submitter	VCV001334459	1	8031023	1	7970963	1334459	1325354		NC_000001.11:7970962:G:A
NM_007262.5(PARK7):c.302T>C (p.Leu101Pro)	PARK7	L101P	Parkinson disease 7	Likely pathogenic(Last reviewed: Jan 5, 2022)	criteria provided, single submitter	VCV001331350	1	8031003	1	7970943	1331350	1322072		NC_000001.11:7970942:T:C
NM_007262.5(PARK7):c.83G>A (p.Arg28Gln)	PARK7	R28Q	Parkinson disease 7	Likely pathogenic(Last reviewed: Sep 21, 2021)	no assertion criteria provided	VCV001319906	1	8022928	1	7962868	1319906	1310154		NC_000001.11:7962867:G:A
NM_007262.5(PARK7):c.429G>A (p.Glu143=)	PARK7		Parkinson disease 7	Likely benign(Last reviewed: Jun 22, 2020)	criteria provided, single submitter	VCV001144766	1	8044973	1	7984913	1144766	1131726		NC_000001.11:7984912:G:A
NM_007262.5(PARK7):c.460A>G (p.Thr154Ala)	PARK7	T154A	Young-onset Parkinson disease	Likely pathogenic(Last reviewed: May 3, 2021)	criteria provided, single submitter	VCV001119998	1	8045004	1	7984944	1119998	1108786		NC_000001.11:7984943:A:G
Single allele	PARK7|TNFRSF9		Parkinson Disease, Juvenile	Pathogenic(Last reviewed: May 12, 2021)	no assertion criteria provided	VCV001098717	1	7995073 - 8031023			1098717	1087426		
NM_007262.5(PARK7):c.91-5C>T	PARK7		Parkinson disease 7	Likely benign(Last reviewed: Apr 11, 2019)	criteria provided, single submitter	VCV001078275	1	8025379	1	7965319	1078275	1067599		NC_000001.11:7965318:C:T
NM_007262.5(PARK7):c.16G>T (p.Ala6Ser)	PARK7	A6S	Parkinson disease 7	Uncertain significance(Last reviewed: May 19, 2018)	criteria provided, single submitter	VCV001015099	1	8022861	1	7962801	1015099	1003014	rs767539467	NC_000001.11:7962800:G:T
NM_007262.5(PARK7):c.471_473del (p.Pro158del)	PARK7	P158del	Parkinson disease 7|Young-onset Parkinson disease|not provided	Likely pathogenic(Last reviewed: May 3, 2021)	criteria provided, multiple submitters, no conflicts	VCV000987356	1	8045015 - 8045017	1	7984955 - 7984957	987356	974988	rs764877312	NC_000001.11:7984954:GCC:
NM_007262.5(PARK7):c.56C>T (p.Thr19Met)	PARK7	T19M	Parkinson disease 7	Uncertain significance(Last reviewed: Sep 9, 2019)	criteria provided, single submitter	VCV000963192	1	8022901	1	7962841	963192	942104	rs758016497	NC_000001.11:7962840:C:T
NM_007262.5(PARK7):c.*185T>A	PARK7		Parkinson disease 7	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000875477	1	8045299	1	7985239	875477	864823	rs1640796249	NC_000001.11:7985238:T:A
NM_007262.5(PARK7):c.*124C>T	PARK7		Parkinson disease 7	Likely benign(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000875476	1	8045238	1	7985178	875476	864822	rs147437667	NC_000001.11:7985177:C:T
NM_007262.5(PARK7):c.*49A>G	PARK7		Parkinson disease 7	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000875475	1	8045163	1	7985103	875475	864821	rs371482698	NC_000001.11:7985102:A:G
NM_007262.5(PARK7):c.502A>G (p.Ile168Val)	PARK7	I168V	Parkinson disease 7	Uncertain significance(Last reviewed: Apr 28, 2017)	criteria provided, single submitter	VCV000875474	1	8045046	1	7984986	875474	864820	rs374962638	NC_000001.11:7984985:A:G
NM_007262.5(PARK7):c.425C>T (p.Ser142Phe)	PARK7	S142F	Parkinson disease 7	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000874552	1	8044969	1	7984909	874552	864819	rs1640786376	NC_000001.11:7984908:C:T
NM_007262.5(PARK7):c.91A>G (p.Ile31Val)	PARK7	I31V	Parkinson disease 7	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000874551	1	8025384	1	7965324	874551	864818	rs749054218	NC_000001.11:7965323:A:G
NM_007262.5(PARK7):c.91-11C>T	PARK7		Parkinson disease 7	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000874550	1	8025373	1	7965313	874550	865210	rs1306465390	NC_000001.11:7965312:C:T
NM_007262.5(PARK7):c.535G>A (p.Ala179Thr)	PARK7	A179T	not provided|Parkinson disease 7	Uncertain significance(Last reviewed: Oct 14, 2020)	criteria provided, multiple submitters, no conflicts	VCV000854701	1	8045079	1	7985019	854701	824426	rs71653622	NC_000001.11:7985018:G:A
NM_007262.5(PARK7):c.101C>T (p.Thr34Ile)	PARK7	T34I	not provided|Parkinson disease 7	Uncertain significance(Last reviewed: Jun 1, 2019)	criteria provided, multiple submitters, no conflicts	VCV000806045	1	8025394	1	7965334	806045	794726	rs772272696	NC_000001.11:7965333:C:T
NM_007262.5(PARK7):c.90+1dup	PARK7		Parkinson disease 7	Likely pathogenic(Last reviewed: Jun 20, 2019)	criteria provided, single submitter	VCV000804432	1	8022932 - 8022933	1	7962872 - 7962873	804432	792720	rs1578089802	NC_000001.11:7962872:GGGG:GGGGG
NM_007262.5(PARK7):c.501A>G (p.Ala167=)	PARK7		Parkinson disease 7	Conflicting interpretations of pathogenicity(Last reviewed: Oct 30, 2020)	criteria provided, conflicting interpretations	VCV000707607	1	8045045	1	7984985	707607	690677	rs71653621	NC_000001.11:7984984:A:G
NM_007262.5(PARK7):c.166G>A (p.Ala56Thr)	PARK7	A56T	not provided|Parkinson disease 7	Benign/Likely benign(Last reviewed: Aug 4, 2021)	criteria provided, multiple submitters, no conflicts	VCV000703804	1	8025459	1	7965399	703804	690676	rs114601558	NC_000001.11:7965398:G:A
NM_007262.5(PARK7):c.252+8dup	PARK7		Parkinson disease 7|not provided	Likely benign(Last reviewed: Dec 31, 2019)	criteria provided, multiple submitters, no conflicts	VCV000675657	1	8029466 - 8029467	1	7969406 - 7969407	675657	658097	rs781094807	NC_000001.11:7969406:AAAAAA:AAAAAAA
NC_000001.10:g.(?_8022836)_(8031035_?)dup	PARK7		Parkinson disease 7	Uncertain significance(Last reviewed: Nov 28, 2018)	criteria provided, single submitter	VCV000650723	1	8022836 - 8031035	1	7962776 - 7970975	650723	650547		
NM_007262.5(PARK7):c.28C>G (p.Leu10Val)	PARK7	L10V	Parkinson disease 7	Uncertain significance(Last reviewed: Nov 29, 2018)	criteria provided, single submitter	VCV000643343	1	8022873	1	7962813	643343	628270	rs1309873819	NC_000001.11:7962812:C:G
NM_007262.5(PARK7):c.310G>A (p.Ala104Thr)	PARK7	A104T	Parkinson disease 7	Uncertain significance(Last reviewed: Dec 3, 2018)	criteria provided, multiple submitters, no conflicts	VCV000642328	1	8031011	1	7970951	642328	628271	rs774005786	NC_000001.11:7970950:G:A
NC_000001.11:g.(?_7969325)_(7969424_?)del	PARK7		Parkinson disease 7	Likely pathogenic(Last reviewed: Jun 5, 2018)	criteria provided, single submitter	VCV000584372	1	8029385 - 8029484	1	7969325 - 7969424	584372	556503		
NM_007262.5(PARK7):c.511G>T (p.Ala171Ser)	PARK7	A171S	Parkinson disease 7	Uncertain significance(Last reviewed: Jul 2, 2018)	criteria provided, single submitter	VCV000582678	1	8045055	1	7984995	582678	558597	rs777026628	NC_000001.11:7984994:G:T
NM_007262.5(PARK7):c.448G>A (p.Gly150Ser)	PARK7	G150S	Parkinson disease 7	Uncertain significance(Last reviewed: Mar 6, 2018)	criteria provided, single submitter	VCV000577231	1	8044992	1	7984932	577231	557378	rs368420490	NC_000001.11:7984931:G:A
NM_007262.5(PARK7):c.105dup (p.Ala36fs)	PARK7	A36fs	Parkinson disease 7	Pathogenic(Last reviewed: Jun 7, 2018)	criteria provided, single submitter	VCV000573287	1	8025396 - 8025397	1	7965336 - 7965337	573287	557376	rs781600849	NC_000001.11:7965336:TT:TTT
NM_007262.5(PARK7):c.91-4G>A	PARK7		Parkinson disease 7	Likely benign(Last reviewed: Sep 26, 2017)	criteria provided, single submitter	VCV000534230	1	8025380	1	7965320	534230	516087	rs756040385	NC_000001.11:7965319:G:A
NM_007262.5(PARK7):c.293G>A (p.Arg98Gln)	PARK7	R98Q	not provided|Parkinson disease 7|Renal cysts and diabetes syndrome|not specified	Benign/Likely benign(Last reviewed: Nov 15, 2020)	criteria provided, multiple submitters, no conflicts	VCV000465831	1	8030994	1	7970934	465831	448380	rs71653619	NC_000001.11:7970933:G:A
NM_007262.5(PARK7):c.191_192del (p.Glu64fs)	PARK7	E64fs	Parkinson disease 7|not provided	Pathogenic(Last reviewed: Nov 21, 2016)	criteria provided, single submitter	VCV000447914	1	8025482 - 8025483	1	7965422 - 7965423	447914	440521	rs1553122929	NC_000001.11:7965421:AGAG:AG
NM_007262.4(PARK7):c.[-24+75_-24+92dup;487G>A]	PARK7	E163K	Parkinson disease 7	Pathogenic(Last reviewed: Nov 1, 2005)	no assertion criteria provided	VCV000446717	1|1	8021910 - 8021911	1|1	7961850 - 7961851	446717	75266|22107	rs200968609|rs74315354	NC_000001.11:7961850:GTGCTGGACGGTGTCCCTGTGCTGGACGGTGTCCC:GTGCTGGACGGTGTCCCTGTGCTGGACGGTGTCCCTGTGCTGGACGGTGTCCC|NC_000001.11:7984970:G:A
NM_007262.5(PARK7):c.*125G>A	PARK7		Parkinson disease 7	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000298124	1	8045239	1	7985179	298124	283319	rs779587926	NC_000001.11:7985178:G:A
NM_007262.5(PARK7):c.500C>G (p.Ala167Gly)	PARK7	A167G	Parkinson disease 7	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000298123	1	8045044	1	7984984	298123	283318	rs886046546	NC_000001.11:7984983:C:G
NM_007262.5(PARK7):c.323-14A>G	PARK7		not provided|Parkinson disease 7	Benign(Last reviewed: Dec 18, 2021)	criteria provided, multiple submitters, no conflicts	VCV000298122	1	8037698	1	7977638	298122	281870	rs72854882	NC_000001.11:7977637:A:G
NM_007262.5(PARK7):c.234C>T (p.Gly78=)	PARK7		Parkinson Disease, Recessive|Parkinson disease 7|not specified|not provided	Benign/Likely benign(Last reviewed: Oct 1, 2020)	criteria provided, multiple submitters, no conflicts	VCV000298121	1	8029446	1	7969386	298121	283121	rs11548937	NC_000001.11:7969385:C:T
NM_007262.5(PARK7):c.223G>A (p.Gly75Ser)	PARK7	G75S	Parkinson disease 7	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000298120	1	8029435	1	7969375	298120	283317	rs886046545	NC_000001.11:7969374:G:A
NM_007262.5(PARK7):c.73G>A (p.Val25Ile)	PARK7	V25I	Parkinson disease 7	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000298119	1	8022918	1	7962858	298119	283116	rs781346135	NC_000001.11:7962857:G:A
NM_007262.5(PARK7):c.59T>C (p.Val20Ala)	PARK7	V20A	Parkinson disease 7	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000298118	1	8022904	1	7962844	298118	281253	rs370430693	NC_000001.11:7962843:T:C
NM_007262.5(PARK7):c.-22C>T	PARK7		Parkinson disease 7|not specified|not provided	Benign(Last reviewed: Jan 30, 2020)	criteria provided, multiple submitters, no conflicts	VCV000298117	1	8022824	1	7962764	298117	283115	rs11548933	NC_000001.11:7962763:C:T
NM_007262.5(PARK7):c.-30G>C	PARK7		Parkinson disease 7	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000298116	1	8021847	1	7961787	298116	281251	rs886046544	NC_000001.11:7961786:G:C
NM_007262.5(PARK7):c.-70C>T	PARK7		not provided|Parkinson disease 7	Benign(Last reviewed: Aug 17, 2018)	criteria provided, multiple submitters, no conflicts	VCV000298115	1	8021807	1	7961747	298115	283316	rs11121064	NC_000001.11:7961746:C:T
NM_007262.5(PARK7):c.-80T>A	PARK7		Parkinson disease 7	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000298114	1	8021797	1	7961737	298114	281869	rs140230911	NC_000001.11:7961736:T:A
NM_007262.5(PARK7):c.-99T>C	PARK7		Parkinson disease 7	Benign(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000298113	1	8021778	1	7961718	298113	283315	rs226249	NC_000001.11:7961717:T:C
NM_001123377.1(PARK7):c.-69G>C	PARK7		Parkinson Disease, Recessive	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000298112	1	8021750	1	7961690	298112	283113	rs557801400	NC_000001.11:7961689:G:C
NM_001123377.1(PARK7):c.-79G>A	PARK7		not provided|Parkinson Disease, Recessive	Benign/Likely benign(Last reviewed: Aug 14, 2018)	criteria provided, multiple submitters, no conflicts	VCV000298111	1	8021740	1	7961680	298111	283314	rs17523802	NC_000001.11:7961679:G:A
NM_007262.5(PARK7):c.399G>C (p.Met133Ile)	PARK7	M133I	Parkinson disease, late-onset	Uncertain significance(Last reviewed: Jan 22, 2014)	no assertion criteria provided	VCV000096726	1	8037788	1	7977728	96726	102612	rs398124657	NC_000001.11:7977727:G:C
NM_007262.5(PARK7):c.115G>T (p.Ala39Ser)	PARK7	A39S	Parkinson disease, autosomal recessive early-onset, digenic, PINK1/DJ1	Pathogenic(Last reviewed: Jun 1, 2006)	no assertion criteria provided	VCV000007069	1	8025408	1	7965348	7069	22108	rs137853051	NC_000001.11:7965347:G:T
NM_007262.5(PARK7):c.192G>C (p.Glu64Asp)	PARK7	E64D	Parkinson disease 7	Pathogenic(Last reviewed: Oct 1, 2004)	no assertion criteria provided	VCV000007067	1	8025485	1	7965425	7067	22106	rs74315353	NC_000001.11:7965424:G:C
NM_007262.5(PARK7):c.446A>C (p.Asp149Ala)	PARK7	D149A	Parkinson disease 7	Likely benign(Last reviewed: Dec 11, 2021)	criteria provided, single submitter	VCV000007066	1	8044990	1	7984930	7066	22105	rs74315352	NC_000001.11:7984929:A:C
NM_007262.5(PARK7):c.78G>A (p.Met26Ile)	PARK7	M26I	Parkinson disease 7	Pathogenic(Last reviewed: Jul 1, 2012)	no assertion criteria provided	VCV000007065	1	8022923	1	7962863	7065	22104	rs74315351	NC_000001.11:7962862:G:A
NM_007262.5(PARK7):c.497T>C (p.Leu166Pro)	PARK7	L166P	Parkinson disease 7	Pathogenic(Last reviewed: Jul 1, 2012)	no assertion criteria provided	VCV000007064	1	8045041	1	7984981	7064	22103	rs28938172	NC_000001.11:7984980:T:C
nsv513788	PARK7		Parkinson disease 7	Pathogenic(Last reviewed: Oct 1, 2010)	no assertion criteria provided	VCV000007063	1	8018845 - 8044954			7063	22102		
NM_018622.7(PARL):c.230G>A (p.Ser77Asn)	PARL	S77N	not provided	Uncertain significance(Last reviewed: Nov 1, 2011)	no assertion criteria provided	VCV000218097	3	183585744	3	183867956	218097	214751	rs571537271	NC_000003.12:183867955:C:T
NM_000285.4(PEPD):c.1310G>A (p.Arg437His)	PEPD	R396H, R373H, R437H	not provided	Uncertain significance(Last reviewed: Sep 17, 2021)	criteria provided, single submitter	VCV001426531	19	33878830	19	33387924	1426531	1366204		NC_000019.10:33387923:C:T
NM_032409.3(PINK1):c.736C>A (p.Arg246=)	PINK1		Parkinson disease 6, autosomal recessive early-onset	Likely benign(Last reviewed: Jun 16, 2021)	criteria provided, single submitter	VCV001674719	1	20966445	1	20639952	1674719	1532725		NC_000001.11:20639951:C:A
NM_032409.3(PINK1):c.1719C>T (p.Leu573=)	PINK1|PINK1-AS		Parkinson disease 6, autosomal recessive early-onset	Likely benign(Last reviewed: Dec 8, 2021)	criteria provided, single submitter	VCV001670253	1	20977157	1	20650664	1670253	1635618		NC_000001.11:20650663:C:T
NM_032409.3(PINK1):c.387+20A>G	PINK1		Parkinson disease 6, autosomal recessive early-onset	Benign(Last reviewed: Oct 28, 2021)	criteria provided, single submitter	VCV001657185	1	20960448	1	20633955	1657185	1628349		NC_000001.11:20633954:A:G
NM_032409.3(PINK1):c.1011C>T (p.Arg337=)	PINK1|PINK1-AS		Parkinson disease 6, autosomal recessive early-onset	Likely benign(Last reviewed: Dec 2, 2021)	criteria provided, single submitter	VCV001653728	1	20972104	1	20645611	1653728	1614078		NC_000001.11:20645610:C:T
NM_032409.3(PINK1):c.1251+19A>G	PINK1|PINK1-AS		Parkinson disease 6, autosomal recessive early-onset	Likely benign(Last reviewed: Jun 29, 2021)	criteria provided, single submitter	VCV001644627	1	20975144	1	20648651	1644627	1522674		NC_000001.11:20648650:A:G
NM_032409.3(PINK1):c.546G>A (p.Leu182=)	PINK1		Parkinson disease 6, autosomal recessive early-onset	Likely benign(Last reviewed: Dec 3, 2021)	criteria provided, single submitter	VCV001632891	1	20964493	1	20638000	1632891	1545285		NC_000001.11:20637999:G:A
NM_032409.3(PINK1):c.960-18del	PINK1|PINK1-AS		Parkinson disease 6, autosomal recessive early-onset	Likely benign(Last reviewed: Jun 14, 2021)	criteria provided, single submitter	VCV001625504	1	20972033	1	20645540	1625504	1607064		NC_000001.11:20645539:CCC:CC
NM_032409.3(PINK1):c.1125C>T (p.Asp375=)	PINK1|PINK1-AS		Parkinson disease 6, autosomal recessive early-onset	Likely benign(Last reviewed: Sep 15, 2021)	criteria provided, single submitter	VCV001621889	1	20974999	1	20648506	1621889	1593092		NC_000001.11:20648505:C:T
NM_032409.3(PINK1):c.1251+9C>T	PINK1|PINK1-AS		Parkinson disease 6, autosomal recessive early-onset	Likely benign(Last reviewed: Aug 7, 2021)	criteria provided, single submitter	VCV001612101	1	20975134	1	20648641	1612101	1535729		NC_000001.11:20648640:C:T
NM_032409.3(PINK1):c.1488+17C>T	PINK1|PINK1-AS		Parkinson disease 6, autosomal recessive early-onset	Likely benign(Last reviewed: Oct 18, 2021)	criteria provided, single submitter	VCV001609977	1	20975741	1	20649248	1609977	1550933		NC_000001.11:20649247:C:T
NM_032409.3(PINK1):c.315G>A (p.Gly105=)	PINK1		Parkinson disease 6, autosomal recessive early-onset	Likely benign(Last reviewed: Sep 20, 2021)	criteria provided, single submitter	VCV001605915	1	20960356	1	20633863	1605915	1560410		NC_000001.11:20633862:G:A
NM_032409.3(PINK1):c.69C>G (p.Gly23=)	PINK1		Parkinson disease 6, autosomal recessive early-onset	Likely benign(Last reviewed: Nov 27, 2021)	criteria provided, single submitter	VCV001602646	1	20960110	1	20633617	1602646	1557603		NC_000001.11:20633616:C:G
NM_032409.3(PINK1):c.675+8C>T	PINK1		Parkinson disease 6, autosomal recessive early-onset	Likely benign(Last reviewed: Aug 1, 2021)	criteria provided, single submitter	VCV001595737	1	20964630	1	20638137	1595737	1656727		NC_000001.11:20638136:C:T
NM_032409.3(PINK1):c.1689G>A (p.Glu563=)	PINK1|PINK1-AS		Parkinson disease 6, autosomal recessive early-onset	Likely benign(Last reviewed: Dec 17, 2021)	criteria provided, single submitter	VCV001591617	1	20977127	1	20650634	1591617	1577733		NC_000001.11:20650633:G:A
NM_032409.3(PINK1):c.1047C>A (p.Gly349=)	PINK1|PINK1-AS		Parkinson disease 6, autosomal recessive early-onset	Likely benign(Last reviewed: Sep 29, 2021)	criteria provided, single submitter	VCV001587244	1	20972140	1	20645647	1587244	1541760		NC_000001.11:20645646:C:A
NM_032409.3(PINK1):c.960-17T>C	PINK1|PINK1-AS		Parkinson disease 6, autosomal recessive early-onset	Likely benign(Last reviewed: Aug 26, 2021)	criteria provided, single submitter	VCV001583410	1	20972036	1	20645543	1583410	1601107		NC_000001.11:20645542:T:C
NM_032409.3(PINK1):c.1512A>C (p.Ala504=)	PINK1|PINK1-AS		Parkinson disease 6, autosomal recessive early-onset	Likely benign(Last reviewed: Apr 27, 2021)	criteria provided, single submitter	VCV001578201	1	20976950	1	20650457	1578201	1587669		NC_000001.11:20650456:A:C
NM_032409.3(PINK1):c.1488+15G>A	PINK1|PINK1-AS		Parkinson disease 6, autosomal recessive early-onset	Likely benign(Last reviewed: Jun 18, 2021)	criteria provided, single submitter	VCV001565696	1	20975739	1	20649246	1565696	1590286		NC_000001.11:20649245:G:A
NM_032409.3(PINK1):c.627G>A (p.Pro209=)	PINK1		Parkinson disease 6, autosomal recessive early-onset	Likely benign(Last reviewed: Sep 25, 2021)	criteria provided, single submitter	VCV001564487	1	20964574	1	20638081	1564487	1654856		NC_000001.11:20638080:G:A
NM_032409.3(PINK1):c.504T>C (p.Ala168=)	PINK1		Parkinson disease 6, autosomal recessive early-onset	Likely benign(Last reviewed: Jun 15, 2021)	criteria provided, single submitter	VCV001559671	1	20964451	1	20637958	1559671	1542262		NC_000001.11:20637957:T:C
NM_032409.3(PINK1):c.429G>A (p.Leu143=)	PINK1		Parkinson disease 6, autosomal recessive early-onset	Likely benign(Last reviewed: Feb 1, 2021)	criteria provided, single submitter	VCV001556563	1	20964376	1	20637883	1556563	1592707		NC_000001.11:20637882:G:A
NM_032409.3(PINK1):c.1419A>G (p.Ala473=)	PINK1|PINK1-AS		Parkinson disease 6, autosomal recessive early-onset	Likely benign(Last reviewed: Oct 18, 2021)	criteria provided, single submitter	VCV001551035	1	20975655	1	20649162	1551035	1638072		NC_000001.11:20649161:A:G
NM_032409.3(PINK1):c.1260G>A (p.Thr420=)	PINK1|PINK1-AS		Parkinson disease 6, autosomal recessive early-onset	Likely benign(Last reviewed: Jul 7, 2021)	criteria provided, single submitter	VCV001550627	1	20975496	1	20649003	1550627	1574316		NC_000001.11:20649002:G:A
NM_032409.3(PINK1):c.960-12C>A	PINK1|PINK1-AS		Parkinson disease 6, autosomal recessive early-onset	Likely benign(Last reviewed: Aug 18, 2021)	criteria provided, single submitter	VCV001537675	1	20972041	1	20645548	1537675	1649954		NC_000001.11:20645547:C:A
NM_032409.3(PINK1):c.338_346del (p.Glu113_Gln115del)	PINK1		Parkinson disease 6, autosomal recessive early-onset	Uncertain significance(Last reviewed: Sep 24, 2021)	criteria provided, single submitter	VCV001524912	1	20960376 - 20960384	1	20633883 - 20633891	1524912	1363252		NC_000001.11:20633882:AGGAAAAACAGG:AGG
NM_032409.3(PINK1):c.1009C>T (p.Arg337Cys)	PINK1|PINK1-AS	R337C	Parkinson disease 6, autosomal recessive early-onset	Uncertain significance(Last reviewed: Aug 14, 2021)	criteria provided, single submitter	VCV001517107	1	20972102	1	20645609	1517107	1515267		NC_000001.11:20645608:C:T
NM_032409.3(PINK1):c.439C>T (p.Arg147Cys)	PINK1	R147C	Parkinson disease 6, autosomal recessive early-onset	Uncertain significance(Last reviewed: Dec 2, 2021)	criteria provided, single submitter	VCV001514024	1	20964386	1	20637893	1514024	1491839		NC_000001.11:20637892:C:T
NM_032409.3(PINK1):c.634C>T (p.Pro212Ser)	PINK1	P212S	Parkinson disease 6, autosomal recessive early-onset	Uncertain significance(Last reviewed: Sep 21, 2021)	criteria provided, single submitter	VCV001511617	1	20964581	1	20638088	1511617	1459098		NC_000001.11:20638087:C:T
NM_032409.3(PINK1):c.1544A>G (p.His515Arg)	PINK1|PINK1-AS	H515R	Parkinson disease 6, autosomal recessive early-onset	Uncertain significance(Last reviewed: Oct 10, 2021)	criteria provided, single submitter	VCV001507469	1	20976982	1	20650489	1507469	1449759		NC_000001.11:20650488:A:G
NM_032409.3(PINK1):c.902C>T (p.Ser301Leu)	PINK1|PINK1-AS	S301L	Parkinson disease 6, autosomal recessive early-onset	Uncertain significance(Last reviewed: Oct 28, 2021)	criteria provided, single submitter	VCV001479260	1	20971108	1	20644615	1479260	1426630		NC_000001.11:20644614:C:T
NM_032409.3(PINK1):c.805G>A (p.Ala269Thr)	PINK1|PINK1-AS	A269T	Parkinson disease 6, autosomal recessive early-onset	Uncertain significance(Last reviewed: Oct 27, 2021)	criteria provided, single submitter	VCV001475039	1	20971011	1	20644518	1475039	1403949		NC_000001.11:20644517:G:A
NM_032409.3(PINK1):c.388-10C>G	PINK1		Parkinson disease 6, autosomal recessive early-onset	Uncertain significance(Last reviewed: Aug 27, 2021)	criteria provided, single submitter	VCV001472135	1	20964325	1	20637832	1472135	1385283		NC_000001.11:20637831:C:G
NM_032409.3(PINK1):c.1264C>T (p.Arg422Cys)	PINK1|PINK1-AS	R422C	Parkinson disease 6, autosomal recessive early-onset	Uncertain significance(Last reviewed: Dec 2, 2021)	criteria provided, single submitter	VCV001470144	1	20975500	1	20649007	1470144	1375987		NC_000001.11:20649006:C:T
NM_032409.3(PINK1):c.85_106del (p.Tyr29fs)	PINK1	Y29fs	Parkinson disease 6, autosomal recessive early-onset	Pathogenic(Last reviewed: Aug 22, 2021)	criteria provided, single submitter	VCV001454290	1	20960116 - 20960137	1	20633623 - 20633644	1454290	1366895		NC_000001.11:20633622:CGGCCGGGCCTACGGCTTGGGGCGGCCGGGCC:CGGCCGGGCC
NM_032409.3(PINK1):c.1627A>G (p.Arg543Gly)	PINK1|PINK1-AS	R543G	Parkinson disease 6, autosomal recessive early-onset	Uncertain significance(Last reviewed: Sep 24, 2021)	criteria provided, single submitter	VCV001447757	1	20977065	1	20650572	1447757	1403644		NC_000001.11:20650571:A:G
NM_032409.3(PINK1):c.371C>T (p.Ala124Val)	PINK1	A124V	Parkinson disease 6, autosomal recessive early-onset	Uncertain significance(Last reviewed: Sep 25, 2021)	criteria provided, single submitter	VCV001447252	1	20960412	1	20633919	1447252	1503307		NC_000001.11:20633918:C:T
NM_032409.3(PINK1):c.1024A>G (p.Met342Val)	PINK1|PINK1-AS	M342V	Parkinson disease 6, autosomal recessive early-onset	Uncertain significance(Last reviewed: Aug 28, 2021)	criteria provided, single submitter	VCV001446048	1	20972117	1	20645624	1446048	1390878		NC_000001.11:20645623:A:G
NM_032409.3(PINK1):c.1167G>A (p.Leu389=)	PINK1|PINK1-AS		Parkinson disease 6, autosomal recessive early-onset	Uncertain significance(Last reviewed: Oct 14, 2021)	criteria provided, single submitter	VCV001442648	1	20975041	1	20648548	1442648	1375412		NC_000001.11:20648547:G:A
NM_032409.3(PINK1):c.1219C>T (p.Arg407Trp)	PINK1|PINK1-AS	R407W	Parkinson disease 6, autosomal recessive early-onset	Uncertain significance(Last reviewed: Oct 8, 2021)	criteria provided, single submitter	VCV001436397	1	20975093	1	20648600	1436397	1340789		NC_000001.11:20648599:C:T
NM_032409.3(PINK1):c.630G>T (p.Gly210=)	PINK1		Parkinson disease 6, autosomal recessive early-onset	Uncertain significance(Last reviewed: Aug 27, 2021)	criteria provided, single submitter	VCV001435547	1	20964577	1	20638084	1435547	1500543		NC_000001.11:20638083:G:T
NM_032409.3(PINK1):c.1475G>A (p.Arg492Gln)	PINK1|PINK1-AS	R492Q	Parkinson disease 6, autosomal recessive early-onset	Uncertain significance(Last reviewed: Nov 17, 2021)	criteria provided, single submitter	VCV001432306	1	20975711	1	20649218	1432306	1484417		NC_000001.11:20649217:G:A
NM_032409.3(PINK1):c.1606G>T (p.Ala536Ser)	PINK1|PINK1-AS	A536S	Parkinson disease 6, autosomal recessive early-onset	Uncertain significance(Last reviewed: Aug 3, 2021)	criteria provided, single submitter	VCV001431892	1	20977044	1	20650551	1431892	1405963		NC_000001.11:20650550:G:T
NM_032409.3(PINK1):c.1252G>A (p.Val418Met)	PINK1|PINK1-AS	V418M	Parkinson disease 6, autosomal recessive early-onset	Uncertain significance(Last reviewed: Sep 18, 2021)	criteria provided, single submitter	VCV001411317	1	20975488	1	20648995	1411317	1343707		NC_000001.11:20648994:G:A
NM_032409.3(PINK1):c.1442A>T (p.Asp481Val)	PINK1|PINK1-AS	D481V	Parkinson disease 6, autosomal recessive early-onset	Uncertain significance(Last reviewed: Aug 26, 2021)	criteria provided, single submitter	VCV001408940	1	20975678	1	20649185	1408940	1496729		NC_000001.11:20649184:A:T
NM_032409.3(PINK1):c.116G>T (p.Gly39Val)	PINK1	G39V	Parkinson disease 6, autosomal recessive early-onset	Uncertain significance(Last reviewed: Aug 4, 2021)	criteria provided, single submitter	VCV001407492	1	20960157	1	20633664	1407492	1483701		NC_000001.11:20633663:G:T
NM_032409.3(PINK1):c.1391G>A (p.Arg464His)	PINK1|PINK1-AS	R464H	Parkinson disease 6, autosomal recessive early-onset	Uncertain significance(Last reviewed: Aug 31, 2021)	criteria provided, single submitter	VCV001406864	1	20975627	1	20649134	1406864	1486922		NC_000001.11:20649133:G:A
NM_032409.3(PINK1):c.311T>G (p.Phe104Cys)	PINK1	F104C	Parkinson disease 6, autosomal recessive early-onset	Uncertain significance(Last reviewed: Nov 5, 2021)	criteria provided, single submitter	VCV001405928	1	20960352	1	20633859	1405928	1493190		NC_000001.11:20633858:T:G
NM_032409.3(PINK1):c.644C>G (p.Pro215Arg)	PINK1	P215R	Parkinson disease 6, autosomal recessive early-onset	Uncertain significance(Last reviewed: Aug 31, 2021)	criteria provided, single submitter	VCV001400880	1	20964591	1	20638098	1400880	1463732		NC_000001.11:20638097:C:G
NM_032409.3(PINK1):c.101C>G (p.Pro34Arg)	PINK1	P34R	Parkinson disease 6, autosomal recessive early-onset	Uncertain significance(Last reviewed: Nov 13, 2021)	criteria provided, single submitter	VCV001399865	1	20960142	1	20633649	1399865	1443955		NC_000001.11:20633648:C:G
NM_032409.3(PINK1):c.1329del (p.Tyr444fs)	PINK1|PINK1-AS	Y444fs	Parkinson disease 6, autosomal recessive early-onset	Pathogenic(Last reviewed: Oct 14, 2021)	criteria provided, single submitter	VCV001399771	1	20975564	1	20649071	1399771	1366128		NC_000001.11:20649070:CC:C
NM_032409.3(PINK1):c.666G>A (p.Trp222Ter)	PINK1	W222*	Parkinson disease 6, autosomal recessive early-onset	Pathogenic(Last reviewed: Aug 16, 2021)	criteria provided, single submitter	VCV001398596	1	20964613	1	20638120	1398596	1427663		NC_000001.11:20638119:G:A
NM_032409.3(PINK1):c.1121C>G (p.Pro374Arg)	PINK1|PINK1-AS	P374R	Parkinson disease 6, autosomal recessive early-onset	Uncertain significance(Last reviewed: Dec 2, 2021)	criteria provided, single submitter	VCV001395782	1	20972214	1	20645721	1395782	1425181		NC_000001.11:20645720:C:G
NM_032409.3(PINK1):c.47C>T (p.Ala16Val)	PINK1	A16V	Parkinson disease 6, autosomal recessive early-onset	Uncertain significance(Last reviewed: Aug 4, 2021)	criteria provided, single submitter	VCV001374264	1	20960088	1	20633595	1374264	1457081		NC_000001.11:20633594:C:T
NM_032409.3(PINK1):c.959+4A>T	PINK1|PINK1-AS		Parkinson disease 6, autosomal recessive early-onset	Uncertain significance(Last reviewed: Nov 29, 2021)	criteria provided, single submitter	VCV001370933	1	20971169	1	20644676	1370933	1427139		NC_000001.11:20644675:A:T
NM_032409.3(PINK1):c.648G>T (p.Leu216Phe)	PINK1	L216F	Parkinson disease 6, autosomal recessive early-onset	Uncertain significance(Last reviewed: Sep 1, 2021)	criteria provided, single submitter	VCV001359078	1	20964595	1	20638102	1359078	1357355		NC_000001.11:20638101:G:T
NM_032409.3(PINK1):c.25C>G (p.Arg9Gly)	PINK1	R9G	Parkinson disease 6, autosomal recessive early-onset	Uncertain significance(Last reviewed: Sep 24, 2021)	criteria provided, single submitter	VCV001356897	1	20960066	1	20633573	1356897	1348328		NC_000001.11:20633572:C:G
NM_032409.3(PINK1):c.1579A>G (p.Met527Val)	PINK1|PINK1-AS	M527V	Parkinson disease 6, autosomal recessive early-onset	Uncertain significance(Last reviewed: Aug 14, 2021)	criteria provided, single submitter	VCV001349437	1	20977017	1	20650524	1349437	1394200		NC_000001.11:20650523:A:G
NM_032409.3(PINK1):c.1609G>A (p.Ala537Thr)	PINK1|PINK1-AS	A537T	Parkinson disease 6, autosomal recessive early-onset	Uncertain significance(Last reviewed: Oct 14, 2021)	criteria provided, single submitter	VCV001345238	1	20977047	1	20650554	1345238	1443204		NC_000001.11:20650553:G:A
NM_032409.3(PINK1):c.292C>T (p.Arg98Trp)	PINK1	R98W	Parkinson disease 6, autosomal recessive early-onset	Likely pathogenic(Last reviewed: Apr 17, 2021)	no assertion criteria provided	VCV001324914	1	20960333	1	20633840	1324914	1315177		NC_000001.11:20633839:C:T
NM_032409.3(PINK1):c.250C>T (p.Gln84Ter)	PINK1	Q84*	Parkinson disease 6, autosomal recessive early-onset	Pathogenic(Last reviewed: Mar 25, 2020)	no assertion criteria provided	VCV001323457	1	20960291	1	20633798	1323457	1313742		NC_000001.11:20633797:C:T
NM_032409.3(PINK1):c.1024A>C (p.Met342Leu)	PINK1|PINK1-AS	M342L	not provided	Uncertain significance(Last reviewed: Nov 7, 2019)	criteria provided, single submitter	VCV001310405	1	20972117	1	20645624	1310405	1302255		NC_000001.11:20645623:A:C
NM_032409.3(PINK1):c.857C>T (p.Pro286Leu)	PINK1|PINK1-AS	P286L	not provided|Parkinson disease 6, autosomal recessive early-onset	Uncertain significance(Last reviewed: Oct 10, 2021)	criteria provided, multiple submitters, no conflicts	VCV001308797	1	20971063	1	20644570	1308797	1300825		NC_000001.11:20644569:C:T
NM_032409.3(PINK1):c.905G>A (p.Arg302His)	PINK1|PINK1-AS	R302H	Parkinson disease 6, autosomal recessive early-onset|not provided	Uncertain significance(Last reviewed: Sep 24, 2021)	criteria provided, multiple submitters, no conflicts	VCV001307790	1	20971111	1	20644618	1307790	1297738		NC_000001.11:20644617:G:A
NM_032409.3(PINK1):c.558G>C (p.Lys186Asn)	PINK1	K186N	Parkinson disease 6, autosomal recessive early-onset	Benign(Last reviewed: Aug 17, 2020)	criteria provided, single submitter	VCV001169544	1	20964505	1	20638012	1169544	1153429		NC_000001.11:20638011:G:C
NM_032409.3(PINK1):c.624T>C (p.Ala208=)	PINK1		Parkinson disease 6, autosomal recessive early-onset	Likely benign(Last reviewed: Mar 6, 2020)	criteria provided, single submitter	VCV001154692	1	20964571	1	20638078	1154692	1130817		NC_000001.11:20638077:T:C
NM_032409.3(PINK1):c.942G>A (p.Leu314=)	PINK1|PINK1-AS		Parkinson disease 6, autosomal recessive early-onset	Likely benign(Last reviewed: Aug 16, 2020)	criteria provided, single submitter	VCV001150377	1	20971148	1	20644655	1150377	1130818		NC_000001.11:20644654:G:A
NM_032409.3(PINK1):c.1530C>T (p.Ser510=)	PINK1|PINK1-AS		Parkinson disease 6, autosomal recessive early-onset	Likely benign(Last reviewed: Jul 9, 2020)	criteria provided, single submitter	VCV001149020	1	20976968	1	20650475	1149020	1130819		NC_000001.11:20650474:C:T
NM_032409.3(PINK1):c.1023G>A (p.Met341Ile)	PINK1|PINK1-AS	M341I	Parkinson disease 6, autosomal recessive early-onset	Likely benign(Last reviewed: Apr 29, 2019)	criteria provided, single submitter	VCV001139313	1	20972116	1	20645623	1139313	1109921		NC_000001.11:20645622:G:A
NM_032409.3(PINK1):c.435G>A (p.Thr145=)	PINK1		Parkinson disease 6, autosomal recessive early-onset	Likely benign(Last reviewed: Feb 26, 2019)	criteria provided, single submitter	VCV001130785	1	20964382	1	20637889	1130785	1109919		NC_000001.11:20637888:G:A
NM_032409.3(PINK1):c.690C>T (p.Ser230=)	PINK1		Parkinson disease 6, autosomal recessive early-onset	Likely benign(Last reviewed: Sep 7, 2019)	criteria provided, single submitter	VCV001130158	1	20966399	1	20639906	1130158	1109920		NC_000001.11:20639905:C:T
NM_032409.3(PINK1):c.426G>A (p.Pro142=)	PINK1		not provided|Parkinson disease 6, autosomal recessive early-onset	Likely benign(Last reviewed: Nov 1, 2021)	criteria provided, multiple submitters, no conflicts	VCV001110165	1	20964373	1	20637880	1110165	1088405		NC_000001.11:20637879:G:A
NC_000001.10:g.(?_20972043)_(20972226_?)del	PINK1		Parkinson disease 6, autosomal recessive early-onset	Pathogenic(Last reviewed: Mar 12, 2020)	criteria provided, single submitter	VCV001074575	1	20972043 - 20972226			1074575	1056845		
NM_032409.3(PINK1):c.488G>A (p.Gly163Asp)	PINK1	G163D	Parkinson disease 6, autosomal recessive early-onset	Uncertain significance(Last reviewed: Apr 26, 2020)	criteria provided, single submitter	VCV001040371	1	20964435	1	20637942	1040371	1022886	rs1252036117	NC_000001.11:20637941:G:A
NM_032409.3(PINK1):c.1123+19A>G	PINK1|PINK1-AS		Parkinson disease 6, autosomal recessive early-onset	Uncertain significance(Last reviewed: Jun 15, 2020)	criteria provided, single submitter	VCV001030968	1	20972235	1	20645742	1030968	1015628	rs762129771	NC_000001.11:20645741:A:G
NM_032409.3(PINK1):c.388-3C>T	PINK1		Parkinson disease 6, autosomal recessive early-onset	Uncertain significance(Last reviewed: Jan 23, 2020)	criteria provided, single submitter	VCV001021120	1	20964332	1	20637839	1021120	1002435	rs371971165	NC_000001.11:20637838:C:T
NM_032409.3(PINK1):c.838G>A (p.Ala280Thr)	PINK1|PINK1-AS	A280T	Parkinson disease 6, autosomal recessive early-onset	Uncertain significance(Last reviewed: Jan 23, 2020)	criteria provided, single submitter	VCV001017772	1	20971044	1	20644551	1017772	1002436	rs772510148	NC_000001.11:20644550:G:A
NM_032409.3(PINK1):c.76G>C (p.Gly26Arg)	PINK1	G26R	Parkinson disease 6, autosomal recessive early-onset	Uncertain significance(Last reviewed: Sep 9, 2020)	criteria provided, single submitter	VCV001016581	1	20960117	1	20633624	1016581	1002434	rs2053015141	NC_000001.11:20633623:G:C
NM_032409.3(PINK1):c.1573G>A (p.Asp525Asn)	PINK1|PINK1-AS	D525N	Parkinson disease 6, autosomal recessive early-onset	Uncertain significance(Last reviewed: Jul 8, 2020)	criteria provided, single submitter	VCV001011956	1	20977011	1	20650518	1011956	987171	rs531477772	NC_000001.11:20650517:G:A
NM_032409.3(PINK1):c.1580T>C (p.Met527Thr)	PINK1|PINK1-AS	M527T	Parkinson disease 6, autosomal recessive early-onset	Uncertain significance(Last reviewed: Oct 10, 2020)	criteria provided, single submitter	VCV001009480	1	20977018	1	20650525	1009480	987172	rs751012180	NC_000001.11:20650524:T:C
NM_032409.3(PINK1):c.1220G>A (p.Arg407Gln)	PINK1|PINK1-AS	R407Q	Parkinson disease 6, autosomal recessive early-onset	Uncertain significance(Last reviewed: Feb 21, 2020)	criteria provided, single submitter	VCV000967822	1	20975094	1	20648601	967822	952221	rs556540177	NC_000001.11:20648600:G:A
NM_032409.3(PINK1):c.1488+1G>A	PINK1|PINK1-AS		Parkinson disease 6, autosomal recessive early-onset	Pathogenic(Last reviewed: Aug 20, 2019)	criteria provided, single submitter	VCV000961640	1	20975725	1	20649232	961640	959540	rs2053233432	NC_000001.11:20649231:G:A
NM_032409.3(PINK1):c.124C>T (p.Arg42Cys)	PINK1	R42C	Parkinson disease 6, autosomal recessive early-onset	Uncertain significance(Last reviewed: Jul 10, 2019)	criteria provided, single submitter	VCV000939290	1	20960165	1	20633672	939290	930252	rs1255530845	NC_000001.11:20633671:C:T
NM_032409.3(PINK1):c.1252-1G>A	PINK1|PINK1-AS		Parkinson disease 6, autosomal recessive early-onset	Likely pathogenic(Last reviewed: Sep 15, 2019)	criteria provided, single submitter	VCV000934238	1	20975487	1	20648994	934238	939792	rs2053228483	NC_000001.11:20648993:G:A
NM_032409.3(PINK1):c.454C>T (p.Arg152Trp)	PINK1	R152W	Parkinson disease 6, autosomal recessive early-onset	Uncertain significance(Last reviewed: Sep 29, 2021)	criteria provided, multiple submitters, no conflicts	VCV000931833	1	20964401	1	20637908	931833	918593	rs45608139	NC_000001.11:20637907:C:T
NM_032409.3(PINK1):c.*817C>A	PINK1|PINK1-AS		Parkinson disease 6, autosomal recessive early-onset	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000876908	1	20978001	1	20651508	876908	863366	rs2053279238	NC_000001.11:20651507:C:A
NM_032409.3(PINK1):c.*702G>A	PINK1|PINK1-AS		Parkinson disease 6, autosomal recessive early-onset	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000876907	1	20977886	1	20651393	876907	863365	rs922209796	NC_000001.11:20651392:G:A
NM_032409.3(PINK1):c.*586T>C	PINK1|PINK1-AS		Parkinson disease 6, autosomal recessive early-onset	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000876906	1	20977770	1	20651277	876906	863364	rs184877436	NC_000001.11:20651276:T:C
NM_032409.3(PINK1):c.*579C>T	PINK1|PINK1-AS		Parkinson disease 6, autosomal recessive early-onset	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000876905	1	20977763	1	20651270	876905	863363	rs2053270701	NC_000001.11:20651269:C:T
NM_032409.3(PINK1):c.1729T>C (p.Trp577Arg)	PINK1|PINK1-AS	W577R	Parkinson disease 6, autosomal recessive early-onset	Uncertain significance(Last reviewed: Apr 27, 2017)	criteria provided, single submitter	VCV000876859	1	20977167	1	20650674	876859	863353	rs747133533	NC_000001.11:20650673:T:C
NM_032409.3(PINK1):c.1728A>G (p.Ser576=)	PINK1|PINK1-AS		not provided|Parkinson disease 6, autosomal recessive early-onset	Conflicting interpretations of pathogenicity(Last reviewed: Jun 1, 2021)	criteria provided, conflicting interpretations	VCV000876858	1	20977166	1	20650673	876858	863352	rs149994404	NC_000001.11:20650672:A:G
NM_032409.3(PINK1):c.813C>T (p.His271=)	PINK1|PINK1-AS		Parkinson disease 6, autosomal recessive early-onset	Uncertain significance(Last reviewed: Apr 27, 2017)	criteria provided, single submitter	VCV000876799	1	20971019	1	20644526	876799	863345	rs28940284	NC_000001.11:20644525:C:T
NM_032409.3(PINK1):c.620G>A (p.Arg207Gln)	PINK1	R207Q	Parkinson disease 6, autosomal recessive early-onset	Uncertain significance(Last reviewed: Apr 2, 2019)	criteria provided, multiple submitters, no conflicts	VCV000876798	1	20964567	1	20638074	876798	863344	rs759468742	NC_000001.11:20638073:G:A
NM_032409.3(PINK1):c.*571C>T	PINK1|PINK1-AS		Parkinson disease 6, autosomal recessive early-onset	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000875913	1	20977755	1	20651262	875913	863362	rs1003457823	NC_000001.11:20651261:C:T
NM_032409.3(PINK1):c.*542G>A	PINK1|PINK1-AS		Parkinson disease 6, autosomal recessive early-onset	Uncertain significance(Last reviewed: Mar 30, 2018)	criteria provided, single submitter	VCV000875912	1	20977726	1	20651233	875912	863361	rs1161485879	NC_000001.11:20651232:G:A
NM_032409.3(PINK1):c.*519G>A	PINK1|PINK1-AS		Parkinson disease 6, autosomal recessive early-onset	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000875911	1	20977703	1	20651210	875911	863360	rs1054458936	NC_000001.11:20651209:G:A
NM_032409.3(PINK1):c.1194G>A (p.Leu398=)	PINK1|PINK1-AS		Parkinson disease 6, autosomal recessive early-onset	Uncertain significance(Last reviewed: Apr 27, 2017)	criteria provided, single submitter	VCV000875861	1	20975068	1	20648575	875861	863351	rs1214490830	NC_000001.11:20648574:G:A
NM_032409.3(PINK1):c.414G>A (p.Pro138=)	PINK1		Parkinson disease 6, autosomal recessive early-onset	Conflicting interpretations of pathogenicity(Last reviewed: Dec 10, 2020)	criteria provided, conflicting interpretations	VCV000875808	1	20964361	1	20637868	875808	863343	rs773637957	NC_000001.11:20637867:G:A
NM_032409.3(PINK1):c.387+14G>A	PINK1		Parkinson disease 6, autosomal recessive early-onset	Benign/Likely benign(Last reviewed: Dec 2, 2021)	criteria provided, multiple submitters, no conflicts	VCV000875807	1	20960442	1	20633949	875807	865097	rs117438827	NC_000001.11:20633948:G:A
NM_032409.3(PINK1):c.279G>C (p.Ala93=)	PINK1		Parkinson disease 6, autosomal recessive early-onset	Uncertain significance(Last reviewed: Apr 27, 2017)	criteria provided, single submitter	VCV000875806	1	20960320	1	20633827	875806	863342	rs1224246757	NC_000001.11:20633826:G:C
NM_032409.3(PINK1):c.*352G>A	PINK1|PINK1-AS		Parkinson disease 6, autosomal recessive early-onset	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000874986	1	20977536	1	20651043	874986	863359	rs1020810162	NC_000001.11:20651042:G:A
NM_032409.3(PINK1):c.*340C>T	PINK1|PINK1-AS		Parkinson disease 6, autosomal recessive early-onset	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000874985	1	20977524	1	20651031	874985	863358	rs1469982205	NC_000001.11:20651030:C:T
NM_032409.3(PINK1):c.*263C>A	PINK1|PINK1-AS		Parkinson disease 6, autosomal recessive early-onset	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000874984	1	20977447	1	20650954	874984	863357	rs1339739201	NC_000001.11:20650953:C:A
NM_032409.3(PINK1):c.1075G>A (p.Ala359Thr)	PINK1|PINK1-AS	A359T	Parkinson disease 6, autosomal recessive early-onset	Conflicting interpretations of pathogenicity(Last reviewed: Jun 24, 2021)	criteria provided, conflicting interpretations	VCV000874927	1	20972168	1	20645675	874927	863349	rs76753586	NC_000001.11:20645674:G:A
NM_032409.3(PINK1):c.1003A>G (p.Ser335Gly)	PINK1|PINK1-AS	S335G	Parkinson disease 6, autosomal recessive early-onset	Uncertain significance(Last reviewed: Apr 27, 2017)	criteria provided, single submitter	VCV000874926	1	20972096	1	20645603	874926	863348	rs144330127	NC_000001.11:20645602:A:G
NM_032409.3(PINK1):c.*113G>A	PINK1|PINK1-AS		Parkinson disease 6, autosomal recessive early-onset	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000874058	1	20977297	1	20650804	874058	863356	rs926301568	NC_000001.11:20650803:G:A
NM_032409.3(PINK1):c.*64G>A	PINK1|PINK1-AS		Parkinson disease 6, autosomal recessive early-onset	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000874057	1	20977248	1	20650755	874057	863355	rs1171595625	NC_000001.11:20650754:G:A
NM_032409.3(PINK1):c.*40G>A	PINK1|PINK1-AS		Parkinson disease 6, autosomal recessive early-onset|not provided	Benign/Likely benign(Last reviewed: Jul 14, 2018)	criteria provided, multiple submitters, no conflicts	VCV000874056	1	20977224	1	20650731	874056	863354	rs115768147	NC_000001.11:20650730:G:A
NM_032409.3(PINK1):c.960-11C>G	PINK1|PINK1-AS		Parkinson disease 6, autosomal recessive early-onset	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000873991	1	20972042	1	20645549	873991	865098	rs371943401	NC_000001.11:20645548:C:G
NM_032409.3(PINK1):c.887C>T (p.Pro296Leu)	PINK1|PINK1-AS	P296L	Parkinson disease 6, autosomal recessive early-onset	Uncertain significance(Last reviewed: Apr 27, 2017)	criteria provided, single submitter	VCV000873990	1	20971093	1	20644600	873990	863347	rs779060308	NC_000001.11:20644599:C:T
NM_032409.3(PINK1):c.835C>T (p.Arg279Cys)	PINK1|PINK1-AS	R279C	Parkinson disease 6, autosomal recessive early-onset	Uncertain significance(Last reviewed: Jun 15, 2017)	criteria provided, single submitter	VCV000873989	1	20971041	1	20644548	873989	863346	rs61735932	NC_000001.11:20644547:C:T
NM_032409.3(PINK1):c.1065A>G (p.Gln355=)	PINK1|PINK1-AS		Parkinson disease 6, autosomal recessive early-onset	Uncertain significance(Last reviewed: Apr 12, 2019)	criteria provided, multiple submitters, no conflicts	VCV000859181	1	20972158	1	20645665	859181	823273	rs370470902	NC_000001.11:20645664:A:G
NM_032409.3(PINK1):c.449G>A (p.Gly150Asp)	PINK1	G150D	Parkinson disease 6, autosomal recessive early-onset	Uncertain significance(Last reviewed: Nov 22, 2019)	criteria provided, single submitter	VCV000846127	1	20964396	1	20637903	846127	823272	rs2053073251	NC_000001.11:20637902:G:A
NM_032409.3(PINK1):c.745T>G (p.Leu249Val)	PINK1	L249V	not provided|Parkinson disease 6, autosomal recessive early-onset	Uncertain significance(Last reviewed: Feb 11, 2020)	criteria provided, multiple submitters, no conflicts	VCV000806077	1	20966454	1	20639961	806077	794551	rs145650643	NC_000001.11:20639960:T:G
NM_032409.3(PINK1):c.1605G>A (p.Ser535=)	PINK1|PINK1-AS		Parkinson disease 6, autosomal recessive early-onset|not provided	Likely benign(Last reviewed: Oct 18, 2021)	criteria provided, single submitter	VCV000798224	1	20977043	1	20650550	798224	780458	rs149070918	NC_000001.11:20650549:G:A
NM_032409.3(PINK1):c.1549C>T (p.Leu517=)	PINK1|PINK1-AS		not provided|Parkinson disease 6, autosomal recessive early-onset	Likely benign(Last reviewed: Nov 30, 2018)	criteria provided, single submitter	VCV000772756	1	20976987	1	20650494	772756	696419	rs149466252	NC_000001.11:20650493:C:T
NM_032409.3(PINK1):c.537C>T (p.Pro179=)	PINK1		Parkinson disease 6, autosomal recessive early-onset	Likely benign(Last reviewed: Mar 19, 2019)	criteria provided, single submitter	VCV000719562	1	20964484	1	20637991	719562	718571	rs773064713	NC_000001.11:20637990:C:T
NM_032409.3(PINK1):c.852C>T (p.Ser284=)	PINK1|PINK1-AS		Parkinson disease 6, autosomal recessive early-onset	Likely benign(Last reviewed: Apr 30, 2020)	criteria provided, single submitter	VCV000712196	1	20971058	1	20644565	712196	718573	rs368453193	NC_000001.11:20644564:C:T
NM_032409.3(PINK1):c.564C>T (p.Thr188=)	PINK1		not provided|Parkinson disease 6, autosomal recessive early-onset	Likely benign(Last reviewed: Nov 13, 2018)	criteria provided, single submitter	VCV000709154	1	20964511	1	20638018	709154	718572	rs754328101	NC_000001.11:20638017:C:T
NM_032409.3(PINK1):c.267C>T (p.Ala89=)	PINK1		not provided|Parkinson disease 6, autosomal recessive early-onset	Conflicting interpretations of pathogenicity(Last reviewed: Aug 28, 2021)	criteria provided, conflicting interpretations	VCV000707527	1	20960308	1	20633815	707527	690471	rs770933972	NC_000001.11:20633814:C:T
NM_032409.3(PINK1):c.1481C>T (p.Ala494Val)	PINK1|PINK1-AS	A494V	not provided|Parkinson disease 6, autosomal recessive early-onset	Conflicting interpretations of pathogenicity(Last reviewed: Dec 2, 2020)	criteria provided, conflicting interpretations	VCV000706953	1	20975717	1	20649224	706953	690475	rs542258150	NC_000001.11:20649223:C:T
NM_032409.3(PINK1):c.1077G>A (p.Ala359=)	PINK1|PINK1-AS		Parkinson disease 6, autosomal recessive early-onset	Likely benign(Last reviewed: Aug 27, 2019)	criteria provided, single submitter	VCV000704989	1	20972170	1	20645677	704989	690473	rs144550985	NC_000001.11:20645676:G:A
NM_032409.3(PINK1):c.948C>T (p.Leu316=)	PINK1|PINK1-AS		Parkinson disease 6, autosomal recessive early-onset	Benign(Last reviewed: Dec 31, 2019)	criteria provided, single submitter	VCV000703838	1	20971154	1	20644661	703838	690472	rs142183624	NC_000001.11:20644660:C:T
NM_032409.3(PINK1):c.1502G>A (p.Arg501Gln)	PINK1|PINK1-AS	R501Q	not provided|Parkinson disease 6, autosomal recessive early-onset	Benign/Likely benign(Last reviewed: Oct 28, 2020)	criteria provided, multiple submitters, no conflicts	VCV000703805	1	20976940	1	20650447	703805	690476	rs61744200	NC_000001.11:20650446:G:A
NM_032409.3(PINK1):c.1231G>A (p.Gly411Ser)	PINK1|PINK1-AS	G411S	Parkinson disease 6, autosomal recessive early-onset|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Dec 31, 2019)	criteria provided, conflicting interpretations	VCV000703421	1	20975105	1	20648612	703421	690474	rs45478900	NC_000001.11:20648611:G:A
NM_032409.3(PINK1):c.273del (p.Cys92fs)	PINK1	C92fs	Parkinson disease 6, autosomal recessive early-onset	Pathogenic(Last reviewed: Dec 26, 2018)	criteria provided, single submitter	VCV000664114	1	20960314	1	20633821	664114	627314	rs755000580	NC_000001.11:20633820:C:
NM_032409.3(PINK1):c.1096G>A (p.Asp366Asn)	PINK1|PINK1-AS	D366N	Parkinson disease 6, autosomal recessive early-onset	Uncertain significance(Last reviewed: Jul 24, 2019)	criteria provided, multiple submitters, no conflicts	VCV000662914	1	20972189	1	20645696	662914	627317	rs200729715	NC_000001.11:20645695:G:A
NM_032409.3(PINK1):c.13C>T (p.Gln5Ter)	PINK1	Q5*	Parkinson disease 6, autosomal recessive early-onset	Pathogenic(Last reviewed: Dec 26, 2018)	criteria provided, single submitter	VCV000661098	1	20960054	1	20633561	661098	627313	rs1005937012	NC_000001.11:20633560:C:T
NM_032409.3(PINK1):c.962A>G (p.Tyr321Cys)	PINK1|PINK1-AS	Y321C	Parkinson disease 6, autosomal recessive early-onset	Uncertain significance(Last reviewed: Sep 7, 2018)	criteria provided, single submitter	VCV000652873	1	20972055	1	20645562	652873	627316	rs755060576	NC_000001.11:20645561:A:G
NM_032409.3(PINK1):c.626C>T (p.Pro209Leu)	PINK1	P209L	Parkinson disease 6, autosomal recessive early-onset	Uncertain significance(Last reviewed: Aug 10, 2018)	criteria provided, single submitter	VCV000647795	1	20964573	1	20638080	647795	627315	rs34677717	NC_000001.11:20638079:C:T
NM_032409.3(PINK1):c.1212C>G (p.Tyr404Ter)	PINK1|PINK1-AS	Y404*	Parkinson disease 6, autosomal recessive early-onset	Uncertain significance(Last reviewed: Sep 17, 2017)	criteria provided, single submitter	VCV000631592	1	20975086	1	20648593	631592	619988	rs747239996	NC_000001.11:20648592:C:G
NM_032409.3(PINK1):c.774C>A (p.Tyr258Ter)	PINK1	Y258*	Parkinson disease 6, autosomal recessive early-onset	Pathogenic(Last reviewed: Oct 11, 2018)	criteria provided, single submitter	VCV000631591	1	20966483	1	20639990	631591	619987	rs756783990	NC_000001.11:20639989:C:A
NM_032409.3(PINK1):c.665G>A (p.Trp222Ter)	PINK1	W222*	Parkinson disease 6, autosomal recessive early-onset	Uncertain significance(Last reviewed: Sep 18, 2017)	criteria provided, single submitter	VCV000631590	1	20964612	1	20638119	631590	619986	rs777160388	NC_000001.11:20638118:G:A
NM_032409.3(PINK1):c.322del (p.Leu108fs)	PINK1	L108fs	Parkinson disease 6, autosomal recessive early-onset	Uncertain significance(Last reviewed: Jan 4, 2018)	criteria provided, single submitter	VCV000631589	1	20960363	1	20633870	631589	619985	rs1557559393	NC_000001.11:20633869:C:
NM_032409.3(PINK1):c.1147G>A (p.Ala383Thr)	PINK1|PINK1-AS	A383T	not provided|Parkinson disease 6, autosomal recessive early-onset	Conflicting interpretations of pathogenicity(Last reviewed: Oct 13, 2019)	criteria provided, conflicting interpretations	VCV000618283	1	20975021	1	20648528	618283	609368	rs45515602	NC_000001.11:20648527:G:A
NM_032409.3(PINK1):c.599del (p.Ala200fs)	PINK1	A200fs	Parkinson disease 6, autosomal recessive early-onset	Pathogenic(Last reviewed: May 2, 2018)	criteria provided, single submitter	VCV000581272	1	20964546	1	20638053	581272	556768	rs1557561340	NC_000001.11:20638052:C:
NM_032409.3(PINK1):c.1153T>C (p.Phe385Leu)	PINK1|PINK1-AS	F385L	Parkinson disease 6, autosomal recessive early-onset|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Nov 17, 2021)	criteria provided, conflicting interpretations	VCV000546594	1	20975027	1	20648534	546594	537083	rs763416852	NC_000001.11:20648533:T:C
NM_032409.3(PINK1):c.1173T>C (p.Asp391=)	PINK1|PINK1-AS		Parkinson disease 6, autosomal recessive early-onset|not provided	Benign/Likely benign(Last reviewed: Nov 15, 2020)	criteria provided, multiple submitters, no conflicts	VCV000534248	1	20975047	1	20648554	534248	515409	rs45499398	NC_000001.11:20648553:T:C
NM_032409.3(PINK1):c.1488G>A (p.Lys496=)	PINK1|PINK1-AS		Parkinson disease 6, autosomal recessive early-onset	Uncertain significance(Last reviewed: Dec 19, 2017)	criteria provided, single submitter	VCV000534247	1	20975724	1	20649231	534247	515514	rs56217826	NC_000001.11:20649230:G:A
NM_032409.3(PINK1):c.1015G>A (p.Ala339Thr)	PINK1|PINK1-AS	A339T	Parkinson disease 6, autosomal recessive early-onset|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Jan 12, 2021)	criteria provided, conflicting interpretations	VCV000500148	1	20972108	1	20645615	500148	491572	rs55831733	NC_000001.11:20645614:G:A
NM_032409.3(PINK1):c.565G>A (p.Gly189Arg)	PINK1	G189R	not provided|Parkinson disease 6, autosomal recessive early-onset	Uncertain significance(Last reviewed: Dec 9, 2021)	criteria provided, multiple submitters, no conflicts	VCV000493026	1	20964512	1	20638019	493026	485989	rs757581951	NC_000001.11:20638018:G:A
NM_032409.3(PINK1):c.935G>A (p.Arg312Gln)	PINK1|PINK1-AS	R312Q	Parkinson disease 6, autosomal recessive early-onset	Uncertain significance(Last reviewed: Apr 19, 2017)	criteria provided, single submitter	VCV000465847	1	20971141	1	20644648	465847	447474	rs202128685	NC_000001.11:20644647:G:A
NM_032409.3(PINK1):c.804A>G (p.Leu268=)	PINK1|PINK1-AS		Parkinson disease 6, autosomal recessive early-onset	Benign(Last reviewed: Aug 4, 2017)	criteria provided, single submitter	VCV000465846	1	20971010	1	20644517	465846	447721	rs200708848	NC_000001.11:20644516:A:G
NM_032409.3(PINK1):c.952A>T (p.Met318Leu)	PINK1|PINK1-AS	M318L	not provided|not specified|Parkinson disease 6, autosomal recessive early-onset	Uncertain significance(Last reviewed: Aug 27, 2021)	criteria provided, multiple submitters, no conflicts	VCV000447942	1	20971158	1	20644665	447942	440434	rs139226733	NC_000001.11:20644664:A:T
NM_032409.3(PINK1):c.851C>A (p.Ser284Tyr)	PINK1|PINK1-AS	S284Y	Parkinson disease 6, autosomal recessive early-onset|not specified	Uncertain significance(Last reviewed: Nov 21, 2021)	criteria provided, multiple submitters, no conflicts	VCV000447941	1	20971057	1	20644564	447941	440433	rs113092523	NC_000001.11:20644563:C:A
NM_032409.3(PINK1):c.67G>A (p.Gly23Ser)	PINK1	G23S	Parkinson disease 6, autosomal recessive early-onset|not specified|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Oct 18, 2021)	criteria provided, conflicting interpretations	VCV000447940	1	20960108	1	20633615	447940	440432	rs551542832	NC_000001.11:20633614:G:A
NM_032409.3(PINK1):c.587C>T (p.Pro196Leu)	PINK1	P196L	not provided|Parkinson disease 6, autosomal recessive early-onset	Uncertain significance(Last reviewed: Dec 15, 2021)	criteria provided, multiple submitters, no conflicts	VCV000445908	1	20964534	1	20638041	445908	439180	rs138302371	NC_000001.11:20638040:C:T
NM_032409.3(PINK1):c.1010G>A (p.Arg337His)	PINK1|PINK1-AS	R337H	Parkinson disease 6, autosomal recessive early-onset|not provided	Uncertain significance(Last reviewed: Oct 31, 2021)	criteria provided, multiple submitters, no conflicts	VCV000432830	1	20972103	1	20645610	432830	425330	rs184043309	NC_000001.11:20645609:G:A
NM_032409.3(PINK1):c.1474C>T (p.Arg492Ter)	PINK1|PINK1-AS	R492*	not provided|Parkinson disease 6, autosomal recessive early-onset	Pathogenic(Last reviewed: Jun 1, 2021)	criteria provided, multiple submitters, no conflicts	VCV000431963	1	20975710	1	20649217	431963	425331	rs34208370	NC_000001.11:20649216:C:T
NM_032409.3(PINK1):c.802C>G (p.Leu268Val)	PINK1|PINK1-AS	L268V	not provided|Parkinson disease 6, autosomal recessive early-onset	Uncertain significance(Last reviewed: Apr 27, 2017)	criteria provided, multiple submitters, no conflicts	VCV000374600	1	20971008	1	20644515	374600	361486	rs372280083	NC_000001.11:20644514:C:G
NM_032409.3(PINK1):c.770C>T (p.Thr257Ile)	PINK1	T257I	not provided|Parkinson disease 6, autosomal recessive early-onset	Uncertain significance(Last reviewed: Apr 27, 2017)	criteria provided, multiple submitters, no conflicts	VCV000374599	1	20966479	1	20639986	374599	361485	rs370906995	NC_000001.11:20639985:C:T
NM_032409.3(PINK1):c.*807T>C	PINK1|PINK1-AS		Parkinson disease 6, autosomal recessive early-onset	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000295032	1	20977991	1	20651498	295032	278559	rs78349864	NC_000001.11:20651497:T:C
NM_032409.3(PINK1):c.*655T>C	PINK1|PINK1-AS		Parkinson disease 6, autosomal recessive early-onset	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000295028	1	20977839	1	20651346	295028	278551	rs141140099	NC_000001.11:20651345:T:C
NM_032409.3(PINK1):c.*613A>G	PINK1|PINK1-AS		Parkinson disease 6, autosomal recessive early-onset	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000295027	1	20977797	1	20651304	295027	278550	rs886045852	NC_000001.11:20651303:A:G
NM_032409.3(PINK1):c.*571del	PINK1|PINK1-AS		Parkinson Disease, Recessive	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000295025	1	20977754	1	20651261	295025	278549	rs556390159	NC_000001.11:20651260:CC:C
NM_032409.3(PINK1):c.*534A>G	PINK1|PINK1-AS		Parkinson disease 6, autosomal recessive early-onset	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000295023	1	20977718	1	20651225	295023	278678	rs553977557	NC_000001.11:20651224:A:G
NM_032409.3(PINK1):c.*532G>A	PINK1|PINK1-AS		Parkinson Disease, Recessive|Parkinson disease 6, autosomal recessive early-onset	Conflicting interpretations of pathogenicity(Last reviewed: Jan 12, 2018)	criteria provided, conflicting interpretations	VCV000295022	1	20977716	1	20651223	295022	278676	rs190393061	NC_000001.11:20651222:G:A
NM_032409.3(PINK1):c.*530AAGT[4]	PINK1|PINK1-AS		Parkinson Disease, Recessive	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000295021	1	20977710 - 20977711	1	20651217 - 20651218	295021	278548	rs3077906	NC_000001.11:20651217:AGTAAGTAAGTAAGT:AGTAAGTAAGTAAGTAAGT
NM_032409.3(PINK1):c.*510G>A	PINK1|PINK1-AS		Parkinson disease 6, autosomal recessive early-onset	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000295020	1	20977694	1	20651201	295020	278543	rs886045850	NC_000001.11:20651200:G:A
NM_032409.3(PINK1):c.*356_*357del	PINK1|PINK1-AS		Parkinson Disease, Recessive	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000295017	1	20977539 - 20977540	1	20651046 - 20651047	295017	279814	rs886045849	NC_000001.11:20651045:GCG:G
NM_032409.3(PINK1):c.*349G>C	PINK1|PINK1-AS		Parkinson disease 6, autosomal recessive early-onset	Likely benign(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000295016	1	20977533	1	20651040	295016	278657	rs114112086	NC_000001.11:20651039:G:C
NM_032409.3(PINK1):c.*121G>A	PINK1|PINK1-AS		Parkinson disease 6, autosomal recessive early-onset	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000295012	1	20977305	1	20650812	295012	279962	rs570308715	NC_000001.11:20650811:G:A
NM_032409.3(PINK1):c.*37A>T	PINK1|PINK1-AS|DDOST		Parkinson Disease, Recessive|Congenital disorder of glycosylation|Parkinson disease 6, autosomal recessive early-onset|not provided	Benign(Last reviewed: Sep 5, 2021)	criteria provided, multiple submitters, no conflicts	VCV000295011	1	20977221	1	20650728	295011	278644	rs686658	NC_000001.11:20650727:A:T
NM_032409.3(PINK1):c.*18G>A	PINK1|PINK1-AS		Parkinson disease 6, autosomal recessive early-onset	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000295010	1	20977202	1	20650709	295010	278542	rs369117599	NC_000001.11:20650708:G:A
NM_032409.3(PINK1):c.1719C>G (p.Leu573=)	PINK1|PINK1-AS		Parkinson disease 6, autosomal recessive early-onset	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000295009	1	20977157	1	20650664	295009	279812	rs201936304	NC_000001.11:20650663:C:G
NM_032409.3(PINK1):c.1698G>A (p.Thr566=)	PINK1|PINK1-AS		not provided|Parkinson disease 6, autosomal recessive early-onset	Conflicting interpretations of pathogenicity(Last reviewed: Jul 27, 2018)	criteria provided, conflicting interpretations	VCV000295008	1	20977136	1	20650643	295008	278541	rs777232150	NC_000001.11:20650642:G:A
NM_032409.3(PINK1):c.1578G>C (p.Lys526Asn)	PINK1|PINK1-AS	K526N	Parkinson disease 6, autosomal recessive early-onset	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000295007	1	20977016	1	20650523	295007	279953	rs886045848	NC_000001.11:20650522:G:C
NM_032409.3(PINK1):c.1562A>C (p.Asn521Thr)	PINK1|PINK1-AS|DDOST	N521T	not provided|Parkinson Disease, Recessive|Congenital disorder of glycosylation|Parkinson disease 6, autosomal recessive early-onset|not specified	Benign/Likely benign(Last reviewed: Nov 30, 2021)	criteria provided, multiple submitters, no conflicts	VCV000295006	1	20977000	1	20650507	295006	279809	rs1043424	NC_000001.11:20650506:A:C
NM_032409.3(PINK1):c.1251+5G>A	PINK1|PINK1-AS		Parkinson disease 6, autosomal recessive early-onset	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000295005	1	20975130	1	20648637	295005	279803	rs756873744	NC_000001.11:20648636:G:A
NM_032409.3(PINK1):c.1018G>A (p.Ala340Thr)	PINK1|PINK1-AS	A340T	not provided|not specified|Parkinson disease 6, autosomal recessive early-onset	Benign(Last reviewed: Sep 3, 2021)	criteria provided, multiple submitters, no conflicts	VCV000295004	1	20972111	1	20645618	295004	278643	rs3738136	NC_000001.11:20645617:G:A
NM_032409.3(PINK1):c.960-11C>T	PINK1|PINK1-AS		not provided|Parkinson disease 6, autosomal recessive early-onset	Conflicting interpretations of pathogenicity(Last reviewed: Nov 29, 2018)	criteria provided, conflicting interpretations	VCV000295003	1	20972042	1	20645549	295003	279798	rs371943401	NC_000001.11:20645548:C:T
NM_032409.3(PINK1):c.826C>T (p.Arg276Trp)	PINK1|PINK1-AS	R276W	Parkinson disease 6, autosomal recessive early-onset	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000295001	1	20971032	1	20644539	295001	278532	rs778009684	NC_000001.11:20644538:C:T
NM_032409.3(PINK1):c.695C>T (p.Ala232Val)	PINK1	A232V	Parkinson disease 6, autosomal recessive early-onset	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000295000	1	20966404	1	20639911	295000	279797	rs144071530	NC_000001.11:20639910:C:T
NM_032409.3(PINK1):c.344A>T (p.Gln115Leu)	PINK1	Q115L	Parkinson disease 6, autosomal recessive early-onset|not provided|not specified	Benign(Last reviewed: Nov 30, 2021)	criteria provided, multiple submitters, no conflicts	VCV000294999	1	20960385	1	20633892	294999	279796	rs148871409	NC_000001.11:20633891:A:T
NM_032409.3(PINK1):c.88G>C (p.Gly30Arg)	PINK1	G30R	Parkinson disease 6, autosomal recessive early-onset	Conflicting interpretations of pathogenicity(Last reviewed: Dec 31, 2019)	criteria provided, conflicting interpretations	VCV000294997	1	20960129	1	20633636	294997	278529	rs569753606	NC_000001.11:20633635:G:C
NM_032409.3(PINK1):c.858G>A (p.Pro286=)	PINK1|PINK1-AS		Parkinson disease 6, autosomal recessive early-onset|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Oct 15, 2019)	criteria provided, conflicting interpretations	VCV000289332	1	20971064	1	20644571	289332	273569	rs148144773	NC_000001.11:20644570:G:A
NM_032409.3(PINK1):c.1251+10G>A	PINK1|PINK1-AS		not provided|Parkinson disease 6, autosomal recessive early-onset	Conflicting interpretations of pathogenicity(Last reviewed: Jul 6, 2019)	criteria provided, conflicting interpretations	VCV000288962	1	20975135	1	20648642	288962	273199	rs192131551	NC_000001.11:20648641:G:A
NM_032409.3(PINK1):c.434C>T (p.Thr145Met)	PINK1	T145M	not specified|not provided|Parkinson disease 6, autosomal recessive early-onset	Conflicting interpretations of pathogenicity(Last reviewed: Dec 4, 2019)	criteria provided, conflicting interpretations	VCV000286781	1	20964381	1	20637888	286781	271018	rs45604240	NC_000001.11:20637887:C:T
NM_032409.3(PINK1):c.1426G>A (p.Glu476Lys)	PINK1|PINK1-AS	E476K	Parkinson disease 6, autosomal recessive early-onset|not specified|not provided	Benign(Last reviewed: Jun 10, 2020)	criteria provided, multiple submitters, no conflicts	VCV000286390	1	20975662	1	20649169	286390	270627	rs115477764	NC_000001.11:20649168:G:A
NM_032409.3(PINK1):c.417G>T (p.Gly139=)	PINK1		Parkinson disease 6, autosomal recessive early-onset|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Jul 6, 2021)	criteria provided, conflicting interpretations	VCV000283173	1	20964364	1	20637871	283173	267410	rs749670160	NC_000001.11:20637870:G:T
NM_032409.3(PINK1):c.388-7A>G	PINK1		Parkinson disease 6, autosomal recessive early-onset|not provided|not specified	Benign(Last reviewed: Sep 5, 2021)	criteria provided, multiple submitters, no conflicts	VCV000262027	1	20964328	1	20637835	262027	249677	rs2298298	NC_000001.11:20637834:A:G
NM_032409.3(PINK1):c.620del (p.Arg207fs)	PINK1	R207fs	Parkinson disease 6, autosomal recessive early-onset	Pathogenic(Last reviewed: Jun 9, 2014)	criteria provided, single submitter	VCV000189240	1	20964567	1	20638074	189240	187107	rs756677845	NC_000001.11:20638073:G:
NM_032409.3(PINK1):c.799C>T (p.Gln267Ter)	PINK1|PINK1-AS	Q267*	Parkinson disease 6, autosomal recessive early-onset	not provided	no assertion provided	VCV000183259	1	20971005	1	20644512	183259	181392	rs730882053	NC_000001.11:20644511:C:T
NM_032409.3(PINK1):c.923T>A (p.Leu308Gln)	PINK1|PINK1-AS	L308Q	Parkinson disease, late-onset	Uncertain significance(Last reviewed: Jan 22, 2014)	no assertion criteria provided	VCV000096729	1	20971129	1	20644636	96729	102615	rs398124659	NC_000001.11:20644635:T:A
NM_032409.3(PINK1):c.644C>T (p.Pro215Leu)	PINK1	P215L	Parkinson disease, late-onset	Uncertain significance(Last reviewed: Jan 22, 2014)	no assertion criteria provided	VCV000096728	1	20964591	1	20638098	96728	102614	rs371854396	NC_000001.11:20638097:C:T
NM_032409.3(PINK1):c.1366C>T (p.Gln456Ter)	PINK1|PINK1-AS	Q456*	not provided|Parkinson disease 6, autosomal recessive early-onset	Pathogenic(Last reviewed: Nov 9, 2021)	criteria provided, multiple submitters, no conflicts	VCV000002415	1	20975602	1	20649109	2415	17454	rs45539432	NC_000001.11:20649108:C:T
NM_032409.3(PINK1):c.650C>A (p.Ala217Asp)	PINK1	A217D	Parkinson disease 6, autosomal recessive early-onset	Pathogenic(Last reviewed: Sep 1, 2006)	no assertion criteria provided	VCV000002414	1	20964597	1	20638104	2414	17453	rs74315360	NC_000001.11:20638103:C:A
NM_032409.3(PINK1):c.938C>T (p.Thr313Met)	PINK1|PINK1-AS	T313M	Parkinson disease 6, autosomal recessive early-onset	Pathogenic(Last reviewed: Aug 27, 2021)	criteria provided, single submitter	VCV000002413	1	20971144	1	20644651	2413	17452	rs74315359	NC_000001.11:20644650:C:T
NM_005216.4(DDOST):c.*807_*5409del	PINK1|PINK1-AS		Parkinson disease 6, autosomal recessive early-onset	Pathogenic(Last reviewed: Jun 14, 2005)	no assertion criteria provided	VCV000002412	1	20973463 - 20978065	1	20646970 - 20651572	2412	17451		
NM_032409.3(PINK1):c.836G>A (p.Arg279His)	PINK1|PINK1-AS	R279H	Parkinson disease 6, autosomal recessive early-onset	Uncertain significance(Last reviewed: Oct 15, 2021)	criteria provided, single submitter	VCV000002411	1	20971042	1	20644549	2411	17450	rs74315358	NC_000001.11:20644548:G:A
NM_032409.3(PINK1):c.1597CAA[3] (p.Gln534dup)	PINK1|PINK1-AS		Parkinson disease 6, autosomal recessive early-onset	Pathogenic(Last reviewed: Sep 1, 2005)	no assertion criteria provided	VCV000002410	1	20977034 - 20977035	1	20650541 - 20650542	2410	17449	rs750664040	NC_000001.11:20650541:CAACAA:CAACAACAA
NM_032409.3(PINK1):c.1570_1573dup (p.Asp525fs)	PINK1|PINK1-AS	D525fs	Parkinson disease 6, autosomal recessive early-onset	Pathogenic(Last reviewed: Sep 1, 2004)	no assertion criteria provided	VCV000002409	1	20977005 - 20977006	1	20650512 - 20650513	2409	17448	rs730880302	NC_000001.11:20650512:AGTTAG:AGTTAGTTAG
NM_032409.3(PINK1):c.736C>T (p.Arg246Ter)	PINK1	R246*	Parkinson disease 6, autosomal recessive early-onset	Pathogenic(Last reviewed: Nov 14, 2018)	criteria provided, single submitter	VCV000002407	1	20966445	1	20639952	2407	17446	rs74315357	NC_000001.11:20639951:C:T
NM_032409.3(PINK1):c.1311G>A (p.Trp437Ter)	PINK1|PINK1-AS	W437*	Parkinson disease 6, autosomal recessive early-onset	Pathogenic(Last reviewed: Sep 1, 2008)	no assertion criteria provided	VCV000002406	1	20975547	1	20649054	2406	17445	rs74315356	NC_000001.11:20649053:G:A
NM_032409.3(PINK1):c.813C>A (p.His271Gln)	PINK1|PINK1-AS	H271Q	Parkinson disease 6, autosomal recessive early-onset	Pathogenic(Last reviewed: Sep 1, 2004)	no assertion criteria provided	VCV000002405	1	20971019	1	20644526	2405	17444	rs28940284	NC_000001.11:20644525:C:A
NM_032409.3(PINK1):c.960-13C>G	PINK1-AS|PINK1		Parkinson disease 6, autosomal recessive early-onset	Likely benign(Last reviewed: Oct 15, 2021)	criteria provided, single submitter	VCV001642137	1	20972040	1	20645547	1642137	1651180		NC_000001.11:20645546:C:G
NM_032409.3(PINK1):c.1017C>T (p.Ala339=)	PINK1-AS|PINK1		Parkinson disease 6, autosomal recessive early-onset	Likely benign(Last reviewed: Aug 19, 2021)	criteria provided, single submitter	VCV001572154	1	20972110	1	20645617	1572154	1538223		NC_000001.11:20645616:C:T
NM_032409.3(PINK1):c.968G>A (p.Cys323Tyr)	PINK1-AS|PINK1	C323Y	Parkinson disease 6, autosomal recessive early-onset	Uncertain significance(Last reviewed: Dec 3, 2021)	criteria provided, single submitter	VCV001403093	1	20972061	1	20645568	1403093	1392705		NC_000001.11:20645567:G:A
NM_032409.3(PINK1):c.1123+4G>C	PINK1-AS|PINK1		Parkinson disease 6, autosomal recessive early-onset	Uncertain significance(Last reviewed: Dec 18, 2021)	criteria provided, single submitter	VCV001382632	1	20972220	1	20645727	1382632	1513106		NC_000001.11:20645726:G:C
NM_032409.3(PINK1):c.1095C>T (p.Ser365=)	PINK1-AS|PINK1		Parkinson disease 6, autosomal recessive early-onset|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Oct 1, 2020)	criteria provided, conflicting interpretations	VCV000874928	1	20972188	1	20645695	874928	863350	rs559921009	NC_000001.11:20645694:C:T
NM_032409.3(PINK1):c.827G>A (p.Arg276Gln)	PINK1-AS|PINK1	R276Q	Parkinson disease 6, autosomal recessive early-onset	Conflicting interpretations of pathogenicity(Last reviewed: Nov 7, 2020)	criteria provided, conflicting interpretations	VCV000787365	1	20971033	1	20644540	787365	707026	rs548506734	NC_000001.11:20644539:G:A
NM_032409.3(PINK1):c.*725GA[4]	PINK1-AS|DDOST|PINK1		Parkinson Disease, Recessive|Congenital disorder of glycosylation	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000295031	1	20977907 - 20977908	1	20651414 - 20651415	295031	278679	rs34361349	NC_000001.11:20651414:AGAGA:AGAGAGAGA
NM_032409.3(PINK1):c.936G>A (p.Arg312=)	PINK1-AS|PINK1		not provided|Parkinson disease 6, autosomal recessive early-onset	Conflicting interpretations of pathogenicity(Last reviewed: Oct 26, 2020)	criteria provided, conflicting interpretations	VCV000295002	1	20971142	1	20644649	295002	278534	rs56200357	NC_000001.11:20644648:G:A
NM_032409.3(PINK1):c.960-5G>A	PINK1-AS|PINK1		not specified|Parkinson disease 6, autosomal recessive early-onset|not provided	Benign(Last reviewed: Sep 5, 2021)	criteria provided, multiple submitters, no conflicts	VCV000262028	1	20972048	1	20645555	262028	249678	rs3131713	NC_000001.11:20645554:G:A
NM_032409.3(PINK1):c.1196C>T (p.Pro399Leu)	PINK1-AS|PINK1	P399L	Parkinson disease, autosomal recessive early-onset, digenic, PINK1/DJ1|Parkinson disease 6, autosomal recessive early-onset	Uncertain significance(Last reviewed: Apr 28, 2017)	criteria provided, single submitter	VCV000002417	1	20975070	1	20648577	2417	17456	rs119451946	NC_000001.11:20648576:C:T
NM_032409.3(PINK1):c.1291T>C (p.Tyr431His)	PINK1-AS|PINK1	Y431H	Parkinson disease 6	risk factor(Last reviewed: Oct 1, 2006)	no assertion criteria provided	VCV000002416	1	20975527	1	20649034	2416	17455	rs74315361	NC_000001.11:20649033:T:C
NM_032409.3(PINK1):c.1040T>C (p.Leu347Pro)	PINK1-AS|PINK1	L347P	Parkinson disease 6, autosomal recessive early-onset	Pathogenic(Last reviewed: Mar 23, 2020)	criteria provided, multiple submitters, no conflicts	VCV000002408	1	20972133	1	20645640	2408	17447	rs28940285	NC_000001.11:20645639:T:C
NM_032409.3(PINK1):c.926G>A (p.Gly309Asp)	PINK1-AS|PINK1	G309D	Parkinson disease 6, autosomal recessive early-onset	Pathogenic(Last reviewed: Feb 15, 2008)	no assertion criteria provided	VCV000002404	1	20971132	1	20644639	2404	17443	rs74315355	NC_000001.11:20644638:G:A
NM_000325.6(PITX2):c.194C>T (p.Pro65Leu)	PITX2	P65L	Wolff-Parkinson-White pattern	Uncertain significance(Last reviewed: Jul 14, 2017)	no assertion criteria provided	VCV000487594	4	111543423	4	110622267	487594	480684	rs1320287028	NC_000004.12:110622266:G:A
NM_003560.4(PLA2G6):c.1786C>T (p.Leu596Phe)	PLA2G6	L364F, L370F, L418F, L542F, L596F	Infantile neuroaxonal dystrophy	Uncertain significance(Last reviewed: Oct 31, 2019)	criteria provided, single submitter	VCV000962233	22	38512175	22	38116168	962233	951474	rs2087181118	NC_000022.11:38116167:G:A
NM_003560.4(PLA2G6):c.547G>A (p.Asp183Asn)	PLA2G6	D183N, D5N	not provided|Infantile neuroaxonal dystrophy	Uncertain significance(Last reviewed: Aug 24, 2020)	criteria provided, multiple submitters, no conflicts	VCV000854667	22	38539174	22	38143167	854667	849346	rs11570646	NC_000022.11:38143166:C:T
NM_003560.4(PLA2G6):c.2240G>A (p.Arg747Gln)	PLA2G6	R515Q, R521Q, R569Q, R693Q, R747Q	Infantile neuroaxonal dystrophy|not provided	Uncertain significance(Last reviewed: May 5, 2021)	criteria provided, multiple submitters, no conflicts	VCV000851527	22	38508547	22	38112540	851527	849341	rs376144077	NC_000022.11:38112539:C:T
NM_003560.4(PLA2G6):c.956C>T (p.Thr319Met)	PLA2G6	T141M, T93M, T319M	Infantile neuroaxonal dystrophy|not specified|not provided|PLA2G6-associated neurodegeneration|Parkinson disease 14	Uncertain significance(Last reviewed: Oct 29, 2021)	criteria provided, multiple submitters, no conflicts	VCV000847008	22	38528959	22	38132952	847008	849345	rs149653983	NC_000022.11:38132951:G:A
NM_003560.4(PLA2G6):c.1061T>C (p.Leu354Pro)	PLA2G6	L128P, L176P, L354P	Infantile neuroaxonal dystrophy|Parkinson disease 14	Pathogenic(Last reviewed: May 6, 2019)	criteria provided, single submitter	VCV000846843	22	38528854	22	38132847	846843	849344	rs1403125636	NC_000022.11:38132846:A:G
NM_003560.4(PLA2G6):c.991G>A (p.Asp331Asn)	PLA2G6	D331N, D105N, D153N	not provided|PLA2G6-associated neurodegeneration|Infantile neuroaxonal dystrophy	Conflicting interpretations of pathogenicity(Last reviewed: May 7, 2018)	criteria provided, conflicting interpretations	VCV000522939	22	38528924	22	38132917	522939	513670	rs199935023	NC_000022.11:38132916:C:T
NM_003560.4(PLA2G6):c.16C>T (p.Arg6Cys)	PLA2G6	R6C	Infantile neuroaxonal dystrophy|not provided|PLA2G6-associated neurodegeneration|Parkinson disease 14|Infantile neuroaxonal dystrophy|Neurodegeneration with brain iron accumulation 2b	Uncertain significance(Last reviewed: Jul 14, 2021)	criteria provided, multiple submitters, no conflicts	VCV000493345	22	38565418	22	38169411	493345	486308	rs143250889	NC_000022.11:38169410:G:A
NM_003560.4(PLA2G6):c.1427+1G>A	PLA2G6		Parkinson disease 14|Infantile neuroaxonal dystrophy|Neurodegeneration with brain iron accumulation 2b|not provided|Infantile neuroaxonal dystrophy	Pathogenic/Likely pathogenic(Last reviewed: Jul 12, 2021)	criteria provided, multiple submitters, no conflicts	VCV000437465	22	38522377	22	38126370	437465	431023	rs750939090	NC_000022.11:38126369:C:T
NM_003560.4(PLA2G6):c.416G>A (p.Arg139His)	PLA2G6	R139H	not provided|Infantile neuroaxonal dystrophy|PLA2G6-associated neurodegeneration|Parkinson disease 14|Infantile neuroaxonal dystrophy|Neurodegeneration with brain iron accumulation 2b	Conflicting interpretations of pathogenicity(Last reviewed: May 20, 2020)	criteria provided, conflicting interpretations	VCV000426191	22	38541454	22	38145447	426191	415714	rs141825182	NC_000022.11:38145446:C:T
NM_003560.4(PLA2G6):c.91G>A (p.Asp31Asn)	PLA2G6	D31N	PLA2G6-associated neurodegeneration|Infantile neuroaxonal dystrophy|not provided|Parkinson disease 14|Infantile neuroaxonal dystrophy|Neurodegeneration with brain iron accumulation 2b	Uncertain significance(Last reviewed: Jul 1, 2021)	criteria provided, multiple submitters, no conflicts	VCV000341650	22	38565343	22	38169336	341650	352560	rs150024227	NC_000022.11:38169335:C:T
NM_003560.4(PLA2G6):c.101C>T (p.Ser34Leu)	PLA2G6	S34L	not specified|Infantile neuroaxonal dystrophy|not provided|PLA2G6-associated neurodegeneration|Parkinson disease 14|Infantile neuroaxonal dystrophy|Neurodegeneration with brain iron accumulation 2b	Uncertain significance(Last reviewed: Mar 2, 2022)	criteria provided, multiple submitters, no conflicts	VCV000341649	22	38565333	22	38169326	341649	347766	rs147948449	NC_000022.11:38169325:G:A
NM_003560.4(PLA2G6):c.1077G>A (p.Ser359=)	PLA2G6		not provided|Infantile neuroaxonal dystrophy	Pathogenic(Last reviewed: Jul 13, 2020)	criteria provided, multiple submitters, no conflicts	VCV000279875	22	38528838	22	38132831	279875	264928	rs368497893	NC_000022.11:38132830:C:T
NM_003560.4(PLA2G6):c.898G>A (p.Ala300Thr)	PLA2G6	A300T, A74T, A122T	PLA2G6-associated neurodegeneration|not provided|Infantile neuroaxonal dystrophy|Parkinson disease 14|Infantile neuroaxonal dystrophy|Neurodegeneration with brain iron accumulation 2b	Conflicting interpretations of pathogenicity(Last reviewed: Nov 27, 2021)	criteria provided, conflicting interpretations	VCV000235257	22	38529017	22	38133010	235257	236944	rs528966598	NC_000022.11:38133009:C:T
NM_003560.4(PLA2G6):c.1615G>A (p.Gly539Ser)	PLA2G6	G539S, G307S, G361S, G313S, G485S	PLA2G6-associated neurodegeneration|Infantile neuroaxonal dystrophy|Neurodegeneration with brain iron accumulation 2b|Parkinson disease 14|not provided|Infantile neuroaxonal dystrophy|Iron accumulation in brain	Conflicting interpretations of pathogenicity(Last reviewed: Oct 15, 2021)	criteria provided, conflicting interpretations	VCV000159740	22	38516893	22	38120886	159740	169787	rs143826762	NC_000022.11:38120885:C:T
NM_003560.4(PLA2G6):c.991G>T (p.Asp331Tyr)	PLA2G6	D331Y, D105Y, D153Y	Parkinson disease 14|Infantile neuroaxonal dystrophy|not provided	Pathogenic(Last reviewed: Jul 13, 2021)	criteria provided, multiple submitters, no conflicts	VCV000030371	22	38528924	22	38132917	30371	39328	rs199935023	NC_000022.11:38132916:C:A
NM_003560.4(PLA2G6):c.216C>A (p.Phe72Leu)	PLA2G6	F72L	Parkinson disease 14	Pathogenic(Last reviewed: Oct 12, 2010)	no assertion criteria provided	VCV000030368	22	38541654	22	38145647	30368	39325	rs774631197	NC_000022.11:38145646:G:T
NM_003560.4(PLA2G6):c.1354C>T (p.Gln452Ter)	PLA2G6	Q452*, Q220*, Q226*, Q274*, Q398*	Parkinson disease 14	Pathogenic(Last reviewed: Oct 12, 2010)	no assertion criteria provided	VCV000030367	22	38522451	22	38126444	30367	39324	rs387906864	NC_000022.11:38126443:G:A
NM_003560.4(PLA2G6):c.1904G>A (p.Arg635Gln)	PLA2G6	R635Q, R403Q, R581Q, R457Q, R409Q	PLA2G6-associated neurodegeneration|Parkinson disease 14	Uncertain significance(Last reviewed: Nov 26, 2018)	criteria provided, single submitter	VCV000030366	22	38511664	22	38115657	30366	39323	rs387906863	NC_000022.11:38115656:C:T
NM_003560.4(PLA2G6):c.2239C>T (p.Arg747Trp)	PLA2G6	R747W, R521W, R515W, R569W, R693W	Parkinson disease 14|Infantile neuroaxonal dystrophy|Neurodegeneration with brain iron accumulation 2b|Parkinson disease 14|not provided	Pathogenic/Likely pathogenic(Last reviewed: Oct 23, 2020)	criteria provided, multiple submitters, no conflicts	VCV000006204	22	38508548	22	38112541	6204	21243	rs121908687	NC_000022.11:38112540:G:A
NM_003560.4(PLA2G6):c.2222G>A (p.Arg741Gln)	PLA2G6	R741Q, R515Q, R687Q, R509Q, R563Q	Neurodegeneration with brain iron accumulation 2b|not provided|Parkinson disease 14|Infantile neuroaxonal dystrophy	Pathogenic/Likely pathogenic(Last reviewed: May 27, 2020)	criteria provided, multiple submitters, no conflicts	VCV000006203	22	38508565	22	38112558	6203	21242	rs121908686	NC_000022.11:38112557:C:T
NM_003560.4(PLA2G6):c.238G>A (p.Ala80Thr)	PLA2G6	A80T	Parkinson disease 14|Infantile neuroaxonal dystrophy|Neurodegeneration with brain iron accumulation 2b|not provided|Infantile neuroaxonal dystrophy|Neurodegeneration with brain iron accumulation 2b	Conflicting interpretations of pathogenicity(Last reviewed: Oct 5, 2020)	criteria provided, conflicting interpretations	VCV000006202	22	38541632	22	38145625	6202	21241	rs121908685	NC_000022.11:38145624:C:T
NM_003560.4(PLA2G6):c.1634A>C (p.Lys545Thr)	PLA2G6	K545T, K491T, K313T, K319T, K367T	Cerebellar ataxia|Congenital cerebellar hypoplasia|Global developmental delay|Microcephaly|Developmental regression|Neurodegeneration with brain iron accumulation 2b|Parkinson disease 14	Pathogenic	criteria provided, single submitter	VCV000006196	22	38516874	22	38120867	6196	21235	rs121908681	NC_000022.11:38120866:T:G
NM_003560.4(PLA2G6):c.2370T>G (p.Tyr790Ter)	PLA2G6	Y790*, Y558*, Y564*, Y612*, Y736*	not provided|Neurodegeneration with brain iron accumulation 2b|Inborn genetic diseases|Abnormality of the nervous system|Iron accumulation in brain|Infantile neuroaxonal dystrophy|Neurodegeneration with brain iron accumulation 2b|Parkinson disease 14|Infantile neuroaxonal dystrophy|Seizure|Autistic disorder|PLA2G6-associated neurodegeneration	Conflicting interpretations of pathogenicity(Last reviewed: Jul 10, 2021)	criteria provided, conflicting interpretations	VCV000006195	22	38508219	22	38112212	6195	21234	rs121908680	NC_000022.11:38112211:A:C
NM_001018111.3(PODXL):c.977G>A (p.Arg326Gln)	PODXL	R326Q, R294Q	Parkinson disease, late-onset	Uncertain significance(Last reviewed: Dec 12, 2015)	criteria provided, single submitter	VCV000218945	7	131194170	7	131509411	218945	215778	rs869312172	NC_000007.14:131509410:C:T
NM_001018111.3(PODXL):c.1214G>A (p.Ser405Asn)	PODXL	S405N, S373N	Parkinson disease, late-onset	Uncertain significance(Last reviewed: Dec 12, 2015)	criteria provided, single submitter	VCV000218944	7	131191373	7	131506614	218944	215777	rs869312171	NC_000007.14:131506613:C:T
NM_001018111.3(PODXL):c.1381C>A (p.Pro461Thr)	PODXL	P461T, P429T	Parkinson disease, late-onset	Uncertain significance(Last reviewed: Dec 12, 2015)	criteria provided, single submitter	VCV000218943	7	131190725	7	131505966	218943	215776	rs869312170	NC_000007.14:131505965:G:T
NM_001018111.3(PODXL):c.89_90insGTCGCCCC (p.Gln32fs)	PODXL	Q32fs	Parkinson disease 2|not provided	Likely pathogenic(Last reviewed: Dec 12, 2015)	criteria provided, single submitter	VCV000218942	7	131241029 - 131241030	7	131556270 - 131556271	218942	215779	rs1554391082	NC_000007.14:131556270:GG:GGGGCGACGG
NM_002693.3(POLG):c.2977C>T (p.Arg993Cys)	POLG	R993C	Progressive sclerosing poliodystrophy|not provided	Uncertain significance(Last reviewed: Mar 23, 2021)	criteria provided, multiple submitters, no conflicts	VCV000405570	15	89864001	15	89320770	405570	400549	rs551811489	NC_000015.10:89320769:G:A
NM_002693.3(POLG):c.752C>T (p.Thr251Ile)	POLG	T251I	Sensory ataxic neuropathy, dysarthria, and ophthalmoparesis|Global developmental delay|Progressive sclerosing poliodystrophy|not specified|POLG-Related Spectrum Disorders|Autosomal dominant progressive external ophthalmoplegia with mitochondrial DNA deletions 1|POLG-related disorders|Mitochondrial DNA depletion syndrome 4B, MNGIE type|Progressive sclerosing poliodystrophy|not provided|Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive 1|Mitochondrial DNA depletion syndrome 4B, MNGIE type|Seizure|Abnormality of the nervous system|Toe walking|Hereditary spastic paraplegia|Mitochondrial DNA depletion syndrome 1 (MNGIE type)	Conflicting interpretations of pathogenicity(Last reviewed: Jan 5, 2022)	criteria provided, conflicting interpretations	VCV000013503	15	89873415	15	89330184	13503	28542	rs113994094	NC_000015.10:89330183:G:A
NM_022114.4(PRDM16):c.1642C>A (p.Pro548Thr)	PRDM16	P548T	Wolff-Parkinson-White pattern	Uncertain significance(Last reviewed: Jul 14, 2017)	no assertion criteria provided	VCV000487633	1	3328403	1	3411839	487633	480676	rs866090726	NC_000001.11:3411838:C:A
NM_022114.4(PRDM16):c.2666C>T (p.Pro889Leu)	PRDM16	P889L	not provided|Left ventricular noncompaction 8|Wolff-Parkinson-White pattern	Uncertain significance(Last reviewed: Sep 7, 2020)	criteria provided, multiple submitters, no conflicts	VCV000487607	1	3331186	1	3414622	487607	480677	rs201814961	NC_000001.11:3414621:C:T
NM_022114.4(PRDM16):c.2855C>T (p.Thr952Met)	PRDM16	T952M	Wolff-Parkinson-White pattern|Left ventricular noncompaction 8	Uncertain significance(Last reviewed: Oct 6, 2021)	criteria provided, single submitter	VCV000487592	1	3334555	1	3417991	487592	480678	rs749180764	NC_000001.11:3417990:C:T
NM_022114.4(PRDM16):c.706G>A (p.Asp236Asn)	PRDM16	D236N	Wolff-Parkinson-White pattern|not provided|Left ventricular noncompaction 8	Likely benign(Last reviewed: Nov 23, 2020)	criteria provided, multiple submitters, no conflicts	VCV000487582	1	3319384	1	3402820	487582	480675	rs185041492	NC_000001.11:3402819:G:A
NM_016203.4(PRKAG2):c.182G>A (p.Arg61Gln)	PRKAG2	R17Q, R61Q	Glycogen storage disease of heart, lethal congenital|not specified|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Oct 11, 2021)	criteria provided, conflicting interpretations	VCV001311028	7	151483560	7	151786474	1311028	1300409		NC_000007.14:151786473:C:T
NM_016203.4(PRKAG2):c.1024G>A (p.Glu342Lys)	PRKAG2	E101K, E217K, E218K, E298K, E342K	not specified|Glycogen storage disease of heart, lethal congenital|Cardiomyopathy	Uncertain significance(Last reviewed: Nov 6, 2021)	criteria provided, multiple submitters, no conflicts	VCV001065164	7	151269777	7	151572691	1065164	1053465		NC_000007.14:151572690:C:T
NM_016203.4(PRKAG2):c.869A>T (p.Lys290Ile)	PRKAG2	K290I, K166I, K165I, K246I, K49I	Glycogen storage disease of heart, lethal congenital	Pathogenic(Last reviewed: Jul 1, 2019)	criteria provided, single submitter	VCV000943169	7	151273534	7	151576448	943169	933790	rs1808950153	NC_000007.14:151576447:T:A
NM_016203.4(PRKAG2):c.413C>G (p.Ser138Cys)	PRKAG2	S138C, S94C	Wolff-Parkinson-White pattern	Uncertain significance(Last reviewed: Apr 2, 2019)	criteria provided, single submitter	VCV000931949	7	151478291	7	151781205	931949	919090	rs2076650862	NC_000007.14:151781204:G:C
NM_016203.4(PRKAG2):c.90G>T (p.Arg30Ser)	PRKAG2	R30S	Cardiomyopathy|Wolff-Parkinson-White pattern|Familial hypertrophic cardiomyopathy 6	Uncertain significance(Last reviewed: Feb 17, 2021)	criteria provided, multiple submitters, no conflicts	VCV000912206	7	151573616	7	151876531	912206	897699	rs1268890991	NC_000007.14:151876530:C:A
NM_016203.4(PRKAG2):c.341C>T (p.Pro114Leu)	PRKAG2	P114L, P70L	Glycogen storage disease of heart, lethal congenital|Cardiomyopathy|not provided|Familial hypertrophic cardiomyopathy 6|Wolff-Parkinson-White pattern	Uncertain significance(Last reviewed: Nov 24, 2021)	criteria provided, multiple submitters, no conflicts	VCV000912141	7	151478363	7	151781277	912141	897696	rs375174733	NC_000007.14:151781276:G:A
NM_016203.4(PRKAG2):c.1324G>A (p.Asp442Asn)	PRKAG2	D201N, D317N, D318N, D442N, D398N	Glycogen storage disease of heart, lethal congenital|Familial hypertrophic cardiomyopathy 6|Wolff-Parkinson-White pattern	Uncertain significance(Last reviewed: Oct 30, 2020)	criteria provided, multiple submitters, no conflicts	VCV000912070	7	151262881	7	151565795	912070	897695	rs199863116	NC_000007.14:151565794:C:T
NM_016203.4(PRKAG2):c.*256T>G	PRKAG2		Familial hypertrophic cardiomyopathy 6|Wolff-Parkinson-White pattern	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000912012	7	151254031	7	151556945	912012	897692	rs1803889003	NC_000007.14:151556944:A:C
NM_016203.4(PRKAG2):c.*953T>A	PRKAG2		Familial hypertrophic cardiomyopathy 6|Wolff-Parkinson-White pattern	Uncertain significance(Last reviewed: Feb 4, 2019)	criteria provided, single submitter	VCV000911968	7	151253334	7	151556248	911968	897685	rs552411344	NC_000007.14:151556247:A:T
NM_016203.4(PRKAG2):c.119T>A (p.Leu40Gln)	PRKAG2	L40Q	Glycogen storage disease of heart, lethal congenital|Cardiomyopathy|Familial hypertrophic cardiomyopathy 6|Wolff-Parkinson-White pattern	Uncertain significance(Last reviewed: Nov 23, 2020)	criteria provided, multiple submitters, no conflicts	VCV000910975	7	151483623	7	151786537	910975	897698	rs139653890	NC_000007.14:151786536:A:T
NM_016203.4(PRKAG2):c.*398C>T	PRKAG2		Familial hypertrophic cardiomyopathy 6|Wolff-Parkinson-White pattern	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000910804	7	151253889	7	151556803	910804	897691	rs1232386894	NC_000007.14:151556802:G:A
NM_016203.4(PRKAG2):c.*399G>A	PRKAG2		not provided|Familial hypertrophic cardiomyopathy 6|Wolff-Parkinson-White pattern	Benign/Likely benign(Last reviewed: Jan 12, 2018)	criteria provided, multiple submitters, no conflicts	VCV000910803	7	151253888	7	151556802	910803	897690	rs112179332	NC_000007.14:151556801:C:T
NM_016203.4(PRKAG2):c.*419C>T	PRKAG2		Familial hypertrophic cardiomyopathy 6|Wolff-Parkinson-White pattern	Uncertain significance(Last reviewed: Apr 27, 2017)	criteria provided, single submitter	VCV000910802	7	151253868	7	151556782	910802	897689	rs951231157	NC_000007.14:151556781:G:A
NM_016203.4(PRKAG2):c.*450T>C	PRKAG2		Familial hypertrophic cardiomyopathy 6|Wolff-Parkinson-White pattern	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000910801	7	151253837	7	151556751	910801	897688	rs1803859194	NC_000007.14:151556750:A:G
NM_016203.4(PRKAG2):c.*1021T>G	PRKAG2		Familial hypertrophic cardiomyopathy 6|Wolff-Parkinson-White pattern	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000910747	7	151253266	7	151556180	910747	897684	rs199973452	NC_000007.14:151556179:A:C
NM_016203.4(PRKAG2):c.*1030T>G	PRKAG2		Familial hypertrophic cardiomyopathy 6|Wolff-Parkinson-White pattern	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000910746	7	151253257	7	151556171	910746	897683	rs867502251	NC_000007.14:151556170:A:C
NM_016203.4(PRKAG2):c.*1043G>A	PRKAG2		Familial hypertrophic cardiomyopathy 6|Wolff-Parkinson-White pattern	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000910745	7	151253244	7	151556158	910745	897682	rs1207057314	NC_000007.14:151556157:C:T
NM_016203.4(PRKAG2):c.-481G>A	PRKAG2|PRKAG2-AS1		Familial hypertrophic cardiomyopathy 6|Wolff-Parkinson-White pattern	Uncertain significance(Last reviewed: Apr 27, 2017)	criteria provided, single submitter	VCV000910143	7	151574186	7	151877101	910143	897700	rs373697168	NC_000007.14:151877100:C:T
NM_016203.4(PRKAG2):c.*56G>A	PRKAG2		Familial hypertrophic cardiomyopathy 6|not provided|Wolff-Parkinson-White pattern	Benign/Likely benign(Last reviewed: Jan 12, 2018)	criteria provided, multiple submitters, no conflicts	VCV000909955	7	151254231	7	151557145	909955	897694	rs141781827	NC_000007.14:151557144:C:T
NM_016203.4(PRKAG2):c.*471T>C	PRKAG2		Familial hypertrophic cardiomyopathy 6|Wolff-Parkinson-White pattern	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000909898	7	151253816	7	151556730	909898	897687	rs1803856114	NC_000007.14:151556729:A:G
NM_016203.4(PRKAG2):c.*156A>G	PRKAG2		Wolff-Parkinson-White pattern|Familial hypertrophic cardiomyopathy 6	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000909098	7	151254131	7	151557045	909098	897693	rs28763997	NC_000007.14:151557044:T:C
NM_016203.4(PRKAG2):c.*771C>T	PRKAG2		Familial hypertrophic cardiomyopathy 6|Wolff-Parkinson-White pattern	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000909038	7	151253516	7	151556430	909038	897686	rs1803806831	NC_000007.14:151556429:G:A
NM_016203.4(PRKAG2):c.278T>C (p.Val93Ala)	PRKAG2	V93A, V49A	Familial hypertrophic cardiomyopathy 6|Wolff-Parkinson-White pattern	Uncertain significance(Last reviewed: Apr 27, 2017)	criteria provided, single submitter	VCV000908128	7	151478426	7	151781340	908128	897697	rs2076656944	NC_000007.14:151781339:A:G
NM_016203.4(PRKAG2):c.31A>G (p.Lys11Glu)	PRKAG2	K11E	Cardiomyopathy|Primary familial hypertrophic cardiomyopathy|Wolff-Parkinson-White pattern|Familial hypertrophic cardiomyopathy 6|Glycogen storage disease of heart, lethal congenital	Uncertain significance(Last reviewed: Dec 6, 2018)	criteria provided, multiple submitters, no conflicts	VCV000520489	7	151573675	7	151876590	520489	511090	rs1041124171	NC_000007.14:151876589:T:C
NM_016203.4(PRKAG2):c.432C>T (p.Pro144=)	PRKAG2		Cardiovascular phenotype|not provided|Cardiomyopathy|Wolff-Parkinson-White pattern|Familial hypertrophic cardiomyopathy 6|Glycogen storage disease of heart, lethal congenital	Conflicting interpretations of pathogenicity(Last reviewed: Dec 4, 2020)	criteria provided, conflicting interpretations	VCV000520278	7	151478272	7	151781186	520278	509882	rs764742900	NC_000007.14:151781185:G:A
NM_016203.4(PRKAG2):c.1679-19A>T	PRKAG2		not specified|Glycogen storage disease of heart, lethal congenital	Benign/Likely benign(Last reviewed: Nov 19, 2021)	criteria provided, multiple submitters, no conflicts	VCV000517071	7	151254337	7	151557251	517071	501991	rs200262620	NC_000007.14:151557250:T:A
NM_016203.4(PRKAG2):c.359G>A (p.Arg120His)	PRKAG2	R120H, R76H	Cardiomyopathy|Wolff-Parkinson-White pattern|Glycogen storage disease of heart, lethal congenital	Conflicting interpretations of pathogenicity(Last reviewed: Dec 2, 2021)	criteria provided, conflicting interpretations	VCV000487637	7	151478345	7	151781259	487637	480696	rs775756069	NC_000007.14:151781258:C:T
NM_016203.4(PRKAG2):c.947-7G>A	PRKAG2		Glycogen storage disease of heart, lethal congenital|Familial hypertrophic cardiomyopathy 6|Wolff-Parkinson-White pattern|Cardiomyopathy	Conflicting interpretations of pathogenicity(Last reviewed: Nov 15, 2019)	criteria provided, conflicting interpretations	VCV000465344	7	151272042	7	151574956	465344	456900	rs1554464198	NC_000007.14:151574955:C:T
NM_016203.4(PRKAG2):c.88A>C (p.Arg30=)	PRKAG2		Glycogen storage disease of heart, lethal congenital|Familial hypertrophic cardiomyopathy 6|Wolff-Parkinson-White pattern|Cardiomyopathy	Conflicting interpretations of pathogenicity(Last reviewed: Mar 8, 2019)	criteria provided, conflicting interpretations	VCV000465343	7	151573618	7	151876533	465343	457592	rs756923555	NC_000007.14:151876532:T:G
NM_016203.4(PRKAG2):c.1584+8G>A	PRKAG2		Glycogen storage disease of heart, lethal congenital|Cardiomyopathy|not specified	Conflicting interpretations of pathogenicity(Last reviewed: Nov 2, 2020)	criteria provided, conflicting interpretations	VCV000465341	7	151261156	7	151564070	465341	456500	rs762649633	NC_000007.14:151564069:C:T
NM_016203.4(PRKAG2):c.1114G>A (p.Asp372Asn)	PRKAG2	D372N, D247N, D328N, D131N, D248N	not provided|Cardiovascular phenotype|Familial hypertrophic cardiomyopathy 6|Glycogen storage disease of heart, lethal congenital|Wolff-Parkinson-White pattern|Cardiomyopathy	Uncertain significance(Last reviewed: Mar 10, 2021)	criteria provided, multiple submitters, no conflicts	VCV000465337	7	151265921	7	151568835	465337	456504	rs760826751	NC_000007.14:151568834:C:T
NM_016203.4(PRKAG2):c.547G>A (p.Glu183Lys)	PRKAG2	E183K, E59K, E139K	Wolff-Parkinson-White pattern|Cardiomyopathy	Conflicting interpretations of pathogenicity(Last reviewed: Dec 22, 2020)	criteria provided, conflicting interpretations	VCV000430968	7	151372643	7	151675557	430968	424509	rs1131692281	NC_000007.14:151675556:C:T
NM_016203.4(PRKAG2):c.750C>T (p.Asp250=)	PRKAG2		not specified|Cardiomyopathy|not provided|Wolff-Parkinson-White pattern|Familial hypertrophic cardiomyopathy 6|Glycogen storage disease of heart, lethal congenital	Conflicting interpretations of pathogenicity(Last reviewed: Dec 2, 2020)	criteria provided, conflicting interpretations	VCV000378428	7	151329159	7	151632073	378428	369358	rs201735117	NC_000007.14:151632072:G:A
NM_016203.4(PRKAG2):c.590C>G (p.Pro197Arg)	PRKAG2	P197R, P153R, P73R	not provided|Wolff-Parkinson-White pattern|Glycogen storage disease of heart, lethal congenital|Left ventricular hypertrophy|Coronary artery disease|Ventricular tachycardia|Stroke|Webbed neck|Hypertensive disorder	Uncertain significance(Last reviewed: Jul 29, 2020)	criteria provided, multiple submitters, no conflicts	VCV000374128	7	151372600	7	151675514	374128	360891	rs368637364	NC_000007.14:151675513:G:C
NM_016203.3(PRKAG2):c.-580C>T	PRKAG2|PRKAG2-AS1		Glycogen storage disease of heart, lethal congenital|Wolff-Parkinson-White pattern|Familial Hypertrophic Cardiomyopathy with Wolff-Parkinson-White Syndrome	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000359367	7	151574285	7	151877200	359367	305452	rs886062109	NC_000007.14:151877199:G:A
NM_016203.3(PRKAG2):c.-575C>T	PRKAG2|PRKAG2-AS1		Glycogen storage disease of heart, lethal congenital|Wolff-Parkinson-White pattern|Familial Hypertrophic Cardiomyopathy with Wolff-Parkinson-White Syndrome	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000359366	7	151574280	7	151877195	359366	310359	rs886062108	NC_000007.14:151877194:G:A
NM_016203.3(PRKAG2):c.-560C>T	PRKAG2|PRKAG2-AS1		Wolff-Parkinson-White pattern|not provided|Familial Hypertrophic Cardiomyopathy with Wolff-Parkinson-White Syndrome	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	VCV000359365	7	151574265	7	151877180	359365	305450	rs117728810	NC_000007.14:151877179:G:A
NM_016203.3(PRKAG2):c.-520C>T	PRKAG2|PRKAG2-AS1		Wolff-Parkinson-White pattern|not provided|Familial Hypertrophic Cardiomyopathy with Wolff-Parkinson-White Syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Jun 19, 2018)	criteria provided, conflicting interpretations	VCV000359364	7	151574225	7	151877140	359364	310235	rs73160072	NC_000007.14:151877139:G:A
NM_016203.3(PRKAG2):c.-517G>T	PRKAG2|PRKAG2-AS1		Glycogen storage disease of heart, lethal congenital|Wolff-Parkinson-White pattern|Familial Hypertrophic Cardiomyopathy with Wolff-Parkinson-White Syndrome	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000359363	7	151574222	7	151877137	359363	305449	rs886062107	NC_000007.14:151877136:C:A
NM_016203.4(PRKAG2):c.-397G>C	PRKAG2		Familial hypertrophic cardiomyopathy 6|Wolff-Parkinson-White pattern	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000359362	7	151574102	7	151877017	359362	310234	rs886062106	NC_000007.14:151877016:C:G
NM_016203.4(PRKAG2):c.-351G>A	PRKAG2		Glycogen storage disease of heart, lethal congenital|Wolff-Parkinson-White pattern|Familial Hypertrophic Cardiomyopathy with Wolff-Parkinson-White Syndrome	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000359361	7	151574056	7	151876971	359361	310230	rs886062105	NC_000007.14:151876970:C:T
NM_016203.4(PRKAG2):c.-322T>C	PRKAG2		Glycogen storage disease of heart, lethal congenital|Wolff-Parkinson-White pattern|not provided|Familial Hypertrophic Cardiomyopathy with Wolff-Parkinson-White Syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	VCV000359360	7	151574027	7	151876942	359360	302225	rs142348760	NC_000007.14:151876941:A:G
NM_016203.4(PRKAG2):c.-287C>G	PRKAG2		Wolff-Parkinson-White pattern|not provided|Familial hypertrophic cardiomyopathy 6	Likely benign(Last reviewed: Jun 26, 2018)	criteria provided, multiple submitters, no conflicts	VCV000359359	7	151573992	7	151876907	359359	310357	rs75059373	NC_000007.14:151876906:G:C
NM_016203.4(PRKAG2):c.-274C>A	PRKAG2		Glycogen storage disease of heart, lethal congenital|Wolff-Parkinson-White pattern|Familial Hypertrophic Cardiomyopathy with Wolff-Parkinson-White Syndrome	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000359358	7	151573979	7	151876894	359358	305448	rs886062104	NC_000007.14:151876893:G:T
NM_016203.4(PRKAG2):c.-262C>T	PRKAG2		Familial hypertrophic cardiomyopathy 6|Wolff-Parkinson-White pattern	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000359357	7	151573967	7	151876882	359357	310347	rs886062103	NC_000007.14:151876881:G:A
NM_016203.4(PRKAG2):c.-252C>T	PRKAG2		Familial hypertrophic cardiomyopathy 6|Wolff-Parkinson-White pattern	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000359356	7	151573957	7	151876872	359356	302224	rs546312513	NC_000007.14:151876871:G:A
NM_016203.4(PRKAG2):c.-249G>C	PRKAG2		Familial hypertrophic cardiomyopathy 6|Wolff-Parkinson-White pattern	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000359355	7	151573954	7	151876869	359355	310346	rs534059998	NC_000007.14:151876868:C:G
NM_016203.4(PRKAG2):c.-90G>T	PRKAG2		Familial hypertrophic cardiomyopathy 6|Wolff-Parkinson-White pattern|not provided	Benign/Likely benign(Last reviewed: Jan 13, 2018)	criteria provided, multiple submitters, no conflicts	VCV000359354	7	151573795	7	151876710	359354	305447	rs76351165	NC_000007.14:151876709:C:A
NM_016203.4(PRKAG2):c.-40C>T	PRKAG2		Glycogen storage disease of heart, lethal congenital|Wolff-Parkinson-White pattern|not provided|Familial Hypertrophic Cardiomyopathy with Wolff-Parkinson-White Syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	VCV000359353	7	151573745	7	151876660	359353	305446	rs148715621	NC_000007.14:151876659:G:A
NM_016203.4(PRKAG2):c.-16A>G	PRKAG2		Familial hypertrophic cardiomyopathy 6|not provided|Wolff-Parkinson-White pattern	Conflicting interpretations of pathogenicity(Last reviewed: May 24, 2018)	criteria provided, conflicting interpretations	VCV000359352	7	151573721	7	151876636	359352	310329	rs200468798	NC_000007.14:151876635:T:C
NM_016203.4(PRKAG2):c.138G>A (p.Pro46=)	PRKAG2		Familial hypertrophic cardiomyopathy 6|Glycogen storage disease of heart, lethal congenital|Wolff-Parkinson-White pattern|not provided|not specified|Cardiomyopathy	Conflicting interpretations of pathogenicity(Last reviewed: May 22, 2021)	criteria provided, conflicting interpretations	VCV000359351	7	151483604	7	151786518	359351	305445	rs767613486	NC_000007.14:151786517:C:T
NM_016203.4(PRKAG2):c.186+7C>T	PRKAG2		Glycogen storage disease of heart, lethal congenital|Wolff-Parkinson-White pattern|not provided|Familial Hypertrophic Cardiomyopathy with Wolff-Parkinson-White Syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Sep 15, 2020)	criteria provided, conflicting interpretations	VCV000359350	7	151483549	7	151786463	359350	302218	rs886062102	NC_000007.14:151786462:G:A
NM_016203.4(PRKAG2):c.224G>C (p.Gly75Ala)	PRKAG2	G75A, G31A	Familial hypertrophic cardiomyopathy 6|Cardiomyopathy|Wolff-Parkinson-White pattern|Glycogen storage disease of heart, lethal congenital	Conflicting interpretations of pathogenicity(Last reviewed: Dec 3, 2020)	criteria provided, conflicting interpretations	VCV000359349	7	151478480	7	151781394	359349	310328	rs199963585	NC_000007.14:151781393:C:G
NM_016203.4(PRKAG2):c.248C>T (p.Pro83Leu)	PRKAG2	P83L, P39L	Familial hypertrophic cardiomyopathy 6|not provided|Cardiomyopathy|Wolff-Parkinson-White pattern|Glycogen storage disease of heart, lethal congenital	Conflicting interpretations of pathogenicity(Last reviewed: Dec 4, 2020)	criteria provided, conflicting interpretations	VCV000359348	7	151478456	7	151781370	359348	305444	rs757900380	NC_000007.14:151781369:G:A
NM_016203.4(PRKAG2):c.395A>G (p.Lys132Arg)	PRKAG2	K132R, K88R	Glycogen storage disease of heart, lethal congenital|Wolff-Parkinson-White pattern|Familial Hypertrophic Cardiomyopathy with Wolff-Parkinson-White Syndrome|Cardiomyopathy	Uncertain significance(Last reviewed: Sep 2, 2020)	criteria provided, multiple submitters, no conflicts	VCV000359347	7	151478309	7	151781223	359347	302217	rs779753891	NC_000007.14:151781222:T:C
NM_016203.4(PRKAG2):c.429G>A (p.Ser143=)	PRKAG2		Familial hypertrophic cardiomyopathy 6|not provided|Cardiomyopathy|Wolff-Parkinson-White pattern|Glycogen storage disease of heart, lethal congenital	Conflicting interpretations of pathogenicity(Last reviewed: Mar 23, 2021)	criteria provided, conflicting interpretations	VCV000359346	7	151478275	7	151781189	359346	305443	rs757727533	NC_000007.14:151781188:C:T
NM_016203.4(PRKAG2):c.433G>A (p.Gly145Arg)	PRKAG2	G145R, G101R	Familial hypertrophic cardiomyopathy 6|Wolff-Parkinson-White pattern|Hypertrophic cardiomyopathy	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, multiple submitters, no conflicts	VCV000359345	7	151478271	7	151781185	359345	310229	rs886062101	NC_000007.14:151781184:C:T
NM_016203.4(PRKAG2):c.787C>A (p.Arg263=)	PRKAG2		Glycogen storage disease of heart, lethal congenital|Wolff-Parkinson-White pattern|Familial Hypertrophic Cardiomyopathy with Wolff-Parkinson-White Syndrome	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000359344	7	151292508	7	151595422	359344	305441	rs886062100	NC_000007.14:151595421:G:T
NM_016203.4(PRKAG2):c.*55C>T	PRKAG2		Familial hypertrophic cardiomyopathy 6|Wolff-Parkinson-White pattern	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000359343	7	151254232	7	151557146	359343	305440	rs371637024	NC_000007.14:151557145:G:A
NM_016203.4(PRKAG2):c.*112A>G	PRKAG2		Familial hypertrophic cardiomyopathy 6|not provided|Wolff-Parkinson-White pattern	Benign(Last reviewed: Jan 13, 2018)	criteria provided, multiple submitters, no conflicts	VCV000359342	7	151254175	7	151557089	359342	302216	rs8961	NC_000007.14:151557088:T:C
NM_016203.4(PRKAG2):c.*127C>G	PRKAG2		not provided|Familial hypertrophic cardiomyopathy 6|Wolff-Parkinson-White pattern	Conflicting interpretations of pathogenicity(Last reviewed: Jan 12, 2018)	criteria provided, conflicting interpretations	VCV000359341	7	151254160	7	151557074	359341	302215	rs189787963	NC_000007.14:151557073:G:C
NM_016203.4(PRKAG2):c.*135T>C	PRKAG2		not provided|Familial hypertrophic cardiomyopathy 6|Wolff-Parkinson-White pattern	Conflicting interpretations of pathogenicity(Last reviewed: Jan 12, 2018)	criteria provided, conflicting interpretations	VCV000359340	7	151254152	7	151557066	359340	305434	rs184932311	NC_000007.14:151557065:A:G
NM_016203.4(PRKAG2):c.*350C>A	PRKAG2		Glycogen storage disease of heart, lethal congenital|Wolff-Parkinson-White pattern|Familial Hypertrophic Cardiomyopathy with Wolff-Parkinson-White Syndrome	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000359339	7	151253937	7	151556851	359339	302214	rs886062099	NC_000007.14:151556850:G:T
NM_016203.4(PRKAG2):c.*365G>A	PRKAG2		Familial hypertrophic cardiomyopathy 6|not provided|Wolff-Parkinson-White pattern	Conflicting interpretations of pathogenicity(Last reviewed: Jan 12, 2018)	criteria provided, conflicting interpretations	VCV000359338	7	151253922	7	151556836	359338	310228	rs886062098	NC_000007.14:151556835:C:T
NM_016203.4(PRKAG2):c.*384C>T	PRKAG2		Familial hypertrophic cardiomyopathy 6|not provided|Wolff-Parkinson-White pattern	Benign/Likely benign(Last reviewed: Jan 12, 2018)	criteria provided, multiple submitters, no conflicts	VCV000359337	7	151253903	7	151556817	359337	310327	rs75418446	NC_000007.14:151556816:G:A
NM_016203.4(PRKAG2):c.*452C>T	PRKAG2		Familial hypertrophic cardiomyopathy 6|Wolff-Parkinson-White pattern	Benign/Likely benign(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000359336	7	151253835	7	151556749	359336	310227	rs17714947	NC_000007.14:151556748:G:A
NM_016203.4(PRKAG2):c.*522G>T	PRKAG2		Wolff-Parkinson-White pattern|Familial hypertrophic cardiomyopathy 6	Benign(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000359335	7	151253765	7	151556679	359335	305426	rs1051956	NC_000007.14:151556678:C:A
NM_016203.4(PRKAG2):c.*572G>A	PRKAG2		Wolff-Parkinson-White pattern|Familial hypertrophic cardiomyopathy 6	Likely benign(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000359334	7	151253715	7	151556629	359334	310221	rs78192883	NC_000007.14:151556628:C:T
NM_016203.4(PRKAG2):c.*612G>A	PRKAG2		Wolff-Parkinson-White pattern|Familial hypertrophic cardiomyopathy 6	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000359333	7	151253675	7	151556589	359333	302212	rs371404960	NC_000007.14:151556588:C:T
NM_016203.4(PRKAG2):c.*614A>T	PRKAG2		Wolff-Parkinson-White pattern|Familial hypertrophic cardiomyopathy 6	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000359332	7	151253673	7	151556587	359332	305406	rs567058170	NC_000007.14:151556586:T:A
NM_016203.4(PRKAG2):c.*835T>C	PRKAG2		Wolff-Parkinson-White pattern|Familial hypertrophic cardiomyopathy 6	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000359331	7	151253452	7	151556366	359331	310325	rs886062097	NC_000007.14:151556365:A:G
NM_016203.4(PRKAG2):c.*887G>A	PRKAG2		Wolff-Parkinson-White pattern|Familial hypertrophic cardiomyopathy 6	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000359330	7	151253400	7	151556314	359330	305405	rs886062096	NC_000007.14:151556313:C:T
NM_016203.4(PRKAG2):c.*896del	PRKAG2		Glycogen storage disease of heart, lethal congenital|Wolff-Parkinson-White pattern|Familial Hypertrophic Cardiomyopathy with Wolff-Parkinson-White Syndrome	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000359329	7	151253391	7	151556305	359329	310209	rs532079387	NC_000007.14:151556304:AAAAA:AAAA
NM_016203.4(PRKAG2):c.*964G>A	PRKAG2		Wolff-Parkinson-White pattern|Familial hypertrophic cardiomyopathy 6	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000359328	7	151253323	7	151556237	359328	305396	rs75512992	NC_000007.14:151556236:C:T
NM_016203.4(PRKAG2):c.*1012T>G	PRKAG2		Wolff-Parkinson-White pattern|Familial hypertrophic cardiomyopathy 6	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000359327	7	151253275	7	151556189	359327	310323	rs886062095	NC_000007.14:151556188:A:C
NM_016203.4(PRKAG2):c.*1021del	PRKAG2		Glycogen storage disease of heart, lethal congenital|Wolff-Parkinson-White pattern|Familial Hypertrophic Cardiomyopathy with Wolff-Parkinson-White Syndrome	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000359326	7	151253266	7	151556180	359326	310322	rs11329945	NC_000007.14:151556179:AAAAAAAAAA:AAAAAAAAA
NM_016203.4(PRKAG2):c.*1021_*1022delinsGT	PRKAG2		Glycogen storage disease of heart, lethal congenital|Wolff-Parkinson-White pattern|Familial Hypertrophic Cardiomyopathy with Wolff-Parkinson-White Syndrome	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000359325	7	151253265 - 151253266	7	151556179 - 151556180	359325	302210	rs886062094	NC_000007.14:151556178:CA:AC
NM_016203.4(PRKAG2):c.*1029dup	PRKAG2		Glycogen storage disease of heart, lethal congenital|Wolff-Parkinson-White pattern|Familial Hypertrophic Cardiomyopathy with Wolff-Parkinson-White Syndrome	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000359324	7	151253257 - 151253258	7	151556171 - 151556172	359324	302207	rs1554444891	NC_000007.14:151556171:CCC:CCCC
NM_016203.4(PRKAG2):c.*1040del	PRKAG2		Glycogen storage disease of heart, lethal congenital|Wolff-Parkinson-White pattern|Familial Hypertrophic Cardiomyopathy with Wolff-Parkinson-White Syndrome	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000359323	7	151253247	7	151556161	359323	305395	rs56898021	NC_000007.14:151556160:AAAAAAAAAAA:AAAAAAAAAA
NM_016203.4(PRKAG2):c.*1040dup	PRKAG2		Glycogen storage disease of heart, lethal congenital|Wolff-Parkinson-White pattern|Familial Hypertrophic Cardiomyopathy with Wolff-Parkinson-White Syndrome	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000359322	7	151253246 - 151253247	7	151556160 - 151556161	359322	302204	rs56898021	NC_000007.14:151556160:AAAAAAAAAAA:AAAAAAAAAAAA
NM_016203.4(PRKAG2):c.*1041dup	PRKAG2		Glycogen storage disease of heart, lethal congenital|Wolff-Parkinson-White pattern|Familial Hypertrophic Cardiomyopathy with Wolff-Parkinson-White Syndrome	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000359321	7	151253245 - 151253246	7	151556159 - 151556160	359321	302201	rs886062093	NC_000007.14:151556159:G:GG
NM_016203.4(PRKAG2):c.*1061G>A	PRKAG2		Wolff-Parkinson-White pattern|Familial hypertrophic cardiomyopathy 6	Benign(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000359320	7	151253226	7	151556140	359320	302196	rs7429	NC_000007.14:151556139:C:T
NM_016203.4(PRKAG2):c.864+35_864+36insA	PRKAG2		not specified|not provided|Familial hypertrophic cardiomyopathy 6|Glycogen storage disease of heart, lethal congenital|Wolff-Parkinson-White pattern	Benign/Likely benign(Last reviewed: Oct 25, 2021)	criteria provided, multiple submitters, no conflicts	VCV000260697	7	151292395 - 151292396	7	151595309 - 151595310	260697	252652	rs35348247	NC_000007.14:151595309::T
NM_016203.4(PRKAG2):c.-26C>T	PRKAG2		not provided|not specified|Familial hypertrophic cardiomyopathy 6|Glycogen storage disease of heart, lethal congenital|Wolff-Parkinson-White pattern	Benign(Last reviewed: Dec 8, 2020)	criteria provided, multiple submitters, no conflicts	VCV000260692	7	151573731	7	151876646	260692	252655	rs66628686	NC_000007.14:151876645:G:A
NM_016203.4(PRKAG2):c.137C>T (p.Pro46Leu)	PRKAG2	P46L, P2L	not specified	Uncertain significance(Last reviewed: Mar 15, 2021)	criteria provided, multiple submitters, no conflicts	VCV000229171	7	151483605	7	151786519	229171	229568	rs373477232	NC_000007.14:151786518:G:A
NM_016203.4(PRKAG2):c.981A>G (p.Leu327=)	PRKAG2		not specified|Cardiomyopathy|not provided|Wolff-Parkinson-White pattern|Familial hypertrophic cardiomyopathy 6|Glycogen storage disease of heart, lethal congenital	Conflicting interpretations of pathogenicity(Last reviewed: Jul 1, 2020)	criteria provided, conflicting interpretations	VCV000227880	7	151272001	7	151574915	227880	229564	rs764162597	NC_000007.14:151574914:T:C
NM_016203.4(PRKAG2):c.1310C>G (p.Ala437Gly)	PRKAG2	A437G, A312G, A393G, A196G, A313G	Wolff-Parkinson-White pattern|Familial hypertrophic cardiomyopathy 6|Glycogen storage disease of heart, lethal congenital|Primary familial hypertrophic cardiomyopathy	Uncertain significance(Last reviewed: Aug 29, 2020)	criteria provided, multiple submitters, no conflicts	VCV000222770	7	151262895	7	151565809	222770	224349	rs762111172	NC_000007.14:151565808:G:C
NM_016203.4(PRKAG2):c.431C>T (p.Pro144Leu)	PRKAG2	P144L, P100L	Glycogen storage disease of heart, lethal congenital|not provided|Wolff-Parkinson-White pattern|Familial hypertrophic cardiomyopathy 6|not specified|Cardiomyopathy|Congestive heart failure	Uncertain significance(Last reviewed: Dec 23, 2020)	criteria provided, multiple submitters, no conflicts	VCV000181485	7	151478273	7	151781187	181485	179133	rs150140412	NC_000007.14:151781186:G:A
NM_016203.4(PRKAG2):c.1646A>C (p.Asp549Ala)	PRKAG2	D549A, D505A, D308A, D424A, D425A	not provided	Likely pathogenic(Last reviewed: Apr 13, 2015)	criteria provided, single submitter	VCV000181481	7	151257642	7	151560556	181481	179112	rs730880982	NC_000007.14:151560555:T:G
NM_016203.4(PRKAG2):c.946+3A>G	PRKAG2		Glycogen storage disease of heart, lethal congenital|Cardiomyopathy|not provided|not specified	Conflicting interpretations of pathogenicity(Last reviewed: Nov 20, 2020)	criteria provided, conflicting interpretations	VCV000181475	7	151273454	7	151576368	181475	179120	rs376173303	NC_000007.14:151576367:T:C
NM_016203.4(PRKAG2):c.866T>C (p.Val289Ala)	PRKAG2	V289A, V165A, V164A, V48A, V245A	Glycogen storage disease of heart, lethal congenital|Wolff-Parkinson-White pattern|Familial hypertrophic cardiomyopathy 6|not provided|Cardiomyopathy	Conflicting interpretations of pathogenicity(Last reviewed: Sep 26, 2020)	criteria provided, conflicting interpretations	VCV000181473	7	151273537	7	151576451	181473	179122	rs730880975	NC_000007.14:151576450:A:G
NM_016203.4(PRKAG2):c.202G>A (p.Gly68Ser)	PRKAG2	G68S, G24S	Familial Hypertrophic Cardiomyopathy with Wolff-Parkinson-White Syndrome|Glycogen storage disease of heart, lethal congenital|Wolff-Parkinson-White pattern|Cardiomyopathy|not specified	Conflicting interpretations of pathogenicity(Last reviewed: Sep 15, 2021)	criteria provided, conflicting interpretations	VCV000181465	7	151478502	7	151781416	181465	179136	rs730880970	NC_000007.14:151781415:C:T
NM_016203.4(PRKAG2):c.1006G>A (p.Val336Ile)	PRKAG2	V336I, V292I, V211I, V212I, V95I	Glycogen storage disease of heart, lethal congenital|not specified|Cardiovascular phenotype|not provided	Uncertain significance(Last reviewed: Oct 5, 2018)	criteria provided, multiple submitters, no conflicts	VCV000179205	7	151269795	7	151572709	179205	174049	rs727504707	NC_000007.14:151572708:C:T
NM_016203.4(PRKAG2):c.*2C>T	PRKAG2		not specified|Cardiomyopathy|Wolff-Parkinson-White pattern|Familial hypertrophic cardiomyopathy 6	Conflicting interpretations of pathogenicity(Last reviewed: Apr 15, 2021)	criteria provided, conflicting interpretations	VCV000177987	7	151254285	7	151557199	177987	174047	rs199559205	NC_000007.14:151557198:G:A
NM_016203.4(PRKAG2):c.1304A>G (p.Asn435Ser)	PRKAG2	N435S, N310S, N311S, N391S, N194S	not provided|Glycogen storage disease of heart, lethal congenital|Wolff-Parkinson-White pattern|Cardiomyopathy	Uncertain significance(Last reviewed: Aug 11, 2021)	criteria provided, multiple submitters, no conflicts	VCV000167533	7	151262901	7	151565815	167533	177380	rs200589374	NC_000007.14:151565814:T:C
NM_016203.4(PRKAG2):c.912G>A (p.Ala304=)	PRKAG2		Cardiomyopathy|Familial Hypertrophic Cardiomyopathy with Wolff-Parkinson-White Syndrome|Cardiovascular phenotype|not specified|not provided|Wolff-Parkinson-White pattern|Glycogen storage disease of heart, lethal congenital	Conflicting interpretations of pathogenicity(Last reviewed: Nov 25, 2020)	criteria provided, conflicting interpretations	VCV000045738	7	151273491	7	151576405	45738	54903	rs145029525	NC_000007.14:151576404:C:T
NM_016203.4(PRKAG2):c.698C>G (p.Ala233Gly)	PRKAG2	A233G, A189G, A109G	not provided|Familial hypertrophic cardiomyopathy 1|Cardiomyopathy|not specified|See cases|Wolff-Parkinson-White pattern|Familial hypertrophic cardiomyopathy 6|Glycogen storage disease of heart, lethal congenital	Conflicting interpretations of pathogenicity(Last reviewed: Apr 8, 2021)	criteria provided, conflicting interpretations	VCV000045733	7	151329211	7	151632125	45733	54898	rs201240745	NC_000007.14:151632124:G:C
NM_016203.4(PRKAG2):c.620C>G (p.Ser207Cys)	PRKAG2	S207C, S163C, S83C	Familial Hypertrophic Cardiomyopathy with Wolff-Parkinson-White Syndrome|not specified|Wolff-Parkinson-White pattern|Glycogen storage disease of heart, lethal congenital	Uncertain significance(Last reviewed: Dec 3, 2019)	criteria provided, multiple submitters, no conflicts	VCV000045729	7	151372570	7	151675484	45729	54894	rs397517277	NC_000007.14:151675483:G:C
NM_016203.4(PRKAG2):c.59G>T (p.Ser20Ile)	PRKAG2	S20I	Cardiovascular phenotype|not provided|not specified|Cardiomyopathy|Wolff-Parkinson-White pattern|Glycogen storage disease of heart, lethal congenital|Familial hypertrophic cardiomyopathy 6	Benign/Likely benign(Last reviewed: Jul 10, 2021)	criteria provided, multiple submitters, no conflicts	VCV000045727	7	151573647	7	151876562	45727	54892	rs116605521	NC_000007.14:151876561:C:A
NM_016203.4(PRKAG2):c.532G>A (p.Glu178Lys)	PRKAG2	E178K, E134K, E54K	Cardiomyopathy|not specified|Familial hypertrophic cardiomyopathy 6|Wolff-Parkinson-White pattern|Glycogen storage disease of heart, lethal congenital	Uncertain significance(Last reviewed: Aug 30, 2021)	criteria provided, multiple submitters, no conflicts	VCV000045723	7	151372658	7	151675572	45723	54888	rs397517273	NC_000007.14:151675571:C:T
NM_016203.4(PRKAG2):c.471C>T (p.Ser157=)	PRKAG2		Cardiovascular phenotype|not provided|Cardiomyopathy|not specified|Familial hypertrophic cardiomyopathy 6|Wolff-Parkinson-White pattern|Glycogen storage disease of heart, lethal congenital	Conflicting interpretations of pathogenicity(Last reviewed: Oct 23, 2020)	criteria provided, conflicting interpretations	VCV000045721	7	151372719	7	151675633	45721	54886	rs141804012	NC_000007.14:151675632:G:A
NM_016203.4(PRKAG2):c.425C>T (p.Thr142Ile)	PRKAG2	T142I, T98I	Cardiomyopathy|Arrhythmogenic right ventricular dysplasia 9|Wolff-Parkinson-White pattern|Familial hypertrophic cardiomyopathy 6|Glycogen storage disease of heart, lethal congenital|not provided|Hypertrophic cardiomyopathy|not specified|Wolff-Parkinson-White pattern|Glycogen storage disease of heart, lethal congenital|Familial hypertrophic cardiomyopathy 6	Uncertain significance(Last reviewed: May 6, 2021)	criteria provided, multiple submitters, no conflicts	VCV000045717	7	151478279	7	151781193	45717	54882	rs397517270	NC_000007.14:151781192:G:A
NM_016203.4(PRKAG2):c.312C>T (p.Thr104=)	PRKAG2		Cardiomyopathy|not provided|not specified|Familial hypertrophic cardiomyopathy 6|Wolff-Parkinson-White pattern|Glycogen storage disease of heart, lethal congenital	Conflicting interpretations of pathogenicity(Last reviewed: Sep 10, 2020)	criteria provided, conflicting interpretations	VCV000045713	7	151478392	7	151781306	45713	54878	rs397517268	NC_000007.14:151781305:G:A
NM_016203.4(PRKAG2):c.247C>T (p.Pro83Ser)	PRKAG2	P83S, P39S	Cardiomyopathy|Cardiovascular phenotype|not provided|not specified|Heart failure|Familial hypertrophic cardiomyopathy 6|Wolff-Parkinson-White pattern|Glycogen storage disease of heart, lethal congenital	Conflicting interpretations of pathogenicity(Last reviewed: Dec 1, 2020)	criteria provided, conflicting interpretations	VCV000045711	7	151478457	7	151781371	45711	54876	rs148791216	NC_000007.14:151781370:G:A
NM_016203.4(PRKAG2):c.240C>A (p.Gly80=)	PRKAG2		not specified|Cardiomyopathy|not provided|Familial hypertrophic cardiomyopathy 6|Wolff-Parkinson-White pattern|Glycogen storage disease of heart, lethal congenital	Conflicting interpretations of pathogenicity(Last reviewed: Dec 3, 2020)	criteria provided, conflicting interpretations	VCV000045710	7	151478464	7	151781378	45710	54875	rs142482217	NC_000007.14:151781377:G:T
NM_016203.4(PRKAG2):c.207G>A (p.Pro69=)	PRKAG2		Cardiovascular phenotype|Cardiomyopathy|not specified|not provided|Wolff-Parkinson-White pattern|Glycogen storage disease of heart, lethal congenital|Familial hypertrophic cardiomyopathy 6	Benign(Last reviewed: Dec 3, 2020)	criteria provided, multiple submitters, no conflicts	VCV000045709	7	151478497	7	151781411	45709	54874	rs144384573	NC_000007.14:151781410:C:T
NM_016203.4(PRKAG2):c.1704G>A (p.Thr568=)	PRKAG2		Cardiomyopathy|Cardiovascular phenotype|not specified|not provided|Familial hypertrophic cardiomyopathy 6|Wolff-Parkinson-White pattern|Glycogen storage disease of heart, lethal congenital	Benign/Likely benign(Last reviewed: Dec 8, 2020)	criteria provided, multiple submitters, no conflicts	VCV000045706	7	151254293	7	151557207	45706	54871	rs138167675	NC_000007.14:151557206:C:T
NM_016203.4(PRKAG2):c.1623T>C (p.Ile541=)	PRKAG2		not specified|Cardiovascular phenotype|Cardiomyopathy|not provided|Familial hypertrophic cardiomyopathy 6|Wolff-Parkinson-White pattern|Glycogen storage disease of heart, lethal congenital	Benign(Last reviewed: Dec 4, 2020)	criteria provided, multiple submitters, no conflicts	VCV000045702	7	151257665	7	151560579	45702	54867	rs28763998	NC_000007.14:151560578:A:G
NM_016203.4(PRKAG2):c.1584+7C>T	PRKAG2		not provided|Cardiomyopathy|not specified|Familial hypertrophic cardiomyopathy 6|Wolff-Parkinson-White pattern|Glycogen storage disease of heart, lethal congenital	Conflicting interpretations of pathogenicity(Last reviewed: Dec 2, 2020)	criteria provided, conflicting interpretations	VCV000045699	7	151261157	7	151564071	45699	54864	rs111627309	NC_000007.14:151564070:G:A
NM_016203.4(PRKAG2):c.1390G>A (p.Asp464Asn)	PRKAG2	D464N, D340N, D339N, D420N, D223N	Cardiomyopathy|Primary familial hypertrophic cardiomyopathy|not provided|not specified|Hypertrophic cardiomyopathy|Wolff-Parkinson-White pattern|Glycogen storage disease of heart, lethal congenital|Familial hypertrophic cardiomyopathy 6	Uncertain significance(Last reviewed: Jul 10, 2020)	criteria provided, multiple submitters, no conflicts	VCV000045697	7	151262815	7	151565729	45697	54862	rs397517264	NC_000007.14:151565728:C:T
NM_016203.4(PRKAG2):c.123C>T (p.Ser41=)	PRKAG2		Cardiovascular phenotype|not provided|not specified|Cardiomyopathy|Familial hypertrophic cardiomyopathy 6|Wolff-Parkinson-White pattern|Glycogen storage disease of heart, lethal congenital	Conflicting interpretations of pathogenicity(Last reviewed: Nov 1, 2021)	criteria provided, conflicting interpretations	VCV000045692	7	151483619	7	151786533	45692	54857	rs397517263	NC_000007.14:151786532:G:A
NM_016203.4(PRKAG2):c.114+12C>T	PRKAG2		not provided|not specified|Wolff-Parkinson-White pattern|Glycogen storage disease of heart, lethal congenital|Familial hypertrophic cardiomyopathy 6	Benign(Last reviewed: Dec 18, 2021)	criteria provided, multiple submitters, no conflicts	VCV000045689	7	151573580	7	151876495	45689	54854	rs77902041	NC_000007.14:151876494:G:A
NM_016203.4(PRKAG2):c.111T>A (p.Ile37=)	PRKAG2		Cardiovascular phenotype|Glycogen storage disease of heart, lethal congenital|Cardiomyopathy|not provided|not specified|Familial hypertrophic cardiomyopathy 6|Wolff-Parkinson-White pattern	Conflicting interpretations of pathogenicity(Last reviewed: Aug 24, 2021)	criteria provided, conflicting interpretations	VCV000045688	7	151573595	7	151876510	45688	54853	rs144426409	NC_000007.14:151876509:A:T
NM_016203.4(PRKAG2):c.1106+9G>C	PRKAG2		not provided|not specified|Cardiomyopathy|Familial hypertrophic cardiomyopathy 6|Wolff-Parkinson-White pattern|Glycogen storage disease of heart, lethal congenital	Conflicting interpretations of pathogenicity(Last reviewed: Nov 27, 2020)	criteria provided, conflicting interpretations	VCV000045687	7	151267248	7	151570162	45687	54852	rs200429988	NC_000007.14:151570161:C:G
NM_016203.4(PRKAG2):c.1098A>G (p.Pro366=)	PRKAG2		not specified|Cardiomyopathy|Cardiovascular phenotype|not provided|Familial hypertrophic cardiomyopathy 6|Wolff-Parkinson-White pattern|Glycogen storage disease of heart, lethal congenital	Conflicting interpretations of pathogenicity(Last reviewed: Dec 1, 2020)	criteria provided, conflicting interpretations	VCV000045686	7	151267265	7	151570179	45686	54851	rs116541276	NC_000007.14:151570178:T:C
NM_016203.4(PRKAG2):c.*3G>A	PRKAG2		not provided|Cardiovascular phenotype|not specified|Cardiomyopathy|Familial hypertrophic cardiomyopathy 6|Wolff-Parkinson-White pattern	Benign/Likely benign(Last reviewed: Jan 16, 2020)	criteria provided, multiple submitters, no conflicts	VCV000045684	7	151254284	7	151557198	45684	54849	rs113234987	NC_000007.14:151557197:C:T
NM_016203.4(PRKAG2):c.298G>A (p.Gly100Ser)	PRKAG2	G100S, G56S	not provided|not specified|Cardiomyopathy|Renal cysts and diabetes syndrome|Familial hypertrophic cardiomyopathy 6|Glycogen storage disease of heart, lethal congenital|Wolff-Parkinson-White pattern|PRKAG2 cardiac syndrome|Cardiovascular phenotype	Conflicting interpretations of pathogenicity(Last reviewed: Sep 13, 2021)	criteria provided, conflicting interpretations	VCV000036697	7	151478406	7	151781320	36697	45358	rs79474211	NC_000007.14:151781319:C:T
NM_016203.4(PRKAG2):c.1593G>A (p.Arg531=)	PRKAG2		not specified|Familial hypertrophic cardiomyopathy 6|Glycogen storage disease of heart, lethal congenital|Wolff-Parkinson-White pattern|Cardiomyopathy|not provided|Cardiovascular phenotype	Benign/Likely benign(Last reviewed: May 22, 2021)	criteria provided, multiple submitters, no conflicts	VCV000036696	7	151257695	7	151560609	36696	45357	rs148197254	NC_000007.14:151560608:C:T
NM_016203.4(PRKAG2):c.1589A>G (p.His530Arg)	PRKAG2	H530R, H406R, H289R, H486R, H405R	Glycogen storage disease of heart, lethal congenital|Familial hypertrophic cardiomyopathy 6|not provided|Hypertrophic cardiomyopathy	Pathogenic(Last reviewed: Sep 19, 2018)	criteria provided, multiple submitters, no conflicts	VCV000006854	7	151257699	7	151560613	6854	21893	rs267606977	NC_000007.14:151560612:T:C
NM_016203.4(PRKAG2):c.1591C>G (p.Arg531Gly)	PRKAG2	R531G, R290G, R407G, R406G, R487G	Wolff-Parkinson-White syndrome, childhood-onset	Pathogenic(Last reviewed: Dec 18, 2001)	no assertion criteria provided	VCV000006851	7	151257697	7	151560611	6851	21890	rs121908990	NC_000007.14:151560610:G:C
NM_016203.4(PRKAG2):c.1463A>T (p.Asn488Ile)	PRKAG2	N488I, N247I, N363I, N364I, N444I	Familial hypertrophic cardiomyopathy 6	Pathogenic(Last reviewed: Feb 1, 2002)	no assertion criteria provided	VCV000006850	7	151261285	7	151564199	6850	21889	rs121908989	NC_000007.14:151564198:T:A
NM_016203.4(PRKAG2):c.1199C>A (p.Thr400Asn)	PRKAG2	T400N, T275N, T276N, T159N, T356N	Hypertrophic cardiomyopathy|Familial hypertrophic cardiomyopathy 6	Likely pathogenic(Last reviewed: Jan 3, 2018)	criteria provided, single submitter	VCV000006849	7	151265836	7	151568750	6849	21888	rs28938173	NC_000007.14:151568749:G:T
NM_016203.4(PRKAG2):c.1050_1051insTTA (p.Glu351_Leu352insLeu)	PRKAG2		Familial hypertrophic cardiomyopathy 6	Pathogenic(Last reviewed: May 15, 2001)	no assertion criteria provided	VCV000006848	7	151269750 - 151269751	7	151572664 - 151572665	6848	21887	rs587776643	NC_000007.14:151572664::TAA
NM_016203.4(PRKAG2):c.1148A>G (p.His383Arg)	PRKAG2	H142R, H383R, H259R, H339R, H258R	not provided|not specified|Familial hypertrophic cardiomyopathy 6	Uncertain significance(Last reviewed: Jan 3, 2020)	criteria provided, multiple submitters, no conflicts	VCV000006847	7	151265887	7	151568801	6847	21886	rs121908988	NC_000007.14:151568800:T:C
NM_016203.4(PRKAG2):c.905G>A (p.Arg302Gln)	PRKAG2	R302Q, R61Q, R178Q, R177Q, R258Q	Cardiomyopathy|not provided|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Primary familial hypertrophic cardiomyopathy|Glycogen storage disease of heart, lethal congenital|Wolff-Parkinson-White pattern|Familial hypertrophic cardiomyopathy 6	Pathogenic(Last reviewed: Jan 3, 2022)	criteria provided, multiple submitters, no conflicts	VCV000006846	7	151273498	7	151576412	6846	21885	rs121908987	NC_000007.14:151576411:C:T
NM_001164760.2(PRKAR1B):c.149T>G (p.Leu50Arg)	PRKAR1B	L50R	not provided	Uncertain significance(Last reviewed: Dec 23, 2021)	no assertion criteria provided	VCV000375411	7	750994	7	711357	375411	362178	rs1057519490	NC_000007.14:711356:A:C
NM_004562.3(PRKN):c.1252T>C (p.Cys418Arg)	PRKN	C418R, C269R, C390R	not provided	Likely pathogenic(Last reviewed: Sep 20, 2021)	criteria provided, single submitter	VCV001488446	6	161781153	6	161360121	1488446	1419917		NC_000006.12:161360120:A:G
NC_000006.11:g.(?_162622143)_(162864525_?)del	PRKN		not provided	Pathogenic(Last reviewed: Jul 29, 2021)	criteria provided, single submitter	VCV001460246	6	162622143 - 162864525			1460246	1493949		
NC_000006.11:g.(?_162394314)_(162683817_?)del	PRKN		not provided	Pathogenic(Last reviewed: Dec 6, 2021)	criteria provided, single submitter	VCV001460162	6	162394314 - 162683817			1460162	1481518		
NM_004562.3(PRKN):c.1334G>A (p.Trp445Ter)	PRKN	W296*, W417*, W445*	not provided	Pathogenic(Last reviewed: Nov 26, 2021)	criteria provided, single submitter	VCV001459191	6	161771195	6	161350163	1459191	1406318		NC_000006.12:161350162:C:T
NM_004562.3(PRKN):c.971del (p.Val324fs)	PRKN	V175fs, V296fs, V324fs	not provided	Pathogenic(Last reviewed: Nov 6, 2021)	criteria provided, single submitter	VCV001456905	6	161969998	6	161548966	1456905	1455007		NC_000006.12:161548965:A:
NC_000006.11:g.(?_162622143)_(162864525_?)dup	PRKN		not provided	Pathogenic(Last reviewed: Nov 8, 2021)	criteria provided, single submitter	VCV001455991	6	162622143 - 162864525			1455991	1380251		
NM_004562.3(PRKN):c.1097G>A (p.Arg366Gln)	PRKN	R338Q, R366Q, R217Q	not provided	Uncertain significance(Last reviewed: Dec 9, 2021)	criteria provided, single submitter	VCV001412480	6	161807896	6	161386864	1412480	1344461		NC_000006.12:161386863:C:T
NC_000006.11:g.(?_162474785)_(162475494_?)del	PRKN		Parkinson disease 2	Pathogenic(Last reviewed: Jan 10, 2022)	no assertion criteria provided	VCV001334464	6	162474785 - 162475494			1334464	1325359		
NM_004562.3(PRKN):c.915G>T (p.Arg305Ser)	PRKN	R156S, R277S, R305S	Parkinson disease 2	Uncertain significance(Last reviewed: Jan 7, 2022)	criteria provided, single submitter	VCV001334463	6	161990405	6	161569373	1334463	1325358		NC_000006.12:161569372:C:A
NM_004562.3(PRKN):c.491del (p.Val164fs)	PRKN	V164fs	Parkinson disease 2	Pathogenic(Last reviewed: Mar 24, 2017)	no assertion criteria provided	VCV001172527	6	162622206	6	162201174	1172527	1161636		NC_000006.12:162201173:A:
GRCh37/hg19 6q26(chr6:161969922-161990424)	PRKN		Young-onset Parkinson disease	Pathogenic(Last reviewed: May 3, 2021)	criteria provided, single submitter	VCV001120009	6	161807890 - 162206818			1120009	1108779		
GRCh37/hg19 6q26(chr6:162206818-162206900)	PRKN		Young-onset Parkinson disease	Likely pathogenic(Last reviewed: May 3, 2021)	criteria provided, single submitter	VCV001120008	6	161990424 - 162394320			1120008	1108780		
NM_004562.3(PRKN):c.1288G>A (p.Gly430Ser)	PRKN	G281S, G402S, G430S	Young-onset Parkinson disease|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Aug 17, 2021)	criteria provided, conflicting interpretations	VCV001120007	6	161771241	6	161350209	1120007	1108787		NC_000006.12:161350208:C:T
GRCh37/hg19 6q26(chr6:162394320-162475157)	PRKN		Young-onset Parkinson disease	Pathogenic(Last reviewed: May 3, 2021)	criteria provided, single submitter	VCV001120006	6	162206900 - 162622150			1120006	1108781		
GRCh37/hg19 6q26(chr6:162864400-162864441)	PRKN		Young-onset Parkinson disease	Pathogenic(Last reviewed: May 3, 2021)	criteria provided, single submitter	VCV001120005	6	162683772 - 163146228			1120005	1108784		
GRCh37/hg19 6q26(chr6:162475128-162475157)	PRKN		Young-onset Parkinson disease	Likely pathogenic(Last reviewed: May 3, 2021)	criteria provided, single submitter	VCV001120004	6	162394382 - 162622150			1120004	1108775		
GRCh37/hg19 6q26(chr6:162475128-162475157)	PRKN		Young-onset Parkinson disease	Likely pathogenic(Last reviewed: May 3, 2021)	criteria provided, single submitter	VCV001120003	6	162394382 - 162622150			1120003	1108782		
GRCh37/hg19 6q26(chr6:162622150-162622256)	PRKN		Young-onset Parkinson disease	Pathogenic(Last reviewed: May 3, 2021)	criteria provided, single submitter	VCV001120002	6	162475157 - 162683576			1120002	1108783		
GRCh37/hg19 6q26(chr6:162683576-162683772)	PRKN		Young-onset Parkinson disease	Likely pathogenic(Last reviewed: May 3, 2021)	criteria provided, single submitter	VCV001120001	6	162622256 - 162864400			1120001	1108777		
GRCh37/hg19 6q26(chr6:162864400-162864441)	PRKN		Young-onset Parkinson disease	Likely pathogenic(Last reviewed: May 3, 2021)	criteria provided, single submitter	VCV001120000	6	162683772 - 163146228			1120000	1108778		
GRCh37/hg19 6q26(chr6:162622150-162683772)	PRKN		Young-onset Parkinson disease	Pathogenic(Last reviewed: May 3, 2021)	criteria provided, single submitter	VCV001119999	6	162475157 - 162864400			1119999	1108776		
NC_000006.11:g.(?_162475113)_(162864519_?)del	PRKN		not provided	Pathogenic(Last reviewed: Aug 20, 2020)	criteria provided, single submitter	VCV001073296	6	162475113 - 162864519			1073296	1057203		
NM_004562.3(PRKN):c.1302G>A (p.Met434Ile)	PRKN	M406I, M434I, M285I	Parkinson disease 2	Uncertain significance(Last reviewed: Jun 3, 2020)	criteria provided, single submitter	VCV001030818	6	161771227	6	161350195	1030818	1016688	rs949479970	NC_000006.12:161350194:C:T
NM_004562.3(PRKN):c.618+7842_618+7934inv	PRKN		Parkinson disease 2	Pathogenic(Last reviewed: Jun 20, 2019)	criteria provided, single submitter	VCV001027679	6	162467189 - 162467281	6	162046157 - 162046249	1027679	1015456		
NM_004562.3(PRKN):c.848T>C (p.Leu283Pro)	PRKN	L134P, L255P, L283P	not provided	Uncertain significance(Last reviewed: Jun 1, 2021)	criteria provided, multiple submitters, no conflicts	VCV001025727	6	162206827	6	161785795	1025727	1006542	rs56154308	NC_000006.12:161785794:A:G
GRCh37/hg19 6q26(chr6:162137107-162137163)	PRKN		Parkinson disease 2	Pathogenic(Last reviewed: Jun 7, 2019)	criteria provided, single submitter	VCV000976673	6	162137107 - 162137163			976673	964910		
NM_004562.3(PRKN):c.1321T>C (p.Cys441Arg)	PRKN	C292R, C413R, C441R	Parkinson disease 2|not provided	Pathogenic(Last reviewed: Sep 2, 2019)	criteria provided, single submitter	VCV000963190	6	161771208	6	161350176	963190	944949	rs778305273	NC_000006.12:161350175:A:G
NM_004562.3(PRKN):c.594C>T (p.Ser198=)	PRKN		Parkinson disease 2	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000907231	6	162475147	6	162054115	907231	895659	rs1777760361	NC_000006.12:162054114:G:A
NM_004562.3(PRKN):c.600C>T (p.His200=)	PRKN		Parkinson disease 2	Uncertain significance(Last reviewed: Apr 28, 2017)	criteria provided, single submitter	VCV000907230	6	162475141	6	162054109	907230	895658	rs72480421	NC_000006.12:162054108:G:A
NM_004562.3(PRKN):c.614G>A (p.Ser205Asn)	PRKN	S205N	Parkinson disease 2	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000907229	6	162475127	6	162054095	907229	895657	rs200985148	NC_000006.12:162054094:C:T
NM_004562.3(PRKN):c.735-14C>G	PRKN		not provided|Parkinson disease 2	Conflicting interpretations of pathogenicity(Last reviewed: Nov 17, 2021)	criteria provided, conflicting interpretations	VCV000907228	6	162206954	6	161785922	907228	896213	rs200157467	NC_000006.12:161785921:G:C
NM_004562.3(PRKN):c.*106G>A	PRKN		Parkinson disease 2	Uncertain significance(Last reviewed: Apr 27, 2017)	criteria provided, single submitter	VCV000907166	6	161771025	6	161349993	907166	895646	rs573670651	NC_000006.12:161349992:C:T
NM_004562.3(PRKN):c.*121A>C	PRKN		Parkinson disease 2	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000907165	6	161771010	6	161349978	907165	895645	rs557142572	NC_000006.12:161349977:T:G
NM_004562.3(PRKN):c.*140A>G	PRKN		Parkinson disease 2	Uncertain significance(Last reviewed: Apr 28, 2017)	criteria provided, single submitter	VCV000907164	6	161770991	6	161349959	907164	895644	rs1182122095	NC_000006.12:161349958:T:C
NM_004562.3(PRKN):c.*320C>A	PRKN		not provided|Parkinson disease 2	Benign(Last reviewed: Oct 27, 2018)	criteria provided, multiple submitters, no conflicts	VCV000907163	6	161770811	6	161349779	907163	895643	rs71653628	NC_000006.12:161349778:G:T
NM_004562.3(PRKN):c.*1909G>A	PRKN		Parkinson disease 2	Likely benign(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000907101	6	161769222	6	161348190	907101	895631	rs148426411	NC_000006.12:161348189:C:T
NM_004562.3(PRKN):c.*1997G>A	PRKN		Parkinson disease 2	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000907100	6	161769134	6	161348102	907100	895630	rs75529362	NC_000006.12:161348101:C:T
NM_004562.3(PRKN):c.*2187C>T	PRKN		Parkinson disease 2	Likely benign(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000907099	6	161768944	6	161347912	907099	895629	rs116309008	NC_000006.12:161347911:G:A
NM_004562.3(PRKN):c.*2192G>A	PRKN		Parkinson disease 2	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000907098	6	161768939	6	161347907	907098	895628	rs1273156810	NC_000006.12:161347906:C:T
NM_004562.3(PRKN):c.-78C>A	PRKN|PACRG		Parkinson disease 2	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000906285	6	163148778	6	162727746	906285	895663	rs765761156	NC_000006.12:162727745:G:T
NM_004562.3(PRKN):c.814C>A (p.Leu272Ile)	PRKN	L244I, L123I, L272I	Parkinson disease 2|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Sep 15, 2021)	criteria provided, conflicting interpretations	VCV000906230	6	162206861	6	161785829	906230	895656	rs141366047	NC_000006.12:161785828:G:T
NM_004562.3(PRKN):c.892A>T (p.Ile298Phe)	PRKN	I149F, I270F, I298F	Parkinson disease 2	Uncertain significance(Last reviewed: Apr 27, 2017)	criteria provided, single submitter	VCV000906229	6	161990428	6	161569396	906229	895655	rs1273010274	NC_000006.12:161569395:T:A
NM_004562.3(PRKN):c.987C>T (p.Gly329=)	PRKN		Parkinson disease 2	Uncertain significance(Last reviewed: Apr 28, 2017)	criteria provided, single submitter	VCV000906228	6	161969982	6	161548950	906228	895654	rs768652293	NC_000006.12:161548949:G:A
NM_004562.3(PRKN):c.*433C>G	PRKN		Parkinson disease 2	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000906165	6	161770698	6	161349666	906165	895642	rs1784443204	NC_000006.12:161349665:G:C
NM_004562.3(PRKN):c.*623T>C	PRKN		Parkinson disease 2	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000906164	6	161770508	6	161349476	906164	895641	rs530999210	NC_000006.12:161349475:A:G
NM_004562.3(PRKN):c.*722G>A	PRKN		Parkinson disease 2	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000906163	6	161770409	6	161349377	906163	895640	rs1784435392	NC_000006.12:161349376:C:T
NM_004562.3(PRKN):c.*1102C>G	PRKN		Parkinson disease 2	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000906162	6	161770029	6	161348997	906162	895639	rs924908743	NC_000006.12:161348996:G:C
NM_004562.3(PRKN):c.*2214C>T	PRKN		Parkinson disease 2	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000906096	6	161768917	6	161347885	906096	895627	rs967885779	NC_000006.12:161347884:G:A
NM_004562.3(PRKN):c.*2232G>A	PRKN		Parkinson disease 2	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000906095	6	161768899	6	161347867	906095	895626	rs541135564	NC_000006.12:161347866:C:T
NM_004562.3(PRKN):c.*2259T>C	PRKN		Parkinson disease 2	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000906094	6	161768872	6	161347840	906094	895625	rs1163661606	NC_000006.12:161347839:A:G
NM_004562.3(PRKN):c.*2451G>A	PRKN		Parkinson disease 2	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000906093	6	161768680	6	161347648	906093	895624	rs371405899	NC_000006.12:161347647:C:T
NM_004562.3(PRKN):c.1041G>A (p.Gln347=)	PRKN		Parkinson disease 2	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000905718	6	161969928	6	161548896	905718	895653	rs766121894	NC_000006.12:161548895:C:T
NM_004562.3(PRKN):c.1056C>T (p.Cys352=)	PRKN		Parkinson disease 2	Uncertain significance(Last reviewed: Jan 15, 2018)	criteria provided, single submitter	VCV000905717	6	161969913	6	161548881	905717	895652	rs780996466	NC_000006.12:161548880:G:A
NM_004562.3(PRKN):c.1193C>T (p.Ala398Val)	PRKN	A249V, A370V, A398V	Parkinson disease 2	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000905716	6	161781212	6	161360180	905716	895651	rs1784919731	NC_000006.12:161360179:G:A
NM_004562.3(PRKN):c.*1158T>C	PRKN		Parkinson disease 2	Uncertain significance(Last reviewed: Mar 23, 2018)	criteria provided, single submitter	VCV000905653	6	161769973	6	161348941	905653	895638	rs1459030812	NC_000006.12:161348940:A:G
NM_004562.3(PRKN):c.*1243C>A	PRKN		Parkinson disease 2	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000905652	6	161769888	6	161348856	905652	895637	rs961026516	NC_000006.12:161348855:G:T
NM_004562.3(PRKN):c.*1383T>C	PRKN		Parkinson disease 2	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000905651	6	161769748	6	161348716	905651	895636	rs1289507934	NC_000006.12:161348715:A:G
NM_004562.3(PRKN):c.*2486C>A	PRKN		Parkinson disease 2	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000905587	6	161768645	6	161347613	905587	895623	rs867195540	NC_000006.12:161347612:G:T
NM_004562.3(PRKN):c.*2488A>G	PRKN		Parkinson disease 2	Uncertain significance(Last reviewed: Feb 2, 2018)	criteria provided, single submitter	VCV000905586	6	161768643	6	161347611	905586	895622	rs924577572	NC_000006.12:161347610:T:C
NM_004562.3(PRKN):c.*2518A>G	PRKN		Parkinson disease 2	Uncertain significance(Last reviewed: Apr 27, 2017)	criteria provided, single submitter	VCV000905585	6	161768613	6	161347581	905585	895621	rs16892479	NC_000006.12:161347580:T:C
NM_004562.3(PRKN):c.247A>G (p.Thr83Ala)	PRKN	T83A	Neoplasm of ovary|not provided|Parkinson disease 2	Uncertain significance(Last reviewed: Nov 3, 2021)	criteria provided, multiple submitters, no conflicts	VCV000903886	6	162683722	6	162262690	903886	895661	rs141825163	NC_000006.12:162262689:T:C
NM_004562.3(PRKN):c.255C>T (p.Gly85=)	PRKN		not provided|Parkinson disease 2	Uncertain significance(Last reviewed: Aug 3, 2021)	criteria provided, multiple submitters, no conflicts	VCV000903885	6	162683714	6	162262682	903885	895660	rs769477007	NC_000006.12:162262681:G:A
NM_004562.3(PRKN):c.1205G>A (p.Arg402His)	PRKN	R253H, R374H, R402H	Parkinson disease 2	Uncertain significance(Last reviewed: Nov 20, 2017)	criteria provided, single submitter	VCV000903817	6	161781200	6	161360168	903817	895650	rs766915327	NC_000006.12:161360167:C:T
NM_004562.3(PRKN):c.1366G>A (p.Val456Ile)	PRKN	V456I, V307I, V428I	not provided|Parkinson disease 2	Uncertain significance(Last reviewed: Aug 7, 2021)	criteria provided, multiple submitters, no conflicts	VCV000903816	6	161771163	6	161350131	903816	895649	rs755627153	NC_000006.12:161350130:C:T
NM_004562.3(PRKN):c.*60C>A	PRKN		Parkinson disease 2	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000903815	6	161771071	6	161350039	903815	895648	rs553007666	NC_000006.12:161350038:G:T
NM_004562.3(PRKN):c.*94A>G	PRKN		not provided|Parkinson disease 2	Benign/Likely benign(Last reviewed: Nov 28, 2020)	criteria provided, multiple submitters, no conflicts	VCV000903814	6	161771037	6	161350005	903814	895647	rs62637702	NC_000006.12:161350004:T:C
NM_004562.3(PRKN):c.*1407C>T	PRKN		Parkinson disease 2	Likely benign(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000903737	6	161769724	6	161348692	903737	895635	rs11961237	NC_000006.12:161348691:G:A
NM_004562.3(PRKN):c.*1500C>T	PRKN		Parkinson disease 2	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000903736	6	161769631	6	161348599	903736	895634	rs1784415095	NC_000006.12:161348598:G:A
NM_004562.3(PRKN):c.*1550A>G	PRKN		Parkinson disease 2	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000903735	6	161769581	6	161348549	903735	895633	rs567890129	NC_000006.12:161348548:T:C
NM_004562.3(PRKN):c.*1576C>T	PRKN		Parkinson disease 2	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000903734	6	161769555	6	161348523	903734	895632	rs1401264418	NC_000006.12:161348522:G:A
NM_004562.3(PRKN):c.110C>T (p.Pro37Leu)	PRKN	P37L	Parkinson disease 2|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Mar 1, 2020)	criteria provided, conflicting interpretations	VCV000871036	6	162864403	6	162443371	871036	859497	rs148990138	NC_000006.12:162443370:G:A
NM_004562.3(PRKN):c.337_376del (p.Pro113fs)	PRKN	P113fs	not provided|Parkinson disease 2|Young-onset Parkinson disease	Pathogenic/Likely pathogenic(Last reviewed: Dec 20, 2021)	criteria provided, multiple submitters, no conflicts	VCV000846957	6	162683593 - 162683632	6	162262561 - 162262600	846957	831746	rs771529549	NC_000006.12:162262560:CAGTGTGCAGAATGACAGCCAGCCCCACAGAGTCTCCTGG:
NM_004562.3(PRKN):c.701G>A (p.Arg234Gln)	PRKN	R234Q, R85Q, R206Q	not provided	Uncertain significance(Last reviewed: Oct 13, 2020)	criteria provided, single submitter	VCV000835347	6	162394367	6	161973335	835347	831744	rs144032774	NC_000006.12:161973334:C:T
NC_000006.12:g.(?_162201121)_(162201262_?)del	PRKN		not provided	Pathogenic(Last reviewed: Feb 25, 2019)	criteria provided, single submitter	VCV000831103	6	162622153 - 162622294			831103	819677		
NC_000006.12:g.(?_162262525)_(162275409_?)dup	PRKN		Parkinson disease 2	Pathogenic(Last reviewed: Jul 29, 2019)	criteria provided, single submitter	VCV000830820	6	162683557 - 162696441			830820	819680		
NM_004562.3(PRKN):c.220_221dup (p.Trp74fs)	PRKN	W74fs	not provided|Parkinson disease 2	Pathogenic/Likely pathogenic(Last reviewed: Oct 21, 2021)	criteria provided, multiple submitters, no conflicts	VCV000817926	6	162683747 - 162683748	6	162262715 - 162262716	817926	805490	rs746646126	NC_000006.12:162262715:CAC:CACAC
NM_004562.3(PRKN):c.1301T>C (p.Met434Thr)	PRKN	M285T, M406T, M434T	Parkinson disease 2	Likely pathogenic(Last reviewed: Nov 22, 2019)	criteria provided, single submitter	VCV000810783	6	161771228	6	161350196	810783	799032	rs1582953433	NC_000006.12:161350195:A:G
NM_004562.3(PRKN):c.101del (p.Gln34fs)	PRKN	Q34fs	Parkinson disease 2	Pathogenic(Last reviewed: Aug 1, 2019)	no assertion criteria provided	VCV000810636	6	162864412	6	162443380	810636	798915	rs748142049	NC_000006.12:162443379:T:
NM_004562.3(PRKN):c.174T>C (p.Asn58=)	PRKN		Parkinson disease 2|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Aug 17, 2018)	criteria provided, conflicting interpretations	VCV000701646	6	162683795	6	162262763	701646	686815	rs536687809	NC_000006.12:162262762:A:G
NM_004562.3(PRKN):c.531C>A (p.Thr177=)	PRKN		Parkinson disease 2|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Dec 23, 2020)	criteria provided, conflicting interpretations	VCV000696404	6	162622166	6	162201134	696404	683771	rs140590552	NC_000006.12:162201133:G:T
NM_004562.3(PRKN):c.517A>G (p.Thr173Ala)	PRKN	T173A	not provided|Parkinson disease 2	Uncertain significance(Last reviewed: Oct 2, 2018)	criteria provided, single submitter	VCV000659916	6	162622180	6	162201148	659916	634771	rs749094429	NC_000006.12:162201147:T:C
NC_000006.11:g.(?_162206794)_(162206950_?)dup	PRKN		not provided	Pathogenic(Last reviewed: Nov 11, 2019)	criteria provided, single submitter	VCV000657369	6	162206794 - 162206950	6	161785762 - 161785918	657369	651489		
NM_004562.3(PRKN):c.1019G>A (p.Gly340Glu)	PRKN	G312E, G191E, G340E	not provided|Parkinson disease 2	Uncertain significance(Last reviewed: Sep 6, 2018)	criteria provided, single submitter	VCV000655063	6	161969950	6	161548918	655063	634764	rs1318163167	NC_000006.12:161548917:C:T
NC_000006.11:g.(?_162622153)_(162683807_?)dup	PRKN		not provided	Uncertain significance(Last reviewed: Nov 29, 2018)	criteria provided, single submitter	VCV000651253	6	162622153 - 162683807	6	162201121 - 162262775	651253	651586		
NM_004562.3(PRKN):c.799T>C (p.Tyr267His)	PRKN	Y239H, Y118H, Y267H	not provided|Parkinson disease 2	Uncertain significance(Last reviewed: Feb 12, 2020)	criteria provided, single submitter	VCV000649511	6	162206876	6	161785844	649511	634766	rs114696251	NC_000006.12:161785843:A:G
NM_004562.3(PRKN):c.300G>C (p.Gln100His)	PRKN	Q100H	not provided|Parkinson disease 2	Uncertain significance(Last reviewed: Oct 10, 2018)	criteria provided, single submitter	VCV000648034	6	162683669	6	162262637	648034	634773	rs1256316516	NC_000006.12:162262636:C:G
NM_004562.3(PRKN):c.758G>A (p.Cys253Tyr)	PRKN	C253Y, C104Y, C225Y	Parkinson disease 2|not provided	Pathogenic(Last reviewed: Dec 1, 2021)	criteria provided, multiple submitters, no conflicts	VCV000645725	6	162206917	6	161785885	645725	634768	rs747427602	NC_000006.12:161785884:C:T
NM_004562.3(PRKN):c.125G>C (p.Arg42Pro)	PRKN	R42P	Parkinson disease 2|not provided	Pathogenic(Last reviewed: Dec 4, 2019)	criteria provided, single submitter	VCV000644125	6	162864388	6	162443356	644125	634774	rs368134308	NC_000006.12:162443355:C:G
NC_000006.11:g.(?_162206784)_(162206960_?)dup	PRKN		Parkinson disease 2	Pathogenic(Last reviewed: Aug 6, 2018)	criteria provided, single submitter	VCV000639364	6	162206784 - 162206960	6	161785752 - 161785928	639364	651540		
NC_000006.11:g.(?_162394314)_(162475226_?)dup	PRKN		Parkinson disease 2	Pathogenic(Last reviewed: Aug 3, 2018)	criteria provided, single submitter	VCV000583917	6	162394314 - 162475226	6	161973282 - 162054194	583917	560506		
NC_000006.12:g.(?_161569335)_(161569436_?)del	PRKN		not provided|Parkinson disease 2	Pathogenic(Last reviewed: Feb 21, 2018)	criteria provided, single submitter	VCV000583674	6	161990367 - 161990468	6	161569335 - 161569436	583674	560399		
NC_000006.11:g.(?_162683537)_(162683817_?)dup	PRKN		not provided|Parkinson disease 2	Pathogenic/Likely pathogenic(Last reviewed: Sep 20, 2021)	criteria provided, single submitter	VCV000583519	6	162683537 - 162683817	6	162262505 - 162262785	583519	560508		
NC_000006.11:g.(?_161969866)_(161970055_?)dup	PRKN		Parkinson disease 2	Uncertain significance(Last reviewed: Mar 6, 2018)	criteria provided, single submitter	VCV000583484	6	161969866 - 161970055	6	161548834 - 161549023	583484	563258		
NC_000006.11:g.(?_162683537)_(162864525_?)dup	PRKN		not provided|Parkinson disease 2	Uncertain significance(Last reviewed: Dec 9, 2021)	criteria provided, single submitter	VCV000583436	6	162683537 - 162864525	6	162262505 - 162443493	583436	563260		
NM_004562.3(PRKN):c.686T>C (p.Ile229Thr)	PRKN	I229T, I80T, I201T	not provided|Parkinson disease 2	Uncertain significance(Last reviewed: Apr 12, 2018)	criteria provided, single submitter	VCV000579186	6	162394382	6	161973350	579186	563480	rs1562430302	NC_000006.12:161973349:A:G
NM_004562.3(PRKN):c.838G>A (p.Asp280Asn)	PRKN	D280N, D252N, D131N	Parkinson disease 2|not provided	Uncertain significance(Last reviewed: Aug 31, 2021)	criteria provided, multiple submitters, no conflicts	VCV000579080	6	162206837	6	161785805	579080	565509	rs72480422	NC_000006.12:161785804:C:T
NM_004562.3(PRKN):c.98G>A (p.Arg33Gln)	PRKN	R33Q	not provided|Parkinson disease 2|Young-onset Parkinson disease	Pathogenic/Likely pathogenic(Last reviewed: May 3, 2021)	criteria provided, multiple submitters, no conflicts	VCV000578186	6	162864415	6	162443383	578186	560658	rs147757966	NC_000006.12:162443382:C:T
NM_004562.3(PRKN):c.930G>C (p.Glu310Asp)	PRKN	E310D, E161D, E282D	Parkinson disease 2|not provided	Uncertain significance(Last reviewed: Mar 9, 2018)	criteria provided, multiple submitters, no conflicts	VCV000577057	6	161990390	6	161569358	577057	565508	rs72480423	NC_000006.12:161569357:C:G
NM_004562.3(PRKN):c.766C>T (p.Arg256Cys)	PRKN	R256C, R107C, R228C	not provided|Parkinson disease 2|Neoplasm of ovary	Uncertain significance(Last reviewed: Nov 3, 2021)	criteria provided, multiple submitters, no conflicts	VCV000574874	6	162206909	6	161785877	574874	560656	rs150562946	NC_000006.12:161785876:G:A
NM_004562.3(PRKN):c.988G>A (p.Val330Met)	PRKN	V330M, V302M, V181M	not provided|Parkinson disease 2	Uncertain significance(Last reviewed: Sep 15, 2021)	criteria provided, single submitter	VCV000574344	6	161969981	6	161548949	574344	560501	rs749768565	NC_000006.12:161548948:C:T
NM_004562.3(PRKN):c.734+1G>A	PRKN		not provided|Parkinson disease 2	Likely pathogenic(Last reviewed: Jun 19, 2018)	criteria provided, single submitter	VCV000571536	6	162394333	6	161973301	571536	565522	rs1562430103	NC_000006.12:161973300:C:T
NM_004562.3(PRKN):c.1117C>A (p.His373Asn)	PRKN	H373N, H224N, H345N	Parkinson disease 2|not provided	Uncertain significance(Last reviewed: Apr 4, 2018)	criteria provided, single submitter	VCV000567796	6	161807876	6	161386844	567796	560654	rs1240306663	NC_000006.12:161386843:G:T
Single allele	PRKN		Parkinson disease 2	Likely pathogenic(Last reviewed: Mar 1, 2018)	criteria provided, single submitter	VCV000560128	6	162621943 - 162941426	6	162200911 - 162520394	560128	550844		
NC_000006.12:g.(?_161785752)_(161973437_?)del	PRKN		Parkinson disease 2|not provided	Pathogenic(Last reviewed: Nov 14, 2017)	criteria provided, single submitter	VCV000536459	6	162206784 - 162394469	6	161785752 - 161973437	536459	521887		
NM_004562.3(PRKN):c.155del (p.Asn52fs)	PRKN	N52fs	Parkinson disease 2|Young-onset Parkinson disease|not provided	Pathogenic(Last reviewed: Jul 27, 2021)	criteria provided, multiple submitters, no conflicts	VCV000536457	6	162864358	6	162443326	536457	521494	rs754809877	NC_000006.12:162443325:TT:T
NM_004562.3(PRKN):c.1A>G (p.Met1Val)	PRKN|PACRG	M1V	not provided|Young-onset Parkinson disease	Likely pathogenic(Last reviewed: May 3, 2021)	criteria provided, multiple submitters, no conflicts	VCV000493448	6	163148700	6	162727668	493448	486411	rs772786691	NC_000006.12:162727667:T:C
NM_004562.3(PRKN):c.8-14A>G	PRKN		not provided|Parkinson disease 2	Uncertain significance(Last reviewed: Sep 4, 2018)	criteria provided, single submitter	VCV000468589	6	162864519	6	162443487	468589	456276	rs769722629	NC_000006.12:162443486:T:C
NM_004562.3(PRKN):c.730G>A (p.Val244Ile)	PRKN	V244I, V216I, V95I	not provided|Parkinson disease 2	Uncertain significance(Last reviewed: Sep 1, 2021)	criteria provided, single submitter	VCV000468588	6	162394338	6	161973306	468588	455450	rs771259513	NC_000006.12:161973305:C:T
NM_004562.3(PRKN):c.458C>G (p.Pro153Arg)	PRKN	P153R	not provided|Parkinson disease 2	Benign/Likely benign(Last reviewed: Dec 31, 2019)	criteria provided, multiple submitters, no conflicts	VCV000468587	6	162622239	6	162201207	468587	455455	rs55654276	NC_000006.12:162201206:G:C
NM_004562.3(PRKN):c.136G>A (p.Ala46Thr)	PRKN	A46T	not provided|Parkinson disease 2	Benign/Likely benign(Last reviewed: Nov 27, 2020)	criteria provided, multiple submitters, no conflicts	VCV000468586	6	162864377	6	162443345	468586	456269	rs75860381	NC_000006.12:162443344:C:T
NM_004562.3(PRKN):c.1330G>C (p.Glu444Gln)	PRKN	E444Q, E416Q, E295Q	not provided|Parkinson disease 2	Uncertain significance(Last reviewed: Jan 23, 2017)	criteria provided, single submitter	VCV000468585	6	161771199	6	161350167	468585	455430	rs772592654	NC_000006.12:161350166:C:G
NM_004562.3(PRKN):c.101A>G (p.Gln34Arg)	PRKN	Q34R	not provided|not specified|Parkinson disease 2	Benign/Likely benign(Last reviewed: Nov 12, 2020)	criteria provided, multiple submitters, no conflicts	VCV000468584	6	162864412	6	162443380	468584	455534	rs148851677	NC_000006.12:162443379:T:C
NM_004562.3(PRKN):c.1001G>A (p.Arg334His)	PRKN	R334H, R185H, R306H	not provided|Parkinson disease 2	Uncertain significance(Last reviewed: Jun 22, 2017)	criteria provided, single submitter	VCV000468583	6	161969968	6	161548936	468583	456260	rs746215864	NC_000006.12:161548935:C:T
NC_000006.11:g.(?_162864322)_(162864525_?)dup	PRKN		not provided|Parkinson disease 2	Pathogenic(Last reviewed: Dec 3, 2021)	criteria provided, single submitter	VCV000468582	6	162864322 - 162864525	6	162443290 - 162443493	468582	455272		
NC_000006.12:g.(?_162262505)_(162443493_?)del	PRKN		not provided|Parkinson disease 2	Pathogenic(Last reviewed: Aug 12, 2021)	criteria provided, single submitter	VCV000468581	6	162683537 - 162864525	6	162262505 - 162443493	468581	455116		
NC_000006.12:g.(?_162262505)_(162262785_?)del	PRKN		not provided|Parkinson disease 2	Pathogenic(Last reviewed: Dec 11, 2021)	criteria provided, single submitter	VCV000468580	6	162683537 - 162683817	6	162262505 - 162262785	468580	455271		
NC_000006.12:g.(?_162201111)_(162262785_?)del	PRKN		not provided|Parkinson disease 2	Pathogenic(Last reviewed: Nov 5, 2021)	criteria provided, single submitter	VCV000468579	6	162622143 - 162683817	6	162201111 - 162262785	468579	455998		
NC_000006.12:g.(?_162201111)_(162201272_?)del	PRKN		not provided|Parkinson disease 2	Pathogenic(Last reviewed: Dec 9, 2021)	criteria provided, single submitter	VCV000468578	6	162622143 - 162622304	6	162201111 - 162201272	468578	455265		
NM_004562.3(PRKN):c.919C>T (p.Leu307=)	PRKN		not provided|Parkinson disease 2	Conflicting interpretations of pathogenicity(Last reviewed: Dec 31, 2019)	criteria provided, conflicting interpretations	VCV000444707	6	161990401	6	161569369	444707	438347	rs138920699	NC_000006.12:161569368:G:A
NM_004562.3(PRKN):c.101_102del (p.Gln34fs)	PRKN	Q34fs	Young-onset Parkinson disease|Parkinson disease 2|not provided	Pathogenic(Last reviewed: Jan 20, 2022)	criteria provided, multiple submitters, no conflicts	VCV000425403	6	162864411 - 162864412	6	162443379 - 162443380	425403	413737	rs55777503	NC_000006.12:162443378:CT:
NM_004562.3(PRKN):c.1204C>T (p.Arg402Cys)	PRKN	R402C, R253C, R374C	Parkinson disease 2|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Oct 27, 2020)	criteria provided, conflicting interpretations	VCV000425402	6	161781201	6	161360169	425402	413736	rs55830907	NC_000006.12:161360168:G:A
NM_004562.3(PRKN):c.535-9T>A	PRKN		not provided|Parkinson disease 2	Conflicting interpretations of pathogenicity(Last reviewed: Nov 27, 2020)	criteria provided, conflicting interpretations	VCV000420046	6	162475215	6	162054183	420046	406849	rs201039350	NC_000006.12:162054182:A:T
NC_000006.12:g.(?_162054091)_(162054174_?)del	PRKN		Parkinson disease 2	Pathogenic(Last reviewed: Sep 23, 2016)	criteria provided, single submitter	VCV000417464	6	162475123 - 162475206	6	162054091 - 162054174	417464	395171		
NC_000006.11:g.(?_162622163)_(162622284_?)dup	PRKN		Parkinson disease 2	Uncertain significance(Last reviewed: Dec 8, 2016)	criteria provided, single submitter	VCV000417461	6	162622163 - 162622284	6	162201131 - 162201252	417461	394998		
NC_000006.12:g.(?_162201131)_(162443473_?)del	PRKN		Parkinson disease 2	Pathogenic(Last reviewed: Nov 12, 2016)	criteria provided, single submitter	VCV000417459	6	162622163 - 162864505	6	162201131 - 162443473	417459	395641		
NM_004562.3(PRKN):c.957T>C (p.Gly319=)	PRKN		not provided|Parkinson disease 2	Benign/Likely benign(Last reviewed: Oct 3, 2020)	criteria provided, multiple submitters, no conflicts	VCV000415532	6	161970012	6	161548980	415532	395226	rs144340740	NC_000006.12:161548979:A:G
NM_004562.3(PRKN):c.574A>C (p.Met192Leu)	PRKN	M192L	not provided|Parkinson disease 2|not specified	Benign(Last reviewed: Nov 17, 2020)	criteria provided, multiple submitters, no conflicts	VCV000415531	6	162475167	6	162054135	415531	395426	rs9456735	NC_000006.12:162054134:T:G
NM_004562.3(PRKN):c.172-9C>G	PRKN		not provided|Parkinson disease 2	Uncertain significance(Last reviewed: Sep 26, 2016)	criteria provided, single submitter	VCV000409271	6	162683806	6	162262774	409271	395080	rs758769558	NC_000006.12:162262773:G:C
NM_004562.3(PRKN):c.689C>T (p.Ala230Val)	PRKN	A230V, A202V, A81V	not provided|Parkinson disease 2	Uncertain significance(Last reviewed: Jul 29, 2016)	criteria provided, single submitter	VCV000409270	6	162394379	6	161973347	409270	395227	rs571490973	NC_000006.12:161973346:G:A
NM_004562.3(PRKN):c.443T>A (p.Val148Glu)	PRKN	V148E	not provided|Parkinson disease 2	Uncertain significance(Last reviewed: Apr 29, 2016)	criteria provided, single submitter	VCV000409269	6	162622254	6	162201222	409269	395079	rs1060502319	NC_000006.12:162201221:A:T
NM_004562.3(PRKN):c.125G>A (p.Arg42His)	PRKN	R42H	not provided|Parkinson disease 2	Uncertain significance(Last reviewed: Feb 25, 2020)	criteria provided, multiple submitters, no conflicts	VCV000409268	6	162864388	6	162443356	409268	395228	rs368134308	NC_000006.12:162443355:C:T
NM_004562.3(PRKN):c.761A>G (p.Asn254Ser)	PRKN	N254S, N226S, N105S	Parkinson disease 2|not provided	Uncertain significance(Last reviewed: Jun 13, 2018)	criteria provided, multiple submitters, no conflicts	VCV000409267	6	162206914	6	161785882	409267	395420	rs139600787	NC_000006.12:161785881:T:C
NM_004562.3(PRKN):c.111G>A (p.Pro37=)	PRKN		not specified|not provided|Parkinson disease 2	Benign(Last reviewed: Apr 22, 2021)	criteria provided, multiple submitters, no conflicts	VCV000356020	6	162864402	6	162443370	356020	306809	rs77795533	NC_000006.12:162443369:C:T
NM_004562.3(PRKN):c.522C>T (p.Leu174=)	PRKN		not provided|Parkinson disease 2	Conflicting interpretations of pathogenicity(Last reviewed: Feb 1, 2021)	criteria provided, conflicting interpretations	VCV000356019	6	162622175	6	162201143	356019	302128	rs147121590	NC_000006.12:162201142:G:A
NM_004562.3(PRKN):c.706A>G (p.Ile236Val)	PRKN	I236V, I87V, I208V	Parkinson disease 2	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000356018	6	162394362	6	161973330	356018	302116	rs886061238	NC_000006.12:161973329:T:C
NM_004562.3(PRKN):c.783A>G (p.Leu261=)	PRKN		not provided|Parkinson disease 2	Benign/Likely benign(Last reviewed: Nov 18, 2020)	criteria provided, multiple submitters, no conflicts	VCV000356017	6	162206892	6	161785860	356017	299590	rs9456711	NC_000006.12:161785859:T:C
NM_004562.3(PRKN):c.1289G>A (p.Gly430Asp)	PRKN	G430D, G281D, G402D	not provided|Parkinson disease 2|Young-onset Parkinson disease	Pathogenic/Likely pathogenic(Last reviewed: May 3, 2021)	criteria provided, multiple submitters, no conflicts	VCV000356016	6	161771240	6	161350208	356016	306532	rs191486604	NC_000006.12:161350207:C:T
NM_004562.3(PRKN):c.1213G>A (p.Ala405Thr)	PRKN	A405T, A256T, A377T	Parkinson disease 2	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000356015	6	161781192	6	161360160	356015	299589	rs886061237	NC_000006.12:161360159:C:T
NM_004562.3(PRKN):c.1364G>A (p.Arg455His)	PRKN	R455H, R306H, R427H	not provided|Parkinson disease 2	Uncertain significance(Last reviewed: Mar 6, 2020)	criteria provided, multiple submitters, no conflicts	VCV000356014	6	161771165	6	161350133	356014	302111	rs748955949	NC_000006.12:161350132:C:T
NM_004562.3(PRKN):c.*15C>A	PRKN		Parkinson disease 2	Likely benign(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000356013	6	161771116	6	161350084	356013	299583	rs35125035	NC_000006.12:161350083:G:T
NM_004562.3(PRKN):c.*98G>A	PRKN		Parkinson disease 2	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000356012	6	161771033	6	161350001	356012	306808	rs771094906	NC_000006.12:161350000:C:T
NM_004562.3(PRKN):c.*108AC[5]	PRKN		Parkinson Disease, Juvenile	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000356011	6	161771015 - 161771016	6	161349983 - 161349984	356011	302108	rs575581029	NC_000006.12:161349983:GTGTGTGTG:GTGTGTGTGTG
NM_004562.3(PRKN):c.*301G>C	PRKN		Parkinson disease 2	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000356010	6	161770830	6	161349798	356010	306531	rs576586040	NC_000006.12:161349797:C:G
NM_004562.3(PRKN):c.*314C>A	PRKN		Parkinson disease 2	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000356009	6	161770817	6	161349785	356009	299582	rs886061236	NC_000006.12:161349784:G:T
NM_004562.3(PRKN):c.*372C>G	PRKN		Parkinson disease 2	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000356008	6	161770759	6	161349727	356008	302107	rs764753874	NC_000006.12:161349726:G:C
NM_004562.3(PRKN):c.*472T>C	PRKN		Parkinson disease 2	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000356007	6	161770659	6	161349627	356007	302104	rs886061235	NC_000006.12:161349626:A:G
NM_004562.3(PRKN):c.*652C>T	PRKN		Parkinson disease 2	Benign(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000356006	6	161770479	6	161349447	356006	299579	rs71653629	NC_000006.12:161349446:G:A
NM_004562.3(PRKN):c.*820A>T	PRKN		Parkinson disease 2	Benign(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000356005	6	161770311	6	161349279	356005	302102	rs74701717	NC_000006.12:161349278:T:A
NM_004562.3(PRKN):c.*887_*890del	PRKN		Parkinson Disease, Juvenile	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000356004	6	161770241 - 161770244	6	161349209 - 161349212	356004	306800	rs572345942	NC_000006.12:161349208:TATCTAT:TAT
NM_004562.3(PRKN):c.*1016C>T	PRKN		Parkinson disease 2	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000356003	6	161770115	6	161349083	356003	302101	rs886061234	NC_000006.12:161349082:G:A
NM_004562.3(PRKN):c.*1024TC[2]	PRKN		Parkinson Disease, Juvenile	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000356002	6	161770102 - 161770103	6	161349070 - 161349071	356002	306529	rs886061233	NC_000006.12:161349069:GAGAGAG:GAGAG
NM_004562.3(PRKN):c.*1156C>G	PRKN		Parkinson disease 2	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000356001	6	161769975	6	161348943	356001	306528	rs886061232	NC_000006.12:161348942:G:C
NM_004562.3(PRKN):c.*1252C>T	PRKN		Parkinson disease 2	Likely benign(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000356000	6	161769879	6	161348847	356000	299576	rs77926621	NC_000006.12:161348846:G:A
NM_004562.3(PRKN):c.*1281C>T	PRKN		Parkinson disease 2	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000355999	6	161769850	6	161348818	355999	306524	rs571904443	NC_000006.12:161348817:G:A
NM_004562.3(PRKN):c.*1296A>G	PRKN		Parkinson disease 2	Benign(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000355998	6	161769835	6	161348803	355998	302100	rs3734464	NC_000006.12:161348802:T:C
NM_004562.3(PRKN):c.*1386A>G	PRKN		Parkinson disease 2	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000355997	6	161769745	6	161348713	355997	306792	rs140107485	NC_000006.12:161348712:T:C
NM_004562.3(PRKN):c.*1462C>A	PRKN		Parkinson disease 2	Likely benign(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000355996	6	161769669	6	161348637	355996	302095	rs11961229	NC_000006.12:161348636:G:T
NM_004562.3(PRKN):c.*1470G>A	PRKN		Parkinson disease 2	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000355995	6	161769661	6	161348629	355995	306785	rs886061231	NC_000006.12:161348628:C:T
NM_004562.3(PRKN):c.*1601G>A	PRKN		Parkinson disease 2	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000355994	6	161769530	6	161348498	355994	306523	rs779851186	NC_000006.12:161348497:C:T
NM_004562.3(PRKN):c.*1685A>G	PRKN		Parkinson disease 2	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000355993	6	161769446	6	161348414	355993	302094	rs187134044	NC_000006.12:161348413:T:C
NM_004562.3(PRKN):c.*1694C>T	PRKN		Parkinson disease 2	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000355992	6	161769437	6	161348405	355992	306784	rs16892481	NC_000006.12:161348404:G:A
NM_004562.3(PRKN):c.*1695G>A	PRKN		Parkinson disease 2	Likely benign(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000355991	6	161769436	6	161348404	355991	302087	rs77283740	NC_000006.12:161348403:C:T
NM_004562.3(PRKN):c.*2021G>A	PRKN		Parkinson disease 2	Benign(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000355990	6	161769110	6	161348078	355990	299575	rs1122470	NC_000006.12:161348077:C:T
NM_004562.3(PRKN):c.*2022T>C	PRKN		Parkinson disease 2	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000355989	6	161769109	6	161348077	355989	299567	rs886061230	NC_000006.12:161348076:A:G
NM_004562.3(PRKN):c.*2194G>A	PRKN		Parkinson disease 2	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000355988	6	161768937	6	161347905	355988	306783	rs149239597	NC_000006.12:161347904:C:T
NM_004562.3(PRKN):c.*2217G>A	PRKN		Parkinson disease 2	Likely benign(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000355987	6	161768914	6	161347882	355987	299566	rs138660139	NC_000006.12:161347881:C:T
NM_004562.3(PRKN):c.*2354C>T	PRKN		Parkinson disease 2	Likely benign(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000355986	6	161768777	6	161347745	355986	299558	rs191130749	NC_000006.12:161347744:G:A
NM_004562.3(PRKN):c.*2363C>A	PRKN		Parkinson Disease, Juvenile	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000355985	6	161768768	6	161347736	355985	302086	rs12215447	NC_000006.12:161347735:G:T
NM_004562.3(PRKN):c.*2443A>G	PRKN		Parkinson disease 2	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000355984	6	161768688	6	161347656	355984	299552	rs886061229	NC_000006.12:161347655:T:C
NM_004562.3(PRKN):c.*2474A>C	PRKN		Parkinson disease 2	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000355983	6	161768657	6	161347625	355983	306775	rs886061228	NC_000006.12:161347624:T:G
NM_004562.3(PRKN):c.*2475A>C	PRKN		Parkinson disease 2	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000355982	6	161768656	6	161347624	355982	306507	rs868117815	NC_000006.12:161347623:T:G
NM_004562.3(PRKN):c.*2480C>A	PRKN		Parkinson disease 2	Benign(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000355981	6	161768651	6	161347619	355981	306772	rs68121389	NC_000006.12:161347618:G:T
NM_004562.3(PRKN):c.*2492A>G	PRKN		Parkinson disease 2	Benign(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000355980	6	161768639	6	161347607	355980	306771	rs117341007	NC_000006.12:161347606:T:C
NM_004562.3(PRKN):c.*2524CA[1]	PRKN		Parkinson Disease, Juvenile	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000355979	6	161768604 - 161768605	6	161347572 - 161347573	355979	299551	rs761920927	NC_000006.12:161347571:TGTG:TG
NM_004562.3(PRKN):c.48G>A (p.Glu16=)	PRKN		Parkinson disease 2|not specified|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Dec 8, 2019)	criteria provided, conflicting interpretations	VCV000289182	6	162864465	6	162443433	289182	273419	rs143477190	NC_000006.12:162443432:C:T
NM_004562.3(PRKN):c.1310C>T (p.Pro437Leu)	PRKN	P437L, P409L, P288L	Parkinson disease 2|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Nov 1, 2021)	criteria provided, conflicting interpretations	VCV000283504	6	161771219	6	161350187	283504	267741	rs149953814	NC_000006.12:161350186:G:A
NM_004562.3(PRKN):c.1000C>T (p.Arg334Cys)	PRKN	R334C, R306C, R185C	Parkinson disease 2|not specified|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Oct 19, 2021)	criteria provided, conflicting interpretations	VCV000281504	6	161969969	6	161548937	281504	265741	rs199657839	NC_000006.12:161548936:G:A
NM_004562.3(PRKN):c.1292G>T (p.Cys431Phe)	PRKN	C431F, C403F, C282F	Parkinson disease 2	Pathogenic(Last reviewed: Aug 1, 2000)	no assertion criteria provided	VCV000050354	6	161771237	6	161350205	50354	59479	rs397514694	NC_000006.12:161350204:C:A
NM_004562.3(PRKN):c.500G>A (p.Ser167Asn)	PRKN	S167N	Parkinson disease 2|not specified|not provided	Benign(Last reviewed: Dec 7, 2020)	criteria provided, multiple submitters, no conflicts	VCV000041223	6	162622197	6	162201165	41223	49647	rs1801474	NC_000006.12:162201164:C:T
NM_004562.3(PRKN):c.1180G>A (p.Asp394Asn)	PRKN	D394N, D245N, D366N	Parkinson disease 2|not specified|not provided	Benign(Last reviewed: Dec 4, 2020)	criteria provided, multiple submitters, no conflicts	VCV000041222	6	161781225	6	161360193	41222	49646	rs1801334	NC_000006.12:161360192:C:T
NM_004562.3(PRKN):c.1138G>C (p.Val380Leu)	PRKN	V380L, V352L, V231L	Parkinson disease 2|not provided|not specified	Benign(Last reviewed: Dec 6, 2020)	criteria provided, multiple submitters, no conflicts	VCV000041221	6	161807855	6	161386823	41221	49645	rs1801582	NC_000006.12:161386822:C:G
NM_004562.3(PRKN):c.1096C>T (p.Arg366Trp)	PRKN	R366W, R217W, R338W	not provided|Parkinson disease 2	Benign/Likely benign(Last reviewed: Nov 14, 2020)	criteria provided, multiple submitters, no conflicts	VCV000041220	6	161807897	6	161386865	41220	49644	rs56092260	NC_000006.12:161386864:G:A
PARK2, EX5-6DEL	PRKN		Parkinson disease 2	Pathogenic(Last reviewed: Feb 1, 2006)	no assertion criteria provided	VCV000007055					7055	22094		
NM_004562.3(PRKN):c.719C>T (p.Thr240Met)	PRKN	T240M, T212M, T91M	Neoplasm of ovary|Parkinson disease 2|not provided|Young-onset Parkinson disease	Conflicting interpretations of pathogenicity(Last reviewed: Aug 18, 2021)	criteria provided, conflicting interpretations	VCV000007054	6	162394349	6	161973317	7054	22093	rs137853054	NC_000006.12:161973316:G:A
PARK2, 1-BP DEL, 1072T	PRKN		Parkinson disease 2	Pathogenic(Last reviewed: Sep 1, 2005)	no assertion criteria provided	VCV000007052					7052	22091		
NM_004562.3(PRKN):c.633A>T (p.Lys211Asn)	PRKN	K211N, K62N, K183N	Parkinson disease 2|not provided	Pathogenic(Last reviewed: Nov 14, 2021)	criteria provided, single submitter	VCV000007051	6	162394435	6	161973403	7051	22090	rs137853060	NC_000006.12:161973402:T:A
NM_004562.3(PRKN):c.823C>T (p.Arg275Trp)	PRKN	R275W, R126W, R247W	Neoplasm of ovary|Lung carcinoma|Leprosy 2|Parkinson disease 2|not provided|Young-onset Parkinson disease|See cases|Parkinson disease 2	Pathogenic(Last reviewed: Oct 13, 2021)	criteria provided, multiple submitters, no conflicts	VCV000007050	6	162206852	6	161785820	7050	22089	rs34424986	NC_000006.12:161785819:G:A
PARK2, 1-BP DEL, 255A	PRKN		Parkinson disease 2	Pathogenic(Last reviewed: Jun 1, 2002)	no assertion criteria provided	VCV000007048					7048	22087		
NM_004562.3(PRKN):c.167T>A (p.Val56Glu)	PRKN	V56E	Parkinson disease 2|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Jan 7, 2022)	criteria provided, conflicting interpretations	VCV000007047	6	162864346	6	162443314	7047	22086	rs137853059	NC_000006.12:162443313:A:T
NM_004562.3(PRKN):c.635G>A (p.Cys212Tyr)	PRKN	C212Y, C184Y, C63Y	Parkinson disease 2|not provided	Pathogenic(Last reviewed: Jan 2, 2020)	criteria provided, single submitter	VCV000007046	6	162394433	6	161973401	7046	22085	rs137853058	NC_000006.12:161973400:C:T
NM_004562.2(PRKN):c.735-?_871+?del	PRKN		Parkinson disease 2	Pathogenic(Last reviewed: Sep 1, 2005)	no assertion criteria provided	VCV000007045	6	162206804 - 162206940	6	161785772 - 161785908	7045	22084		
PARK2, 1-BP DEL, 202A	PRKN		Parkinson disease 2	Pathogenic(Last reviewed: Apr 22, 2003)	no assertion criteria provided	VCV000007044					7044	22083		
NM_004562.3(PRKN):c.483A>T (p.Lys161Asn)	PRKN	K161N	Parkinson disease 2	Pathogenic(Last reviewed: Sep 1, 2005)	no assertion criteria provided	VCV000007043	6	162622214	6	162201182	7043	22082	rs137853057	NC_000006.12:162201181:T:A
NM_004562.3(PRKN):c.1358G>A (p.Trp453Ter)	PRKN	W453*, W304*, W425*	not provided|Parkinson disease 2	Likely pathogenic(Last reviewed: Jun 1, 2018)	criteria provided, single submitter	VCV000007042	6	161771171	6	161350139	7042	22081	rs137853056	NC_000006.12:161350138:C:T
NM_004562.2(PRKN):c.872-?_1083+?del	PRKN		Parkinson disease 2	Pathogenic(Last reviewed: Oct 24, 1998)	no assertion criteria provided	VCV000007041	6	161969886 - 161990448	6	161548854 - 161569416	7041	22080		
NM_004562.2(PRKN):c.8-?_171+?del	PRKN		Parkinson disease 2	Pathogenic(Last reviewed: Dec 4, 2019)	criteria provided, single submitter	VCV000007040	6	162864342 - 162864505	6	162443310 - 162443473	7040	22079		
NM_004562.3(PRKN):c.245C>A (p.Ala82Glu)	PRKN	A82E	not specified|not provided|Parkinson disease 2	Conflicting interpretations of pathogenicity(Last reviewed: Mar 1, 2022)	criteria provided, conflicting interpretations	VCV000007038	6	162683724	6	162262692	7038	22077	rs55774500	NC_000006.12:162262691:G:T
NM_004562.3(PRKN):c.931C>T (p.Gln311Ter)	PRKN	Q311*, Q162*, Q283*	Parkinson disease 2	Pathogenic(Last reviewed: Sep 1, 2005)	no assertion criteria provided	VCV000007037	6	161990389	6	161569357	7037	22076	rs137853055	NC_000006.12:161569356:G:A
NM_004562.3(PRKN):c.719C>G (p.Thr240Arg)	PRKN	T240R, T212R, T91R	Parkinson disease 2	Pathogenic(Last reviewed: Sep 1, 2005)	no assertion criteria provided	VCV000007036	6	162394349	6	161973317	7036	22075	rs137853054	NC_000006.12:161973316:G:C
NM_004562.2(PRKN):c.413-?_534+?del	PRKN		Parkinson disease 2	Pathogenic(Last reviewed: Dec 1, 2005)	no assertion criteria provided	VCV000007035	6	162622163 - 162622284	6	162201131 - 162201252	7035	22074		
NM_004562.2(PRKN):c.172-?_871+?del	PRKN		Parkinson disease 2	Pathogenic(Last reviewed: Apr 9, 1998)	no assertion criteria provided	VCV000007034	6	162206804 - 162683797	6	161785772 - 162262765	7034	22073		
NM_000311.5(PRNP):c.154_177[(6_13)]	PRNP		Genetic prion disease|Huntington disease-like 1|Gerstmann-Straussler-Scheinker syndrome|Creutzfeldt-Jakob Disease, Familial	Pathogenic(Last reviewed: Dec 18, 2008)	no assertion criteria provided	VCV000013394	20	4680026 - 4680049	20	4699379 - 4699380	13394	28433	rs193922906	
NM_002778.4(PSAP):c.1235G>A (p.Cys412Tyr)	PSAP	C412Y, C414Y, C415Y	PARKINSON DISEASE 24, AUTOSOMAL DOMINANT, SUSCEPTIBILITY TO	risk factor(Last reviewed: Aug 26, 2021)	no assertion criteria provided	VCV001210323	10	73579337	10	71819580	1210323	1200323		NC_000010.11:71819579:C:T
NM_002778.4(PSAP):c.1431G>A (p.Leu477=)	PSAP		PARKINSON DISEASE 24, AUTOSOMAL DOMINANT, SUSCEPTIBILITY TO	risk factor(Last reviewed: Aug 26, 2021)	no assertion criteria provided	VCV001210322	10	73578788	10	71819031	1210322	1200322		NC_000010.11:71819030:C:T
NM_002778.4(PSAP):c.1358A>C (p.Gln453Pro)	PSAP	Q453P, Q455P, Q456P	PARKINSON DISEASE 24, AUTOSOMAL DOMINANT, SUSCEPTIBILITY TO	risk factor(Last reviewed: Aug 26, 2021)	no assertion criteria provided	VCV001210321	10	73578861	10	71819104	1210321	1200321		NC_000010.11:71819103:T:G
NM_002778.4(PSAP):c.470A>G (p.Asn157Ser)	PSAP	N157S	Parkinson disease, late-onset	Pathogenic(Last reviewed: Apr 22, 2020)	no assertion criteria provided	VCV000870633	10	73588740	10	71828983	870633	858795	rs756379007	NC_000010.11:71828982:T:C
PSEN1, 3-BP DEL	PSEN1		Alzheimer disease, familial, 3, with spastic paraparesis and unusual plaques	Pathogenic(Last reviewed: Mar 1, 2005)	no assertion criteria provided	VCV000018154					18154	33193		
NM_000021.4(PSEN1):c.1307C>A (p.Pro436Gln)	PSEN1	P436Q, P432Q	not provided|Alzheimer disease, type 3	Pathogenic(Last reviewed: Jun 15, 2004)	no assertion criteria provided	VCV000018150	14	73685900	14	73219192	18150	33189	rs121917808	NC_000014.9:73219191:C:A
PTH, IVS2DS, G-C, +1, EX2DEL	PTH		Familial isolated hypoparathyroidism	Pathogenic(Last reviewed: May 1, 1992)	no assertion criteria provided	VCV000013757					13757	28796		
NM_171998.4(RAB39B):c.624GAG[1] (p.Arg210del)	RAB39B	R210del	Parkinson disease, X-linked dominant	Uncertain significance(Last reviewed: Sep 14, 2015)	criteria provided, single submitter	VCV000218364	X	154490101 - 154490103	X	155260816 - 155260818	218364	215089	rs864309529	NC_000023.11:155260815:CTCCTC:CTC
NM_171998.4(RAB39B):c.428C>G (p.Ala143Gly)	RAB39B	A143G	Parkinson disease, X-linked dominant	Uncertain significance(Last reviewed: Sep 14, 2015)	criteria provided, single submitter	VCV000218363	X	154490302	X	155261017	218363	215091	rs864309528	NC_000023.11:155261016:G:C
NM_171998.4(RAB39B):c.574G>A (p.Gly192Arg)	RAB39B	G192R	Early-onset parkinsonism-intellectual disability syndrome|Parkinson disease, X-linked dominant	Pathogenic(Last reviewed: Sep 14, 2015)	criteria provided, single submitter	VCV000218362	X	154490156	X	155260871	218362	215090	rs864309527	NC_000023.11:155260870:C:T
NM_001134363.3(RBM20):c.934C>A (p.Leu312Met)	RBM20	L312M	Wolff-Parkinson-White pattern	Uncertain significance(Last reviewed: Jul 14, 2017)	no assertion criteria provided	VCV000487629	10	112541301	10	110781543	487629	480702	rs1164333931	NC_000010.11:110781542:C:A
NM_020975.6(RET):c.431G>A (p.Arg144His)	RET	R144H	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2|Multiple endocrine neoplasia, type 2a|Familial medullary thyroid carcinoma	Uncertain significance(Last reviewed: May 21, 2020)	criteria provided, multiple submitters, no conflicts	VCV000216729	10	43597883	10	43102435	216729	212769	rs551142665	NC_000010.11:43102434:G:A
(AAGGG)exp	RFC1		Parkinson disease, late-onset	Pathogenic(Last reviewed: Nov 24, 2021)	no assertion criteria provided	VCV001333160			4	39348425 - 39349149	1333160	1323917		
NM_022450.5(RHBDF1):c.47A>C (p.Lys16Thr)	RHBDF1	K16T	Wolff-Parkinson-White pattern	Uncertain significance(Last reviewed: Jul 14, 2017)	no assertion criteria provided	VCV000487618	16	114967	16	64969	487618	480720	rs999812302	NC_000016.10:64968:T:G
NM_022450.5(RHBDF1):c.1613C>T (p.Ala538Val)	RHBDF1	A538V	Wolff-Parkinson-White pattern	Uncertain significance(Last reviewed: Jul 14, 2017)	no assertion criteria provided	VCV000487611	16	110482	16	60484	487611	480717	rs201706583	NC_000016.10:60483:G:A
NM_022450.5(RHBDF1):c.200G>A (p.Arg67Gln)	RHBDF1	R67Q	Wolff-Parkinson-White pattern	Uncertain significance(Last reviewed: Jul 14, 2017)	no assertion criteria provided	VCV000487605	16	114745	16	64747	487605	480719	rs757169652	NC_000016.10:64746:C:T
NM_022450.5(RHBDF1):c.14G>A (p.Arg5His)	RHBDF1	R5H	Wolff-Parkinson-White pattern	Uncertain significance(Last reviewed: Jul 14, 2017)	no assertion criteria provided	VCV000487604	16	115000	16	65002	487604	480721	rs376110986	NC_000016.10:65001:C:T
NM_022450.5(RHBDF1):c.1384G>A (p.Gly462Arg)	RHBDF1	G462R	Wolff-Parkinson-White pattern	Uncertain significance(Last reviewed: Jul 14, 2017)	no assertion criteria provided	VCV000487583	16	111394	16	61396	487583	480718	rs760441920	NC_000016.10:61395:C:T
NM_001206671.4(RIC3):c.169C>A (p.Pro57Thr)	RIC3	P57T, P8T	not provided	Uncertain significance(Last reviewed: Sep 26, 2016)	no assertion criteria provided	VCV000254687	11	8161696	11	8140149	254687	249263	rs778138358	NC_000011.10:8140148:G:T
NM_001143854.2(RPH3A):c.1349C>G (p.Thr450Ser)	RPH3A	T446S, T450S, T383S	not specified	Uncertain significance(Last reviewed: Jan 14, 2016)	criteria provided, single submitter	VCV000224156	12	113321120	12	112883315	224156	225884	rs869312710	NC_000012.12:112883314:C:G
NM_001035.3(RYR2):c.3767C>T (p.Pro1256Leu)	RYR2	P1256L	Catecholaminergic polymorphic ventricular tachycardia|Wolff-Parkinson-White pattern|not provided|Cardiomyopathy	Uncertain significance(Last reviewed: Dec 16, 2020)	criteria provided, multiple submitters, no conflicts	VCV000487620	1	237753261	1	237589961	487620	480674	rs773915323	NC_000001.11:237589960:C:T
NM_001035.3(RYR2):c.2984T>C (p.Met995Thr)	RYR2	M995T	Catecholaminergic polymorphic ventricular tachycardia|Wolff-Parkinson-White pattern|not provided	Uncertain significance(Last reviewed: Feb 3, 2021)	criteria provided, multiple submitters, no conflicts	VCV000487602	1	237711808	1	237548508	487602	480673	rs1009381849	NC_000001.11:237548507:T:C
NM_001035.3(RYR2):c.4747C>T (p.Pro1583Ser)	RYR2	P1583S	not specified|not provided|Wolff-Parkinson-White pattern|Cardiomyopathy|Catecholaminergic polymorphic ventricular tachycardia	Conflicting interpretations of pathogenicity(Last reviewed: Jul 27, 2021)	criteria provided, conflicting interpretations	VCV000419965	1	237774125	1	237610825	419965	405107	rs200070226	NC_000001.11:237610824:C:T
NM_001035.3(RYR2):c.3181G>A (p.Gly1061Ser)	RYR2	G1061S	not provided|Arrhythmogenic right ventricular dysplasia, familial, 2|Catecholaminergic polymorphic ventricular tachycardia type 1|Wolff-Parkinson-White pattern	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000296718	1	237713958	1	237550658	296718	281616	rs747447414	NC_000001.11:237550657:G:A
NM_001035.3(RYR2):c.11919T>G (p.Asp3973Glu)	RYR2	D3973E	Catecholaminergic polymorphic ventricular tachycardia|Cardiomyopathy|Wolff-Parkinson-White pattern|not specified	Uncertain significance(Last reviewed: May 10, 2021)	criteria provided, multiple submitters, no conflicts	VCV000201316	1	237944903	1	237781603	201316	196689	rs370103782	NC_000001.11:237781602:T:G
NM_001035.3(RYR2):c.982G>A (p.Ala328Thr)	RYR2	A328T	Arrhythmogenic right ventricular dysplasia, familial, 2|Cardiomyopathy|not provided|Wolff-Parkinson-White pattern|Catecholaminergic polymorphic ventricular tachycardia type 1|Catecholaminergic polymorphic ventricular tachycardia	Uncertain significance(Last reviewed: Sep 30, 2019)	criteria provided, multiple submitters, no conflicts	VCV000093480	1	237586525	1	237423225	93480	99385	rs201669522	NC_000001.11:237423224:G:A
NM_001035.3(RYR2):c.8162T>C (p.Ile2721Thr)	RYR2	I2721T	not specified|Arrhythmogenic right ventricular cardiomyopathy|not provided|Cardiovascular phenotype|Arrhythmogenic right ventricular dysplasia, familial, 2|Cardiomyopathy|Catecholaminergic polymorphic ventricular tachycardia type 1|Catecholaminergic polymorphic ventricular tachycardia|Wolff-Parkinson-White pattern	Conflicting interpretations of pathogenicity(Last reviewed: Dec 29, 2020)	criteria provided, conflicting interpretations	VCV000043828	1	237821276	1	237657976	43828	52997	rs201500134	NC_000001.11:237657975:T:C
NM_014363.6(SACS):c.9956_9957del (p.Lys3319fs)	SACS	K3319fs, K3172fs	Spastic paraplegia|not provided	Pathogenic/Likely pathogenic(Last reviewed: Nov 9, 2021)	criteria provided, multiple submitters, no conflicts	VCV000817415	13	23908058 - 23908059	13	23333919 - 23333920	817415	805768	rs772704931	NC_000013.11:23333918:TTT:T
NM_138967.4(SCAMP5):c.271C>T (p.Arg91Trp)	SCAMP5	R91W	not provided	Uncertain significance(Last reviewed: Nov 10, 2020)	no assertion criteria provided	VCV000983558	15	75309068	15	75016727	983558	971626	rs747966691	NC_000015.10:75016726:C:T
NM_000335.5(SCN5A):c.1705C>G (p.Arg569Gly)	SCN5A	R569G	Wolff-Parkinson-White pattern|Cardiac arrhythmia|not provided	Uncertain significance(Last reviewed: Dec 31, 2019)	criteria provided, multiple submitters, no conflicts	VCV000201576	3	38645388	3	38603897	201576	196972	rs199473576	NC_000003.12:38603896:G:C
NM_000335.5(SCN5A):c.1567C>T (p.Arg523Cys)	SCN5A	R523C	not provided|Brugada syndrome|Congenital long QT syndrome|Wolff-Parkinson-White pattern|Cardiac arrhythmia|Brugada syndrome 1|Long QT syndrome 3|Dilated cardiomyopathy 1E|Progressive familial heart block, type 1A|Paroxysmal familial ventricular fibrillation 1|Atrial fibrillation, familial, 10	Conflicting interpretations of pathogenicity(Last reviewed: Feb 18, 2021)	criteria provided, conflicting interpretations	VCV000067667	3	38645526	3	38604035	67667	78562	rs199473119	NC_000003.12:38604034:G:A
NM_001080517.3(SETD5):c.648del (p.Gln216fs)	SETD5	Q118fs, Q216fs	Intellectual disability	Pathogenic(Last reviewed: Apr 20, 2020)	criteria provided, single submitter	VCV000978944	3	9482220	3	9440536	978944	966943	rs2041147607	NC_000003.12:9440535:G:
NM_012434.5(SLC17A5):c.1177G>A (p.Val393Ile)	SLC17A5	V393I	not provided|Focal segmental glomerulosclerosis|Sialic acid storage disease, severe infantile type|Salla disease	Uncertain significance(Last reviewed: Sep 5, 2021)	criteria provided, multiple submitters, no conflicts	VCV000558967	6	74320205	6	73610482	558967	549612	rs140060360	NC_000006.12:73610481:C:T
NM_012434.5(SLC17A5):c.899C>T (p.Ser300Phe)	SLC17A5	S300F	not provided|Salla disease|Sialic acid storage disease, severe infantile type|Salla disease|Sialic acid storage disease, severe infantile type	Conflicting interpretations of pathogenicity(Last reviewed: Sep 5, 2021)	criteria provided, conflicting interpretations	VCV000191213	6	74331606	6	73621883	191213	189016	rs142553916	NC_000006.12:73621882:G:A
NM_000441.2(SLC26A4):c.85G>C (p.Glu29Gln)	SLC26A4|SLC26A4-AS1	E29Q	not provided|SLC26A4-Related Disorders|Rare genetic deafness|Pendred syndrome|Deafness, autosomal recessive 4, with enlarged vestibular aqueduct|Wolff-Parkinson-White pattern	Pathogenic(Last reviewed: Sep 5, 2021)	criteria provided, multiple submitters, no conflicts	VCV000004839	7	107302171	7	107661726	4839	19878	rs111033205	NC_000007.14:107661725:G:C
NM_018713.3(SLC30A10):c.284C>T (p.Thr95Ile)	SLC30A10	T95I	Hypermanganesemia with dystonia, polycythemia, and cirrhosis|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Nov 26, 2021)	criteria provided, conflicting interpretations	VCV000295593	1	220101499	1	219928157	295593	279268	rs188273166	NC_000001.11:219928156:G:A
NM_017986.4(SLC52A1):c.1240G>A (p.Ala414Thr)	SLC52A1	A414T	Maternal riboflavin deficiency	Uncertain significance(Last reviewed: Apr 9, 2018)	criteria provided, single submitter	VCV000583054	17	4936359	17	5033064	583054	571709	rs142353672	NC_000017.11:5033063:C:T
NM_001044.5(SLC6A3):c.70G>A (p.Val24Met)	SLC6A3	V24M	Parkinsonism-dystonia, infantile, 1|Tobacco addiction, susceptibility to|Parkinsonism-dystonia, infantile	Uncertain significance(Last reviewed: Dec 19, 2019)	criteria provided, multiple submitters, no conflicts	VCV000538067	5	1443243	5	1443128	538067	521089	rs201800694	NC_000005.10:1443127:C:T
NM_003073.5(SMARCB1):c.34C>T (p.Gln12Ter)	SMARCB1	Q12*	Schwannomatosis 1	Pathogenic(Last reviewed: Apr 1, 2007)	no assertion criteria provided	VCV000008026	22	24129390	22	23787203	8026	23065	rs74315513	NC_000022.11:23787202:C:T
NM_000543.5(SMPD1):c.1133G>A (p.Arg378His)	SMPD1	R378H, R377H, R71H	not provided|Niemann-Pick disease, type A|Niemann-Pick disease, type B|Niemann-Pick disease, type A	Conflicting interpretations of pathogenicity(Last reviewed: Feb 26, 2021)	criteria provided, conflicting interpretations	VCV000554977	11	6414487	11	6393257	554977	546349	rs559088058	NC_000011.10:6393256:G:A
NM_000543.5(SMPD1):c.1474G>A (p.Gly492Ser)	SMPD1	G492S, G448S, G185S, G491S	not provided|Sphingomyelin/cholesterol lipidosis|not specified|Niemann-Pick disease, type B|Niemann-Pick disease, type A|Niemann-Pick disease, type A|Niemann-Pick disease, type B	Conflicting interpretations of pathogenicity(Last reviewed: Jul 22, 2021)	criteria provided, conflicting interpretations	VCV000445832	11	6415259	11	6394029	445832	439104	rs144873307	NC_000011.10:6394028:G:A
NM_000543.5(SMPD1):c.733T>C (p.Tyr245His)	SMPD1	Y245H, Y244H	not provided|Sphingomyelin/cholesterol lipidosis	Uncertain significance(Last reviewed: Feb 5, 2021)	criteria provided, multiple submitters, no conflicts	VCV000291201	11	6413028	11	6391798	291201	275438	rs370178721	NC_000011.10:6391797:T:C
NM_000543.5(SMPD1):c.1165C>T (p.Arg389Cys)	SMPD1	R389C, R388C, R82C	Niemann-Pick disease, type B|Niemann-Pick disease, type A|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Jan 24, 2022)	criteria provided, conflicting interpretations	VCV000289909	11	6414519	11	6393289	289909	274146	rs570674743	NC_000011.10:6393288:C:T
NM_000543.5(SMPD1):c.996del (p.Phe333fs)	SMPD1	F332fs, F333fs, P12fs	not provided|Sphingomyelin/cholesterol lipidosis|Niemann-Pick disease, type A|Niemann-Pick disease, type B|Niemann-Pick disease, type A|Niemann-Pick disease, type B	Pathogenic(Last reviewed: Oct 19, 2020)	criteria provided, multiple submitters, no conflicts	VCV000002990	11	6413286	11	6392056	2990	18029	rs387906289	NC_000011.10:6392055:CCCCCC:CCCCC
NM_000345.4(SNCA):c.246G>A (p.Val82=)	SNCA		Parkinson disease 1|Lewy body dementia	Likely benign(Last reviewed: Mar 30, 2021)	criteria provided, single submitter	VCV001670833	4	90743457	4	89822306	1670833	1605140		NC_000004.12:89822305:C:T
NM_000345.4(SNCA):c.391-16A>G	SNCA		Parkinson disease 1|Lewy body dementia	Likely benign(Last reviewed: Oct 19, 2021)	criteria provided, single submitter	VCV001657000	4	90647827	4	89726676	1657000	1562384		NC_000004.12:89726675:T:C
NM_000345.4(SNCA):c.121+13C>T	SNCA		Parkinson disease 1|Lewy body dementia	Likely benign(Last reviewed: Oct 27, 2021)	criteria provided, single submitter	VCV001654927	4	90756685	4	89835534	1654927	1549500		NC_000004.12:89835533:G:A
NM_000345.4(SNCA):c.306+8T>C	SNCA		Parkinson disease 1|Lewy body dementia	Likely benign(Last reviewed: Oct 28, 2020)	criteria provided, single submitter	VCV001590414	4	90743389	4	89822238	1590414	1642307		NC_000004.12:89822237:A:G
NM_000345.4(SNCA):c.390+11A>C	SNCA		Parkinson disease 1|Lewy body dementia	Likely benign(Last reviewed: Jul 20, 2021)	criteria provided, single submitter	VCV001553611	4	90650334	4	89729183	1553611	1521791		NC_000004.12:89729182:T:G
NM_000345.4(SNCA):c.359C>T (p.Pro120Leu)	SNCA	P72L, P120L	Lewy body dementia|Parkinson disease 1	Uncertain significance(Last reviewed: Oct 26, 2021)	criteria provided, single submitter	VCV001524438	4	90650376	4	89729225	1524438	1462913		NC_000004.12:89729224:G:A
NM_000345.4(SNCA):c.247G>C (p.Glu83Gln)	SNCA	E83Q	Lewy body dementia|Parkinson disease 1	Uncertain significance(Last reviewed: Aug 13, 2021)	criteria provided, single submitter	VCV001509118	4	90743456	4	89822305	1509118	1452235		NC_000004.12:89822304:C:G
NM_000345.4(SNCA):c.391-7A>G	SNCA		Parkinson disease 1|Lewy body dementia	Uncertain significance(Last reviewed: Oct 12, 2021)	criteria provided, single submitter	VCV001472092	4	90647818	4	89726667	1472092	1385240		NC_000004.12:89726666:T:C
NC_000004.11:g.(?_90647779)_(90756818_?)dup	SNCA		Parkinson disease 1|Lewy body dementia	Pathogenic(Last reviewed: Nov 27, 2021)	criteria provided, single submitter	VCV001454898	4	90647779 - 90756818			1454898	1441384		
NM_000345.4(SNCA):c.158C>T (p.Ala53Val)	SNCA	A53V	Parkinson disease 1|Lewy body dementia	Uncertain significance(Last reviewed: Aug 27, 2021)	criteria provided, single submitter	VCV001393530	4	90749299	4	89828148	1393530	1399382		NC_000004.12:89828147:G:A
NM_000345.4(SNCA):c.163+6C>A	SNCA		Lewy body dementia|Parkinson disease 1	Uncertain significance(Last reviewed: Apr 18, 2021)	criteria provided, single submitter	VCV001388864	4	90749288	4	89828137	1388864	1384094		NC_000004.12:89828136:G:T
NM_000345.4(SNCA):c.122-2A>C	SNCA		Lewy body dementia|Parkinson disease 1	Uncertain significance(Last reviewed: Oct 14, 2021)	criteria provided, single submitter	VCV001373474	4	90749337	4	89828186	1373474	1463474		NC_000004.12:89828185:T:G
NC_000004.11:g.(?_90647315)_(90756828_?)del	SNCA		Lewy body dementia|Parkinson disease 1	Uncertain significance(Last reviewed: Apr 8, 2021)	criteria provided, single submitter	VCV001372807	4	90647315 - 90756828			1372807	1440185		
GRCh37/hg19 4q22.1(chr4:90647779-90756863)x3	SNCA		Lewy body dementia|Parkinson disease 1	not provided	no assertion provided	VCV001339894	4	90647779 - 90756863			1339894	1331104		
NM_000345.4(SNCA):c.306+7C>T	SNCA		Lewy body dementia|Parkinson disease 1	Likely benign(Last reviewed: Jun 18, 2020)	criteria provided, single submitter	VCV001147109	4	90743390	4	89822239	1147109	1136038		NC_000004.12:89822238:G:A
GRCh37/hg19 4q22.1(chr4:90647764-90758128)	SNCA		Young-onset Parkinson disease	Pathogenic(Last reviewed: May 3, 2021)	criteria provided, single submitter	VCV001120010	4	90647764 - 90758128			1120010	1108774		
NM_000345.4(SNCA):c.71A>G (p.Gln24Arg)	SNCA	Q24R	Lewy body dementia|Parkinson disease 1	Uncertain significance(Last reviewed: Aug 27, 2020)	criteria provided, single submitter	VCV001051847	4	90756748	4	89835597	1051847	1042983		NC_000004.12:89835596:T:C
NM_000345.4(SNCA):c.*464C>A	SNCA		Lewy body dementia|Parkinson disease 1	Uncertain significance(Last reviewed: Jan 29, 2020)	criteria provided, single submitter	VCV001020728	4	90647315	4	89726164	1020728	1005504	rs183204610	NC_000004.12:89726163:G:T
NM_000345.4(SNCA):c.47T>C (p.Val16Ala)	SNCA	V16A	Parkinson disease 1|Lewy body dementia	Uncertain significance(Last reviewed: Jan 8, 2020)	criteria provided, single submitter	VCV001009952	4	90756772	4	89835621	1009952	990319	rs1289802008	NC_000004.12:89835620:A:G
NM_000345.4(SNCA):c.100A>G (p.Lys34Glu)	SNCA	K34E	Parkinson disease 1|Lewy body dementia	Uncertain significance(Last reviewed: Aug 23, 2020)	criteria provided, single submitter	VCV001003636	4	90756719	4	89835568	1003636	990318	rs1330229174	NC_000004.12:89835567:T:C
NM_000345.4(SNCA):c.249G>A (p.Glu83=)	SNCA		Parkinson Disease, Dominant	Likely benign(Last reviewed: Apr 27, 2017)	criteria provided, single submitter	VCV000907548	4	90743454	4	89822303	907548	892534	rs1737224483	NC_000004.12:89822302:C:T
NM_000345.4(SNCA):c.382C>A (p.Pro128Thr)	SNCA	P80T, P128T	Parkinson Disease, Dominant	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000907547	4	90650353	4	89729202	907547	892533	rs750899874	NC_000004.12:89729201:G:T
NM_000345.4(SNCA):c.*56C>G	SNCA		Parkinson Disease, Dominant	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000907546	4	90647723	4	89726572	907546	892532	rs778443752	NC_000004.12:89726571:G:C
NM_000345.4(SNCA):c.*77C>A	SNCA		Parkinson Disease, Dominant	Likely benign(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000907545	4	90647702	4	89726551	907545	892531	rs145304567	NC_000004.12:89726550:G:T
NM_000345.4(SNCA):c.*112A>G	SNCA		Parkinson Disease, Dominant	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000907544	4	90647667	4	89726516	907544	892530	rs748631342	NC_000004.12:89726515:T:C
NM_000345.4(SNCA):c.*114C>G	SNCA		Parkinson Disease, Dominant	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000907543	4	90647665	4	89726514	907543	892529	rs1724920607	NC_000004.12:89726513:G:C
NM_000345.4(SNCA):c.*1292C>T	SNCA		Parkinson Disease, Dominant	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000907477	4	90646487	4	89725336	907477	892518	rs867272212	NC_000004.12:89725335:G:A
NM_000345.4(SNCA):c.*1311C>T	SNCA		Parkinson Disease, Dominant	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000907476	4	90646468	4	89725317	907476	892517	rs1305349888	NC_000004.12:89725316:G:A
NM_000345.4(SNCA):c.*1518T>C	SNCA		Parkinson Disease, Dominant	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000907475	4	90646261	4	89725110	907475	892516	rs1724761878	NC_000004.12:89725109:A:G
NM_000345.4(SNCA):c.*1678G>A	SNCA		Parkinson Disease, Dominant	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000907474	4	90646101	4	89724950	907474	892515	rs998774082	NC_000004.12:89724949:C:T
NM_000345.4(SNCA):c.*116C>T	SNCA		Parkinson Disease, Dominant	Likely benign(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000906531	4	90647663	4	89726512	906531	892528	rs144511886	NC_000004.12:89726511:G:A
NM_000345.4(SNCA):c.*249G>A	SNCA		Parkinson Disease, Dominant	Benign(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000906530	4	90647530	4	89726379	906530	892527	rs553599518	NC_000004.12:89726378:C:T
NM_000345.4(SNCA):c.*504T>C	SNCA		Parkinson Disease, Dominant	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000906529	4	90647275	4	89726124	906529	892526	rs1724880624	NC_000004.12:89726123:A:G
NM_000345.4(SNCA):c.*1716A>T	SNCA		Parkinson Disease, Dominant	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000906480	4	90646063	4	89724912	906480	892514	rs765029456	NC_000004.12:89724911:T:A
NM_000345.4(SNCA):c.*1893T>C	SNCA		Parkinson Disease, Dominant	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000906479	4	90645886	4	89724735	906479	892513	rs561717303	NC_000004.12:89724734:A:G
NM_000345.4(SNCA):c.*1983A>G	SNCA		Parkinson Disease, Dominant	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000906478	4	90645796	4	89724645	906478	892512	rs766004459	NC_000004.12:89724644:T:C
NM_000345.4(SNCA):c.*2047G>A	SNCA		Parkinson Disease, Dominant	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000906477	4	90645732	4	89724581	906477	892511	rs1724721752	NC_000004.12:89724580:C:T
NM_000345.4(SNCA):c.-127C>T	SNCA|SNCA-AS1		Parkinson Disease, Dominant	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000904994	4	90758214	4	89837063	904994	892536	rs764272411	NC_000004.12:89837062:G:A
NM_000345.4(SNCA):c.*852G>A	SNCA		Parkinson Disease, Dominant	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000904938	4	90646927	4	89725776	904938	892525	rs150645039	NC_000004.12:89725775:C:T
NM_000345.4(SNCA):c.*894G>A	SNCA		Parkinson Disease, Dominant	Benign(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000904937	4	90646885	4	89725734	904937	892524	rs192179063	NC_000004.12:89725733:C:T
NM_000345.4(SNCA):c.*923A>G	SNCA		Parkinson Disease, Dominant	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000904936	4	90646856	4	89725705	904936	892523	rs925720552	NC_000004.12:89725704:T:C
NM_000345.4(SNCA):c.*2106G>A	SNCA		Parkinson Disease, Dominant	Likely benign(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000904878	4	90645673	4	89724522	904878	892510	rs555697933	NC_000004.12:89724521:C:T
NM_000345.4(SNCA):c.*2230G>A	SNCA		Parkinson Disease, Dominant	Benign(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000904877	4	90645549	4	89724398	904877	892509	rs183802441	NC_000004.12:89724397:C:T
NM_000345.4(SNCA):c.*2320A>T	SNCA		Parkinson Disease, Dominant	Likely benign(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000904876	4	90645459	4	89724308	904876	892508	rs529553259	NC_000004.12:89724307:T:A
NM_000345.4(SNCA):c.-115C>G	SNCA|SNCA-AS1		Parkinson Disease, Dominant	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000904212	4	90758202	4	89837051	904212	892535	rs926228768	NC_000004.12:89837050:G:C
NM_000345.4(SNCA):c.-26+7G>A	SNCA|SNCA-AS1		Parkinson Disease, Dominant	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000904211	4	90758106	4	89836955	904211	896007	rs548276692	NC_000004.12:89836954:C:T
NM_000345.4(SNCA):c.121+11C>T	SNCA		Parkinson disease 1|Lewy body dementia|Parkinson Disease, Dominant	Benign/Likely benign(Last reviewed: Mar 25, 2021)	criteria provided, multiple submitters, no conflicts	VCV000904210	4	90756687	4	89835536	904210	896006	rs35135226	NC_000004.12:89835535:G:A
NM_000345.4(SNCA):c.*1276C>T	SNCA		Parkinson Disease, Dominant	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000904158	4	90646503	4	89725352	904158	892522	rs201351609	NC_000004.12:89725351:G:A
NM_000345.4(SNCA):c.*1280T>C	SNCA		Parkinson Disease, Dominant	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000904157	4	90646499	4	89725348	904157	892521	rs200268319	NC_000004.12:89725347:A:G
NM_000345.4(SNCA):c.*1285T>A	SNCA		Parkinson Disease, Dominant	Uncertain significance(Last reviewed: Jan 17, 2018)	criteria provided, single submitter	VCV000904156	4	90646494	4	89725343	904156	892520	rs1402261655	NC_000004.12:89725342:A:T
NM_000345.4(SNCA):c.*1287G>T	SNCA		Parkinson Disease, Dominant	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000904155	4	90646492	4	89725341	904155	892519	rs377356638	NC_000004.12:89725340:C:A
NM_000345.4(SNCA):c.*2396G>A	SNCA		Parkinson Disease, Dominant	Uncertain significance(Last reviewed: Mar 23, 2018)	criteria provided, single submitter	VCV000904097	4	90645383	4	89724232	904097	892507	rs924716962	NC_000004.12:89724231:C:T
NM_000345.4(SNCA):c.225A>T (p.Thr75=)	SNCA		Lewy body dementia|Parkinson disease 1|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Jul 9, 2020)	criteria provided, conflicting interpretations	VCV000872747	4	90743478	4	89822327	872747	859358	rs149401968	NC_000004.12:89822326:T:A
NM_000345.4(SNCA):c.156G>T (p.Val52=)	SNCA		Parkinson disease 1|Lewy body dementia	Likely benign(Last reviewed: Nov 21, 2019)	criteria provided, single submitter	VCV000772345	4	90749301	4	89828150	772345	698680	rs148108612	NC_000004.12:89828149:C:A
NM_000345.4(SNCA):c.147G>A (p.Val49=)	SNCA		Lewy body dementia|Parkinson disease 1	Likely benign(Last reviewed: Dec 31, 2019)	criteria provided, single submitter	VCV000767542	4	90749310	4	89828159	767542	698681	rs141859659	NC_000004.12:89828158:C:T
NM_000345.4(SNCA):c.163+7T>G	SNCA		Parkinson disease 1|Lewy body dementia|not provided	Likely benign(Last reviewed: Jul 24, 2018)	criteria provided, single submitter	VCV000763646	4	90749287	4	89828136	763646	774989	rs1578405610	NC_000004.12:89828135:A:C
NM_000345.4(SNCA):c.216G>A (p.Thr72=)	SNCA		Lewy body dementia|Parkinson disease 1|not provided|Parkinson Disease, Dominant	Conflicting interpretations of pathogenicity(Last reviewed: Oct 26, 2020)	criteria provided, conflicting interpretations	VCV000705925	4	90743487	4	89822336	705925	691638	rs144758871	NC_000004.12:89822335:C:T
NM_000345.4(SNCA):c.287A>G (p.Lys96Arg)	SNCA	K96R	Lewy body dementia|Parkinson disease 1|not provided|Parkinson Disease, Dominant	Benign(Last reviewed: Sep 28, 2021)	criteria provided, multiple submitters, no conflicts	VCV000704527	4	90743416	4	89822265	704527	691637	rs548523899	NC_000004.12:89822264:T:C
NM_000345.4(SNCA):c.349C>A (p.Pro117Thr)	SNCA	P117T, P69T	Lewy body dementia|Parkinson disease 1	Uncertain significance(Last reviewed: Dec 4, 2018)	criteria provided, single submitter	VCV000652694	4	90650386	4	89729235	652694	632527	rs145138372	NC_000004.12:89729234:G:T
NC_000004.11:g.(?_90647315)_(90756828_?)dup	SNCA		Lewy body dementia|Parkinson disease 1	Pathogenic(Last reviewed: Nov 26, 2019)	criteria provided, single submitter	VCV000639372	4	90647315 - 90756828	4	89726164 - 89835677	639372	651126		
NM_000345.4(SNCA):c.-26+1G>A	SNCA|SNCA-AS1		Parkinson Disease, Dominant	Uncertain significance(Last reviewed: Sep 18, 2017)	criteria provided, single submitter	VCV000631952	4	90758112	4	89836961	631952	620776	rs1560562993	NC_000004.12:89836960:C:T
NC_000004.11:g.(?_90647315)_(90756838_?)dup	SNCA		Parkinson disease 1|Lewy body dementia	Pathogenic(Last reviewed: May 12, 2018)	criteria provided, single submitter	VCV000531846	4	90647315 - 90756838	4	89726164 - 89835687	531846	519673		
NM_001146055.2(SNCA):c.-26+1042G>A	SNCA|SNCA-AS1		Parkinson Disease, Dominant	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000369445	4	90758361	4	89837210	369445	353674	rs372025454	NC_000004.12:89837209:C:T
NM_001146055.2(SNCA):c.-26+1065A>C	SNCA|SNCA-AS1		Parkinson Disease, Dominant	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000350112	4	90758338	4	89837187	350112	299966	rs767878442	NC_000004.12:89837186:T:G
NM_000345.4(SNCA):c.-219G>C	SNCA|SNCA-AS1		Parkinson Disease, Dominant	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000350111	4	90758306	4	89837155	350111	299952	rs757451373	NC_000004.12:89837154:C:G
NM_000345.4(SNCA):c.-42T>C	SNCA|SNCA-AS1		Parkinson Disease, Dominant	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000350109	4	90758129	4	89836978	350109	294667	rs886059730	NC_000004.12:89836977:A:G
NM_000345.4(SNCA):c.-40G>A	SNCA|SNCA-AS1		Parkinson Disease, Dominant	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000350108	4	90758127	4	89836976	350108	294666	rs886059729	NC_000004.12:89836975:C:T
NM_000345.4(SNCA):c.-26+15C>T	SNCA|SNCA-AS1		Parkinson Disease, Dominant	Likely benign(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000350107	4	90758098	4	89836947	350107	299943	rs545809130	NC_000004.12:89836946:G:A
NM_000345.4(SNCA):c.243A>G (p.Thr81=)	SNCA		Parkinson disease 1|Lewy body dementia|Parkinson Disease, Dominant|not provided	Benign(Last reviewed: Dec 3, 2018)	criteria provided, multiple submitters, no conflicts	VCV000350106	4	90743460	4	89822309	350106	299978	rs568436589	NC_000004.12:89822308:T:C
NM_000345.4(SNCA):c.298T>C (p.Leu100=)	SNCA		Parkinson disease 1|Lewy body dementia|Parkinson Disease, Dominant	Conflicting interpretations of pathogenicity(Last reviewed: Oct 4, 2020)	criteria provided, conflicting interpretations	VCV000350105	4	90743405	4	89822254	350105	299977	rs138969470	NC_000004.12:89822253:A:G
NM_000345.4(SNCA):c.408C>T (p.Tyr136=)	SNCA		Parkinson disease 1|Lewy body dementia|Parkinson Disease, Dominant|not provided	Benign(Last reviewed: Nov 23, 2020)	criteria provided, multiple submitters, no conflicts	VCV000350104	4	90647794	4	89726643	350104	294660	rs76642636	NC_000004.12:89726642:G:A
NM_000345.4(SNCA):c.*139T>G	SNCA		Parkinson Disease, Dominant|not provided	Benign/Likely benign(Last reviewed: Jul 5, 2018)	criteria provided, multiple submitters, no conflicts	VCV000350103	4	90647640	4	89726489	350103	294658	rs10024743	NC_000004.12:89726488:A:C
NM_000345.4(SNCA):c.*173G>A	SNCA		Parkinson Disease, Dominant	Benign(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000350102	4	90647606	4	89726455	350102	299932	rs79726680	NC_000004.12:89726454:C:T
NM_000345.4(SNCA):c.*211G>A	SNCA		Parkinson Disease, Dominant	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000350101	4	90647568	4	89726417	350101	299924	rs886059728	NC_000004.12:89726416:C:T
NM_000345.4(SNCA):c.*277G>T	SNCA		Parkinson Disease, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000350100	4	90647502	4	89726351	350100	296195	rs886059727	NC_000004.12:89726350:C:A
NM_000345.4(SNCA):c.*465A>T	SNCA		Parkinson Disease, Dominant	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000350099	4	90647314	4	89726163	350099	299976	rs886059726	NC_000004.12:89726162:T:A
NM_000345.4(SNCA):c.*501C>T	SNCA		Parkinson disease 1|Lewy body dementia|Parkinson Disease, Dominant	Benign(Last reviewed: Nov 27, 2020)	criteria provided, multiple submitters, no conflicts	VCV000350098	4	90647278	4	89726127	350098	299975	rs17016074	NC_000004.12:89726126:G:A
NM_000345.4(SNCA):c.*575ATTTT[1]	SNCA		Parkinson Disease, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000350097	4	90647195 - 90647199	4	89726044 - 89726048	350097	294655	rs756360541	NC_000004.12:89726043:AAAATAAAATA:AAAATA
NM_000345.4(SNCA):c.*593C>A	SNCA		Parkinson Disease, Dominant	Benign(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000350096	4	90647186	4	89726035	350096	294651	rs35101723	NC_000004.12:89726034:G:T
NM_000345.4(SNCA):c.*630T>G	SNCA		Parkinson Disease, Dominant	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000350095	4	90647149	4	89725998	350095	299973	rs886059725	NC_000004.12:89725997:A:C
NM_000345.4(SNCA):c.*860T>A	SNCA		Parkinson Disease, Dominant	Likely benign(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000350094	4	90646919	4	89725768	350094	299923	rs577490090	NC_000004.12:89725767:A:T
NM_000345.4(SNCA):c.*893C>T	SNCA		Parkinson Disease, Dominant|not provided	Benign(Last reviewed: Feb 25, 2021)	criteria provided, multiple submitters, no conflicts	VCV000350093	4	90646886	4	89725735	350093	299919	rs356165	NC_000004.12:89725734:G:A
NM_000345.4(SNCA):c.*1002T>G	SNCA		Parkinson Disease, Dominant	Benign(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000350092	4	90646777	4	89725626	350092	299964	rs182722435	NC_000004.12:89725625:A:C
NM_000345.4(SNCA):c.*1033T>C	SNCA		Parkinson Disease, Dominant	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000350091	4	90646746	4	89725595	350091	299913	rs550521282	NC_000004.12:89725594:A:G
NM_000345.4(SNCA):c.*1047T>G	SNCA		Parkinson Disease, Dominant	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000350090	4	90646732	4	89725581	350090	294649	rs532025477	NC_000004.12:89725580:A:C
NM_000345.4(SNCA):c.*1077del	SNCA		Parkinson Disease, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000350089	4	90646702	4	89725551	350089	299963	rs886059724	NC_000004.12:89725550:A:
NM_000345.4(SNCA):c.*1078A>T	SNCA		Parkinson Disease, Dominant	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000350088	4	90646701	4	89725550	350088	299912	rs886059723	NC_000004.12:89725549:T:A
NM_000345.4(SNCA):c.*1245del	SNCA		Parkinson Disease, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000350087	4	90646534	4	89725383	350087	294645	rs886059722	NC_000004.12:89725382:AAAAAAAAAAA:AAAAAAAAAA
NM_000345.4(SNCA):c.*1260CT[7]	SNCA		Parkinson Disease, Dominant	Benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000350086	4	90646502 - 90646505	4	89725351 - 89725354	350086	299959	rs5860180	NC_000004.12:89725350:AGAGAGAGAGAGAGAGAGA:AGAGAGAGAGAGAGA
NM_000345.4(SNCA):c.*1287G>A	SNCA		Parkinson Disease, Dominant	Benign(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000350085	4	90646492	4	89725341	350085	299958	rs377356638	NC_000004.12:89725340:C:T
NM_000345.4(SNCA):c.*1289T>C	SNCA		Parkinson Disease, Dominant	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000350084	4	90646490	4	89725339	350084	294641	rs527798413	NC_000004.12:89725338:A:G
NM_000345.4(SNCA):c.*1291_*1292insTTTCT	SNCA		Parkinson Disease, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000350083	4	90646487 - 90646488	4	89725336 - 89725337	350083	299903	rs1553905630	NC_000004.12:89725336:AGA:AGAAAAGA
NM_000345.4(SNCA):c.*1292_*1296dup	SNCA		Parkinson Disease, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000350082	4	90646482 - 90646483	4	89725331 - 89725332	350082	294640	rs886059721	NC_000004.12:89725331:AAAAGA:AAAAGAAAAGA
NM_000345.4(SNCA):c.*1291_*1292insTTTTT	SNCA		Parkinson Disease, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000350081	4	90646487 - 90646488	4	89725336 - 89725337	350081	296179	rs886059720	NC_000004.12:89725336:A:AAAAAA
NM_000345.4(SNCA):c.*1291_*1292insTTT	SNCA		Parkinson Disease, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000350080	4	90646487 - 90646488	4	89725336 - 89725337	350080	299956	rs886059720	NC_000004.12:89725336:A:AAAA
NM_000345.4(SNCA):c.*1308_*1309dup	SNCA		Parkinson Disease, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000350079	4	90646469 - 90646470	4	89725318 - 89725319	350079	299953	rs397994464	NC_000004.12:89725318:AAAAAAAAAAAAAAAAA:AAAAAAAAAAAAAAAAAAA
NM_000345.4(SNCA):c.*1305_*1309dup	SNCA		Parkinson Disease, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000350078	4	90646469 - 90646470	4	89725318 - 89725319	350078	294637	rs397994464	NC_000004.12:89725318:AAAAAAAAAAAAAAAAA:AAAAAAAAAAAAAAAAAAAAAA
NM_000345.4(SNCA):c.*1306_*1309dup	SNCA		Parkinson Disease, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000350077	4	90646469 - 90646470	4	89725318 - 89725319	350077	294636	rs397994464	NC_000004.12:89725318:AAAAAAAAAAAAAAAAA:AAAAAAAAAAAAAAAAAAAAA
NM_000345.4(SNCA):c.*1310A>T	SNCA		Parkinson Disease, Dominant	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000350076	4	90646469	4	89725318	350076	299944	rs886059719	NC_000004.12:89725317:T:A
NM_000345.4(SNCA):c.*1306_*1310dup	SNCA		Parkinson Disease, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000350075	4	90646468 - 90646469	4	89725317 - 89725318	350075	299890	rs1553905608	NC_000004.12:89725317:TAAAA:TAAAATAAAA
NM_000345.4(SNCA):c.*1308_*1310dup	SNCA		Parkinson Disease, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000350074	4	90646468 - 90646469	4	89725317 - 89725318	350074	294634	rs1553905607	NC_000004.12:89725317:TAA:TAATAA
NM_000345.4(SNCA):c.*1310_*1311insTTTTT	SNCA		Parkinson Disease, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000350073	4	90646468 - 90646469	4	89725317 - 89725318	350073	294633	rs886059718	NC_000004.12:89725317::AAAAA
NM_000345.4(SNCA):c.*1310_*1311insTTT	SNCA		Parkinson Disease, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000350072	4	90646468 - 90646469	4	89725317 - 89725318	350072	299881	rs886059718	NC_000004.12:89725317::AAA
NM_000345.4(SNCA):c.*1311del	SNCA		Parkinson Disease, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000350071	4	90646468	4	89725317	350071	296153	rs886059717	NC_000004.12:89725316:G:
NM_000345.4(SNCA):c.*1307_*1311dup	SNCA		Parkinson Disease, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000350070	4	90646467 - 90646468	4	89725316 - 89725317	350070	299888	rs886059716	NC_000004.12:89725316:GTAAA:GTAAAGTAAA
NM_000345.4(SNCA):c.*1325A>G	SNCA		Parkinson Disease, Dominant	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000350069	4	90646454	4	89725303	350069	294630	rs886059715	NC_000004.12:89725302:T:C
NM_000345.4(SNCA):c.*1677C>T	SNCA		Parkinson Disease, Dominant	Benign(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000350068	4	90646102	4	89724951	350068	296145	rs17016072	NC_000004.12:89724950:G:A
NM_000345.4(SNCA):c.*1702G>A	SNCA		Parkinson Disease, Dominant	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000350067	4	90646077	4	89724926	350067	299935	rs886059714	NC_000004.12:89724925:C:T
NM_000345.4(SNCA):c.*1896C>T	SNCA		Parkinson Disease, Dominant	Benign(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000350066	4	90645883	4	89724732	350066	299878	rs186189862	NC_000004.12:89724731:G:A
NM_000345.4(SNCA):c.*2037T>C	SNCA		Parkinson Disease, Dominant	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000350065	4	90645742	4	89724591	350065	299930	rs553070344	NC_000004.12:89724590:A:G
NM_000345.4(SNCA):c.*2105G>A	SNCA		Parkinson Disease, Dominant	Benign(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000350064	4	90645674	4	89724523	350064	299868	rs3857053	NC_000004.12:89724522:C:T
NM_000345.4(SNCA):c.*2108A>T	SNCA		Parkinson Disease, Dominant	Benign(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000350063	4	90645671	4	89724520	350063	294628	rs1045722	NC_000004.12:89724519:T:A
NM_000345.4(SNCA):c.*2227C>A	SNCA		Parkinson Disease, Dominant	Likely benign(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000350062	4	90645552	4	89724401	350062	296144	rs551886776	NC_000004.12:89724400:G:T
NM_000345.4(SNCA):c.*2269C>T	SNCA		Parkinson Disease, Dominant	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000350061	4	90645510	4	89724359	350061	299859	rs886059713	NC_000004.12:89724358:G:A
NM_000345.4(SNCA):c.*2277A>C	SNCA		Parkinson Disease, Dominant	Likely benign(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000350060	4	90645502	4	89724351	350060	299856	rs375815714	NC_000004.12:89724350:T:G
NM_000345.4(SNCA):c.*2291C>T	SNCA		Parkinson Disease, Dominant	Likely benign(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000350059	4	90645488	4	89724337	350059	296136	rs550895688	NC_000004.12:89724336:G:A
NM_000345.4(SNCA):c.*2330C>T	SNCA		Parkinson Disease, Dominant	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000350058	4	90645449	4	89724298	350058	299848	rs886059712	NC_000004.12:89724297:G:A
NM_000345.4(SNCA):c.*2501C>A	SNCA		Parkinson Disease, Dominant	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000350057	4	90645278	4	89724127	350057	299916	rs886059711	NC_000004.12:89724126:G:T
NM_000345.4(SNCA):c.150T>G (p.His50Gln)	SNCA	H50Q	Parkinson Disease, Dominant|Parkinson disease 1|Lewy body dementia|Parkinson disease 1	Uncertain significance(Last reviewed: Mar 14, 2020)	criteria provided, multiple submitters, no conflicts	VCV000162095	4	90749307	4	89828156	162095	171811	rs201106962	NC_000004.12:89828155:A:C
NM_000345.4(SNCA):c.152G>A (p.Gly51Asp)	SNCA	G51D	Parkinson disease 1	Pathogenic(Last reviewed: Feb 7, 2022)	no assertion criteria provided	VCV000097000	4	90749305	4	89828154	97000	102896	rs431905511	NC_000004.12:89828153:C:T
SNCA, DUPLICATION	SNCA		Lewy body dementia|Parkinson disease 1	Pathogenic(Last reviewed: Oct 14, 2008)	no assertion criteria provided	VCV000014011					14011	29050		
NM_000345.4(SNCA):c.136G>A (p.Glu46Lys)	SNCA	E46K	Lewy body dementia	Pathogenic(Last reviewed: Mar 4, 2005)	no assertion criteria provided	VCV000014010	4	90749321	4	89828170	14010	29049	rs104893875	NC_000004.12:89828169:C:T
NM_000345.4(SNCA):c.88G>C (p.Ala30Pro)	SNCA	A30P	Parkinson disease 1	Pathogenic(Last reviewed: Nov 22, 2013)	no assertion criteria provided	VCV000014008	4	90756731	4	89835580	14008	29047	rs104893878	NC_000004.12:89835579:C:G
NM_000345.4(SNCA):c.157G>A (p.Ala53Thr)	SNCA	A53T	Parkinson disease 1|Lewy body dementia|Parkinson disease 1	Pathogenic(Last reviewed: Mar 10, 2017)	criteria provided, single submitter	VCV000014007	4	90749300	4	89828149	14007	29046	rs104893877	NC_000004.12:89828148:C:T
NM_000345.4(SNCA):c.-129G>A	SNCA-AS1|SNCA		Parkinson Disease, Dominant	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000350110	4	90758216	4	89837065	350110	296211	rs367902113	NC_000004.12:89837064:C:T
NM_005460.4(SNCAIP):c.*253T>A	SNCAIP|MGC32805		Parkinson Disease, Dominant/Recessive	Likely benign(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000907910	5	121799444	5	122463749	907910	892686	rs189562625	NC_000005.10:122463748:T:A
NM_005460.4(SNCAIP):c.1206C>T (p.Arg402=)	SNCAIP		Parkinson Disease, Dominant/Recessive	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000907840	5	121767687	5	122431992	907840	892671	rs1158148020	NC_000005.10:122431991:C:T
NM_005460.4(SNCAIP):c.-26G>A	SNCAIP		Parkinson Disease, Dominant/Recessive	Likely benign(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000907795	5	121726804	5	122391109	907795	892661	rs369556081	NC_000005.10:122391108:G:A
NM_005460.4(SNCAIP):c.-46-6G>A	SNCAIP		Parkinson Disease, Dominant/Recessive	Uncertain significance(Last reviewed: Apr 27, 2017)	criteria provided, single submitter	VCV000907794	5	121726778	5	122391083	907794	896015	rs375818767	NC_000005.10:122391082:G:A
NM_005460.4(SNCAIP):c.-48G>A	SNCAIP		Parkinson Disease, Dominant/Recessive	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000907793	5	121647978	5	122312283	907793	892660	rs1580686722	NC_000005.10:122312282:G:A
NM_005460.4(SNCAIP):c.-54C>A	SNCAIP		Parkinson Disease, Dominant/Recessive	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000907792	5	121647972	5	122312277	907792	892659	rs1418351789	NC_000005.10:122312276:C:A
NM_005460.4(SNCAIP):c.1087G>A (p.Ala363Thr)	SNCAIP	A410T, A363T, A57T	Parkinson Disease, Dominant/Recessive	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000906851	5	121761131	5	122425436	906851	892670	rs145038921	NC_000005.10:122425435:G:A
NM_005460.4(SNCAIP):c.1002+7A>G	SNCAIP		Parkinson Disease, Dominant/Recessive	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000906850	5	121759441	5	122423746	906850	896017	rs574376579	NC_000005.10:122423745:A:G
NM_005460.4(SNCAIP):c.1002+2T>C	SNCAIP		Parkinson Disease, Dominant/Recessive	Uncertain significance(Last reviewed: May 2, 2017)	criteria provided, single submitter	VCV000906849	5	121759436	5	122423741	906849	896016	rs1776845244	NC_000005.10:122423740:T:C
NM_005460.4(SNCAIP):c.806G>A (p.Arg269Gln)	SNCAIP	R269Q, R316Q	Parkinson Disease, Dominant/Recessive	Likely benign(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000906848	5	121759238	5	122423543	906848	892669	rs776653393	NC_000005.10:122423542:G:A
NM_005460.4(SNCAIP):c.709G>A (p.Glu237Lys)	SNCAIP	E237K, E284K	Parkinson Disease, Dominant/Recessive	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000906847	5	121759141	5	122423446	906847	892668	rs771056040	NC_000005.10:122423445:G:A
NM_005460.4(SNCAIP):c.2685C>T (p.Thr895=)	SNCAIP|MGC32805		Parkinson Disease, Dominant/Recessive	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000905321	5	121787227	5	122451532	905321	892681	rs1387612218	NC_000005.10:122451531:C:T
NM_005460.4(SNCAIP):c.417G>A (p.Ser139=)	SNCAIP		Parkinson Disease, Dominant/Recessive	Benign(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000905253	5	121758849	5	122423154	905253	892667	rs79757283	NC_000005.10:122423153:G:A
NM_005460.4(SNCAIP):c.388C>T (p.Pro130Ser)	SNCAIP	P130S, P177S	Parkinson Disease, Dominant/Recessive	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000904473	5	121758820	5	122423125	904473	892666	rs1776726284	NC_000005.10:122423124:C:T
NM_005460.4(SNCAIP):c.292A>G (p.Lys98Glu)	SNCAIP	K98E, K145E	Parkinson Disease, Dominant/Recessive	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000904472	5	121758724	5	122423029	904472	892665	rs1776706630	NC_000005.10:122423028:A:G
NM_005460.4(SNCAIP):c.258A>G (p.Pro86=)	SNCAIP		Parkinson Disease, Dominant/Recessive	Likely benign(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000904471	5	121758690	5	122422995	904471	892664	rs148912393	NC_000005.10:122422994:A:G
NM_005460.4(SNCAIP):c.198C>T (p.Ile66=)	SNCAIP		Parkinson Disease, Dominant/Recessive	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000904470	5	121758630	5	122422935	904470	892663	rs370204801	NC_000005.10:122422934:C:T
NM_005460.4(SNCAIP):c.137G>A (p.Ser46Asn)	SNCAIP	S46N, S93N	Parkinson Disease, Dominant/Recessive	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000904469	5	121758569	5	122422874	904469	892662	rs1393526827	NC_000005.10:122422873:G:A
NM_005460.4(SNCAIP):c.111G>A (p.Thr37=)	SNCAIP	R22H, R20H	not provided|Parkinson Disease, Dominant/Recessive	Likely benign(Last reviewed: Dec 31, 2019)	criteria provided, multiple submitters, no conflicts	VCV000784627	5	121739541	5	122403846	784627	709594	rs10070158	NC_000005.10:122403845:G:A
NM_005460.4(SNCAIP):c.1510C>T (p.Leu504=)	SNCAIP|MGC32805		Parkinson Disease, Dominant/Recessive|not provided	Likely benign(Last reviewed: Nov 6, 2018)	criteria provided, multiple submitters, no conflicts	VCV000350495	5	121780345	5	122444650	350495	294999	rs113042472	NC_000005.10:122444649:C:T
NM_005460.4(SNCAIP):c.1218C>T (p.Ser406=)	SNCAIP		Parkinson Disease, Dominant/Recessive|not provided	Benign(Last reviewed: Jun 26, 2018)	criteria provided, multiple submitters, no conflicts	VCV000350494	5	121767699	5	122432004	350494	300472	rs148152880	NC_000005.10:122432003:C:T
NM_005460.4(SNCAIP):c.1134C>T (p.Leu378=)	SNCAIP		Parkinson Disease, Dominant/Recessive|not provided	Benign(Last reviewed: Dec 31, 2019)	criteria provided, multiple submitters, no conflicts	VCV000350493	5	121761178	5	122425483	350493	294994	rs55770446	NC_000005.10:122425482:C:T
NM_005460.4(SNCAIP):c.786A>C (p.Thr262=)	SNCAIP		Parkinson Disease, Dominant/Recessive	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000350492	5	121759218	5	122423523	350492	300471	rs147831994	NC_000005.10:122423522:A:C
NM_005460.4(SNCAIP):c.708C>T (p.Thr236=)	SNCAIP		Parkinson Disease, Dominant/Recessive	Likely benign(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000350491	5	121759140	5	122423445	350491	296761	rs377374083	NC_000005.10:122423444:C:T
NM_005460.4(SNCAIP):c.688A>G (p.Lys230Glu)	SNCAIP	K230E, K277E	Parkinson Disease, Dominant/Recessive	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000350490	5	121759120	5	122423425	350490	300469	rs374522874	NC_000005.10:122423424:A:G
NM_005460.4(SNCAIP):c.672C>T (p.Val224=)	SNCAIP		Parkinson Disease, Dominant/Recessive	Likely benign(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000350489	5	121759104	5	122423409	350489	300540	rs376151621	NC_000005.10:122423408:C:T
NM_005460.4(SNCAIP):c.665C>T (p.Ser222Leu)	SNCAIP	S222L, S269L	Parkinson Disease, Dominant/Recessive	Likely benign(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000350488	5	121759097	5	122423402	350488	294993	rs147594642	NC_000005.10:122423401:C:T
NM_005460.4(SNCAIP):c.636C>T (p.Pro212=)	SNCAIP		Parkinson Disease, Dominant/Recessive|not provided	Benign/Likely benign(Last reviewed: Dec 31, 2019)	criteria provided, multiple submitters, no conflicts	VCV000350487	5	121759068	5	122423373	350487	300451	rs56331004	NC_000005.10:122423372:C:T
NM_005460.4(SNCAIP):c.608A>G (p.Asn203Ser)	SNCAIP	N203S, N250S	Parkinson Disease, Dominant/Recessive	Likely benign(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000350486	5	121759040	5	122423345	350486	296739	rs144384727	NC_000005.10:122423344:A:G
NM_005460.4(SNCAIP):c.444C>T (p.Leu148=)	SNCAIP		Parkinson Disease, Dominant/Recessive	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000350485	5	121758876	5	122423181	350485	300525	rs762767013	NC_000005.10:122423180:C:T
NM_005460.4(SNCAIP):c.429G>A (p.Leu143=)	SNCAIP		Parkinson Disease, Dominant/Recessive	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000350484	5	121758861	5	122423166	350484	296738	rs886059825	NC_000005.10:122423165:G:A
NM_005460.4(SNCAIP):c.204T>C (p.Asp68=)	SNCAIP		Parkinson Disease, Dominant/Recessive	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000350483	5	121758636	5	122422941	350483	300518	rs770583296	NC_000005.10:122422940:T:C
NM_005460.4(SNCAIP):c.81G>A (p.Thr27=)	SNCAIP	R12Q, R10Q	not provided|Parkinson Disease, Dominant/Recessive	Benign(Last reviewed: Dec 31, 2019)	criteria provided, multiple submitters, no conflicts	VCV000350482	5	121739511	5	122403816	350482	300450	rs149915358	NC_000005.10:122403815:G:A
NM_005460.4(SNCAIP):c.-13G>T	SNCAIP		Parkinson Disease, Dominant/Recessive	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000350481	5	121726817	5	122391122	350481	300509	rs762576870	NC_000005.10:122391121:G:T
NM_005460.4(SNCAIP):c.-47+3G>A	SNCAIP		Parkinson Disease, Dominant/Recessive	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000350480	5	121647982	5	122312287	350480	300501	rs886059824	NC_000005.10:122312286:G:A
NM_005460.4(SNCAIP):c.-49C>G	SNCAIP		Parkinson Disease, Dominant/Recessive	Benign(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000350479	5	121647977	5	122312282	350479	296735	rs192969505	NC_000005.10:122312281:C:G
NM_005460.4(SNCAIP):c.-66C>T	SNCAIP		Parkinson Disease, Dominant/Recessive	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000350478	5	121647960	5	122312265	350478	294991	rs886059823	NC_000005.10:122312264:C:T
NM_005460.4(SNCAIP):c.1861C>T (p.Arg621Cys)	SNCAIP|MGC32805	R621C, R561C, R253C, R255C, R217C, R315C, R668C	not provided|Parkinson disease, late-onset|Parkinson Disease, Dominant/Recessive	Likely benign(Last reviewed: Dec 31, 2019)	criteria provided, multiple submitters, no conflicts	VCV000006078	5	121786403	5	122450708	6078	21117	rs28937592	NC_000005.10:122450707:C:T
NM_003098.3(SNTA1):c.1088A>C (p.Glu363Ala)	SNTA1	E363A	Long QT syndrome|Long QT syndrome 12|not provided|Wolff-Parkinson-White pattern|Cardiovascular phenotype	Conflicting interpretations of pathogenicity(Last reviewed: Oct 18, 2019)	criteria provided, conflicting interpretations	VCV000190918	20	31998090	20	33410284	190918	188722	rs147964932	NC_000020.11:33410283:T:G
NM_025137.4(SPG11):c.5121G>T (p.Glu1707Asp)	SPG11	E1707D	Spastic paraplegia 11, autosomal recessive|not provided|Intellectual disability	Uncertain significance(Last reviewed: Jan 4, 2022)	criteria provided, multiple submitters, no conflicts	VCV000406519	15	44877834	15	44585636	406519	400100	rs145643238	NC_000015.10:44585635:C:A
NM_203446.3(SYNJ1):c.*798T>C	SYNJ1		Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Likely benign(Last reviewed: Nov 1, 2021)	criteria provided, single submitter	VCV001673659	21	34003317	21	32631007	1673659	1648959		NC_000021.9:32631006:A:G
NM_203446.3(SYNJ1):c.3697+12T>G	SYNJ1		Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Likely benign(Last reviewed: Nov 27, 2021)	criteria provided, single submitter	VCV001673649	21	34011969	21	32639659	1673649	1648949		NC_000021.9:32639658:A:C
NM_203446.3(SYNJ1):c.949-15C>T	SYNJ1		Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Likely benign(Last reviewed: Jul 26, 2021)	criteria provided, single submitter	VCV001673485	21	34058242	21	32685932	1673485	1595672		NC_000021.9:32685931:G:A
NM_203446.3(SYNJ1):c.852-20T>C	SYNJ1		Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Likely benign(Last reviewed: Apr 16, 2021)	criteria provided, single submitter	VCV001672865	21	34059404	21	32687094	1672865	1531312		NC_000021.9:32687093:A:G
NM_203446.3(SYNJ1):c.2043C>G (p.Thr681=)	SYNJ1		Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Likely benign(Last reviewed: Jun 28, 2021)	criteria provided, single submitter	VCV001671004	21	34038355	21	32666045	1671004	1529894		NC_000021.9:32666044:G:C
NM_203446.3(SYNJ1):c.3639G>A (p.Arg1213=)	SYNJ1		Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Likely benign(Last reviewed: Jun 6, 2021)	criteria provided, single submitter	VCV001670135	21	34012039	21	32639729	1670135	1635500		NC_000021.9:32639728:C:T
NM_203446.3(SYNJ1):c.24G>T (p.Arg8=)	SYNJ1		Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Likely benign(Last reviewed: Jan 8, 2021)	criteria provided, single submitter	VCV001669972	21	34099183	21	32726872	1669972	1582650		NC_000021.9:32726871:C:A
NM_203446.3(SYNJ1):c.-23+11C>T	SYNJ1		Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Likely benign(Last reviewed: Aug 2, 2021)	criteria provided, single submitter	VCV001668418	21	34100246	21	32727935	1668418	1633792		NC_000021.9:32727934:G:A
NM_203446.3(SYNJ1):c.3396T>C (p.Ala1132=)	SYNJ1		Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Likely benign(Last reviewed: Dec 26, 2020)	criteria provided, single submitter	VCV001668115	21	34017312	21	32645002	1668115	1569980		NC_000021.9:32645001:A:G
NM_203446.3(SYNJ1):c.*519C>T	SYNJ1		Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Likely benign(Last reviewed: Jun 21, 2021)	criteria provided, single submitter	VCV001667815	21	34003596	21	32631286	1667815	1657098		NC_000021.9:32631285:G:A
NM_203446.3(SYNJ1):c.3518-17T>C	SYNJ1		Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Likely benign(Last reviewed: Apr 12, 2021)	criteria provided, single submitter	VCV001666613	21	34014293	21	32641983	1666613	1568924		NC_000021.9:32641982:A:G
NM_203446.3(SYNJ1):c.1335T>C (p.Ala445=)	SYNJ1		Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Likely benign(Last reviewed: Jun 19, 2021)	criteria provided, single submitter	VCV001665759	21	34053824	21	32681514	1665759	1590142		NC_000021.9:32681513:A:G
NM_203446.3(SYNJ1):c.387T>C (p.Tyr129=)	SYNJ1		Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Likely benign(Last reviewed: May 26, 2021)	criteria provided, single submitter	VCV001662542	21	34072240	21	32699930	1662542	1642765		NC_000021.9:32699929:A:G
NM_203446.3(SYNJ1):c.-19T>A	SYNJ1		Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Likely benign(Last reviewed: Oct 30, 2021)	criteria provided, single submitter	VCV001661840	21	34099225	21	32726914	1661840	1608201		NC_000021.9:32726913:A:T
NM_203446.3(SYNJ1):c.2037T>C (p.His679=)	SYNJ1		Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Likely benign(Last reviewed: Dec 30, 2020)	criteria provided, single submitter	VCV001661819	21	34038361	21	32666051	1661819	1608180		NC_000021.9:32666050:A:G
NM_203446.3(SYNJ1):c.3273A>C (p.Ala1091=)	SYNJ1		Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Likely benign(Last reviewed: Dec 9, 2020)	criteria provided, single submitter	VCV001660173	21	34018074	21	32645764	1660173	1575496		NC_000021.9:32645763:T:G
NM_203446.3(SYNJ1):c.2579+14_2579+15del	SYNJ1		Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Likely benign(Last reviewed: Jun 3, 2021)	criteria provided, single submitter	VCV001658621	21	34029298 - 34029299	21	32656988 - 32656989	1658621	1563997		NC_000021.9:32656987:TG:
NM_203446.3(SYNJ1):c.1851G>A (p.Lys617=)	SYNJ1		Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Likely benign(Last reviewed: May 13, 2021)	criteria provided, single submitter	VCV001658188	21	34038844	21	32666534	1658188	1594189		NC_000021.9:32666533:C:T
NM_203446.3(SYNJ1):c.3589-16T>G	SYNJ1		Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Likely benign(Last reviewed: Sep 29, 2021)	criteria provided, single submitter	VCV001656870	21	34012105	21	32639795	1656870	1562254		NC_000021.9:32639794:A:C
NM_203446.3(SYNJ1):c.3456G>C (p.Gly1152=)	SYNJ1		Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Likely benign(Last reviewed: Nov 23, 2020)	criteria provided, single submitter	VCV001654769	21	34015742	21	32643432	1654769	1580398		NC_000021.9:32643431:C:G
NM_203446.3(SYNJ1):c.1281A>G (p.Ser427=)	SYNJ1		Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Likely benign(Last reviewed: Aug 11, 2021)	criteria provided, single submitter	VCV001654746	21	34053878	21	32681568	1654746	1580375		NC_000021.9:32681567:T:C
NM_203446.3(SYNJ1):c.1952+19C>T	SYNJ1		Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Likely benign(Last reviewed: Aug 24, 2021)	criteria provided, single submitter	VCV001654482	21	34038724	21	32666414	1654482	1580112		NC_000021.9:32666413:G:A
NM_203446.3(SYNJ1):c.1726+18T>C	SYNJ1		Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Likely benign(Last reviewed: Oct 23, 2021)	criteria provided, single submitter	VCV001654301	21	34045632	21	32673322	1654301	1527119		NC_000021.9:32673321:A:G
NM_203446.3(SYNJ1):c.1047T>C (p.Ser349=)	SYNJ1		Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Likely benign(Last reviewed: Mar 27, 2021)	criteria provided, single submitter	VCV001653681	21	34058129	21	32685819	1653681	1614031		NC_000021.9:32685818:A:G
NM_203446.3(SYNJ1):c.*721C>T	SYNJ1		Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Likely benign(Last reviewed: Jun 24, 2021)	criteria provided, single submitter	VCV001649311	21	34003394	21	32631084	1649311	1567166		NC_000021.9:32631083:G:A
NM_203446.3(SYNJ1):c.-73C>G	SYNJ1		Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Likely benign(Last reviewed: Nov 19, 2021)	criteria provided, single submitter	VCV001647529	21	34100307	21	32727996	1647529	1566257		NC_000021.9:32727995:G:C
NM_203446.3(SYNJ1):c.3517+13G>C	SYNJ1		Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Likely benign(Last reviewed: Nov 6, 2021)	criteria provided, single submitter	VCV001646295	21	34014392	21	32642082	1646295	1533865		NC_000021.9:32642081:C:G
NM_203446.3(SYNJ1):c.*195T>C	SYNJ1		Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Likely benign(Last reviewed: Mar 25, 2021)	criteria provided, single submitter	VCV001645875	21	34003920	21	32631610	1645875	1565479		NC_000021.9:32631609:A:G
NM_203446.3(SYNJ1):c.790-18A>G	SYNJ1		Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Likely benign(Last reviewed: Sep 9, 2021)	criteria provided, single submitter	VCV001642573	21	34060695	21	32688385	1642573	1552671		NC_000021.9:32688384:T:C
NM_203446.3(SYNJ1):c.1290C>T (p.Ser430=)	SYNJ1		Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Likely benign(Last reviewed: Feb 14, 2021)	criteria provided, single submitter	VCV001642474	21	34053869	21	32681559	1642474	1552572		NC_000021.9:32681558:G:A
NM_203446.3(SYNJ1):c.1201-16_1201-15del	SYNJ1		Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Likely benign(Last reviewed: Jun 9, 2021)	criteria provided, single submitter	VCV001641426	21	34053973 - 34053974	21	32681663 - 32681664	1641426	1585824		NC_000021.9:32681662:AA:
NM_203446.3(SYNJ1):c.-64C>A	SYNJ1		Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Likely benign(Last reviewed: Oct 2, 2021)	criteria provided, single submitter	VCV001641424	21	34100298	21	32727987	1641424	1585822		NC_000021.9:32727986:G:T
NM_203446.3(SYNJ1):c.1812-16T>G	SYNJ1		Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Likely benign(Last reviewed: Jul 21, 2021)	criteria provided, single submitter	VCV001641420	21	34038899	21	32666589	1641420	1520354		NC_000021.9:32666588:A:C
NM_203446.3(SYNJ1):c.2875-20T>C	SYNJ1		Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Likely benign(Last reviewed: Oct 12, 2021)	criteria provided, single submitter	VCV001636873	21	34022676	21	32650366	1636873	1612162		NC_000021.9:32650365:A:G
NM_203446.3(SYNJ1):c.3478+12C>T	SYNJ1		Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Likely benign(Last reviewed: Aug 11, 2021)	criteria provided, single submitter	VCV001635328	21	34015708	21	32643398	1635328	1611054		NC_000021.9:32643397:G:A
NM_203446.3(SYNJ1):c.2520G>A (p.Thr840=)	SYNJ1		Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Likely benign(Last reviewed: Feb 18, 2021)	criteria provided, single submitter	VCV001634992	21	34029372	21	32657062	1634992	1610718		NC_000021.9:32657061:C:T
NM_203446.3(SYNJ1):c.1811+9G>A	SYNJ1		Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Likely benign(Last reviewed: Feb 22, 2021)	criteria provided, single submitter	VCV001633794	21	34042589	21	32670279	1633794	1661195		NC_000021.9:32670278:C:T
NM_203446.3(SYNJ1):c.3015T>C (p.Val1005=)	SYNJ1		Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Likely benign(Last reviewed: Oct 14, 2021)	criteria provided, single submitter	VCV001627333	21	34022516	21	32650206	1627333	1616358		NC_000021.9:32650205:A:G
NM_203446.3(SYNJ1):c.2304+20A>G	SYNJ1		Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Likely benign(Last reviewed: Oct 22, 2021)	criteria provided, single submitter	VCV001626317	21	34037203	21	32664893	1626317	1583322		NC_000021.9:32664892:T:C
NM_203446.3(SYNJ1):c.125-13del	SYNJ1		Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Likely benign(Last reviewed: Apr 10, 2021)	criteria provided, single submitter	VCV001625780	21	34074370	21	32702060	1625780	1607340		NC_000021.9:32702059:G:
NM_203446.3(SYNJ1):c.479+13T>A	SYNJ1		Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Likely benign(Last reviewed: May 31, 2021)	criteria provided, single submitter	VCV001622517	21	34072135	21	32699825	1622517	1561364		NC_000021.9:32699824:A:T
NM_203446.3(SYNJ1):c.834T>C (p.Asn278=)	SYNJ1		Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Likely benign(Last reviewed: Oct 6, 2021)	criteria provided, single submitter	VCV001621277	21	34060633	21	32688323	1621277	1615524		NC_000021.9:32688322:A:G
NM_203446.3(SYNJ1):c.3393G>A (p.Gly1131=)	SYNJ1		Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Likely benign(Last reviewed: Sep 6, 2021)	criteria provided, single submitter	VCV001620695	21	34017315	21	32645005	1620695	1549167		NC_000021.9:32645004:C:T
NM_203446.3(SYNJ1):c.211+19A>G	SYNJ1		Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Likely benign(Last reviewed: Mar 3, 2021)	criteria provided, single submitter	VCV001619721	21	34074252	21	32701942	1619721	1527736		NC_000021.9:32701941:T:C
NM_203446.3(SYNJ1):c.851+20G>C	SYNJ1		Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Likely benign(Last reviewed: Aug 26, 2021)	criteria provided, single submitter	VCV001619208	21	34060596	21	32688286	1619208	1548982		NC_000021.9:32688285:C:G
NM_203446.3(SYNJ1):c.124+20C>T	SYNJ1		Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Likely benign(Last reviewed: Nov 23, 2021)	criteria provided, single submitter	VCV001618614	21	34099063	21	32726752	1618614	1580747		NC_000021.9:32726751:G:A
NM_203446.3(SYNJ1):c.1929A>G (p.Arg643=)	SYNJ1		Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Likely benign(Last reviewed: Nov 27, 2020)	criteria provided, single submitter	VCV001617456	21	34038766	21	32666456	1617456	1548533		NC_000021.9:32666455:T:C
NM_203446.3(SYNJ1):c.1353+15A>C	SYNJ1		Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Likely benign(Last reviewed: Oct 22, 2021)	criteria provided, single submitter	VCV001616864	21	34053791	21	32681481	1616864	1579867		NC_000021.9:32681480:T:G
NM_203446.3(SYNJ1):c.3369A>C (p.Pro1123=)	SYNJ1		Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Likely benign(Last reviewed: May 8, 2021)	criteria provided, single submitter	VCV001616649	21	34017978	21	32645668	1616649	1526838		NC_000021.9:32645667:T:G
NM_203446.3(SYNJ1):c.706-11T>C	SYNJ1		Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Benign(Last reviewed: Nov 28, 2021)	criteria provided, single submitter	VCV001615907	21	34066632	21	32694322	1615907	1613627		NC_000021.9:32694321:A:G
NM_203446.3(SYNJ1):c.3391+8C>T	SYNJ1		Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Likely benign(Last reviewed: Nov 2, 2021)	criteria provided, single submitter	VCV001614833	21	34017948	21	32645638	1614833	1664107		NC_000021.9:32645637:G:A
NM_203446.3(SYNJ1):c.-23+19G>A	SYNJ1		Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Likely benign(Last reviewed: Oct 20, 2021)	criteria provided, single submitter	VCV001611945	21	34100238	21	32727927	1611945	1535573		NC_000021.9:32727926:C:T
NM_203446.3(SYNJ1):c.705+17A>G	SYNJ1		Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Likely benign(Last reviewed: Sep 11, 2021)	criteria provided, single submitter	VCV001611325	21	34067350	21	32695040	1611325	1650788		NC_000021.9:32695039:T:C
NM_203446.3(SYNJ1):c.*513T>C	SYNJ1		Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Likely benign(Last reviewed: Dec 18, 2020)	criteria provided, single submitter	VCV001610822	21	34003602	21	32631292	1610822	1585640		NC_000021.9:32631291:A:G
NM_203446.3(SYNJ1):c.3479-14T>C	SYNJ1		Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Likely benign(Last reviewed: Oct 14, 2021)	criteria provided, single submitter	VCV001610814	21	34014457	21	32642147	1610814	1585632		NC_000021.9:32642146:A:G
NM_203446.3(SYNJ1):c.480-17A>C	SYNJ1		Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Likely benign(Last reviewed: Aug 9, 2021)	criteria provided, single submitter	VCV001610812	21	34067609	21	32695299	1610812	1585630		NC_000021.9:32695298:T:G
NM_203446.3(SYNJ1):c.*390G>A	SYNJ1		Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Likely benign(Last reviewed: Oct 5, 2021)	criteria provided, single submitter	VCV001608276	21	34003725	21	32631415	1608276	1539715		NC_000021.9:32631414:C:T
NM_203446.3(SYNJ1):c.*4-17C>T	SYNJ1		Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Likely benign(Last reviewed: Sep 15, 2021)	criteria provided, single submitter	VCV001604745	21	34004128	21	32631818	1604745	1623899		NC_000021.9:32631817:G:A
NM_203446.3(SYNJ1):c.852-10_852-7del	SYNJ1		Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Likely benign(Last reviewed: Oct 5, 2021)	criteria provided, single submitter	VCV001604411	21	34059391 - 34059394	21	32687081 - 32687084	1604411	1558925		NC_000021.9:32687080:AAGAAAGAAAG:AAGAAAG
NM_203446.3(SYNJ1):c.-23+16G>C	SYNJ1		Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Likely benign(Last reviewed: Oct 28, 2021)	criteria provided, single submitter	VCV001604394	21	34100241	21	32727930	1604394	1558908		NC_000021.9:32727929:C:G
NM_203446.3(SYNJ1):c.1811+8A>G	SYNJ1		Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Likely benign(Last reviewed: Jul 1, 2021)	criteria provided, single submitter	VCV001604222	21	34042590	21	32670280	1604222	1558736		NC_000021.9:32670279:T:C
NM_203446.3(SYNJ1):c.1811+8_1811+9insCTT	SYNJ1		Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Likely benign(Last reviewed: Jul 1, 2021)	criteria provided, single submitter	VCV001604221	21	34042589 - 34042590	21	32670279 - 32670280	1604221	1558735		NC_000021.9:32670279::AAG
NM_203446.3(SYNJ1):c.1510+16_1510+17del	SYNJ1		Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Benign(Last reviewed: Dec 19, 2021)	criteria provided, single submitter	VCV001600919	21	34050938 - 34050939	21	32678628 - 32678629	1600919	1546346		NC_000021.9:32678627:ATATA:ATA
NM_203446.3(SYNJ1):c.-23+15G>A	SYNJ1		Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Benign(Last reviewed: Sep 25, 2021)	criteria provided, single submitter	VCV001600629	21	34100242	21	32727931	1600629	1546056		NC_000021.9:32727930:C:T
NM_203446.3(SYNJ1):c.1510+13T>A	SYNJ1		Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Benign(Last reviewed: Dec 19, 2021)	criteria provided, single submitter	VCV001599243	21	34050942	21	32678632	1599243	1544677		NC_000021.9:32678631:A:T
NM_203446.3(SYNJ1):c.-61C>A	SYNJ1		Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Likely benign(Last reviewed: Sep 24, 2021)	criteria provided, single submitter	VCV001598069	21	34100295	21	32727984	1598069	1660675		NC_000021.9:32727983:G:T
NM_203446.3(SYNJ1):c.1959T>G (p.Val653=)	SYNJ1		Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Likely benign(Last reviewed: Aug 7, 2021)	criteria provided, single submitter	VCV001596871	21	34038439	21	32666129	1596871	1602466		NC_000021.9:32666128:A:C
NM_203446.3(SYNJ1):c.3037+18A>G	SYNJ1		Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Likely benign(Last reviewed: Mar 25, 2021)	criteria provided, single submitter	VCV001596393	21	34022476	21	32650166	1596393	1633476		NC_000021.9:32650165:T:C
NM_203446.3(SYNJ1):c.3333C>G (p.Pro1111=)	SYNJ1		Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Likely benign(Last reviewed: May 16, 2021)	criteria provided, single submitter	VCV001595705	21	34018014	21	32645704	1595705	1656695		NC_000021.9:32645703:G:C
NM_203446.3(SYNJ1):c.3589-16T>C	SYNJ1		Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Likely benign(Last reviewed: Jun 19, 2021)	criteria provided, single submitter	VCV001595079	21	34012105	21	32639795	1595079	1590719		NC_000021.9:32639794:A:G
NM_203446.3(SYNJ1):c.-37G>A	SYNJ1		Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Likely benign(Last reviewed: Nov 4, 2021)	criteria provided, single submitter	VCV001594891	21	34100271	21	32727960	1594891	1622014		NC_000021.9:32727959:C:T
NM_203446.3(SYNJ1):c.*762G>A	SYNJ1		Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Likely benign(Last reviewed: Oct 2, 2021)	criteria provided, single submitter	VCV001591546	21	34003353	21	32631043	1591546	1577662		NC_000021.9:32631042:C:T
NM_203446.3(SYNJ1):c.706-7T>C	SYNJ1		Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Likely benign(Last reviewed: Nov 9, 2021)	criteria provided, single submitter	VCV001590990	21	34066628	21	32694318	1590990	1555468		NC_000021.9:32694317:A:G
NM_203446.3(SYNJ1):c.3588+20G>A	SYNJ1		Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Likely benign(Last reviewed: Oct 27, 2021)	criteria provided, single submitter	VCV001590573	21	34014186	21	32641876	1590573	1642466		NC_000021.9:32641875:C:T
NM_203446.3(SYNJ1):c.1118+7C>T	SYNJ1		Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Likely benign(Last reviewed: Aug 2, 2021)	criteria provided, single submitter	VCV001590318	21	34058051	21	32685741	1590318	1642211		NC_000021.9:32685740:G:A
NM_203446.3(SYNJ1):c.351A>G (p.Ser117=)	SYNJ1		Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Likely benign(Last reviewed: Dec 16, 2020)	criteria provided, single submitter	VCV001589561	21	34072276	21	32699966	1589561	1607583		NC_000021.9:32699965:T:C
NM_203446.3(SYNJ1):c.759T>G (p.Val253=)	SYNJ1		Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Likely benign(Last reviewed: Oct 28, 2021)	criteria provided, single submitter	VCV001584234	21	34066568	21	32694258	1584234	1581492		NC_000021.9:32694257:A:C
NM_203446.3(SYNJ1):c.1404T>C (p.Phe468=)	SYNJ1		Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Likely benign(Last reviewed: Nov 27, 2021)	criteria provided, single submitter	VCV001583647	21	34051061	21	32678751	1583647	1601342		NC_000021.9:32678750:A:G
NM_203446.3(SYNJ1):c.1534+16T>A	SYNJ1		Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Likely benign(Last reviewed: Aug 17, 2021)	criteria provided, single submitter	VCV001583596	21	34048626	21	32676316	1583596	1601291		NC_000021.9:32676315:A:T
NM_203446.3(SYNJ1):c.1534+9T>C	SYNJ1		Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Likely benign(Last reviewed: May 25, 2021)	criteria provided, single submitter	VCV001583546	21	34048633	21	32676323	1583546	1601241		NC_000021.9:32676322:A:G
NM_203446.3(SYNJ1):c.2146-14C>G	SYNJ1		Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Likely benign(Last reviewed: Nov 5, 2021)	criteria provided, single submitter	VCV001580703	21	34037395	21	32665085	1580703	1565830		NC_000021.9:32665084:G:C
NM_203446.3(SYNJ1):c.*60A>C	SYNJ1		Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Likely benign(Last reviewed: Nov 14, 2021)	criteria provided, single submitter	VCV001575707	21	34004055	21	32631745	1575707	1551735		NC_000021.9:32631744:T:G
NM_203446.3(SYNJ1):c.684C>T (p.Ala228=)	SYNJ1		Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Likely benign(Last reviewed: Nov 24, 2021)	criteria provided, single submitter	VCV001575046	21	34067388	21	32695078	1575046	1585369		NC_000021.9:32695077:G:A
NM_203446.3(SYNJ1):c.3840G>A (p.Leu1280=)	SYNJ1		Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Likely benign(Last reviewed: May 18, 2021)	criteria provided, single submitter	VCV001574545	21	34011293	21	32638983	1574545	1659730		NC_000021.9:32638982:C:T
NM_203446.3(SYNJ1):c.435G>T (p.Ala145=)	SYNJ1		Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Likely benign(Last reviewed: Nov 5, 2021)	criteria provided, single submitter	VCV001574161	21	34072192	21	32699882	1574161	1539364		NC_000021.9:32699881:C:A
NM_203446.3(SYNJ1):c.2795+16T>A	SYNJ1		Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Likely benign(Last reviewed: Aug 31, 2021)	criteria provided, single submitter	VCV001563094	21	34028981	21	32656671	1563094	1556092		NC_000021.9:32656670:A:T
NM_203446.3(SYNJ1):c.537A>G (p.Leu179=)	SYNJ1		Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Likely benign(Last reviewed: Jun 14, 2021)	criteria provided, single submitter	VCV001562615	21	34067535	21	32695225	1562615	1643026		NC_000021.9:32695224:T:C
NM_203446.3(SYNJ1):c.1566G>A (p.Glu522=)	SYNJ1		Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Likely benign(Last reviewed: Sep 15, 2021)	criteria provided, single submitter	VCV001562563	21	34045810	21	32673500	1562563	1642974		NC_000021.9:32673499:C:T
NM_203446.3(SYNJ1):c.2580-20A>G	SYNJ1		Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Likely benign(Last reviewed: Aug 30, 2021)	criteria provided, single submitter	VCV001562357	21	34029232	21	32656922	1562357	1577421		NC_000021.9:32656921:T:C
NM_203446.3(SYNJ1):c.429T>C (p.Leu143=)	SYNJ1		Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Likely benign(Last reviewed: Jul 27, 2021)	criteria provided, single submitter	VCV001561384	21	34072198	21	32699888	1561384	1554809		NC_000021.9:32699887:A:G
NM_203446.3(SYNJ1):c.2514G>C (p.Leu838=)	SYNJ1		Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Likely benign(Last reviewed: Nov 27, 2021)	criteria provided, single submitter	VCV001559167	21	34029378	21	32657068	1559167	1629618		NC_000021.9:32657067:C:G
NM_203446.3(SYNJ1):c.480-7C>T	SYNJ1		Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Likely benign(Last reviewed: May 10, 2021)	criteria provided, single submitter	VCV001558348	21	34067599	21	32695289	1558348	1594937		NC_000021.9:32695288:G:A
NM_203446.3(SYNJ1):c.2145+13T>C	SYNJ1		Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Likely benign(Last reviewed: Dec 12, 2021)	criteria provided, single submitter	VCV001554925	21	34038240	21	32665930	1554925	1564669		NC_000021.9:32665929:A:G
NM_203446.3(SYNJ1):c.3558A>T (p.Pro1186=)	SYNJ1		Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Likely benign(Last reviewed: Aug 28, 2021)	criteria provided, single submitter	VCV001554663	21	34014236	21	32641926	1554663	1652099		NC_000021.9:32641925:T:A
NM_203446.3(SYNJ1):c.3391+15T>A	SYNJ1		Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Likely benign(Last reviewed: Nov 2, 2021)	criteria provided, single submitter	VCV001554421	21	34017941	21	32645631	1554421	1651857		NC_000021.9:32645630:A:T
NM_203446.3(SYNJ1):c.480-18T>G	SYNJ1		Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Likely benign(Last reviewed: Nov 22, 2021)	criteria provided, single submitter	VCV001554223	21	34067610	21	32695300	1554223	1588307		NC_000021.9:32695299:A:C
NM_203446.3(SYNJ1):c.3411C>T (p.Pro1137=)	SYNJ1		Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Likely benign(Last reviewed: Dec 2, 2021)	criteria provided, single submitter	VCV001553687	21	34017297	21	32644987	1553687	1521867		NC_000021.9:32644986:G:A
NM_203446.3(SYNJ1):c.1535-18G>A	SYNJ1		Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Likely benign(Last reviewed: Apr 23, 2021)	criteria provided, single submitter	VCV001553525	21	34045859	21	32673549	1553525	1521705		NC_000021.9:32673548:C:T
NM_203446.3(SYNJ1):c.1617C>A (p.Thr539=)	SYNJ1		Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Likely benign(Last reviewed: Apr 23, 2021)	criteria provided, single submitter	VCV001553187	21	34045759	21	32673449	1553187	1552971		NC_000021.9:32673448:G:T
NM_203446.3(SYNJ1):c.126A>G (p.Ser42=)	SYNJ1		Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Likely benign(Last reviewed: Nov 4, 2021)	criteria provided, single submitter	VCV001551613	21	34074356	21	32702046	1551613	1551392		NC_000021.9:32702045:T:C
NM_203446.3(SYNJ1):c.*720T>C	SYNJ1		Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Likely benign(Last reviewed: Apr 12, 2021)	criteria provided, single submitter	VCV001550220	21	34003395	21	32631085	1550220	1659156		NC_000021.9:32631084:A:G
NM_203446.3(SYNJ1):c.3588+15G>A	SYNJ1		Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Likely benign(Last reviewed: Sep 22, 2021)	criteria provided, single submitter	VCV001550033	21	34014191	21	32641881	1550033	1658969		NC_000021.9:32641880:C:T
NM_203446.3(SYNJ1):c.-23+20G>A	SYNJ1		Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Likely benign(Last reviewed: Jun 1, 2021)	criteria provided, single submitter	VCV001548800	21	34100237	21	32727926	1548800	1572915		NC_000021.9:32727925:C:T
NM_203446.3(SYNJ1):c.3248-18C>T	SYNJ1		Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Likely benign(Last reviewed: Oct 25, 2021)	criteria provided, single submitter	VCV001547666	21	34018117	21	32645807	1547666	1624740		NC_000021.9:32645806:G:A
NM_203446.3(SYNJ1):c.2400C>T (p.Arg800=)	SYNJ1		Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Likely benign(Last reviewed: Nov 9, 2021)	criteria provided, single submitter	VCV001547049	21	34030087	21	32657777	1547049	1571592		NC_000021.9:32657776:G:A
NM_203446.3(SYNJ1):c.3765G>A (p.Pro1255=)	SYNJ1		Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Likely benign(Last reviewed: Aug 11, 2021)	criteria provided, single submitter	VCV001544901	21	34011368	21	32639058	1544901	1644307		NC_000021.9:32639057:C:T
NM_203446.3(SYNJ1):c.-51A>C	SYNJ1		Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Likely benign(Last reviewed: Mar 26, 2021)	criteria provided, single submitter	VCV001544524	21	34100285	21	32727974	1544524	1524802		NC_000021.9:32727973:T:G
NM_203446.3(SYNJ1):c.2580-14C>T	SYNJ1		Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Likely benign(Last reviewed: Sep 24, 2021)	criteria provided, single submitter	VCV001543986	21	34029226	21	32656916	1543986	1611524		NC_000021.9:32656915:G:A
NM_203446.3(SYNJ1):c.2337C>G (p.Thr779=)	SYNJ1		Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Likely benign(Last reviewed: Mar 13, 2021)	criteria provided, single submitter	VCV001540890	21	34030150	21	32657840	1540890	1609292		NC_000021.9:32657839:G:C
NM_203446.3(SYNJ1):c.3518-9T>C	SYNJ1		Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Likely benign(Last reviewed: Mar 25, 2021)	criteria provided, single submitter	VCV001539637	21	34014285	21	32641975	1539637	1660563		NC_000021.9:32641974:A:G
NM_203446.3(SYNJ1):c.243C>T (p.Val81=)	SYNJ1		Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Likely benign(Last reviewed: Apr 13, 2021)	criteria provided, single submitter	VCV001539066	21	34072384	21	32700074	1539066	1597947		NC_000021.9:32700073:G:A
NM_203446.3(SYNJ1):c.706-19A>G	SYNJ1		Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Likely benign(Last reviewed: Nov 13, 2021)	criteria provided, single submitter	VCV001538722	21	34066640	21	32694330	1538722	1544207		NC_000021.9:32694329:T:C
NM_203446.3(SYNJ1):c.1726+10_1726+11insA	SYNJ1		Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Likely benign(Last reviewed: Mar 2, 2021)	criteria provided, single submitter	VCV001537920	21	34045639 - 34045640	21	32673329 - 32673330	1537920	1619147		NC_000021.9:32673329::T
NM_203446.3(SYNJ1):c.*148A>C	SYNJ1		Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Likely benign(Last reviewed: Jul 15, 2021)	criteria provided, single submitter	VCV001537768	21	34003967	21	32631657	1537768	1650047		NC_000021.9:32631656:T:G
NM_203446.3(SYNJ1):c.1824G>A (p.Gln608=)	SYNJ1		Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Likely benign(Last reviewed: Jul 21, 2021)	criteria provided, single submitter	VCV001536259	21	34038871	21	32666561	1536259	1618348		NC_000021.9:32666560:C:T
NM_203446.3(SYNJ1):c.3392-20A>G	SYNJ1		Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Likely benign(Last reviewed: Apr 8, 2021)	criteria provided, single submitter	VCV001536198	21	34017336	21	32645026	1536198	1618287		NC_000021.9:32645025:T:C
NM_203446.3(SYNJ1):c.2715A>G (p.Pro905=)	SYNJ1		Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Likely benign(Last reviewed: Feb 21, 2021)	criteria provided, single submitter	VCV001536150	21	34029077	21	32656767	1536150	1648854		NC_000021.9:32656766:T:C
NM_203446.3(SYNJ1):c.2875-4C>A	SYNJ1		Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Likely benign(Last reviewed: Mar 31, 2021)	criteria provided, single submitter	VCV001535226	21	34022660	21	32650350	1535226	1531938		NC_000021.9:32650349:G:T
NM_203446.3(SYNJ1):c.125-17A>G	SYNJ1		Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Likely benign(Last reviewed: Nov 23, 2021)	criteria provided, single submitter	VCV001534782	21	34074374	21	32702064	1534782	1617298		NC_000021.9:32702063:T:C
NM_203446.3(SYNJ1):c.3248-19C>T	SYNJ1		Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Likely benign(Last reviewed: Mar 1, 2021)	criteria provided, single submitter	VCV001533485	21	34018118	21	32645808	1533485	1530625		NC_000021.9:32645807:G:A
NM_203446.3(SYNJ1):c.-64C>G	SYNJ1		Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Likely benign(Last reviewed: Feb 12, 2021)	criteria provided, single submitter	VCV001532395	21	34100298	21	32727987	1532395	1636006		NC_000021.9:32727986:G:C
NM_203446.3(SYNJ1):c.2462-19T>C	SYNJ1		Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Likely benign(Last reviewed: Feb 6, 2021)	criteria provided, single submitter	VCV001530779	21	34029449	21	32657139	1530779	1635251		NC_000021.9:32657138:A:G
NM_203446.3(SYNJ1):c.949-9del	SYNJ1		Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Benign(Last reviewed: Oct 4, 2021)	criteria provided, single submitter	VCV001530198	21	34058236	21	32685926	1530198	1581983		NC_000021.9:32685925:AAAAA:AAAA
NM_203446.3(SYNJ1):c.3430+12C>T	SYNJ1		Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Likely benign(Last reviewed: Nov 23, 2021)	criteria provided, single submitter	VCV001528204	21	34017266	21	32644956	1528204	1603351		NC_000021.9:32644955:G:A
NM_203446.3(SYNJ1):c.1996A>G (p.Thr666Ala)	SYNJ1	T661A, T705A, T666A	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Sep 15, 2021)	criteria provided, single submitter	VCV001521982	21	34038402	21	32666092	1521982	1343997		NC_000021.9:32666091:T:C
NM_203446.3(SYNJ1):c.1055A>C (p.Lys352Thr)	SYNJ1	K352T, K391T	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Aug 24, 2021)	criteria provided, single submitter	VCV001519313	21	34058121	21	32685811	1519313	1433810		NC_000021.9:32685810:T:G
NM_203446.3(SYNJ1):c.1346A>G (p.Lys449Arg)	SYNJ1	K488R, K449R	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Nov 14, 2021)	criteria provided, single submitter	VCV001518053	21	34053813	21	32681503	1518053	1512325		NC_000021.9:32681502:T:C
NM_203446.3(SYNJ1):c.-55C>G	SYNJ1	C21W	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Aug 26, 2021)	criteria provided, single submitter	VCV001516899	21	34100289	21	32727978	1516899	1495672		NC_000021.9:32727977:G:C
NM_203446.3(SYNJ1):c.2045G>A (p.Ser682Asn)	SYNJ1	S677N, S682N, S721N	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Sep 26, 2021)	criteria provided, single submitter	VCV001516244	21	34038353	21	32666043	1516244	1498898		NC_000021.9:32666042:C:T
NM_203446.3(SYNJ1):c.1646G>A (p.Arg549His)	SYNJ1	R549H, R588H, R544H	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Sep 15, 2021)	criteria provided, single submitter	VCV001516243	21	34045730	21	32673420	1516243	1498897		NC_000021.9:32673419:C:T
NM_203446.3(SYNJ1):c.2983A>C (p.Ser995Arg)	SYNJ1	S1034R, S990R, S995R	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Nov 26, 2021)	criteria provided, single submitter	VCV001514695	21	34022548	21	32650238	1514695	1485738		NC_000021.9:32650237:T:G
NM_203446.3(SYNJ1):c.802C>T (p.Arg268Cys)	SYNJ1	R307C, R268C	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Dec 2, 2021)	criteria provided, single submitter	VCV001511883	21	34060665	21	32688355	1511883	1455518		NC_000021.9:32688354:G:A
NM_203446.3(SYNJ1):c.439C>T (p.Arg147Cys)	SYNJ1	R147C, R186C	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Aug 31, 2021)	criteria provided, single submitter	VCV001511140	21	34072188	21	32699878	1511140	1377955		NC_000021.9:32699877:G:A
NM_203446.3(SYNJ1):c.2788_2793del (p.Leu930_Ile931del)	SYNJ1		Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Aug 13, 2021)	criteria provided, single submitter	VCV001509868	21	34028999 - 34029004	21	32656689 - 32656694	1509868	1445787		NC_000021.9:32656688:TATAAGTATAA:TATAA
NC_000021.8:g.(?_34029319)_(34031816_?)del	SYNJ1		Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Likely pathogenic(Last reviewed: Jul 19, 2021)	criteria provided, single submitter	VCV001509533	21	34029319 - 34031816			1509533	1365154		
NM_203446.3(SYNJ1):c.*482T>C	SYNJ1	F1418S, F1504S	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Sep 24, 2021)	criteria provided, single submitter	VCV001508400	21	34003633	21	32631323	1508400	1439612		NC_000021.9:32631322:A:G
NM_203446.3(SYNJ1):c.63A>G (p.Ile21Met)	SYNJ1	I60M, I21M	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Aug 31, 2021)	criteria provided, single submitter	VCV001506867	21	34099144	21	32726833	1506867	1426927		NC_000021.9:32726832:T:C
NM_203446.3(SYNJ1):c.409A>G (p.Ile137Val)	SYNJ1	I176V, I137V	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Aug 14, 2021)	criteria provided, single submitter	VCV001506794	21	34072218	21	32699908	1506794	1426854		NC_000021.9:32699907:T:C
NM_203446.3(SYNJ1):c.2696C>T (p.Ser899Leu)	SYNJ1	S894L, S899L, S938L	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Aug 17, 2021)	criteria provided, single submitter	VCV001506386	21	34029096	21	32656786	1506386	1430311		NC_000021.9:32656785:G:A
NM_203446.3(SYNJ1):c.3517+6A>C	SYNJ1		Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Apr 6, 2021)	criteria provided, single submitter	VCV001505996	21	34014399	21	32642089	1505996	1339726		NC_000021.9:32642088:T:G
NM_203446.3(SYNJ1):c.*530G>A	SYNJ1	W1434*, W1520*	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Aug 22, 2021)	criteria provided, single submitter	VCV001505272	21	34003585	21	32631275	1505272	1414140		NC_000021.9:32631274:C:T
NM_203446.3(SYNJ1):c.*628T>A	SYNJ1	S1467T, S1553T	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Sep 1, 2021)	criteria provided, single submitter	VCV001504698	21	34003487	21	32631177	1504698	1417449		NC_000021.9:32631176:A:T
NM_203446.3(SYNJ1):c.3675C>G (p.Ser1225Arg)	SYNJ1	S1178R, S1264R, S1209R, S1225R	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Nov 22, 2021)	criteria provided, single submitter	VCV001504166	21	34012003	21	32639693	1504166	1337042		NC_000021.9:32639692:G:C
NM_203446.3(SYNJ1):c.3770C>G (p.Ala1257Gly)	SYNJ1	A1210G, A1296G, A1257G, A1241G	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Aug 26, 2021)	criteria provided, single submitter	VCV001502735	21	34011363	21	32639053	1502735	1404329		NC_000021.9:32639052:G:C
NM_203446.3(SYNJ1):c.3355C>T (p.Arg1119Cys)	SYNJ1	R1114C, R1119C, R1158C	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Sep 16, 2021)	criteria provided, single submitter	VCV001502726	21	34017992	21	32645682	1502726	1404320		NC_000021.9:32645681:G:A
NM_203446.3(SYNJ1):c.2096A>G (p.Glu699Gly)	SYNJ1	E694G, E699G, E738G	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Nov 4, 2021)	criteria provided, single submitter	VCV001501470	21	34038302	21	32665992	1501470	1398338		NC_000021.9:32665991:T:C
NM_203446.3(SYNJ1):c.1228G>C (p.Gly410Arg)	SYNJ1	G449R, G410R	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Oct 20, 2021)	criteria provided, single submitter	VCV001499374	21	34053931	21	32681621	1499374	1389077		NC_000021.9:32681620:C:G
NM_203446.3(SYNJ1):c.601G>C (p.Ala201Pro)	SYNJ1	A240P, A201P	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Sep 24, 2021)	criteria provided, single submitter	VCV001498941	21	34067471	21	32695161	1498941	1488688		NC_000021.9:32695160:C:G
NM_203446.3(SYNJ1):c.3827C>G (p.Pro1276Arg)	SYNJ1	P1229R, P1315R, P1276R, P1260R	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Aug 16, 2021)	criteria provided, single submitter	VCV001498828	21	34011306	21	32638996	1498828	1488576		NC_000021.9:32638995:G:C
NM_203446.3(SYNJ1):c.2708C>A (p.Ser903Tyr)	SYNJ1	S942Y, S898Y, S903Y	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Aug 13, 2021)	criteria provided, single submitter	VCV001496116	21	34029084	21	32656774	1496116	1363031		NC_000021.9:32656773:G:T
NM_203446.3(SYNJ1):c.*797T>A	SYNJ1	F1523Y, F1609Y	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Aug 31, 2021)	criteria provided, single submitter	VCV001495761	21	34003318	21	32631008	1495761	1462810		NC_000021.9:32631007:A:T
NM_203446.3(SYNJ1):c.2143A>C (p.Met715Leu)	SYNJ1	M715L, M710L, M754L	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Sep 1, 2021)	criteria provided, single submitter	VCV001495600	21	34038255	21	32665945	1495600	1462649		NC_000021.9:32665944:T:G
NM_203446.3(SYNJ1):c.2849A>G (p.Asn950Ser)	SYNJ1	N945S, N950S, N989S	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Aug 13, 2021)	criteria provided, single submitter	VCV001493357	21	34025623	21	32653313	1493357	1355555		NC_000021.9:32653312:T:C
NM_203446.3(SYNJ1):c.*643A>C	SYNJ1	N1558H, N1472H	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Aug 27, 2021)	criteria provided, single submitter	VCV001491370	21	34003472	21	32631162	1491370	1508605		NC_000021.9:32631161:T:G
NM_203446.3(SYNJ1):c.3430+1G>A	SYNJ1		Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Likely pathogenic(Last reviewed: Aug 12, 2021)	criteria provided, single submitter	VCV001490816	21	34017277	21	32644967	1490816	1511923		NC_000021.9:32644966:C:T
NM_203446.3(SYNJ1):c.1726+6C>T	SYNJ1		Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Nov 4, 2021)	criteria provided, single submitter	VCV001490654	21	34045644	21	32673334	1490654	1511761		NC_000021.9:32673333:G:A
NM_203446.3(SYNJ1):c.1259G>A (p.Arg420His)	SYNJ1	R459H, R420H	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Nov 9, 2021)	criteria provided, single submitter	VCV001488630	21	34053900	21	32681590	1488630	1420101		NC_000021.9:32681589:C:T
NM_203446.3(SYNJ1):c.*152T>C	SYNJ1	L1308S, L1394S	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Sep 24, 2021)	criteria provided, single submitter	VCV001487344	21	34003963	21	32631653	1487344	1485237		NC_000021.9:32631652:A:G
NM_203446.3(SYNJ1):c.3550G>C (p.Ala1184Pro)	SYNJ1	A1137P, A1184P, A1223P, A1168P	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Sep 24, 2021)	criteria provided, single submitter	VCV001486891	21	34014244	21	32641934	1486891	1406748		NC_000021.9:32641933:C:G
NM_203446.3(SYNJ1):c.*474G>A	SYNJ1		Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Aug 31, 2021)	criteria provided, single submitter	VCV001485656	21	34003641	21	32631331	1485656	1472003		NC_000021.9:32631330:C:T
NM_203446.3(SYNJ1):c.3263C>G (p.Ala1088Gly)	SYNJ1	A1083G, A1127G, A1088G	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Oct 22, 2021)	criteria provided, single submitter	VCV001485534	21	34018084	21	32645774	1485534	1471881		NC_000021.9:32645773:G:C
NM_203446.3(SYNJ1):c.1711A>G (p.Ile571Val)	SYNJ1	I610V, I566V, I571V	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Aug 28, 2021)	criteria provided, single submitter	VCV001484924	21	34045665	21	32673355	1484924	1478462		NC_000021.9:32673354:T:C
NM_203446.3(SYNJ1):c.1200+2dup	SYNJ1		Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Oct 13, 2021)	criteria provided, single submitter	VCV001481490	21	34056345 - 34056346	21	32684035 - 32684036	1481490	1367008		NC_000021.9:32684035:A:AA
NM_203446.3(SYNJ1):c.976G>T (p.Ala326Ser)	SYNJ1	A326S, A365S	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Dec 1, 2021)	criteria provided, single submitter	VCV001479167	21	34058200	21	32685890	1479167	1426538		NC_000021.9:32685889:C:A
NM_203446.3(SYNJ1):c.*594C>G	SYNJ1	D1541E, D1455E	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Oct 5, 2021)	criteria provided, single submitter	VCV001479133	21	34003521	21	32631211	1479133	1426504		NC_000021.9:32631210:G:C
NM_203446.3(SYNJ1):c.*347A>G	SYNJ1	K1459R, K1373R	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Nov 24, 2021)	criteria provided, single submitter	VCV001478300	21	34003768	21	32631458	1478300	1351807		NC_000021.9:32631457:T:C
NM_203446.3(SYNJ1):c.*388G>A	SYNJ1	E1473K, E1387K	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Aug 27, 2021)	criteria provided, single submitter	VCV001477809	21	34003727	21	32631417	1477809	1436688		NC_000021.9:32631416:C:T
NM_203446.3(SYNJ1):c.2774T>A (p.Phe925Tyr)	SYNJ1	F920Y, F925Y, F964Y	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Aug 14, 2021)	criteria provided, single submitter	VCV001477639	21	34029018	21	32656708	1477639	1436518		NC_000021.9:32656707:A:T
NM_203446.3(SYNJ1):c.*109T>C	SYNJ1	S1294P, S1380P	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Aug 30, 2021)	criteria provided, single submitter	VCV001477558	21	34004006	21	32631696	1477558	1413742		NC_000021.9:32631695:A:G
NM_203446.3(SYNJ1):c.3037+11_3037+12insGGAAGGTTTGTTTCTTTTTTTTTTTTTTTTTTTTTTNNNNNNNNNNACTCGGGATCCTCCCGCCTCTGCCTCCCAATGAGCTGGGATTACAGGCGAGAGCCACGTCGCCCGGCC	SYNJ1		Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Sep 10, 2021)	criteria provided, single submitter	VCV001475797	21	34022482 - 34022483	21	32650172 - 32650173	1475797	1400828		
NM_203446.3(SYNJ1):c.3575G>T (p.Ser1192Ile)	SYNJ1	S1192I, S1176I, S1145I, S1231I	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Aug 20, 2021)	criteria provided, single submitter	VCV001475337	21	34014219	21	32641909	1475337	1404246		NC_000021.9:32641908:C:A
NM_203446.3(SYNJ1):c.2473G>T (p.Asp825Tyr)	SYNJ1	D864Y, D825Y, D820Y	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Sep 1, 2021)	criteria provided, single submitter	VCV001473382	21	34029419	21	32657109	1473382	1391262		NC_000021.9:32657108:C:A
NM_203446.3(SYNJ1):c.1005TCA[3] (p.His336dup)	SYNJ1		Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Sep 4, 2021)	criteria provided, single submitter	VCV001472995	21	34058165 - 34058166	21	32685855 - 32685856	1472995	1501240		NC_000021.9:32685855:TGATGAT:TGATGATGAT
NM_203446.3(SYNJ1):c.3578C>G (p.Thr1193Arg)	SYNJ1	T1232R, T1146R, T1177R, T1193R	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Sep 2, 2021)	criteria provided, single submitter	VCV001472109	21	34014216	21	32641906	1472109	1385257		NC_000021.9:32641905:G:C
NM_203446.3(SYNJ1):c.2386A>G (p.Ser796Gly)	SYNJ1	S796G, S835G, S791G	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Aug 27, 2021)	criteria provided, single submitter	VCV001471702	21	34030101	21	32657791	1471702	1388730		NC_000021.9:32657790:T:C
NM_203446.3(SYNJ1):c.1699A>C (p.Lys567Gln)	SYNJ1	K562Q, K567Q, K606Q	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Aug 27, 2021)	criteria provided, single submitter	VCV001471193	21	34045677	21	32673367	1471193	1488264		NC_000021.9:32673366:T:G
NM_203446.3(SYNJ1):c.3318G>C (p.Lys1106Asn)	SYNJ1	K1106N, K1145N, K1101N	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Sep 25, 2021)	criteria provided, single submitter	VCV001470118	21	34018029	21	32645719	1470118	1375961		NC_000021.9:32645718:C:G
NM_203446.3(SYNJ1):c.2793A>G (p.Ile931Met)	SYNJ1	I970M, I931M, I926M	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Aug 27, 2021)	criteria provided, single submitter	VCV001469142	21	34028999	21	32656689	1469142	1370251		NC_000021.9:32656688:T:C
NM_203446.3(SYNJ1):c.2302C>G (p.Gln768Glu)	SYNJ1	Q763E, Q768E, Q807E	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Oct 24, 2021)	criteria provided, single submitter	VCV001468364	21	34037225	21	32664915	1468364	1362608		NC_000021.9:32664914:G:C
NM_203446.3(SYNJ1):c.1697C>T (p.Pro566Leu)	SYNJ1	P561L, P605L, P566L	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Sep 14, 2021)	criteria provided, single submitter	VCV001467732	21	34045679	21	32673369	1467732	1462114		NC_000021.9:32673368:G:A
NM_203446.3(SYNJ1):c.-78C>T	SYNJ1	P14S	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Nov 29, 2021)	criteria provided, single submitter	VCV001467507	21	34100312	21	32728001	1467507	1357014		NC_000021.9:32728000:G:A
NM_203446.3(SYNJ1):c.727G>T (p.Val243Phe)	SYNJ1	V282F, V243F	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Sep 1, 2021)	criteria provided, single submitter	VCV001467147	21	34066600	21	32694290	1467147	1346774		NC_000021.9:32694289:C:A
NM_203446.3(SYNJ1):c.*644A>G	SYNJ1	N1558S, N1472S	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Aug 30, 2021)	criteria provided, single submitter	VCV001466276	21	34003471	21	32631161	1466276	1449101		NC_000021.9:32631160:T:C
NM_203446.3(SYNJ1):c.2453A>G (p.Asp818Gly)	SYNJ1	D818G, D857G, D813G	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Aug 24, 2021)	criteria provided, single submitter	VCV001465489	21	34030034	21	32657724	1465489	1353722		NC_000021.9:32657723:T:C
NM_203446.3(SYNJ1):c.*182A>G	SYNJ1	N1404S, N1318S	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Sep 5, 2021)	criteria provided, single submitter	VCV001464187	21	34003933	21	32631623	1464187	1435858		NC_000021.9:32631622:T:C
NM_203446.3(SYNJ1):c.3490C>T (p.Pro1164Ser)	SYNJ1	P1148S, P1164S, P1203S	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Jul 31, 2021)	criteria provided, single submitter	VCV001463385	21	34014432	21	32642122	1463385	1507948		NC_000021.9:32642121:G:A
NM_203446.3(SYNJ1):c.*367A>G	SYNJ1	T1380A, T1466A	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Sep 27, 2021)	criteria provided, single submitter	VCV001462533	21	34003748	21	32631438	1462533	1432936		NC_000021.9:32631437:T:C
NC_000021.8:g.(?_34072128)_(34074377_?)del	SYNJ1		Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Pathogenic(Last reviewed: Aug 12, 2021)	criteria provided, single submitter	VCV001458746	21	34072128 - 34074377			1458746	1491095		
NM_203446.3(SYNJ1):c.1696_1699del (p.Pro566fs)	SYNJ1	P561fs, P566fs, P605fs	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Pathogenic(Last reviewed: Dec 14, 2020)	criteria provided, single submitter	VCV001457746	21	34045677 - 34045680	21	32673367 - 32673370	1457746	1471313		NC_000021.9:32673366:TGGGTG:TG
NM_203446.3(SYNJ1):c.-12G>T	SYNJ1	E36*	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Pathogenic(Last reviewed: Dec 19, 2020)	criteria provided, single submitter	VCV001457606	21	34099218	21	32726907	1457606	1393547		NC_000021.9:32726906:C:A
NM_203446.3(SYNJ1):c.748C>T (p.Arg250Ter)	SYNJ1	R289*, R250*	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Pathogenic(Last reviewed: Sep 6, 2021)	criteria provided, single submitter	VCV001456091	21	34066579	21	32694269	1456091	1458033		NC_000021.9:32694268:G:A
NM_203446.3(SYNJ1):c.1256_1257insAACT (p.Arg420fs)	SYNJ1	R420fs, R459fs	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Pathogenic(Last reviewed: Nov 10, 2020)	criteria provided, single submitter	VCV001455593	21	34053902 - 34053903	21	32681592 - 32681593	1455593	1464708		NC_000021.9:32681592::AGTT
NM_203446.3(SYNJ1):c.*14A>G	SYNJ1	N1348S, N1262S	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Oct 10, 2021)	criteria provided, single submitter	VCV001451114	21	34004101	21	32631791	1451114	1429369		NC_000021.9:32631790:T:C
NM_203446.3(SYNJ1):c.3004G>C (p.Asp1002His)	SYNJ1	D997H, D1002H, D1041H	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Nov 6, 2021)	criteria provided, single submitter	VCV001450354	21	34022527	21	32650217	1450354	1436234		NC_000021.9:32650216:C:G
NM_203446.3(SYNJ1):c.*320C>T	SYNJ1	A1450V, A1364V	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Aug 29, 2021)	criteria provided, single submitter	VCV001450261	21	34003795	21	32631485	1450261	1436141		NC_000021.9:32631484:G:A
NM_203446.3(SYNJ1):c.1369C>T (p.Arg457Cys)	SYNJ1	R496C, R457C, R460C	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Oct 2, 2021)	criteria provided, single submitter	VCV001449955	21	34051096	21	32678786	1449955	1413137		NC_000021.9:32678785:G:A
NM_203446.3(SYNJ1):c.3568G>A (p.Gly1190Arg)	SYNJ1	G1143R, G1190R, G1174R, G1229R	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Dec 14, 2021)	criteria provided, single submitter	VCV001449602	21	34014226	21	32641916	1449602	1416658		NC_000021.9:32641915:C:T
NM_203446.3(SYNJ1):c.494A>G (p.His165Arg)	SYNJ1	H165R, H204R	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Sep 20, 2021)	criteria provided, single submitter	VCV001448823	21	34067578	21	32695268	1448823	1423522		NC_000021.9:32695267:T:C
NM_203446.3(SYNJ1):c.1744A>G (p.Thr582Ala)	SYNJ1	T577A, T582A, T621A	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Nov 3, 2021)	criteria provided, single submitter	VCV001447060	21	34042665	21	32670355	1447060	1410553		NC_000021.9:32670354:T:C
NM_203446.3(SYNJ1):c.*431G>A	SYNJ1	G1487D, G1401D	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Sep 24, 2021)	criteria provided, single submitter	VCV001446911	21	34003684	21	32631374	1446911	1410404		NC_000021.9:32631373:C:T
NM_203446.3(SYNJ1):c.3124C>T (p.Pro1042Ser)	SYNJ1	P1042S, P1037S, P1081S	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Aug 17, 2021)	criteria provided, single submitter	VCV001446655	21	34018826	21	32646516	1446655	1387606		NC_000021.9:32646515:G:A
NM_203446.3(SYNJ1):c.3665A>G (p.Glu1222Gly)	SYNJ1	E1175G, E1206G, E1222G, E1261G	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Sep 24, 2021)	criteria provided, single submitter	VCV001446054	21	34012013	21	32639703	1446054	1390884		NC_000021.9:32639702:T:C
NM_203446.3(SYNJ1):c.3301C>G (p.Gln1101Glu)	SYNJ1	Q1096E, Q1101E, Q1140E	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Sep 2, 2021)	criteria provided, single submitter	VCV001445629	21	34018046	21	32645736	1445629	1490500		NC_000021.9:32645735:G:C
NM_203446.3(SYNJ1):c.*277A>G	SYNJ1	I1350V, I1436V	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Oct 24, 2021)	criteria provided, single submitter	VCV001444744	21	34003838	21	32631528	1444744	1384834		NC_000021.9:32631527:T:C
NM_203446.3(SYNJ1):c.1511-5C>A	SYNJ1		Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Aug 24, 2021)	criteria provided, single submitter	VCV001442872	21	34048670	21	32676360	1442872	1371759		NC_000021.9:32676359:G:T
NM_203446.3(SYNJ1):c.2461+4G>A	SYNJ1		Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Dec 14, 2020)	criteria provided, single submitter	VCV001442126	21	34030022	21	32657712	1442126	1474991		NC_000021.9:32657711:C:T
NM_203446.3(SYNJ1):c.301A>T (p.Thr101Ser)	SYNJ1	T140S, T101S	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Sep 1, 2021)	criteria provided, single submitter	VCV001439929	21	34072326	21	32700016	1439929	1368379		NC_000021.9:32700015:T:A
NM_203446.3(SYNJ1):c.3587C>G (p.Pro1196Arg)	SYNJ1	P1149R, P1180R, P1235R, P1196R	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Sep 1, 2021)	criteria provided, single submitter	VCV001439859	21	34014207	21	32641897	1439859	1368309		NC_000021.9:32641896:G:C
NM_203446.3(SYNJ1):c.130G>T (p.Ala44Ser)	SYNJ1	A44S, A83S	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Aug 28, 2021)	criteria provided, single submitter	VCV001437886	21	34074352	21	32702042	1437886	1510623		NC_000021.9:32702041:C:A
NM_203446.3(SYNJ1):c.1402T>G (p.Phe468Val)	SYNJ1	F468V, F471V, F507V	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Nov 5, 2021)	criteria provided, single submitter	VCV001436977	21	34051063	21	32678753	1436977	1435548		NC_000021.9:32678752:A:C
NM_203446.3(SYNJ1):c.2296G>T (p.Ala766Ser)	SYNJ1	A805S, A761S, A766S	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Sep 24, 2021)	criteria provided, single submitter	VCV001432500	21	34037231	21	32664921	1432500	1484611		NC_000021.9:32664920:C:A
NM_203446.3(SYNJ1):c.3378TCC[1] (p.Pro1129del)	SYNJ1	P1129del, P1124del, P1168del	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Sep 24, 2021)	criteria provided, single submitter	VCV001432212	21	34017964 - 34017966	21	32645654 - 32645656	1432212	1484323		NC_000021.9:32645653:GGAGGAGG:GGAGG
NM_203446.3(SYNJ1):c.2663T>G (p.Val888Gly)	SYNJ1	V888G, V883G, V927G	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Dec 17, 2021)	criteria provided, single submitter	VCV001432013	21	34029129	21	32656819	1432013	1406084		NC_000021.9:32656818:A:C
NM_203446.3(SYNJ1):c.*278T>G	SYNJ1	I1436S, I1350S	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset|not provided	Uncertain significance(Last reviewed: Mar 1, 2022)	criteria provided, multiple submitters, no conflicts	VCV001429172	21	34003837	21	32631527	1429172	1454289		NC_000021.9:32631526:A:C
NM_003895.3(SYNJ1):c.12A>T (p.Arg4Ser)	SYNJ1	R4S	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Aug 27, 2021)	criteria provided, single submitter	VCV001428130	21	34100340	21	32728029	1428130	1464285		NC_000021.9:32728028:T:A
NM_203446.3(SYNJ1):c.3572A>T (p.Tyr1191Phe)	SYNJ1	Y1144F, Y1230F, Y1175F, Y1191F	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Aug 20, 2021)	criteria provided, single submitter	VCV001427274	21	34014222	21	32641912	1427274	1444676		NC_000021.9:32641911:T:A
NM_203446.3(SYNJ1):c.3448A>C (p.Ser1150Arg)	SYNJ1	S1150R, S1189R	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Aug 31, 2021)	criteria provided, single submitter	VCV001426984	21	34015750	21	32643440	1426984	1444386		NC_000021.9:32643439:T:G
NM_203446.3(SYNJ1):c.295A>G (p.Thr99Ala)	SYNJ1	T99A, T138A	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Aug 28, 2021)	criteria provided, single submitter	VCV001425480	21	34072332	21	32700022	1425480	1431719		NC_000021.9:32700021:T:C
NM_203446.3(SYNJ1):c.3766C>T (p.Pro1256Ser)	SYNJ1	P1209S, P1256S, P1240S, P1295S	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Sep 24, 2021)	criteria provided, single submitter	VCV001425394	21	34011367	21	32639057	1425394	1431633		NC_000021.9:32639056:G:A
NM_203446.3(SYNJ1):c.652G>A (p.Val218Ile)	SYNJ1	V218I, V257I	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Aug 28, 2021)	criteria provided, single submitter	VCV001424849	21	34067420	21	32695110	1424849	1353356		NC_000021.9:32695109:C:T
NM_203446.3(SYNJ1):c.290G>A (p.Arg97Gln)	SYNJ1	R136Q, R97Q	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Nov 15, 2021)	criteria provided, single submitter	VCV001422639	21	34072337	21	32700027	1422639	1412533		NC_000021.9:32700026:C:T
NM_203446.3(SYNJ1):c.786G>T (p.Leu262Phe)	SYNJ1	L301F, L262F	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Sep 1, 2021)	criteria provided, single submitter	VCV001422568	21	34066541	21	32694231	1422568	1416339		NC_000021.9:32694230:C:A
NM_203446.3(SYNJ1):c.345del (p.Ile116fs)	SYNJ1	I155fs, I116fs	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Pathogenic(Last reviewed: Oct 24, 2021)	criteria provided, single submitter	VCV001422351	21	34072282	21	32699972	1422351	1416123		NC_000021.9:32699971:G:
NM_203446.3(SYNJ1):c.1200+6A>C	SYNJ1		Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Oct 18, 2021)	criteria provided, single submitter	VCV001422275	21	34056342	21	32684032	1422275	1416047		NC_000021.9:32684031:T:G
NM_203446.3(SYNJ1):c.2396G>C (p.Cys799Ser)	SYNJ1	C838S, C794S, C799S	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Aug 14, 2021)	criteria provided, single submitter	VCV001419799	21	34030091	21	32657781	1419799	1410017		NC_000021.9:32657780:C:G
NM_203446.3(SYNJ1):c.3637C>G (p.Arg1213Gly)	SYNJ1	R1166G, R1197G, R1213G, R1252G	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Nov 23, 2021)	criteria provided, single submitter	VCV001419418	21	34012041	21	32639731	1419418	1387097		NC_000021.9:32639730:G:C
NM_203446.3(SYNJ1):c.255G>T (p.Met85Ile)	SYNJ1	M124I, M85I	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Aug 26, 2021)	criteria provided, single submitter	VCV001418932	21	34072372	21	32700062	1418932	1390492		NC_000021.9:32700061:C:A
NM_203446.3(SYNJ1):c.2523G>T (p.Trp841Cys)	SYNJ1	W836C, W841C, W880C	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Aug 26, 2021)	criteria provided, single submitter	VCV001413374	21	34029369	21	32657059	1413374	1461415		NC_000021.9:32657058:C:A
NM_203446.3(SYNJ1):c.3370C>G (p.Gln1124Glu)	SYNJ1	Q1163E, Q1119E, Q1124E	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Nov 2, 2021)	criteria provided, single submitter	VCV001411503	21	34017977	21	32645667	1411503	1447952		NC_000021.9:32645666:G:C
NM_203446.3(SYNJ1):c.*251A>T	SYNJ1	N1427I, N1341I	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Aug 26, 2021)	criteria provided, single submitter	VCV001409999	21	34003864	21	32631554	1409999	1435254		NC_000021.9:32631553:T:A
NM_203446.3(SYNJ1):c.3721C>A (p.Leu1241Met)	SYNJ1	L1241M, L1194M, L1225M, L1280M	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Sep 1, 2021)	criteria provided, single submitter	VCV001409967	21	34011412	21	32639102	1409967	1435222		NC_000021.9:32639101:G:T
NM_203446.3(SYNJ1):c.*255G>T	SYNJ1	M1428I, M1342I	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Oct 12, 2021)	criteria provided, single submitter	VCV001409554	21	34003860	21	32631550	1409554	1340623		NC_000021.9:32631549:C:A
NM_203446.3(SYNJ1):c.463G>A (p.Asp155Asn)	SYNJ1	D155N, D194N	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Nov 24, 2021)	criteria provided, single submitter	VCV001408777	21	34072164	21	32699854	1408777	1500443		NC_000021.9:32699853:C:T
NM_203446.3(SYNJ1):c.2399G>A (p.Arg800His)	SYNJ1	R839H, R795H, R800H	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Aug 28, 2021)	criteria provided, single submitter	VCV001407053	21	34030088	21	32657778	1407053	1487111		NC_000021.9:32657777:C:T
NM_203446.3(SYNJ1):c.851+5G>A	SYNJ1		Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Nov 23, 2021)	criteria provided, single submitter	VCV001406258	21	34060611	21	32688301	1406258	1408279		NC_000021.9:32688300:C:T
NM_203446.3(SYNJ1):c.409A>T (p.Ile137Phe)	SYNJ1	I176F, I137F	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Aug 14, 2021)	criteria provided, single submitter	VCV001402659	21	34072218	21	32699908	1402659	1477085		NC_000021.9:32699907:T:A
NM_203446.3(SYNJ1):c.3049G>T (p.Asp1017Tyr)	SYNJ1	D1056Y, D1017Y, D1012Y	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Aug 15, 2021)	criteria provided, single submitter	VCV001402351	21	34018901	21	32646591	1402351	1454161		NC_000021.9:32646590:C:A
NM_203446.3(SYNJ1):c.1415A>G (p.Lys472Arg)	SYNJ1	K472R, K475R, K511R	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Sep 9, 2021)	criteria provided, single submitter	VCV001402285	21	34051050	21	32678740	1402285	1454095		NC_000021.9:32678739:T:C
NM_203446.3(SYNJ1):c.1208C>T (p.Ala403Val)	SYNJ1	A403V, A442V	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Sep 24, 2021)	criteria provided, single submitter	VCV001401228	21	34053951	21	32681641	1401228	1379216		NC_000021.9:32681640:G:A
NM_203446.3(SYNJ1):c.691G>T (p.Val231Leu)	SYNJ1	V231L, V270L	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Sep 24, 2021)	criteria provided, single submitter	VCV001400119	21	34067381	21	32695071	1400119	1444208		NC_000021.9:32695070:C:A
NM_203446.3(SYNJ1):c.431A>C (p.Asn144Thr)	SYNJ1	N183T, N144T	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Aug 27, 2021)	criteria provided, single submitter	VCV001397387	21	34072196	21	32699886	1397387	1437954		NC_000021.9:32699885:T:G
NM_203446.3(SYNJ1):c.*284G>C	SYNJ1	G1438A, G1352A	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Sep 17, 2021)	criteria provided, single submitter	VCV001397143	21	34003831	21	32631521	1397143	1415016		NC_000021.9:32631520:C:G
NM_203446.3(SYNJ1):c.-7_-5del	SYNJ1	R39del	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Sep 1, 2021)	criteria provided, single submitter	VCV001396770	21	34099211 - 34099213	21	32726900 - 32726902	1396770	1414645		NC_000021.9:32726899:CTT:
NM_203446.3(SYNJ1):c.614C>T (p.Ser205Leu)	SYNJ1	S244L, S205L	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Aug 26, 2021)	criteria provided, single submitter	VCV001395177	21	34067458	21	32695148	1395177	1412191		NC_000021.9:32695147:G:A
NM_203446.3(SYNJ1):c.406G>A (p.Gly136Ser)	SYNJ1	G136S, G175S	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Aug 26, 2021)	criteria provided, single submitter	VCV001392668	21	34072221	21	32699911	1392668	1502570		NC_000021.9:32699910:C:T
NM_203446.3(SYNJ1):c.1880T>C (p.Leu627Pro)	SYNJ1	L666P, L622P, L627P	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Sep 1, 2021)	criteria provided, single submitter	VCV001391617	21	34038815	21	32666505	1391617	1386416		NC_000021.9:32666504:A:G
NM_203446.3(SYNJ1):c.685A>C (p.Asn229His)	SYNJ1	N229H, N268H	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Nov 27, 2021)	criteria provided, single submitter	VCV001390936	21	34067387	21	32695077	1390936	1489654		NC_000021.9:32695076:T:G
NM_203446.3(SYNJ1):c.*449C>A	SYNJ1	A1407D, A1493D	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Sep 1, 2021)	criteria provided, single submitter	VCV001390723	21	34003666	21	32631356	1390723	1489441		NC_000021.9:32631355:G:T
NM_203446.3(SYNJ1):c.1244C>T (p.Pro415Leu)	SYNJ1	P454L, P415L	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Aug 31, 2021)	criteria provided, single submitter	VCV001390399	21	34053915	21	32681605	1390399	1396572		NC_000021.9:32681604:G:A
NM_203446.3(SYNJ1):c.846T>G (p.Phe282Leu)	SYNJ1	F321L, F282L	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Aug 26, 2021)	criteria provided, single submitter	VCV001389501	21	34060621	21	32688311	1389501	1376981		NC_000021.9:32688310:A:C
NM_203446.3(SYNJ1):c.*41C>T	SYNJ1	S1271L, S1357L	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Aug 30, 2021)	criteria provided, single submitter	VCV001388889	21	34004074	21	32631764	1388889	1384119		NC_000021.9:32631763:G:A
NM_203446.3(SYNJ1):c.425G>A (p.Ser142Asn)	SYNJ1	S181N, S142N	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Aug 31, 2021)	criteria provided, single submitter	VCV001388642	21	34072202	21	32699892	1388642	1383873		NC_000021.9:32699891:C:T
NM_203446.3(SYNJ1):c.914A>C (p.Lys305Thr)	SYNJ1	K344T, K305T	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Aug 24, 2021)	criteria provided, single submitter	VCV001388390	21	34059322	21	32687012	1388390	1371131		NC_000021.9:32687011:T:G
NM_203446.3(SYNJ1):c.124+3A>G	SYNJ1		Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Apr 24, 2021)	criteria provided, single submitter	VCV001388277	21	34099080	21	32726769	1388277	1371018		NC_000021.9:32726768:T:C
NM_203446.3(SYNJ1):c.2713C>A (p.Pro905Thr)	SYNJ1	P900T, P905T, P944T	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Oct 21, 2021)	criteria provided, single submitter	VCV001387926	21	34029079	21	32656769	1387926	1374547		NC_000021.9:32656768:G:T
NM_203446.3(SYNJ1):c.2165A>C (p.His722Pro)	SYNJ1	H761P, H717P, H722P	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Oct 15, 2021)	criteria provided, single submitter	VCV001387280	21	34037362	21	32665052	1387280	1474005		NC_000021.9:32665051:T:G
NM_203446.3(SYNJ1):c.1645C>T (p.Arg549Cys)	SYNJ1	R549C, R544C, R588C	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Aug 31, 2021)	criteria provided, single submitter	VCV001387081	21	34045731	21	32673421	1387081	1381446		NC_000021.9:32673420:G:A
NM_203446.3(SYNJ1):c.2126G>A (p.Arg709Gln)	SYNJ1	R704Q, R748Q, R709Q	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Oct 18, 2021)	criteria provided, single submitter	VCV001387067	21	34038272	21	32665962	1387067	1381432		NC_000021.9:32665961:C:T
NM_203446.3(SYNJ1):c.1318T>C (p.Tyr440His)	SYNJ1	Y440H, Y479H	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Aug 24, 2021)	criteria provided, single submitter	VCV001385291	21	34053841	21	32681531	1385291	1368037		NC_000021.9:32681530:A:G
NM_203446.3(SYNJ1):c.1510+20T>C	SYNJ1		Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Likely benign(Last reviewed: Dec 14, 2021)	criteria provided, single submitter	VCV001381471	21	34050935	21	32678625	1381471	1496434		NC_000021.9:32678624:A:G
NM_203446.3(SYNJ1):c.434C>G (p.Ala145Gly)	SYNJ1	A145G, A184G	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Nov 3, 2021)	criteria provided, single submitter	VCV001381024	21	34072193	21	32699883	1381024	1499867		NC_000021.9:32699882:G:C
NM_203446.3(SYNJ1):c.*707C>T	SYNJ1	P1579L, P1493L	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Sep 15, 2021)	criteria provided, single submitter	VCV001380991	21	34003408	21	32631098	1380991	1499834		NC_000021.9:32631097:G:A
NM_203446.3(SYNJ1):c.*679T>A	SYNJ1	C1484S, C1570S	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Sep 4, 2021)	criteria provided, single submitter	VCV001379613	21	34003436	21	32631126	1379613	1482992		NC_000021.9:32631125:A:T
NM_203446.3(SYNJ1):c.2260C>T (p.Leu754Phe)	SYNJ1	L793F, L749F, L754F	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Aug 24, 2021)	criteria provided, single submitter	VCV001377365	21	34037267	21	32664957	1377365	1473035		NC_000021.9:32664956:G:A
NM_203446.3(SYNJ1):c.3588+5G>A	SYNJ1		Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Aug 23, 2021)	criteria provided, single submitter	VCV001377251	21	34014201	21	32641891	1377251	1405180		NC_000021.9:32641890:C:T
NM_203446.3(SYNJ1):c.690T>G (p.Phe230Leu)	SYNJ1	F269L, F230L	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Aug 22, 2021)	criteria provided, single submitter	VCV001376874	21	34067382	21	32695072	1376874	1479738		NC_000021.9:32695071:A:C
NM_203446.3(SYNJ1):c.*793G>T	SYNJ1	D1522Y, D1608Y	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Nov 17, 2021)	criteria provided, single submitter	VCV001376690	21	34003322	21	32631012	1376690	1479554		NC_000021.9:32631011:C:A
NM_203446.3(SYNJ1):c.3187T>C (p.Ser1063Pro)	SYNJ1	S1063P, S1058P, S1102P	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Aug 16, 2021)	criteria provided, single submitter	VCV001375402	21	34018763	21	32646453	1375402	1392175		NC_000021.9:32646452:A:G
NM_203446.3(SYNJ1):c.3196A>G (p.Ile1066Val)	SYNJ1	I1105V, I1061V, I1066V	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Dec 18, 2021)	criteria provided, single submitter	VCV001374520	21	34018754	21	32646444	1374520	1453489		NC_000021.9:32646443:T:C
NM_203446.3(SYNJ1):c.*521C>T	SYNJ1	P1431L, P1517L	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Oct 2, 2021)	criteria provided, single submitter	VCV001369097	21	34003594	21	32631284	1369097	1417987		NC_000021.9:32631283:G:A
NM_203446.3(SYNJ1):c.868A>G (p.Lys290Glu)	SYNJ1	K290E, K329E	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Sep 17, 2021)	criteria provided, single submitter	VCV001368523	21	34059368	21	32687058	1368523	1340116		NC_000021.9:32687057:T:C
NM_203446.3(SYNJ1):c.1195T>G (p.Leu399Val)	SYNJ1	L438V, L399V	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Oct 20, 2021)	criteria provided, single submitter	VCV001365199	21	34056353	21	32684043	1365199	1502243		NC_000021.9:32684042:A:C
NM_203446.3(SYNJ1):c.447G>T (p.Met149Ile)	SYNJ1	M149I, M188I	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Aug 31, 2021)	criteria provided, single submitter	VCV001364415	21	34072180	21	32699870	1364415	1386354		NC_000021.9:32699869:C:A
NM_203446.3(SYNJ1):c.-62G>A	SYNJ1	G19D	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Aug 18, 2021)	criteria provided, single submitter	VCV001364101	21	34100296	21	32727985	1364101	1386040		NC_000021.9:32727984:C:T
NM_203446.3(SYNJ1):c.3287A>G (p.Gln1096Arg)	SYNJ1	Q1091R, Q1096R, Q1135R	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Aug 14, 2021)	criteria provided, single submitter	VCV001361906	21	34018060	21	32645750	1361906	1376532		NC_000021.9:32645749:T:C
NM_203446.3(SYNJ1):c.*536C>T	SYNJ1	T1436I, T1522I	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Sep 1, 2021)	criteria provided, single submitter	VCV001361858	21	34003579	21	32631269	1361858	1376484		NC_000021.9:32631268:G:A
NM_203446.3(SYNJ1):c.295del (p.Thr99fs)	SYNJ1	T138fs, T99fs	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Pathogenic(Last reviewed: Sep 22, 2021)	criteria provided, single submitter	VCV001361698	21	34072332	21	32700022	1361698	1476422		NC_000021.9:32700021:T:
NM_203446.3(SYNJ1):c.*560del	SYNJ1	G1444fs, G1530fs	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Oct 14, 2021)	criteria provided, single submitter	VCV001361368	21	34003555	21	32631245	1361368	1383740		NC_000021.9:32631244:CC:C
NM_203446.3(SYNJ1):c.99C>G (p.Phe33Leu)	SYNJ1	F33L, F72L	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Sep 24, 2021)	criteria provided, single submitter	VCV001359720	21	34099108	21	32726797	1359720	1473595		NC_000021.9:32726796:G:C
NM_203446.3(SYNJ1):c.924A>G (p.Glu308=)	SYNJ1		Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Dec 6, 2021)	criteria provided, single submitter	VCV001358038	21	34059312	21	32687002	1358038	1460337		NC_000021.9:32687001:T:C
NM_203446.3(SYNJ1):c.1100A>G (p.Asn367Ser)	SYNJ1	N367S, N406S	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Aug 5, 2021)	criteria provided, single submitter	VCV001357025	21	34058076	21	32685766	1357025	1348455		NC_000021.9:32685765:T:C
NM_203446.3(SYNJ1):c.3551_3552insGCA (p.Ala1184_Gly1185insGln)	SYNJ1		Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Aug 26, 2021)	criteria provided, single submitter	VCV001356868	21	34014242 - 34014243	21	32641932 - 32641933	1356868	1348299		NC_000021.9:32641932::TGC
NM_203446.3(SYNJ1):c.3166A>C (p.Ile1056Leu)	SYNJ1	I1056L, I1095L, I1051L	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Aug 15, 2021)	criteria provided, single submitter	VCV001356193	21	34018784	21	32646474	1356193	1354488		NC_000021.9:32646473:T:G
NM_203446.3(SYNJ1):c.1468G>C (p.Ala490Pro)	SYNJ1	A529P, A490P, A493P	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Dec 10, 2021)	criteria provided, single submitter	VCV001355465	21	34050997	21	32678687	1355465	1509216		NC_000021.9:32678686:C:G
NM_203446.3(SYNJ1):c.320G>A (p.Arg107Gln)	SYNJ1	R107Q, R146Q	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Oct 29, 2021)	criteria provided, single submitter	VCV001355434	21	34072307	21	32699997	1355434	1509185		NC_000021.9:32699996:C:T
NM_203446.3(SYNJ1):c.790-20A>G	SYNJ1		Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Aug 13, 2021)	criteria provided, single submitter	VCV001354726	21	34060697	21	32688387	1354726	1434311		NC_000021.9:32688386:T:C
NM_203446.3(SYNJ1):c.3788C>G (p.Pro1263Arg)	SYNJ1	P1302R, P1216R, P1247R, P1263R	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Aug 27, 2021)	criteria provided, single submitter	VCV001354669	21	34011345	21	32639035	1354669	1434254		NC_000021.9:32639034:G:C
NM_203446.3(SYNJ1):c.3703A>G (p.Thr1235Ala)	SYNJ1	T1188A, T1235A, T1274A, T1219A	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Aug 24, 2021)	criteria provided, single submitter	VCV001352122	21	34011430	21	32639120	1352122	1482658		NC_000021.9:32639119:T:C
NM_203446.3(SYNJ1):c.313T>C (p.Ser105Pro)	SYNJ1	S105P, S144P	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Sep 1, 2021)	criteria provided, single submitter	VCV001352056	21	34072314	21	32700004	1352056	1482592		NC_000021.9:32700003:A:G
NM_203446.3(SYNJ1):c.877T>C (p.Tyr293His)	SYNJ1	Y293H, Y332H	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Aug 27, 2021)	criteria provided, single submitter	VCV001352007	21	34059359	21	32687049	1352007	1482543		NC_000021.9:32687048:A:G
NM_203446.3(SYNJ1):c.789+4T>A	SYNJ1		Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: May 3, 2021)	criteria provided, single submitter	VCV001350879	21	34066534	21	32694224	1350879	1492467		NC_000021.9:32694223:A:T
NM_203446.3(SYNJ1):c.1201-20T>G	SYNJ1		Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Aug 13, 2021)	criteria provided, single submitter	VCV001349652	21	34053978	21	32681668	1349652	1394415		NC_000021.9:32681667:A:C
NM_203446.3(SYNJ1):c.2818G>T (p.Val940Phe)	SYNJ1	V940F, V979F, V935F	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Sep 1, 2021)	criteria provided, single submitter	VCV001348995	21	34025654	21	32653344	1348995	1479006		NC_000021.9:32653343:C:A
NM_203446.3(SYNJ1):c.2777G>A (p.Gly926Asp)	SYNJ1	G921D, G965D, G926D	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Sep 1, 2021)	criteria provided, single submitter	VCV001346917	21	34029015	21	32656705	1346917	1453030		NC_000021.9:32656704:C:T
NM_203446.3(SYNJ1):c.*641dup	SYNJ1	L1557fs, L1471fs	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Oct 22, 2021)	criteria provided, single submitter	VCV001346321	21	34003473 - 34003474	21	32631163 - 32631164	1346321	1378609		NC_000021.9:32631163:AA:AAA
NM_203446.3(SYNJ1):c.1448A>G (p.Asn483Ser)	SYNJ1	N486S, N522S, N483S	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Sep 24, 2021)	criteria provided, single submitter	VCV001345983	21	34051017	21	32678707	1345983	1378272		NC_000021.9:32678706:T:C
NM_203446.3(SYNJ1):c.1183G>A (p.Ala395Thr)	SYNJ1	A395T, A434T	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Sep 24, 2021)	criteria provided, single submitter	VCV001339951	21	34056365	21	32684055	1339951	1331160		NC_000021.9:32684054:C:T
NM_203446.3(SYNJ1):c.885A>G (p.Lys295=)	SYNJ1		not provided|Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Conflicting interpretations of pathogenicity(Last reviewed: Nov 1, 2021)	criteria provided, conflicting interpretations	VCV001335468	21	34059351	21	32687041	1335468	1326439		NC_000021.9:32687040:T:C
NM_203446.3(SYNJ1):c.1001A>G (p.Asp334Gly)	SYNJ1	D334G, D373G	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Benign(Last reviewed: Jul 15, 2021)	criteria provided, single submitter	VCV001334915	21	34058175	21	32685865	1334915	1325889		NC_000021.9:32685864:T:C
NM_203446.3(SYNJ1):c.343C>T (p.Arg115Cys)	SYNJ1	R115C, R154C	not provided|Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Aug 31, 2021)	criteria provided, multiple submitters, no conflicts	VCV001326691	21	34072284	21	32699974	1326691	1317050		NC_000021.9:32699973:G:A
NM_203446.3(SYNJ1):c.3607G>A (p.Gly1203Arg)	SYNJ1	G1156R, G1187R, G1203R, G1242R	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset|not provided	Uncertain significance(Last reviewed: Aug 31, 2021)	criteria provided, multiple submitters, no conflicts	VCV001307823	21	34012071	21	32639761	1307823	1297770		NC_000021.9:32639760:C:T
NM_203446.3(SYNJ1):c.3595C>T (p.Pro1199Ser)	SYNJ1	P1152S, P1183S, P1199S, P1238S	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset|not provided	Uncertain significance(Last reviewed: Sep 1, 2021)	criteria provided, multiple submitters, no conflicts	VCV001307537	21	34012083	21	32639773	1307537	1298807		NC_000021.9:32639772:G:A
NM_203446.3(SYNJ1):c.-59G>A	SYNJ1	G20D	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset|not provided	Uncertain significance(Last reviewed: Oct 19, 2021)	criteria provided, multiple submitters, no conflicts	VCV001305930	21	34100293	21	32727982	1305930	1297201		NC_000021.9:32727981:C:T
NM_203446.3(SYNJ1):c.3479-18del	SYNJ1		not provided|Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Benign(Last reviewed: Dec 18, 2021)	criteria provided, multiple submitters, no conflicts	VCV001273393	21	34014461	21	32642151	1273393	1263942		NC_000021.9:32642150:AAAAAAAAA:AAAAAAAA
NM_203446.3(SYNJ1):c.3588+14C>T	SYNJ1		Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset|not specified|not provided	Benign(Last reviewed: Dec 8, 2021)	criteria provided, multiple submitters, no conflicts	VCV001209924	21	34014192	21	32641882	1209924	1200088		NC_000021.9:32641881:G:A
NM_203446.3(SYNJ1):c.*690G>A	SYNJ1		Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Benign(Last reviewed: Oct 20, 2020)	criteria provided, single submitter	VCV001169968	21	34003425	21	32631115	1169968	1158955		NC_000021.9:32631114:C:T
NM_203446.3(SYNJ1):c.1182G>A (p.Gln394=)	SYNJ1		Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Benign(Last reviewed: Jun 12, 2020)	criteria provided, single submitter	VCV001169220	21	34056366	21	32684056	1169220	1158959		NC_000021.9:32684055:C:T
NM_203446.3(SYNJ1):c.1971T>C (p.Thr657=)	SYNJ1		Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Benign(Last reviewed: Sep 9, 2020)	criteria provided, single submitter	VCV001168786	21	34038427	21	32666117	1168786	1158957		NC_000021.9:32666116:A:G
NM_203446.3(SYNJ1):c.1201-3A>T	SYNJ1		Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53|not provided|not specified	Benign(Last reviewed: Dec 8, 2020)	criteria provided, multiple submitters, no conflicts	VCV001168202	21	34053961	21	32681651	1168202	1158958		NC_000021.9:32681650:T:A
NM_203446.3(SYNJ1):c.3697+10C>G	SYNJ1		Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Benign(Last reviewed: Feb 14, 2020)	criteria provided, single submitter	VCV001167619	21	34011971	21	32639661	1167619	1158956		NC_000021.9:32639660:G:C
NM_203446.3(SYNJ1):c.125-6_125-5del	SYNJ1		Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Benign(Last reviewed: Mar 23, 2020)	criteria provided, single submitter	VCV001165211	21	34074362 - 34074363	21	32702052 - 32702053	1165211	1158960		NC_000021.9:32702051:AAAAAAAA:AAAAAA
NM_203446.3(SYNJ1):c.462T>A (p.Thr154=)	SYNJ1		Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Likely benign(Last reviewed: Jan 29, 2020)	criteria provided, single submitter	VCV001160938	21	34072165	21	32699855	1160938	1149710		NC_000021.9:32699854:A:T
NM_203446.3(SYNJ1):c.705+9A>G	SYNJ1		Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Likely benign(Last reviewed: Oct 27, 2019)	criteria provided, single submitter	VCV001160911	21	34067358	21	32695048	1160911	1149708		NC_000021.9:32695047:T:C
NM_203446.3(SYNJ1):c.1017T>C (p.Val339=)	SYNJ1		Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Likely benign(Last reviewed: Oct 8, 2020)	criteria provided, single submitter	VCV001160684	21	34058159	21	32685849	1160684	1149705		NC_000021.9:32685848:A:G
NM_203446.3(SYNJ1):c.*753T>C	SYNJ1		Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Likely benign(Last reviewed: Aug 6, 2020)	criteria provided, single submitter	VCV001160648	21	34003362	21	32631052	1160648	1149686		NC_000021.9:32631051:A:G
NM_203446.3(SYNJ1):c.2217C>T (p.Asn739=)	SYNJ1		Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Likely benign(Last reviewed: Oct 20, 2020)	criteria provided, single submitter	VCV001158092	21	34037310	21	32665000	1158092	1149699		NC_000021.9:32664999:G:A
NM_203446.3(SYNJ1):c.711G>A (p.Val237=)	SYNJ1		Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Likely benign(Last reviewed: Mar 26, 2020)	criteria provided, single submitter	VCV001157232	21	34066616	21	32694306	1157232	1149707		NC_000021.9:32694305:C:T
NM_203446.3(SYNJ1):c.597G>A (p.Ala199=)	SYNJ1		Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Likely benign(Last reviewed: Oct 29, 2020)	criteria provided, single submitter	VCV001156550	21	34067475	21	32695165	1156550	1149709		NC_000021.9:32695164:C:T
NM_203446.3(SYNJ1):c.1719G>A (p.Glu573=)	SYNJ1		Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Likely benign(Last reviewed: Mar 6, 2020)	criteria provided, single submitter	VCV001156418	21	34045657	21	32673347	1156418	1149701		NC_000021.9:32673346:C:T
NM_203446.3(SYNJ1):c.1257T>G (p.Thr419=)	SYNJ1		Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Likely benign(Last reviewed: Jul 2, 2020)	criteria provided, single submitter	VCV001156265	21	34053902	21	32681592	1156265	1149704		NC_000021.9:32681591:A:C
NM_203446.3(SYNJ1):c.3879C>G (p.Ser1293=)	SYNJ1		Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Likely benign(Last reviewed: Mar 30, 2019)	criteria provided, single submitter	VCV001156013	21	34011254	21	32638944	1156013	1149691		NC_000021.9:32638943:G:C
NM_203446.3(SYNJ1):c.2685A>T (p.Thr895=)	SYNJ1		Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Likely benign(Last reviewed: Nov 3, 2019)	criteria provided, single submitter	VCV001155432	21	34029107	21	32656797	1155432	1149698		NC_000021.9:32656796:T:A
NM_203446.3(SYNJ1):c.2202A>C (p.Arg734=)	SYNJ1		Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Likely benign(Last reviewed: May 14, 2019)	criteria provided, single submitter	VCV001153296	21	34037325	21	32665015	1153296	1149700		NC_000021.9:32665014:T:G
NM_203446.3(SYNJ1):c.3589-8A>T	SYNJ1		Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Likely benign(Last reviewed: May 4, 2020)	criteria provided, single submitter	VCV001152452	21	34012097	21	32639787	1152452	1149693		NC_000021.9:32639786:T:A
NM_203446.3(SYNJ1):c.3327G>A (p.Pro1109=)	SYNJ1		Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Likely benign(Last reviewed: Feb 12, 2020)	criteria provided, single submitter	VCV001152089	21	34018020	21	32645710	1152089	1149696		NC_000021.9:32645709:C:T
NM_203446.3(SYNJ1):c.873C>T (p.Asn291=)	SYNJ1		Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Likely benign(Last reviewed: Nov 14, 2019)	criteria provided, single submitter	VCV001151977	21	34059363	21	32687053	1151977	1149706		NC_000021.9:32687052:G:A
NM_203446.3(SYNJ1):c.1611C>G (p.Val537=)	SYNJ1		Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Likely benign(Last reviewed: Feb 10, 2020)	criteria provided, single submitter	VCV001151828	21	34045765	21	32673455	1151828	1149702		NC_000021.9:32673454:G:C
NM_203446.3(SYNJ1):c.150G>A (p.Lys50=)	SYNJ1		Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Likely benign(Last reviewed: Oct 13, 2020)	criteria provided, single submitter	VCV001150726	21	34074332	21	32702022	1150726	1149712		NC_000021.9:32702021:C:T
NM_203446.3(SYNJ1):c.*665C>G	SYNJ1	T1479R, T1565R	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Likely benign(Last reviewed: May 24, 2019)	criteria provided, single submitter	VCV001149531	21	34003450	21	32631140	1149531	1149687		NC_000021.9:32631139:G:C
NM_203446.3(SYNJ1):c.2802A>G (p.Val934=)	SYNJ1		Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Likely benign(Last reviewed: Jul 9, 2019)	criteria provided, single submitter	VCV001149203	21	34025670	21	32653360	1149203	1149697		NC_000021.9:32653359:T:C
NM_203446.3(SYNJ1):c.*443G>A	SYNJ1	S1405N, S1491N	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Likely benign(Last reviewed: Jan 28, 2020)	criteria provided, single submitter	VCV001147907	21	34003672	21	32631362	1147907	1149688		NC_000021.9:32631361:C:T
NM_203446.3(SYNJ1):c.3588+7A>G	SYNJ1		Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Likely benign(Last reviewed: Oct 4, 2020)	criteria provided, single submitter	VCV001147806	21	34014199	21	32641889	1147806	1149694		NC_000021.9:32641888:T:C
NM_203446.3(SYNJ1):c.3714T>G (p.Pro1238=)	SYNJ1		Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Likely benign(Last reviewed: Mar 14, 2020)	criteria provided, single submitter	VCV001147414	21	34011419	21	32639109	1147414	1149692		NC_000021.9:32639108:A:C
NM_203446.3(SYNJ1):c.*75A>G	SYNJ1		Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Likely benign(Last reviewed: Oct 28, 2020)	criteria provided, single submitter	VCV001144796	21	34004040	21	32631730	1144796	1149689		NC_000021.9:32631729:T:C
NM_203446.3(SYNJ1):c.3378T>A (p.Pro1126=)	SYNJ1		Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Likely benign(Last reviewed: May 27, 2019)	criteria provided, single submitter	VCV001144320	21	34017969	21	32645659	1144320	1149695		NC_000021.9:32645658:A:T
NM_203446.3(SYNJ1):c.435G>A (p.Ala145=)	SYNJ1		Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Likely benign(Last reviewed: Sep 7, 2020)	criteria provided, single submitter	VCV001143311	21	34072192	21	32699882	1143311	1149711		NC_000021.9:32699881:C:T
NM_203446.3(SYNJ1):c.1311T>C (p.Ser437=)	SYNJ1		Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Likely benign(Last reviewed: Sep 11, 2020)	criteria provided, single submitter	VCV001141863	21	34053848	21	32681538	1141863	1149703		NC_000021.9:32681537:A:G
NM_203446.3(SYNJ1):c.*60A>G	SYNJ1		Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Likely benign(Last reviewed: Jul 16, 2020)	criteria provided, single submitter	VCV001141633	21	34004055	21	32631745	1141633	1149690		NC_000021.9:32631744:T:C
NM_203446.3(SYNJ1):c.3261C>T (p.Asp1087=)	SYNJ1		Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Likely benign(Last reviewed: Jul 16, 2019)	criteria provided, single submitter	VCV001138103	21	34018086	21	32645776	1138103	1128755		NC_000021.9:32645775:G:A
NM_203446.3(SYNJ1):c.3489C>T (p.Ser1163=)	SYNJ1		Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Likely benign(Last reviewed: Oct 13, 2020)	criteria provided, single submitter	VCV001137259	21	34014433	21	32642123	1137259	1128752		NC_000021.9:32642122:G:A
NM_203446.3(SYNJ1):c.1179G>T (p.Val393=)	SYNJ1		Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Likely benign(Last reviewed: Mar 10, 2020)	criteria provided, single submitter	VCV001136800	21	34056369	21	32684059	1136800	1128766		NC_000021.9:32684058:C:A
NM_203446.3(SYNJ1):c.3807A>C (p.Ala1269=)	SYNJ1		Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Likely benign(Last reviewed: Sep 24, 2020)	criteria provided, single submitter	VCV001136484	21	34011326	21	32639016	1136484	1128747		NC_000021.9:32639015:T:G
NM_203446.3(SYNJ1):c.2994G>A (p.Leu998=)	SYNJ1		Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Likely benign(Last reviewed: Nov 4, 2019)	criteria provided, single submitter	VCV001136379	21	34022537	21	32650227	1136379	1128757		NC_000021.9:32650226:C:T
NM_203446.3(SYNJ1):c.2587G>A (p.Val863Ile)	SYNJ1	V858I, V863I, V902I	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Likely benign(Last reviewed: Aug 6, 2020)	criteria provided, single submitter	VCV001136325	21	34029205	21	32656895	1136325	1128761		NC_000021.9:32656894:C:T
NM_203446.3(SYNJ1):c.-64C>T	SYNJ1		Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Likely benign(Last reviewed: Jun 30, 2020)	criteria provided, single submitter	VCV001135357	21	34100298	21	32727987	1135357	1128768		NC_000021.9:32727986:G:A
NM_003895.3(SYNJ1):c.9G>A (p.Lys3=)	SYNJ1		Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Likely benign(Last reviewed: Aug 2, 2020)	criteria provided, single submitter	VCV001134388	21	34100343	21	32728032	1134388	1128769		NC_000021.9:32728031:C:T
NM_203446.3(SYNJ1):c.2860C>T (p.Leu954=)	SYNJ1		Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Likely benign(Last reviewed: Oct 12, 2020)	criteria provided, single submitter	VCV001132567	21	34025612	21	32653302	1132567	1128758		NC_000021.9:32653301:G:A
NM_203446.3(SYNJ1):c.2607T>C (p.Asp869=)	SYNJ1		Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Likely benign(Last reviewed: Mar 10, 2020)	criteria provided, single submitter	VCV001131326	21	34029185	21	32656875	1131326	1128760		NC_000021.9:32656874:A:G
NM_203446.3(SYNJ1):c.3697+8C>T	SYNJ1		Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Likely benign(Last reviewed: Oct 2, 2019)	criteria provided, single submitter	VCV001131278	21	34011973	21	32639663	1131278	1128751		NC_000021.9:32639662:G:A
NM_203446.3(SYNJ1):c.3431-10C>T	SYNJ1		Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Likely benign(Last reviewed: Oct 23, 2019)	criteria provided, single submitter	VCV001130551	21	34015777	21	32643467	1130551	1128754		NC_000021.9:32643466:G:A
NM_203446.3(SYNJ1):c.*9A>G	SYNJ1		Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Likely benign(Last reviewed: Oct 21, 2019)	criteria provided, single submitter	VCV001129811	21	34004106	21	32631796	1129811	1128745		NC_000021.9:32631795:T:C
NM_203446.3(SYNJ1):c.3195C>T (p.Pro1065=)	SYNJ1		Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Likely benign(Last reviewed: Jul 21, 2020)	criteria provided, single submitter	VCV001129554	21	34018755	21	32646445	1129554	1128756		NC_000021.9:32646444:G:A
NM_203446.3(SYNJ1):c.*303T>G	SYNJ1		Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Likely benign(Last reviewed: Apr 23, 2020)	criteria provided, single submitter	VCV001129034	21	34003812	21	32631502	1129034	1128744		NC_000021.9:32631501:A:C
NM_203446.3(SYNJ1):c.2295T>C (p.Asn765=)	SYNJ1		Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Likely benign(Last reviewed: Sep 1, 2020)	criteria provided, single submitter	VCV001128623	21	34037232	21	32664922	1128623	1128762		NC_000021.9:32664921:A:G
NM_203446.3(SYNJ1):c.3915+7C>G	SYNJ1		Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Likely benign(Last reviewed: Apr 27, 2020)	criteria provided, single submitter	VCV001128183	21	34011211	21	32638901	1128183	1128746		NC_000021.9:32638900:G:C
NM_203446.3(SYNJ1):c.3786G>A (p.Glu1262=)	SYNJ1		Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Likely benign(Last reviewed: Apr 8, 2020)	criteria provided, single submitter	VCV001127875	21	34011347	21	32639037	1127875	1128748		NC_000021.9:32639036:C:T
NM_203446.3(SYNJ1):c.-22-10G>A	SYNJ1		Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Likely benign(Last reviewed: Sep 14, 2020)	criteria provided, single submitter	VCV001127579	21	34099238	21	32726927	1127579	1128767		NC_000021.9:32726926:C:T
NM_203446.3(SYNJ1):c.*411C>T	SYNJ1		Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Likely benign(Last reviewed: May 10, 2019)	criteria provided, single submitter	VCV001127312	21	34003704	21	32631394	1127312	1128743		NC_000021.9:32631393:G:A
NM_203446.3(SYNJ1):c.3783A>G (p.Gln1261=)	SYNJ1		Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Likely benign(Last reviewed: Jan 23, 2020)	criteria provided, single submitter	VCV001127292	21	34011350	21	32639040	1127292	1128749		NC_000021.9:32639039:T:C
NM_203446.3(SYNJ1):c.3431-6A>G	SYNJ1		Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Likely benign(Last reviewed: Feb 14, 2020)	criteria provided, single submitter	VCV001126754	21	34015773	21	32643463	1126754	1128753		NC_000021.9:32643462:T:C
NM_203446.3(SYNJ1):c.1728T>C (p.Asp576=)	SYNJ1		Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Likely benign(Last reviewed: Oct 10, 2020)	criteria provided, single submitter	VCV001123709	21	34042681	21	32670371	1123709	1128765		NC_000021.9:32670370:A:G
NM_203446.3(SYNJ1):c.3732G>A (p.Gln1244=)	SYNJ1		Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Likely benign(Last reviewed: Jul 13, 2020)	criteria provided, single submitter	VCV001123555	21	34011401	21	32639091	1123555	1128750		NC_000021.9:32639090:C:T
NM_203446.3(SYNJ1):c.2079G>A (p.Gly693=)	SYNJ1		Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Likely benign(Last reviewed: Nov 27, 2019)	criteria provided, single submitter	VCV001123411	21	34038319	21	32666009	1123411	1128763		NC_000021.9:32666008:C:T
NM_203446.3(SYNJ1):c.2795+7T>C	SYNJ1		Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Likely benign(Last reviewed: Jul 30, 2019)	criteria provided, single submitter	VCV001122116	21	34028990	21	32656680	1122116	1128759		NC_000021.9:32656679:A:G
NM_203446.3(SYNJ1):c.2076A>T (p.Ala692=)	SYNJ1		Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Likely benign(Last reviewed: Mar 7, 2020)	criteria provided, single submitter	VCV001121508	21	34038322	21	32666012	1121508	1128764		NC_000021.9:32666011:T:A
NM_203446.3(SYNJ1):c.*132C>A	SYNJ1		Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Likely benign(Last reviewed: Feb 26, 2020)	criteria provided, single submitter	VCV001119715	21	34003983	21	32631673	1119715	1107334		NC_000021.9:32631672:G:T
NM_203446.3(SYNJ1):c.38T>C (p.Leu13Ser)	SYNJ1	L13S, L52S	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Mar 5, 2021)	criteria provided, conflicting interpretations	VCV001119322	21	34099169	21	32726858	1119322	1107355		NC_000021.9:32726857:A:G
NM_203446.3(SYNJ1):c.*187T>C	SYNJ1		Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Likely benign(Last reviewed: Mar 4, 2020)	criteria provided, single submitter	VCV001118406	21	34003928	21	32631618	1118406	1107333		NC_000021.9:32631617:A:G
NM_203446.3(SYNJ1):c.*396T>C	SYNJ1		Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Likely benign(Last reviewed: Feb 20, 2020)	criteria provided, single submitter	VCV001117002	21	34003719	21	32631409	1117002	1107330		NC_000021.9:32631408:A:G
NM_203446.3(SYNJ1):c.*393C>T	SYNJ1		Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Likely benign(Last reviewed: Nov 11, 2020)	criteria provided, single submitter	VCV001116849	21	34003722	21	32631412	1116849	1107331		NC_000021.9:32631411:G:A
NM_203446.3(SYNJ1):c.2766T>C (p.Phe922=)	SYNJ1		Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Likely benign(Last reviewed: Feb 7, 2019)	criteria provided, single submitter	VCV001115577	21	34029026	21	32656716	1115577	1107340		NC_000021.9:32656715:A:G
NM_203446.3(SYNJ1):c.*540C>T	SYNJ1		Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Likely benign(Last reviewed: Aug 30, 2019)	criteria provided, single submitter	VCV001114590	21	34003575	21	32631265	1114590	1107329		NC_000021.9:32631264:G:A
NM_203446.3(SYNJ1):c.*270C>T	SYNJ1		Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Likely benign(Last reviewed: Mar 11, 2020)	criteria provided, single submitter	VCV001114327	21	34003845	21	32631535	1114327	1107332		NC_000021.9:32631534:G:A
NM_203446.3(SYNJ1):c.-22-4G>A	SYNJ1		Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Likely benign(Last reviewed: Jul 22, 2019)	criteria provided, single submitter	VCV001114235	21	34099232	21	32726921	1114235	1107356		NC_000021.9:32726920:C:T
NM_203446.3(SYNJ1):c.1045A>G (p.Ser349Gly)	SYNJ1	S349G, S388G	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Likely benign(Last reviewed: Aug 3, 2020)	criteria provided, single submitter	VCV001113763	21	34058131	21	32685821	1113763	1107350		NC_000021.9:32685820:T:C
NM_203446.3(SYNJ1):c.303T>C (p.Thr101=)	SYNJ1		Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Likely benign(Last reviewed: Nov 19, 2019)	criteria provided, single submitter	VCV001112820	21	34072324	21	32700014	1112820	1107354		NC_000021.9:32700013:A:G
NM_203446.3(SYNJ1):c.3517+7A>G	SYNJ1		Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Likely benign(Last reviewed: Aug 14, 2020)	criteria provided, single submitter	VCV001111106	21	34014398	21	32642088	1111106	1107336		NC_000021.9:32642087:T:C
NM_203446.3(SYNJ1):c.2304+9A>G	SYNJ1		Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Likely benign(Last reviewed: Mar 20, 2020)	criteria provided, single submitter	VCV001110400	21	34037214	21	32664904	1110400	1107344		NC_000021.9:32664903:T:C
NM_203446.3(SYNJ1):c.-25G>A	SYNJ1		Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Likely benign(Last reviewed: Oct 5, 2020)	criteria provided, single submitter	VCV001109613	21	34100259	21	32727948	1109613	1107357		NC_000021.9:32727947:C:T
NM_203446.3(SYNJ1):c.747C>T (p.Ile249=)	SYNJ1		Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Likely benign(Last reviewed: Aug 20, 2020)	criteria provided, single submitter	VCV001108337	21	34066580	21	32694270	1108337	1107353		NC_000021.9:32694269:G:A
NM_203446.3(SYNJ1):c.1800T>C (p.Ile600=)	SYNJ1		Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Likely benign(Last reviewed: Apr 9, 2020)	criteria provided, single submitter	VCV001107637	21	34042609	21	32670299	1107637	1107347		NC_000021.9:32670298:A:G
NM_203446.3(SYNJ1):c.2325A>G (p.Glu775=)	SYNJ1		Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Likely benign(Last reviewed: Aug 2, 2020)	criteria provided, single submitter	VCV001107342	21	34030162	21	32657852	1107342	1107343		NC_000021.9:32657851:T:C
NM_203446.3(SYNJ1):c.2025A>G (p.Arg675=)	SYNJ1		Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Likely benign(Last reviewed: Nov 16, 2019)	criteria provided, single submitter	VCV001106986	21	34038373	21	32666063	1106986	1107346		NC_000021.9:32666062:T:C
NM_203446.3(SYNJ1):c.-34C>T	SYNJ1		Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Likely benign(Last reviewed: Nov 27, 2020)	criteria provided, single submitter	VCV001106933	21	34100268	21	32727957	1106933	1107358		NC_000021.9:32727956:G:A
NM_203446.3(SYNJ1):c.762A>G (p.Pro254=)	SYNJ1		Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Likely benign(Last reviewed: Feb 12, 2020)	criteria provided, single submitter	VCV001106824	21	34066565	21	32694255	1106824	1107352		NC_000021.9:32694254:T:C
NM_203446.3(SYNJ1):c.2223A>G (p.Glu741=)	SYNJ1		Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Likely benign(Last reviewed: Sep 9, 2020)	criteria provided, single submitter	VCV001105035	21	34037304	21	32664994	1105035	1107345		NC_000021.9:32664993:T:C
NM_203446.3(SYNJ1):c.851+10T>C	SYNJ1		Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Likely benign(Last reviewed: Feb 14, 2020)	criteria provided, single submitter	VCV001104014	21	34060606	21	32688296	1104014	1107351		NC_000021.9:32688295:A:G
NM_203446.3(SYNJ1):c.1118+9G>A	SYNJ1		Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Likely benign(Last reviewed: Jun 28, 2019)	criteria provided, single submitter	VCV001103736	21	34058049	21	32685739	1103736	1107349		NC_000021.9:32685738:C:T
NM_203446.3(SYNJ1):c.2955A>G (p.Lys985=)	SYNJ1		Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Likely benign(Last reviewed: Jun 19, 2020)	criteria provided, single submitter	VCV001102559	21	34022576	21	32650266	1102559	1107337		NC_000021.9:32650265:T:C
NM_203446.3(SYNJ1):c.2909G>C (p.Ser970Thr)	SYNJ1	S1009T, S965T, S970T	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Likely benign(Last reviewed: Mar 26, 2020)	criteria provided, single submitter	VCV001102053	21	34022622	21	32650312	1102053	1107339		NC_000021.9:32650311:C:G
NM_203446.3(SYNJ1):c.2403C>T (p.Thr801=)	SYNJ1		Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Likely benign(Last reviewed: Aug 14, 2019)	criteria provided, single submitter	VCV001102039	21	34030084	21	32657774	1102039	1107341		NC_000021.9:32657773:G:A
NM_203446.3(SYNJ1):c.*21C>A	SYNJ1		Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Likely benign(Last reviewed: Aug 2, 2019)	criteria provided, single submitter	VCV001101028	21	34004094	21	32631784	1101028	1107335		NC_000021.9:32631783:G:T
NM_203446.3(SYNJ1):c.2373C>T (p.Asp791=)	SYNJ1		Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Likely benign(Last reviewed: Oct 1, 2019)	criteria provided, single submitter	VCV001100687	21	34030114	21	32657804	1100687	1107342		NC_000021.9:32657803:G:A
NM_203446.3(SYNJ1):c.2937A>G (p.Glu979=)	SYNJ1		Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Likely benign(Last reviewed: Feb 2, 2019)	criteria provided, single submitter	VCV001100339	21	34022594	21	32650284	1100339	1107338		NC_000021.9:32650283:T:C
NM_203446.3(SYNJ1):c.1176T>C (p.Ser392=)	SYNJ1		Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Likely benign(Last reviewed: Jan 11, 2020)	criteria provided, single submitter	VCV001099008	21	34056372	21	32684062	1099008	1107348		NC_000021.9:32684061:A:G
NM_203446.3(SYNJ1):c.*729G>A	SYNJ1		Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Likely benign(Last reviewed: Jun 15, 2019)	criteria provided, single submitter	VCV001097087	21	34003386	21	32631076	1097087	1085613		NC_000021.9:32631075:C:T
NM_203446.3(SYNJ1):c.3392-10G>C	SYNJ1		Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Likely benign(Last reviewed: Mar 11, 2019)	criteria provided, single submitter	VCV001097058	21	34017326	21	32645016	1097058	1085621		NC_000021.9:32645015:C:G
NM_203446.3(SYNJ1):c.*741C>T	SYNJ1		Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Likely benign(Last reviewed: Apr 9, 2020)	criteria provided, single submitter	VCV001094900	21	34003374	21	32631064	1094900	1085612		NC_000021.9:32631063:G:A
NM_203446.3(SYNJ1):c.*633C>T	SYNJ1		Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Likely benign(Last reviewed: Aug 6, 2020)	criteria provided, single submitter	VCV001093632	21	34003482	21	32631172	1093632	1085614		NC_000021.9:32631171:G:A
NM_203446.3(SYNJ1):c.2352T>C (p.Tyr784=)	SYNJ1		Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Likely benign(Last reviewed: Dec 27, 2019)	criteria provided, single submitter	VCV001093571	21	34030135	21	32657825	1093571	1085626		NC_000021.9:32657824:A:G
NM_203446.3(SYNJ1):c.1953-10T>C	SYNJ1		Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Likely benign(Last reviewed: Nov 6, 2020)	criteria provided, single submitter	VCV001092383	21	34038455	21	32666145	1092383	1085627		NC_000021.9:32666144:A:G
NM_203446.3(SYNJ1):c.3270A>G (p.Pro1090=)	SYNJ1		Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Likely benign(Last reviewed: Oct 15, 2020)	criteria provided, single submitter	VCV001091449	21	34018077	21	32645767	1091449	1085622		NC_000021.9:32645766:T:C
NM_203446.3(SYNJ1):c.981T>C (p.Asp327=)	SYNJ1		Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Likely benign(Last reviewed: Aug 22, 2019)	criteria provided, single submitter	VCV001089846	21	34058195	21	32685885	1089846	1085631		NC_000021.9:32685884:A:G
NM_203446.3(SYNJ1):c.162C>T (p.Ser54=)	SYNJ1		Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Likely benign(Last reviewed: Jul 15, 2020)	criteria provided, single submitter	VCV001089580	21	34074320	21	32702010	1089580	1085633		NC_000021.9:32702009:G:A
NM_203446.3(SYNJ1):c.2757G>T (p.Leu919=)	SYNJ1		Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Likely benign(Last reviewed: Nov 12, 2019)	criteria provided, single submitter	VCV001088259	21	34029035	21	32656725	1088259	1085623		NC_000021.9:32656724:C:A
NM_203446.3(SYNJ1):c.2580-7C>T	SYNJ1		Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Likely benign(Last reviewed: Mar 5, 2019)	criteria provided, single submitter	VCV001085170	21	34029219	21	32656909	1085170	1085624		NC_000021.9:32656908:G:A
NM_203446.3(SYNJ1):c.1671A>G (p.Thr557=)	SYNJ1		Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Likely benign(Last reviewed: Mar 28, 2019)	criteria provided, single submitter	VCV001084481	21	34045705	21	32673395	1084481	1085628		NC_000021.9:32673394:T:C
NM_203446.3(SYNJ1):c.3915+10A>G	SYNJ1		Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Likely benign(Last reviewed: Feb 25, 2020)	criteria provided, single submitter	VCV001084001	21	34011208	21	32638898	1084001	1085616		NC_000021.9:32638897:T:C
NM_203446.3(SYNJ1):c.3517+10C>T	SYNJ1		Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Likely benign(Last reviewed: Mar 28, 2020)	criteria provided, single submitter	VCV001083529	21	34014395	21	32642085	1083529	1085620		NC_000021.9:32642084:G:A
NM_203446.3(SYNJ1):c.1659T>C (p.Phe553=)	SYNJ1		Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Likely benign(Last reviewed: Dec 16, 2019)	criteria provided, single submitter	VCV001083263	21	34045717	21	32673407	1083263	1085629		NC_000021.9:32673406:A:G
NM_203446.3(SYNJ1):c.3635C>T (p.Ala1212Val)	SYNJ1	A1165V, A1196V, A1212V, A1251V	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Likely benign(Last reviewed: Oct 5, 2020)	criteria provided, single submitter	VCV001082568	21	34012043	21	32639733	1082568	1085619		NC_000021.9:32639732:G:A
NM_203446.3(SYNJ1):c.-61C>T	SYNJ1		Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Likely benign(Last reviewed: May 19, 2019)	criteria provided, single submitter	VCV001081943	21	34100295	21	32727984	1081943	1085634		NC_000021.9:32727983:G:A
NM_203446.3(SYNJ1):c.1150T>C (p.Leu384=)	SYNJ1		Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Likely benign(Last reviewed: Apr 6, 2020)	criteria provided, single submitter	VCV001081409	21	34056398	21	32684088	1081409	1085630		NC_000021.9:32684087:A:G
NM_203446.3(SYNJ1):c.3912G>T (p.Pro1304=)	SYNJ1		Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Likely benign(Last reviewed: Oct 8, 2020)	criteria provided, single submitter	VCV001081128	21	34011221	21	32638911	1081128	1085617		NC_000021.9:32638910:C:A
NM_203446.3(SYNJ1):c.3753T>G (p.Ser1251=)	SYNJ1		not provided|Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Likely benign(Last reviewed: Oct 1, 2021)	criteria provided, multiple submitters, no conflicts	VCV001079551	21	34011380	21	32639070	1079551	1085618		NC_000021.9:32639069:A:C
NM_203446.3(SYNJ1):c.*459A>G	SYNJ1		Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Likely benign(Last reviewed: Apr 23, 2019)	criteria provided, single submitter	VCV001078685	21	34003656	21	32631346	1078685	1085615		NC_000021.9:32631345:T:C
NM_203446.3(SYNJ1):c.2439G>A (p.Arg813=)	SYNJ1		Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Likely benign(Last reviewed: Aug 21, 2020)	criteria provided, single submitter	VCV001077637	21	34030048	21	32657738	1077637	1085625		NC_000021.9:32657737:C:T
NM_203446.3(SYNJ1):c.948+7A>G	SYNJ1		Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Likely benign(Last reviewed: Jun 3, 2020)	criteria provided, single submitter	VCV001077636	21	34059281	21	32686971	1077636	1085632		NC_000021.9:32686970:T:C
NM_203446.3(SYNJ1):c.3865C>T (p.Arg1289Ter)	SYNJ1	R1242*, R1273*, R1289*, R1328*	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Pathogenic(Last reviewed: Oct 15, 2020)	criteria provided, single submitter	VCV001076901	21	34011268	21	32638958	1076901	1064882		NC_000021.9:32638957:G:A
NM_203446.3(SYNJ1):c.1279_1280dup (p.Met428fs)	SYNJ1	M428fs, M467fs	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Pathogenic(Last reviewed: Sep 20, 2020)	criteria provided, single submitter	VCV001075587	21	34053878 - 34053879	21	32681568 - 32681569	1075587	1064884		NC_000021.9:32681568:GA:GAGA
NM_203446.3(SYNJ1):c.1093dup (p.Tyr365fs)	SYNJ1	Y365fs, Y404fs	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Pathogenic(Last reviewed: Jun 29, 2020)	criteria provided, single submitter	VCV001074545	21	34058082 - 34058083	21	32685772 - 32685773	1074545	1064885		NC_000021.9:32685772:AAAAAAA:AAAAAAAA
NM_203446.3(SYNJ1):c.3438dup (p.Ala1147fs)	SYNJ1	A1147fs, A1186fs	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Pathogenic(Last reviewed: Aug 20, 2020)	criteria provided, single submitter	VCV001070684	21	34015759 - 34015760	21	32643449 - 32643450	1070684	1064883		NC_000021.9:32643449:T:TT
NM_003895.3(SYNJ1):c.12_13dup (p.Trp5fs)	SYNJ1	W5fs	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Pathogenic(Last reviewed: Jul 21, 2020)	criteria provided, single submitter	VCV001069960	21	34100338 - 34100339	21	32728027 - 32728028	1069960	1064886		NC_000021.9:32728027:AT:ATAT
NM_203446.3(SYNJ1):c.2603T>C (p.Ile868Thr)	SYNJ1	I863T, I868T, I907T	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Sep 7, 2020)	criteria provided, single submitter	VCV001063784	21	34029189	21	32656879	1063784	1051848		NC_000021.9:32656878:A:G
NM_203446.3(SYNJ1):c.121C>T (p.Leu41Phe)	SYNJ1	L41F, L80F	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Sep 15, 2020)	criteria provided, single submitter	VCV001062858	21	34099086	21	32726775	1062858	1051859		NC_000021.9:32726774:G:A
NM_203446.3(SYNJ1):c.455A>G (p.Gln152Arg)	SYNJ1	Q152R, Q191R	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Jan 7, 2020)	criteria provided, single submitter	VCV001060872	21	34072172	21	32699862	1060872	1051857		NC_000021.9:32699861:T:C
NM_203446.3(SYNJ1):c.*89C>T	SYNJ1	A1287V, A1373V	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Sep 24, 2020)	criteria provided, single submitter	VCV001059946	21	34004026	21	32631716	1059946	1051841		NC_000021.9:32631715:G:A
NM_203446.3(SYNJ1):c.-23+3G>A	SYNJ1		Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Sep 3, 2020)	criteria provided, single submitter	VCV001059706	21	34100254	21	32727943	1059706	1051860		NC_000021.9:32727942:C:T
NM_203446.3(SYNJ1):c.*598C>A	SYNJ1	L1457M, L1543M	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Feb 12, 2020)	criteria provided, single submitter	VCV001059323	21	34003517	21	32631207	1059323	1051839		NC_000021.9:32631206:G:T
NM_203446.3(SYNJ1):c.3275CGC[3] (p.Pro1093dup)	SYNJ1		Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Oct 8, 2020)	criteria provided, single submitter	VCV001058736	21	34018066 - 34018067	21	32645756 - 32645757	1058736	1051846		NC_000021.9:32645756:GCGGCG:GCGGCGGCG
NM_203446.3(SYNJ1):c.3598C>T (p.Pro1200Ser)	SYNJ1	P1153S, P1184S, P1200S, P1239S	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Mar 23, 2020)	criteria provided, single submitter	VCV001058703	21	34012080	21	32639770	1058703	1051845		NC_000021.9:32639769:G:A
NM_203446.3(SYNJ1):c.741A>G (p.Ile247Met)	SYNJ1	I247M, I286M	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Aug 31, 2020)	criteria provided, single submitter	VCV001057776	21	34066586	21	32694276	1057776	1051855		NC_000021.9:32694275:T:C
NM_203446.3(SYNJ1):c.2201G>A (p.Arg734Gln)	SYNJ1	R729Q, R734Q, R773Q	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Oct 20, 2020)	criteria provided, single submitter	VCV001057755	21	34037326	21	32665016	1057755	1051850		NC_000021.9:32665015:C:T
NM_203446.3(SYNJ1):c.2525C>A (p.Thr842Asn)	SYNJ1	T837N, T842N, T881N	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Oct 24, 2020)	criteria provided, single submitter	VCV001057509	21	34029367	21	32657057	1057509	1051849		NC_000021.9:32657056:G:T
NM_203446.3(SYNJ1):c.988A>T (p.Met330Leu)	SYNJ1	M330L, M369L	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Jan 16, 2020)	criteria provided, single submitter	VCV001056959	21	34058188	21	32685878	1056959	1051853		NC_000021.9:32685877:T:A
NM_203446.3(SYNJ1):c.2113A>T (p.Ile705Leu)	SYNJ1	I700L, I705L, I744L	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Jul 13, 2020)	criteria provided, single submitter	VCV001056898	21	34038285	21	32665975	1056898	1051851		NC_000021.9:32665974:T:A
NM_203446.3(SYNJ1):c.3832C>A (p.Pro1278Thr)	SYNJ1	P1231T, P1262T, P1278T, P1317T	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Sep 24, 2020)	criteria provided, single submitter	VCV001056884	21	34011301	21	32638991	1056884	1051843		NC_000021.9:32638990:G:T
NM_203446.3(SYNJ1):c.3604G>T (p.Ala1202Ser)	SYNJ1	A1155S, A1186S, A1202S, A1241S	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: May 22, 2020)	criteria provided, single submitter	VCV001055785	21	34012074	21	32639764	1055785	1051844		NC_000021.9:32639763:C:A
NM_203446.3(SYNJ1):c.193G>A (p.Val65Ile)	SYNJ1	V104I, V65I	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Feb 21, 2020)	criteria provided, single submitter	VCV001055087	21	34074289	21	32701979	1055087	1051858		NC_000021.9:32701978:C:T
NM_203446.3(SYNJ1):c.2786T>G (p.Ile929Arg)	SYNJ1	I924R, I929R, I968R	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Feb 21, 2020)	criteria provided, single submitter	VCV001054047	21	34029006	21	32656696	1054047	1051847		NC_000021.9:32656695:A:C
NM_203446.3(SYNJ1):c.*119C>T	SYNJ1	T1297M, T1383M	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Sep 25, 2020)	criteria provided, single submitter	VCV001053673	21	34003996	21	32631686	1053673	1051840		NC_000021.9:32631685:G:A
NM_203446.3(SYNJ1):c.856T>C (p.Phe286Leu)	SYNJ1	F286L, F325L	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Oct 15, 2020)	criteria provided, single submitter	VCV001053057	21	34059380	21	32687070	1053057	1051854		NC_000021.9:32687069:A:G
NM_203446.3(SYNJ1):c.1370G>A (p.Arg457His)	SYNJ1	R457H, R460H, R496H	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Sep 11, 2020)	criteria provided, single submitter	VCV001052149	21	34051095	21	32678785	1052149	1051852		NC_000021.9:32678784:C:T
NM_203446.3(SYNJ1):c.559G>A (p.Val187Ile)	SYNJ1	V187I, V226I	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Feb 17, 2020)	criteria provided, single submitter	VCV001052026	21	34067513	21	32695203	1052026	1051856		NC_000021.9:32695202:C:T
NM_203446.3(SYNJ1):c.*88G>C	SYNJ1	A1287P, A1373P	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Jul 9, 2020)	criteria provided, single submitter	VCV001051293	21	34004027	21	32631717	1051293	1051842		NC_000021.9:32631716:C:G
NM_203446.3(SYNJ1):c.952C>A (p.His318Asn)	SYNJ1	H357N, H318N	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: May 22, 2020)	criteria provided, single submitter	VCV001046811	21	34058224	21	32685914	1046811	1034876	rs2041822657	NC_000021.9:32685913:G:T
NM_203446.3(SYNJ1):c.3475G>A (p.Glu1159Lys)	SYNJ1	E1198K, E1159K	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Oct 1, 2020)	criteria provided, single submitter	VCV001044826	21	34015723	21	32643413	1044826	1034868	rs561276644	NC_000021.9:32643412:C:T
NM_203446.3(SYNJ1):c.*265C>A	SYNJ1	P1346T, P1432T	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Feb 2, 2020)	criteria provided, single submitter	VCV001044768	21	34003850	21	32631540	1044768	1034864	rs769312346	NC_000021.9:32631539:G:T
NM_203446.3(SYNJ1):c.*195T>G	SYNJ1		Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Feb 17, 2020)	criteria provided, single submitter	VCV001044445	21	34003920	21	32631610	1044445	1034865	rs1323976540	NC_000021.9:32631609:A:C
NM_203446.3(SYNJ1):c.3806C>G (p.Ala1269Gly)	SYNJ1	A1222G, A1253G, A1269G, A1308G	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Sep 20, 2020)	criteria provided, single submitter	VCV001044285	21	34011327	21	32639017	1044285	1034866	rs2039705571	NC_000021.9:32639016:G:C
NM_203446.3(SYNJ1):c.2608A>G (p.Ile870Val)	SYNJ1	I909V, I865V, I870V	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Apr 28, 2020)	criteria provided, single submitter	VCV001044033	21	34029184	21	32656874	1044033	1034871	rs2040476929	NC_000021.9:32656873:T:C
NM_203446.3(SYNJ1):c.2372A>G (p.Asp791Gly)	SYNJ1	D786G, D830G, D791G	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Feb 6, 2020)	criteria provided, single submitter	VCV001043701	21	34030115	21	32657805	1043701	1034872	rs1195357077	NC_000021.9:32657804:T:C
NM_203446.3(SYNJ1):c.*295A>G	SYNJ1	T1356A, T1442A	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Oct 9, 2020)	criteria provided, single submitter	VCV001042375	21	34003820	21	32631510	1042375	1034863	rs2039325513	NC_000021.9:32631509:T:C
NM_203446.3(SYNJ1):c.1868A>G (p.Asn623Ser)	SYNJ1	N623S, N662S, N618S	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Sep 15, 2020)	criteria provided, single submitter	VCV001042251	21	34038827	21	32666517	1042251	1034873	rs1298315820	NC_000021.9:32666516:T:C
NM_203446.3(SYNJ1):c.-83A>G	SYNJ1	D12G	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: May 14, 2020)	criteria provided, single submitter	VCV001041856	21	34100317	21	32728006	1041856	1034881	rs775805673	NC_000021.9:32728005:T:C
NM_203446.3(SYNJ1):c.3688A>C (p.Thr1230Pro)	SYNJ1	T1214P, T1230P, T1183P, T1269P	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Oct 5, 2020)	criteria provided, single submitter	VCV001040229	21	34011990	21	32639680	1040229	1034867	rs2039743427	NC_000021.9:32639679:T:G
NM_203446.3(SYNJ1):c.3266A>G (p.Gln1089Arg)	SYNJ1	Q1089R, Q1128R, Q1084R	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Mar 14, 2020)	criteria provided, single submitter	VCV001039933	21	34018081	21	32645771	1039933	1034869	rs779932426	NC_000021.9:32645770:T:C
NM_203446.3(SYNJ1):c.1825A>C (p.Lys609Gln)	SYNJ1	K604Q, K648Q, K609Q	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Oct 15, 2020)	criteria provided, single submitter	VCV001038345	21	34038870	21	32666560	1038345	1034874	rs760221186	NC_000021.9:32666559:T:G
NM_203446.3(SYNJ1):c.*755C>T	SYNJ1	P1509L, P1595L	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Jan 31, 2020)	criteria provided, single submitter	VCV001038118	21	34003360	21	32631050	1038118	1034862	rs2039299981	NC_000021.9:32631049:G:A
NM_203446.3(SYNJ1):c.887A>G (p.Gln296Arg)	SYNJ1	Q296R, Q335R	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Jul 21, 2020)	criteria provided, single submitter	VCV001037836	21	34059349	21	32687039	1037836	1034877	rs2041858912	NC_000021.9:32687038:T:C
NM_203446.3(SYNJ1):c.-23G>C	SYNJ1	R32T	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Oct 10, 2020)	criteria provided, single submitter	VCV001037566	21	34100257	21	32727946	1037566	1034880	rs1195858283	NC_000021.9:32727945:C:G
NM_203446.3(SYNJ1):c.161C>T (p.Ser54Phe)	SYNJ1	S54F, S93F	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Sep 8, 2020)	criteria provided, single submitter	VCV001037081	21	34074321	21	32702011	1037081	1034878	rs2042421673	NC_000021.9:32702010:G:A
NM_203446.3(SYNJ1):c.96G>A (p.Met32Ile)	SYNJ1	M71I, M32I	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Aug 16, 2020)	criteria provided, single submitter	VCV001035303	21	34099111	21	32726800	1035303	1034879	rs770096593	NC_000021.9:32726799:C:T
NM_203446.3(SYNJ1):c.1265A>C (p.Gln422Pro)	SYNJ1	Q461P, Q422P	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Sep 24, 2020)	criteria provided, single submitter	VCV001035021	21	34053894	21	32681584	1035021	1034875	rs1474918219	NC_000021.9:32681583:T:G
NM_203446.3(SYNJ1):c.3007G>A (p.Ala1003Thr)	SYNJ1	A998T, A1042T, A1003T	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Mar 19, 2020)	criteria provided, single submitter	VCV001034741	21	34022524	21	32650214	1034741	1034870	rs911362591	NC_000021.9:32650213:C:T
NM_203446.3(SYNJ1):c.359G>A (p.Arg120Gln)	SYNJ1	R120Q, R159Q	not provided|Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Sep 3, 2020)	criteria provided, multiple submitters, no conflicts	VCV001026655	21	34072268	21	32699958	1026655	1014308	rs768435291	NC_000021.9:32699957:C:T
NM_203446.3(SYNJ1):c.2446C>T (p.Pro816Ser)	SYNJ1	P811S, P816S, P855S	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Apr 24, 2020)	criteria provided, single submitter	VCV001026478	21	34030041	21	32657731	1026478	1014296	rs1473591033	NC_000021.9:32657730:G:A
NM_203446.3(SYNJ1):c.3355C>A (p.Arg1119Ser)	SYNJ1	R1114S, R1119S, R1158S	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Mar 23, 2020)	criteria provided, single submitter	VCV001026362	21	34017992	21	32645682	1026362	1014292	rs1157846436	NC_000021.9:32645681:G:T
NM_203446.3(SYNJ1):c.3680C>G (p.Thr1227Arg)	SYNJ1	T1180R, T1211R, T1227R, T1266R	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Mar 5, 2020)	criteria provided, single submitter	VCV001025770	21	34011998	21	32639688	1025770	1014289	rs1275854378	NC_000021.9:32639687:G:C
NM_203446.3(SYNJ1):c.*668A>C	SYNJ1	N1480T, N1566T	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Jan 31, 2020)	criteria provided, single submitter	VCV001025546	21	34003447	21	32631137	1025546	1014280	rs2039305821	NC_000021.9:32631136:T:G
NM_203446.3(SYNJ1):c.*319G>C	SYNJ1	A1364P, A1450P	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Feb 21, 2020)	criteria provided, single submitter	VCV001024664	21	34003796	21	32631486	1024664	1014281	rs565075239	NC_000021.9:32631485:C:G
NM_203446.3(SYNJ1):c.-23G>A	SYNJ1	R32K	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Jul 9, 2020)	criteria provided, single submitter	VCV001024247	21	34100257	21	32727946	1024247	1014310	rs1195858283	NC_000021.9:32727945:C:T
NM_203446.3(SYNJ1):c.1427T>C (p.Ile476Thr)	SYNJ1	I476T, I479T, I515T	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Mar 23, 2020)	criteria provided, single submitter	VCV001023898	21	34051038	21	32678728	1023898	1014299	rs771070426	NC_000021.9:32678727:A:G
NM_203446.3(SYNJ1):c.*257G>A	SYNJ1	R1343Q, R1429Q	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Sep 2, 2020)	criteria provided, single submitter	VCV001023642	21	34003858	21	32631548	1023642	1014283	rs112469776	NC_000021.9:32631547:C:T
NM_203446.3(SYNJ1):c.*309T>G	SYNJ1	S1360R, S1446R	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Aug 26, 2020)	criteria provided, single submitter	VCV001023572	21	34003806	21	32631496	1023572	1014282	rs750670440	NC_000021.9:32631495:A:C
NM_203446.3(SYNJ1):c.3873G>T (p.Arg1291Ser)	SYNJ1	R1244S, R1275S, R1291S, R1330S	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Jul 12, 2020)	criteria provided, single submitter	VCV001023024	21	34011260	21	32638950	1023024	1014286	rs141669628	NC_000021.9:32638949:C:A
NM_203446.3(SYNJ1):c.*110C>T	SYNJ1	S1294F, S1380F	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Oct 13, 2020)	criteria provided, single submitter	VCV001022955	21	34004005	21	32631695	1022955	1014285	rs959757570	NC_000021.9:32631694:G:A
NM_203446.3(SYNJ1):c.601G>T (p.Ala201Ser)	SYNJ1	A201S, A240S	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Jun 16, 2020)	criteria provided, single submitter	VCV001022534	21	34067471	21	32695161	1022534	1014302	rs371958110	NC_000021.9:32695160:C:A
NM_203446.3(SYNJ1):c.2125C>G (p.Arg709Gly)	SYNJ1	R704G, R709G, R748G	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Jul 10, 2020)	criteria provided, single submitter	VCV001022461	21	34038273	21	32665963	1022461	1014297	rs2040913777	NC_000021.9:32665962:G:C
NM_203446.3(SYNJ1):c.3637C>T (p.Arg1213Trp)	SYNJ1	R1166W, R1197W, R1213W, R1252W	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Sep 25, 2020)	criteria provided, single submitter	VCV001020401	21	34012041	21	32639731	1020401	1014290	rs779662077	NC_000021.9:32639730:G:A
NM_203446.3(SYNJ1):c.437A>G (p.His146Arg)	SYNJ1	H146R, H185R	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Sep 3, 2020)	criteria provided, single submitter	VCV001020033	21	34072190	21	32699880	1020033	1014307	rs2042338087	NC_000021.9:32699879:T:C
NM_203446.3(SYNJ1):c.-30A>G	SYNJ1	R30G	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Jun 20, 2020)	criteria provided, single submitter	VCV001019696	21	34100264	21	32727953	1019696	1014311	rs2043551030	NC_000021.9:32727952:T:C
NM_203446.3(SYNJ1):c.1701G>C (p.Lys567Asn)	SYNJ1	K562N, K567N, K606N	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Jun 8, 2020)	criteria provided, single submitter	VCV001019669	21	34045675	21	32673365	1019669	1014298	rs147684005	NC_000021.9:32673364:C:G
NM_203446.3(SYNJ1):c.3296C>T (p.Pro1099Leu)	SYNJ1	P1094L, P1099L, P1138L	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Sep 24, 2020)	criteria provided, single submitter	VCV001019084	21	34018051	21	32645741	1019084	1014293	rs1447192933	NC_000021.9:32645740:G:A
NM_203446.3(SYNJ1):c.574A>G (p.Ile192Val)	SYNJ1	I192V, I231V	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Aug 11, 2020)	criteria provided, single submitter	VCV001018958	21	34067498	21	32695188	1018958	1014303	rs2042159051	NC_000021.9:32695187:T:C
NM_203446.3(SYNJ1):c.3249T>G (p.Ser1083Arg)	SYNJ1	S1078R, S1083R, S1122R	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Feb 2, 2020)	criteria provided, single submitter	VCV001017909	21	34018098	21	32645788	1017909	1014294	rs1396229702	NC_000021.9:32645787:A:C
NM_203446.3(SYNJ1):c.549G>A (p.Met183Ile)	SYNJ1	M183I, M222I	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Sep 10, 2020)	criteria provided, single submitter	VCV001016682	21	34067523	21	32695213	1016682	1014304	rs760573856	NC_000021.9:32695212:C:T
NM_203446.3(SYNJ1):c.3409C>T (p.Pro1137Ser)	SYNJ1	P1137S, P1176S	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Sep 10, 2020)	criteria provided, single submitter	VCV001016679	21	34017299	21	32644989	1016679	1014291	rs1461988082	NC_000021.9:32644988:G:A
NM_203446.3(SYNJ1):c.528T>A (p.Asp176Glu)	SYNJ1	D176E, D215E	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Feb 3, 2020)	criteria provided, single submitter	VCV001016420	21	34067544	21	32695234	1016420	1014305	rs1277503442	NC_000021.9:32695233:A:T
NM_203446.3(SYNJ1):c.3866G>C (p.Arg1289Pro)	SYNJ1	R1242P, R1273P, R1289P, R1328P	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Sep 7, 2020)	criteria provided, single submitter	VCV001016371	21	34011267	21	32638957	1016371	1014287	rs780038881	NC_000021.9:32638956:C:G
NM_203446.3(SYNJ1):c.-56_-55delinsAT	SYNJ1	C21Y	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Jul 26, 2020)	criteria provided, single submitter	VCV001016364	21	34100289 - 34100290	21	32727978 - 32727979	1016364	1014313	rs2043553723	NC_000021.9:32727977:GC:AT
NM_203446.3(SYNJ1):c.3796C>T (p.Pro1266Ser)	SYNJ1	P1219S, P1250S, P1266S, P1305S	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Jun 12, 2020)	criteria provided, single submitter	VCV001016247	21	34011337	21	32639027	1016247	1014288	rs2039706224	NC_000021.9:32639026:G:A
NM_203446.3(SYNJ1):c.1315A>G (p.Ile439Val)	SYNJ1	I439V, I478V	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Apr 9, 2020)	criteria provided, single submitter	VCV001016131	21	34053844	21	32681534	1016131	1014301	rs1569085743	NC_000021.9:32681533:T:C
NM_203446.3(SYNJ1):c.2861T>G (p.Leu954Arg)	SYNJ1	L949R, L954R, L993R	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Feb 19, 2020)	criteria provided, single submitter	VCV001016093	21	34025611	21	32653301	1016093	1014295	rs755535504	NC_000021.9:32653300:A:C
NM_203446.3(SYNJ1):c.1400T>A (p.Phe467Tyr)	SYNJ1	F467Y, F470Y, F506Y	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: May 11, 2020)	criteria provided, single submitter	VCV001015083	21	34051065	21	32678755	1015083	1014300	rs922232672	NC_000021.9:32678754:A:T
NM_203446.3(SYNJ1):c.-43G>C	SYNJ1	R25S	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Mar 17, 2020)	criteria provided, single submitter	VCV001014911	21	34100277	21	32727966	1014911	1014312	rs2043552321	NC_000021.9:32727965:C:G
NM_203446.3(SYNJ1):c.440G>A (p.Arg147His)	SYNJ1	R147H, R186H	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Mar 20, 2020)	criteria provided, single submitter	VCV001014566	21	34072187	21	32699877	1014566	1014306	rs749741780	NC_000021.9:32699876:C:T
NM_203446.3(SYNJ1):c.4G>A (p.Ala2Thr)	SYNJ1	A2T, A41T	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: May 3, 2020)	criteria provided, single submitter	VCV001014043	21	34099203	21	32726892	1014043	1014309	rs2043481026	NC_000021.9:32726891:C:T
NM_203446.3(SYNJ1):c.*227_*244dup	SYNJ1		Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Jul 15, 2020)	criteria provided, single submitter	VCV001013690	21	34003870 - 34003871	21	32631560 - 32631561	1013690	1014284	rs1332100317	NC_000021.9:32631560:GGGATTGACTCCGAGCTGG:GGGATTGACTCCGAGCTGGGGATTGACTCCGAGCTGG
NM_203446.3(SYNJ1):c.1399T>C (p.Phe467Leu)	SYNJ1	F467L, F470L, F506L	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Feb 26, 2020)	criteria provided, single submitter	VCV001011703	21	34051066	21	32678756	1011703	999149	rs2041510835	NC_000021.9:32678755:A:G
NM_003895.3(SYNJ1):c.13T>C (p.Trp5Arg)	SYNJ1	W5R	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Aug 26, 2020)	criteria provided, single submitter	VCV001010675	21	34100339	21	32728028	1010675	999160	rs1255271636	NC_000021.9:32728027:A:G
NM_203446.3(SYNJ1):c.225A>C (p.Leu75Phe)	SYNJ1	L114F, L75F	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Oct 1, 2020)	criteria provided, single submitter	VCV001010606	21	34072402	21	32700092	1010606	999156	rs2042346717	NC_000021.9:32700091:T:G
NM_203446.3(SYNJ1):c.2332G>A (p.Val778Ile)	SYNJ1	V773I, V778I, V817I	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Jan 27, 2020)	criteria provided, single submitter	VCV001010158	21	34030155	21	32657845	1010158	999146	rs762956275	NC_000021.9:32657844:C:T
NM_203446.3(SYNJ1):c.948G>C (p.Gln316His)	SYNJ1	Q316H, Q355H	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Oct 24, 2020)	criteria provided, single submitter	VCV001009571	21	34059288	21	32686978	1009571	999150	rs1569093889	NC_000021.9:32686977:C:G
NM_203446.3(SYNJ1):c.156A>G (p.Thr52=)	SYNJ1		Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Oct 24, 2020)	criteria provided, single submitter	VCV001009506	21	34074326	21	32702016	1009506	999157	rs144728528	NC_000021.9:32702015:T:C
NM_203446.3(SYNJ1):c.*276del	SYNJ1	F1349fs, F1435fs	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Jun 18, 2020)	criteria provided, single submitter	VCV001009392	21	34003839	21	32631529	1009392	999141	rs1324658792	NC_000021.9:32631528:AAA:AA
NM_203446.3(SYNJ1):c.517G>A (p.Val173Met)	SYNJ1	V173M, V212M	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: May 31, 2020)	criteria provided, single submitter	VCV001005847	21	34067555	21	32695245	1005847	999154	rs756663722	NC_000021.9:32695244:C:T
NM_203446.3(SYNJ1):c.3749A>T (p.Gln1250Leu)	SYNJ1	Q1203L, Q1234L, Q1250L, Q1289L	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Jun 17, 2020)	criteria provided, single submitter	VCV001005510	21	34011384	21	32639074	1005510	999143	rs1433204750	NC_000021.9:32639073:T:A
NM_203446.3(SYNJ1):c.*526G>A	SYNJ1	G1433R, G1519R	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Mar 5, 2020)	criteria provided, single submitter	VCV001005279	21	34003589	21	32631279	1005279	999140	rs1304102538	NC_000021.9:32631278:C:T
NM_203446.3(SYNJ1):c.1601G>A (p.Arg534Gln)	SYNJ1	R529Q, R534Q, R573Q	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Apr 28, 2020)	criteria provided, single submitter	VCV001004293	21	34045775	21	32673465	1004293	999148	rs750585610	NC_000021.9:32673464:C:T
NM_203446.3(SYNJ1):c.344G>A (p.Arg115His)	SYNJ1	R115H, R154H	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Aug 2, 2020)	criteria provided, single submitter	VCV001003992	21	34072283	21	32699973	1003992	999155	rs951976946	NC_000021.9:32699972:C:T
NM_203446.3(SYNJ1):c.842C>T (p.Ala281Val)	SYNJ1	A281V, A320V	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: May 22, 2020)	criteria provided, single submitter	VCV001002258	21	34060625	21	32688315	1002258	999151	rs1046699971	NC_000021.9:32688314:G:A
NM_203446.3(SYNJ1):c.3560G>A (p.Gly1187Glu)	SYNJ1	G1140E, G1171E, G1187E, G1226E	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Mar 6, 2020)	criteria provided, single submitter	VCV001002142	21	34014234	21	32641924	1002142	999144	rs1601244421	NC_000021.9:32641923:C:T
NM_203446.3(SYNJ1):c.809G>T (p.Arg270Leu)	SYNJ1	R270L, R309L	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Mar 23, 2020)	criteria provided, single submitter	VCV001000830	21	34060658	21	32688348	1000830	999152	rs532075408	NC_000021.9:32688347:C:A
NM_203446.3(SYNJ1):c.2050T>G (p.Cys684Gly)	SYNJ1	C679G, C684G, C723G	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Oct 23, 2020)	criteria provided, single submitter	VCV001000814	21	34038348	21	32666038	1000814	999147	rs751110096	NC_000021.9:32666037:A:C
NM_203446.3(SYNJ1):c.3391+6A>C	SYNJ1		Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Jan 29, 2020)	criteria provided, single submitter	VCV001000406	21	34017950	21	32645640	1000406	999145	rs745914222	NC_000021.9:32645639:T:G
NM_203446.3(SYNJ1):c.46C>T (p.Pro16Ser)	SYNJ1	P16S, P55S	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Oct 11, 2020)	criteria provided, single submitter	VCV000999277	21	34099161	21	32726850	999277	999158	rs1487423508	NC_000021.9:32726849:G:A
NM_203446.3(SYNJ1):c.549G>T (p.Met183Ile)	SYNJ1	M183I, M222I	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: May 14, 2020)	criteria provided, single submitter	VCV000999098	21	34067523	21	32695213	999098	999153	rs760573856	NC_000021.9:32695212:C:A
NM_203446.3(SYNJ1):c.-57T>G	SYNJ1	C21G	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Jul 2, 2020)	criteria provided, multiple submitters, no conflicts	VCV000998439	21	34100291	21	32727980	998439	999159	rs921606190	NC_000021.9:32727979:A:C
NM_203446.3(SYNJ1):c.*232C>T	SYNJ1	R1335W, R1421W	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53|not provided	Uncertain significance(Last reviewed: Aug 31, 2021)	criteria provided, multiple submitters, no conflicts	VCV000995023	21	34003883	21	32631573	995023	983229	rs373563239	NC_000021.9:32631572:G:A
NM_203446.3(SYNJ1):c.577T>C (p.Tyr193His)	SYNJ1	Y193H, Y232H	Parkinson disease 20, early-onset	Uncertain significance	criteria provided, single submitter	VCV000992918	21	34067495	21	32695185	992918	980856	rs2042158818	NC_000021.9:32695184:A:G
NM_203446.3(SYNJ1):c.2254del (p.Asp752fs)	SYNJ1	D747fs, D752fs, D791fs	Parkinson disease 20, early-onset	Likely pathogenic	criteria provided, single submitter	VCV000992917	21	34037273	21	32664963	992917	980855	rs2040866242	NC_000021.9:32664962:CCC:CC
NM_203446.3(SYNJ1):c.3359C>T (p.Pro1120Leu)	SYNJ1	P1120L, P1115L, P1159L	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: May 17, 2018)	criteria provided, single submitter	VCV000978523	21	34017988	21	32645678	978523	575149	rs773242399	NC_000021.9:32645677:G:A
NM_203446.3(SYNJ1):c.1367C>A (p.Ala456Asp)	SYNJ1	A456D, A459D, A495D	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Oct 23, 2019)	criteria provided, single submitter	VCV000972193	21	34051098	21	32678788	972193	958939	rs2041512501	NC_000021.9:32678787:G:T
NM_203446.3(SYNJ1):c.3602G>A (p.Arg1201His)	SYNJ1	R1154H, R1240H, R1185H, R1201H	not provided|Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Nov 13, 2019)	criteria provided, multiple submitters, no conflicts	VCV000970653	21	34012076	21	32639766	970653	958934	rs376836481	NC_000021.9:32639765:C:T
NM_203446.3(SYNJ1):c.2744T>G (p.Ile915Ser)	SYNJ1	I910S, I954S, I915S	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Oct 12, 2019)	criteria provided, single submitter	VCV000970332	21	34029048	21	32656738	970332	958937	rs867564053	NC_000021.9:32656737:A:C
NM_203446.3(SYNJ1):c.1886C>T (p.Ala629Val)	SYNJ1	A629V, A624V, A668V	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Jul 23, 2019)	criteria provided, single submitter	VCV000970028	21	34038809	21	32666499	970028	958938	rs773372851	NC_000021.9:32666498:G:A
NM_203446.3(SYNJ1):c.3340G>A (p.Val1114Ile)	SYNJ1	V1109I, V1114I, V1153I	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Mar 14, 2020)	criteria provided, single submitter	VCV000969879	21	34018007	21	32645697	969879	958935	rs527362526	NC_000021.9:32645696:C:T
NM_203446.3(SYNJ1):c.542G>A (p.Arg181His)	SYNJ1	R181H, R220H	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Oct 10, 2020)	criteria provided, single submitter	VCV000969151	21	34067530	21	32695220	969151	958941	rs763977309	NC_000021.9:32695219:C:T
NM_203446.3(SYNJ1):c.2760G>C (p.Gln920His)	SYNJ1	Q920H, Q915H, Q959H	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Oct 23, 2019)	criteria provided, single submitter	VCV000968963	21	34029032	21	32656722	968963	958936	rs777815557	NC_000021.9:32656721:C:G
NM_203446.3(SYNJ1):c.889A>G (p.Ile297Val)	SYNJ1	I297V, I336V	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Oct 7, 2019)	criteria provided, single submitter	VCV000967394	21	34059347	21	32687037	967394	958940	rs775110785	NC_000021.9:32687036:T:C
NM_203446.3(SYNJ1):c.*485A>T	SYNJ1	D1505V, D1419V	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Nov 7, 2019)	criteria provided, single submitter	VCV000966535	21	34003630	21	32631320	966535	958933	rs764848521	NC_000021.9:32631319:T:A
NM_203446.3(SYNJ1):c.1812-10T>A	SYNJ1		Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Oct 19, 2019)	criteria provided, single submitter	VCV000965674	21	34038893	21	32666583	965674	960950	rs2040942245	NC_000021.9:32666582:A:T
NM_203446.3(SYNJ1):c.*763A>G	SYNJ1	T1512A, T1598A	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Oct 3, 2019)	criteria provided, single submitter	VCV000965663	21	34003352	21	32631042	965663	958932	rs778073626	NC_000021.9:32631041:T:C
NM_203446.3(SYNJ1):c.*806G>C	SYNJ1	R1612T, R1526T	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Aug 21, 2019)	criteria provided, single submitter	VCV000964521	21	34003309	21	32630999	964521	951192	rs772562248	NC_000021.9:32630998:C:G
NM_203446.3(SYNJ1):c.2524A>G (p.Thr842Ala)	SYNJ1	T842A, T837A, T881A	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Sep 30, 2019)	criteria provided, single submitter	VCV000963122	21	34029368	21	32657058	963122	951201	rs779943757	NC_000021.9:32657057:T:C
NM_203446.3(SYNJ1):c.3476A>T (p.Glu1159Val)	SYNJ1	E1198V, E1159V	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Jan 6, 2020)	criteria provided, single submitter	VCV000962874	21	34015722	21	32643412	962874	951199	rs2039931880	NC_000021.9:32643411:T:A
NM_203446.3(SYNJ1):c.789+1G>A	SYNJ1		Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Likely pathogenic(Last reviewed: Oct 26, 2019)	criteria provided, single submitter	VCV000962464	21	34066537	21	32694227	962464	960325	rs2042124608	NC_000021.9:32694226:C:T
NM_203446.3(SYNJ1):c.*541G>A	SYNJ1	E1438K, E1524K	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Aug 22, 2019)	criteria provided, single submitter	VCV000961882	21	34003574	21	32631264	961882	951196	rs770188528	NC_000021.9:32631263:C:T
NM_203446.3(SYNJ1):c.*412C>G	SYNJ1	P1481A, P1395A	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Oct 8, 2019)	criteria provided, single submitter	VCV000961830	21	34003703	21	32631393	961830	951197	rs1012542243	NC_000021.9:32631392:G:C
NM_203446.3(SYNJ1):c.-56G>T	SYNJ1	C21F	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Jun 29, 2020)	criteria provided, single submitter	VCV000961827	21	34100290	21	32727979	961827	951207	rs1486511197	NC_000021.9:32727978:C:A
NM_203446.3(SYNJ1):c.841G>C (p.Ala281Pro)	SYNJ1	A281P, A320P	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Jul 8, 2020)	criteria provided, single submitter	VCV000961375	21	34060626	21	32688316	961375	951204	rs2041902084	NC_000021.9:32688315:C:G
NM_203446.3(SYNJ1):c.2902T>G (p.Leu968Val)	SYNJ1	L1007V, L968V, L963V	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Aug 1, 2019)	criteria provided, single submitter	VCV000959786	21	34022629	21	32650319	959786	951200	rs1372258834	NC_000021.9:32650318:A:C
NM_203446.3(SYNJ1):c.35A>G (p.Lys12Arg)	SYNJ1	K12R, K51R	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: May 29, 2020)	criteria provided, single submitter	VCV000959287	21	34099172	21	32726861	959287	951206	rs2043479501	NC_000021.9:32726860:T:C
NM_203446.3(SYNJ1):c.-75G>A	SYNJ1	G15S	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Jul 17, 2019)	criteria provided, single submitter	VCV000958535	21	34100309	21	32727998	958535	951209	rs2043555401	NC_000021.9:32727997:C:T
NM_203446.3(SYNJ1):c.550T>A (p.Cys184Ser)	SYNJ1	C223S, C184S	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Oct 30, 2019)	criteria provided, single submitter	VCV000956704	21	34067522	21	32695212	956704	951205	rs903887015	NC_000021.9:32695211:A:T
NM_203446.3(SYNJ1):c.1042C>A (p.His348Asn)	SYNJ1	H348N, H387N	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Oct 18, 2019)	criteria provided, single submitter	VCV000956460	21	34058134	21	32685824	956460	951203	rs2041820050	NC_000021.9:32685823:G:T
NM_203446.3(SYNJ1):c.*613A>C	SYNJ1	S1462R, S1548R	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Aug 29, 2019)	criteria provided, single submitter	VCV000956367	21	34003502	21	32631192	956367	951195	rs769954720	NC_000021.9:32631191:T:G
NM_203446.3(SYNJ1):c.*719CT[1]	SYNJ1	L1498fs, L1584fs	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Nov 16, 2019)	criteria provided, single submitter	VCV000955394	21	34003393 - 34003394	21	32631083 - 32631084	955394	951193	rs1236484854	NC_000021.9:32631082:AGAG:AG
NM_203446.3(SYNJ1):c.*100G>T	SYNJ1	A1291S, A1377S	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Jul 23, 2019)	criteria provided, single submitter	VCV000954583	21	34004015	21	32631705	954583	951198	rs2039335923	NC_000021.9:32631704:C:A
NM_203446.3(SYNJ1):c.1046G>T (p.Ser349Ile)	SYNJ1	S349I, S388I	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Oct 20, 2019)	criteria provided, single submitter	VCV000954122	21	34058130	21	32685820	954122	951202	rs748368610	NC_000021.9:32685819:C:A
NM_203446.3(SYNJ1):c.-63G>A	SYNJ1	G19S	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Oct 20, 2019)	criteria provided, single submitter	VCV000954119	21	34100297	21	32727986	954119	951208	rs779276328	NC_000021.9:32727985:C:T
NM_203446.3(SYNJ1):c.*704C>G	SYNJ1	P1492R, P1578R	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Nov 14, 2019)	criteria provided, single submitter	VCV000953612	21	34003411	21	32631101	953612	951194	rs367591704	NC_000021.9:32631100:G:C
NM_203446.3(SYNJ1):c.1846C>A (p.Gln616Lys)	SYNJ1	Q616K, Q655K, Q611K	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Jun 5, 2019)	criteria provided, single submitter	VCV000952808	21	34038849	21	32666539	952808	929298	rs2040940591	NC_000021.9:32666538:G:T
NM_203446.3(SYNJ1):c.*806G>A	SYNJ1	R1526K, R1612K	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: May 19, 2019)	criteria provided, single submitter	VCV000952732	21	34003309	21	32630999	952732	929282	rs772562248	NC_000021.9:32630998:C:T
NM_203446.3(SYNJ1):c.-89G>T	SYNJ1	G10V	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Jun 9, 2019)	criteria provided, single submitter	VCV000952376	21	34100323	21	32728012	952376	929303	rs1339841336	NC_000021.9:32728011:C:A
NM_203446.3(SYNJ1):c.*709C>T	SYNJ1	P1494S, P1580S	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Oct 26, 2020)	criteria provided, single submitter	VCV000951974	21	34003406	21	32631096	951974	929285	rs912535820	NC_000021.9:32631095:G:A
NM_203446.3(SYNJ1):c.*602G>A	SYNJ1	G1544D, G1458D	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Aug 31, 2020)	criteria provided, single submitter	VCV000951973	21	34003513	21	32631203	951973	929287	rs375352780	NC_000021.9:32631202:C:T
NM_203446.3(SYNJ1):c.-29G>A	SYNJ1	R30K	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Jun 9, 2019)	criteria provided, single submitter	VCV000951416	21	34100263	21	32727952	951416	929301	rs2043550944	NC_000021.9:32727951:C:T
NM_203446.3(SYNJ1):c.443G>A (p.Ser148Asn)	SYNJ1	S148N, S187N	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Jul 24, 2019)	criteria provided, single submitter	VCV000951273	21	34072184	21	32699874	951273	929299	rs2042337641	NC_000021.9:32699873:C:T
NM_203446.3(SYNJ1):c.2609T>C (p.Ile870Thr)	SYNJ1	I870T, I909T, I865T	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Mar 10, 2020)	criteria provided, single submitter	VCV000950655	21	34029183	21	32656873	950655	929296	rs753305423	NC_000021.9:32656872:A:G
NM_203446.3(SYNJ1):c.3145_3147dup (p.Ser1049dup)	SYNJ1		Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Jul 25, 2020)	criteria provided, single submitter	VCV000950573	21	34018802 - 34018803	21	32646492 - 32646493	950573	929294	rs2040075484	NC_000021.9:32646492:ACTA:ACTACTA
NM_203446.3(SYNJ1):c.3457del (p.Gly1152_Val1153insTer)	SYNJ1		Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Pathogenic(Last reviewed: Jun 29, 2019)	criteria provided, single submitter	VCV000950404	21	34015741	21	32643431	950404	929292	rs2039933328	NC_000021.9:32643430:CCCC:CCC
NM_203446.3(SYNJ1):c.3481C>G (p.Pro1161Ala)	SYNJ1	P1161A, P1145A, P1200A	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Jun 10, 2019)	criteria provided, single submitter	VCV000950300	21	34014441	21	32642131	950300	929291	rs1473250864	NC_000021.9:32642130:G:C
NM_203446.3(SYNJ1):c.*158A>G	SYNJ1	Q1310R, Q1396R	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Jun 27, 2019)	criteria provided, single submitter	VCV000949578	21	34003957	21	32631647	949578	929289	rs1340359289	NC_000021.9:32631646:T:C
NM_203446.3(SYNJ1):c.3673A>T (p.Ser1225Cys)	SYNJ1	S1178C, S1209C, S1264C, S1225C	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Mar 4, 2020)	criteria provided, single submitter	VCV000949440	21	34012005	21	32639695	949440	929290	rs2039744699	NC_000021.9:32639694:T:A
NM_203446.3(SYNJ1):c.*737C>G	SYNJ1	T1503S, T1589S	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Jan 16, 2020)	criteria provided, single submitter	VCV000948839	21	34003378	21	32631068	948839	929283	rs746226206	NC_000021.9:32631067:G:C
NM_203446.3(SYNJ1):c.3181G>C (p.Val1061Leu)	SYNJ1	V1100L, V1056L, V1061L	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Apr 6, 2019)	criteria provided, single submitter	VCV000948127	21	34018769	21	32646459	948127	929293	rs753032623	NC_000021.9:32646458:C:G
NM_203446.3(SYNJ1):c.*469T>C	SYNJ1	F1414L, F1500L	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Aug 8, 2019)	criteria provided, single submitter	VCV000947823	21	34003646	21	32631336	947823	929288	rs753264526	NC_000021.9:32631335:A:G
NM_203446.3(SYNJ1):c.*733G>A	SYNJ1	G1502S, G1588S	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: May 31, 2020)	criteria provided, single submitter	VCV000946789	21	34003382	21	32631072	946789	929284	rs758953009	NC_000021.9:32631071:C:T
NM_203446.3(SYNJ1):c.1353+5A>G	SYNJ1		Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Oct 3, 2020)	criteria provided, single submitter	VCV000946737	21	34053801	21	32681491	946737	941257	rs376825246	NC_000021.9:32681490:T:C
NM_203446.3(SYNJ1):c.2708C>G (p.Ser903Cys)	SYNJ1	S942C, S898C, S903C	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Jul 9, 2019)	criteria provided, single submitter	VCV000945946	21	34029084	21	32656774	945946	929295	rs373328306	NC_000021.9:32656773:G:C
NM_203446.3(SYNJ1):c.-60G>T	SYNJ1	G20C	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Jun 27, 2019)	criteria provided, single submitter	VCV000945173	21	34100294	21	32727983	945173	929302	rs535611172	NC_000021.9:32727982:C:A
NM_203446.3(SYNJ1):c.1961C>T (p.Ala654Val)	SYNJ1	A693V, A654V, A649V	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: May 21, 2019)	criteria provided, single submitter	VCV000945015	21	34038437	21	32666127	945015	929297	rs2040918972	NC_000021.9:32666126:G:A
NM_203446.3(SYNJ1):c.*689C>T	SYNJ1	P1487L, P1573L	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: May 7, 2019)	criteria provided, single submitter	VCV000944936	21	34003426	21	32631116	944936	929286	rs766938091	NC_000021.9:32631115:G:A
NM_203446.3(SYNJ1):c.434C>T (p.Ala145Val)	SYNJ1	A184V, A145V	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Jun 17, 2019)	criteria provided, single submitter	VCV000944403	21	34072193	21	32699883	944403	929300	rs111886678	NC_000021.9:32699882:G:A
NM_203446.3(SYNJ1):c.790-6T>G	SYNJ1		Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Jul 6, 2019)	criteria provided, single submitter	VCV000944369	21	34060683	21	32688373	944369	941258	rs2041904445	NC_000021.9:32688372:A:C
NM_203446.3(SYNJ1):c.53T>A (p.Phe18Tyr)	SYNJ1	F57Y, F18Y	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Sep 6, 2019)	criteria provided, single submitter	VCV000943891	21	34099154	21	32726843	943891	939081	rs2043478146	NC_000021.9:32726842:A:T
NM_203446.3(SYNJ1):c.*676T>C	SYNJ1	F1569L, F1483L	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Mar 4, 2020)	criteria provided, single submitter	VCV000943773	21	34003439	21	32631129	943773	939069	rs2039305600	NC_000021.9:32631128:A:G
NM_203446.3(SYNJ1):c.-64_-53dup	SYNJ1		Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Oct 14, 2019)	criteria provided, single submitter	VCV000943080	21	34100286 - 34100287	21	32727975 - 32727976	943080	939083	rs1427487040	NC_000021.9:32727975:CCGCAGCCGCCGCC:CCGCAGCCGCCGCCGCAGCCGCCGCC
NM_203446.3(SYNJ1):c.3764C>T (p.Pro1255Leu)	SYNJ1	P1294L, P1208L, P1255L, P1239L	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Sep 20, 2019)	criteria provided, single submitter	VCV000941115	21	34011369	21	32639059	941115	939072	rs141785091	NC_000021.9:32639058:G:A
NM_203446.3(SYNJ1):c.1867A>G (p.Asn623Asp)	SYNJ1	N618D, N623D, N662D	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Sep 18, 2019)	criteria provided, single submitter	VCV000940831	21	34038828	21	32666518	940831	939074	rs377719553	NC_000021.9:32666517:T:C
NM_203446.3(SYNJ1):c.33C>G (p.His11Gln)	SYNJ1	H50Q, H11Q	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Aug 23, 2019)	criteria provided, single submitter	VCV000940698	21	34099174	21	32726863	940698	939082	rs750372776	NC_000021.9:32726862:G:C
NM_203446.3(SYNJ1):c.592C>A (p.Gln198Lys)	SYNJ1	Q237K, Q198K	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Aug 28, 2019)	criteria provided, single submitter	VCV000940408	21	34067480	21	32695170	940408	939079	rs771210989	NC_000021.9:32695169:G:T
NM_203446.3(SYNJ1):c.1717G>C (p.Glu573Gln)	SYNJ1	E568Q, E573Q, E612Q	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Oct 8, 2019)	criteria provided, single submitter	VCV000939879	21	34045659	21	32673349	939879	939075	rs1057062132	NC_000021.9:32673348:C:G
NM_203446.3(SYNJ1):c.*124C>T	SYNJ1	P1385S, P1299S	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Apr 17, 2020)	criteria provided, single submitter	VCV000939861	21	34003991	21	32631681	939861	939070	rs770180376	NC_000021.9:32631680:G:A
NM_203446.3(SYNJ1):c.1465T>G (p.Leu489Val)	SYNJ1	L528V, L492V, L489V	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Jun 17, 2019)	criteria provided, single submitter	VCV000939253	21	34051000	21	32678690	939253	939076	rs1261158817	NC_000021.9:32678689:A:C
NM_203446.3(SYNJ1):c.749G>A (p.Arg250Gln)	SYNJ1	R250Q, R289Q	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Nov 6, 2019)	criteria provided, single submitter	VCV000938727	21	34066578	21	32694268	938727	939078	rs762909719	NC_000021.9:32694267:C:T
NM_203446.3(SYNJ1):c.862A>C (p.Thr288Pro)	SYNJ1	T288P, T327P	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Jun 18, 2019)	criteria provided, single submitter	VCV000936901	21	34059374	21	32687064	936901	939077	rs571120951	NC_000021.9:32687063:T:G
NM_203446.3(SYNJ1):c.344G>T (p.Arg115Leu)	SYNJ1	R154L, R115L	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Feb 23, 2020)	criteria provided, single submitter	VCV000936877	21	34072283	21	32699973	936877	939080	rs951976946	NC_000021.9:32699972:C:A
NM_203446.3(SYNJ1):c.3364C>T (p.Pro1122Ser)	SYNJ1	P1122S, P1117S, P1161S	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Jul 5, 2019)	criteria provided, single submitter	VCV000936291	21	34017983	21	32645673	936291	939073	rs1274970038	NC_000021.9:32645672:G:A
NM_203446.3(SYNJ1):c.3780G>T (p.Leu1260Phe)	SYNJ1	L1213F, L1260F, L1244F, L1299F	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Jun 14, 2019)	criteria provided, single submitter	VCV000935179	21	34011353	21	32639043	935179	939071	rs758900160	NC_000021.9:32639042:C:A
NM_203446.3(SYNJ1):c.2668G>C (p.Gly890Arg)	SYNJ1	G885R, G890R, G929R	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Feb 11, 2019)	criteria provided, single submitter	VCV000864653	21	34029124	21	32656814	864653	848696	rs1187688126	NC_000021.9:32656813:C:G
NM_203446.3(SYNJ1):c.2282T>C (p.Ile761Thr)	SYNJ1	I756T, I800T, I761T	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Mar 7, 2019)	criteria provided, single submitter	VCV000863393	21	34037245	21	32664935	863393	848699	rs373953139	NC_000021.9:32664934:A:G
NM_203446.3(SYNJ1):c.*770C>T	SYNJ1	A1514V, A1600V	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Jan 17, 2019)	criteria provided, single submitter	VCV000863244	21	34003345	21	32631035	863244	848671	rs2039298283	NC_000021.9:32631034:G:A
NM_203446.3(SYNJ1):c.*442A>G	SYNJ1	S1491G, S1405G	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Feb 18, 2019)	criteria provided, single submitter	VCV000863007	21	34003673	21	32631363	863007	848675	rs1443131725	NC_000021.9:32631362:T:C
NM_203446.3(SYNJ1):c.244A>T (p.Thr82Ser)	SYNJ1	T82S, T121S	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Dec 31, 2019)	criteria provided, single submitter	VCV000862638	21	34072383	21	32700073	862638	848712	rs2042346087	NC_000021.9:32700072:T:A
NM_203446.3(SYNJ1):c.3202C>G (p.Pro1068Ala)	SYNJ1	P1068A, P1063A, P1107A	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Apr 23, 2019)	criteria provided, single submitter	VCV000862404	21	34018748	21	32646438	862404	848687	rs1374696982	NC_000021.9:32646437:G:C
NM_203446.3(SYNJ1):c.407G>A (p.Gly136Asp)	SYNJ1	G136D, G175D	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: May 21, 2019)	criteria provided, single submitter	VCV000862230	21	34072220	21	32699910	862230	848709	rs771507886	NC_000021.9:32699909:C:T
NM_203446.3(SYNJ1):c.83A>C (p.Glu28Ala)	SYNJ1	E28A, E67A	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Jul 9, 2020)	criteria provided, single submitter	VCV000861393	21	34099124	21	32726813	861393	848716	rs199750187	NC_000021.9:32726812:T:G
NM_203446.3(SYNJ1):c.*235A>C	SYNJ1	S1336R, S1422R	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Jun 17, 2020)	criteria provided, single submitter	VCV000861168	21	34003880	21	32631570	861168	848677	rs769099271	NC_000021.9:32631569:T:G
NM_203446.3(SYNJ1):c.3036A>C (p.Glu1012Asp)	SYNJ1	E1051D, E1007D, E1012D	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Apr 16, 2019)	criteria provided, single submitter	VCV000860291	21	34022495	21	32650185	860291	848691	rs2040223517	NC_000021.9:32650184:T:G
NM_203446.3(SYNJ1):c.2782G>A (p.Val928Ile)	SYNJ1	V923I, V928I, V967I	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Oct 23, 2020)	criteria provided, single submitter	VCV000859863	21	34029010	21	32656700	859863	848694	rs1327987813	NC_000021.9:32656699:C:T
NM_203446.3(SYNJ1):c.356T>C (p.Val119Ala)	SYNJ1	V119A, V158A	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Nov 27, 2019)	criteria provided, single submitter	VCV000859361	21	34072271	21	32699961	859361	848710	rs2042341669	NC_000021.9:32699960:A:G
NM_203446.3(SYNJ1):c.2525C>T (p.Thr842Ile)	SYNJ1	T837I, T842I, T881I	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Nov 21, 2019)	criteria provided, single submitter	VCV000859350	21	34029367	21	32657057	859350	848697	rs370346211	NC_000021.9:32657056:G:A
NM_203446.3(SYNJ1):c.*807A>G	SYNJ1		Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Jun 6, 2020)	criteria provided, single submitter	VCV000858730	21	34003308	21	32630998	858730	848670	rs2039296175	NC_000021.9:32630997:T:C
NM_203446.3(SYNJ1):c.3175G>A (p.Gly1059Ser)	SYNJ1	G1098S, G1054S, G1059S	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Feb 6, 2019)	criteria provided, single submitter	VCV000858529	21	34018775	21	32646465	858529	848688	rs2040073930	NC_000021.9:32646464:C:T
NM_203446.3(SYNJ1):c.2236A>C (p.Ile746Leu)	SYNJ1	I746L, I741L, I785L	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Mar 23, 2019)	criteria provided, single submitter	VCV000858033	21	34037291	21	32664981	858033	848700	rs2040867077	NC_000021.9:32664980:T:G
NM_203446.3(SYNJ1):c.3352A>G (p.Thr1118Ala)	SYNJ1	T1157A, T1118A, T1113A	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Feb 2, 2020)	criteria provided, single submitter	VCV000857362	21	34017995	21	32645685	857362	848685	rs1189796802	NC_000021.9:32645684:T:C
NM_203446.3(SYNJ1):c.2814G>A (p.Met938Ile)	SYNJ1	M933I, M977I, M938I	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Dec 5, 2019)	criteria provided, single submitter	VCV000856645	21	34025658	21	32653348	856645	848693	rs546854566	NC_000021.9:32653347:C:T
NM_203446.3(SYNJ1):c.1534+5A>G	SYNJ1		Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Mar 1, 2019)	criteria provided, single submitter	VCV000856584	21	34048637	21	32676327	856584	852914	rs367718431	NC_000021.9:32676326:T:C
NM_203446.3(SYNJ1):c.3368C>A (p.Pro1123Gln)	SYNJ1	P1123Q, P1118Q, P1162Q	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Dec 4, 2019)	criteria provided, single submitter	VCV000856384	21	34017979	21	32645669	856384	848684	rs748154988	NC_000021.9:32645668:G:T
NM_203446.3(SYNJ1):c.3248-6T>G	SYNJ1		Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Jul 10, 2019)	criteria provided, single submitter	VCV000855423	21	34018105	21	32645795	855423	851857	rs567223330	NC_000021.9:32645794:A:C
NM_203446.3(SYNJ1):c.3042T>A (p.Asp1014Glu)	SYNJ1	D1053E, D1009E, D1014E	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: May 21, 2019)	criteria provided, single submitter	VCV000855210	21	34018908	21	32646598	855210	848690	rs115353088	NC_000021.9:32646597:A:T
NM_203446.3(SYNJ1):c.*712C>T	SYNJ1	P1495S, P1581S	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Nov 21, 2019)	criteria provided, single submitter	VCV000854482	21	34003403	21	32631093	854482	848672	rs2039303366	NC_000021.9:32631092:G:A
NM_203446.3(SYNJ1):c.3915+5G>A	SYNJ1		Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Feb 21, 2020)	criteria provided, single submitter	VCV000854383	21	34011213	21	32638903	854383	852396	rs61750220	NC_000021.9:32638902:C:T
NM_203446.3(SYNJ1):c.1349C>A (p.Ala450Glu)	SYNJ1	A450E, A489E	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Apr 4, 2019)	criteria provided, single submitter	VCV000854207	21	34053810	21	32681500	854207	848705	rs1416896181	NC_000021.9:32681499:G:T
NM_203446.3(SYNJ1):c.1835C>A (p.Ala612Asp)	SYNJ1	A612D, A607D, A651D	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Oct 1, 2020)	criteria provided, single submitter	VCV000854051	21	34038860	21	32666550	854051	848704	rs2040941103	NC_000021.9:32666549:G:T
NM_203446.3(SYNJ1):c.-81G>T	SYNJ1	A13S	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Dec 27, 2019)	criteria provided, single submitter	VCV000852777	21	34100315	21	32728004	852777	848720	rs907760868	NC_000021.9:32728003:C:A
NM_203446.3(SYNJ1):c.212G>A (p.Gly71Asp)	SYNJ1	G110D, G71D	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Aug 24, 2020)	criteria provided, single submitter	VCV000852235	21	34072415	21	32700105	852235	848714	rs1438911029	NC_000021.9:32700104:C:T
NM_203446.3(SYNJ1):c.*638C>T	SYNJ1	T1556I, T1470I	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Nov 20, 2019)	criteria provided, single submitter	VCV000852145	21	34003477	21	32631167	852145	848673	rs755473642	NC_000021.9:32631166:G:A
NM_203446.3(SYNJ1):c.220A>G (p.Met74Val)	SYNJ1	M74V, M113V	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Nov 20, 2019)	criteria provided, single submitter	VCV000852144	21	34072407	21	32700097	852144	848713	rs762562029	NC_000021.9:32700096:T:C
NM_203446.3(SYNJ1):c.3584G>C (p.Arg1195Thr)	SYNJ1	R1179T, R1148T, R1195T, R1234T	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Nov 7, 2019)	criteria provided, single submitter	VCV000850502	21	34014210	21	32641900	850502	848680	rs1336877948	NC_000021.9:32641899:C:G
NM_203446.3(SYNJ1):c.133G>A (p.Glu45Lys)	SYNJ1	E45K, E84K	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Feb 12, 2020)	criteria provided, single submitter	VCV000850483	21	34074349	21	32702039	850483	848715	rs2042422640	NC_000021.9:32702038:C:T
NM_203446.3(SYNJ1):c.3547C>G (p.Leu1183Val)	SYNJ1	L1136V, L1222V, L1167V, L1183V	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Dec 11, 2019)	criteria provided, single submitter	VCV000849387	21	34014247	21	32641937	849387	848681	rs2039857400	NC_000021.9:32641936:G:C
NM_203446.3(SYNJ1):c.1157G>A (p.Cys386Tyr)	SYNJ1	C386Y, C425Y	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Feb 17, 2020)	criteria provided, single submitter	VCV000849125	21	34056391	21	32684081	849125	848706	rs2041732521	NC_000021.9:32684080:C:T
NM_203446.3(SYNJ1):c.*256C>T	SYNJ1	R1343*, R1429*	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Dec 30, 2019)	criteria provided, single submitter	VCV000848334	21	34003859	21	32631549	848334	848676	rs565341830	NC_000021.9:32631548:G:A
NM_203446.3(SYNJ1):c.3126del (p.Ser1043fs)	SYNJ1	S1043fs, S1082fs, S1038fs	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Pathogenic(Last reviewed: Dec 24, 2019)	criteria provided, single submitter	VCV000848199	21	34018824	21	32646514	848199	848689	rs1230133310	NC_000021.9:32646513:GGGGG:GGGG
NM_203446.3(SYNJ1):c.29A>G (p.Tyr10Cys)	SYNJ1	Y10C, Y49C	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Feb 21, 2020)	criteria provided, single submitter	VCV000848124	21	34099178	21	32726867	848124	848717	rs967674859	NC_000021.9:32726866:T:C
NM_203446.3(SYNJ1):c.1957G>A (p.Val653Ile)	SYNJ1	V653I, V692I, V648I	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Mar 5, 2020)	criteria provided, single submitter	VCV000847083	21	34038441	21	32666131	847083	573749	rs1456047190	NC_000021.9:32666130:C:T
NM_203446.3(SYNJ1):c.564A>C (p.Glu188Asp)	SYNJ1	E227D, E188D	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Jul 26, 2019)	criteria provided, single submitter	VCV000846518	21	34067508	21	32695198	846518	848708	rs1423467857	NC_000021.9:32695197:T:G
NM_203446.3(SYNJ1):c.3347C>T (p.Pro1116Leu)	SYNJ1	P1111L, P1155L, P1116L	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Jul 30, 2019)	criteria provided, single submitter	VCV000846437	21	34018000	21	32645690	846437	848686	rs765746949	NC_000021.9:32645689:G:A
NM_203446.3(SYNJ1):c.*186_*187insATTACT	SYNJ1		Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Jan 23, 2019)	criteria provided, single submitter	VCV000846293	21	34003928 - 34003929	21	32631618 - 32631619	846293	848678	rs57257560	NC_000021.9:32631618:A:AGTAATA
NM_203446.3(SYNJ1):c.1126A>G (p.Ser376Gly)	SYNJ1	S376G, S415G	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Dec 8, 2019)	criteria provided, single submitter	VCV000844134	21	34056422	21	32684112	844134	848707	rs1163151498	NC_000021.9:32684111:T:C
NM_203446.3(SYNJ1):c.2885G>A (p.Arg962Gln)	SYNJ1	R1001Q, R957Q, R962Q	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Nov 26, 2019)	criteria provided, single submitter	VCV000844027	21	34022646	21	32650336	844027	848692	rs371117480	NC_000021.9:32650335:C:T
NM_203446.3(SYNJ1):c.3403C>T (p.Pro1135Ser)	SYNJ1	P1174S, P1135S	not provided|Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Dec 24, 2020)	criteria provided, multiple submitters, no conflicts	VCV000843708	21	34017305	21	32644995	843708	848683	rs151126056	NC_000021.9:32644994:G:A
NM_203446.3(SYNJ1):c.3520C>T (p.Arg1174Cys)	SYNJ1	R1158C, R1213C, R1127C, R1174C	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: May 29, 2019)	criteria provided, single submitter	VCV000843574	21	34014274	21	32641964	843574	848682	rs1367145848	NC_000021.9:32641963:G:A
NM_203446.3(SYNJ1):c.2113A>G (p.Ile705Val)	SYNJ1	I700V, I744V, I705V	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Sep 10, 2020)	criteria provided, single submitter	VCV000840666	21	34038285	21	32665975	840666	848701	rs761614356	NC_000021.9:32665974:T:C
NM_203446.3(SYNJ1):c.2047C>T (p.Leu683Phe)	SYNJ1	L683F, L678F, L722F	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Aug 5, 2019)	criteria provided, single submitter	VCV000839942	21	34038351	21	32666041	839942	848702	rs2040916269	NC_000021.9:32666040:G:A
NM_203446.3(SYNJ1):c.254T>A (p.Met85Lys)	SYNJ1	M124K, M85K	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Jan 31, 2019)	criteria provided, single submitter	VCV000839553	21	34072373	21	32700063	839553	848711	rs2042345500	NC_000021.9:32700062:A:T
NM_203446.3(SYNJ1):c.2364G>C (p.Leu788Phe)	SYNJ1	L783F, L788F, L827F	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Jan 30, 2020)	criteria provided, single submitter	VCV000838918	21	34030123	21	32657813	838918	848698	rs2040517909	NC_000021.9:32657812:C:G
NM_203446.3(SYNJ1):c.2720A>G (p.Asn907Ser)	SYNJ1	N902S, N907S, N946S	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Dec 19, 2019)	criteria provided, single submitter	VCV000838036	21	34029072	21	32656762	838036	848695	rs542405957	NC_000021.9:32656761:T:C
NM_203446.3(SYNJ1):c.1876G>A (p.Val626Met)	SYNJ1	V665M, V621M, V626M	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Dec 24, 2019)	criteria provided, single submitter	VCV000837638	21	34038819	21	32666509	837638	848703	rs2040938849	NC_000021.9:32666508:C:T
NM_203446.3(SYNJ1):c.-47G>C	SYNJ1	R24T	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Nov 20, 2019)	criteria provided, single submitter	VCV000837456	21	34100281	21	32727970	837456	848718	rs1018405878	NC_000021.9:32727969:C:G
NM_203446.3(SYNJ1):c.3601C>G (p.Arg1201Gly)	SYNJ1	R1154G, R1201G, R1185G, R1240G	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Jan 21, 2020)	criteria provided, single submitter	VCV000837455	21	34012077	21	32639767	837455	848679	rs114994257	NC_000021.9:32639766:G:C
NM_203446.3(SYNJ1):c.*576_*584del	SYNJ1		Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Apr 4, 2019)	criteria provided, single submitter	VCV000836370	21	34003531 - 34003539	21	32631221 - 32631229	836370	848674	rs769088554	NC_000021.9:32631220:GCTGACTTTG:G
NM_203446.3(SYNJ1):c.-68G>A	SYNJ1	C17Y	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Mar 13, 2019)	criteria provided, single submitter	VCV000835467	21	34100302	21	32727991	835467	848719	rs746182035	NC_000021.9:32727990:C:T
NC_000021.9:g.(?_32727926)_(32728060_?)del	SYNJ1		Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Pathogenic(Last reviewed: Aug 8, 2019)	criteria provided, single submitter	VCV000833242	21	34100237 - 34100371			833242	821362		
NC_000021.8:g.(?_34000069)_(34101351_?)dup	SYNJ1		Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Dec 3, 2019)	criteria provided, single submitter	VCV000832807	21	34000069 - 34101351			832807	821352		
NM_203446.3(SYNJ1):c.1277G>A (p.Arg426Gln)	SYNJ1	R426Q, R465Q	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset|not provided	Uncertain significance(Last reviewed: Sep 9, 2019)	criteria provided, multiple submitters, no conflicts	VCV000809285	21	34053882	21	32681572	809285	798022	rs1601403500	NC_000021.9:32681571:C:T
NM_203446.3(SYNJ1):c.2505C>A (p.Ser835Arg)	SYNJ1	S830R, S835R, S874R	Epileptic encephalopathy, early infantile, 53|Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset|not provided	Uncertain significance(Last reviewed: Oct 14, 2020)	criteria provided, multiple submitters, no conflicts	VCV000809282	21	34029387	21	32657077	809282	798019	rs748032685	NC_000021.9:32657076:G:T
NM_203446.3(SYNJ1):c.*108A>G	SYNJ1		Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Likely benign(Last reviewed: Feb 21, 2020)	criteria provided, single submitter	VCV000799758	21	34004007	21	32631697	799758	786481	rs371381727	NC_000021.9:32631696:T:C
NM_203446.3(SYNJ1):c.1878G>A (p.Val626=)	SYNJ1		Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Likely benign(Last reviewed: Dec 31, 2019)	criteria provided, single submitter	VCV000798065	21	34038817	21	32666507	798065	786483	rs1601348321	NC_000021.9:32666506:C:T
NM_203446.3(SYNJ1):c.1611C>T (p.Val537=)	SYNJ1		Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Likely benign(Last reviewed: Jan 27, 2020)	criteria provided, single submitter	VCV000794335	21	34045765	21	32673455	794335	786484	rs150180190	NC_000021.9:32673454:G:A
NM_203446.3(SYNJ1):c.3392-5A>T	SYNJ1		Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Likely benign(Last reviewed: Jul 10, 2020)	criteria provided, single submitter	VCV000794326	21	34017321	21	32645011	794326	788353	rs776721216	NC_000021.9:32645010:T:A
NM_203446.3(SYNJ1):c.706-7del	SYNJ1		Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Benign(Last reviewed: Feb 21, 2020)	criteria provided, single submitter	VCV000793252	21	34066628	21	32694318	793252	788255	rs202044634	NC_000021.9:32694317:AAAAAAAAA:AAAAAAAA
NM_203446.3(SYNJ1):c.1323A>G (p.Ala441=)	SYNJ1		not provided|Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Likely benign(Last reviewed: Oct 20, 2018)	criteria provided, single submitter	VCV000793246	21	34053836	21	32681526	793246	786485	rs1468223961	NC_000021.9:32681525:T:C
NM_203446.3(SYNJ1):c.2875-6C>T	SYNJ1		Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Likely benign(Last reviewed: Feb 24, 2020)	criteria provided, single submitter	VCV000790290	21	34022662	21	32650352	790290	780000	rs183558612	NC_000021.9:32650351:G:A
NM_203446.3(SYNJ1):c.*732C>T	SYNJ1		Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Benign(Last reviewed: Nov 24, 2020)	criteria provided, single submitter	VCV000783108	21	34003383	21	32631073	783108	717181	rs148676465	NC_000021.9:32631072:G:A
NM_203446.3(SYNJ1):c.2547T>C (p.Tyr849=)	SYNJ1		Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Likely benign(Last reviewed: Sep 10, 2020)	criteria provided, single submitter	VCV000773999	21	34029345	21	32657035	773999	705657	rs61756207	NC_000021.9:32657034:A:G
NM_203446.3(SYNJ1):c.3591G>A (p.Thr1197=)	SYNJ1		Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Likely benign(Last reviewed: Nov 26, 2020)	criteria provided, single submitter	VCV000772993	21	34012087	21	32639777	772993	705656	rs764207431	NC_000021.9:32639776:C:T
NM_203446.3(SYNJ1):c.*618A>G	SYNJ1		Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Likely benign(Last reviewed: Oct 14, 2020)	criteria provided, single submitter	VCV000767326	21	34003497	21	32631187	767326	705654	rs139212871	NC_000021.9:32631186:T:C
NM_203446.3(SYNJ1):c.-31G>C	SYNJ1		Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Likely benign(Last reviewed: Oct 27, 2020)	criteria provided, single submitter	VCV000766465	21	34100265	21	32727954	766465	773293	rs751083536	NC_000021.9:32727953:C:G
NM_203446.3(SYNJ1):c.969A>G (p.Glu323=)	SYNJ1		not provided|Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Likely benign(Last reviewed: Aug 17, 2018)	criteria provided, single submitter	VCV000765753	21	34058207	21	32685897	765753	773291	rs1601418926	NC_000021.9:32685896:T:C
NM_203446.3(SYNJ1):c.-49A>G	SYNJ1		not provided|Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Likely benign(Last reviewed: Aug 27, 2020)	criteria provided, single submitter	VCV000765717	21	34100283	21	32727972	765717	773294	rs780877494	NC_000021.9:32727971:T:C
NM_203446.3(SYNJ1):c.706-8T>C	SYNJ1		not provided|Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Likely benign(Last reviewed: Aug 9, 2018)	criteria provided, single submitter	VCV000765259	21	34066629	21	32694319	765259	776697	rs752261171	NC_000021.9:32694318:A:G
NM_203446.3(SYNJ1):c.1511-4A>G	SYNJ1		Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Likely benign(Last reviewed: Dec 31, 2019)	criteria provided, single submitter	VCV000763054	21	34048669	21	32676359	763054	776946	rs533995497	NC_000021.9:32676358:T:C
NM_203446.3(SYNJ1):c.3285G>T (p.Pro1095=)	SYNJ1		Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Likely benign(Last reviewed: Jul 30, 2019)	criteria provided, single submitter	VCV000763053	21	34018062	21	32645752	763053	773284	rs376395608	NC_000021.9:32645751:C:A
NM_203446.3(SYNJ1):c.2976A>G (p.Ser992=)	SYNJ1		not provided|Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Likely benign(Last reviewed: Jul 3, 2018)	criteria provided, single submitter	VCV000761985	21	34022555	21	32650245	761985	773285	rs115204185	NC_000021.9:32650244:T:C
NM_203446.3(SYNJ1):c.2580-9T>C	SYNJ1		not provided|Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Likely benign(Last reviewed: Jun 7, 2020)	criteria provided, single submitter	VCV000760946	21	34029221	21	32656911	760946	776708	rs1601308461	NC_000021.9:32656910:A:G
NM_203446.3(SYNJ1):c.2541_2542delinsTT (p.His848Tyr)	SYNJ1	H848Y, H887Y, H843Y	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Likely benign(Last reviewed: Dec 31, 2019)	criteria provided, single submitter	VCV000760171	21	34029350 - 34029351	21	32657040 - 32657041	760171	773286	rs1601309236	NC_000021.9:32657039:GC:AA
NM_203446.3(SYNJ1):c.*174G>A	SYNJ1		not provided|Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Likely benign(Last reviewed: Dec 13, 2021)	criteria provided, single submitter	VCV000758075	21	34003941	21	32631631	758075	773283	rs745464855	NC_000021.9:32631630:C:T
NM_203446.3(SYNJ1):c.1167A>G (p.Arg389=)	SYNJ1		Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53|not provided	Likely benign(Last reviewed: Aug 29, 2020)	criteria provided, single submitter	VCV000757163	21	34056381	21	32684071	757163	773290	rs747274485	NC_000021.9:32684070:T:C
NM_203446.3(SYNJ1):c.2795+10T>C	SYNJ1		Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Likely benign(Last reviewed: May 27, 2020)	criteria provided, single submitter	VCV000755071	21	34028987	21	32656677	755071	776945	rs756959605	NC_000021.9:32656676:A:G
NM_203446.3(SYNJ1):c.1641A>G (p.Gln547=)	SYNJ1		not provided|Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Likely benign(Last reviewed: Oct 9, 2018)	criteria provided, single submitter	VCV000754998	21	34045735	21	32673425	754998	773289	rs753893833	NC_000021.9:32673424:T:C
NM_203446.3(SYNJ1):c.949-31_949-2del	SYNJ1		Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53|not provided	Likely benign(Last reviewed: Feb 7, 2020)	criteria provided, single submitter	VCV000754385	21	34058229 - 34058258	21	32685919 - 32685948	754385	776715	rs1281313151	NC_000021.9:32685918:TGAAAGTAAAAAGGCAAATATTCATCTAAATGAAAGTAAAAAGGCAAATAT:TGAAAGTAAAAAGGCAAATAT
NM_203446.3(SYNJ1):c.3392-8A>T	SYNJ1		Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Likely benign(Last reviewed: Jun 22, 2020)	criteria provided, single submitter	VCV000752644	21	34017324	21	32645014	752644	776944	rs533064963	NC_000021.9:32645013:T:A
NM_203446.3(SYNJ1):c.1848G>A (p.Gln616=)	SYNJ1		Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53|not provided	Likely benign(Last reviewed: Jan 30, 2021)	criteria provided, single submitter	VCV000752508	21	34038847	21	32666537	752508	773288	rs1601348530	NC_000021.9:32666536:C:T
NM_203446.3(SYNJ1):c.1968T>C (p.Asp656=)	SYNJ1		not provided|Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Likely benign(Last reviewed: Jul 10, 2020)	criteria provided, single submitter	VCV000748526	21	34038430	21	32666120	748526	757746	rs140112176	NC_000021.9:32666119:A:G
NM_203446.3(SYNJ1):c.2691G>A (p.Leu897=)	SYNJ1		Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Benign(Last reviewed: Mar 26, 2020)	criteria provided, single submitter	VCV000746655	21	34029101	21	32656791	746655	757741	rs115263361	NC_000021.9:32656790:C:T
NM_203446.3(SYNJ1):c.3357C>T (p.Arg1119=)	SYNJ1		Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Likely benign(Last reviewed: Dec 31, 2019)	criteria provided, single submitter	VCV000745451	21	34017990	21	32645680	745451	757740	rs1601259728	NC_000021.9:32645679:G:A
NM_203446.3(SYNJ1):c.3585A>G (p.Arg1195=)	SYNJ1		not provided|Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Likely benign(Last reviewed: Jun 19, 2020)	criteria provided, single submitter	VCV000744345	21	34014209	21	32641899	744345	757739	rs1404447301	NC_000021.9:32641898:T:C
NM_203446.3(SYNJ1):c.126A>T (p.Ser42=)	SYNJ1		not provided|Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Likely benign(Last reviewed: Jan 29, 2018)	criteria provided, single submitter	VCV000743558	21	34074356	21	32702046	743558	757748	rs1286622528	NC_000021.9:32702045:T:A
NM_203446.3(SYNJ1):c.789+10T>C	SYNJ1		not provided|Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Likely benign(Last reviewed: Jan 29, 2018)	criteria provided, single submitter	VCV000743543	21	34066528	21	32694218	743543	760715	rs1601446146	NC_000021.9:32694217:A:G
NM_203446.3(SYNJ1):c.3633C>T (p.His1211=)	SYNJ1		Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Likely benign(Last reviewed: Oct 21, 2019)	criteria provided, single submitter	VCV000742958	21	34012045	21	32639735	742958	757738	rs771394723	NC_000021.9:32639734:G:A
NM_203446.3(SYNJ1):c.2205C>T (p.Ile735=)	SYNJ1		Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Likely benign(Last reviewed: Oct 29, 2020)	criteria provided, single submitter	VCV000742896	21	34037322	21	32665012	742896	757743	rs149236383	NC_000021.9:32665011:G:A
NM_203446.3(SYNJ1):c.3690G>A (p.Thr1230=)	SYNJ1		Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Likely benign(Last reviewed: Aug 21, 2020)	criteria provided, single submitter	VCV000742419	21	34011988	21	32639678	742419	757737	rs1446522492	NC_000021.9:32639677:C:T
NM_203446.3(SYNJ1):c.3747G>A (p.Pro1249=)	SYNJ1		Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Likely benign(Last reviewed: Sep 9, 2019)	criteria provided, single submitter	VCV000741641	21	34011386	21	32639076	741641	757736	rs138579227	NC_000021.9:32639075:C:T
NM_203446.3(SYNJ1):c.2472A>C (p.Leu824=)	SYNJ1		Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset|not provided	Likely benign(Last reviewed: Aug 26, 2020)	criteria provided, single submitter	VCV000739738	21	34029420	21	32657110	739738	757742	rs1601309726	NC_000021.9:32657109:T:G
NM_203446.3(SYNJ1):c.2055C>T (p.Phe685=)	SYNJ1		not provided|Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Likely benign(Last reviewed: Oct 24, 2021)	criteria provided, single submitter	VCV000739586	21	34038343	21	32666033	739586	757745	rs765857459	NC_000021.9:32666032:G:A
NM_203446.3(SYNJ1):c.1245T>C (p.Pro415=)	SYNJ1		Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Likely benign(Last reviewed: Sep 10, 2020)	criteria provided, single submitter	VCV000739404	21	34053914	21	32681604	739404	757747	rs111655347	NC_000021.9:32681603:A:G
NM_203446.3(SYNJ1):c.2157A>G (p.Leu719=)	SYNJ1		Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Likely benign(Last reviewed: Sep 2, 2020)	criteria provided, single submitter	VCV000739403	21	34037370	21	32665060	739403	757744	rs112875942	NC_000021.9:32665059:T:C
NM_203446.3(SYNJ1):c.1119-7G>C	SYNJ1		Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset|not provided	Likely benign(Last reviewed: Mar 22, 2018)	criteria provided, single submitter	VCV000739137	21	34056436	21	32684126	739137	760792	rs562245468	NC_000021.9:32684125:C:G
NM_203446.3(SYNJ1):c.1081T>A (p.Tyr361Asn)	SYNJ1	Y361N, Y400N	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Benign(Last reviewed: Nov 23, 2020)	criteria provided, single submitter	VCV000733580	21	34058095	21	32685785	733580	742588	rs533216340	NC_000021.9:32685784:A:T
NM_203446.3(SYNJ1):c.480-5A>G	SYNJ1		not provided|Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Likely benign(Last reviewed: Mar 14, 2021)	criteria provided, single submitter	VCV000731532	21	34067597	21	32695287	731532	745327	rs1001176616	NC_000021.9:32695286:T:C
NM_203446.3(SYNJ1):c.324C>T (p.Ile108=)	SYNJ1		not provided|Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Likely benign(Last reviewed: Dec 2, 2020)	criteria provided, single submitter	VCV000729814	21	34072303	21	32699993	729814	742591	rs551070196	NC_000021.9:32699992:G:A
NM_203446.3(SYNJ1):c.831C>T (p.Ala277=)	SYNJ1		Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Likely benign(Last reviewed: Mar 3, 2020)	criteria provided, single submitter	VCV000729536	21	34060636	21	32688326	729536	742589	rs148732160	NC_000021.9:32688325:G:A
NM_203446.3(SYNJ1):c.*333C>T	SYNJ1		Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Likely benign(Last reviewed: Nov 11, 2020)	criteria provided, single submitter	VCV000727422	21	34003782	21	32631472	727422	742586	rs548047319	NC_000021.9:32631471:G:A
NM_203446.3(SYNJ1):c.789+8_789+11del	SYNJ1		Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Likely benign(Last reviewed: Mar 26, 2020)	criteria provided, single submitter	VCV000725945	21	34066527 - 34066530	21	32694217 - 32694220	725945	745133	rs751922511	NC_000021.9:32694216:CAAACA:CA
NM_203446.3(SYNJ1):c.2958T>C (p.Ile986=)	SYNJ1		Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset|not provided	Likely benign(Last reviewed: Jun 17, 2020)	criteria provided, single submitter	VCV000723019	21	34022573	21	32650263	723019	742587	rs879835661	NC_000021.9:32650262:A:G
NM_203446.3(SYNJ1):c.1707T>G (p.Ala569=)	SYNJ1		Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Likely benign(Last reviewed: Jul 30, 2020)	criteria provided, single submitter	VCV000718212	21	34045669	21	32673359	718212	728860	rs1384171922	NC_000021.9:32673358:A:C
NM_203446.3(SYNJ1):c.2172T>C (p.Tyr724=)	SYNJ1		Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Likely benign(Last reviewed: Dec 31, 2019)	criteria provided, single submitter	VCV000708833	21	34037355	21	32665045	708833	728859	rs144454116	NC_000021.9:32665044:A:G
NM_203446.3(SYNJ1):c.*677_*679del	SYNJ1	F1569del, F1483del	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Likely benign(Last reviewed: Nov 24, 2020)	criteria provided, single submitter	VCV000708218	21	34003436 - 34003438	21	32631126 - 32631128	708218	728858	rs528030561	NC_000021.9:32631125:AGAAG:AG
NM_203446.3(SYNJ1):c.883A>C (p.Lys295Gln)	SYNJ1	K334Q, K295Q	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Likely benign(Last reviewed: Feb 21, 2020)	criteria provided, single submitter	VCV000707464	21	34059353	21	32687043	707464	694623	rs554456240	NC_000021.9:32687042:T:G
NM_203446.3(SYNJ1):c.*120G>A	SYNJ1		not provided|Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Likely benign(Last reviewed: Jan 27, 2020)	criteria provided, single submitter	VCV000707260	21	34003995	21	32631685	707260	694622	rs377721268	NC_000021.9:32631684:C:T
NM_203446.3(SYNJ1):c.2954A>G (p.Lys985Arg)	SYNJ1	K985R, K1024R, K980R	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Jul 17, 2018)	criteria provided, single submitter	VCV000665872	21	34022577	21	32650267	665872	648905	rs1325187801	NC_000021.9:32650266:T:C
NM_203446.3(SYNJ1):c.1004A>C (p.Tyr335Ser)	SYNJ1	Y374S, Y335S	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Dec 13, 2018)	criteria provided, single submitter	VCV000665285	21	34058172	21	32685862	665285	648918	rs1469620917	NC_000021.9:32685861:T:G
NM_203446.3(SYNJ1):c.177A>G (p.Ala59=)	SYNJ1		Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Oct 29, 2019)	criteria provided, single submitter	VCV000664700	21	34074305	21	32701995	664700	648924	rs749212329	NC_000021.9:32701994:T:C
NM_203446.3(SYNJ1):c.1554G>C (p.Lys518Asn)	SYNJ1	K557N, K513N, K518N	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Nov 12, 2019)	criteria provided, single submitter	VCV000664236	21	34045822	21	32673512	664236	648914	rs371301276	NC_000021.9:32673511:C:G
NM_203446.3(SYNJ1):c.768C>G (p.Phe256Leu)	SYNJ1	F256L, F295L	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Oct 3, 2018)	criteria provided, single submitter	VCV000664226	21	34066559	21	32694249	664226	648919	rs1456955061	NC_000021.9:32694248:G:C
NM_203446.3(SYNJ1):c.2996T>A (p.Leu999His)	SYNJ1	L1038H, L994H, L999H	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Aug 10, 2018)	criteria provided, single submitter	VCV000663525	21	34022535	21	32650225	663525	648903	rs1601283152	NC_000021.9:32650224:A:T
NM_203446.3(SYNJ1):c.3652A>G (p.Arg1218Gly)	SYNJ1	R1171G, R1202G, R1257G, R1218G	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Mar 19, 2019)	criteria provided, single submitter	VCV000663463	21	34012026	21	32639716	663463	648899	rs139146760	NC_000021.9:32639715:T:C
NM_203446.3(SYNJ1):c.*678C>G	SYNJ1	F1569L, F1483L	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Aug 2, 2018)	criteria provided, single submitter	VCV000662893	21	34003437	21	32631127	662893	648890	rs760299495	NC_000021.9:32631126:G:C
NM_203446.3(SYNJ1):c.*127G>C	SYNJ1	V1300L, V1386L	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Jan 24, 2020)	criteria provided, single submitter	VCV000662385	21	34003988	21	32631678	662385	648896	rs1342453394	NC_000021.9:32631677:C:G
NM_203446.3(SYNJ1):c.2981C>A (p.Thr994Lys)	SYNJ1	T1033K, T989K, T994K	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Dec 19, 2019)	criteria provided, single submitter	VCV000662045	21	34022550	21	32650240	662045	648904	rs776726487	NC_000021.9:32650239:G:T
NM_203446.3(SYNJ1):c.*233G>A	SYNJ1	R1421Q, R1335Q	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Dec 28, 2018)	criteria provided, single submitter	VCV000661401	21	34003882	21	32631572	661401	648895	rs765410501	NC_000021.9:32631571:C:T
NM_203446.3(SYNJ1):c.1449T>G (p.Asn483Lys)	SYNJ1	N486K, N483K, N522K	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Nov 1, 2018)	criteria provided, single submitter	VCV000659932	21	34051016	21	32678706	659932	648916	rs1490214505	NC_000021.9:32678705:A:C
NM_203446.3(SYNJ1):c.3823G>A (p.Gly1275Ser)	SYNJ1	G1314S, G1259S, G1228S, G1275S	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Mar 29, 2019)	criteria provided, single submitter	VCV000658700	21	34011310	21	32639000	658700	648897	rs1601231173	NC_000021.9:32638999:C:T
NM_203446.3(SYNJ1):c.2884C>T (p.Arg962Trp)	SYNJ1	R957W, R962W, R1001W	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Nov 1, 2018)	criteria provided, single submitter	VCV000658652	21	34022647	21	32650337	658652	648907	rs149147152	NC_000021.9:32650336:G:A
NM_203446.3(SYNJ1):c.2462-6C>A	SYNJ1		Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Mar 4, 2020)	criteria provided, single submitter	VCV000658593	21	34029436	21	32657126	658593	653575	rs1601309850	NC_000021.9:32657125:G:T
NM_203446.3(SYNJ1):c.3376C>A (p.Pro1126Thr)	SYNJ1	P1121T, P1165T, P1126T	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Dec 2, 2020)	criteria provided, multiple submitters, no conflicts	VCV000658281	21	34017971	21	32645661	658281	648902	rs1485482944	NC_000021.9:32645660:G:T
NM_203446.3(SYNJ1):c.*666A>G	SYNJ1		Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Oct 24, 2020)	criteria provided, single submitter	VCV000657310	21	34003449	21	32631139	657310	648891	rs763776246	NC_000021.9:32631138:T:C
NM_203446.3(SYNJ1):c.3803C>T (p.Ala1268Val)	SYNJ1	A1221V, A1252V, A1307V, A1268V	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Aug 8, 2018)	criteria provided, single submitter	VCV000656584	21	34011330	21	32639020	656584	648898	rs1601231363	NC_000021.9:32639019:G:A
NM_203446.3(SYNJ1):c.*257G>T	SYNJ1	R1343L, R1429L	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Dec 2, 2019)	criteria provided, single submitter	VCV000655746	21	34003858	21	32631548	655746	648893	rs112469776	NC_000021.9:32631547:C:A
NM_203446.3(SYNJ1):c.2250T>A (p.Asn750Lys)	SYNJ1	N745K, N750K, N789K	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Oct 19, 2020)	criteria provided, single submitter	VCV000653769	21	34037277	21	32664967	653769	648911	rs570501803	NC_000021.9:32664966:A:T
NM_203446.3(SYNJ1):c.583G>A (p.Ala195Thr)	SYNJ1	A195T, A234T	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: May 25, 2020)	criteria provided, single submitter	VCV000653212	21	34067489	21	32695179	653212	648921	rs774367309	NC_000021.9:32695178:C:T
NM_003895.3(SYNJ1):c.7A>C (p.Lys3Gln)	SYNJ1	K3Q	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Feb 21, 2020)	criteria provided, single submitter	VCV000652266	21	34100345	21	32728034	652266	648926	rs1037328706	NC_000021.9:32728033:T:G
NM_203446.3(SYNJ1):c.2685A>G (p.Thr895=)	SYNJ1		Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Oct 15, 2019)	criteria provided, single submitter	VCV000651107	21	34029107	21	32656797	651107	648908	rs939655575	NC_000021.9:32656796:T:C
NM_203446.3(SYNJ1):c.2090T>C (p.Val697Ala)	SYNJ1	V692A, V697A, V736A	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Sep 8, 2019)	criteria provided, single submitter	VCV000649325	21	34038308	21	32665998	649325	648912	rs764946363	NC_000021.9:32665997:A:G
NM_203446.3(SYNJ1):c.200G>A (p.Arg67Gln)	SYNJ1	R106Q, R67Q	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Sep 28, 2018)	criteria provided, single submitter	VCV000648787	21	34074282	21	32701972	648787	648923	rs969446324	NC_000021.9:32701971:C:T
NM_203446.3(SYNJ1):c.*491A>C	SYNJ1	Q1507P, Q1421P	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Jul 11, 2018)	criteria provided, single submitter	VCV000647401	21	34003624	21	32631314	647401	648892	rs776115769	NC_000021.9:32631313:T:G
NM_203446.3(SYNJ1):c.622A>G (p.Ser208Gly)	SYNJ1	S208G, S247G	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: May 7, 2019)	criteria provided, single submitter	VCV000646785	21	34067450	21	32695140	646785	648920	rs1601449471	NC_000021.9:32695139:T:C
NM_203446.3(SYNJ1):c.-86G>A	SYNJ1	S11N	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Jul 13, 2020)	criteria provided, single submitter	VCV000646660	21	34100320	21	32728009	646660	648925	rs768854034	NC_000021.9:32728008:C:T
NM_203446.3(SYNJ1):c.1291G>A (p.Val431Met)	SYNJ1	V431M, V470M	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Aug 25, 2018)	criteria provided, single submitter	VCV000646642	21	34053868	21	32681558	646642	648917	rs749980859	NC_000021.9:32681557:C:T
NM_203446.3(SYNJ1):c.3634G>A (p.Ala1212Thr)	SYNJ1	A1196T, A1251T, A1165T, A1212T	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Oct 25, 2018)	criteria provided, single submitter	VCV000646428	21	34012044	21	32639734	646428	648900	rs769125182	NC_000021.9:32639733:C:T
NM_203446.3(SYNJ1):c.1507C>T (p.Arg503Cys)	SYNJ1	R506C, R503C, R542C	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Jun 30, 2020)	criteria provided, single submitter	VCV000645824	21	34050958	21	32678648	645824	648915	rs115061921	NC_000021.9:32678647:G:A
NM_203446.3(SYNJ1):c.2567C>A (p.Thr856Asn)	SYNJ1	T851N, T856N, T895N	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: May 3, 2019)	criteria provided, single submitter	VCV000644595	21	34029325	21	32657015	644595	648909	rs1191504880	NC_000021.9:32657014:G:T
NM_203446.3(SYNJ1):c.3431-8C>A	SYNJ1		Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Sep 28, 2018)	criteria provided, single submitter	VCV000644375	21	34015775	21	32643465	644375	653662	rs369584002	NC_000021.9:32643464:G:T
NM_203446.3(SYNJ1):c.3392-5A>G	SYNJ1		Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Sep 14, 2018)	criteria provided, single submitter	VCV000644039	21	34017321	21	32645011	644039	653666	rs776721216	NC_000021.9:32645010:T:C
NM_203446.3(SYNJ1):c.326A>T (p.Asp109Val)	SYNJ1	D109V, D148V	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Sep 7, 2018)	criteria provided, single submitter	VCV000642833	21	34072301	21	32699991	642833	648922	rs764528223	NC_000021.9:32699990:T:A
NM_203446.3(SYNJ1):c.3581C>G (p.Ala1194Gly)	SYNJ1	A1178G, A1233G, A1147G, A1194G	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Oct 8, 2020)	criteria provided, single submitter	VCV000642561	21	34014213	21	32641903	642561	648901	rs779766895	NC_000021.9:32641902:G:C
NM_203446.3(SYNJ1):c.1789G>A (p.Ala597Thr)	SYNJ1	A592T, A597T, A636T	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Dec 5, 2018)	criteria provided, single submitter	VCV000642097	21	34042620	21	32670310	642097	648913	rs1601363222	NC_000021.9:32670309:C:T
NM_203446.3(SYNJ1):c.2896A>G (p.Ile966Val)	SYNJ1	I1005V, I961V, I966V	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Jun 6, 2020)	criteria provided, single submitter	VCV000641996	21	34022635	21	32650325	641996	648906	rs1601283648	NC_000021.9:32650324:T:C
NM_203446.3(SYNJ1):c.2519C>T (p.Thr840Met)	SYNJ1	T840M, T835M, T879M	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Sep 19, 2018)	criteria provided, single submitter	VCV000640780	21	34029373	21	32657063	640780	648910	rs560413403	NC_000021.9:32657062:G:A
NM_203446.3(SYNJ1):c.*767T>G	SYNJ1	L1599W, L1513W	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Nov 15, 2018)	criteria provided, single submitter	VCV000639005	21	34003348	21	32631038	639005	648889	rs764949465	NC_000021.9:32631037:A:C
NM_203446.3(SYNJ1):c.*253A>G	SYNJ1	M1428V, M1342V	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Jul 15, 2018)	criteria provided, single submitter	VCV000638900	21	34003862	21	32631552	638900	648894	rs1398328287	NC_000021.9:32631551:T:C
NM_203446.3(SYNJ1):c.3601C>T (p.Arg1201Cys)	SYNJ1	R1240C, R1185C, R1154C, R1201C	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53|Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 1	Conflicting interpretations of pathogenicity(Last reviewed: Oct 6, 2020)	criteria provided, conflicting interpretations	VCV000634476	21	34012077	21	32639767	634476	622474	rs114994257	NC_000021.9:32639766:G:A
NM_203446.3(SYNJ1):c.*186_*187insAATACT	SYNJ1		Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53|Epileptic encephalopathy, early infantile, 53|not specified|not provided|Parkinson disease 20, early-onset	Benign(Last reviewed: Jul 15, 2021)	criteria provided, multiple submitters, no conflicts	VCV000586762	21	34003928 - 34003929	21	32631618 - 32631619	586762	577888	rs57257560	NC_000021.9:32631618:A:AGTATTA
NM_203446.3(SYNJ1):c.3721C>T (p.Leu1241=)	SYNJ1		Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53|not specified|not provided	Benign(Last reviewed: Dec 8, 2020)	criteria provided, multiple submitters, no conflicts	VCV000586761	21	34011412	21	32639102	586761	577889	rs2230766	NC_000021.9:32639101:G:A
NM_203446.3(SYNJ1):c.3518-7G>T	SYNJ1		Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53|Epileptic encephalopathy, early infantile, 53|not specified|not provided|Parkinson disease 20, early-onset	Benign(Last reviewed: Jul 15, 2021)	criteria provided, multiple submitters, no conflicts	VCV000586760	21	34014283	21	32641973	586760	577890	rs2833929	NC_000021.9:32641972:C:A
NM_203446.3(SYNJ1):c.3278C>T (p.Pro1093Leu)	SYNJ1	P1132L, P1088L, P1093L	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53|not provided	Uncertain significance(Last reviewed: Sep 24, 2021)	criteria provided, multiple submitters, no conflicts	VCV000586759	21	34018069	21	32645759	586759	577891	rs1326671091	NC_000021.9:32645758:G:A
NM_203446.3(SYNJ1):c.884A>G (p.Lys295Arg)	SYNJ1	K334R, K295R	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53|not specified|not provided	Benign(Last reviewed: Dec 5, 2020)	criteria provided, multiple submitters, no conflicts	VCV000586758	21	34059352	21	32687042	586758	577892	rs2254562	NC_000021.9:32687041:T:C
NM_203446.3(SYNJ1):c.2874+6G>A	SYNJ1		Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Feb 10, 2018)	criteria provided, single submitter	VCV000583130	21	34025592	21	32653282	583130	573055	rs368204504	NC_000021.9:32653281:C:T
NM_203446.3(SYNJ1):c.470G>C (p.Arg157Thr)	SYNJ1	R196T, R157T	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Feb 26, 2018)	criteria provided, single submitter	VCV000582994	21	34072157	21	32699847	582994	573063	rs375831365	NC_000021.9:32699846:C:G
NM_203446.3(SYNJ1):c.1106G>A (p.Ser369Asn)	SYNJ1	S408N, S369N	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Apr 5, 2020)	criteria provided, single submitter	VCV000582650	21	34058070	21	32685760	582650	573754	rs147544792	NC_000021.9:32685759:C:T
NM_203446.3(SYNJ1):c.2653G>A (p.Val885Ile)	SYNJ1	V924I, V880I, V885I	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Jun 26, 2018)	criteria provided, single submitter	VCV000581736	21	34029139	21	32656829	581736	573746	rs763757097	NC_000021.9:32656828:C:T
NM_203446.3(SYNJ1):c.3097T>C (p.Ser1033Pro)	SYNJ1	S1072P, S1028P, S1033P	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Feb 19, 2018)	criteria provided, multiple submitters, no conflicts	VCV000580644	21	34018853	21	32646543	580644	573738	rs61752559	NC_000021.9:32646542:A:G
NM_203446.3(SYNJ1):c.2378A>G (p.Tyr793Cys)	SYNJ1	Y832C, Y793C, Y788C	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Nov 30, 2018)	criteria provided, single submitter	VCV000579673	21	34030109	21	32657799	579673	573058	rs1283151166	NC_000021.9:32657798:T:C
NM_203446.3(SYNJ1):c.3281_3286del (p.Leu1094_Pro1095del)	SYNJ1		Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Jun 2, 2018)	criteria provided, single submitter	VCV000579422	21	34018061 - 34018066	21	32645751 - 32645756	579422	573038	rs1283379982	NC_000021.9:32645750:GCGGCAGCGGC:GCGGC
NM_203446.3(SYNJ1):c.2744T>C (p.Ile915Thr)	SYNJ1	I954T, I910T, I915T	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Jun 26, 2018)	criteria provided, single submitter	VCV000578766	21	34029048	21	32656738	578766	573740	rs867564053	NC_000021.9:32656737:A:G
NM_203446.3(SYNJ1):c.3797C>G (p.Pro1266Arg)	SYNJ1	P1305R, P1219R, P1250R, P1266R	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Mar 26, 2018)	criteria provided, single submitter	VCV000577253	21	34011336	21	32639026	577253	573731	rs767170641	NC_000021.9:32639025:G:C
NM_203446.3(SYNJ1):c.803G>A (p.Arg268His)	SYNJ1	R307H, R268H	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Oct 9, 2020)	criteria provided, multiple submitters, no conflicts	VCV000576906	21	34060664	21	32688354	576906	571498	rs201796096	NC_000021.9:32688353:C:T
NM_203446.3(SYNJ1):c.3882T>G (p.His1294Gln)	SYNJ1	H1333Q, H1247Q, H1278Q, H1294Q	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Jun 26, 2018)	criteria provided, single submitter	VCV000576646	21	34011251	21	32638941	576646	573729	rs1569025711	NC_000021.9:32638940:A:C
NM_203446.3(SYNJ1):c.3139C>G (p.Arg1047Gly)	SYNJ1	R1086G, R1042G, R1047G	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Oct 28, 2020)	criteria provided, single submitter	VCV000576516	21	34018811	21	32646501	576516	573050	rs147931121	NC_000021.9:32646500:G:C
NM_203446.3(SYNJ1):c.3587C>A (p.Pro1196Gln)	SYNJ1	P1235Q, P1180Q, P1149Q, P1196Q	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000576177	21	34014207	21	32641897	576177	575148	rs61752550	NC_000021.9:32641896:G:T
NM_203446.3(SYNJ1):c.1603G>A (p.Val535Ile)	SYNJ1	V574I, V530I, V535I	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Sep 1, 2020)	criteria provided, single submitter	VCV000575982	21	34045773	21	32673463	575982	573750	rs145712835	NC_000021.9:32673462:C:T
NM_203446.3(SYNJ1):c.930G>A (p.Met310Ile)	SYNJ1	M349I, M310I	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Aug 11, 2020)	criteria provided, single submitter	VCV000575493	21	34059306	21	32686996	575493	573756	rs749045961	NC_000021.9:32686995:C:T
NM_203446.3(SYNJ1):c.3587C>T (p.Pro1196Leu)	SYNJ1	P1235L, P1149L, P1180L, P1196L	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Nov 17, 2018)	criteria provided, single submitter	VCV000575346	21	34014207	21	32641897	575346	571479	rs61752550	NC_000021.9:32641896:G:A
NM_003895.3(SYNJ1):c.24G>A (p.Trp8Ter)	SYNJ1	W8*	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Pathogenic(Last reviewed: Jun 7, 2018)	criteria provided, single submitter	VCV000575322	21	34100328	21	32728017	575322	571505	rs1569147057	NC_000021.9:32728016:C:T
NM_203446.3(SYNJ1):c.1508G>A (p.Arg503His)	SYNJ1	R542H, R503H, R506H	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Sep 15, 2020)	criteria provided, single submitter	VCV000574661	21	34050957	21	32678647	574661	571492	rs756697570	NC_000021.9:32678646:C:T
NM_203446.3(SYNJ1):c.2254G>T (p.Asp752Tyr)	SYNJ1	D791Y, D752Y, D747Y	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53|not provided	Uncertain significance(Last reviewed: Oct 7, 2020)	criteria provided, multiple submitters, no conflicts	VCV000573462	21	34037273	21	32664963	573462	573060	rs145978776	NC_000021.9:32664962:C:A
NM_203446.3(SYNJ1):c.*613A>G	SYNJ1	S1548G, S1462G	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: May 4, 2019)	criteria provided, single submitter	VCV000573244	21	34003502	21	32631192	573244	573029	rs769954720	NC_000021.9:32631191:T:C
NM_203446.3(SYNJ1):c.2781A>G (p.Glu927=)	SYNJ1		Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: May 2, 2018)	criteria provided, single submitter	VCV000572728	21	34029011	21	32656701	572728	573739	rs1350091132	NC_000021.9:32656700:T:C
NM_203446.3(SYNJ1):c.3610G>A (p.Val1204Ile)	SYNJ1	V1243I, V1157I, V1188I, V1204I	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Jan 10, 2018)	criteria provided, single submitter	VCV000572373	21	34012068	21	32639758	572373	573036	rs1569027714	NC_000021.9:32639757:C:T
NM_203446.3(SYNJ1):c.25A>G (p.Ile9Val)	SYNJ1	I48V, I9V	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Mar 7, 2019)	criteria provided, single submitter	VCV000572043	21	34099182	21	32726871	572043	571503	rs757895747	NC_000021.9:32726870:T:C
NM_203446.3(SYNJ1):c.*316del	SYNJ1	T1363fs, T1449fs	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: May 17, 2018)	criteria provided, single submitter	VCV000571107	21	34003799	21	32631489	571107	571475	rs1569014970	NC_000021.9:32631488:T:
NM_203446.3(SYNJ1):c.3767C>T (p.Pro1256Leu)	SYNJ1	P1295L, P1209L, P1240L, P1256L	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Sep 1, 2020)	criteria provided, single submitter	VCV000571046	21	34011366	21	32639056	571046	571476	rs147025577	NC_000021.9:32639055:G:A
NM_203446.3(SYNJ1):c.2793_2797del (p.Arg932fs)	SYNJ1	R971fs, R927fs, R932fs	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Pathogenic(Last reviewed: Jun 13, 2018)	criteria provided, single submitter	VCV000570902	21	34028997 - 34029001	21	32656687 - 32656691	570902	571490	rs778394516	NC_000021.9:32656686:CTTAT:
NM_203446.3(SYNJ1):c.1201-2A>G	SYNJ1		Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Likely pathogenic(Last reviewed: Jan 18, 2018)	criteria provided, single submitter	VCV000570738	21	34053960	21	32681650	570738	573062	rs1569086116	NC_000021.9:32681649:T:C
NM_203446.3(SYNJ1):c.41A>G (p.Asp14Gly)	SYNJ1	D53G, D14G	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Feb 24, 2020)	criteria provided, single submitter	VCV000570473	21	34099166	21	32726855	570473	575151	rs565807712	NC_000021.9:32726854:T:C
NM_203446.3(SYNJ1):c.20T>A (p.Phe7Tyr)	SYNJ1	F46Y, F7Y	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset|not provided	Uncertain significance(Last reviewed: Sep 1, 2019)	criteria provided, multiple submitters, no conflicts	VCV000570462	21	34099187	21	32726876	570462	573759	rs748690832	NC_000021.9:32726875:A:T
NM_203446.3(SYNJ1):c.630A>T (p.Glu210Asp)	SYNJ1	E249D, E210D	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Jun 28, 2018)	criteria provided, single submitter	VCV000570013	21	34067442	21	32695132	570013	571499	rs1377390036	NC_000021.9:32695131:T:A
NM_203446.3(SYNJ1):c.3320G>A (p.Arg1107Gln)	SYNJ1	R1146Q, R1102Q, R1107Q	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Jun 19, 2018)	criteria provided, single submitter	VCV000569857	21	34018027	21	32645717	569857	573736	rs917502531	NC_000021.9:32645716:C:T
NM_203446.3(SYNJ1):c.*212C>T	SYNJ1	T1414I, T1328I	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Jun 25, 2018)	criteria provided, single submitter	VCV000569496	21	34003903	21	32631593	569496	575147	rs754791304	NC_000021.9:32631592:G:A
NM_203446.3(SYNJ1):c.2171A>G (p.Tyr724Cys)	SYNJ1	Y763C, Y724C, Y719C	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Jul 22, 2019)	criteria provided, single submitter	VCV000569415	21	34037356	21	32665046	569415	575150	rs201485861	NC_000021.9:32665045:T:C
NM_203446.3(SYNJ1):c.3554G>A (p.Gly1185Asp)	SYNJ1	G1224D, G1138D, G1169D, G1185D	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Mar 26, 2019)	criteria provided, single submitter	VCV000568134	21	34014240	21	32641930	568134	571485	rs1569030684	NC_000021.9:32641929:C:T
NM_203446.3(SYNJ1):c.2475TCT[1] (p.Leu827del)	SYNJ1	L866del, L822del, L827del	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Jan 29, 2018)	criteria provided, single submitter	VCV000567697	21	34029412 - 34029414	21	32657102 - 32657104	567697	573748	rs769856515	NC_000021.9:32657101:AGAAGA:AGA
NM_203446.3(SYNJ1):c.3746C>T (p.Pro1249Leu)	SYNJ1	P1288L, P1202L, P1233L, P1249L	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Sep 3, 2019)	criteria provided, single submitter	VCV000567214	21	34011387	21	32639077	567214	573034	rs149288077	NC_000021.9:32639076:G:A
NM_203446.3(SYNJ1):c.3057T>G (p.Ser1019Arg)	SYNJ1	S1058R, S1014R, S1019R	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: May 15, 2018)	criteria provided, single submitter	VCV000566546	21	34018893	21	32646583	566546	571486	rs767760891	NC_000021.9:32646582:A:C
NM_203446.3(SYNJ1):c.211G>C (p.Gly71Arg)	SYNJ1	G110R, G71R	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Jan 7, 2019)	criteria provided, single submitter	VCV000565896	21	34074271	21	32701961	565896	573757	rs1569113660	NC_000021.9:32701960:C:G
NM_203446.3(SYNJ1):c.3215C>A (p.Pro1072Gln)	SYNJ1	P1111Q, P1067Q, P1072Q	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Dec 24, 2019)	criteria provided, single submitter	VCV000565611	21	34018735	21	32646425	565611	573042	rs771524798	NC_000021.9:32646424:G:T
NM_203446.3(SYNJ1):c.395G>A (p.Trp132Ter)	SYNJ1	W171*, W132*	Parkinson disease 20, early-onset	Pathogenic(Last reviewed: Aug 30, 2016)	criteria provided, single submitter	VCV000549503	21	34072232	21	32699922	549503	539985	rs1555907463	NC_000021.9:32699921:C:T
NM_203446.3(SYNJ1):c.3747G>T (p.Pro1249=)	SYNJ1		Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Likely benign(Last reviewed: Jul 29, 2020)	criteria provided, single submitter	VCV000544589	21	34011386	21	32639076	544589	533759	rs138579227	NC_000021.9:32639075:C:A
NM_203446.3(SYNJ1):c.*738C>T	SYNJ1		Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Likely benign(Last reviewed: Nov 6, 2020)	criteria provided, single submitter	VCV000544588	21	34003377	21	32631067	544588	533778	rs747245690	NC_000021.9:32631066:G:A
NM_203446.3(SYNJ1):c.3912G>A (p.Pro1304=)	SYNJ1		Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Likely benign(Last reviewed: Aug 7, 2020)	criteria provided, single submitter	VCV000544587	21	34011221	21	32638911	544587	533788	rs372695378	NC_000021.9:32638910:C:T
NM_203446.3(SYNJ1):c.*315G>A	SYNJ1		Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53|not provided	Benign/Likely benign(Last reviewed: Mar 16, 2021)	criteria provided, multiple submitters, no conflicts	VCV000544586	21	34003800	21	32631490	544586	534349	rs145347648	NC_000021.9:32631489:C:T
NM_203446.3(SYNJ1):c.3285G>A (p.Pro1095=)	SYNJ1		Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Likely benign(Last reviewed: Nov 16, 2020)	criteria provided, single submitter	VCV000544585	21	34018062	21	32645752	544585	533768	rs376395608	NC_000021.9:32645751:C:T
NM_203446.3(SYNJ1):c.2146-8G>A	SYNJ1		Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Likely benign(Last reviewed: Sep 17, 2019)	criteria provided, single submitter	VCV000544584	21	34037389	21	32665079	544584	533789	rs759701632	NC_000021.9:32665078:C:T
NM_203446.3(SYNJ1):c.93C>G (p.Leu31=)	SYNJ1		Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Likely benign(Last reviewed: Aug 2, 2020)	criteria provided, single submitter	VCV000544583	21	34099114	21	32726803	544583	533825	rs201322530	NC_000021.9:32726802:G:C
NM_203446.3(SYNJ1):c.706-15dup	SYNJ1		Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Benign(Last reviewed: Nov 21, 2020)	criteria provided, single submitter	VCV000544582	21	34066627 - 34066628	21	32694317 - 32694318	544582	533791	rs202044634	NC_000021.9:32694317:AAAAAAAAA:AAAAAAAAAA
NM_203446.3(SYNJ1):c.165A>G (p.Lys55=)	SYNJ1		Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Likely benign(Last reviewed: Jan 17, 2018)	criteria provided, single submitter	VCV000544581	21	34074317	21	32702007	544581	533792	rs141138675	NC_000021.9:32702006:T:C
NM_203446.3(SYNJ1):c.2997T>C (p.Leu999=)	SYNJ1		Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Likely benign(Last reviewed: Oct 24, 2020)	criteria provided, single submitter	VCV000544580	21	34022534	21	32650224	544580	533775	rs111774827	NC_000021.9:32650223:A:G
NM_203446.3(SYNJ1):c.1535C>T (p.Ala512Val)	SYNJ1	A551V, A507V, A512V	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Likely benign(Last reviewed: Dec 31, 2019)	criteria provided, single submitter	VCV000544579	21	34045841	21	32673531	544579	533814	rs115989459	NC_000021.9:32673530:G:A
NM_203446.3(SYNJ1):c.*312C>T	SYNJ1		Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Likely benign(Last reviewed: Oct 20, 2020)	criteria provided, single submitter	VCV000544578	21	34003803	21	32631493	544578	534351	rs149199429	NC_000021.9:32631492:G:A
NM_203446.3(SYNJ1):c.2943G>T (p.Met981Ile)	SYNJ1	M1020I, M981I, M976I	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53|not provided	Benign/Likely benign(Last reviewed: Feb 4, 2021)	criteria provided, multiple submitters, no conflicts	VCV000544577	21	34022588	21	32650278	544577	533777	rs115683257	NC_000021.9:32650277:C:A
NM_203446.3(SYNJ1):c.*186_*187insAATAC	SYNJ1	L1320fs, L1406fs	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Benign(Last reviewed: Oct 19, 2017)	criteria provided, single submitter	VCV000544576	21	34003928 - 34003929	21	32631618 - 32631619	544576	533787	rs869265580	NC_000021.9:32631618::GTATT
NM_203446.3(SYNJ1):c.2844C>T (p.Ala948=)	SYNJ1		Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53|not provided	Likely benign(Last reviewed: Jan 2, 2020)	criteria provided, single submitter	VCV000544575	21	34025628	21	32653318	544575	534360	rs1432339434	NC_000021.9:32653317:G:A
NM_203446.3(SYNJ1):c.1914G>A (p.Leu638=)	SYNJ1		Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Benign(Last reviewed: Nov 3, 2020)	criteria provided, single submitter	VCV000544574	21	34038781	21	32666471	544574	534367	rs534908601	NC_000021.9:32666470:C:T
NM_203446.3(SYNJ1):c.2226T>A (p.Val742=)	SYNJ1		Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Benign(Last reviewed: Oct 5, 2020)	criteria provided, single submitter	VCV000544573	21	34037301	21	32664991	544573	533794	rs566533509	NC_000021.9:32664990:A:T
NM_203446.3(SYNJ1):c.*521C>G	SYNJ1	P1517R, P1431R	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Mar 1, 2019)	criteria provided, single submitter	VCV000544572	21	34003594	21	32631284	544572	534347	rs749527882	NC_000021.9:32631283:G:C
NM_203446.3(SYNJ1):c.-67_-56del	SYNJ1		Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Aug 31, 2017)	criteria provided, single submitter	VCV000544571	21	34100290 - 34100301	21	32727979 - 32727990	544571	533795	rs1035093736	NC_000021.9:32727978:CAGCCGCCGCCACAGCCGCCG:CAGCCGCCG
NM_203446.3(SYNJ1):c.3410C>T (p.Pro1137Leu)	SYNJ1	P1176L, P1137L	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Aug 25, 2020)	criteria provided, single submitter	VCV000544570	21	34017298	21	32644988	544570	533786	rs569046864	NC_000021.9:32644987:G:A
NM_203446.3(SYNJ1):c.3580G>C (p.Ala1194Pro)	SYNJ1	A1233P, A1178P, A1147P, A1194P	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Oct 24, 2020)	criteria provided, single submitter	VCV000544569	21	34014214	21	32641904	544569	534356	rs77164494	NC_000021.9:32641903:C:G
NM_203446.3(SYNJ1):c.1832G>T (p.Trp611Leu)	SYNJ1	W650L, W606L, W611L	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Oct 27, 2017)	criteria provided, single submitter	VCV000544568	21	34038863	21	32666553	544568	533800	rs1481650772	NC_000021.9:32666552:C:A
NM_203446.3(SYNJ1):c.3837T>A (p.Asn1279Lys)	SYNJ1	N1318K, N1232K, N1263K, N1279K	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Jan 23, 2020)	criteria provided, single submitter	VCV000544567	21	34011296	21	32638986	544567	533751	rs1555888329	NC_000021.9:32638985:A:T
NM_203446.3(SYNJ1):c.2462-10C>G	SYNJ1		Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Aug 14, 2017)	criteria provided, single submitter	VCV000544566	21	34029440	21	32657130	544566	533784	rs775703634	NC_000021.9:32657129:G:C
NM_203446.3(SYNJ1):c.3179C>G (p.Pro1060Arg)	SYNJ1	P1099R, P1060R, P1055R	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Oct 28, 2017)	criteria provided, single submitter	VCV000544565	21	34018771	21	32646461	544565	533809	rs1430500307	NC_000021.9:32646460:G:C
NM_203446.3(SYNJ1):c.1466T>C (p.Leu489Ser)	SYNJ1	L528S, L489S, L492S	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Sep 25, 2017)	criteria provided, single submitter	VCV000544564	21	34050999	21	32678689	544564	533802	rs1238065971	NC_000021.9:32678688:A:G
NM_203446.3(SYNJ1):c.3829dup (p.Gln1277fs)	SYNJ1	Q1230fs, Q1316fs, Q1261fs, Q1277fs	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Aug 29, 2017)	criteria provided, single submitter	VCV000544563	21	34011303 - 34011304	21	32638993 - 32638994	544563	534354	rs1555888341	NC_000021.9:32638993:GGGGG:GGGGGG
NM_203446.3(SYNJ1):c.3908A>G (p.Gln1303Arg)	SYNJ1	Q1342R, Q1256R, Q1287R, Q1303R	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Aug 17, 2020)	criteria provided, single submitter	VCV000544562	21	34011225	21	32638915	544562	533779	rs546986773	NC_000021.9:32638914:T:C
NM_203446.3(SYNJ1):c.3811A>G (p.Met1271Val)	SYNJ1	M1310V, M1224V, M1255V, M1271V	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Aug 22, 2017)	criteria provided, single submitter	VCV000544561	21	34011322	21	32639012	544561	533758	rs751069566	NC_000021.9:32639011:T:C
NM_203446.3(SYNJ1):c.2120T>C (p.Ile707Thr)	SYNJ1	I746T, I707T, I702T	not provided|Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Conflicting interpretations of pathogenicity(Last reviewed: Oct 1, 2021)	criteria provided, conflicting interpretations	VCV000544560	21	34038278	21	32665968	544560	533799	rs147929290	NC_000021.9:32665967:A:G
NM_203446.3(SYNJ1):c.2786T>C (p.Ile929Thr)	SYNJ1	I968T, I929T, I924T	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Aug 31, 2017)	criteria provided, single submitter	VCV000544559	21	34029006	21	32656696	544559	533782	rs755258923	NC_000021.9:32656695:A:G
NM_203446.3(SYNJ1):c.3304C>T (p.Pro1102Ser)	SYNJ1	P1141S, P1102S, P1097S	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Aug 21, 2019)	criteria provided, single submitter	VCV000544558	21	34018043	21	32645733	544558	533801	rs1368672974	NC_000021.9:32645732:G:A
NM_203446.3(SYNJ1):c.1306A>G (p.Ile436Val)	SYNJ1	I475V, I436V	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: May 3, 2019)	criteria provided, single submitter	VCV000544557	21	34053853	21	32681543	544557	533804	rs763870801	NC_000021.9:32681542:T:C
NM_203446.3(SYNJ1):c.1609G>A (p.Val537Ile)	SYNJ1	V576I, V537I, V532I	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Sep 18, 2017)	criteria provided, single submitter	VCV000544556	21	34045767	21	32673457	544556	534368	rs1555898799	NC_000021.9:32673456:C:T
NM_203446.3(SYNJ1):c.2792T>C (p.Ile931Thr)	SYNJ1	I970T, I931T, I926T	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Nov 15, 2017)	criteria provided, single submitter	VCV000544555	21	34029000	21	32656690	544555	533781	rs932390799	NC_000021.9:32656689:A:G
NM_203446.3(SYNJ1):c.2597T>C (p.Ile866Thr)	SYNJ1	I905T, I861T, I866T	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Oct 14, 2020)	criteria provided, single submitter	VCV000544554	21	34029195	21	32656885	544554	533811	rs114053718	NC_000021.9:32656884:A:G
NM_203446.3(SYNJ1):c.809G>A (p.Arg270His)	SYNJ1	R309H, R270H	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Oct 9, 2020)	criteria provided, single submitter	VCV000544553	21	34060658	21	32688348	544553	533815	rs532075408	NC_000021.9:32688347:C:T
NM_203446.3(SYNJ1):c.*188T>C	SYNJ1	L1406S, L1320S	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Aug 31, 2018)	criteria provided, single submitter	VCV000544552	21	34003927	21	32631617	544552	533780	rs866258846	NC_000021.9:32631616:A:G
NM_203446.3(SYNJ1):c.311T>C (p.Ile104Thr)	SYNJ1	I143T, I104T	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Sep 25, 2017)	criteria provided, single submitter	VCV000544551	21	34072316	21	32700006	544551	533818	rs779426150	NC_000021.9:32700005:A:G
NM_203446.3(SYNJ1):c.2631G>C (p.Glu877Asp)	SYNJ1	E916D, E872D, E877D	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Sep 14, 2017)	criteria provided, single submitter	VCV000544550	21	34029161	21	32656851	544550	534364	rs375526059	NC_000021.9:32656850:C:G
NM_203446.3(SYNJ1):c.3209G>A (p.Arg1070Gln)	SYNJ1	R1109Q, R1070Q, R1065Q	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Aug 29, 2020)	criteria provided, single submitter	VCV000544549	21	34018741	21	32646431	544549	533805	rs141107054	NC_000021.9:32646430:C:T
NM_203446.3(SYNJ1):c.199C>T (p.Arg67Trp)	SYNJ1	R106W, R67W	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Jan 4, 2018)	criteria provided, single submitter	VCV000544548	21	34074283	21	32701973	544548	533816	rs372488661	NC_000021.9:32701972:G:A
NM_203446.3(SYNJ1):c.3524G>C (p.Ser1175Thr)	SYNJ1	S1214T, S1128T, S1159T, S1175T	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Dec 9, 2017)	criteria provided, single submitter	VCV000544547	21	34014270	21	32641960	544547	533798	rs994115947	NC_000021.9:32641959:C:G
NM_203446.3(SYNJ1):c.-42A>G	SYNJ1	R26G	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Aug 25, 2020)	criteria provided, single submitter	VCV000544546	21	34100276	21	32727965	544546	534372	rs988950141	NC_000021.9:32727964:T:C
NM_203446.3(SYNJ1):c.851G>A (p.Arg284Lys)	SYNJ1	R323K, R284K	not provided|Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset|Inborn genetic diseases	Conflicting interpretations of pathogenicity(Last reviewed: Nov 6, 2020)	criteria provided, conflicting interpretations	VCV000521749	21	34060616	21	32688306	521749	512478	rs565013600	NC_000021.9:32688305:C:T
NM_203446.3(SYNJ1):c.843T>C (p.Ala281=)	SYNJ1		Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Likely benign(Last reviewed: Dec 4, 2020)	criteria provided, single submitter	VCV000478369	21	34060624	21	32688314	478369	469576	rs372016074	NC_000021.9:32688313:A:G
NM_203446.3(SYNJ1):c.842C>G (p.Ala281Gly)	SYNJ1	A320G, A281G	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Aug 1, 2017)	criteria provided, single submitter	VCV000478368	21	34060625	21	32688315	478368	471589	rs1046699971	NC_000021.9:32688314:G:C
NM_203446.3(SYNJ1):c.808C>T (p.Arg270Cys)	SYNJ1	R309C, R270C	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: May 2, 2019)	criteria provided, single submitter	VCV000478367	21	34060659	21	32688349	478367	471591	rs547450707	NC_000021.9:32688348:G:A
NM_203446.3(SYNJ1):c.705+7A>G	SYNJ1		not provided|Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Benign(Last reviewed: Dec 31, 2019)	criteria provided, multiple submitters, no conflicts	VCV000478366	21	34067360	21	32695050	478366	471594	rs187016397	NC_000021.9:32695049:T:C
NM_203446.3(SYNJ1):c.573A>G (p.Thr191=)	SYNJ1		not provided|Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Benign/Likely benign(Last reviewed: Feb 1, 2022)	criteria provided, multiple submitters, no conflicts	VCV000478365	21	34067499	21	32695189	478365	471129	rs61756694	NC_000021.9:32695188:T:C
NM_203446.3(SYNJ1):c.479+9A>G	SYNJ1		not provided|Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Benign(Last reviewed: Dec 8, 2020)	criteria provided, multiple submitters, no conflicts	VCV000478364	21	34072139	21	32699829	478364	471133	rs76502784	NC_000021.9:32699828:T:C
NM_203446.3(SYNJ1):c.421T>C (p.Leu141=)	SYNJ1		Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Likely benign(Last reviewed: Aug 27, 2020)	criteria provided, single submitter	VCV000478363	21	34072206	21	32699896	478363	471599	rs140461566	NC_000021.9:32699895:A:G
NM_203446.3(SYNJ1):c.*761C>T	SYNJ1	T1597M, T1511M	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Likely benign(Last reviewed: Nov 23, 2020)	criteria provided, single submitter	VCV000478362	21	34003354	21	32631044	478362	469550	rs111516740	NC_000021.9:32631043:G:A
NM_203446.3(SYNJ1):c.*728C>T	SYNJ1	P1586L, P1500L	not provided|Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Likely benign(Last reviewed: Jan 18, 2021)	criteria provided, multiple submitters, no conflicts	VCV000478361	21	34003387	21	32631077	478361	471083	rs2230767	NC_000021.9:32631076:G:A
NM_203446.3(SYNJ1):c.*611C>T	SYNJ1	P1547L, P1461L	not provided|Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Benign/Likely benign(Last reviewed: Dec 2, 2020)	criteria provided, multiple submitters, no conflicts	VCV000478360	21	34003504	21	32631194	478360	471567	rs76056543	NC_000021.9:32631193:G:A
NM_203446.3(SYNJ1):c.*574T>A	SYNJ1	S1535T, S1449T	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: May 23, 2017)	criteria provided, single submitter	VCV000478359	21	34003541	21	32631231	478359	471088	rs138122167	NC_000021.9:32631230:A:T
NM_203446.3(SYNJ1):c.*552G>A	SYNJ1		not provided|Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Likely benign(Last reviewed: Nov 13, 2020)	criteria provided, multiple submitters, no conflicts	VCV000478358	21	34003563	21	32631253	478358	469552	rs146425050	NC_000021.9:32631252:C:T
NM_203446.3(SYNJ1):c.*522G>A	SYNJ1		Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Likely benign(Last reviewed: Oct 3, 2020)	criteria provided, single submitter	VCV000478357	21	34003593	21	32631283	478357	471092	rs777945782	NC_000021.9:32631282:C:T
NM_203446.3(SYNJ1):c.*329G>A	SYNJ1	G1453E, G1367E	not provided|Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Benign(Last reviewed: Dec 8, 2020)	criteria provided, multiple submitters, no conflicts	VCV000478356	21	34003786	21	32631476	478356	471569	rs61750217	NC_000021.9:32631475:C:T
NM_203446.3(SYNJ1):c.*234G>T	SYNJ1		Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Likely benign(Last reviewed: Apr 14, 2020)	criteria provided, single submitter	VCV000478355	21	34003881	21	32631571	478355	470593	rs777299829	NC_000021.9:32631570:C:A
NM_203446.3(SYNJ1):c.*223A>G	SYNJ1	I1418V, I1332V	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Likely benign(Last reviewed: Nov 23, 2020)	criteria provided, single submitter	VCV000478354	21	34003892	21	32631582	478354	471571	rs113978322	NC_000021.9:32631581:T:C
NM_203446.3(SYNJ1):c.*173C>T	SYNJ1	T1401M, T1315M	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Jun 6, 2020)	criteria provided, single submitter	VCV000478353	21	34003942	21	32631632	478353	470595	rs1341548536	NC_000021.9:32631631:G:A
NM_203446.3(SYNJ1):c.*4G>A	SYNJ1	V1345I, V1259I	not provided|Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Likely benign(Last reviewed: Mar 18, 2021)	criteria provided, multiple submitters, no conflicts	VCV000478352	21	34004111	21	32631801	478352	471096	rs115648918	NC_000021.9:32631800:C:T
NM_203446.3(SYNJ1):c.3762C>T (p.Pro1254=)	SYNJ1		Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Likely benign(Last reviewed: Dec 2, 2020)	criteria provided, single submitter	VCV000478351	21	34011371	21	32639061	478351	469557	rs201117151	NC_000021.9:32639060:G:A
NM_203446.3(SYNJ1):c.3722T>C (p.Leu1241Pro)	SYNJ1	L1280P, L1194P, L1225P, L1241P	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Sep 30, 2020)	criteria provided, single submitter	VCV000478350	21	34011411	21	32639101	478350	470597	rs548516848	NC_000021.9:32639100:A:G
NM_203446.3(SYNJ1):c.3691T>C (p.Ser1231Pro)	SYNJ1	S1270P, S1184P, S1215P, S1231P	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Oct 7, 2020)	criteria provided, single submitter	VCV000478349	21	34011987	21	32639677	478349	471573	rs767695759	NC_000021.9:32639676:A:G
NM_203446.3(SYNJ1):c.3689C>T (p.Thr1230Met)	SYNJ1	T1269M, T1183M, T1214M, T1230M	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: May 20, 2020)	criteria provided, single submitter	VCV000478348	21	34011989	21	32639679	478348	471102	rs752805765	NC_000021.9:32639678:G:A
NM_203446.3(SYNJ1):c.3638G>A (p.Arg1213Gln)	SYNJ1	R1252Q, R1197Q, R1166Q, R1213Q	not provided|Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Oct 1, 2021)	criteria provided, multiple submitters, no conflicts	VCV000478347	21	34012040	21	32639730	478347	471106	rs144048853	NC_000021.9:32639729:C:T
NM_203446.3(SYNJ1):c.3636G>A (p.Ala1212=)	SYNJ1		Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Likely benign(Last reviewed: Nov 14, 2020)	criteria provided, single submitter	VCV000478346	21	34012042	21	32639732	478346	470598	rs576444776	NC_000021.9:32639731:C:T
NM_203446.3(SYNJ1):c.3590C>T (p.Thr1197Met)	SYNJ1	T1236M, T1181M, T1150M, T1197M	not provided|Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Likely benign(Last reviewed: Aug 1, 2021)	criteria provided, multiple submitters, no conflicts	VCV000478345	21	34012088	21	32639778	478345	469561	rs145937537	NC_000021.9:32639777:G:A
NM_203446.3(SYNJ1):c.3588G>A (p.Pro1196=)	SYNJ1		Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Dec 15, 2019)	criteria provided, single submitter	VCV000478344	21	34014206	21	32641896	478344	470600	rs1160685381	NC_000021.9:32641895:C:T
NM_203446.3(SYNJ1):c.3431G>A (p.Gly1144Asp)	SYNJ1	G1183D, G1144D	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset|not provided	Uncertain significance(Last reviewed: Oct 28, 2021)	criteria provided, multiple submitters, no conflicts	VCV000478343	21	34015767	21	32643457	478343	469562	rs142964720	NC_000021.9:32643456:C:T
NM_203446.3(SYNJ1):c.3915+5G>T	SYNJ1		Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset|not provided	Benign(Last reviewed: Dec 2, 2020)	criteria provided, multiple submitters, no conflicts	VCV000478342	21	34011213	21	32638903	478342	471100	rs61750220	NC_000021.9:32638902:C:A
NM_203446.3(SYNJ1):c.3369A>G (p.Pro1123=)	SYNJ1		Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset|not provided|not specified	Benign/Likely benign(Last reviewed: Mar 1, 2022)	criteria provided, multiple submitters, no conflicts	VCV000478341	21	34017978	21	32645668	478341	471107	rs368850131	NC_000021.9:32645667:T:C
NM_203446.3(SYNJ1):c.3290A>G (p.Lys1097Arg)	SYNJ1	K1136R, K1092R, K1097R	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Jun 24, 2017)	criteria provided, single submitter	VCV000478340	21	34018057	21	32645747	478340	471114	rs946267411	NC_000021.9:32645746:T:C
NM_203446.3(SYNJ1):c.3205A>G (p.Ser1069Gly)	SYNJ1	S1108G, S1064G, S1069G	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Likely benign(Last reviewed: Dec 31, 2019)	criteria provided, single submitter	VCV000478339	21	34018745	21	32646435	478339	470606	rs149817769	NC_000021.9:32646434:T:C
NM_203446.3(SYNJ1):c.2882A>G (p.Asn961Ser)	SYNJ1	N1000S, N956S, N961S	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Aug 3, 2017)	criteria provided, single submitter	VCV000478338	21	34022649	21	32650339	478338	470608	rs754401787	NC_000021.9:32650338:T:C
NM_203446.3(SYNJ1):c.2875-5G>A	SYNJ1		not provided|Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Likely benign(Last reviewed: Oct 29, 2020)	criteria provided, single submitter	VCV000478337	21	34022661	21	32650351	478337	471575	rs376206541	NC_000021.9:32650350:C:T
NM_203446.3(SYNJ1):c.2874+5G>A	SYNJ1		Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Apr 8, 2021)	criteria provided, conflicting interpretations	VCV000478336	21	34025593	21	32653283	478336	471577	rs371765751	NC_000021.9:32653282:C:T
NM_203446.3(SYNJ1):c.2604A>G (p.Ile868Met)	SYNJ1	I907M, I863M, I868M	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Aug 6, 2020)	criteria provided, single submitter	VCV000478335	21	34029188	21	32656878	478335	471579	rs377165480	NC_000021.9:32656877:T:C
NM_203446.3(SYNJ1):c.2586C>T (p.Val862=)	SYNJ1		Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Likely benign(Last reviewed: Apr 9, 2020)	criteria provided, single submitter	VCV000478334	21	34029206	21	32656896	478334	469563	rs771973400	NC_000021.9:32656895:G:A
NM_203446.3(SYNJ1):c.2346G>A (p.Pro782=)	SYNJ1		Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset|not provided	Likely benign(Last reviewed: Nov 21, 2020)	criteria provided, multiple submitters, no conflicts	VCV000478333	21	34030141	21	32657831	478333	469565	rs61753644	NC_000021.9:32657830:C:T
NM_203446.3(SYNJ1):c.1933_1934delinsAG (p.Gln645Arg)	SYNJ1	Q645R, Q640R, Q684R	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Jun 8, 2017)	criteria provided, single submitter	VCV000478332	21	34038761 - 34038762	21	32666451 - 32666452	478332	471120	rs1555896707	NC_000021.9:32666450:TG:CT
NM_203446.3(SYNJ1):c.1906G>A (p.Val636Ile)	SYNJ1	V675I, V631I, V636I	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53|Epileptic encephalopathy, early infantile, 1|Parkinson disease 20, early-onset	Conflicting interpretations of pathogenicity(Last reviewed: Oct 9, 2020)	criteria provided, conflicting interpretations	VCV000478331	21	34038789	21	32666479	478331	471582	rs373820739	NC_000021.9:32666478:C:T
NM_203446.3(SYNJ1):c.1830C>G (p.Leu610=)	SYNJ1		Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Likely benign(Last reviewed: Nov 6, 2020)	criteria provided, single submitter	VCV000478330	21	34038865	21	32666555	478330	471125	rs115658799	NC_000021.9:32666554:G:C
NM_203446.3(SYNJ1):c.1555A>G (p.Ser519Gly)	SYNJ1	S558G, S514G, S519G	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset|not provided	Uncertain significance(Last reviewed: Oct 3, 2020)	criteria provided, multiple submitters, no conflicts	VCV000478329	21	34045821	21	32673511	478329	470609	rs148901211	NC_000021.9:32673510:T:C
NM_203446.3(SYNJ1):c.1546G>A (p.Val516Ile)	SYNJ1	V555I, V511I, V516I	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Benign(Last reviewed: Dec 4, 2020)	criteria provided, single submitter	VCV000478328	21	34045830	21	32673520	478328	470612	rs113708828	NC_000021.9:32673519:C:T
NM_203446.3(SYNJ1):c.1481G>A (p.Arg494Gln)	SYNJ1	R533Q, R497Q, R494Q	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Feb 3, 2017)	criteria provided, single submitter	VCV000478327	21	34050984	21	32678674	478327	471585	rs781599934	NC_000021.9:32678673:C:T
NM_203446.3(SYNJ1):c.6G>A (p.Ala2=)	SYNJ1		Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset|not provided	Benign/Likely benign(Last reviewed: Dec 1, 2021)	criteria provided, multiple submitters, no conflicts	VCV000478326	21	34099201	21	32726890	478326	471135	rs61750221	NC_000021.9:32726889:C:T
NM_203446.3(SYNJ1):c.1119-8G>T	SYNJ1		Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset|not specified|not provided	Benign(Last reviewed: Sep 16, 2021)	criteria provided, multiple submitters, no conflicts	VCV000478325	21	34056437	21	32684127	478325	469567	rs138882423	NC_000021.9:32684126:C:A
NM_203446.3(SYNJ1):c.1030G>A (p.Ala344Thr)	SYNJ1	A383T, A344T	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset|not provided	Likely benign(Last reviewed: Jan 18, 2021)	criteria provided, multiple submitters, no conflicts	VCV000478324	21	34058146	21	32685836	478324	471126	rs114942253	NC_000021.9:32685835:C:T
NM_203446.3(SYNJ1):c.1002C>T (p.Asp334=)	SYNJ1		Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Likely benign(Last reviewed: Sep 14, 2019)	criteria provided, single submitter	VCV000478323	21	34058174	21	32685864	478323	469569	rs763601982	NC_000021.9:32685863:G:A
NM_203446.3(SYNJ1):c.909A>G (p.Gly303=)	SYNJ1		Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset|not provided	Likely benign(Last reviewed: Feb 1, 2022)	criteria provided, multiple submitters, no conflicts	VCV000478316	21	34059327	21	32687017	478316	470613	rs145522240	NC_000021.9:32687016:T:C
NM_203446.3(SYNJ1):c.43C>T (p.Pro15Ser)	SYNJ1	P54S, P15S	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset|not provided	Benign/Likely benign(Last reviewed: Sep 6, 2021)	criteria provided, multiple submitters, no conflicts	VCV000445927	21	34099164	21	32726853	445927	439199	rs61755328	NC_000021.9:32726852:G:A
NM_203446.3(SYNJ1):c.1259G>C (p.Arg420Pro)	SYNJ1	R459P, R420P	Parkinson disease 20, early-onset	Pathogenic(Last reviewed: Mar 8, 2017)	no assertion criteria provided	VCV000393356	21	34053900	21	32681590	393356	380176	rs1060499619	NC_000021.9:32681589:C:G
NM_203446.3(SYNJ1):c.656G>A (p.Arg219Gln)	SYNJ1	R258Q, R219Q	Parkinson disease 20, early-onset|Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Pathogenic(Last reviewed: Oct 20, 2021)	criteria provided, multiple submitters, no conflicts	VCV000088844	21	34067416	21	32695106	88844	94413	rs398122403	NC_000021.9:32695105:C:T
NM_203446.3(SYNJ1):c.2739C>T (p.Ala913=)	SYNJ1		Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Likely benign(Last reviewed: Jan 15, 2020)	criteria provided, single submitter	VCV000081827	21	34029053	21	32656743	81827	92718	rs267606107	NC_000021.9:32656742:G:A
NM_007375.4(TARDBP):c.1144G>A (p.Ala382Thr)	TARDBP		FRONTOTEMPORAL DEMENTIA WITH TDP43 INCLUSIONS, TARDBP-RELATED|Amyotrophic lateral sclerosis type 10|not provided	Likely pathogenic(Last reviewed: Mar 31, 2020)	criteria provided, multiple submitters, no conflicts	VCV000021474	1	11082610	1	11022553	21474	34326	rs367543041	NC_000001.11:11022552:G:A
NM_001077653.2(TBX20):c.995del (p.Pro332fs)	TBX20	P332fs	Hypoplastic left heart syndrome|Hypoplastic right heart syndrome|Wolff-Parkinson-White pattern	Pathogenic(Last reviewed: Dec 1, 2015)	no assertion criteria provided	VCV000438266	7	35244090	7	35204478	438266	431889	rs1554284604	NC_000007.14:35204477:GGGG:GGG
NM_005996.4(TBX3):c.991C>T (p.Gln331Ter)	TBX3	Q331*, Q351*	Ulnar-mammary syndrome	Pathogenic(Last reviewed: Dec 1, 2009)	no assertion criteria provided	VCV000031909	12	115114166	12	114676361	31909	40565	rs397514484	NC_000012.12:114676360:G:A
NM_181486.4(TBX5):c.618T>G (p.Phe206Leu)	TBX5	F206L, F156L	Wolff-Parkinson-White pattern	Uncertain significance(Last reviewed: Jul 14, 2017)	no assertion criteria provided	VCV000487603	12	114832591	12	114394786	487603	480709	rs533581420	NC_000012.12:114394785:A:C
NM_003673.4(TCAP):c.97C>T (p.Arg33Trp)	TCAP	R33W	Wolff-Parkinson-White pattern|not provided|Familial hypertrophic cardiomyopathy 1|Primary familial hypertrophic cardiomyopathy|Hypertrophic cardiomyopathy 25	Uncertain significance(Last reviewed: Dec 16, 2019)	criteria provided, multiple submitters, no conflicts	VCV000282451	17	37821709	17	39665456	282451	266688	rs145524909	NC_000017.11:39665455:C:T
NM_003242.6(TGFBR2):c.1563G>A (p.Trp521Ter)	TGFBR2	W521*, W546*	Familial thoracic aortic aneurysm and aortic dissection|Wolff-Parkinson-White pattern	Uncertain significance(Last reviewed: Jul 16, 2018)	criteria provided, single submitter	VCV000487632	3	30732950	3	30691458	487632	480682	rs1553631968	NC_000003.12:30691457:G:A
NM_000360.4(TH):c.391T>G (p.Phe131Val)	TH	F158V, F131V, F162V	not provided|Dystonia|Autosomal recessive DOPA responsive dystonia	Uncertain significance(Last reviewed: Dec 17, 2021)	criteria provided, multiple submitters, no conflicts	VCV000643112	11	2189817	11	2168587	643112	639869	rs200536568	NC_000011.10:2168586:A:C
NM_000360.4(TH):c.406G>A (p.Val136Met)	TH	V136M, V167M, V163M	not provided|Autosomal recessive DOPA responsive dystonia|Dystonia	Uncertain significance(Last reviewed: Jan 8, 2020)	criteria provided, multiple submitters, no conflicts	VCV000304078	11	2189802	11	2168572	304078	326007	rs142046543	NC_000011.10:2168571:C:T
NM_000360.4(TH):c.1400A>G (p.Asp467Gly)	TH	D467G, D498G, D494G	Autosomal recessive DOPA responsive dystonia	Conflicting interpretations of pathogenicity(Last reviewed: Jul 23, 2020)	criteria provided, conflicting interpretations	VCV000304067	11	2185557	11	2164327	304067	313638	rs771351747	NC_000011.10:2164326:T:C
NM_001009923.2(TMEM230):c.1A>G (p.Met1Val)	TMEM230	M1V	not provided	Uncertain significance(Last reviewed: Sep 30, 2021)	criteria provided, single submitter	VCV001435559	20	5093674	20	5113028	1435559	1500555		NC_000020.11:5113027:T:C
NM_001009923.2(TMEM230):c.422G>T (p.Arg141Leu)	TMEM230	R141L, R78L	not provided	Uncertain significance(Last reviewed: Apr 1, 2014)	no assertion criteria provided	VCV000243014	20	5081567	20	5100921	243014	244095	rs764786986	NC_000020.11:5100920:C:A
NM_001382273.1(TNK2):c.1088T>C (p.Val363Ala)	TNK2	V363A, V387A, V395A	Parkinson disease	Uncertain significance(Last reviewed: Jan 1, 2016)	criteria provided, single submitter	VCV000224860	3	195605390	3	195878519	224860	226710	rs370013968	NC_000003.12:195878518:A:G
NM_001382273.1(TNK2):c.2675G>A (p.Arg892His)	TNK2	R877H, R916H, R909H, R892H, R901H, R924H	Parkinson disease|not provided|not specified	Conflicting interpretations of pathogenicity(Last reviewed: Nov 27, 2021)	criteria provided, conflicting interpretations	VCV000224859	3	195594494	3	195867623	224859	226709	rs112384084	NC_000003.12:195867622:C:T
NM_001382273.1(TNK2):c.2981C>T (p.Ala994Val)	TNK2	A977V, A1003V, A1011V, A1018V, A1026V, A979V, A994V	Parkinson disease	Uncertain significance(Last reviewed: Jan 1, 2016)	criteria provided, single submitter	VCV000224858	3	195594092	3	195867221	224858	226708	rs571171423	NC_000003.12:195867220:G:A
NM_001382273.1(TNK2):c.1957G>A (p.Val653Met)	TNK2	V638M, V677M, V670M, V653M, V662M, V685M	Infantile epilepsy|Parkinson disease|Autosomal recessive infantile epilepsy	Conflicting interpretations of pathogenicity(Last reviewed: Jan 1, 2016)	criteria provided, conflicting interpretations	VCV000088849	3	195595212	3	195868341	88849	94418	rs201407161	NC_000003.12:195868340:C:T
NM_000363.5(TNNI3):c.466C>G (p.Gln156Glu)	TNNI3	Q156E	Dilated cardiomyopathy 2A|Familial hypertrophic cardiomyopathy 7|Familial restrictive cardiomyopathy 1|Familial Hypertrophic Cardiomyopathy with Wolff-Parkinson-White Syndrome	Uncertain significance(Last reviewed: Apr 27, 2017)	criteria provided, single submitter	VCV000894379	19	55665481	19	55154113	894379	882546	rs2085712011	NC_000019.10:55154112:G:C
NM_000363.5(TNNI3):c.104C>A (p.Ala35Asp)	TNNI3	A35D	Dilated cardiomyopathy 2A|Familial hypertrophic cardiomyopathy 7|Familial restrictive cardiomyopathy 1|Familial Hypertrophic Cardiomyopathy with Wolff-Parkinson-White Syndrome	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000894052	19	55668422	19	55157054	894052	882547	rs1190447904	NC_000019.10:55157053:G:T
NM_000363.5(TNNI3):c.*44A>G	TNNI3		Familial restrictive cardiomyopathy 1|Dilated cardiomyopathy 2A|Familial hypertrophic cardiomyopathy 7|Familial Hypertrophic Cardiomyopathy with Wolff-Parkinson-White Syndrome	Uncertain significance(Last reviewed: Apr 27, 2017)	criteria provided, single submitter	VCV000893714	19	55663158	19	55151790	893714	882545	rs1182120462	NC_000019.10:55151789:T:C
NM_000363.5(TNNI3):c.-45C>T	TNNI3		Familial hypertrophic cardiomyopathy 7|Familial restrictive cardiomyopathy 1|Familial Hypertrophic Cardiomyopathy with Wolff-Parkinson-White Syndrome|Dilated cardiomyopathy 2A	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000893021	19	55669002	19	55157634	893021	882548	rs1242688089	NC_000019.10:55157633:G:A
NM_000363.4(TNNI3):c.-148A>G	TNNI3		Hypertrophic cardiomyopathy|Familial restrictive cardiomyopathy|not provided|Dilated Cardiomyopathy, Recessive|Familial Hypertrophic Cardiomyopathy with Wolff-Parkinson-White Syndrome	Likely benign(Last reviewed: Jul 11, 2018)	criteria provided, multiple submitters, no conflicts	VCV000369294	19	55669105	19	55157737	369294	353523	rs73935313	NC_000019.10:55157736:T:C
NM_000363.5(TNNI3):c.-133G>T	TNNI3		Familial Hypertrophic Cardiomyopathy with Wolff-Parkinson-White Syndrome|Dilated Cardiomyopathy, Recessive|Hypertrophic cardiomyopathy|Familial restrictive cardiomyopathy	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000330203	19	55669090	19	55157722	330203	350409	rs886054636	NC_000019.10:55157721:C:A
NM_000363.5(TNNI3):c.-103C>T	TNNI3		Dilated Cardiomyopathy, Recessive|Familial Hypertrophic Cardiomyopathy with Wolff-Parkinson-White Syndrome|Familial restrictive cardiomyopathy|not provided|Hypertrophic cardiomyopathy	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	VCV000330202	19	55669060	19	55157692	330202	334391	rs557391836	NC_000019.10:55157691:G:A
NM_000363.5(TNNI3):c.-85A>C	TNNI3		Familial Hypertrophic Cardiomyopathy with Wolff-Parkinson-White Syndrome|Dilated Cardiomyopathy, Recessive|Familial restrictive cardiomyopathy|not provided|Hypertrophic cardiomyopathy	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	VCV000330201	19	55669042	19	55157674	330201	350406	rs186540595	NC_000019.10:55157673:T:G
NM_000363.5(TNNI3):c.157C>T (p.Leu53=)	TNNI3		Cardiomyopathy|Hypertrophic cardiomyopathy|Familial restrictive cardiomyopathy|Familial Hypertrophic Cardiomyopathy with Wolff-Parkinson-White Syndrome|Dilated Cardiomyopathy, Recessive	Conflicting interpretations of pathogenicity(Last reviewed: Jan 30, 2021)	criteria provided, conflicting interpretations	VCV000330200	19	55667694	19	55156326	330200	344273	rs763981651	NC_000019.10:55156325:G:A
NM_000363.5(TNNI3):c.283-9C>T	TNNI3		Familial Hypertrophic Cardiomyopathy with Wolff-Parkinson-White Syndrome|Cardiomyopathy|Dilated cardiomyopathy 2A|Familial hypertrophic cardiomyopathy 7|Familial restrictive cardiomyopathy 1|Hypertrophic cardiomyopathy	Conflicting interpretations of pathogenicity(Last reviewed: Apr 26, 2019)	criteria provided, conflicting interpretations	VCV000330199	19	55666207	19	55154839	330199	349397	rs759922995	NC_000019.10:55154838:G:A
NM_000363.5(TNNI3):c.550-11C>T	TNNI3		Familial hypertrophic cardiomyopathy 7|Familial Hypertrophic Cardiomyopathy with Wolff-Parkinson-White Syndrome|Familial restrictive cardiomyopathy 1|Dilated cardiomyopathy 2A	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000330198	19	55663296	19	55151928	330198	344272	rs886054635	NC_000019.10:55151927:G:A
NM_000363.5(TNNI3):c.109-15A>G	TNNI3		Familial hypertrophic cardiomyopathy 7|Familial restrictive cardiomyopathy 1|Dilated cardiomyopathy 2A|not specified|Cardiomyopathy|Familial Hypertrophic Cardiomyopathy with Wolff-Parkinson-White Syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Mar 8, 2019)	criteria provided, conflicting interpretations	VCV000229330	19	55668027	19	55156659	229330	231083	rs779144176	NC_000019.10:55156658:T:C
NM_000363.5(TNNI3):c.*35C>T	TNNI3		Familial Hypertrophic Cardiomyopathy with Wolff-Parkinson-White Syndrome|not provided|Familial hypertrophic cardiomyopathy 7|Familial restrictive cardiomyopathy 1|Dilated cardiomyopathy 2A	Conflicting interpretations of pathogenicity(Last reviewed: Jan 12, 2018)	criteria provided, conflicting interpretations	VCV000188677	19	55663167	19	55151799	188677	186575	rs375447438	NC_000019.10:55151798:G:A
NM_000363.5(TNNI3):c.-47C>T	TNNI3		Familial Hypertrophic Cardiomyopathy with Wolff-Parkinson-White Syndrome|Cardiomyopathy|Familial restrictive cardiomyopathy 1|Dilated cardiomyopathy 2A|Familial hypertrophic cardiomyopathy 7|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Mar 1, 2022)	criteria provided, conflicting interpretations	VCV000188667	19	55669004	19	55157636	188667	186585	rs202159627	NC_000019.10:55157635:G:A
NM_000363.5(TNNI3):c.-98C>A	TNNI3		Familial Hypertrophic Cardiomyopathy with Wolff-Parkinson-White Syndrome|not provided|Familial hypertrophic cardiomyopathy 7|Familial restrictive cardiomyopathy 1|Dilated cardiomyopathy 2A	Conflicting interpretations of pathogenicity(Last reviewed: Jan 13, 2018)	criteria provided, conflicting interpretations	VCV000188666	19	55669055	19	55157687	188666	186586	rs12973773	NC_000019.10:55157686:G:T
NM_000363.5(TNNI3):c.372+7C>T	TNNI3		Familial restrictive cardiomyopathy 1|Dilated cardiomyopathy 2A|Familial hypertrophic cardiomyopathy 7|Hypertrophic cardiomyopathy|not specified|not provided|Familial Hypertrophic Cardiomyopathy with Wolff-Parkinson-White Syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Aug 14, 2020)	criteria provided, conflicting interpretations	VCV000165519	19	55666102	19	55154734	165519	176339	rs367809676	NC_000019.10:55154733:G:A
NM_000363.5(TNNI3):c.139T>C (p.Leu47=)	TNNI3		Familial Hypertrophic Cardiomyopathy with Wolff-Parkinson-White Syndrome|not specified|Cardiomyopathy|Familial hypertrophic cardiomyopathy 7|Familial restrictive cardiomyopathy 1|Dilated cardiomyopathy 2A|Hypertrophic cardiomyopathy	Conflicting interpretations of pathogenicity(Last reviewed: Nov 15, 2020)	criteria provided, conflicting interpretations	VCV000137685	19	55667982	19	55156614	137685	141388	rs587780967	NC_000019.10:55156613:A:G
NM_003283.6(TNNT1):c.33-8G>A	TNNI3|TNNT1		Hypertrophic cardiomyopathy|Familial Hypertrophic Cardiomyopathy with Wolff-Parkinson-White Syndrome|Dilated Cardiomyopathy, Recessive|Nemaline Myopathy, Recessive|Nemaline myopathy 5|not specified|Familial restrictive cardiomyopathy	Benign/Likely benign(Last reviewed: Dec 4, 2020)	criteria provided, multiple submitters, no conflicts	VCV000130603	19	55658397	19	55147029	130603	136049	rs76630067	NC_000019.10:55147028:C:T
NM_000363.5(TNNI3):c.373-4C>G	TNNI3		Dilated cardiomyopathy 2A|Familial restrictive cardiomyopathy 1|Familial hypertrophic cardiomyopathy 7|not provided|not specified|Hypertrophic cardiomyopathy|Familial Hypertrophic Cardiomyopathy with Wolff-Parkinson-White Syndrome|Cardiomyopathy	Conflicting interpretations of pathogenicity(Last reviewed: Dec 2, 2020)	criteria provided, conflicting interpretations	VCV000043378	19	55665578	19	55154210	43378	52548	rs2288530	NC_000019.10:55154209:G:C
NM_000363.5(TNNI3):c.373-15C>G	TNNI3		not provided|Dilated cardiomyopathy 2A|Familial restrictive cardiomyopathy 1|Familial hypertrophic cardiomyopathy 7|not specified|Familial Hypertrophic Cardiomyopathy with Wolff-Parkinson-White Syndrome|Hypertrophic cardiomyopathy|Cardiomyopathy	Conflicting interpretations of pathogenicity(Last reviewed: Nov 17, 2021)	criteria provided, conflicting interpretations	VCV000043377	19	55665589	19	55154221	43377	52547	rs192630178	NC_000019.10:55154220:G:C
NM_000363.5(TNNI3):c.273G>A (p.Ala91=)	TNNI3		Cardiomyopathy|not provided|Dilated cardiomyopathy 2A|not specified|Familial restrictive cardiomyopathy 1|Familial hypertrophic cardiomyopathy 7|Familial Hypertrophic Cardiomyopathy with Wolff-Parkinson-White Syndrome|Hypertrophic cardiomyopathy	Conflicting interpretations of pathogenicity(Last reviewed: Dec 6, 2020)	criteria provided, conflicting interpretations	VCV000043372	19	55667578	19	55156210	43372	52542	rs75491697	NC_000019.10:55156209:C:T
NM_000363.5(TNNI3):c.235C>T (p.Arg79Cys)	TNNI3	R79C	not specified|Dilated cardiomyopathy 2A|Cardiomyopathy|Familial restrictive cardiomyopathy 1|Familial hypertrophic cardiomyopathy 7|Hypertrophic cardiomyopathy|Familial Hypertrophic Cardiomyopathy with Wolff-Parkinson-White Syndrome|Cardiovascular phenotype|not provided|Familial hypertrophic cardiomyopathy 1	Conflicting interpretations of pathogenicity(Last reviewed: Nov 25, 2020)	criteria provided, conflicting interpretations	VCV000043367	19	55667616	19	55156248	43367	52537	rs3729712	NC_000019.10:55156247:G:A
NM_000363.5(TNNI3):c.198G>A (p.Glu66=)	TNNI3		Dilated cardiomyopathy 2A|Familial restrictive cardiomyopathy 1|Cardiovascular phenotype|Cardiomyopathy|Familial hypertrophic cardiomyopathy 7|not specified|not provided|Hypertrophic cardiomyopathy|Dilated Cardiomyopathy, Recessive|Familial Hypertrophic Cardiomyopathy with Wolff-Parkinson-White Syndrome|Familial restrictive cardiomyopathy	Benign/Likely benign(Last reviewed: Dec 7, 2020)	criteria provided, multiple submitters, no conflicts	VCV000043364	19	55667653	19	55156285	43364	52534	rs3729710	NC_000019.10:55156284:C:T
NM_000363.5(TNNI3):c.151-6C>G	TNNI3		Dilated cardiomyopathy 2A|not specified|not provided|Familial restrictive cardiomyopathy 1|Familial hypertrophic cardiomyopathy 7|Cardiomyopathy|Familial Hypertrophic Cardiomyopathy with Wolff-Parkinson-White Syndrome|Hypertrophic cardiomyopathy	Conflicting interpretations of pathogenicity(Last reviewed: Aug 20, 2020)	criteria provided, conflicting interpretations	VCV000043363	19	55667706	19	55156338	43363	52533	rs377258542	NC_000019.10:55156337:G:C
NM_000363.5(TNNI3):c.12-7del	TNNI3		not specified|Dilated Cardiomyopathy, Recessive|Familial Hypertrophic Cardiomyopathy with Wolff-Parkinson-White Syndrome|Familial restrictive cardiomyopathy|Hypertrophic cardiomyopathy|Cardiomyopathy|Familial hypertrophic cardiomyopathy 1	Conflicting interpretations of pathogenicity(Last reviewed: Dec 6, 2020)	criteria provided, conflicting interpretations	VCV000043361	19	55668683	19	55157315	43361	52531	rs370714315	NC_000019.10:55157314:GG:G
NM_003283.6(TNNT1):c.35A>G (p.Glu12Gly)	TNNI3|TNNT1	E12G	Hypertrophic cardiomyopathy|Familial restrictive cardiomyopathy|not specified|Dilated Cardiomyopathy, Recessive|Familial Hypertrophic Cardiomyopathy with Wolff-Parkinson-White Syndrome|not provided|Nemaline myopathy 5	Benign/Likely benign(Last reviewed: Sep 10, 2021)	criteria provided, multiple submitters, no conflicts	VCV000031865	19	55658387	19	55147019	31865	40525	rs112562759	NC_000019.10:55147018:T:C
NM_003283.6(TNNT1):c.-20A>G	TNNI3|TNNT1		Hypertrophic cardiomyopathy|not specified|not provided|Nemaline myopathy 5|Familial Hypertrophic Cardiomyopathy with Wolff-Parkinson-White Syndrome|Dilated Cardiomyopathy, Recessive|Nemaline Myopathy, Recessive|Familial restrictive cardiomyopathy	Benign/Likely benign(Last reviewed: Jan 13, 2018)	criteria provided, multiple submitters, no conflicts	VCV000031855	19	55660537	19	55149169	31855	40515	rs9636153	NC_000019.10:55149168:T:C
NM_000363.5(TNNI3):c.607G>A (p.Gly203Ser)	TNNI3	G203S	Familial hypertrophic cardiomyopathy 7	Pathogenic(Last reviewed: Aug 1, 1997)	no assertion criteria provided	VCV000012432	19	55663228	19	55151860	12432	27471	rs267607127	NC_000019.10:55151859:C:T
NM_000363.5(TNNI3):c.244C>T (p.Pro82Ser)	TNNI3	P82S	Familial restrictive cardiomyopathy 1|Dilated cardiomyopathy 2A|Familial hypertrophic cardiomyopathy 7|not provided|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Familial restrictive cardiomyopathy|Cardiomyopathy|not specified|Familial Hypertrophic Cardiomyopathy with Wolff-Parkinson-White Syndrome|Dilated Cardiomyopathy, Recessive|Cardiomyopathy|Amyloidogenic transthyretin amyloidosis	Benign/Likely benign(Last reviewed: Dec 7, 2020)	criteria provided, multiple submitters, no conflicts	VCV000012421	19	55667607	19	55156239	12421	27460	rs77615401	NC_000019.10:55156238:G:A
NM_001276345.2(TNNT2):c.3G>A (p.Met1Ile)	TNNT2	M1I	not provided|Wolff-Parkinson-White pattern	Uncertain significance(Last reviewed: Sep 2, 2019)	criteria provided, single submitter	VCV000487631	1	201342380	1	201373252	487631	480671	rs1289914935	NC_000001.11:201373251:C:T
NM_001276345.2(TNNT2):c.360T>G (p.Phe120Leu)	TNNT2	F110L, F120L, F105L	Primary familial hypertrophic cardiomyopathy|Hypertrophic cardiomyopathy|Hypertrophic cardiomyopathy|Wolff-Parkinson-White pattern|not provided	Pathogenic/Likely pathogenic(Last reviewed: Nov 27, 2018)	criteria provided, multiple submitters, no conflicts	VCV000177807	1	201334370	1	201365242	177807	172501	rs727504331	NC_000001.11:201365241:A:C
NM_001276345.2(TNNT2):c.281G>C (p.Arg94Thr)	TNNT2	R84T, R94T, R93T, R79T	Cardiovascular phenotype|not provided|Hypertrophic cardiomyopathy|Cardiomyopathy|Familial hypertrophic cardiomyopathy 2|Left ventricular noncompaction 6|Familial restrictive cardiomyopathy 3|not specified	Uncertain significance(Last reviewed: Feb 26, 2021)	criteria provided, multiple submitters, no conflicts	VCV000043623	1	201334751	1	201365623	43623	52792	rs397516452	NC_000001.11:201365622:C:G
NM_003285.3(TNR):c.463T>A (p.Cys155Ser)	TNR	C155S	Parkinson disease	Uncertain significance(Last reviewed: Jan 1, 2016)	criteria provided, single submitter	VCV000224865	1	175375388	1	175406252	224865	226707	rs150331590	NC_000001.11:175406251:A:T
NM_003285.3(TNR):c.496A>G (p.Thr166Ala)	TNR	T166A	Parkinson disease|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Dec 31, 2019)	criteria provided, conflicting interpretations	VCV000224864	1	175375355	1	175406219	224864	226706	rs147204644	NC_000001.11:175406218:T:C
NM_003285.3(TNR):c.538A>C (p.Asn180His)	TNR	N180H	Parkinson disease|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Dec 31, 2019)	criteria provided, conflicting interpretations	VCV000224863	1	175372714	1	175403578	224863	226705	rs61731112	NC_000001.11:175403577:T:G
NM_003285.3(TNR):c.1732C>T (p.Arg578Ter)	TNR	R578*, R245*	Parkinson disease	Uncertain significance(Last reviewed: Jan 1, 2016)	criteria provided, single submitter	VCV000224862	1	175355213	1	175386077	224862	226704	rs869312899	NC_000001.11:175386076:G:A
NM_003285.3(TNR):c.1774A>G (p.Thr592Ala)	TNR	T592A, T259A	Parkinson disease	Uncertain significance(Last reviewed: Jan 1, 2016)	criteria provided, single submitter	VCV000224861	1	175355171	1	175386035	224861	226703	rs140481433	NC_000001.11:175386034:T:C
NM_017636.4(TRPM4):c.2732C>T (p.Thr911Met)	TRPM4	T911M, T557M, T766M, T796M, T737M, T375M	Wolff-Parkinson-White pattern|Progressive familial heart block type IB	Uncertain significance(Last reviewed: Dec 16, 2021)	criteria provided, single submitter	VCV000487616	19	49703643	19	49200386	487616	480724	rs148006852	NC_000019.10:49200385:C:T
NM_001297663.2(TTC39A):c.1322C>T (p.Thr441Met)	TTC39A	T445M, T414M, T18M, T85M, T441M, T442M, T477M	Wolff-Parkinson-White pattern	Uncertain significance(Last reviewed: Jul 14, 2017)	no assertion criteria provided	VCV000487628	1	51756242	1	51290570	487628	480680	rs756251338	NC_000001.11:51290569:G:A
NM_001297663.2(TTC39A):c.1490C>G (p.Ala497Gly)	TTC39A	A501G, A141G, A470G, A533G, A497G, A498G, A74G	Wolff-Parkinson-White pattern	Uncertain significance(Last reviewed: Jul 14, 2017)	no assertion criteria provided	VCV000487623	1	51755680	1	51290008	487623	480679	rs1553171591	NC_000001.11:51290007:G:C
NM_001267550.2(TTN):c.66904C>T (p.Leu22302=)	TTN|TTN-AS1		Wolff-Parkinson-White pattern	Likely pathogenic(Last reviewed: Jul 14, 2017)	no assertion criteria provided	VCV000487595	2	179445202	2	178580475	487595	480681	rs1553624186	NC_000002.12:178580474:G:A
NM_001267550.2(TTN):c.92683C>T (p.Arg30895Ter)	TTN|TTN-AS1	R30895*, R21955*, R22022*, R21830*, R28327*, R29254*	Dilated cardiomyopathy 1G|Primary dilated cardiomyopathy|Wolff-Parkinson-White pattern|Dilated cardiomyopathy 1G|Limb-girdle muscular dystrophy, type 2J	Likely pathogenic(Last reviewed: Nov 20, 2021)	criteria provided, multiple submitters, no conflicts	VCV000223300	2	179413670	2	178548943	223300	225032	rs869312065	NC_000002.12:178548942:G:A
NM_001267550.2(TTN):c.46065G>C (p.Lys15355Asn)	TTN	K15355N, K12787N, K13714N, K6290N, K6415N, K6482N	Limb-girdle muscular dystrophy, type 2J|Dilated cardiomyopathy 1G|not specified|Myopathy, early-onset, with fatal cardiomyopathy|not provided|Tibial muscular dystrophy|Cardiomyopathy|Dilated Cardiomyopathy, Dominant|Limb-Girdle Muscular Dystrophy, Recessive|Hypertrophic cardiomyopathy|Myopathy, myofibrillar, 9, with early respiratory failure	Conflicting interpretations of pathogenicity(Last reviewed: Jan 8, 2021)	criteria provided, conflicting interpretations	VCV000046995	2	179485183	2	178620456	46995	56160	rs397517583	NC_000002.12:178620455:C:G
NM_001267550.2(TTN):c.95270T>C (p.Ile31757Thr)	TTN-AS1|TTN	I29189T, I31757T, I30116T, I22817T, I22692T, I22884T	Limb-girdle muscular dystrophy, type 2J|Tibial muscular dystrophy|Dilated cardiomyopathy 1G|not provided|Cardiomyopathy|Myopathy, early-onset, with fatal cardiomyopathy|Myopathy, myofibrillar, 9, with early respiratory failure|Limb-girdle muscular dystrophy, type 2J|Dilated cardiomyopathy 1G|not specified	Conflicting interpretations of pathogenicity(Last reviewed: Mar 1, 2022)	criteria provided, conflicting interpretations	VCV000096316	2	179410693	2	178545966	96316	102210	rs72648259	NC_000002.12:178545965:A:G
NM_021830.5(TWNK):c.1001G>A (p.Arg334Gln)	TWNK	R334Q	Mitochondrial disease|Progressive external ophthalmoplegia with mitochondrial DNA deletions, digenic|Infantile onset spinocerebellar ataxia|not provided	Pathogenic(Last reviewed: Aug 1, 2016)	criteria provided, multiple submitters, no conflicts	VCV000004623	10	102748968	10	100989211	4623	19662	rs28937887	NC_000010.11:100989210:G:A
NM_004181.5(UCHL1):c.-17C>T	UCHL1		Parkinson disease 5	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000903526	4	41258977	4	41256960	903526	890659	rs367935445	NC_000004.12:41256959:C:T
NM_004181.5(UCHL1):c.-25T>C	UCHL1		Parkinson disease 5	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000903525	4	41258969	4	41256952	903525	890658	rs1780982671	NC_000004.12:41256951:T:C
NM_004181.5(UCHL1):c.-26C>T	UCHL1		Parkinson disease 5	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000903524	4	41258968	4	41256951	903524	890657	rs746877403	NC_000004.12:41256950:C:T
NM_004181.5(UCHL1):c.-46T>C	UCHL1		Parkinson disease 5	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000903523	4	41258948	4	41256931	903523	890656	rs901082145	NC_000004.12:41256930:T:C
NM_004181.5(UCHL1):c.*276T>A	UCHL1		Parkinson disease 5	Likely benign(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000901643	4	41270366	4	41268349	901643	890664	rs116336893	NC_000004.12:41268348:T:A
NM_004181.5(UCHL1):c.*250T>C	UCHL1		Parkinson disease 5	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000901642	4	41270340	4	41268323	901642	890663	rs564857603	NC_000004.12:41268322:T:C
NC_000004.12:g.41256926C>A	UCHL1		Parkinson disease 5	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000901592	4	41258943	4	41256926	901592	890655	rs371943957	NC_000004.12:41256925:C:A
NC_000004.12:g.41256918C>G	UCHL1		Parkinson disease 5	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000901591	4	41258935	4	41256918	901591	890654	rs577696101	NC_000004.12:41256917:C:G
NM_004181.5(UCHL1):c.*84C>G	UCHL1		Parkinson disease 5	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000901096	4	41270174	4	41268157	901096	890662	rs959534314	NC_000004.12:41268156:C:G
NM_004181.5(UCHL1):c.586-4C>A	UCHL1		Parkinson disease 5	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000901095	4	41270000	4	41267983	901095	891794	rs1431899503	NC_000004.12:41267982:C:A
NM_004181.5(UCHL1):c.457C>T (p.Arg153Trp)	UCHL1	R153W	Parkinson disease 5	Uncertain significance(Last reviewed: Apr 27, 2017)	criteria provided, single submitter	VCV000901094	4	41263938	4	41261921	901094	890661	rs139583787	NC_000004.12:41261920:C:T
NM_004181.5(UCHL1):c.223G>A (p.Val75Ile)	UCHL1	V75I	Parkinson disease 5	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000899925	4	41262712	4	41260695	899925	890660	rs148096293	NC_000004.12:41260694:G:A
NM_004181.5(UCHL1):c.174+6G>A	UCHL1		Parkinson disease 5	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000899924	4	41259760	4	41257743	899924	891793	rs1379113927	NC_000004.12:41257742:G:A
NM_004181.5(UCHL1):c.69C>T (p.Ala23=)	UCHL1		not provided|Parkinson disease 5	Likely benign(Last reviewed: Sep 21, 2018)	criteria provided, multiple submitters, no conflicts	VCV000771361	4	41259649	4	41257632	771361	698518	rs753720793	NC_000004.12:41257631:C:T
NM_004181.5(UCHL1):c.412-4G>A	UCHL1		Parkinson disease 5|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Jan 13, 2018)	criteria provided, conflicting interpretations	VCV000731878	4	41263889	4	41261872	731878	744105	rs765745344	NC_000004.12:41261871:G:A
NM_004181.5(UCHL1):c.533G>A (p.Arg178Gln)	UCHL1	R178Q	Spastic paraplegia 79, autosomal recessive|Parkinson disease 5	Uncertain significance(Last reviewed: Apr 27, 2017)	criteria provided, single submitter	VCV000375649	4	41266126	4	41264109	375649	362490	rs768996179	NC_000004.12:41264108:G:A
NM_004181.5(UCHL1):c.*309T>C	UCHL1		Parkinson disease 5	Benign(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000348778	4	41270399	4	41268382	348778	294817	rs78683791	NC_000004.12:41268381:T:C
NM_004181.5(UCHL1):c.*294G>A	UCHL1		Parkinson disease 5	Benign(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000348777	4	41270384	4	41268367	348777	298513	rs116700032	NC_000004.12:41268366:G:A
NM_004181.5(UCHL1):c.*125C>T	UCHL1		Parkinson disease 5	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000348776	4	41270215	4	41268198	348776	293418	rs886059408	NC_000004.12:41268197:C:T
NM_004181.5(UCHL1):c.609A>G (p.Glu203=)	UCHL1		not provided|Parkinson disease 5	Benign(Last reviewed: Dec 31, 2019)	criteria provided, multiple submitters, no conflicts	VCV000348775	4	41270027	4	41268010	348775	298451	rs147661219	NC_000004.12:41268009:A:G
NM_004181.5(UCHL1):c.558C>T (p.Gly186=)	UCHL1		not provided|Parkinson disease 5	Benign/Likely benign(Last reviewed: Sep 10, 2021)	criteria provided, multiple submitters, no conflicts	VCV000348774	4	41266151	4	41264134	348774	298512	rs116680633	NC_000004.12:41264133:C:T
NM_004181.5(UCHL1):c.527-3C>T	UCHL1		Parkinson disease 5	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000348773	4	41266117	4	41264100	348773	298447	rs749663332	NC_000004.12:41264099:C:T
NM_004181.5(UCHL1):c.513C>T (p.His171=)	UCHL1		not provided|Parkinson disease 5	Likely benign(Last reviewed: Dec 31, 2019)	criteria provided, multiple submitters, no conflicts	VCV000348772	4	41265295	4	41263278	348772	298446	rs145093131	NC_000004.12:41263277:C:T
NM_004181.5(UCHL1):c.326-4del	UCHL1		not provided|Parkinson Disease, Dominant	Benign/Likely benign(Last reviewed: Oct 20, 2021)	criteria provided, multiple submitters, no conflicts	VCV000348771	4	41263719	4	41261702	348771	293417	rs3214812	NC_000004.12:41261701:TTTTTTTTTT:TTTTTTTTT
NM_004181.5(UCHL1):c.175-5C>T	UCHL1		not provided|Parkinson disease 5	Benign/Likely benign(Last reviewed: Dec 31, 2019)	criteria provided, multiple submitters, no conflicts	VCV000348770	4	41262659	4	41260642	348770	298445	rs373327947	NC_000004.12:41260641:C:T
NM_004181.5(UCHL1):c.45+6T>C	UCHL1		not provided|Parkinson disease 5	Benign(Last reviewed: Dec 18, 2021)	criteria provided, multiple submitters, no conflicts	VCV000348769	4	41259149	4	41257132	348769	293414	rs11556273	NC_000004.12:41257131:T:C
NM_004181.5(UCHL1):c.33+5G>C	UCHL1		Parkinson disease 5	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000348768	4	41259031	4	41257014	348768	294808	rs886059407	NC_000004.12:41257013:G:C
NM_004181.5(UCHL1):c.-16C>T	UCHL1		not provided|Parkinson disease 5	Benign(Last reviewed: Apr 19, 2021)	criteria provided, multiple submitters, no conflicts	VCV000348767	4	41258978	4	41256961	348767	294806	rs9321	NC_000004.12:41256960:C:T
NM_004181.5(UCHL1):c.-24A>G	UCHL1		not provided|Parkinson disease 5	Benign(Last reviewed: Apr 19, 2021)	criteria provided, multiple submitters, no conflicts	VCV000348766	4	41258970	4	41256953	348766	298506	rs11556271	NC_000004.12:41256952:A:G
NM_004181.5(UCHL1):c.-47C>T	UCHL1		Parkinson disease 5	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000348765	4	41258947	4	41256930	348765	298505	rs752001613	NC_000004.12:41256929:C:T
NM_004181.4(UCHL1):c.-71C>G	UCHL1		Parkinson disease 5	Benign(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000348764	4	41258923	4	41256906	348764	298441	rs201100258	NC_000004.12:41256905:C:G
NM_004181.5(UCHL1):c.370A>C (p.Met124Leu)	UCHL1	M124L	not specified|Parkinson disease 5|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Nov 29, 2021)	criteria provided, conflicting interpretations	VCV000252624	4	41263776	4	41261759	252624	246966	rs150601238	NC_000004.12:41261758:A:C
NM_004181.5(UCHL1):c.20A>C (p.Glu7Ala)	UCHL1	E7A	Spastic paraplegia 79, autosomal recessive	Pathogenic(Last reviewed: Feb 26, 2013)	no assertion criteria provided	VCV000088635	4	41259013	4	41256996	88635	94224	rs397515634	NC_000004.12:41256995:A:C
NM_004181.5(UCHL1):c.53C>A (p.Ser18Tyr)	UCHL1	S18Y	not provided|Parkinson disease 5	Benign(Last reviewed: Dec 17, 2021)	criteria provided, multiple submitters, no conflicts	VCV000012298	4	41259633	4	41257616	12298	27337	rs5030732	NC_000004.12:41257615:C:A
NM_004181.5(UCHL1):c.279C>G (p.Ile93Met)	UCHL1	I93M	Parkinson disease 5	risk factor(Last reviewed: Apr 1, 2006)	no assertion criteria provided	VCV000012297	4	41262768	4	41260751	12297	27336	rs121917767	NC_000004.12:41260750:C:G
NM_014000.3(VCL):c.3379G>A (p.Val1127Ile)	VCL	V1127I, V1059I	Wolff-Parkinson-White pattern	Uncertain significance(Last reviewed: Jul 14, 2017)	no assertion criteria provided	VCV000487634	10	75877901	10	74118143	487634	480706	rs1312868617	NC_000010.11:74118142:G:A
NM_014000.3(VCL):c.550C>T (p.His184Tyr)	VCL	H184Y	not provided|Wolff-Parkinson-White pattern	Uncertain significance(Last reviewed: Jan 28, 2020)	criteria provided, single submitter	VCV000487630	10	75832538	10	74072780	487630	480704	rs1321660809	NC_000010.11:74072779:C:T
NM_014000.3(VCL):c.1928C>T (p.Thr643Met)	VCL	T643M	Dilated cardiomyopathy 1W|Wolff-Parkinson-White pattern|not provided	Uncertain significance(Last reviewed: Aug 27, 2019)	criteria provided, multiple submitters, no conflicts	VCV000487627	10	75860761	10	74101003	487627	480705	rs150643310	NC_000010.11:74101002:C:T
NM_007126.5(VCP):c.1944T>C (p.Pro648=)	VCP		Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia	Likely benign(Last reviewed: Jun 1, 2021)	criteria provided, single submitter	VCV001670212	9	35059550	9	35059553	1670212	1635577		NC_000009.12:35059552:A:G
NM_007126.5(VCP):c.446-11T>C	VCP		Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia	Likely benign(Last reviewed: Nov 18, 2021)	criteria provided, single submitter	VCV001669043	9	35065389	9	35065392	1669043	1602929		NC_000009.12:35065391:A:G
NM_007126.5(VCP):c.1317C>T (p.Ala439=)	VCP		Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia	Likely benign(Last reviewed: May 5, 2021)	criteria provided, single submitter	VCV001666646	9	35061054	9	35061057	1666646	1622071		NC_000009.12:35061056:G:A
NM_007126.5(VCP):c.15C>T (p.Ala5=)	VCP		Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia	Likely benign(Last reviewed: Jan 11, 2021)	criteria provided, single submitter	VCV001660685	9	35072336	9	35072339	1660685	1641787		NC_000009.12:35072338:G:A
NM_007126.5(VCP):c.1617C>T (p.Phe539=)	VCP		Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia	Likely benign(Last reviewed: Nov 21, 2020)	criteria provided, single submitter	VCV001654172	9	35060388	9	35060391	1654172	1526990		NC_000009.12:35060390:G:A
NM_007126.5(VCP):c.2315+8G>C	VCP		Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia	Likely benign(Last reviewed: Oct 28, 2021)	criteria provided, single submitter	VCV001652973	9	35057365	9	35057368	1652973	1579473		NC_000009.12:35057367:C:G
NM_007126.5(VCP):c.531T>A (p.Ala177=)	VCP		Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia	Likely benign(Last reviewed: Nov 15, 2020)	criteria provided, single submitter	VCV001651962	9	35065293	9	35065296	1651962	1613188		NC_000009.12:35065295:A:T
NM_007126.5(VCP):c.1182G>A (p.Val394=)	VCP		Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia	Likely benign(Last reviewed: May 3, 2021)	criteria provided, single submitter	VCV001651577	9	35061586	9	35061589	1651577	1547026		NC_000009.12:35061588:C:T
NM_007126.5(VCP):c.446-7C>T	VCP		Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia	Likely benign(Last reviewed: Aug 12, 2021)	criteria provided, single submitter	VCV001642651	9	35065385	9	35065388	1642651	1552749		NC_000009.12:35065387:G:A
NM_007126.5(VCP):c.1512G>A (p.Leu504=)	VCP		Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia	Likely benign(Last reviewed: Aug 5, 2021)	criteria provided, single submitter	VCV001641980	9	35060493	9	35060496	1641980	1651023		NC_000009.12:35060495:C:T
NM_007126.5(VCP):c.708+19G>C	VCP		Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia	Likely benign(Last reviewed: Oct 25, 2021)	criteria provided, single submitter	VCV001639891	9	35064132	9	35064135	1639891	1571311		NC_000009.12:35064134:C:G
NM_007126.5(VCP):c.1494G>A (p.Glu498=)	VCP		Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia	Likely benign(Last reviewed: Jul 21, 2021)	criteria provided, single submitter	VCV001638808	9	35060511	9	35060514	1638808	1624494		NC_000009.12:35060513:C:T
NM_007126.5(VCP):c.303-21_303-19del	VCP		Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia	Likely benign(Last reviewed: Nov 11, 2021)	criteria provided, single submitter	VCV001629460	9	35066833 - 35066835	9	35066836 - 35066838	1629460	1532244		NC_000009.12:35066835:CTCC:C
NM_007126.5(VCP):c.2175T>C (p.Asp725=)	VCP		Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia	Likely benign(Last reviewed: Jan 8, 2021)	criteria provided, single submitter	VCV001626465	9	35057513	9	35057516	1626465	1583470		NC_000009.12:35057515:A:G
NM_007126.5(VCP):c.1696-15C>G	VCP		Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia	Likely benign(Last reviewed: Aug 28, 2021)	criteria provided, single submitter	VCV001623631	9	35059813	9	35059816	1623631	1594398		NC_000009.12:35059815:G:C
NM_007126.5(VCP):c.1569G>A (p.Gly523=)	VCP		Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia	Likely benign(Last reviewed: Aug 27, 2021)	criteria provided, single submitter	VCV001623437	9	35060436	9	35060439	1623437	1540639		NC_000009.12:35060438:C:T
NM_007126.5(VCP):c.577-10C>T	VCP		Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia	Likely benign(Last reviewed: May 20, 2021)	criteria provided, single submitter	VCV001622707	9	35064292	9	35064295	1622707	1561552		NC_000009.12:35064294:G:A
NM_007126.5(VCP):c.670C>T (p.Leu224=)	VCP		Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia	Likely benign(Last reviewed: Oct 5, 2021)	criteria provided, single submitter	VCV001621539	9	35064189	9	35064192	1621539	1528685		NC_000009.12:35064191:G:A
NM_007126.5(VCP):c.2160+14C>A	VCP		Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia	Likely benign(Last reviewed: Nov 5, 2021)	criteria provided, single submitter	VCV001618706	9	35059047	9	35059050	1618706	1580839		NC_000009.12:35059049:G:T
NM_007126.5(VCP):c.1482+9A>G	VCP		Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia	Likely benign(Last reviewed: Jul 21, 2021)	criteria provided, single submitter	VCV001618210	9	35060789	9	35060792	1618210	1527532		NC_000009.12:35060791:T:C
NM_007126.5(VCP):c.946-12del	VCP		Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia	Likely benign(Last reviewed: Oct 18, 2021)	criteria provided, single submitter	VCV001609083	9	35062147	9	35062150	1609083	1573953		NC_000009.12:35062149:GG:G
NM_007126.5(VCP):c.1359+15C>T	VCP		Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia	Likely benign(Last reviewed: Dec 14, 2021)	criteria provided, single submitter	VCV001608233	9	35060997	9	35061000	1608233	1539672		NC_000009.12:35060999:G:A
NM_007126.5(VCP):c.1081+9T>C	VCP		Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia	Likely benign(Last reviewed: Sep 30, 2021)	criteria provided, single submitter	VCV001607569	9	35061991	9	35061994	1607569	1637524		NC_000009.12:35061993:A:G
NM_007126.5(VCP):c.738T>A (p.Pro246=)	VCP		Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia	Likely benign(Last reviewed: May 31, 2021)	criteria provided, single submitter	VCV001602094	9	35063048	9	35063051	1602094	1633220		NC_000009.12:35063050:A:T
NM_007126.5(VCP):c.1483-14C>T	VCP		Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia	Likely benign(Last reviewed: Aug 4, 2021)	criteria provided, single submitter	VCV001597403	9	35060536	9	35060539	1597403	1664937		NC_000009.12:35060538:G:A
NM_007126.5(VCP):c.2028T>C (p.Ala676=)	VCP		Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia	Likely benign(Last reviewed: Nov 4, 2020)	criteria provided, single submitter	VCV001596465	9	35059193	9	35059196	1596465	1633548		NC_000009.12:35059195:A:G
NM_007126.5(VCP):c.45C>T (p.Ala15=)	VCP		Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia	Likely benign(Last reviewed: Oct 14, 2021)	criteria provided, single submitter	VCV001595005	9	35068332	9	35068335	1595005	1590645		NC_000009.12:35068334:G:A
NM_007126.5(VCP):c.1696-8T>C	VCP		Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia	Likely benign(Last reviewed: Nov 23, 2021)	criteria provided, single submitter	VCV001591848	9	35059806	9	35059809	1591848	1577964		NC_000009.12:35059808:A:G
NM_007126.5(VCP):c.1483-20C>T	VCP		Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia	Likely benign(Last reviewed: Jul 13, 2021)	criteria provided, single submitter	VCV001588222	9	35060542	9	35060545	1588222	1574765		NC_000009.12:35060544:G:A
NM_007126.5(VCP):c.1360-5T>C	VCP		Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia	Likely benign(Last reviewed: Oct 31, 2021)	criteria provided, single submitter	VCV001584759	9	35060925	9	35060928	1584759	1560910		NC_000009.12:35060927:A:G
NM_007126.5(VCP):c.418C>T (p.Leu140=)	VCP		Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia	Likely benign(Last reviewed: Sep 18, 2021)	criteria provided, single submitter	VCV001584232	9	35066699	9	35066702	1584232	1581490		NC_000009.12:35066701:G:A
NM_007126.5(VCP):c.446-15T>C	VCP		Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia	Likely benign(Last reviewed: Oct 6, 2021)	criteria provided, single submitter	VCV001580964	9	35065393	9	35065396	1580964	1566091		NC_000009.12:35065395:A:G
NM_007126.5(VCP):c.192A>G (p.Arg64=)	VCP		Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia	Likely benign(Last reviewed: Sep 3, 2021)	criteria provided, single submitter	VCV001580470	9	35067998	9	35068001	1580470	1653292		NC_000009.12:35068000:T:C
NM_007126.5(VCP):c.946-15A>T	VCP		Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia	Likely benign(Last reviewed: Aug 16, 2021)	criteria provided, single submitter	VCV001574552	9	35062150	9	35062153	1574552	1659737		NC_000009.12:35062152:T:A
NM_007126.5(VCP):c.330C>T (p.Tyr110=)	VCP		Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia	Likely benign(Last reviewed: Sep 8, 2021)	criteria provided, single submitter	VCV001565881	9	35066787	9	35066790	1565881	1590470		NC_000009.12:35066789:G:A
NM_007126.5(VCP):c.1566T>C (p.Cys522=)	VCP		Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia	Likely benign(Last reviewed: Dec 25, 2020)	criteria provided, single submitter	VCV001565880	9	35060439	9	35060442	1565880	1590469		NC_000009.12:35060441:A:G
NM_007126.5(VCP):c.302+2TG[3]	VCP		Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia	Likely benign(Last reviewed: Nov 16, 2021)	criteria provided, single submitter	VCV001565616	9	35067879 - 35067880	9	35067882 - 35067883	1565616	1590206		NC_000009.12:35067881:CACACACAC:CACACAC
NM_007126.5(VCP):c.302+12G>A	VCP		Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia	Likely benign(Last reviewed: Jun 15, 2021)	criteria provided, single submitter	VCV001564892	9	35067876	9	35067879	1564892	1567846		NC_000009.12:35067878:C:T
NM_007126.5(VCP):c.577-15C>T	VCP		Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia	Likely benign(Last reviewed: Nov 17, 2021)	criteria provided, single submitter	VCV001564821	9	35064297	9	35064300	1564821	1567775		NC_000009.12:35064299:G:A
NM_007126.5(VCP):c.1695+11A>G	VCP		Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia	Likely benign(Last reviewed: Oct 14, 2021)	criteria provided, single submitter	VCV001564078	9	35060299	9	35060302	1564078	1589099		NC_000009.12:35060301:T:C
NM_007126.5(VCP):c.129+11G>C	VCP		Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia	Likely benign(Last reviewed: Jul 28, 2021)	criteria provided, single submitter	VCV001563922	9	35068237	9	35068240	1563922	1588943		NC_000009.12:35068239:C:G
NM_007126.5(VCP):c.446-16C>T	VCP		Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia	Likely benign(Last reviewed: Oct 8, 2021)	criteria provided, single submitter	VCV001563648	9	35065394	9	35065397	1563648	1620152		NC_000009.12:35065396:G:A
NM_007126.5(VCP):c.1332T>C (p.Ser444=)	VCP		Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia	Likely benign(Last reviewed: Nov 28, 2021)	criteria provided, single submitter	VCV001560570	9	35061039	9	35061042	1560570	1576061		NC_000009.12:35061041:A:G
NM_007126.5(VCP):c.129+12C>T	VCP		Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia	Likely benign(Last reviewed: Dec 15, 2021)	criteria provided, single submitter	VCV001559942	9	35068236	9	35068239	1559942	1542532		NC_000009.12:35068238:G:A
NM_007126.5(VCP):c.366A>G (p.Thr122=)	VCP		Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia	Likely benign(Last reviewed: Apr 21, 2021)	criteria provided, single submitter	VCV001550945	9	35066751	9	35066754	1550945	1637982		NC_000009.12:35066753:T:C
NM_007126.5(VCP):c.708+14G>T	VCP		Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia	Likely benign(Last reviewed: Dec 2, 2021)	criteria provided, single submitter	VCV001547285	9	35064137	9	35064140	1547285	1571828		NC_000009.12:35064139:C:A
NM_007126.5(VCP):c.577-9C>T	VCP		Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia	Likely benign(Last reviewed: Oct 19, 2021)	criteria provided, single submitter	VCV001546918	9	35064291	9	35064294	1546918	1645894		NC_000009.12:35064293:G:A
NM_007126.5(VCP):c.792C>T (p.Ala264=)	VCP		Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia	Likely benign(Last reviewed: Oct 10, 2021)	criteria provided, single submitter	VCV001546468	9	35062994	9	35062997	1546468	1526317		NC_000009.12:35062996:G:A
NM_007126.5(VCP):c.312A>G (p.Pro104=)	VCP		Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia	Likely benign(Last reviewed: Oct 23, 2021)	criteria provided, single submitter	VCV001544115	9	35066805	9	35066808	1544115	1611653		NC_000009.12:35066807:T:C
NM_007126.5(VCP):c.702T>C (p.Gly234=)	VCP		Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia	Likely benign(Last reviewed: Nov 4, 2021)	criteria provided, single submitter	VCV001542199	9	35064157	9	35064160	1542199	1545953		NC_000009.12:35064159:A:G
NM_007126.5(VCP):c.129+16A>T	VCP		Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia	Likely benign(Last reviewed: Sep 15, 2021)	criteria provided, single submitter	VCV001541960	9	35068232	9	35068235	1541960	1545714		NC_000009.12:35068234:T:A
NM_007126.5(VCP):c.1482+18A>G	VCP		Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia	Benign(Last reviewed: Dec 10, 2021)	criteria provided, single submitter	VCV001539857	9	35060780	9	35060783	1539857	1630175		NC_000009.12:35060782:T:C
NM_007126.5(VCP):c.946-17dup	VCP		Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia	Likely benign(Last reviewed: Mar 9, 2021)	criteria provided, single submitter	VCV001539226	9	35062151 - 35062152	9	35062154 - 35062155	1539226	1650641		NC_000009.12:35062154:T:TT
NM_007126.5(VCP):c.446-11T>G	VCP		Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia	Likely benign(Last reviewed: Sep 21, 2021)	criteria provided, single submitter	VCV001538077	9	35065389	9	35065392	1538077	1619303		NC_000009.12:35065391:A:C
NM_007126.5(VCP):c.1360-12C>T	VCP		Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia	Likely benign(Last reviewed: Aug 9, 2021)	criteria provided, single submitter	VCV001533636	9	35060932	9	35060935	1533636	1584126		NC_000009.12:35060934:G:A
NM_007126.5(VCP):c.2161-4A>G	VCP		Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia	Likely benign(Last reviewed: Jul 15, 2021)	criteria provided, single submitter	VCV001531243	9	35057531	9	35057534	1531243	1604661		NC_000009.12:35057533:T:C
NM_007126.5(VCP):c.87T>C (p.Asp29=)	VCP		Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia	Likely benign(Last reviewed: Jul 21, 2021)	criteria provided, single submitter	VCV001531135	9	35068290	9	35068293	1531135	1604553		NC_000009.12:35068292:A:G
NM_007126.5(VCP):c.1696-34_1716dup	VCP		Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia	Uncertain significance(Last reviewed: Aug 26, 2021)	criteria provided, single submitter	VCV001523242	9	35059777 - 35059778	9	35059780 - 35059781	1523242	1350411		
NM_007126.5(VCP):c.284G>A (p.Arg95His)	VCP	R50H, R95H	Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia	Likely pathogenic(Last reviewed: Aug 31, 2021)	criteria provided, single submitter	VCV001513178	9	35067906	9	35067909	1513178	1472233		NC_000009.12:35067908:C:T
NM_007126.5(VCP):c.1482+4G>A	VCP		Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia	Uncertain significance(Last reviewed: Nov 15, 2021)	criteria provided, single submitter	VCV001513065	9	35060794	9	35060797	1513065	1381156		NC_000009.12:35060796:C:T
NM_007126.5(VCP):c.1837A>G (p.Thr613Ala)	VCP	T613A, T568A	Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia	Uncertain significance(Last reviewed: Aug 3, 2021)	criteria provided, single submitter	VCV001509783	9	35059657	9	35059660	1509783	1445702		NC_000009.12:35059659:T:C
NM_007126.5(VCP):c.810T>C (p.Asn270=)	VCP		Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia	Uncertain significance(Last reviewed: Oct 31, 2021)	criteria provided, single submitter	VCV001502791	9	35062976	9	35062979	1502791	1404384		NC_000009.12:35062978:A:G
NM_007126.5(VCP):c.946-8T>A	VCP		Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia	Uncertain significance(Last reviewed: Sep 1, 2021)	criteria provided, single submitter	VCV001499978	9	35062143	9	35062146	1499978	1385798		NC_000009.12:35062145:A:T
NM_007126.5(VCP):c.1202A>T (p.Asn401Ile)	VCP	N356I, N401I	Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia	Uncertain significance(Last reviewed: Sep 2, 2021)	criteria provided, single submitter	VCV001497171	9	35061169	9	35061172	1497171	1475792		NC_000009.12:35061171:T:A
NM_007126.5(VCP):c.273C>A (p.Asn91Lys)	VCP	N46K, N91K	Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia	Uncertain significance(Last reviewed: Sep 1, 2021)	criteria provided, single submitter	VCV001496153	9	35067917	9	35067920	1496153	1363068		NC_000009.12:35067919:G:T
NM_007126.5(VCP):c.1402G>A (p.Val468Met)	VCP	V468M, V423M	Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia	Uncertain significance(Last reviewed: Nov 22, 2021)	criteria provided, single submitter	VCV001479926	9	35060878	9	35060881	1479926	1364596		NC_000009.12:35060880:C:T
NM_007126.5(VCP):c.1283A>T (p.Asp428Val)	VCP	D383V, D428V	Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia	Uncertain significance(Last reviewed: Aug 31, 2021)	criteria provided, single submitter	VCV001472483	9	35061088	9	35061091	1472483	1397865		NC_000009.12:35061090:T:A
NM_007126.5(VCP):c.1993C>T (p.Pro665Ser)	VCP	P620S, P665S	Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia	Uncertain significance(Last reviewed: Aug 27, 2021)	criteria provided, single submitter	VCV001470708	9	35059501	9	35059504	1470708	1394935		NC_000009.12:35059503:G:A
NM_007126.5(VCP):c.1265C>G (p.Ala422Gly)	VCP	A422G, A377G	Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia	Uncertain significance(Last reviewed: Nov 8, 2021)	criteria provided, single submitter	VCV001466584	9	35061106	9	35061109	1466584	1347942		NC_000009.12:35061108:G:C
NM_007126.5(VCP):c.1521C>T (p.Gly507=)	VCP		Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia	Uncertain significance(Last reviewed: Dec 15, 2021)	criteria provided, single submitter	VCV001461605	9	35060484	9	35060487	1461605	1494548		NC_000009.12:35060486:G:A
NM_007126.5(VCP):c.463C>A (p.Arg155Ser)	VCP	R155S, R110S	Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia	Pathogenic(Last reviewed: Sep 1, 2021)	criteria provided, single submitter	VCV001457380	9	35065361	9	35065364	1457380	1393321		NC_000009.12:35065363:G:T
NM_007126.5(VCP):c.469G>A (p.Gly157Arg)	VCP	G112R, G157R	Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia	Pathogenic(Last reviewed: Oct 15, 2021)	criteria provided, single submitter	VCV001457379	9	35065355	9	35065358	1457379	1393320		NC_000009.12:35065357:C:T
NM_007126.5(VCP):c.472A>G (p.Met158Val)	VCP	M158V, M113V	Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia	Pathogenic(Last reviewed: Aug 11, 2021)	criteria provided, single submitter	VCV001457378	9	35065352	9	35065355	1457378	1393319		NC_000009.12:35065354:T:C
NM_007126.5(VCP):c.73C>T (p.Arg25Trp)	VCP	R25W	Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia	Uncertain significance(Last reviewed: Aug 26, 2021)	criteria provided, single submitter	VCV001436607	9	35068304	9	35068307	1436607	1340998		NC_000009.12:35068306:G:A
NM_007126.5(VCP):c.1790C>T (p.Ala597Val)	VCP	A552V, A597V	Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia	Uncertain significance(Last reviewed: Aug 27, 2021)	criteria provided, single submitter	VCV001431328	9	35059704	9	35059707	1431328	1490627		NC_000009.12:35059706:G:A
NM_007126.5(VCP):c.82G>A (p.Val28Ile)	VCP	V28I	Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia	Uncertain significance(Last reviewed: Nov 23, 2021)	criteria provided, single submitter	VCV001427125	9	35068295	9	35068298	1427125	1444527		NC_000009.12:35068297:C:T
NM_007126.5(VCP):c.1294C>G (p.Leu432Val)	VCP	L432V, L387V	Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia	Uncertain significance(Last reviewed: Oct 3, 2021)	criteria provided, single submitter	VCV001426610	9	35061077	9	35061080	1426610	1366283		NC_000009.12:35061079:G:C
NM_007126.5(VCP):c.811+5G>C	VCP		Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia	Uncertain significance(Last reviewed: Mar 4, 2021)	criteria provided, single submitter	VCV001411582	9	35062970	9	35062973	1411582	1448031		NC_000009.12:35062972:C:G
NM_007126.5(VCP):c.1162A>G (p.Met388Val)	VCP	M388V, M343V	Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia	Uncertain significance(Last reviewed: Aug 28, 2021)	criteria provided, single submitter	VCV001404434	9	35061606	9	35061609	1404434	1480130		NC_000009.12:35061608:T:C
NM_007126.5(VCP):c.273C>G (p.Asn91Lys)	VCP	N46K, N91K	Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia	Uncertain significance(Last reviewed: Oct 26, 2021)	criteria provided, single submitter	VCV001403085	9	35067917	9	35067920	1403085	1392697		NC_000009.12:35067919:G:C
NM_007126.5(VCP):c.367G>A (p.Val123Met)	VCP	V78M, V123M	Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia	Uncertain significance(Last reviewed: Aug 28, 2021)	criteria provided, single submitter	VCV001395756	9	35066750	9	35066753	1395756	1425155		NC_000009.12:35066752:C:T
NM_007126.5(VCP):c.62A>G (p.Asn21Ser)	VCP	N21S	Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia	Uncertain significance(Last reviewed: Aug 30, 2021)	criteria provided, single submitter	VCV001394525	9	35068315	9	35068318	1394525	1338547		NC_000009.12:35068317:T:C
NM_007126.5(VCP):c.677A>T (p.His226Leu)	VCP	H226L, H181L	Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia	Uncertain significance(Last reviewed: Nov 4, 2021)	criteria provided, single submitter	VCV001391195	9	35064182	9	35064185	1391195	1389875		NC_000009.12:35064184:T:A
NM_007126.5(VCP):c.1985G>A (p.Arg662His)	VCP	R617H, R662H	Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia	Uncertain significance(Last reviewed: Nov 23, 2021)	criteria provided, single submitter	VCV001390232	9	35059509	9	35059512	1390232	1373831		NC_000009.12:35059511:C:T
NM_007126.5(VCP):c.1211A>C (p.His404Pro)	VCP	H404P, H359P	Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia	Uncertain significance(Last reviewed: Aug 26, 2021)	criteria provided, single submitter	VCV001387478	9	35061160	9	35061163	1387478	1474203		NC_000009.12:35061162:T:G
NM_007126.5(VCP):c.233C>G (p.Ser78Cys)	VCP	S78C, S33C	Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia	Uncertain significance(Last reviewed: Dec 1, 2021)	criteria provided, single submitter	VCV001385111	9	35067957	9	35067960	1385111	1367857		NC_000009.12:35067959:G:C
NM_007126.5(VCP):c.451A>G (p.Ile151Val)	VCP	I151V, I106V	Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia	Uncertain significance(Last reviewed: Jul 13, 2021)	criteria provided, single submitter	VCV001382557	9	35065373	9	35065376	1382557	1513031		NC_000009.12:35065375:T:C
NM_007126.5(VCP):c.1459C>T (p.Arg487Cys)	VCP	R442C, R487C	Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia	Uncertain significance(Last reviewed: Nov 14, 2021)	criteria provided, single submitter	VCV001360978	9	35060821	9	35060824	1360978	1360544		NC_000009.12:35060823:G:A
NM_007126.5(VCP):c.365C>T (p.Thr122Ile)	VCP	T122I, T77I	Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia	Uncertain significance(Last reviewed: Aug 27, 2021)	criteria provided, single submitter	VCV001360048	9	35066752	9	35066755	1360048	1473921		NC_000009.12:35066754:G:A
NM_007126.5(VCP):c.1768A>G (p.Ile590Val)	VCP	I590V, I545V	Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia	Uncertain significance(Last reviewed: Sep 1, 2021)	criteria provided, single submitter	VCV001359439	9	35059726	9	35059729	1359439	1370619		NC_000009.12:35059728:T:C
NM_007126.5(VCP):c.310C>T (p.Pro104Ser)	VCP	P59S, P104S	Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia	Uncertain significance(Last reviewed: Aug 30, 2021)	criteria provided, single submitter	VCV001357446	9	35066807	9	35066810	1357446	1345420		NC_000009.12:35066809:G:A
NM_007126.5(VCP):c.2233C>T (p.Arg745Cys)	VCP	R700C, R745C	Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia	Uncertain significance(Last reviewed: Oct 28, 2021)	criteria provided, single submitter	VCV001349844	9	35057455	9	35057458	1349844	1472667		NC_000009.12:35057457:G:A
NM_007126.5(VCP):c.1186C>G (p.Leu396Val)	VCP	L396V, L351V	Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia	Uncertain significance(Last reviewed: Sep 1, 2021)	criteria provided, single submitter	VCV001348994	9	35061582	9	35061585	1348994	1479005		NC_000009.12:35061584:G:C
NM_007126.5(VCP):c.1357C>T (p.Arg453Trp)	VCP	R408W, R453W	Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia|not provided	Uncertain significance(Last reviewed: Dec 13, 2021)	criteria provided, multiple submitters, no conflicts	VCV001313226	9	35061014	9	35061017	1313226	1303487		NC_000009.12:35061016:G:A
NM_007126.5(VCP):c.446-17A>G	VCP		Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|not provided	Likely benign(Last reviewed: Sep 2, 2021)	criteria provided, single submitter	VCV001284707	9	35065395	9	35065398	1284707	1274559		NC_000009.12:35065397:T:C
NM_007126.5(VCP):c.2193C>T (p.Ile731=)	VCP		Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia	Benign(Last reviewed: Oct 23, 2019)	criteria provided, single submitter	VCV001169485	9	35057495	9	35057498	1169485	1156213		NC_000009.12:35057497:G:A
NM_007126.5(VCP):c.465T>G (p.Arg155=)	VCP		Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia	Benign(Last reviewed: Oct 7, 2019)	criteria provided, single submitter	VCV001167708	9	35065359	9	35065362	1167708	1156215		NC_000009.12:35065361:A:C
NM_007126.5(VCP):c.2229G>A (p.Ala743=)	VCP		Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia	Benign(Last reviewed: Aug 14, 2020)	criteria provided, single submitter	VCV001167285	9	35057459	9	35057462	1167285	1156212		NC_000009.12:35057461:C:T
NM_007126.5(VCP):c.1407A>G (p.Val469=)	VCP		Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia	Benign(Last reviewed: Nov 19, 2020)	criteria provided, single submitter	VCV001167035	9	35060873	9	35060876	1167035	1156214		NC_000009.12:35060875:T:C
NM_007126.5(VCP):c.54A>G (p.Lys18=)	VCP		Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia	Benign(Last reviewed: Sep 29, 2020)	criteria provided, single submitter	VCV001164584	9	35068323	9	35068326	1164584	1156216		NC_000009.12:35068325:T:C
NM_007126.5(VCP):c.804G>A (p.Leu268=)	VCP		Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia	Likely benign(Last reviewed: Mar 2, 2020)	criteria provided, single submitter	VCV001162132	9	35062982	9	35062985	1162132	1140515		NC_000009.12:35062984:C:T
NM_007126.5(VCP):c.2197C>A (p.Arg733=)	VCP		Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia	Likely benign(Last reviewed: Oct 18, 2020)	criteria provided, single submitter	VCV001160158	9	35057491	9	35057494	1160158	1140511		NC_000009.12:35057493:G:T
NM_007126.5(VCP):c.1437C>T (p.Ile479=)	VCP		Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia	Likely benign(Last reviewed: Sep 18, 2019)	criteria provided, single submitter	VCV001153191	9	35060843	9	35060846	1153191	1140513		NC_000009.12:35060845:G:A
NM_007126.5(VCP):c.1696-5dup	VCP		Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia	Likely benign(Last reviewed: Jan 3, 2020)	criteria provided, single submitter	VCV001149313	9	35059802 - 35059803	9	35059805 - 35059806	1149313	1140512		NC_000009.12:35059805:A:AA
NM_007126.5(VCP):c.147G>A (p.Leu49=)	VCP		Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia	Likely benign(Last reviewed: Jan 15, 2020)	criteria provided, single submitter	VCV001149179	9	35068043	9	35068046	1149179	1140516		NC_000009.12:35068045:C:T
NM_007126.5(VCP):c.897C>G (p.Ala299=)	VCP		Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia	Likely benign(Last reviewed: Sep 9, 2020)	criteria provided, single submitter	VCV001145804	9	35062262	9	35062265	1145804	1140514		NC_000009.12:35062264:G:C
NM_007126.5(VCP):c.1360-9C>T	VCP		Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia	Likely benign(Last reviewed: Jun 7, 2020)	criteria provided, single submitter	VCV001141057	9	35060929	9	35060932	1141057	1119689		NC_000009.12:35060931:G:A
NM_007126.5(VCP):c.975A>G (p.Val325=)	VCP		Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia	Likely benign(Last reviewed: Oct 19, 2019)	criteria provided, single submitter	VCV001133903	9	35062106	9	35062109	1133903	1119691		NC_000009.12:35062108:T:C
NM_007126.5(VCP):c.1081+8C>T	VCP		Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia	Likely benign(Last reviewed: Dec 17, 2019)	criteria provided, single submitter	VCV001131632	9	35061992	9	35061995	1131632	1119690		NC_000009.12:35061994:G:A
NM_007126.5(VCP):c.349C>T (p.Leu117=)	VCP		Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia	Likely benign(Last reviewed: May 12, 2020)	criteria provided, single submitter	VCV001126709	9	35066768	9	35066771	1126709	1119693		NC_000009.12:35066770:G:A
NM_007126.5(VCP):c.2223C>T (p.Arg741=)	VCP		Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia	Likely benign(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV001124905	9	35057465	9	35057468	1124905	1119687		NC_000009.12:35057467:G:A
NM_007126.5(VCP):c.711T>G (p.Pro237=)	VCP		Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia	Likely benign(Last reviewed: Jul 22, 2020)	criteria provided, single submitter	VCV001123267	9	35063075	9	35063078	1123267	1119692		NC_000009.12:35063077:A:C
NM_007126.5(VCP):c.2161-5T>C	VCP		Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia	Likely benign(Last reviewed: Feb 22, 2020)	criteria provided, single submitter	VCV001121489	9	35057532	9	35057535	1121489	1119688		NC_000009.12:35057534:A:G
NM_007126.5(VCP):c.675A>G (p.Arg225=)	VCP		Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia	Likely benign(Last reviewed: Mar 26, 2019)	criteria provided, single submitter	VCV001109941	9	35064184	9	35064187	1109941	1098114		NC_000009.12:35064186:T:C
NM_007126.5(VCP):c.351G>T (p.Leu117=)	VCP		Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia	Likely benign(Last reviewed: Jan 27, 2019)	criteria provided, single submitter	VCV001109164	9	35066766	9	35066769	1109164	1098116		NC_000009.12:35066768:C:A
NM_007126.5(VCP):c.2316-8G>A	VCP		Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia	Likely benign(Last reviewed: Feb 15, 2020)	criteria provided, single submitter	VCV001106973	9	35057227	9	35057230	1106973	1098111		NC_000009.12:35057229:C:T
NM_007126.5(VCP):c.1776T>C (p.Asp592=)	VCP		Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia	Likely benign(Last reviewed: Feb 27, 2020)	criteria provided, single submitter	VCV001106594	9	35059718	9	35059721	1106594	1098112		NC_000009.12:35059720:A:G
NM_007126.5(VCP):c.577-15C>G	VCP		Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia	Likely benign(Last reviewed: Oct 21, 2020)	criteria provided, single submitter	VCV001101373	9	35064297	9	35064300	1101373	1098115		NC_000009.12:35064299:G:C
NM_007126.5(VCP):c.1474C>T (p.Leu492=)	VCP		Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia	Likely benign(Last reviewed: Feb 6, 2020)	criteria provided, single submitter	VCV001100637	9	35060806	9	35060809	1100637	1098113		NC_000009.12:35060808:G:A
NM_007126.5(VCP):c.2109C>T (p.Ile703=)	VCP		Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia|not provided	Likely benign(Last reviewed: Jul 5, 2019)	criteria provided, single submitter	VCV001096276	9	35059112	9	35059115	1096276	1076437		NC_000009.12:35059114:G:A
NM_007126.5(VCP):c.1839A>C (p.Thr613=)	VCP		Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia	Likely benign(Last reviewed: Jan 27, 2020)	criteria provided, single submitter	VCV001092902	9	35059655	9	35059658	1092902	1076438		NC_000009.12:35059657:T:G
NM_007126.5(VCP):c.120C>T (p.Ser40=)	VCP		Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia	Likely benign(Last reviewed: Jun 7, 2020)	criteria provided, single submitter	VCV001090775	9	35068257	9	35068260	1090775	1076444		NC_000009.12:35068259:G:A
NM_007126.5(VCP):c.1611C>G (p.Ala537=)	VCP		Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia	Likely benign(Last reviewed: Jun 8, 2020)	criteria provided, single submitter	VCV001089780	9	35060394	9	35060397	1089780	1076439		NC_000009.12:35060396:G:C
NM_007126.5(VCP):c.210C>T (p.Ile70=)	VCP		Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia	Likely benign(Last reviewed: Aug 14, 2020)	criteria provided, single submitter	VCV001089398	9	35067980	9	35067983	1089398	1076442		NC_000009.12:35067982:G:A
NM_007126.5(VCP):c.446-5C>T	VCP		Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia	Likely benign(Last reviewed: Nov 24, 2020)	criteria provided, single submitter	VCV001079222	9	35065383	9	35065386	1079222	1076441		NC_000009.12:35065385:G:A
NM_007126.5(VCP):c.168A>C (p.Thr56=)	VCP		Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia	Likely benign(Last reviewed: Sep 29, 2019)	criteria provided, single submitter	VCV001078388	9	35068022	9	35068025	1078388	1076443		NC_000009.12:35068024:T:G
NM_007126.5(VCP):c.664C>T (p.Leu222=)	VCP		Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia	Likely benign(Last reviewed: Nov 25, 2019)	criteria provided, single submitter	VCV001077761	9	35064195	9	35064198	1077761	1076440		NC_000009.12:35064197:G:A
NM_007126.5(VCP):c.2345G>T (p.Gly782Val)	VCP	G737V, G782V	Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia	Uncertain significance(Last reviewed: Oct 1, 2020)	criteria provided, single submitter	VCV001058517	9	35057190	9	35057193	1058517	1046162		NC_000009.12:35057192:C:A
NM_007126.5(VCP):c.512G>A (p.Ser171Asn)	VCP	S126N, S171N	Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia	Uncertain significance(Last reviewed: May 14, 2020)	criteria provided, single submitter	VCV001053574	9	35065312	9	35065315	1053574	1046163		NC_000009.12:35065314:C:T
NM_007126.5(VCP):c.130-3C>T	VCP		Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia	Uncertain significance(Last reviewed: Mar 5, 2020)	criteria provided, single submitter	VCV001045485	9	35068063	9	35068066	1045485	1029190	rs767838037	NC_000009.12:35068065:G:A
NM_007126.5(VCP):c.331G>A (p.Gly111Ser)	VCP	G66S, G111S	Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia	Uncertain significance(Last reviewed: Sep 1, 2020)	criteria provided, single submitter	VCV001043684	9	35066786	9	35066789	1043684	1029189	rs752038734	NC_000009.12:35066788:C:T
NM_007126.5(VCP):c.1318G>A (p.Glu440Lys)	VCP	E395K, E440K	Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia	Uncertain significance(Last reviewed: Jul 9, 2020)	criteria provided, single submitter	VCV001039996	9	35061053	9	35061056	1039996	1029187	rs955652521	NC_000009.12:35061055:C:T
NM_007126.5(VCP):c.2126G>A (p.Arg709Gln)	VCP	R709Q, R664Q	Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia	Uncertain significance(Last reviewed: Oct 16, 2020)	criteria provided, single submitter	VCV001039720	9	35059095	9	35059098	1039720	1029186	rs746617777	NC_000009.12:35059097:C:T
NM_007126.5(VCP):c.577-2A>G	VCP		Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia	Uncertain significance(Last reviewed: Feb 27, 2020)	criteria provided, single submitter	VCV001038018	9	35064284	9	35064287	1038018	1029188	rs1828784075	NC_000009.12:35064286:T:C
NM_007126.5(VCP):c.268A>G (p.Asn90Asp)	VCP	N45D, N90D	Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia	Uncertain significance(Last reviewed: Aug 19, 2020)	criteria provided, single submitter	VCV001024805	9	35067922	9	35067925	1024805	1008633	rs1828865209	NC_000009.12:35067924:T:C
NM_007126.5(VCP):c.1144C>G (p.Gln382Glu)	VCP	Q337E, Q382E	Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia	Uncertain significance(Last reviewed: Oct 26, 2020)	criteria provided, single submitter	VCV001022767	9	35061624	9	35061627	1022767	1008631	rs1828722725	NC_000009.12:35061626:G:C
NM_007126.5(VCP):c.94A>G (p.Ile32Val)	VCP	I32V	Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia	Uncertain significance(Last reviewed: Aug 25, 2020)	criteria provided, single submitter	VCV001019616	9	35068283	9	35068286	1019616	1008635	rs1828872947	NC_000009.12:35068285:T:C
NM_007126.5(VCP):c.237T>A (p.Asp79Glu)	VCP	D34E, D79E	Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia	Uncertain significance(Last reviewed: Feb 28, 2020)	criteria provided, single submitter	VCV001014881	9	35067953	9	35067956	1014881	1008634	rs746810092	NC_000009.12:35067955:A:T
NM_007126.5(VCP):c.460G>T (p.Val154Phe)	VCP	V109F, V154F	Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia	Uncertain significance(Last reviewed: Aug 23, 2020)	criteria provided, single submitter	VCV001013993	9	35065364	9	35065367	1013993	1008632	rs1587127201	NC_000009.12:35065366:C:A
NM_007126.5(VCP):c.265C>T (p.Arg89Trp)	VCP	R44W, R89W	Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia	Uncertain significance(Last reviewed: May 12, 2020)	criteria provided, single submitter	VCV001010487	9	35067925	9	35067928	1010487	993443	rs1828865320	NC_000009.12:35067927:G:A
NM_007126.5(VCP):c.401A>G (p.Tyr134Cys)	VCP	Y134C, Y89C	Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia	Uncertain significance(Last reviewed: Oct 13, 2020)	criteria provided, single submitter	VCV001000668	9	35066716	9	35066719	1000668	993442	rs1828840466	NC_000009.12:35066718:T:C
NM_007126.5(VCP):c.294T>A (p.Asp98Glu)	VCP	D53E, D98E	Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1	Likely pathogenic(Last reviewed: May 31, 2019)	criteria provided, single submitter	VCV000976025	9	35067896	9	35067899	976025	964331	rs1828864269	NC_000009.12:35067898:A:T
NM_007126.5(VCP):c.1864G>T (p.Ala622Ser)	VCP	A577S, A622S	Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia	Uncertain significance(Last reviewed: Oct 25, 2019)	criteria provided, single submitter	VCV000972527	9	35059630	9	35059633	972527	955812	rs1828681453	NC_000009.12:35059632:C:A
NM_007126.5(VCP):c.2132G>A (p.Arg711Gln)	VCP	R666Q, R711Q	Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia	Uncertain significance(Last reviewed: Oct 2, 2019)	criteria provided, single submitter	VCV000966733	9	35059089	9	35059092	966733	955811	rs779670266	NC_000009.12:35059091:C:T
NM_007126.5(VCP):c.1106T>C (p.Ile369Thr)	VCP	I369T, I324T	not provided|Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia	Uncertain significance(Last reviewed: Jan 6, 2020)	criteria provided, multiple submitters, no conflicts	VCV000963526	9	35061662	9	35061665	963526	946601	rs1828723406	NC_000009.12:35061664:A:G
NM_007126.5(VCP):c.1324A>G (p.Met442Val)	VCP	M397V, M442V	Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia	Uncertain significance(Last reviewed: Nov 5, 2019)	criteria provided, single submitter	VCV000961078	9	35061047	9	35061050	961078	946600	rs1828712085	NC_000009.12:35061049:T:C
NM_007126.5(VCP):c.313T>C (p.Cys105Arg)	VCP	C105R, C60R	Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia	Uncertain significance(Last reviewed: Oct 14, 2019)	criteria provided, single submitter	VCV000960799	9	35066804	9	35066807	960799	946602	rs1828842736	NC_000009.12:35066806:A:G
NM_007126.5(VCP):c.2194C>T (p.Arg732Cys)	VCP	R687C, R732C	Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia	Uncertain significance(Last reviewed: May 24, 2019)	criteria provided, single submitter	VCV000952496	9	35057494	9	35057497	952496	925568	rs758602597	NC_000009.12:35057496:G:A
NM_007126.5(VCP):c.767G>A (p.Arg256Gln)	VCP	R256Q, R211Q	Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia	Uncertain significance(Last reviewed: Apr 11, 2019)	criteria provided, single submitter	VCV000946240	9	35063019	9	35063022	946240	925569	rs1828757317	NC_000009.12:35063021:C:T
NM_007126.5(VCP):c.453T>G (p.Ile151Met)	VCP	I151M, I106M	Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia	Uncertain significance(Last reviewed: Jul 24, 2019)	criteria provided, single submitter	VCV000942825	9	35065371	9	35065374	942825	934749	rs1828808459	NC_000009.12:35065373:A:C
NM_007126.5(VCP):c.523A>G (p.Ile175Val)	VCP	I130V, I175V	Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia	Uncertain significance(Last reviewed: Jun 18, 2019)	criteria provided, single submitter	VCV000942537	9	35065301	9	35065304	942537	934748	rs1828806031	NC_000009.12:35065303:T:C
NM_007126.5(VCP):c.377T>G (p.Ile126Ser)	VCP	I126S, I81S	Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia	Uncertain significance(Last reviewed: Sep 9, 2019)	criteria provided, single submitter	VCV000942237	9	35066740	9	35066743	942237	934750	rs1828841085	NC_000009.12:35066742:A:C
NM_007126.5(VCP):c.2242A>T (p.Ser748Cys)	VCP	S748C, S703C	Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia	Uncertain significance(Last reviewed: Sep 19, 2019)	criteria provided, single submitter	VCV000940463	9	35057446	9	35057449	940463	934747	rs1828632660	NC_000009.12:35057448:T:A
NM_007126.5(VCP):c.30T>A (p.Asp10Glu)	VCP	D10E	Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1	Uncertain significance(Last reviewed: Jun 10, 2019)	criteria provided, single submitter	VCV000931551	9	35068347	9	35068350	931551	919228	rs1828874096	NC_000009.12:35068349:A:T
NM_007126.5(VCP):c.130-9T>C	VCP		Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000914689	9	35068069	9	35068072	914689	903400	rs1828868223	NC_000009.12:35068071:A:G
NM_007126.5(VCP):c.1293C>T (p.Asp431=)	VCP		Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000914650	9	35061078	9	35061081	914650	901970	rs1828712869	NC_000009.12:35061080:G:A
NM_007126.5(VCP):c.*216G>A	VCP		Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000914611	9	35056898	9	35056901	914611	901966	rs567542622	NC_000009.12:35056900:C:T
NM_007126.5(VCP):c.*217G>T	VCP		Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000914610	9	35056897	9	35056900	914610	901965	rs981870646	NC_000009.12:35056899:C:A
NM_007126.5(VCP):c.335A>G (p.Lys112Arg)	VCP	K112R, K67R	Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000914194	9	35066782	9	35066785	914194	901975	rs766787045	NC_000009.12:35066784:T:C
NM_007126.5(VCP):c.384T>C (p.Gly128=)	VCP		Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia	Conflicting interpretations of pathogenicity(Last reviewed: Nov 9, 2021)	criteria provided, conflicting interpretations	VCV000914193	9	35066733	9	35066736	914193	901974	rs367703031	NC_000009.12:35066735:A:G
NM_007126.5(VCP):c.446-4G>A	VCP		Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia	Conflicting interpretations of pathogenicity(Last reviewed: Oct 14, 2021)	criteria provided, conflicting interpretations	VCV000914192	9	35065382	9	35065385	914192	903399	rs370700002	NC_000009.12:35065384:C:T
NM_007126.5(VCP):c.591C>G (p.Ser197=)	VCP		Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000914191	9	35064268	9	35064271	914191	901973	rs866003333	NC_000009.12:35064270:G:C
NM_007126.5(VCP):c.*367G>A	VCP		Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000914100	9	35056747	9	35056750	914100	901964	rs768675930	NC_000009.12:35056749:C:T
NM_007126.5(VCP):c.697A>G (p.Ile233Val)	VCP	I188V, I233V	Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1|not provided	Uncertain significance(Last reviewed: Nov 20, 2020)	criteria provided, multiple submitters, no conflicts	VCV000913795	9	35064162	9	35064165	913795	901972	rs750335399	NC_000009.12:35064164:T:C
NM_007126.5(VCP):c.794T>C (p.Phe265Ser)	VCP	F265S, F220S	Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000913794	9	35062992	9	35062995	913794	901971	rs1828756507	NC_000009.12:35062994:A:G
NM_007126.5(VCP):c.*12C>T	VCP		Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1	Benign/Likely benign(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000913746	9	35057102	9	35057105	913746	901969	rs62544156	NC_000009.12:35057104:G:A
NM_007126.5(VCP):c.*15C>T	VCP		Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1	Benign/Likely benign(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000913745	9	35057099	9	35057102	913745	901968	rs762559031	NC_000009.12:35057101:G:A
NM_007126.5(VCP):c.*885G>A	VCP		Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000913703	9	35056229	9	35056232	913703	903397	rs925146670	NC_000009.12:35056231:C:T
NM_007126.5(VCP):c.812-7C>G	VCP		Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1|Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia	Benign/Likely benign(Last reviewed: Nov 7, 2021)	criteria provided, multiple submitters, no conflicts	VCV000912685	9	35062354	9	35062357	912685	903398	rs764429197	NC_000009.12:35062356:G:C
NM_007126.5(VCP):c.*63G>A	VCP		Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000912643	9	35057051	9	35057054	912643	901967	rs969638105	NC_000009.12:35057053:C:T
NM_007126.5(VCP):c.*1001C>T	VCP		Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia	Benign/Likely benign(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000912608	9	35056113	9	35056116	912608	903396	rs192556285	NC_000009.12:35056115:G:A
NM_007126.5(VCP):c.*1040T>C	VCP		Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000912607	9	35056074	9	35056077	912607	903395	rs188935092	NC_000009.12:35056076:A:G
NM_007126.5(VCP):c.41C>T (p.Thr14Ile)	VCP	T14I	not specified|Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1	Uncertain significance(Last reviewed: Mar 31, 2020)	criteria provided, multiple submitters, no conflicts	VCV000873235	9	35068336	9	35068339	873235	861363	rs1219381953	NC_000009.12:35068338:G:A
NM_007126.5(VCP):c.1996G>A (p.Val666Ile)	VCP	V621I, V666I	Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia	Uncertain significance(Last reviewed: Feb 10, 2019)	criteria provided, single submitter	VCV000847962	9	35059498	9	35059501	847962	836085	rs754268174	NC_000009.12:35059500:C:T
NM_007126.5(VCP):c.995T>C (p.Met332Thr)	VCP	M287T, M332T	Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia	Uncertain significance(Last reviewed: Feb 17, 2020)	criteria provided, single submitter	VCV000846874	9	35062086	9	35062089	846874	836086	rs1828737891	NC_000009.12:35062088:A:G
NM_007126.5(VCP):c.446-4_446-3delinsAT	VCP		Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia	Uncertain significance(Last reviewed: Apr 17, 2019)	criteria provided, single submitter	VCV000842949	9	35065381 - 35065382	9	35065384 - 35065385	842949	851337	rs1828808684	NC_000009.12:35065383:GC:AT
NM_007126.5(VCP):c.2228C>T (p.Ala743Val)	VCP	A698V, A743V	Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia	Uncertain significance(Last reviewed: Apr 6, 2020)	criteria provided, single submitter	VCV000837640	9	35057460	9	35057463	837640	836084	rs771662410	NC_000009.12:35057462:G:A
NM_007126.5(VCP):c.648A>G (p.Ile216Met)	VCP	I171M, I216M	Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia	Uncertain significance(Last reviewed: Aug 25, 2019)	criteria provided, single submitter	VCV000836876	9	35064211	9	35064214	836876	836087	rs1828783140	NC_000009.12:35064213:T:C
NM_007126.5(VCP):c.2345G>C (p.Gly782Ala)	VCP	G737A, G782A	Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia	Uncertain significance(Last reviewed: Dec 13, 2019)	criteria provided, single submitter	VCV000835129	9	35057190	9	35057193	835129	836083	rs1828626335	NC_000009.12:35057192:C:G
NM_007126.5(VCP):c.390C>G (p.Leu130=)	VCP		Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|not provided	Likely benign(Last reviewed: Dec 24, 2018)	criteria provided, single submitter	VCV000799309	9	35066727	9	35066730	799309	783401	rs1587128848	NC_000009.12:35066729:G:C
NM_007126.5(VCP):c.372A>G (p.Glu124=)	VCP		Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia|not provided	Likely benign(Last reviewed: Nov 29, 2018)	criteria provided, single submitter	VCV000795668	9	35066745	9	35066748	795668	783402	rs1587128887	NC_000009.12:35066747:T:C
NM_007126.5(VCP):c.519T>C (p.Tyr173=)	VCP		not provided|Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia	Likely benign(Last reviewed: Jun 19, 2021)	criteria provided, single submitter	VCV000795114	9	35065305	9	35065308	795114	783400	rs762659353	NC_000009.12:35065307:A:G
NM_007126.5(VCP):c.1696-4A>G	VCP		Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia	Likely benign(Last reviewed: Sep 24, 2020)	criteria provided, single submitter	VCV000790949	9	35059802	9	35059805	790949	779588	rs963637081	NC_000009.12:35059804:T:C
NM_007126.5(VCP):c.924C>T (p.Ala308=)	VCP		Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia	Likely benign(Last reviewed: Feb 14, 2020)	criteria provided, single submitter	VCV000767613	9	35062235	9	35062238	767613	700987	rs199504528	NC_000009.12:35062237:G:A
NM_007126.5(VCP):c.732C>T (p.Tyr244=)	VCP		not provided|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia	Conflicting interpretations of pathogenicity(Last reviewed: Jul 2, 2018)	criteria provided, conflicting interpretations	VCV000767349	9	35063054	9	35063057	767349	700988	rs201610567	NC_000009.12:35063056:G:A
NM_007126.5(VCP):c.1191A>G (p.Glu397=)	VCP		not provided|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia	Likely benign(Last reviewed: Dec 12, 2018)	criteria provided, single submitter	VCV000765862	9	35061577	9	35061580	765862	767389	rs1587122637	NC_000009.12:35061579:T:C
NM_007126.5(VCP):c.618T>C (p.Ile206=)	VCP		Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia|not provided	Likely benign(Last reviewed: Aug 16, 2018)	criteria provided, single submitter	VCV000765640	9	35064241	9	35064244	765640	767392	rs1471384169	NC_000009.12:35064243:A:G
NM_007126.5(VCP):c.1017A>T (p.Ala339=)	VCP		Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia|not provided	Likely benign(Last reviewed: Jun 13, 2018)	criteria provided, single submitter	VCV000765533	9	35062064	9	35062067	765533	767390	rs565534943	NC_000009.12:35062066:T:A
NM_007126.5(VCP):c.1371C>T (p.Ser457=)	VCP		Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia|not provided	Likely benign(Last reviewed: Oct 11, 2018)	criteria provided, single submitter	VCV000764681	9	35060909	9	35060912	764681	767388	rs747614057	NC_000009.12:35060911:G:A
NM_007126.5(VCP):c.709-4A>G	VCP		not provided|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia	Likely benign(Last reviewed: May 17, 2018)	criteria provided, single submitter	VCV000760866	9	35063081	9	35063084	760866	775389	rs1587124649	NC_000009.12:35063083:T:C
NM_007126.5(VCP):c.624C>T (p.Gly208=)	VCP		Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia	Likely benign(Last reviewed: Jul 11, 2019)	criteria provided, single submitter	VCV000753125	9	35064235	9	35064238	753125	767391	rs781273474	NC_000009.12:35064237:G:A
NM_007126.5(VCP):c.18-6T>A	VCP		Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia|not provided	Likely benign(Last reviewed: Aug 25, 2020)	criteria provided, single submitter	VCV000751037	9	35068365	9	35068368	751037	775544	rs1587130773	NC_000009.12:35068367:A:T
NM_007126.5(VCP):c.1401C>T (p.Thr467=)	VCP		Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia|not provided	Likely benign(Last reviewed: Jun 5, 2018)	criteria provided, single submitter	VCV000747649	9	35060879	9	35060882	747649	751685	rs916113917	NC_000009.12:35060881:G:A
NM_007126.5(VCP):c.628A>C (p.Arg210=)	VCP		Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|not provided	Likely benign(Last reviewed: Nov 26, 2018)	criteria provided, single submitter	VCV000743902	9	35064231	9	35064234	743902	751687	rs755168304	NC_000009.12:35064233:T:G
NM_007126.5(VCP):c.2160+8T>G	VCP		not provided|Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia	Benign(Last reviewed: Sep 9, 2020)	criteria provided, single submitter	VCV000742604	9	35059053	9	35059056	742604	759748	rs564249854	NC_000009.12:35059055:A:C
NM_007126.5(VCP):c.345T>C (p.His115=)	VCP		Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|not provided	Likely benign(Last reviewed: Jan 16, 2018)	criteria provided, single submitter	VCV000741897	9	35066772	9	35066775	741897	751688	rs775348132	NC_000009.12:35066774:A:G
NM_007126.5(VCP):c.1476G>A (p.Leu492=)	VCP		Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia|not provided	Likely benign(Last reviewed: Aug 6, 2020)	criteria provided, single submitter	VCV000733355	9	35060804	9	35060807	733355	737121	rs759475496	NC_000009.12:35060806:C:T
NM_007126.5(VCP):c.1887T>C (p.Ile629=)	VCP		Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia	Likely benign(Last reviewed: Nov 3, 2020)	criteria provided, single submitter	VCV000733166	9	35059607	9	35059610	733166	737120	rs777402266	NC_000009.12:35059609:A:G
NM_007126.5(VCP):c.1081+8C>A	VCP		Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|not provided	Likely benign(Last reviewed: Sep 3, 2021)	criteria provided, single submitter	VCV000720473	9	35061992	9	35061995	720473	730637	rs763106348	NC_000009.12:35061994:G:T
NM_007126.5(VCP):c.1847dup (p.Asn616fs)	VCP	N571fs, N616fs	Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|not provided	Likely benign(Last reviewed: Aug 6, 2021)	criteria provided, single submitter	VCV000718252	9	35059646 - 35059647	9	35059649 - 35059650	718252	723558	rs751290466	NC_000009.12:35059649:TTTTTTTTT:TTTTTTTTTT
NM_007126.5(VCP):c.2052A>G (p.Gly684=)	VCP		Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia	Likely benign(Last reviewed: Feb 1, 2019)	criteria provided, single submitter	VCV000709727	9	35059169	9	35059172	709727	723557	rs753011642	NC_000009.12:35059171:T:C
NM_007126.5(VCP):c.832T>C (p.Leu278=)	VCP		Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1|not specified|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia	Benign(Last reviewed: Feb 1, 2021)	criteria provided, multiple submitters, no conflicts	VCV000706186	9	35062327	9	35062330	706186	692665	rs200670526	NC_000009.12:35062329:A:G
NM_007126.5(VCP):c.2166A>G (p.Val722=)	VCP		not provided|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia	Likely benign(Last reviewed: Jan 16, 2020)	criteria provided, single submitter	VCV000705822	9	35057522	9	35057525	705822	692664	rs781606619	NC_000009.12:35057524:T:C
NM_007126.5(VCP):c.1180G>A (p.Val394Met)	VCP	V394M, V349M	Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1	Uncertain significance(Last reviewed: Dec 6, 2018)	criteria provided, single submitter	VCV000656560	9	35061588	9	35061591	656560	638219	rs1587122661	NC_000009.12:35061590:C:T
NM_007126.5(VCP):c.2266G>A (p.Glu756Lys)	VCP	E711K, E756K	Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1	Uncertain significance(Last reviewed: Nov 7, 2018)	criteria provided, single submitter	VCV000653332	9	35057422	9	35057425	653332	638217	rs1587117319	NC_000009.12:35057424:C:T
NM_007126.5(VCP):c.2014T>G (p.Leu672Val)	VCP	L627V, L672V	Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia	Uncertain significance(Last reviewed: Aug 9, 2018)	criteria provided, single submitter	VCV000647081	9	35059207	9	35059210	647081	638218	rs757829124	NC_000009.12:35059209:A:C
NM_007126.5(VCP):c.512G>T (p.Ser171Ile)	VCP	S126I, S171I	Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia	Uncertain significance(Last reviewed: Mar 22, 2019)	criteria provided, single submitter	VCV000640109	9	35065312	9	35065315	640109	638220	rs200911363	NC_000009.12:35065314:C:A
NM_007126.5(VCP):c.84T>A (p.Val28=)	VCP		Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia	Uncertain significance(Last reviewed: Dec 24, 2018)	criteria provided, single submitter	VCV000638960	9	35068293	9	35068296	638960	638221	rs1587130660	NC_000009.12:35068295:A:T
NM_007126.5(VCP):c.340A>G (p.Ile114Val)	VCP	I114V, I69V	not provided|Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia	Uncertain significance(Last reviewed: Aug 29, 2019)	criteria provided, multiple submitters, no conflicts	VCV000597496	9	35066777	9	35066780	597496	588557	rs549915384	NC_000009.12:35066779:T:C
NM_007126.5(VCP):c.284G>C (p.Arg95Pro)	VCP	R95P, R50P	Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia|not provided	Uncertain significance(Last reviewed: Dec 29, 2019)	criteria provided, multiple submitters, no conflicts	VCV000595911	9	35067906	9	35067909	595911	586972	rs758169026	NC_000009.12:35067908:C:G
NM_007126.5(VCP):c.1488T>C (p.Pro496=)	VCP		Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Aug 29, 2020)	criteria provided, conflicting interpretations	VCV000595430	9	35060517	9	35060520	595430	586492	rs1563976866	NC_000009.12:35060519:A:G
NM_007126.5(VCP):c.1242G>A (p.Leu414=)	VCP		not provided|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia	Conflicting interpretations of pathogenicity(Last reviewed: Dec 1, 2021)	criteria provided, conflicting interpretations	VCV000594371	9	35061129	9	35061132	594371	585434	rs375262833	NC_000009.12:35061131:C:T
NM_007126.5(VCP):c.258A>G (p.Arg86=)	VCP		Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Nov 12, 2018)	criteria provided, conflicting interpretations	VCV000594266	9	35067932	9	35067935	594266	585329	rs1563980979	NC_000009.12:35067934:T:C
NM_007126.5(VCP):c.1156A>G (p.Lys386Glu)	VCP	K386E, K341E	not provided|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia	Uncertain significance(Last reviewed: Aug 9, 2020)	criteria provided, multiple submitters, no conflicts	VCV000594143	9	35061612	9	35061615	594143	585206	rs1563977665	NC_000009.12:35061614:T:C
NM_007126.5(VCP):c.1863C>T (p.Gly621=)	VCP		Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Jun 30, 2020)	criteria provided, conflicting interpretations	VCV000593323	9	35059631	9	35059634	593323	584387	rs376510669	NC_000009.12:35059633:G:A
NM_007126.5(VCP):c.277C>T (p.Arg93Cys)	VCP	R93C, R48C	not provided|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1	Pathogenic(Last reviewed: Apr 1, 2020)	criteria provided, multiple submitters, no conflicts	VCV000593071	9	35067913	9	35067916	593071	584135	rs1554669087	NC_000009.12:35067915:G:A
NM_007126.5(VCP):c.320A>T (p.Asp107Val)	VCP	D107V, D62V	Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1	Uncertain significance(Last reviewed: Jun 29, 2018)	criteria provided, single submitter	VCV000575232	9	35066797	9	35066800	575232	569010	rs1563980440	NC_000009.12:35066799:T:A
NM_007126.5(VCP):c.1984C>T (p.Arg662Cys)	VCP	R662C, R617C	Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia	Uncertain significance(Last reviewed: Apr 11, 2018)	criteria provided, single submitter	VCV000572697	9	35059510	9	35059513	572697	563947	rs765795425	NC_000009.12:35059512:G:A
NM_007126.5(VCP):c.374G>A (p.Gly125Asp)	VCP	G125D, G80D	Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1	Uncertain significance(Last reviewed: Apr 29, 2021)	criteria provided, multiple submitters, no conflicts	VCV000569394	9	35066743	9	35066746	569394	565887	rs1563980403	NC_000009.12:35066745:C:T
NM_007126.5(VCP):c.2397C>G (p.Asp799Glu)	VCP	D799E, D754E	Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1	Uncertain significance(Last reviewed: Jul 3, 2018)	criteria provided, single submitter	VCV000568017	9	35057138	9	35057141	568017	563943	rs1329151473	NC_000009.12:35057140:G:C
NM_007126.5(VCP):c.1194+3G>A	VCP		Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|not provided	Uncertain significance(Last reviewed: Oct 1, 2020)	criteria provided, multiple submitters, no conflicts	VCV000565903	9	35061571	9	35061574	565903	563957	rs183223259	NC_000009.12:35061573:C:T
NM_007126.5(VCP):c.2316-4A>G	VCP		Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia	Likely benign(Last reviewed: Jul 24, 2020)	criteria provided, single submitter	VCV000532767	9	35057223	9	35057226	532767	524547	rs755625059	NC_000009.12:35057225:T:C
NM_007126.5(VCP):c.2161-6C>T	VCP		Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia	Likely benign(Last reviewed: Mar 12, 2019)	criteria provided, single submitter	VCV000532766	9	35057533	9	35057536	532766	525095	rs199513619	NC_000009.12:35057535:G:A
NM_007126.5(VCP):c.213C>T (p.Val71=)	VCP		Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia	Likely benign(Last reviewed: Oct 17, 2017)	criteria provided, single submitter	VCV000532765	9	35067977	9	35067980	532765	525108	rs1195805928	NC_000009.12:35067979:G:A
NM_007126.5(VCP):c.552C>T (p.Cys184=)	VCP		Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia	Likely benign(Last reviewed: Dec 11, 2017)	criteria provided, single submitter	VCV000532764	9	35065272	9	35065275	532764	524557	rs769455914	NC_000009.12:35065274:G:A
NM_007126.5(VCP):c.1950G>A (p.Glu650=)	VCP		Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia	Likely benign(Last reviewed: Dec 27, 2017)	criteria provided, single submitter	VCV000532763	9	35059544	9	35059547	532763	525101	rs752382520	NC_000009.12:35059546:C:T
NM_007126.5(VCP):c.1329C>T (p.Asn443=)	VCP		Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia	Likely benign(Last reviewed: Dec 6, 2017)	criteria provided, single submitter	VCV000532762	9	35061042	9	35061045	532762	524550	rs748816624	NC_000009.12:35061044:G:A
NM_007126.5(VCP):c.478G>C (p.Ala160Pro)	VCP	A160P, A115P	not provided|Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia|Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia	Conflicting interpretations of pathogenicity(Last reviewed: Oct 6, 2020)	criteria provided, conflicting interpretations	VCV000532761	9	35065346	9	35065349	532761	524559	rs1554668805	NC_000009.12:35065348:C:G
NM_007126.5(VCP):c.1327A>C (p.Asn443His)	VCP	N443H, N398H	Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia	Uncertain significance(Last reviewed: Dec 22, 2019)	criteria provided, single submitter	VCV000532760	9	35061044	9	35061047	532760	524552	rs770514866	NC_000009.12:35061046:T:G
NM_007126.5(VCP):c.1360-4C>G	VCP		Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia	Uncertain significance(Last reviewed: Dec 14, 2017)	criteria provided, single submitter	VCV000532759	9	35060924	9	35060927	532759	524945	rs769279961	NC_000009.12:35060926:G:C
NM_007126.5(VCP):c.479C>T (p.Ala160Val)	VCP	A160V, A115V	Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia	Uncertain significance(Last reviewed: Oct 23, 2017)	criteria provided, single submitter	VCV000532758	9	35065345	9	35065348	532758	525102	rs1554668804	NC_000009.12:35065347:G:A
NM_007126.5(VCP):c.1433A>G (p.Asp478Gly)	VCP	D478G, D433G	Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia|not provided	Uncertain significance(Last reviewed: Aug 24, 2021)	criteria provided, multiple submitters, no conflicts	VCV000502413	9	35060847	9	35060850	502413	493837	rs1554668345	NC_000009.12:35060849:T:C
NM_007126.5(VCP):c.1896C>A (p.Ala632=)	VCP		not provided|Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia	Conflicting interpretations of pathogenicity(Last reviewed: Dec 3, 2020)	criteria provided, conflicting interpretations	VCV000501835	9	35059598	9	35059601	501835	493259	rs141275388	NC_000009.12:35059600:G:T
NM_007126.5(VCP):c.1875G>T (p.Arg625=)	VCP		not specified|Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia	Benign/Likely benign(Last reviewed: Dec 31, 2019)	criteria provided, multiple submitters, no conflicts	VCV000501479	9	35059619	9	35059622	501479	492903	rs201410035	NC_000009.12:35059621:C:A
NM_007126.5(VCP):c.811+2_811+3inv	VCP		Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia	Uncertain significance(Last reviewed: Aug 20, 2020)	criteria provided, single submitter	VCV000464111	9	35062972 - 35062973	9	35062975 - 35062976	464111	460015		NC_000009.12:35062974:CA:TG
NM_007126.5(VCP):c.576+10C>G	VCP		Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia|not provided	Likely benign(Last reviewed: Jun 27, 2016)	criteria provided, single submitter	VCV000464110	9	35065238	9	35065241	464110	459451	rs757728490	NC_000009.12:35065240:G:C
NM_007126.5(VCP):c.426G>A (p.Ala142=)	VCP		not provided|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia	Conflicting interpretations of pathogenicity(Last reviewed: May 29, 2019)	criteria provided, conflicting interpretations	VCV000464109	9	35066691	9	35066694	464109	459155	rs577812326	NC_000009.12:35066693:C:T
NM_007126.5(VCP):c.303-3C>T	VCP		Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia	Uncertain significance(Last reviewed: Aug 3, 2017)	criteria provided, single submitter	VCV000464108	9	35066817	9	35066820	464108	459547	rs1183711292	NC_000009.12:35066819:G:A
NM_007126.5(VCP):c.2412G>A (p.Leu804=)	VCP		not provided|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia	Likely benign(Last reviewed: Jan 24, 2018)	criteria provided, single submitter	VCV000464107	9	35057123	9	35057126	464107	459154	rs757712897	NC_000009.12:35057125:C:T
NM_007126.5(VCP):c.1696-7C>T	VCP		Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia	Likely benign(Last reviewed: Jun 12, 2017)	criteria provided, single submitter	VCV000464106	9	35059805	9	35059808	464106	459539	rs1554668202	NC_000009.12:35059807:G:A
NM_007126.5(VCP):c.1202A>G (p.Asn401Ser)	VCP	N401S, N356S	not provided|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia	Benign/Likely benign(Last reviewed: Feb 19, 2021)	criteria provided, multiple submitters, no conflicts	VCV000464105	9	35061169	9	35061172	464105	460014	rs148329626	NC_000009.12:35061171:T:C
NM_007126.5(VCP):c.1017A>G (p.Ala339=)	VCP		not provided|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia	Likely benign(Last reviewed: May 27, 2020)	criteria provided, single submitter	VCV000464104	9	35062064	9	35062067	464104	459544	rs565534943	NC_000009.12:35062066:T:C
NM_007126.5(VCP):c.1082-9G>T	VCP		Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia|Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1|not provided|not specified	Benign(Last reviewed: Nov 25, 2020)	criteria provided, multiple submitters, no conflicts	VCV000464103	9	35061695	9	35061698	464103	459541	rs12349922	NC_000009.12:35061697:C:A
NM_007126.5(VCP):c.278G>A (p.Arg93His)	VCP	R93H, R48H	not provided|Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia	Conflicting interpretations of pathogenicity(Last reviewed: Mar 15, 2022)	criteria provided, conflicting interpretations	VCV000449554	9	35067912	9	35067915	449554	444478	rs779959657	NC_000009.12:35067914:C:T
NM_007126.3(VCP):c.-370G>A	VCP		Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000366727	9	35072720	9	35072723	366727	318546	rs886063895	NC_000009.12:35072722:C:T
NM_007126.5(VCP):c.-267C>T	VCP		Inclusion Body Myopathy, Dominant|Amyotrophic Lateral Sclerosis, Dominant|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1	Benign/Likely benign(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000366726	9	35072617	9	35072620	366726	312633	rs184152880	NC_000009.12:35072619:G:A
NM_007126.5(VCP):c.-250C>T	VCP		Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000366725	9	35072600	9	35072603	366725	312632	rs886063894	NC_000009.12:35072602:G:A
NM_007126.5(VCP):c.-215A>G	VCP		Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000366723	9	35072565	9	35072568	366723	312631	rs886063893	NC_000009.12:35072567:T:C
NM_007126.5(VCP):c.-53C>T	VCP		Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000366722	9	35072403	9	35072406	366722	319056	rs369830702	NC_000009.12:35072405:G:A
NM_007126.5(VCP):c.18-5T>C	VCP		not provided|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1|not specified|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia	Benign(Last reviewed: Dec 1, 2020)	criteria provided, multiple submitters, no conflicts	VCV000366721	9	35068364	9	35068367	366721	318534	rs114256093	NC_000009.12:35068366:A:G
NM_007126.5(VCP):c.185A>G (p.Lys62Arg)	VCP	K62R, K17R	Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000366720	9	35068005	9	35068008	366720	319050	rs886063892	NC_000009.12:35068007:T:C
NM_007126.5(VCP):c.927C>T (p.Ile309=)	VCP		Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1|not provided|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|not specified|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia	Benign(Last reviewed: Nov 21, 2020)	criteria provided, multiple submitters, no conflicts	VCV000366719	9	35062232	9	35062235	366719	319044	rs34097935	NC_000009.12:35062234:G:A
NM_007126.5(VCP):c.1092C>T (p.Asp364=)	VCP		Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1|not provided|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|not specified|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia	Benign/Likely benign(Last reviewed: Jun 19, 2021)	criteria provided, multiple submitters, no conflicts	VCV000366718	9	35061676	9	35061679	366718	319032	rs61752947	NC_000009.12:35061678:G:A
NM_007126.5(VCP):c.1360-6T>C	VCP		Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000366717	9	35060926	9	35060929	366717	308255	rs370296303	NC_000009.12:35060928:A:G
NM_007126.5(VCP):c.*64C>T	VCP		Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000366715	9	35057050	9	35057053	366715	308247	rs553370942	NC_000009.12:35057052:G:A
NM_007126.5(VCP):c.*153G>T	VCP		Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1|not provided|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia	Benign(Last reviewed: Jul 6, 2018)	criteria provided, multiple submitters, no conflicts	VCV000366714	9	35056961	9	35056964	366714	318529	rs1053318	NC_000009.12:35056963:C:A
NM_007126.5(VCP):c.*172C>G	VCP		Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000366713	9	35056942	9	35056945	366713	312628	rs886063890	NC_000009.12:35056944:G:C
NM_007126.5(VCP):c.*184G>A	VCP		Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000366712	9	35056930	9	35056933	366712	308246	rs886063889	NC_000009.12:35056932:C:T
NM_007126.5(VCP):c.*347C>T	VCP		Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000366711	9	35056767	9	35056770	366711	312619	rs886063888	NC_000009.12:35056769:G:A
NM_007126.5(VCP):c.*382C>T	VCP		Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000366710	9	35056732	9	35056735	366710	308244	rs749381324	NC_000009.12:35056734:G:A
NM_007126.5(VCP):c.*438A>G	VCP		Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1	Benign(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000366708	9	35056676	9	35056679	366708	308243	rs137953487	NC_000009.12:35056678:T:C
NM_007126.5(VCP):c.*596C>T	VCP		Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1	Benign(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000366707	9	35056518	9	35056521	366707	308235	rs55745923	NC_000009.12:35056520:G:A
NM_007126.5(VCP):c.*700C>A	VCP		Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000366706	9	35056414	9	35056417	366706	318528	rs537730311	NC_000009.12:35056416:G:T
NM_007126.5(VCP):c.*788G>A	VCP		Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000366705	9	35056326	9	35056329	366705	312609	rs886063887	NC_000009.12:35056328:C:T
NM_007126.5(VCP):c.*906A>G	VCP		Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia	Benign(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000366704	9	35056208	9	35056211	366704	318524	rs76360394	NC_000009.12:35056210:T:C
NM_007126.5(VCP):c.954C>T (p.Gly318=)	VCP		not provided|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia	Uncertain significance(Last reviewed: Dec 12, 2019)	criteria provided, multiple submitters, no conflicts	VCV000287400	9	35062127	9	35062130	287400	271637	rs377316335	NC_000009.12:35062129:G:A
NM_007126.5(VCP):c.*4G>T	VCP		not provided|Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|not specified|Intellectual disability	Conflicting interpretations of pathogenicity(Last reviewed: Apr 13, 2021)	criteria provided, conflicting interpretations	VCV000284304	9	35057110	9	35057113	284304	268541	rs201091341	NC_000009.12:35057112:C:A
NM_007126.5(VCP):c.79A>G (p.Ile27Val)	VCP	I27V	not specified|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia|not provided|Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|Intellectual disability	Benign(Last reviewed: Jan 18, 2021)	criteria provided, multiple submitters, no conflicts	VCV000284302	9	35068298	9	35068301	284302	268539	rs140913250	NC_000009.12:35068300:T:C
NM_007126.5(VCP):c.1584C>T (p.Ala528=)	VCP		Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia|not provided|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1|not specified	Conflicting interpretations of pathogenicity(Last reviewed: Mar 1, 2022)	criteria provided, conflicting interpretations	VCV000283215	9	35060421	9	35060424	283215	267452	rs147623367	NC_000009.12:35060423:G:A
NM_007126.5(VCP):c.283C>T (p.Arg95Cys)	VCP	R95C, R50C	Spastic paraplegia|not provided|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia|Amyotrophic lateral sclerosis|Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1	Pathogenic/Likely pathogenic(Last reviewed: Jan 1, 2022)	criteria provided, multiple submitters, no conflicts	VCV000280124	9	35067907	9	35067910	280124	264531	rs121909332	NC_000009.12:35067909:G:A
NM_007126.5(VCP):c.475C>T (p.Arg159Cys)	VCP	R159C, R114C	not provided|Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia	Pathogenic/Likely pathogenic(Last reviewed: Mar 31, 2020)	criteria provided, multiple submitters, no conflicts	VCV000280123	9	35065349	9	35065352	280123	264328	rs387906789	NC_000009.12:35065351:G:A
NM_007126.5(VCP):c.811+3G>A	VCP		Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1|not specified|not provided|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia	Benign(Last reviewed: Dec 4, 2020)	criteria provided, multiple submitters, no conflicts	VCV000260128	9	35062972	9	35062975	260128	253532	rs514492	NC_000009.12:35062974:C:T
NM_007126.5(VCP):c.577-21_577-18del	VCP		Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia|not specified	Likely benign(Last reviewed: Apr 18, 2021)	criteria provided, multiple submitters, no conflicts	VCV000260127	9	35064300 - 35064303	9	35064303 - 35064306	260127	253533	rs763622603	NC_000009.12:35064302:AAAGAAAG:AAAG
NM_007126.5(VCP):c.1704A>G (p.Gln568=)	VCP		not provided|not specified|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1	Benign/Likely benign(Last reviewed: Apr 1, 2021)	criteria provided, multiple submitters, no conflicts	VCV000260125	9	35059790	9	35059793	260125	253525	rs142577424	NC_000009.12:35059792:T:C
NM_007126.5(VCP):c.1695+8A>G	VCP		Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1|not provided|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia|not specified	Benign(Last reviewed: Dec 4, 2020)	criteria provided, multiple submitters, no conflicts	VCV000260124	9	35060302	9	35060305	260124	253526	rs684562	NC_000009.12:35060304:T:C
NM_007126.5(VCP):c.1360-14C>G	VCP		not specified|not provided|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1	Benign(Last reviewed: Dec 16, 2021)	criteria provided, multiple submitters, no conflicts	VCV000260122	9	35060934	9	35060937	260122	253527	rs144304208	NC_000009.12:35060936:G:C
NM_007126.5(VCP):c.1194+9ATG[2]	VCP		Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia|not specified	Likely benign(Last reviewed: Dec 2, 2021)	criteria provided, multiple submitters, no conflicts	VCV000260120	9	35061557 - 35061559	9	35061560 - 35061562	260120	253529	rs886038581	NC_000009.12:35061559:CATCATCATCA:CATCATCA
NM_007126.5(VCP):c.1082-18_1082-8dup	VCP		not specified|not provided|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia|Inclusion Body Myopathy, Dominant|Amyotrophic Lateral Sclerosis, Dominant	Benign(Last reviewed: Dec 4, 2020)	criteria provided, multiple submitters, no conflicts	VCV000260119	9	35061693 - 35061694	9	35061696 - 35061697	260119	253530	rs11272867	NC_000009.12:35061696:ACAGTACACAAACA:ACAGTACACAAACAGTACACAAACA
NM_007126.5(VCP):c.1081+17C>T	VCP		not specified|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia|not provided	Benign/Likely benign(Last reviewed: Dec 11, 2021)	criteria provided, multiple submitters, no conflicts	VCV000260118	9	35061983	9	35061986	260118	253531	rs200756991	NC_000009.12:35061985:G:A
NM_007126.5(VCP):c.290G>A (p.Gly97Glu)	VCP	G97E, G52E	Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia|Charcot-Marie-Tooth disease, axonal, type 2y	Pathogenic(Last reviewed: Oct 12, 2021)	criteria provided, single submitter	VCV000218306	9	35067900	9	35067903	218306	215002	rs864309502	NC_000009.12:35067902:C:T
NM_007126.5(VCP):c.553G>A (p.Glu185Lys)	VCP	E185K, E140K	Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|Charcot-Marie-Tooth disease, axonal, type 2y	Conflicting interpretations of pathogenicity(Last reviewed: Sep 19, 2018)	criteria provided, conflicting interpretations	VCV000218305	9	35065271	9	35065274	218305	215001	rs864309501	NC_000009.12:35065273:C:T
NM_007126.5(VCP):c.271A>T (p.Asn91Tyr)	VCP	N91Y, N46Y	INCLUSION BODY MYOPATHY WITHOUT EARLY-ONSET PAGET DISEASE AND FRONTOTEMPORAL DEMENTIA 1|Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia	Pathogenic/Likely pathogenic(Last reviewed: Dec 23, 2020)	no assertion criteria provided	VCV000217877	9	35067919	9	35067922	217877	214539	rs863225291	NC_000009.12:35067921:T:A
NM_007126.5(VCP):c.463C>G (p.Arg155Gly)	VCP	R155G, R110G	Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|not provided|Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1	Conflicting interpretations of pathogenicity(Last reviewed: Nov 5, 2018)	criteria provided, conflicting interpretations	VCV000217028	9	35065361	9	35065364	217028	213592	rs121909330	NC_000009.12:35065363:G:C
NM_007126.5(VCP):c.2406T>C (p.Asp802=)	VCP		not specified|Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|not provided|Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia	Conflicting interpretations of pathogenicity(Last reviewed: Apr 26, 2021)	criteria provided, conflicting interpretations	VCV000194756	9	35057129	9	35057132	194756	191919	rs145508640	NC_000009.12:35057131:A:G
NM_007126.5(VCP):c.2214A>G (p.Glu738=)	VCP		Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1|not provided|Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|not specified	Benign/Likely benign(Last reviewed: Dec 2, 2020)	criteria provided, multiple submitters, no conflicts	VCV000194645	9	35057474	9	35057477	194645	191808	rs374391034	NC_000009.12:35057476:T:C
NM_007126.5(VCP):c.476G>A (p.Arg159His)	VCP	R159H, R114H	Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|not provided|Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1	Pathogenic(Last reviewed: Nov 1, 2020)	criteria provided, multiple submitters, no conflicts	VCV000008474	9	35065348	9	35065351	8474	23513	rs121909335	NC_000009.12:35065350:C:T
NM_007126.5(VCP):c.572G>A (p.Arg191Gln)	VCP	R191Q, R146Q	Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|not provided|Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia	Pathogenic/Likely pathogenic(Last reviewed: Aug 8, 2020)	criteria provided, multiple submitters, no conflicts	VCV000008473	9	35065252	9	35065255	8473	23512	rs121909334	NC_000009.12:35065254:C:T
NM_007126.5(VCP):c.464G>C (p.Arg155Pro)	VCP	R155P, R110P	Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia	Pathogenic(Last reviewed: Oct 27, 2020)	criteria provided, single submitter	VCV000008472	9	35065360	9	35065363	8472	23511	rs121909329	NC_000009.12:35065362:C:G
NM_007126.5(VCP):c.283C>G (p.Arg95Gly)	VCP	R95G, R50G	Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1	Pathogenic(Last reviewed: Jan 15, 2006)	no assertion criteria provided	VCV000008471	9	35067907	9	35067910	8471	23510	rs121909332	NC_000009.12:35067909:G:C
NM_007126.5(VCP):c.695C>A (p.Ala232Glu)	VCP	A232E, A187E	Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1|not provided	Pathogenic(Last reviewed: Aug 1, 2020)	criteria provided, single submitter	VCV000008470	9	35064164	9	35064167	8470	23509	rs121909331	NC_000009.12:35064166:G:T
NM_007126.5(VCP):c.463C>T (p.Arg155Cys)	VCP	R155C, R110C	Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|not provided|Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1	Pathogenic/Likely pathogenic(Last reviewed: Apr 1, 2021)	criteria provided, multiple submitters, no conflicts	VCV000008469	9	35065361	9	35065364	8469	23508	rs121909330	NC_000009.12:35065363:G:A
NM_007126.5(VCP):c.464G>A (p.Arg155His)	VCP	R155H, R110H	Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1|not provided|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia	Pathogenic(Last reviewed: Mar 25, 2021)	criteria provided, multiple submitters, no conflicts	VCV000008468	9	35065360	9	35065363	8468	23507	rs121909329	NC_000009.12:35065362:C:T
NM_020821.3(VPS13C):c.1126T>G (p.Tyr376Asp)	VPS13C	Y333D, Y376D	not provided	Uncertain significance(Last reviewed: Oct 4, 2021)	criteria provided, single submitter	VCV001484156	15	62299671	15	62007472	1484156	1455086		NC_000015.10:62007471:A:C
NM_020821.3(VPS13C):c.6247C>T (p.Pro2083Ser)	VPS13C	P2040S, P2083S	not provided	Uncertain significance(Last reviewed: Oct 24, 2021)	criteria provided, single submitter	VCV001481111	15	62221739	15	61929540	1481111	1451549		NC_000015.10:61929539:G:A
NM_020821.3(VPS13C):c.3466C>T (p.Arg1156Cys)	VPS13C	R1156C, R1113C	not provided	Uncertain significance(Last reviewed: Oct 17, 2021)	criteria provided, single submitter	VCV001466450	15	62254707	15	61962508	1466450	1347809		NC_000015.10:61962507:G:A
NM_020821.3(VPS13C):c.6610-1G>T	VPS13C		Parkinson disease 23, autosomal recessive early-onset	Likely pathogenic(Last reviewed: Feb 4, 2021)	no assertion criteria provided	VCV001325347	15	62214962	15	61922763	1325347	1315604		NC_000015.10:61922762:C:A
NM_020821.3(VPS13C):c.10786_10792del (p.Pro3596fs)	VPS13C	P3553fs, P3596fs	Parkinson disease 23, autosomal recessive early-onset	Likely pathogenic(Last reviewed: Sep 6, 2021)	no assertion criteria provided	VCV001325346	15	62160929 - 62160935	15	61868730 - 61868736	1325346	1315603		NC_000015.10:61868729:GAGGGGG:
NM_020821.3(VPS13C):c.8806C>T (p.Arg2936Ter)	VPS13C	R2893*, R2936*	Parkinson disease 23, autosomal recessive early-onset	Likely pathogenic(Last reviewed: Jan 8, 2020)	no assertion criteria provided	VCV001325345	15	62202414	15	61910215	1325345	1315602		NC_000015.10:61910214:G:A
NM_020821.3(VPS13C):c.5842_5843insATGA (p.Ile1948fs)	VPS13C	I1905fs, I1948fs	Parkinson disease 23, autosomal recessive early-onset	Pathogenic(Last reviewed: Mar 3, 2020)	no assertion criteria provided	VCV001323755	15	62226443 - 62226444	15	61934244 - 61934245	1323755	1314036		NC_000015.10:61934244:T:TCATT
NM_020821.3(VPS13C):c.7519_7523del (p.Arg2507fs)	VPS13C	R2464fs, R2507fs	Parkinson disease 23, autosomal recessive early-onset	Pathogenic(Last reviewed: Aug 28, 2019)	no assertion criteria provided	VCV001323754	15	62211603 - 62211607	15	61919404 - 61919408	1323754	1314035		NC_000015.10:61919403:GGTCTGG:GG
NM_020821.3(VPS13C):c.10060G>T (p.Glu3354Ter)	VPS13C	E3311*, E3354*	Parkinson disease 23, autosomal recessive early-onset	Pathogenic(Last reviewed: Oct 11, 2019)	no assertion criteria provided	VCV001323753	15	62170888	15	61878689	1323753	1314034		NC_000015.10:61878688:C:A
NM_020821.3(VPS13C):c.9541C>T (p.Arg3181Ter)	VPS13C	R3138*, R3181*	not provided|Parkinson disease 23, autosomal recessive early-onset	Uncertain significance(Last reviewed: May 8, 2021)	criteria provided, single submitter	VCV001323752	15	62174878	15	61882679	1323752	1314033		NC_000015.10:61882678:G:A
NM_020821.3(VPS13C):c.7274C>T (p.Thr2425Met)	VPS13C	T2425M, T2382M	Parkinson disease 23, autosomal recessive early-onset	Uncertain significance(Last reviewed: Jan 22, 2020)	criteria provided, single submitter	VCV001030584	15	62212469	15	61920270	1030584	1017938	rs547200034	NC_000015.10:61920269:G:A
NM_020821.3(VPS13C):c.1483+1G>A	VPS13C		Parkinson disease 23, autosomal recessive early-onset	Likely pathogenic(Last reviewed: Oct 4, 2019)	criteria provided, single submitter	VCV001030583	15	62283871	15	61991672	1030583	1017939	rs2046226928	NC_000015.10:61991671:C:T
NM_020821.3(VPS13C):c.1409G>A (p.Arg470His)	VPS13C	R427H, R470H	Parkinson disease 23, autosomal recessive early-onset	Uncertain significance(Last reviewed: Jan 22, 2020)	criteria provided, single submitter	VCV001029636	15	62283946	15	61991747	1029636	1017940	rs142155201	NC_000015.10:61991746:C:T
NM_020821.3(VPS13C):c.1111C>T (p.Arg371Ter)	VPS13C	R328*, R371*	Parkinson disease 23, autosomal recessive early-onset	Pathogenic(Last reviewed: Jan 1, 2019)	criteria provided, single submitter	VCV000982938	15	62300861	15	62008662	982938	971025	rs752457309	NC_000015.10:62008661:G:A
NM_020821.3(VPS13C):c.5653A>C (p.Asn1885His)	VPS13C	N1842H, N1885H	not specified	Uncertain significance(Last reviewed: May 11, 2020)	criteria provided, single submitter	VCV000932210	15	62228898	15	61936699	932210	920500	rs757119917	NC_000015.10:61936698:T:G
NM_020821.3(VPS13C):c.1102A>G (p.Thr368Ala)	VPS13C	T325A, T368A	not specified|not provided	Uncertain significance(Last reviewed: Oct 23, 2021)	criteria provided, multiple submitters, no conflicts	VCV000932179	15	62300870	15	62008671	932179	920501	rs150098264	NC_000015.10:62008670:T:C
NM_020821.3(VPS13C):c.9020G>A (p.Arg3007Gln)	VPS13C	R3007Q, R2964Q	Parkinson disease 23, autosomal recessive early-onset	Uncertain significance(Last reviewed: Feb 19, 2018)	no assertion criteria provided	VCV000599078	15	62199548	15	61907349	599078	590310	rs778287890	NC_000015.10:61907348:C:T
NM_020821.3(VPS13C):c.387C>T (p.Gly129=)	VPS13C		not provided|Parkinson disease 23, autosomal recessive early-onset	Conflicting interpretations of pathogenicity(Last reviewed: Dec 31, 2019)	criteria provided, conflicting interpretations	VCV000547944	15	62320618	15	62028419	547944	538444	rs139665824	NC_000015.10:62028418:G:A
NM_020821.3(VPS13C):c.802_805dup (p.Arg269fs)	VPS13C	R269fs, R226fs	Parkinson disease 23, autosomal recessive early-onset	Pathogenic(Last reviewed: Dec 20, 2019)	no assertion criteria provided	VCV000224604	15	62305257 - 62305258	15	62013058 - 62013059	224604	226382	rs869320761	NC_000015.10:62013058:TCTG:TCTGTCTG
NM_020821.3(VPS13C):c.4777del (p.Gln1593fs)	VPS13C	Q1550fs, Q1593fs	Parkinson disease|Parkinson disease 23, autosomal recessive early-onset	Pathogenic(Last reviewed: Nov 16, 2015)	criteria provided, single submitter	VCV000222071	15	62239491	15	61947292	222071	223767	rs869312811	NC_000015.10:61947291:GGG:GG
NM_020821.3(VPS13C):c.4165G>C (p.Gly1389Arg)	VPS13C	G1389R, G1346R	Parkinson disease|Parkinson disease 23, autosomal recessive early-onset	Pathogenic(Last reviewed: Nov 16, 2015)	criteria provided, single submitter	VCV000222070	15	62250807	15	61958608	222070	223768	rs369100678	NC_000015.10:61958607:C:G
NM_020821.3(VPS13C):c.9568G>T (p.Glu3190Ter)	VPS13C	E3190*, E3147*	Parkinson disease|Parkinson disease 23, autosomal recessive early-onset	Pathogenic(Last reviewed: Nov 16, 2015)	criteria provided, single submitter	VCV000222069	15	62174851	15	61882652	222069	223765	rs869312810	NC_000015.10:61882651:C:A
NM_020821.3(VPS13C):c.806_807insCAGA (p.Arg269fs)	VPS13C	R226fs, R269fs	Parkinson disease	Pathogenic(Last reviewed: Nov 16, 2015)	criteria provided, single submitter	VCV000222068	15	62305256 - 62305257	15	62013057 - 62013058	222068	223769	rs879253853	NC_000015.10:62013057::TCTG
NM_020821.3(VPS13C):c.8445+2T>G	VPS13C		Parkinson disease|Parkinson disease 23, autosomal recessive early-onset	Pathogenic(Last reviewed: Nov 16, 2015)	criteria provided, single submitter	VCV000222067	15	62207830	15	61915631	222067	223766	rs869312809	NC_000015.10:61915630:A:C
NM_018206.6(VPS35):c.2316C>T (p.Asn772=)	VPS35		Parkinson disease 17	Likely benign(Last reviewed: Jun 19, 2021)	criteria provided, single submitter	VCV001668953	16	46694459	16	46660547	1668953	1602839		NC_000016.10:46660546:G:A
NM_018206.6(VPS35):c.2049G>A (p.Thr683=)	VPS35		Parkinson disease 17	Likely benign(Last reviewed: Jul 6, 2021)	criteria provided, single submitter	VCV001657629	16	46696173	16	46662261	1657629	1541367		NC_000016.10:46662260:C:T
NM_018206.6(VPS35):c.4-15T>C	VPS35		Parkinson disease 17	Likely benign(Last reviewed: Jun 7, 2021)	criteria provided, single submitter	VCV001655702	16	46717533	16	46683621	1655702	1616052		NC_000016.10:46683620:A:G
NM_018206.6(VPS35):c.1368+17G>A	VPS35		Parkinson disease 17	Likely benign(Last reviewed: Dec 2, 2021)	criteria provided, single submitter	VCV001634971	16	46706160	16	46672248	1634971	1610697		NC_000016.10:46672247:C:T
NM_018206.6(VPS35):c.2122A>C (p.Asn708His)	VPS35	N708H	Parkinson disease 17	Benign(Last reviewed: Jul 22, 2021)	criteria provided, single submitter	VCV001621519	16	46695719	16	46661807	1621519	1528665		NC_000016.10:46661806:T:G
NM_018206.6(VPS35):c.915-16T>G	VPS35		Parkinson disease 17	Benign(Last reviewed: Jun 14, 2021)	criteria provided, single submitter	VCV001608805	16	46708588	16	46674676	1608805	1660223		NC_000016.10:46674675:A:C
NM_018206.6(VPS35):c.222G>A (p.Leu74=)	VPS35		Parkinson disease 17	Likely benign(Last reviewed: Dec 11, 2021)	criteria provided, single submitter	VCV001587650	16	46715390	16	46681478	1587650	1595301		NC_000016.10:46681477:C:T
NM_018206.6(VPS35):c.1002A>G (p.Thr334=)	VPS35		Parkinson disease 17	Likely benign(Last reviewed: Aug 26, 2021)	criteria provided, single submitter	VCV001569613	16	46708485	16	46674573	1569613	1559584		NC_000016.10:46674572:T:C
NM_018206.6(VPS35):c.1557T>C (p.Ala519=)	VPS35		Parkinson disease 17	Likely benign(Last reviewed: Jun 23, 2021)	criteria provided, single submitter	VCV001568189	16	46702932	16	46669020	1568189	1570281		NC_000016.10:46669019:A:G
NM_018206.6(VPS35):c.914+11C>A	VPS35		Parkinson disease 17	Likely benign(Last reviewed: Jun 9, 2021)	criteria provided, single submitter	VCV001565051	16	46710484	16	46676572	1565051	1568005		NC_000016.10:46676571:G:T
NM_018206.6(VPS35):c.9A>C (p.Thr3=)	VPS35		Parkinson disease 17	Likely benign(Last reviewed: Jul 31, 2021)	criteria provided, single submitter	VCV001562402	16	46717513	16	46683601	1562402	1577466		NC_000016.10:46683600:T:G
NM_018206.6(VPS35):c.2068-18C>G	VPS35		Parkinson disease 17	Likely benign(Last reviewed: Oct 28, 2021)	criteria provided, single submitter	VCV001532390	16	46695791	16	46661879	1532390	1636001		NC_000016.10:46661878:G:C
NM_018206.6(VPS35):c.1262T>A (p.Phe421Tyr)	VPS35	F421Y	Parkinson disease 17	Uncertain significance(Last reviewed: Aug 28, 2021)	criteria provided, single submitter	VCV001521803	16	46706283	16	46672371	1521803	1343818		NC_000016.10:46672370:A:T
NM_018206.6(VPS35):c.110A>G (p.Asn37Ser)	VPS35	N37S	Parkinson disease 17	Uncertain significance(Last reviewed: Dec 3, 2021)	criteria provided, single submitter	VCV001489932	16	46716080	16	46682168	1489932	1514925		NC_000016.10:46682167:T:C
NM_018206.6(VPS35):c.2060G>A (p.Gly687Glu)	VPS35	G687E	Parkinson disease 17	Uncertain significance(Last reviewed: Aug 14, 2021)	criteria provided, single submitter	VCV001485006	16	46696162	16	46662250	1485006	1393732		NC_000016.10:46662249:C:T
NM_018206.6(VPS35):c.2074G>A (p.Gly692Arg)	VPS35	G692R	Parkinson disease 17	Uncertain significance(Last reviewed: Aug 14, 2021)	criteria provided, single submitter	VCV001470508	16	46695767	16	46661855	1470508	1372470		NC_000016.10:46661854:C:T
NM_018206.6(VPS35):c.2339G>A (p.Arg780Gln)	VPS35	R780Q	Parkinson disease 17	Uncertain significance(Last reviewed: Aug 28, 2021)	criteria provided, single submitter	VCV001436205	16	46694436	16	46660524	1436205	1497320		NC_000016.10:46660523:C:T
NM_018206.6(VPS35):c.977A>T (p.Asp326Val)	VPS35	D326V	Parkinson disease 17	Uncertain significance(Last reviewed: Aug 16, 2021)	criteria provided, single submitter	VCV001375085	16	46708510	16	46674598	1375085	1466371		NC_000016.10:46674597:T:A
NM_018206.6(VPS35):c.1495C>T (p.Arg499Cys)	VPS35	R499C	Parkinson disease 17	Uncertain significance(Last reviewed: Aug 31, 2021)	criteria provided, single submitter	VCV001369465	16	46705646	16	46671734	1369465	1414478		NC_000016.10:46671733:G:A
NM_018206.6(VPS35):c.1804G>A (p.Val602Ile)	VPS35	V602I	Parkinson disease 17	Uncertain significance(Last reviewed: Nov 1, 2021)	criteria provided, single submitter	VCV001359994	16	46696918	16	46663006	1359994	1473867		NC_000016.10:46663005:C:T
NM_018206.6(VPS35):c.1142A>G (p.Asn381Ser)	VPS35	N381S	Parkinson disease 17	Uncertain significance(Last reviewed: Sep 20, 2021)	criteria provided, single submitter	VCV001356064	16	46708244	16	46674332	1356064	1354360		NC_000016.10:46674331:T:C
NM_018206.6(VPS35):c.1938C>T (p.His646=)	VPS35		not specified|Parkinson disease 17	Benign(Last reviewed: Dec 8, 2020)	criteria provided, single submitter	VCV001166780	16	46696284	16	46662372	1166780	1157736		NC_000016.10:46662371:G:A
NM_018206.6(VPS35):c.1893C>T (p.Ile631=)	VPS35		Parkinson disease 17	Likely benign(Last reviewed: Mar 3, 2020)	criteria provided, single submitter	VCV001155329	16	46696329	16	46662417	1155329	1146153		NC_000016.10:46662416:G:A
NM_018206.6(VPS35):c.1369-9A>G	VPS35		Parkinson disease 17	Likely benign(Last reviewed: May 29, 2020)	criteria provided, single submitter	VCV001150728	16	46705781	16	46671869	1150728	1146154		NC_000016.10:46671868:T:C
NM_018206.6(VPS35):c.1371G>A (p.Val457=)	VPS35		Parkinson disease 17	Likely benign(Last reviewed: Apr 5, 2019)	criteria provided, single submitter	VCV001088814	16	46705770	16	46671858	1088814	1082041		NC_000016.10:46671857:C:T
NM_018206.6(VPS35):c.1290C>T (p.Tyr430=)	VPS35		Parkinson disease 17	Likely benign(Last reviewed: Dec 4, 2019)	criteria provided, single submitter	VCV001083536	16	46706255	16	46672343	1083536	1082042		NC_000016.10:46672342:G:A
NM_018206.6(VPS35):c.13C>T (p.Gln5Ter)	VPS35	Q5*	Parkinson disease 17	Uncertain significance(Last reviewed: Jun 21, 2020)	criteria provided, single submitter	VCV001050911	16	46717509	16	46683597	1050911	1049630		NC_000016.10:46683596:G:A
NM_018206.6(VPS35):c.1895T>C (p.Ile632Thr)	VPS35	I632T	Parkinson disease 17	Uncertain significance(Last reviewed: Jan 8, 2020)	criteria provided, single submitter	VCV001021992	16	46696327	16	46662415	1021992	1012169	rs756550058	NC_000016.10:46662414:A:G
NM_018206.6(VPS35):c.993G>T (p.Gln331His)	VPS35	Q331H	Parkinson disease 17	Uncertain significance(Last reviewed: Sep 15, 2019)	criteria provided, single submitter	VCV000961428	16	46708494	16	46674582	961428	949404	rs1483697832	NC_000016.10:46674581:C:A
NM_018206.6(VPS35):c.506+4A>C	VPS35		Parkinson disease 17	Uncertain significance(Last reviewed: Sep 21, 2019)	criteria provided, single submitter	VCV000960311	16	46714579	16	46680667	960311	960159	rs760012192	NC_000016.10:46680666:T:G
NM_018206.6(VPS35):c.2350C>A (p.Pro784Thr)	VPS35	P784T	Parkinson disease 17	Uncertain significance(Last reviewed: May 21, 2019)	criteria provided, single submitter	VCV000947902	16	46694425	16	46660513	947902	927819	rs1965895979	NC_000016.10:46660512:G:T
NM_018206.6(VPS35):c.1900A>G (p.Thr634Ala)	VPS35	T634A	Parkinson disease 17	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000887867	16	46696322	16	46662410	887867	875299	rs1965927007	NC_000016.10:46662409:T:C
NM_018206.6(VPS35):c.2073C>T (p.His691=)	VPS35		Parkinson disease 17	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000887866	16	46695768	16	46661856	887866	875298	rs542139125	NC_000016.10:46661855:G:A
NM_018206.6(VPS35):c.2211+11T>C	VPS35		Parkinson disease 17	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000887865	16	46695619	16	46661707	887865	876670	rs375273548	NC_000016.10:46661706:A:G
NM_018206.6(VPS35):c.-35C>G	VPS35		Parkinson disease 17	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000886664	16	46723080	16	46689168	886664	875305	rs189775907	NC_000016.10:46689167:G:C
NM_018206.6(VPS35):c.2353G>C (p.Glu785Gln)	VPS35	E785Q	Parkinson disease 17	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000886615	16	46694422	16	46660510	886615	875297	rs1965895878	NC_000016.10:46660509:C:G
NM_018206.6(VPS35):c.*34A>G	VPS35		Parkinson disease 17	Likely benign(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000886614	16	46694350	16	46660438	886614	875296	rs779980787	NC_000016.10:46660437:T:C
NM_018206.6(VPS35):c.*161C>T	VPS35		Parkinson disease 17	Uncertain significance(Last reviewed: Apr 27, 2017)	criteria provided, single submitter	VCV000886613	16	46694223	16	46660311	886613	875295	rs1965892398	NC_000016.10:46660310:G:A
NM_018206.6(VPS35):c.*283C>A	VPS35		Parkinson disease 17	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000886612	16	46694101	16	46660189	886612	875294	rs199765664	NC_000016.10:46660188:G:T
NM_018206.6(VPS35):c.*289C>T	VPS35		Parkinson disease 17	Likely benign(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000886611	16	46694095	16	46660183	886611	875293	rs145606241	NC_000016.10:46660182:G:A
NM_018206.6(VPS35):c.*345T>G	VPS35		Parkinson disease 17	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000886610	16	46694039	16	46660127	886610	875292	rs1006640513	NC_000016.10:46660126:A:C
NM_018206.6(VPS35):c.505G>C (p.Asp169His)	VPS35	D169H	Parkinson disease 17	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000885653	16	46714584	16	46680672	885653	875304	rs1434089382	NC_000016.10:46680671:C:G
NM_018206.6(VPS35):c.648G>A (p.Leu216=)	VPS35		Parkinson disease 17	Conflicting interpretations of pathogenicity(Last reviewed: Dec 9, 2021)	criteria provided, conflicting interpretations	VCV000885652	16	46712927	16	46679015	885652	875303	rs763697798	NC_000016.10:46679014:C:T
NM_018206.6(VPS35):c.*422C>A	VPS35		Parkinson disease 17	Benign(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000885588	16	46693962	16	46660050	885588	875291	rs181198454	NC_000016.10:46660049:G:T
NM_018206.6(VPS35):c.*575A>T	VPS35		Parkinson disease 17	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000885587	16	46693809	16	46659897	885587	875290	rs768759859	NC_000016.10:46659896:T:A
NM_018206.6(VPS35):c.1268C>T (p.Pro423Leu)	VPS35	P423L	Parkinson disease 17	Benign(Last reviewed: Apr 28, 2017)	criteria provided, single submitter	VCV000884714	16	46706277	16	46672365	884714	875302	rs373075116	NC_000016.10:46672364:G:A
NM_018206.6(VPS35):c.1317T>C (p.Tyr439=)	VPS35		Parkinson disease 17	Likely benign(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000884713	16	46706228	16	46672316	884713	875301	rs187425753	NC_000016.10:46672315:A:G
NM_018206.6(VPS35):c.1525-5G>T	VPS35		Parkinson disease 17	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000884712	16	46702969	16	46669057	884712	876671	rs1966030456	NC_000016.10:46669056:C:A
NM_018206.6(VPS35):c.1809A>T (p.Ala603=)	VPS35		Parkinson disease 17	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000884711	16	46696913	16	46663001	884711	875300	rs142063738	NC_000016.10:46663000:T:A
NM_018206.6(VPS35):c.1151A>G (p.Asn384Ser)	VPS35	N384S	Parkinson disease 17	Uncertain significance(Last reviewed: Mar 7, 2019)	criteria provided, single submitter	VCV000855930	16	46708235	16	46674323	855930	843874	rs762573165	NC_000016.10:46674322:T:C
NM_018206.6(VPS35):c.1480T>A (p.Phe494Ile)	VPS35	F494I	Parkinson disease 17	Uncertain significance(Last reviewed: Jan 16, 2019)	criteria provided, single submitter	VCV000838576	16	46705661	16	46671749	838576	843873	rs141253289	NC_000016.10:46671748:A:T
NM_018206.6(VPS35):c.2145A>G (p.Leu715=)	VPS35		Parkinson disease 17|not provided	Benign/Likely benign(Last reviewed: Sep 10, 2018)	criteria provided, multiple submitters, no conflicts	VCV000707481	16	46695696	16	46661784	707481	693878	rs145033509	NC_000016.10:46661783:T:C
NM_018206.6(VPS35):c.1020A>G (p.Gln340=)	VPS35		Parkinson disease 17	Likely benign(Last reviewed: Dec 31, 2019)	criteria provided, single submitter	VCV000704463	16	46708366	16	46674454	704463	693881	rs188883365	NC_000016.10:46674453:T:C
NM_018206.6(VPS35):c.834T>C (p.Thr278=)	VPS35		Parkinson disease 17|not provided	Benign(Last reviewed: Sep 3, 2021)	criteria provided, multiple submitters, no conflicts	VCV000704148	16	46710575	16	46676663	704148	693882	rs148572750	NC_000016.10:46676662:A:G
NM_018206.6(VPS35):c.1398G>A (p.Thr466=)	VPS35		Parkinson disease 17|not provided	Benign(Last reviewed: Jul 31, 2021)	criteria provided, single submitter	VCV000703950	16	46705743	16	46671831	703950	693880	rs150810185	NC_000016.10:46671830:C:T
NM_018206.6(VPS35):c.915-3del	VPS35		Parkinson disease 17|not provided	Benign(Last reviewed: Aug 5, 2020)	criteria provided, single submitter	VCV000703789	16	46708575	16	46674663	703789	695697	rs569369937	NC_000016.10:46674662:AAAAAAAAAAAAAA:AAAAAAAAAAAAA
NM_018206.6(VPS35):c.1420C>G (p.Gln474Glu)	VPS35	Q474E	Parkinson disease 17	Conflicting interpretations of pathogenicity(Last reviewed: Jun 22, 2019)	criteria provided, conflicting interpretations	VCV000651640	16	46705721	16	46671809	651640	644687	rs370401767	NC_000016.10:46671808:G:C
NM_018206.6(VPS35):c.1550T>G (p.Phe517Cys)	VPS35	F517C	Parkinson disease 17	Uncertain significance(Last reviewed: Feb 27, 2018)	criteria provided, single submitter	VCV000579180	16	46702939	16	46669027	579180	570298	rs1567264486	NC_000016.10:46669026:A:C
NM_018206.6(VPS35):c.1313G>A (p.Cys438Tyr)	VPS35	C438Y	Parkinson disease 17	Uncertain significance(Last reviewed: May 7, 2018)	criteria provided, single submitter	VCV000571710	16	46706232	16	46672320	571710	570197	rs745893720	NC_000016.10:46672319:C:T
NM_018206.6(VPS35):c.945A>T (p.Gly315=)	VPS35		Parkinson disease 17|not provided	Likely benign(Last reviewed: Oct 1, 2021)	criteria provided, multiple submitters, no conflicts	VCV000539748	16	46708542	16	46674630	539748	530114	rs144346159	NC_000016.10:46674629:T:A
NM_018206.6(VPS35):c.2359G>A (p.Glu787Lys)	VPS35	E787K	Parkinson disease 17	Uncertain significance(Last reviewed: Apr 19, 2017)	no assertion criteria provided	VCV000487679	16	46694416	16	46660504	487679	480750	rs777050595	NC_000016.10:46660503:C:T
NM_018206.6(VPS35):c.2320C>A (p.Leu774Met)	VPS35	L774M	not provided|Parkinson disease 17	Uncertain significance(Last reviewed: Jan 1, 2021)	criteria provided, multiple submitters, no conflicts	VCV000487678	16	46694455	16	46660543	487678	480751	rs192419029	NC_000016.10:46660542:G:T
NM_018206.6(VPS35):c.2210C>T (p.Ala737Val)	VPS35	A737V	Parkinson disease 17	Uncertain significance(Last reviewed: Oct 28, 2021)	criteria provided, single submitter	VCV000487677	16	46695631	16	46661719	487677	480752	rs749516404	NC_000016.10:46661718:G:A
NM_018206.6(VPS35):c.1819A>G (p.Met607Val)	VPS35	M607V	Parkinson disease 17	Uncertain significance(Last reviewed: Apr 19, 2017)	no assertion criteria provided	VCV000487676	16	46696903	16	46662991	487676	480753	rs1555523076	NC_000016.10:46662990:T:C
NM_018206.6(VPS35):c.1796A>G (p.His599Arg)	VPS35	H599R	Parkinson disease 17	Uncertain significance(Last reviewed: Apr 19, 2017)	no assertion criteria provided	VCV000487675	16	46696926	16	46663014	487675	480754	rs1434487321	NC_000016.10:46663013:T:C
NM_018206.6(VPS35):c.1679T>C (p.Ile560Thr)	VPS35	I560T	Parkinson disease 17	Uncertain significance(Last reviewed: Apr 19, 2017)	no assertion criteria provided	VCV000487674	16	46697043	16	46663131	487674	480755	rs760128592	NC_000016.10:46663130:A:G
NM_018206.6(VPS35):c.1570C>T (p.Arg524Trp)	VPS35	R524W	Parkinson disease 17	Uncertain significance(Last reviewed: Apr 19, 2017)	no assertion criteria provided	VCV000487673	16	46702919	16	46669007	487673	480756	rs184277092	NC_000016.10:46669006:G:A
NM_018206.6(VPS35):c.1520A>T (p.Tyr507Phe)	VPS35	Y507F	Parkinson disease 17	Uncertain significance(Last reviewed: Apr 19, 2017)	no assertion criteria provided	VCV000487672	16	46705621	16	46671709	487672	480757	rs1555465749	NC_000016.10:46671708:T:A
NM_018206.6(VPS35):c.946C>T (p.Pro316Ser)	VPS35	P316S	Parkinson disease 17	Uncertain significance(Last reviewed: Apr 19, 2017)	no assertion criteria provided	VCV000487671	16	46708541	16	46674629	487671	480758	rs770029606	NC_000016.10:46674628:G:A
NM_018206.6(VPS35):c.723T>G (p.Ile241Met)	VPS35	I241M	Parkinson disease 17	Uncertain significance(Last reviewed: Apr 19, 2017)	no assertion criteria provided	VCV000487670	16	46711308	16	46677396	487670	480759	rs192783364	NC_000016.10:46677395:A:C
NM_018206.6(VPS35):c.171G>A (p.Met57Ile)	VPS35	M57I	Parkinson disease 17	Uncertain significance(Last reviewed: Apr 19, 2017)	no assertion criteria provided	VCV000487669	16	46716019	16	46682107	487669	480760	rs183554824	NC_000016.10:46682106:C:T
NM_018206.6(VPS35):c.151G>A (p.Gly51Ser)	VPS35	G51S	Parkinson disease 17	Benign(Last reviewed: Oct 7, 2020)	criteria provided, single submitter	VCV000487668	16	46716039	16	46682127	487668	480761	rs193077277	NC_000016.10:46682126:C:T
NM_018206.6(VPS35):c.1938= (p.His646=)	VPS35		Parkinson disease 17	Benign(Last reviewed: Dec 29, 2019)	criteria provided, single submitter	VCV000472501	16	46696284	16	46662372	472501	466454	rs168745	NC_000016.10:46662371:G:G
NM_018206.6(VPS35):c.1881C>T (p.Ala627=)	VPS35		Parkinson disease 17	Likely benign(Last reviewed: Dec 31, 2019)	criteria provided, single submitter	VCV000472500	16	46696341	16	46662429	472500	466705	rs138794859	NC_000016.10:46662428:G:A
NM_018206.6(VPS35):c.1391T>C (p.Val464Ala)	VPS35	V464A	Parkinson disease 17	Uncertain significance(Last reviewed: Jan 27, 2017)	criteria provided, single submitter	VCV000472499	16	46705750	16	46671838	472499	466476	rs1555465774	NC_000016.10:46671837:A:G
NM_018206.6(VPS35):c.959C>T (p.Ala320Val)	VPS35	A320V	Parkinson disease 17|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Oct 13, 2020)	criteria provided, conflicting interpretations	VCV000450710	16	46708528	16	46674616	450710	445582	rs747944333	NC_000016.10:46674615:G:A
NM_018206.6(VPS35):c.-35C>T	VPS35		Parkinson disease 17	Likely benign(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000319299	16	46723080	16	46689168	319299	325368	rs189775907	NC_000016.10:46689167:G:A
NM_018206.6(VPS35):c.-19C>T	VPS35		Parkinson disease 17	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000319297	16	46723064	16	46689152	319297	325366	rs573920049	NC_000016.10:46689151:G:A
NM_018206.6(VPS35):c.89T>A (p.Met30Lys)	VPS35	M30K	Parkinson disease 17	Uncertain significance(Last reviewed: Sep 4, 2021)	criteria provided, multiple submitters, no conflicts	VCV000319296	16	46717433	16	46683521	319296	335061	rs145147781	NC_000016.10:46683520:A:T
NM_018206.6(VPS35):c.678C>T (p.Arg226=)	VPS35		not provided|Parkinson disease 17	Likely benign(Last reviewed: Sep 11, 2018)	criteria provided, multiple submitters, no conflicts	VCV000319295	16	46712897	16	46678985	319295	341511	rs376845827	NC_000016.10:46678984:G:A
NM_018206.6(VPS35):c.851G>A (p.Arg284Gln)	VPS35	R284Q	Parkinson disease 17	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000319294	16	46710558	16	46676646	319294	343010	rs771276024	NC_000016.10:46676645:C:T
NM_018206.6(VPS35):c.1035G>A (p.Glu345=)	VPS35		not provided|Parkinson disease 17	Conflicting interpretations of pathogenicity(Last reviewed: May 29, 2018)	criteria provided, conflicting interpretations	VCV000319293	16	46708351	16	46674439	319293	335043	rs563975281	NC_000016.10:46674438:C:T
NM_018206.6(VPS35):c.1145A>G (p.Lys382Arg)	VPS35	K382R	not provided|Parkinson disease 17	Benign(Last reviewed: Jun 10, 2020)	criteria provided, multiple submitters, no conflicts	VCV000319292	16	46708241	16	46674329	319292	325362	rs116254156	NC_000016.10:46674328:T:C
NM_018206.6(VPS35):c.1488T>C (p.His496=)	VPS35		Parkinson disease 17	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000319291	16	46705653	16	46671741	319291	335042	rs776877370	NC_000016.10:46671740:A:G
NM_018206.6(VPS35):c.1912A>T (p.Met638Leu)	VPS35	M638L	Parkinson disease 17	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000319290	16	46696310	16	46662398	319290	341506	rs144997996	NC_000016.10:46662397:T:A
NM_018206.6(VPS35):c.2241C>T (p.Ile747=)	VPS35		not provided|Parkinson disease 17	Benign/Likely benign(Last reviewed: Jan 12, 2020)	criteria provided, multiple submitters, no conflicts	VCV000319289	16	46694534	16	46660622	319289	325360	rs140543776	NC_000016.10:46660621:G:A
NM_018206.6(VPS35):c.*258del	VPS35		Parkinson Disease, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000319288	16	46694126	16	46660214	319288	341504	rs886052012	NC_000016.10:46660213:C:
NM_018206.6(VPS35):c.*259_*260dup	VPS35		Parkinson Disease, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000319287	16	46694123 - 46694124	16	46660211 - 46660212	319287	335039	rs886052011	NC_000016.10:46660211:TA:TATA
NM_018206.6(VPS35):c.*275_*276insCAA	VPS35		Parkinson Disease, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000319286	16	46694108 - 46694109	16	46660196 - 46660197	319286	343006	rs886052010	NC_000016.10:46660196:TT:TTGTT
NM_018206.6(VPS35):c.*276A>C	VPS35		Parkinson disease 17	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000319285	16	46694108	16	46660196	319285	341503	rs886052009	NC_000016.10:46660195:T:G
NM_018206.6(VPS35):c.*276_*277insCAA	VPS35		Parkinson Disease, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000319284	16	46694107 - 46694108	16	46660195 - 46660196	319284	341499	rs886052008	NC_000016.10:46660195:TT:TTGTT
NM_018206.6(VPS35):c.*277_*278insCA	VPS35		Parkinson Disease, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000319283	16	46694106 - 46694107	16	46660194 - 46660195	319283	325358	rs886052007	NC_000016.10:46660194:T:TGT
NM_018206.6(VPS35):c.*278_*279insCAA	VPS35		Parkinson Disease, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000319282	16	46694105 - 46694106	16	46660193 - 46660194	319282	343005	rs575317929	NC_000016.10:46660193:TT:TTGTT
NM_018206.6(VPS35):c.*279_*280insCAAA	VPS35		Parkinson Disease, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000319281	16	46694104 - 46694105	16	46660192 - 46660193	319281	343001	rs886052006	NC_000016.10:46660192:TTT:TTTGTTT
NM_018206.6(VPS35):c.*281delinsAAAAA	VPS35		Parkinson Disease, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000319280	16	46694103	16	46660191	319280	325355	rs1555522775	NC_000016.10:46660190:G:TTTTT
NM_018206.6(VPS35):c.*281delinsAAAA	VPS35		Parkinson Disease, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000319279	16	46694103	16	46660191	319279	342998	rs1555522775	NC_000016.10:46660190:G:TTTT
NM_018206.6(VPS35):c.*283del	VPS35		not provided|Parkinson Disease, Dominant	Conflicting interpretations of pathogenicity(Last reviewed: Sep 2, 2019)	criteria provided, conflicting interpretations	VCV000319278	16	46694101	16	46660189	319278	325357	rs886052005	NC_000016.10:46660188:G:
NM_018206.6(VPS35):c.*281CA[1]	VPS35		Parkinson Disease, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000319277	16	46694100 - 46694101	16	46660188 - 46660189	319277	342996	rs879039152	NC_000016.10:46660187:TGTGT:TGT
NM_018206.6(VPS35):c.*285_*287dup	VPS35		Parkinson Disease, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000319276	16	46694096 - 46694097	16	46660184 - 46660185	319276	342992	rs369068093	NC_000016.10:46660184:TTTT:TTTTTTT
NM_018206.6(VPS35):c.*287dup	VPS35		Parkinson Disease, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000319275	16	46694096 - 46694097	16	46660184 - 46660185	319275	342995	rs369068093	NC_000016.10:46660184:TTTT:TTTTT
NM_018206.6(VPS35):c.*287_*288insAAAC	VPS35		Parkinson Disease, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000319274	16	46694096 - 46694097	16	46660184 - 46660185	319274	335036	rs1555522760	NC_000016.10:46660184::GTTT
NM_018206.6(VPS35):c.*287_*288insAAC	VPS35		Parkinson Disease, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000319273	16	46694096 - 46694097	16	46660184 - 46660185	319273	342991	rs1555522760	NC_000016.10:46660184::GTT
NM_018206.6(VPS35):c.*346G>A	VPS35		Parkinson disease 17	Benign(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000319272	16	46694038	16	46660126	319272	342990	rs545755034	NC_000016.10:46660125:C:T
NM_018206.6(VPS35):c.*354G>C	VPS35		Parkinson disease 17	Benign(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000319271	16	46694030	16	46660118	319271	342989	rs572048744	NC_000016.10:46660117:C:G
NM_018206.6(VPS35):c.*380G>A	VPS35		Parkinson disease 17	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000319270	16	46694004	16	46660092	319270	341497	rs886052004	NC_000016.10:46660091:C:T
NM_018206.6(VPS35):c.*401G>A	VPS35		Parkinson disease 17	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000319269	16	46693983	16	46660071	319269	342987	rs553790361	NC_000016.10:46660070:C:T
NM_018206.6(VPS35):c.*617A>G	VPS35		Parkinson disease 17	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000319268	16	46693767	16	46659855	319268	341495	rs746602580	NC_000016.10:46659854:T:C
NM_018206.6(VPS35):c.*761_*762dup	VPS35		Parkinson Disease, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000319267	16	46693621 - 46693622	16	46659709 - 46659710	319267	335034	rs34926621	NC_000016.10:46659709:AAAAAAAAAAA:AAAAAAAAAAAAA
NM_018206.6(VPS35):c.*762dup	VPS35		Parkinson Disease, Dominant	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000319266	16	46693621 - 46693622	16	46659709 - 46659710	319266	341491	rs34926621	NC_000016.10:46659709:AAAAAAAAAAA:AAAAAAAAAAAA
NM_014321.4(ORC6):c.-47G>A	VPS35|ORC6		Parkinson Disease, Dominant|Meier-Gorlin syndrome 3|Meier-Gorlin syndrome|not specified	Conflicting interpretations of pathogenicity(Last reviewed: Jan 13, 2018)	criteria provided, conflicting interpretations	VCV000260387	16	46723571	16	46689659	260387	255744	rs144065502	NC_000016.10:46689658:G:A
NM_014321.4(ORC6):c.-20T>C	VPS35|ORC6		not specified|Meier-Gorlin syndrome 3|Meier-Gorlin syndrome|Parkinson Disease, Dominant	Benign(Last reviewed: Sep 5, 2021)	criteria provided, multiple submitters, no conflicts	VCV000260386	16	46723598	16	46689686	260386	255745	rs33994299	NC_000016.10:46689685:T:C
NM_018206.6(VPS35):c.1576C>T (p.Arg526Cys)	VPS35	R526C	Parkinson disease, late-onset	Uncertain significance(Last reviewed: Jan 22, 2014)	no assertion criteria provided	VCV000096727	16	46702913	16	46669001	96727	102613	rs398124658	NC_000016.10:46669000:G:A
NM_018206.6(VPS35):c.1858G>A (p.Asp620Asn)	VPS35	D620N	Parkinson disease 17	Pathogenic(Last reviewed: Apr 19, 2017)	no assertion criteria provided	VCV000030196	16	46696364	16	46662452	30196	39152	rs188286943	NC_000016.10:46662451:C:T
NM_007013.4(WWP1):c.1879A>T (p.Met627Leu)	WWP1	M627L	Wolff-Parkinson-White pattern	Uncertain significance(Last reviewed: Jul 14, 2017)	no assertion criteria provided	VCV000487621	8	87454888	8	86442659	487621	480701	rs773370868	NC_000008.11:86442658:A:T
